Disease,NCT Number,Study Title,Study URL,Study Results,Conditions,Interventions,Sex,Age,Phases,Locations,Principal_Investigators
Epilepsy,NCT02269137,Assessment of Severity and Prognosis for Patients With Status Epileptics(SE),https://clinicaltrials.gov/study/NCT02269137,NO,Status Epileptics,,ALL,"CHILD, ADULT, OLDER_ADULT",,"The Department of Neurology, Xijing Hospital, Xi'an, Shaanxi, 710032, China","Study Director : Wen Jiang, MD , The Department of Neurology, Xijing Hospital"
Epilepsy,NCT02560597,Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy,https://clinicaltrials.gov/study/NCT02560597,NO,Epilepsia Partialis Continua|Status Epilepticus,PROCEDURE: repetitive transcranial magnetic stimulation,ALL,"ADULT, OLDER_ADULT",,"University Hospital, Ghent, Ghent, 9000, Belgium","Principal Investigator : Alfred Meurs, MD, PhD , University Hospital, Ghent"
Epilepsy,NCT03154307,Repeated TMS at Low Frequencies to Reduce Seizure Occurrence,https://clinicaltrials.gov/study/NCT03154307,YES,"Epilepsy|Status Epilepticus|Epilepsia Partialis Continua|Epilepsia Partialis Continua, Refractory (Medically)",DEVICE: Low frequency repeated TMS (LF-rTMS),ALL,"ADULT, OLDER_ADULT",,"Baptist Hospital of Miami, Miami, Florida, 33176, United States","Principal Investigator : Alberto Pinzon, M.D., Ph.D. , Baptist Health South Florida"
Epilepsy,NCT02968966,Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies,https://clinicaltrials.gov/study/NCT02968966,NO,"Seizure, Epileptic",OTHER: Therapy regime,ALL,CHILD,PHASE2,"Universtiy Hospital, TÃ¼bingen, 72076, Germany","Principal Investigator : Markus Wolff, Dr. , University Children's Hospital TÃ¼bingen"
Epilepsy,NCT05459597,Antiepileptic Drugs in Elderly Patients,https://clinicaltrials.gov/study/NCT05459597,NO,"Seizure, Epileptic",DRUG: antiepileptic drugs,ALL,OLDER_ADULT,,"Wei Zhao, Jinan, Shandong, China","Study Chair : Wei Zhao , Qianfoshan Hospital"
Epilepsy,NCT01116700,Dexmedetomidine in Seizure Patients,https://clinicaltrials.gov/study/NCT01116700,NO,Seizure Disorders,DRUG: Dexmedetomidine,ALL,"ADULT, OLDER_ADULT",PHASE1,"University of California San Francisco, San Francisco, California, 94122, United States","Principal Investigator : Alana M Flexman, MD , UCSF Department of Anesthesia Principal Investigator : Pekka Talke, MD , UCSF Department of Anesthesia Principal Investigator : Paul Garcia, MD , UCSF Department of Neurology"
Epilepsy,NCT05431595,Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy,https://clinicaltrials.gov/study/NCT05431595,NO,Delirium|Epileptics|Neuroleptics,DRUG: Haloperidol|DRUG: Chlorpromazine|DRUG: Valproate|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"MD Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : David Hui, MD , M.D. Anderson Cancer Center"
Epilepsy,NCT03860467,Epileptic Seizures in Intensive Care Units,https://clinicaltrials.gov/study/NCT03860467,NO,Epileptic Seizure,OTHER: collection of patient data,ALL,"ADULT, OLDER_ADULT",,"Clinic for Intensive Care Medicine, University Hospital Basel, Basel, 4031, Switzerland","Principal Investigator : Raoul Sutter, PD Dr. med , Clinic for Intensive Care Medicine, University Hospital Basel"
Epilepsy,NCT02229318,A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.,https://clinicaltrials.gov/study/NCT02229318,YES,Seizure Disorders,DIETARY_SUPPLEMENT: FruitiVits,ALL,CHILD,,"The Children's Hospital of Philadelphia, Division of Neurology, Philadelphia, Pennsylvania, 19104, United States","Principal Investigator : Christina Bergqvist, M.D , Children's Hospital of Philadelphia"
Epilepsy,NCT01159431,External Trigeminal Nerve Stimulation for Epilepsy,https://clinicaltrials.gov/study/NCT01159431,YES,Epilepsy|Seizure Disorders,DEVICE: Trigeminal Nerve Stimulation,ALL,"ADULT, OLDER_ADULT",PHASE2,"USC Department of Neurology, Los Angeles, California, 90033, United States|Olive View/UCLA Medical Center, Sylmar, California, 91342, United States","Principal Investigator : Christopher M DeGiorgio, MD , UCLA Department of Neurology Principal Investigator : Christi Heck, MD , University of Southern California"
Epilepsy,NCT02304029,Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy,https://clinicaltrials.gov/study/NCT02304029,NO,Epileptic Seizures,DEVICE: MRI,ALL,"ADULT, OLDER_ADULT",,"Assistance Publique - Hopitaux de Marseille, Marseille, 13005, France|CHU Montpellier, Montpellier, France|CHU NICE, Nice, France|CHU Nimes, Nimes, France",
Epilepsy,NCT05567042,A Clinical Study of Epilepsy Localization and Prognosis Based on PET and Resting-state fMRI,https://clinicaltrials.gov/study/NCT05567042,NO,Epileptic Seizure,OTHER: No intervention,ALL,"CHILD, ADULT, OLDER_ADULT",,,
Epilepsy,NCT01351727,Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors,https://clinicaltrials.gov/study/NCT01351727,NO,Epileptic Seizures,,ALL,OLDER_ADULT,,"Pima, Cochise, Santa Cruz Counties, Tucson, Arizona, 85724, United States",
Epilepsy,NCT02134366,Clobazam Use in Epilepsia Partialis Continua - Pilot Study,https://clinicaltrials.gov/study/NCT02134366,NO,Epilepsia Partialis Continua|Kojewnikov's Epilepsy|Epilepsy,DRUG: Clobazam|DRUG: Clonazepam|DRUG: Lorazepam,ALL,"ADULT, OLDER_ADULT",PHASE3,"Cooper Universtiy Hospital, Camden, New Jersey, 08103, United States","Principal Investigator : Melissa Carran, MD , Cooper University Health System"
Epilepsy,NCT04204863,Status Epilepticus Population Study (STEPS),https://clinicaltrials.gov/study/NCT04204863,NO,Epileptic Seizures,OTHER: collection of patient data,ALL,"ADULT, OLDER_ADULT",,"Cantonal Hospital Aarau (KSA), Aarau, 5001, Switzerland|Clinic for Intensive Care Medicine, University Hospital Basel, Basel, 4031, Switzerland","Principal Investigator : Raoul Sutter, PD Dr. med , Clinic for Intensive Care Medicine, University Hospital Basel"
Epilepsy,NCT05725174,Volatile Non-Invasive Biomarkers of Epileptic Seizures,https://clinicaltrials.gov/study/NCT05725174,NO,Epilepsy|Non-Epileptic Seizure,OTHER: Sample Collection,ALL,"ADULT, OLDER_ADULT",,"Chalfont Centre for Epilepsy, London, Buckinghamshire, SL9 0RJ, United Kingdom|National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, United Kingdom","Principal Investigator : Matthew Walker, MB BChir FRCP , Professor"
Epilepsy,NCT05241366,TMS vs Conventional Therapy for the Treatment of Functional Neurological Non Epileptic Seizure Disorder,https://clinicaltrials.gov/study/NCT05241366,NO,Psychogenic Non-Epileptic Seizure,DEVICE: Transcranial Magnetic Stimulation|DEVICE: Sham Transcranial Magnetic Stimulation coil,ALL,"ADULT, OLDER_ADULT",,"Instituto Nacional de Neurologia Y Neurocirugia Mvs, Mexico, Ciudad De Mexico, 14269, Mexico","Principal Investigator : Ã‰dgar Daniel Crail MelÃ©ndez, MD , Instituto Nacional de NeurologÃ­a y NeurocirugÃ­a Manuel Velasco SuÃ¡rez"
Epilepsy,NCT01313260,Structural and Functional Connectivity in Partial Epilepsies Studied With MRI and MEG,https://clinicaltrials.gov/study/NCT01313260,NO,Epilepsies,,ALL,ADULT,,"ICM (Brain and Spine Institute), Paris, 75013, France","Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France"
Epilepsy,NCT04572243,A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome,https://clinicaltrials.gov/study/NCT04572243,NO,"Epilepsies, Myoclonic",DRUG: Placebo|DRUG: Lorcaserin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Children's of Alabama / University of Alabama at Birmingham, Birmingham, Alabama, 35226, United States|University of California Los Angeles (UCLA), Los Angeles, California, 90095, United States|UCSD Rady's Children's Hosptial, San Diego, California, 92123, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Northwest Florida Clinical Research Group, Gulf Breeze, Florida, 32561, United States|Joe DiMaggio Children's Hospital, Hollywood, Florida, 33021, United States|Miami Children's Hospital - Nicklaus Children's Hospital, Miami, Florida, 33155, United States|Pediatric Neurology, P.A., Winter Park, Florida, 32789, United States|Rare Disease Research Center Pediatrics, LLC, Atlanta, Georgia, 30318, United States|Mid-Atlantic Epilepsy and Sleep Center - Bethesda, Bethesda, Maryland, 20817, United States|Spectrum Health/ Helen DeVos Children's Hospital, Grand Rapids, Michigan, 49503, United States|University of Missouri, Department of Child Health, Division of Neurology, Columbia, Missouri, 65201, United States|Institute of Neurology and Neurosurgery at Saint Barnabas, Livingston, New Jersey, 07039, United States|Northwell Health - Neuroscience Institute at Great Neck, New Hyde Park, New York, 10075, United States|NYU Langone Comprehensive Epilepsy Center, New York, New York, 10016, United States|New York Medical College, New York, New York, 10019-1147, United States|NorthWell Health - Lennox Hill Hospital, New York, New York, 11021, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|University of North Carolina, Chapel Hill, North Carolina, 27599-7025, United States|Duke University Hospital Center, Durham, North Carolina, 27710, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|MultiCare Institute for Research & Innovation, Tacoma, Washington, 98405, United States|Alberta Children's Hospital, Calgary, Alberta, AB T3B 6A8, Canada|Stollery Children's Hospital, Edmonton, Alberta, T6G 1C9, Canada|BC Children's Hospital, Vancouver, British Columbia, V6H 3N1, Canada|Children's Hospital - VH, London Health Sciences Centre, London, Ontario, N6A 4G5, Canada|University of Toronto Division of Hematology Oncology/The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada",Eisai Inc.
Epilepsy,NCT06143241,Cognitive Function and Glymphatic System in Children With Epilepsy,https://clinicaltrials.gov/study/NCT06143241,NO,"Epilepsy|Cognitive Dysfunction|Seizure, Epileptic",DEVICE: Threshold IMT|DRUG: Antiepileptic medication,ALL,CHILD,,"Ege University, Izmir, Bornova, 35080, Turkey",Ege University
Epilepsy,NCT01450423,Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy,https://clinicaltrials.gov/study/NCT01450423,NO,Epilepsy|Epilepsia|Epileptic Seizures|Seizure Disorder,BEHAVIORAL: Physical activity,ALL,"CHILD, ADULT",PHASE2,"Center of Research in Childhood Health, University of Southern Denmark, Odense, Region of Southern Denmark, 5000, Denmark|Epilepsy clinic, Odense University Hospital, Odense, Region of Southern Denmark, 5000, Denmark","Principal Investigator : Lars Bo Andersen, Professor , Center of Research in Childhood Health (RICH), University of Southern Denmark"
Epilepsy,NCT03329703,Project UPLIFT for Psychogenic Non-Epileptic Seizures,https://clinicaltrials.gov/study/NCT03329703,NO,Psychogenic Non-Epileptic Seizure|Depression|Non-Epileptic Seizure|Psychogenic Seizure,BEHAVIORAL: Project UPLIFT,ALL,"ADULT, OLDER_ADULT",,"Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States","Principal Investigator : Lindsay Schommer, APRN , Dartmouth-Hitchcock Medical Center"
Epilepsy,NCT04061707,Subcutaneous EEG: Forecasting of Epileptic Seizures,https://clinicaltrials.gov/study/NCT04061707,NO,"Epilepsies, Focal",,ALL,"ADULT, OLDER_ADULT",,"King's College Hospital NHS Foundation Trust, London, SE5 9RS, United Kingdom","Principal Investigator : Mark P Richardson, BM FRCP PhD , King's College London"
Epilepsy,NCT01978470,External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy,https://clinicaltrials.gov/study/NCT01978470,NO,Seizure Disorder,DEVICE: External Trigeminal Nerve Stimulation (eTNS),ALL,"ADULT, OLDER_ADULT",,"Olive View/UCLA Medical Center, Sylmar, California, United States",Olive View-UCLA Education & Research Institute
Epilepsy,NCT00542802,Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis,https://clinicaltrials.gov/study/NCT00542802,NO,Epileptic Seizures|Stroke,DRUG: Levetiracetam|DRUG: Carbamazepine,ALL,"ADULT, OLDER_ADULT",PHASE3,"Ospedale S. Giacomo, Novi Ligure, AL, 15057, Italy|Ospedale S. Croce E Carle, Cuneo, CN, 12100, Italy|Ospedale S. Martino, Genova, GE, 16132, Italy|Istituto Clinico Humanitas, Rozzano, MI, 20089, Italy|USL 2 Ospedale B.G. Villa, CittÃ della Pieve, PG, 06062, Italy|Ospedale Civile San Giovanni Battista di Foligno, Foligno, PG, Italy|Ospedale Santa Maria della Misericordia, Sant'Andrea delle Fratte, PG, 06131, Italy|Istituto Neurologico C. Mondino, Pavia, PV, 27100, Italy|Ospedale Guzzardi, Vittoria, RG, 97019, Italy|Ospedale Di Portogruaro, Portogruaro, VE, 30026, Italy|Ospedale Civile, Vibo Valentia, VV, 89900, Italy|Policlinico Umberto I, Ancona, 60020, Italy|Ospedale A. Perrino, Brindisi, 72100, Italy|Ospedale Cannizzaro, Catania, 95126, Italy|Ospedale San Martino, Genova, Italy|Ospedale Civile Imperia ASL 1, Imperia, 18100, Italy|Ospedale A. Cardarelli-, Napoli, 80131, Italy|Ospedale Cardarelli, Napoli, 80131, Italy|Ospedale Civico, Palermo, 90100, Italy|Osp. Guglielmo da saliceto, Piacenza, 29100, Italy|Arcispedale S. Maria Nuova, Reggio Emilia, 42100, Italy|Ospedale SS. Annunziata - Ospedale Civile, Taranto, Italy|Ospedale Molinette-UniversitÃ di Torino, Torino, Italy|Azienda Ospedaliera Universitaria Trieste, Trieste, 34149, Italy","Principal Investigator : domenico consoli, doctor , Ospedale Civile Vibo Valentia"
Epilepsy,NCT02976545,Emotional Lived in Patients Suffering From Psychogenic Nonepileptic Seizures : Study by Functional Magnetic Resonance Imaging,https://clinicaltrials.gov/study/NCT02976545,NO,Psychogenic Non-epileptic Seizures,DEVICE: fMRI (functional Magnetic Resonance Imaging)|BEHAVIORAL: psychiatric evaluation,FEMALE,"ADULT, OLDER_ADULT",,"CHRU de Nancy, Nancy, 54000, France","Central Hospital, Nancy, France"
Epilepsy,NCT06374966,Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy,https://clinicaltrials.gov/study/NCT06374966,NO,"Epilepsies, Partial",DRUG: Zonisamide,ALL,"CHILD, ADULT, OLDER_ADULT",,"Hangzhou Children's Hospital, Hangzhou, Zhejiang, 310005, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China|Huzhou Third People's Hospital, Huzhou, Zhejiang, 313002, China|Jiaxing Second hospital, Jiaxing, Zhejiang, 314099, China|Jinhua Second hospital, Jinhua, Zhejiang, 321016, China|The Fourth Affilicated Hospital of Zhejiang University School of Medicine, Jinhua, Zhejiang, 322099, China|Lishui People's Hospital, Lishui, Zhejiang, 323050, China|Ningbo Women And Children's Hospital, Ningbo, Zhejiang, 315012, China|Ningbo Medical center Lihuili hospital, Ningbo, Zhejiang, 315048, China|Yuyao People's hospital, Yuyao, Zhejiang, 315499, China","Principal Investigator : Shuang Wang, doctorate , Second Affiliated Hospital, School of Medicine, Zhejiang University"
Epilepsy,NCT05958069,The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients,https://clinicaltrials.gov/study/NCT05958069,NO,Epileptic Seizures Related to Drugs,DRUG: minocycline,ALL,"CHILD, ADULT, OLDER_ADULT",,"XijingHospital, Xi'an, Shaanxi, 710032, China","Study Chair : Wen jiang , The First Affiliated Hospital of Air Force Military Medical University Principal Investigator : Lei Ma , The First Affiliated Hospital of Air Force Military Medical University Principal Investigator : yuanyuan Wang , XijingHospital Principal Investigator : mengmeng Hu , XijingHospital"
Epilepsy,NCT05419180,Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies,https://clinicaltrials.gov/study/NCT05419180,NO,Pharmacoresistant Focal Epilepsies,DRUG: Stiripentol,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Centre de RÃ©fÃ©rence Epilepsies Rares / Centre Investigation Clinique (CIC) - HÃ´pital Necker-Enfants Malades, Paris, 75015, France",Biocodex
Epilepsy,NCT03533374,Validation of Criteria for Identification of Epileptiform Discharges in EEG Recordings of Patients With Epilepsy,https://clinicaltrials.gov/study/NCT03533374,YES,Epilepsy|Non-Epileptic Seizure,DIAGNOSTIC_TEST: Electroencephalogram (EEG) and visual evaluation,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Aarhus University Hospital Central Denmark Region Filadelfia Epilepsy Hospital University Health Network, Toronto University Hospital Erlangen Oslo University Hospital Show fewer collaborators"
Epilepsy,NCT04309812,Transcranial Direct Current to Treat Epilepsy at Home,https://clinicaltrials.gov/study/NCT04309812,NO,"Epilepsies, Partial",DEVICE: transcranial direct current stimulation (tDCS),ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Stanford Hospital, Stanford, California, 94305-5235, United States|Stanford University School of Medicine, Stanford, California, 94305-5235, United States",Stanford University
Epilepsy,NCT06222840,Electro-clinical Features and Functional Connectivity Analysis in SYN1 Gene Mutation-related Epilepsy,https://clinicaltrials.gov/study/NCT06222840,NO,Epileptic Syndromes,OTHER: Electro-clinical analysis of epileptic seizures|OTHER: Electro-encephalographic cases|OTHER: Clinical datas analysis|OTHER: Electro-encephalographic control,ALL,"CHILD, ADULT, OLDER_ADULT",,"CHU Saint Etienne, Saint-Ã‰tienne, 42000, France","Principal Investigator : Laure MAZZOLA, MD , CHU Saint Etienne"
Epilepsy,NCT01663545,Brain P-gp and Inflammation in People With Epilepsy,https://clinicaltrials.gov/study/NCT01663545,NO,"Epilepsies, Partial",,ALL,ADULT,,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States","Principal Investigator : William H Theodore, M.D. , National Institute of Neurological Disorders and Stroke (NINDS)"
Epilepsy,NCT03054961,Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study,https://clinicaltrials.gov/study/NCT03054961,NO,"Epilepsies, Partial",DEVICE: Near-infrared spectroscopy,ALL,"CHILD, ADULT, OLDER_ADULT",,"The Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States","Principal Investigator : Rene Andrade-Machado, MD , Medical College of Wisconsin"
Epilepsy,NCT06223334,Epileptic Syndromes in Infants and Early Childhood,https://clinicaltrials.gov/study/NCT06223334,NO,Epileptic Syndromes,OTHER: No intervention,ALL,CHILD,,"Assiut child university hospital, Assiut, 71515, Egypt|AlAzhar university hospital Assiut branch, Assiut, 71524, Egypt",
Epilepsy,NCT03882151,Added Value of Automated Electrical Source Localization (EPILOG PreOpÂ®) to Presurgical Evaluation of Refractory Epilepsy,https://clinicaltrials.gov/study/NCT03882151,NO,"Epilepsies, Partial",DIAGNOSTIC_TEST: electrical source imaging,ALL,"CHILD, ADULT, OLDER_ADULT",,"Saint-Luc University Hospital, Brussels, 1200, Belgium|Centre Hospitalier William Lennox, Ottignies, 1340, Belgium",
Epilepsy,NCT03689114,"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)",https://clinicaltrials.gov/study/NCT03689114,NO,"Epilepsies, Partial",DRUG: Low dose carbamazepine|DRUG: Standard dose carbamazepine|DRUG: Low dose levetiracetam|DRUG: Standard dose levetiracetam|DRUG: Low dose valproate|DRUG: Standard dose valproate|DRUG: Low dose zonisamide|DRUG: Standard dose zonisamide|DRUG: Low dose oxcarbazepine|DRUG: Standard dose oxcarbazepine|DRUG: Low dose topiramate|DRUG: Standard dose topiramate|DRUG: Low dose lamotrigine|DRUG: Standard dose lamotrigine|DRUG: Low dose gabapentin|DRUG: Standard dose gabapentin,ALL,"ADULT, OLDER_ADULT",PHASE4,"ASST Monza Ospedale San Gerardo, Monza, 20900, Italy","Principal Investigator : Ettore Beghi, MD , Istituto di Ricerche Farmacologiche Mario Negri IRCCS"
Epilepsy,NCT03484039,Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy,https://clinicaltrials.gov/study/NCT03484039,NO,Epilepsy|Seizure Disorder,BEHAVIORAL: Medication Adherence|BEHAVIORAL: Seizure Documentation|BEHAVIORAL: Memory Improvement|BEHAVIORAL: Stress Management,ALL,"ADULT, OLDER_ADULT",,"UF Health Jacksonville, Jacksonville, Florida, 32209, United States","Principal Investigator : Ramon Edmundo D Bautista, MD , University of Florida"
Epilepsy,NCT01919307,Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures,https://clinicaltrials.gov/study/NCT01919307,YES,"Convulsion, Non-Epileptic",OTHER: Auricular acupuncture,ALL,"ADULT, OLDER_ADULT",,"Denver Health Medical Center, Denver, Colorado, 80204, United States","Principal Investigator : Edward Maa, MD , Denver Health"
Epilepsy,NCT05273398,Effects of Diazepam on RNS Detections,https://clinicaltrials.gov/study/NCT05273398,NO,"Epilepsies, Partial",DRUG: nasal diazepam,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Cincinnati, Cincinnati, Ohio, 45267, United States","Principal Investigator : Michael D Privitera , University of Cincinnati"
Epilepsy,NCT01762215,Policy on Optimal Epilepsy Management,https://clinicaltrials.gov/study/NCT01762215,NO,Epilepsy|Seizure Disorder,BEHAVIORAL: PatientsLikeMe.com,ALL,"ADULT, OLDER_ADULT",,"San Francisco VA Medical Center, San Francisco, California, 94121, United States","San Francisco Veterans Affairs Medical Center Veterans Administration Epilepsy Centers of Excellence (ECoE) University of California, San Francisco PatientsLikeMe UCB Pharma"
Epilepsy,NCT01745952,Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS),https://clinicaltrials.gov/study/NCT01745952,YES,"Epilepsies, Partial",DEVICE: figure-of-eight active rTMS coil|DEVICE: round active rTMS coil|DEVICE: sham rTMS coil (figure-of-eight),ALL,"CHILD, ADULT, OLDER_ADULT",,"University Hospitals Leuven, department of Neurology, Leuven, 3000, Belgium","Principal Investigator : Van Paesschen Wim, MD, PhD , Universitaire Ziekenhuizen KU Leuven"
Epilepsy,NCT02311829,Evaluation of a Telephone Follow-up Procedure on the Quality of Life in Psychogenic Non-epileptic Seizures,https://clinicaltrials.gov/study/NCT02311829,NO,Psychogenic Non Epileptic Seizure,OTHER: Telephone follow-up device,ALL,"ADULT, OLDER_ADULT",,"Chu Strasbourg, Strasbourg, Alsace, 67 098, France|Chu Dijon, Dijon, Bourgogne, 21 079, France|Chu Reims, Reims, Champagne Ardennes, 51 092, France|Chu Nancy, Nancy, Lorraine, 54 035, France","Principal Investigator : Louis MAILLARD, PU-PH, HDR , Central Hospital, Nancy, France"
Epilepsy,NCT02635633,"Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept",https://clinicaltrials.gov/study/NCT02635633,NO,"Epilepsies, Partial",DEVICE: continuous thetaburst stimulation,ALL,"ADULT, OLDER_ADULT",,"University Hospital Ghent, Ghent, 9000, Belgium","Principal Investigator : Kristl Vonck, MD, PhD , University Hospital, Ghent"
Epilepsy,NCT00179426,Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy,https://clinicaltrials.gov/study/NCT00179426,NO,Seizure Disorder|Epilepsy,,MALE,ADULT,,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States","Principal Investigator : Andrew G. Herzog, M.D., M.Sc. , Beth Israel Deaconess Medical Center"
Epilepsy,NCT00955357,Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures,https://clinicaltrials.gov/study/NCT00955357,YES,Partial Epilepsies,DRUG: Lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"103, Irvine, California, United States|123, Rancho Mirage, California, United States|156, Clearwater, Florida, United States|157, Destin, Florida, United States|140, Hollywood, Florida, United States|161, Ocala, Florida, United States|108, Atlanta, Georgia, United States|112, Atlanta, Georgia, United States|124, Augusta, Georgia, United States|115, Macon, Georgia, United States|118, Rome, Georgia, United States|128, Flossmoor, Illinois, United States|130, Des Moines, Iowa, United States|102, Bowling Green, Kentucky, United States|117, Paducah, Kentucky, United States|107, Houma, Louisiana, United States|145, Ruston, Louisiana, United States|101, Annapolis, Maryland, United States|162, Waldorf, Maryland, United States|153, Boston, Massachusetts, United States|136, Pittsfield, Massachusetts, United States|144, Springfield, Massachusetts, United States|151, Kansas City, Missouri, United States|114, Paterson, New Jersey, United States|109, Brooklyn, New York, United States|133, Brooklyn, New York, United States|127, West Seneca, New York, United States|158, Charlotte, North Carolina, United States|139, Bismarck, North Dakota, United States|134, Akron, Ohio, United States|150, Canton, Ohio, United States|141, Tulsa, Oklahoma, United States|121, Indiana, Pennsylvania, United States|120, Columbia, South Carolina, United States|149, Orangeburg, South Carolina, United States|152, Spartanburg, South Carolina, United States|148, Austin, Texas, United States|154, Dallas, Texas, United States|146, Tomball, Texas, United States|119, Fredericksburg, Virginia, United States|503, Wien, Austria|703, Blagoevrad, Bulgaria|706, Pleven, Bulgaria|700, Sofia, Bulgaria|702, Sofia, Bulgaria|704, Sofia, Bulgaria|705, Sofia, Bulgaria|707, Sofia, Bulgaria|708, Sofia, Bulgaria|701, Varna, Bulgaria|736, Hradec Kralove, Czechia|735, Litomerice, Czechia|732, Ostrava-Hrabuvka, Czechia|733, Ostrava, Czechia|737, Praha 11, Czechia|734, Trutnov, Czechia|930, Aarhus, Denmark|400, Helsinki, Finland|402, Oulu, Finland|401, Tampere, Finland|610, Strasbourg, France|611, Toulon, France|521, Athens, Greece|520, Thessaloniki, Greece|552, Faenza, Italy|546, Gallarate, Italy|541, Napoli, Italy|559, Pietra Ligure, Italy|557, Prato, Italy|540, Roma, Italy|549, Roma, Italy|542, Taranto, Italy|547, Torino, Italy|551, Trieste, Italy|180, Aguascalientes, Mexico|183, Chihuahua, Mexico|185, Chihuahua, Mexico|184, Ciudad Juarez, Mexico|189, Guadalajara, Mexico|181, Mexico DF, Mexico|193, Mexico DF, Mexico|195, Mexico DF, Mexico|186, Monterrey, Mexico|187, Monterrey, Mexico|188, Monterrey, Mexico|182, Polanco, Mexico|815, Bucarest, Romania|810, Cluj-napoca, Romania|814, Oradea, Romania|813, Targu Mures, Romania|830, Kazan, Russian Federation|831, Kazan, Russian Federation|834, Moscow, Russian Federation|833, Novosibirsk, Russian Federation|598, Terrassa, Barcelona, Spain|592, Almeria, Spain|597, Bajo Sevilla, Spain|590, Barcelona, Spain|596, Santiago de Compostela, Spain|594, Valencia, Spain|599, Valladolid, Spain|892, Lausanne, Switzerland|713, Adana, Turkey|714, Ankara, Turkey|710, Eskisehir, Turkey|711, Istanbul, Turkey|719, Istanbul, Turkey|717, Izmir, Turkey|718, Trabzon, Turkey","Study Director : UCB Clinical Trial Call Center , +1 877 822 9493 (UCB)"
Epilepsy,NCT00280696,A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00280696,NO,"Epilepsies, Partial",DRUG: Levetiracetam 250 mg|DRUG: Levetiracetam 500 mg|OTHER: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Aichi-gun, Aichi, Japan|Nagoya, Aichi, Japan|Nayoga, Aichi, Japan|Hirosaki, Aomori, Japan|Kitakyusyu, Fukuoka, Japan|Kurume, Fukuoka, Japan|Fukuyama, Hiroshima, Japan|Asahikawa, Hokkaido, Japan|Hakodate, Hokkaido, Japan|Sapporo, Hokkaido, Japan|Kobe, Hyogo, Japan|Kahoku-gun, Ishikawa, Japan|Kikuchi-gun, Kumamoto, Japan|Sendai, Miyagi, Japan|Omura, Nagasaki, Japan|Izumi, Osaka, Japan|Neyagawa, Osaka, Japan|Suita, Osaka, Japan|Kawachi-gun, Tochigi, Japan|Kodaira, Tokyo, Japan|Ube, Yamaguchi, Japan|Chiba, Japan|Fukuoka, Japan|Gihu, Japan|Hiroshima, Japan|Kagoshima, Japan|Kobe, Japan|Kyoto, Japan|Miyazaki, Japan|Nagaoka, Japan|Niigata, Japan|Okayama, Japan|Osaka, Japan|Shizuoka, Japan|Tokyo, Japan|Toyama, Japan|Yamagata, Japan","Study Director : UCB Clinical Trial Call Center , UCB Pharma"
Epilepsy,NCT03807141,Evaluation of the Modified Atkins Diet in Children With Epileptic Spasms,https://clinicaltrials.gov/study/NCT03807141,NO,Epileptic Spasms,OTHER: Modified Atkins diet,ALL,CHILD,PHASE2|PHASE3,"Lady Hardinge Medical College, New Delhi, Delhi, 110018, India",Lady Hardinge Medical College
Epilepsy,NCT04802135,Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy,https://clinicaltrials.gov/study/NCT04802135,NO,Epileptic Encephalopathy,OTHER: Survey,ALL,"CHILD, ADULT, OLDER_ADULT",,"CHU Angers, Angers, France|CHU Bordeaux, Bordeaux, France|CHU Brest, Brest, France|CHRU Lille, Lille, France|CHU Limoges, Limoges, France|Hospices Civils Lyon, Lyon, France|HÃ´pital La Timone, Marseille, 13005, France|CHU Montpellier, Montpellier, France|APHP PitiÃ© SalpÃªtriÃ¨re, Paris, France|APHP Robert DebrÃ©, Paris, France|HÃ´pital Necker, Paris, France|CHU Rennes, Rennes, France|CHRU Strasbourg, Strasbourg, France|CHU Toulouse, Toulouse, France|CHU Tours, Tours, France","Study Director : Jean Olivier Arnaud , Assistance Publique - HÃ´pitaux de Marseille"
Epilepsy,NCT00255411,Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure,https://clinicaltrials.gov/study/NCT00255411,NO,Psychogenic Movement Disorders|Non-epileptic Seizures,,ALL,"ADULT, OLDER_ADULT",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",National Institute of Neurological Disorders and Stroke (NINDS)
Epilepsy,NCT04147663,Epidemiology of Suspected Epileptic Seizures,https://clinicaltrials.gov/study/NCT04147663,NO,Epilepsy,OTHER: describe the management of the adult population suffering from suspected seizure by the emergency structures,ALL,"ADULT, OLDER_ADULT",,"Centre Hospitalier St Joseph St Luc, Lyon, 69007, France","Principal Investigator : Sylvie MEYRAN, MD , Centre Hospitalier Saint Joseph St Luc de Lyon"
Epilepsy,NCT00212745,Pilot Trial of a Behavioral Treatment for Epilepsy,https://clinicaltrials.gov/study/NCT00212745,NO,"Epilepsies, Partial",BEHAVIORAL: Andrews/Reiter behavioral treatment for epilepsy,ALL,"CHILD, ADULT",PHASE1|PHASE2,"Oregon Health and Science University, Portland, Oregon, 97239, United States","Principal Investigator : Siegward M Elsas, M.D. , Oregon Health and Science University"
Epilepsy,NCT01235403,Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure,https://clinicaltrials.gov/study/NCT01235403,YES,Partial Epilepsies,DRUG: Lacosamide,ALL,"ADULT, OLDER_ADULT",PHASE4,"Amiens, France|Aubenas, France|Auxerre, France|Bordeaux, France|Brest, France|Caen, France|Carpentras, France|Chateaubriand, France|Colmar, France|CrÃ©teil, France|Gap, France|Gonesse, France|La Rochelle, France|Laval, France|Limoges, France|Marseille, France|MontluÃ§on, France|Nice, France|NÃ®mes, France|Paris, France|Perpignan, France|Poitiers, France|Pringy, France|Rennes, France|Rouen, France|Saint Aubin Sur Cie, France|Saint Julien En Gengvois, France|Saint-Malo, France|St Brieuc, France|Toulouse, France|Vienne, France|Villeurbanne, France","Study Director : UCB Clinical Trial Call Center , +1 877 822 9493 (UCB)"
Epilepsy,NCT00072813,MRI in Autosomal Dominant Partial Epilepsy With Auditory Features,https://clinicaltrials.gov/study/NCT00072813,NO,"Epilepsies, Partial",,ALL,"ADULT, OLDER_ADULT",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|Columbia University, New York, New York, 10032-3784, United States",National Institute of Neurological Disorders and Stroke (NINDS)
Epilepsy,NCT00771927,Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures,https://clinicaltrials.gov/study/NCT00771927,YES,"Epilepsies, Partial",DRUG: Lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",,"Bron, France|Dijon, France|La Tronche, France|Montpellier, France|Nantes, France|Paris, France|Saint Brieuc, France|Tain L'Hermitage, France|Aschaffenburg, Germany|Bad Berka, Germany|Berlin, Germany|Bernau, Germany|Bielefeld, Germany|Bonn, Germany|Dresden, Germany|Dusseldorf, Germany|Erlangen, Germany|Essen, Germany|Freiburg, Germany|Gottingen, Germany|Halle, Germany|Hamburg, Germany|Jena, Germany|Kehl-Kork, Germany|Kiel, Germany|Koningstein-Falkenstein, Germany|Krefeld, Germany|Mainz, Germany|Marburg, Germany|Munster, Germany|MÃ¼nchen, Germany|Neuburg, Germany|Neukirchen-Vluyn, Germany|Oldenburg, Germany|Osnabruck, Germany|Potsdam, Germany|Radeberg, Sachsen, Germany|Ravensburg, Germany|Rotenburg/WÃ¼mme, Germany|Stuttgart, Germany|Ulm, Germany|Vogtareuth, Germany|Westerstede, Germany|Blaricum, Netherlands|Heeze, Netherlands|Nijmegen, Netherlands|Barcelona, Spain|El Vendrell, Spain|Plymouth, Devon, United Kingdom|Fulwood, Preston, Lancashire, United Kingdom|Bangor, United Kingdom|Birmingham, United Kingdom|Cardiff, United Kingdom|Dundee, United Kingdom|Edinburgh, United Kingdom|Leeds, United Kingdom|Leicester, United Kingdom|London, United Kingdom|Middlesborough, United Kingdom|Salford, United Kingdom|Sheffield, United Kingdom|Stoke on Trent, United Kingdom","Study Director : UCB Clinical Trial Call Center , +1 877 822 9493 (UCB)"
Epilepsy,NCT00918047,Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients,https://clinicaltrials.gov/study/NCT00918047,NO,"Epilepsies, Partial",DRUG: SPN-804O,ALL,CHILD,PHASE1,"Little Rock, Arkansas, United States|Loxahatchee Groves, Florida, United States|Tampa, Florida, United States|Rockville, Maryland, United States|Lake Success, New York, United States|Rochester, New York, United States|Kingsport, Tennessee, United States|San Antonio, Texas, United States","Supernus Pharmaceuticals, Inc."
Epilepsy,NCT03169751,An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures,https://clinicaltrials.gov/study/NCT03169751,NO,Non-Epileptic Seizure|Motor Seizure|Epilepsy,DEVICE: Brain Sentinel Monitoring and Alerting System,ALL,"ADULT, OLDER_ADULT",,"Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhugel, Wien, 1130, Austria","Principal Investigator : Christoph Baumgartner, MD , Krankenhaus Hietzing mit Neurologischem Zentrum RosenhÃ¼gel"
Epilepsy,NCT00512317,Open-label Extension to Protocol 1042-0600,https://clinicaltrials.gov/study/NCT00512317,YES,"Epilepsies, Partial",DRUG: ganaxolone,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Alabama, Birmingham, Alabama, 35294-0021, United States|Barrow Neurological Institute, Phoenix, Arizona, 85013, United States|Arkansas Epilepsy Program, Little Rock, Arkansas, 72205, United States|University of Southern California Adult Comprehensive Epilepsy Center, Los Angeles, California, 90033, United States|University of California-Davis, Sacramento, California, 95817, United States|Anchutz Outpatient Pavillion Neurosciences Clinic/ University of Colorado Hospital, Aurora, Colorado, 80010-0045, United States|Yale University School of Medicine, New Haven, Connecticut, 06520, United States|University of Florida McKnight Brain Institute, Gainesville, Florida, 32610-0236, United States|Intercoastal Neurology, Sarasota, Florida, 34232, United States|Emory HealthCare, Atlanta, Georgia, 30322, United States|Southern Illinois University Medical Center, Springfield, Illinois, 62702, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Kentucky, Dept. of Neurology, Lexington, Kentucky, 40536, United States|Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, 20817, United States|2799 West Grand blvd. CFP 071, Detroit, Michigan, 48202, United States|Minnesota Epilepsy Group, PA, Saint Paul, Minnesota, 55102-2383, United States|Comprehensive Epilepsy Care Center for Children and Adults, Chesterfield, Missouri, 63017, United States|Neurosciences Institute at Albany Medical Center, Albany, New York, 12208, United States|SUNY Upstate Medical University, Syracuse, New York, 13210, United States|Ohio State University Medical Center, Columbus, Ohio, 43210, United States|Riddle Health Care Center for Neuroscience, Media, Pennsylvania, 19063, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Neurological Clinic of Texas, P.A., Dallas, Texas, 75230, United States|Virginia Commonwealth University, Richmond, Virginia, 23298, United States",
Epilepsy,NCT02598076,Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures,https://clinicaltrials.gov/study/NCT02598076,YES,"Psychogenic Non-epileptic Seizures, Motivational Interviewing",BEHAVIORAL: motivational interviewing|BEHAVIORAL: standard psychotherapy,ALL,"ADULT, OLDER_ADULT",,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States",
Epilepsy,NCT01098162,VimpatÂ® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug,https://clinicaltrials.gov/study/NCT01098162,YES,"Epilepsies, Partial",,ALL,"CHILD, ADULT, OLDER_ADULT",,"55, Aachen, Germany|119, Aalen, Germany|194, Aichach, Germany|191, Altenburg, Germany|136, Alzenau, Germany|78, Aschaffenburg, Germany|35, Bad Berka, Germany|90, Baesweiler, Germany|107, Berlin, Germany|10A, Berlin, Germany|141, Berlin, Germany|25, Berlin, Germany|49, Berlin, Germany|66, Berlin, Germany|75, Berlin, Germany|36, Bielefeld, Germany|5, Bonn, Germany|175, Brandenburg, Germany|192, BÃ¶blingen, Germany|105, Chemnitz, Germany|182, CoppenbrÃ¼gge, Germany|161, Dortmund, Germany|128, Dresden, Germany|21, Dresden, Germany|39, Dresden, Germany|111, DÃ¼ren, Germany|38, DÃ¼sseldorf, Germany|7, Eberswalde, Germany|102, Eisenach, Germany|174, Eisenach, Germany|56, Ellwangen, Germany|50, Erbach, Germany|179, Erfurt, Germany|186, Erfurt, Germany|6, Erlangen, Germany|12, Essen, Germany|27, Freiburg, Germany|137, Fulda, Germany|112, Gelsenkirchen, Germany|103, Gera, Germany|1, Greifswald, Germany|47, Grevenbroich, Germany|158, GÃ¶ttingen, Germany|65, GÃ¶ttingen, Germany|88, GÃ¶ttingen, Germany|134, Halle (Saale), Germany|160, Hamburg, Germany|71, Hamburg, Germany|93, Hamm, Germany|147, Heilbronn, Germany|122, Herborn, Germany|15, Herdecke, Germany|130, HÃ¶chberg, Germany|40, Immenstadt, Germany|52, Jena, Germany|61, JÃ¼lich, Germany|44, Karlstadt, Germany|133, Kastellaun, Germany|125, Kaufbeuren, Germany|16, Kiel, Germany|99, Kleve, Germany|37, Krefeld, Germany|176, KÃ¶ln, Germany|180, KÃ¶ln, Germany|46, Lappersdorf, Germany|113, Leipzig, Germany|4, Leipzig, Germany|68, Leipzig, Germany|81, Leipzig, Germany|138, Lohr am Main, Germany|131, Ludwigsburg, Germany|148, LÃ¼denscheid, Germany|33, Mainz, Germany|154, Mannheim, Germany|151, MÃ¼hlhausen, Germany|101, MÃ¼nchen, Germany|167, MÃ¼nchen, Germany|2, MÃ¼nchen, Germany|43, Neuburg, Germany|62, Neukirchen-Vluyn, Germany|123, Neumarkt, Germany|69, NÃ¼rnberg, Germany|80, Oelde, Germany|98, Oldenburg, Germany|87, Oranienburg, Germany|57, Potsdam, Germany|3, Radeberg, Germany|159, Rathenow, Germany|45, Ravensburg, Germany|95, Rostock, Germany|85, RÃ¼sselsheim, Germany|20, Schleswig, Germany|157, SchlÃ¼chtern, Germany|166, Schorndorf, Germany|181, Schriesheim, Germany|168, Schwedt, Germany|150, SchwÃ¤b. GmÃ¼nd, Germany|140, Senftenberg, Germany|164, Siegen, Germany|144, Sondershausen, Germany|127, Stralsund, Germany|14, Stuttgart, Germany|170, Stuttgart, Germany|104, Traunstein, Germany|183, Troisdorf, Germany|17, TÃ¼bingen, Germany|13, Ulm, Germany|48, Ulm, Germany|54, Unterhaching, Germany|171, Wermsdorf, Germany|143, Westerstede, Germany|79, Wismar, Germany|169, Wolfratshausen, Germany","Study Director : UCB Clinical Trial Call Center , +1 877 822 9493 (UCB)"
Epilepsy,NCT00367432,A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00367432,YES,Epilepsies|Partial,DRUG: Levetiracetam,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Aichi-gun, Aichi, Japan|Nagoya, Aichi, Japan|Hirosaki, Aomori, Japan|Matsudo, Chiba, Japan|Kitakyusyu, Fukuoka, Japan|Koga, Fukuoka, Japan|Kurume, Fukuoka, Japan|Fukuyama, Hiroshima, Japan|Asahikawa, Hokkaido, Japan|Hakodate, Hokkaido, Japan|Sapporo, Hokkaido, Japan|Kobe, Hyogo, Japan|Kahoku-gun, Ishikawa, Japan|Kanazawa, Ishikawa, Japan|Zentsuji, Kagawa, Japan|Koshi, Kumamoto, Japan|Tsu, Mie, Japan|Iwanuma, Miyagi, Japan|Sendai, Miyagi, Japan|Omura, Nagasaki, Japan|Kashihara, Nara, Japan|Nagaoka, Niigata, Japan|Beppu, Oita, Japan|Izumi, Osaka, Japan|Neyagawa, Osaka, Japan|Suita, Osaka, Japan|Takatsuki, Osaka, Japan|Iruma-gun, Saitama, Japan|Shimotsuga-gun, Tochigi, Japan|Shimotsuke, Tochigi, Japan|Komatsushima, Tokushima, Japan|Chiyoda-Ku, Tokyo, Japan|Kodaira, Tokyo, Japan|Kokubunji, Tokyo, Japan|Shinjuku-ku, Tokyo, Japan|Taito-ku, Tokyo, Japan|Ube, Yamaguchi, Japan|Aomori, Japan|Chiba, Japan|Fukuoka, Japan|Fukushima, Japan|Gifu, Japan|Hiroshima, Japan|Kagoshima, Japan|Kumamoto, Japan|Kyoto, Japan|Miyazaki, Japan|Niigata, Japan|Okayama, Japan|Osaka, Japan|Shizuoka, Japan|Toyama, Japan|Yamagata, Japan","Study Director : UCB Clinical Trial Call Center , +1 877 822 9493"
Epilepsy,NCT03559673,Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures,https://clinicaltrials.gov/study/NCT03559673,NO,"Epilepsies, Partial",DRUG: Lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",,,
Epilepsy,NCT01441401,Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan),https://clinicaltrials.gov/study/NCT01441401,YES,"Epilepsies, Partial",DRUG: gabapentin,ALL,CHILD,,,"Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT06007053,Retraining and Control Therapy (ReACT) R33 Phase,https://clinicaltrials.gov/study/NCT06007053,NO,"Convulsion, Non-Epileptic",BEHAVIORAL: ReACT|BEHAVIORAL: Supportive Therapy,ALL,"CHILD, ADULT",,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States","Principal Investigator : Aaron Fobian, PhD , University of Alabama at Birmingham"
Epilepsy,NCT00422110,A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures,https://clinicaltrials.gov/study/NCT00422110,NO,"Epilepsies, Partial",DRUG: Seletracetam,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,,
Epilepsy,NCT03024827,Cannabidiol in Children With Refractory Epileptic Encephalopathy,https://clinicaltrials.gov/study/NCT03024827,NO,Epileptic Encephalopathy,DRUG: CanniMedÂ® 1:20,ALL,CHILD,PHASE1,"University of British Columbia, Vancouver, British Columbia, V6T1Z4, Canada|University of Manitoba, Winnipeg, Manitoba, R3T 2N2, Canada|Universite de Montreal, Montreal, Quebec, H3T1J4, Canada|University of Saskatchewan, Saskatoon, Saskatchewan, S7N5C5, Canada","Principal Investigator : Richard Huntsman, MD , Dalhousie University Principal Investigator : Richard Tang-Wai, MD , Loma Linda University Principal Investigator : Jane Alcorn, PhD , University of Saskatchewan"
Epilepsy,NCT05096273,Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES,https://clinicaltrials.gov/study/NCT05096273,NO,"Convulsion, Non-Epileptic",BEHAVIORAL: ReACT,ALL,"CHILD, ADULT",,"Sparks Center Office of Psychiatric Research, Birmingham, Alabama, 35294, United States",University of Alabama at Birmingham
Epilepsy,NCT03857074,Effects of Green Light Exposure on Epileptic Spikes in Patients With Refractory Epilepsy,https://clinicaltrials.gov/study/NCT03857074,NO,Epilepsy|Epilepsy Intractable,DEVICE: Green Light Exposure,ALL,"CHILD, ADULT",,"Boston Children's Hospital, Boston, Massachusetts, 02130, United States","Principal Investigator : Alexander Rotenberg, MD, PhD , Boston Children's Hospital Principal Investigator : Phillip Pearl, MD , Boston Children's Hospital"
Epilepsy,NCT00772603,Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures,https://clinicaltrials.gov/study/NCT00772603,YES,"Epilepsies, Partial",DRUG: Placebo|DRUG: 2400mg SPN-804|DRUG: 1200mg SPN-804,ALL,"ADULT, OLDER_ADULT",PHASE3,"Huntsville, Alabama, United States|Northport, Alabama, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Little Rock, Arkansas, United States|Riverside, California, United States|West Los Angeles, California, United States|Aurora, Colorado, United States|Jacksonville, Florida, United States|Miami, Florida, United States|Sarasota, Florida, United States|Atlanta, Georgia, United States|Springfield, Illinois, United States|Lexington, Kentucky, United States|Bethesda, Maryland, United States|Missoula, Montana, United States|Camden, New Jersey, United States|New York, New York, United States|Oklahoma City, Oklahoma, United States|Philadelphia, Pennsylvania, United States|Nashville, Tennessee, United States|Baytown, Texas, United States|Temple, Texas, United States|Blagoevgrad, Bulgaria|Pleven, Bulgaria|Plovdiv, Bulgaria|Ruse, Bulgaria|Sofia, Bulgaria|Varna, Bulgaria|Edmonton, Alberta, Canada|Greenfield Park, Quebec, Canada|Dubrovnik, Croatia|Rijeka, Croatia|Zadar, Croatia|Zagreb, Croatia|Ciudad JuÃ¡rez, Chihuahua, Mexico|Mexico City, DF, Mexico|Toluca, Estado de Mexico, Mexico|Guadalajara, Jalisco, Mexico|Zapopan, Jalisco, Mexico|Monterrey, Nuevo Leon, Mexico|San Luis Potosi, San Luis PotosÃ­, Mexico|Aguascalientes, Mexico|Chihuahua, Mexico|Durango, Mexico|Puebla, Mexico|Gizycko, Poland|Katowice, Poland|Konskie, Poland|Krakow, Poland|Lodz, Poland|Lublin, Poland|Warszawa, Poland|Wilkowice, Poland|Zabrze, Poland|Bucharest, Romania|Campulung Muscel, Romania|Cluj-Napoca, Romania|Craiova, Romania|St Petersburg, Sestroretsk, Russian Federation|Kazan, Russian Federation|Kirov, Russian Federation|Kursk, Russian Federation|Moscow, Russian Federation|Nizhniy Novgorod, Russian Federation|Nizhny Novgorod, Russian Federation|Novosibirsk, Russian Federation|Pyatigorsk, Russian Federation|Samara, Russian Federation|Smolensk, Russian Federation|St Petersburg, Russian Federation|St. Petersburg, Russian Federation|Yaroslavl, Russian Federation",
Epilepsy,NCT02603991,Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE),https://clinicaltrials.gov/study/NCT02603991,NO,Epileptic Encephalopathy,PROCEDURE: PINS Vagus Nerve Stimulator|DRUG: Levetiracetam,ALL,"CHILD, ADULT",,"Beijing Tiantan Hospital, Beijing, Beijing, 100050, China",
Epilepsy,NCT00297323,An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy,https://clinicaltrials.gov/study/NCT00297323,NO,"Seizures, Epileptic",DRUG: Topiramate,ALL,"CHILD, ADULT, OLDER_ADULT",,,
Epilepsy,NCT05865561,Identification of Volatile Organic Compounds (VOCs) as Biopredictors of Epileptic Seizures,https://clinicaltrials.gov/study/NCT05865561,NO,Epilepsy,OTHER: VOC sampling,ALL,"ADULT, OLDER_ADULT",,,
Epilepsy,NCT02801136,Treatment Outcomes of ReACT for PNES,https://clinicaltrials.gov/study/NCT02801136,NO,"Convulsion, Non-Epileptic",BEHAVIORAL: ReACT|BEHAVIORAL: Supportive Therapy,ALL,"CHILD, ADULT",,"Sparks Center Office of Psychiatric Research, Birmingham, Alabama, 35294, United States",University of Alabama at Birmingham
Epilepsy,NCT00522275,Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00522275,YES,Partial Epilepsies,DRUG: lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Birmingham, Alabama, United States|Mobile, Alabama, United States|Phoenix, Arizona, United States|Little Rock, Arkansas, United States|Los Angeles, California, United States|San Francisco, California, United States|Englewood, Colorado, United States|Fairfield, Connecticut, United States|Bradenton, Florida, United States|Jacksonville, Florida, United States|Maitland, Florida, United States|Saint Petersburg, Florida, United States|Tallahassee, Florida, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Springfield, Illinois, United States|Indianapolis, Indiana, United States|Wichita, Kansas, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|Baltimore, Maryland, United States|Bethesda, Maryland, United States|Boston, Massachusetts, United States|Golden Valley, Minnesota, United States|Saint Cloud, Minnesota, United States|Saint Paul, Minnesota, United States|Chesterfield, Missouri, United States|Somerset, New Jersey, United States|Albuquerque, New Mexico, United States|Buffalo, New York, United States|New York, New York, United States|Rochester, New York, United States|Syracuse, New York, United States|Asheville, North Carolina, United States|Durham, North Carolina, United States|Greenville, North Carolina, United States|Winston-Salem, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Toledo, Ohio, United States|Tulsa, Oklahoma, United States|Medford, Oregon, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Providence, Rhode Island, United States|Beaufort, South Carolina, United States|Charleston, South Carolina, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|San Antonio, Texas, United States|Charlottesville, Virginia, United States|Newport News, Virginia, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Seattle, Washington, United States|Morgantown, West Virginia, United States|Marshfield, Wisconsin, United States|Milwaukee, Wisconsin, United States","Study Director : UCB Clinical Trial Call Center , +1 877 822 9493 (UCB)"
Epilepsy,NCT00524030,Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00524030,YES,"Epilepsies, Partial",DRUG: pregabalin 600 mg/day|DRUG: pregabalin 150 mg/day,ALL,"ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Northport, Alabama, 35476, United States|Pfizer Investigational Site, Phoenix, Arizona, 85003, United States|Pfizer Investigational Site, Phoenix, Arizona, 85013, United States|Pfizer Investigational Site, Sun City, Arizona, 85351, United States|Pfizer Investigational Site, Fayetteville, Arkansas, 72703, United States|Pfizer Investigational Site, Fullerton, California, 92835, United States|Pfizer Investigational Site, Long Beach, California, 90806, United States|Pfizer Investigational Site, Modesto, California, 95355, United States|Pfizer Investigational Site, Murrieta, California, 92562, United States|Pfizer Investigational Site, Newport Beach, California, 92660, United States|Pfizer Investigational Site, Temecula, California, 92591, United States|Pfizer Investigational Site, Denver, Colorado, 80204, United States|Pfizer Investigational Site, Jacksonville, Florida, 32209, United States|Pfizer Investigational Site, Melbourne, Florida, 32901, United States|Pfizer Investigational Site, Miami, Florida, 33126, United States|Pfizer Investigational Site, Miami, Florida, 33136, United States|Pfizer Investigational Site, Sarasota, Florida, 34232, United States|Pfizer Investigational Site, Sarasota, Florida, 34233, United States|Pfizer Investigational Site, Atlanta, Georgia, 30309, United States|Pfizer Investigational Site, Atlanta, Georgia, 30342, United States|Pfizer Investigational Site, Decatur, Georgia, 30033, United States|Pfizer Investigational Site, Lawrenceville, Georgia, 30045, United States|Pfizer Investigational Site, Suwanee, Georgia, 30024, United States|Pfizer Investigational Site, Anderson, Indiana, 46016, United States|Pfizer Investigational Site, Danville, Indiana, 46122, United States|Pfizer Investigational Site, Fort Wayne, Indiana, 46805, United States|Pfizer Investigational Site, Kansas City, Kansas, 66160, United States|Pfizer Investigational Site, Bowling Green, Kentucky, 42101, United States|Pfizer Investigational Site, Lexington, Kentucky, 40536-0284, United States|Pfizer Investigational Site, Lexington, Kentucky, 40536, United States|Pfizer Investigational Site, Houma, Louisiana, 70363, United States|Pfizer Investigational Site, Shreveport, Louisiana, 71105-5634, United States|Pfizer Investigational Site, Pikesville, Maryland, 21208, United States|Pfizer Investigational Site, Worcester, Massachusetts, 01605, United States|Pfizer Investigational Site, Worcester, Massachusetts, 01608, United States|Pfizer Investigational Site, Detroit, Michigan, 48202, United States|Pfizer Investigational Site, Minneapolis, Minnesota, 55422, United States|Pfizer Investigational Site, Flowood, Mississippi, 39232, United States|Pfizer Investigational Site, Hattiesburg, Mississippi, 39401-7246, United States|Pfizer Investigational Site, Great Falls, Montana, 59405, United States|Pfizer Investigational Site, Cedarhurst, New York, 11516, United States|Pfizer Investigational Site, Charlotte, North Carolina, 28207, United States|Pfizer Investigational Site, Charlotte, North Carolina, 28209, United States|Pfizer Investigational Site, Rocky Mount, North Carolina, 27804, United States|Pfizer Investigational Site, Cleveland, Ohio, 44195, United States|Pfizer Investigational Site, Columbus, Ohio, 43210-1250, United States|Pfizer Investigational Site, Columbus, Ohio, 43210, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73112, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73120, United States|Pfizer Investigational Site, Altoona, Pennsylvania, 16602, United States|Pfizer Investigational Site, Indiana, Pennsylvania, 15701, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19140, United States|Pfizer Investigational Site, Memphis, Tennessee, 38120, United States|Pfizer Investigational Site, Memphis, Tennessee, 38163, United States|Pfizer Investigational Site, Nashville, Tennessee, 37232, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Houston, Texas, 77074-2906, United States|Pfizer Investigational Site, San Antonio, Texas, 78258, United States|Pfizer Investigational Site, Temple, Texas, 76508, United States|Pfizer Investigational Site, Murray, Utah, 84107, United States|Pfizer Investigational Site, Salt Lake City, Utah, 84107, United States|Pfizer Investigational Site, West Jordan, Utah, 84088, United States|Pfizer Investigational Site, Milwaukee, Wisconsin, 53226, United States|Pfizer Investigational Site, Beroun, 266 01, Czechia|Pfizer Investigational Site, Brno 2, 602 00, Czechia|Pfizer Investigational Site, Litomysl, 570 14, Czechia|Pfizer Investigational Site, New Territories, Hong Kong|Pfizer Investigational Site, Dnipropetrovsk, 49027, Ukraine|Pfizer Investigational Site, Dnipropetrovsk, 49115, Ukraine|Pfizer Investigational Site, Kharkiv, 61018, Ukraine|Pfizer Investigational Site, Kharkiv, 61068, Ukraine|Pfizer Investigational Site, Lugansk, 91045, Ukraine|Pfizer Investigational Site, Odessa, 65025, Ukraine","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00215215,Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures,https://clinicaltrials.gov/study/NCT00215215,NO,"Epilepsies, Partial",DEVICE: Vagus Nerve Stimulation Therapy,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Bronislav Shafran, M.D., P.C., Phoenix, Arizona, 85003, United States|Xenoscience, Phoenix, Arizona, 85013, United States|Dedicated Clinical Research, Inc., Sun City, Arizona, 85351, United States|USC Comprehensive Epilepsy Center, Los Angeles, California, 90033, United States|Certified Clinical Research, Roseville, California, 95661, United States|Pediatric Diagnostic Center, Ventura, California, 93003, United States|University of Florida, Department of Neurology, Gainesville, Florida, 32610, United States|Neurology Associates, P.A., Maitland, Florida, 32751, United States|Child Neurology Center of Northwest Florida, Pensacola, Florida, 32504, United States|Pediatric Neurology of Idaho, Boise, Idaho, 83712, United States|Freeport Health Network, Department of Neurology, Freeport, Illinois, 61032, United States|Wayne State University School of Medicine, Department of Neurology, Detroit, Michigan, 48201, United States|Weill-Cornell Medical College, N.Y. Presbyterian Hospital, Comprehensive Epilepsy Center, New York, New York, 10021, United States|William Huffstutter, M.D., Asheville, North Carolina, 28801, United States|Medford Neurological and Spine Clinic, Medford, Oregon, 997504, United States|Neurology and Sleep Medicine, Bethlehem, Pennsylvania, 18015, United States|Mid-South Physicians Group, P.L.L.C., Germantown, Tennessee, 38138, United States|Hermann Hospital, UT Comprehensive Epilepsy Center, Houston, Texas, 77030, United States|Texas Tech University Health Sciences Center, Lubbock, Texas, 79430, United States|Texas Association of Pediatric Neurology, San Antonio, Texas, 78258, United States|Pivotal Research Centers, Midvale, Utah, 84047, United States|Pharmaceutical Research Organization, South Ogden, Utah, 84403, United States|Regional Epilepsy Center Saint Luke's Medical Center, Milwaukee, Wisconsin, 53215, United States","Study Director : Carol C Base, RN, MS , Cyberonics, Inc."
Epilepsy,NCT00437281,"Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures",https://clinicaltrials.gov/study/NCT00437281,YES,"Epilepsies, Partial",DRUG: Placebo|DRUG: Pregabalin,ALL,CHILD,PHASE1|PHASE2,"Pfizer Investigational Site, Mobile, Alabama, 36604, United States|Pfizer Investigational Site, Mobile, Alabama, 36693, United States|Pfizer Investigational Site, Phoenix, Arizona, 85016, United States|Pfizer Investigational Site, Jonesboro, Arkansas, 72401, United States|Pfizer Investigational Site, Little Rock, Arkansas, 72205, United States|Pfizer Investigational Site, San Francisco, California, 94143, United States|Pfizer Investigational Site, Gulf Breeze, Florida, 32561, United States|Pfizer Investigational Site, Pensacola, Florida, 32504, United States|Pfizer Investigational Site, Tampa, Florida, 33603, United States|Pfizer Investigational Site, Tampa, Florida, 33609, United States|Pfizer Investigational Site, Springfield, Missouri, 65804, United States|Pfizer Investigational Site, Buffalo, New York, 14222, United States|Pfizer Investigational Site, Durham, North Carolina, 27710, United States|Pfizer Investigational Site, Houston, Texas, 77030, United States|Pfizer Investigational Site, San Antonio, Texas, 78258, United States|Pfizer Investigational Site, Seoul, 120-752, Korea, Republic of|Pfizer Investigational Site, Mexico, DF, 06720, Mexico|Pfizer Investigational Site, Guadalajara, Jalisco, 44280, Mexico","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT01764516,Study on Serum Zinc and Selenium Levels in Epileptic Patients,https://clinicaltrials.gov/study/NCT01764516,NO,Generalized Epileptic,,ALL,ADULT,,"Vali-Asr Hospital, Arak, Central province, Iran, Islamic Republic of","Principal Investigator : Heidar N Farahani, PhD , Department of Biochemistry,Arak medical sciences university"
Epilepsy,NCT00620555,A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00620555,YES,"Epilepsies, Partial",DRUG: gabapentin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Obu-shi,Morioka-machi, Aichi, Japan|Pfizer Investigational Site, Jonan-ku, Fukuoka, Japan|Pfizer Investigational Site, Kobe, Hyogo, Japan|Pfizer Investigational Site, Suma-Ku,Kobe, Hyogo, Japan|Pfizer Investigational Site, Kanazawa, Ishikawa, Japan|Pfizer Investigational Site, Zentsuuji, Kagawa, Japan|Pfizer Investigational Site, Yokohama, Kanagawa Pref., Japan|Pfizer Investigational Site, Sendai-shi, Miyagi-ken, Japan|Pfizer Investigational Site, Showa-Ku, Nagoya, Japan|Pfizer Investigational Site, Niigata-shi, Niigata, Japan|Pfizer Investigational Site, Kurashiki-City, Okayama Pref., Japan|Pfizer Investigational Site, Okayama-shi, Okayama, Japan|Pfizer Investigational Site, Izumi-shi, Osaka, Japan|Pfizer Investigational Site, Miyakojima-ku, Osaka, Japan|Pfizer Investigational Site, Suita, Osaka, Japan|Pfizer Investigational Site, Shizuoka-shi, Shizuoka, Japan|Pfizer Investigational Site, Kodaira, Tokyo, Japan|Pfizer Investigational Site, Setagaya-ku, Tokyo, Japan|Pfizer Investigational Site, Shinjuku-ku, Tokyo, Japan|Pfizer Investigational Site, Hiroshima, Japan|Pfizer Investigational Site, Saitama, Japan|Pfizer Investigational Site, Yamagata, Japan","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00448916,Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures,https://clinicaltrials.gov/study/NCT00448916,YES,"Epilepsies, Partial",DRUG: Pregabalin,ALL,CHILD,PHASE3,"University of South Alabama, Mobile, Alabama, 36604, United States|University of South Alabama Department of Neurology, Mobile, Alabama, 36693, United States|Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|The Children's Clinica of Jonesboro, P.A, Jonesboro, Arkansas, 72401, United States|Clinical Study Centers, L. L. C., Little Rock, Arkansas, 72205, United States|UCSF Neurology Clinic, San Francisco, California, 94143, United States|Child Neurology Center of Northwest Florida, Gulf Breeze, Florida, 32561, United States|The Office of Sergio J Jacinto, MD, Tampa, Florida, 33603, United States|Pediatric Epilepsy & Neurology Specialists, Tampa, Florida, 33609, United States|St. John's Clinic, Springfield, Missouri, 65804, United States|St. John's Hospital, Springfield, Missouri, 65804, United States|Women and Children's Hospital of Buffalo, Buffalo, New York, 14222, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Baylor College of Medicine - Texas Children's Hospital, Houston, Texas, 77030, United States|Texas Children's Hospital, Houston, Texas, 77030, United States|Road Runner Research, Ltd., San Antonio, Texas, 78258, United States|Yonsei University College of Medicine Severance Hospital / Department of Pediatric Neurology, Seoul, 120-752, Korea, Republic of|Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, 44280, Mexico","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00351611,Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo,https://clinicaltrials.gov/study/NCT00351611,YES,"Epilepsies, Partial",DRUG: Lyrica (pregabalin)|DRUG: placebo,ALL,"ADULT, OLDER_ADULT",PHASE4,"Neurology Center, P.C., Mobile, Alabama, 36607, United States|Premier Medical Group, Mobile, Alabama, 36608, United States|Neurology Clinic, PC, Northport, Alabama, 35476, United States|North River Ophthalmology, Tuscaloosa, Alabama, 35406, United States|Western Neurosurgery, Tucson, Arizona, 85710, United States|Office of Robert Snyder, MD, Tucson, Arizona, 85712, United States|REM Medical Clinical Research, Tucson, Arizona, 85712, United States|NEA Baptist Clinic - Clinical Research Center, Jonesboro, Arkansas, 72401, United States|NEA Baptist Clinic, Jonesboro, Arkansas, 72401, United States|NEA Baptst Clinic, Jonesboro, Arkansas, 72401, United States|Chenal MRI, Little Rock, Arkansas, 72205, United States|Clinical Trials, Inc., Little Rock, Arkansas, 72205, United States|Eye Care Arkansas, Little Rock, Arkansas, 72205, United States|Radiology Consultants, Little Rock, Arkansas, 72205, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|Barbara Swartz, MD, Inc, Costa Mesa, California, 92627, United States|Mireille P. Hamparian, Glendale, California, 91206, United States|Lakeside Vision Center, Irvine, California, 92604, United States|Eye Treatment Center, Inc., Long Beach, California, 90813, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, 92658, United States|Clinical Innovations, Inc., Paramount, California, 90723, United States|Yale University School of Medicine, New Haven, Connecticut, 06520-8018, United States|Bradenton Research Center, Inc, Bradenton, Florida, 34205, United States|The Eye Associates, Bradenton, Florida, 34209, United States|SJS Clinical Research, Inc., Destin, Florida, 32541, United States|White Wilson Medical Center, Fort Walton Beach, Florida, 32547, United States|Pharmax Research Clinic, Inc., Miami, Florida, 33126, United States|Dr. Raul F. Masvidal, MD, PA, Miami, Florida, 33134, United States|David M Klein, MD, PA, Port Charlotte, Florida, 33948, United States|Medsol Clinical Research Center, Inc, Port Charlotte, Florida, 33952, United States|Intercoastal Medical Research Center, Sarasota, Florida, 34232, United States|Dr. Nicholas Monsul, Sarasota, Florida, 34239, United States|Sarasota Retinal Institute, Sarasota, Florida, 34239, United States|Coastal Research Associates, LLC, Atlanta, Georgia, 30339, United States|Comprehensive Neurology Specialists, PC, Suwanee, Georgia, 30024, United States|Professional Research Network of Kansas, Wichita, Kansas, 67203, United States|Vitreo-Retinal Consultants and Surgeons, Wichita, Kansas, 67214, United States|Neuromedical Clinic of Central Louisiana, Alexandria, Louisiana, 71301, United States|Louisiana Eye and Laser Center, Alexandria, Louisiana, 71303, United States|University of Maryland Eye Associates, P.A., Baltimore, Maryland, 21201, United States|University of Maryland School of Medicine, Baltimore, Maryland, 21201, United States|University of Maryland, Baltimore, Maryland, 21201, United States|Glaucoma Plus Eye Care, LLC, Columbia, Maryland, 21044, United States|Center for Brain and Neuro Care, LLC, Fulton, Maryland, 20759, United States|Bergman Eye Associates, Hagerstown, Maryland, 21740, United States|Neurology Consultant, P.A., Hagerstown, Maryland, 21740, United States|The Center for Clinical Research, Hagerstown, Maryland, 21740, United States|Harper Hospital, Detroit, Michigan, 48201, United States|Wayne State University, Detroit, Michigan, 48201, United States|Fraser Eye Care Center, Fraser, Michigan, 48026, United States|Minneapolis Clinic of Neurology, Ltd, Golden Valley, Minnesota, 55422, United States|University of Missouri, Columbia, Missouri, 65212, United States|CCN-MS & Neurology Associates, Columbia, Missouri, 65401, United States|Nevada Eye Care, Las Vegas, Nevada, 89119, United States|Neurology Center of Las Vegas, Las Vegas, Nevada, 89128, United States|Institute of Neurological Care, Englewood Cliffs, New Jersey, 07632, United States|Office of Patricia Burke, MD, Paramus, New Jersey, 07652, United States|Dent Neurologic Institute, Amherst, New York, 14226, United States|Dent Neurosciences Research Center, Amherst, New York, 14226, United States|Western New York Ophthalmology Group, Amherst, New York, 14226, United States|Buffalo General Hospital, Buffalo, New York, 14203, United States|The Jacobs Neurological Institute Comprehensive Epilepsy Center, Buffalo, New York, 14209, United States|Guilford Neurologic Associates, Inc, Greensboro, North Carolina, 27405, United States|Digby Eye Associates, Greensboro, North Carolina, 27408, United States|Clinical Research of Winston-Salem, Winston-Salem, North Carolina, 27103, United States|Salem Neurological Center, PA, Winston-Salem, North Carolina, 27103, United States|Office of Dr. James D. Branch, MD, Winston-Salem, North Carolina, 27107, United States|MetroHealth Medical Center, Cleveland, Ohio, 44109, United States|The Cleveland Clinic, Cleveland, Ohio, 44195, United States|The Ohio State University Medical Center, Columbus, Ohio, 43210, United States|Jeffrey Shaver, MD, Edmond, Oklahoma, 73013, United States|Sooner Clinical Research, Oklahoma City, Oklahoma, 73112, United States|Clinical Trials of America, Inc., Eugene, Oregon, 97401, United States|Oregon Eye Consultants, LLC, Eugene, Oregon, 97401, United States|Pacific Women's Center, LLC, Eugene, Oregon, 97401, United States|Oregon Neurology Associates, Springfield, Oregon, 97477, United States|Daniel J. Nadler, MD, PC, Beaver, Pennsylvania, 15009, United States|Heritage Valley Health System, Beaver, Pennsylvania, 15009, United States|Valley Neurological Associates, Monaca, Pennsylvania, 15061, United States|Center For Advanced Eye Care, Greenville, South Carolina, 29615, United States|Premier Neurology, PC, Greer, South Carolina, 29650, United States|Coastal Carolina Research Center, Mount Pleasant, South Carolina, 29464, United States|Glaucoma Consultants and Center for Eye Research, PA, Mount Pleasant, South Carolina, 29464, United States|Tidewater Neurology, Mount Pleasant, South Carolina, 29464, United States|Neurology Centers of the Carolinas, Spartanburg, South Carolina, 29302, United States|Piedmont Eye Associates, Spartanburg, South Carolina, 29303, United States|Envision Eye Care, Bristol, Tennessee, 37620, United States|Tri-state Mountain Neurology Associates, PC, Johnson City, Tennessee, 37604, United States|Semmes Murphey Clinic, Memphis, Tennessee, 38104, United States|Semmes Murphey Clinic, Memphis, Tennessee, 38120, United States|University of Tennessee Health Science Center, Memphis, Tennessee, 38163, United States|FutureSearch Trials of Neurology, Austin, Texas, 78731, United States|Texan Eye, Austin, Texas, 78731, United States|Texas Neurology, PA, Dallas, Texas, 75214, United States|Glaucoma Associates of Texas, Dallas, Texas, 75231, United States|Egret Bay Neurology, PA, Houston, Texas, 77058, United States|DeHaven Eye Clinic, Longview, Texas, 75601, United States|Diagnostic Clinic of Longview Center for Clinical Research, Longview, Texas, 75605, United States|Diagnostic Clinic of Longview, PA, Longview, Texas, 75605, United States|Coastal Eye Associates, Webster, Texas, 77598, United States|Neurological Associates Sarah Cannon Cancer Institute;, Richmond, Virginia, 23229, United States|Medical College of Wisconsin Department of Neurology Froedtert Memorial Hospital, Milwaukee, Wisconsin, 53226-3522, United States|Medical College of Wisconsin Eye Institute, Milwaukee, Wisconsin, 53226, United States|DKC 2, Sofia, 1000, Bulgaria|Chetvarta nevrologichna klinika, Sofia, 1113, Bulgaria|Otdelenie po Nevrologia, Vtora MBAL, Sofia, 1202, Bulgaria|Otdelenie po nevrologia, MBAL ""Tokuda Bolnitsa"", Sofia, 1407, Bulgaria|Universitetska mnogoprofilna bolnitsa za aktivno lechenieAleksandrovska, Klinika po Nevrologia, Sofia, 1431, Bulgaria|Otdelenie po nervni bolesti, MBAL Doverie, Sofia, 1632, Bulgaria|Fakultni Thomayerova nemocnice, Praha 4, 140 59, Czechia|NEUROPS s.r.o., Rychnov nad Kneznou, 516 01, Czechia|Ocni ambulance, Rychnov nad Kneznou, 516 01, Czechia|Synexus Kft., Budapest, 1036, Hungary|Budapest Retina Associates Kft., Budapest, 1133, Hungary|Orszagos Idegtudomanyi Intezet, Stroke es Epilepszia Osztaly, Budapest, 1145, Hungary|Orszagos Idegtudomanyi Intezet, Budapest, 1145, Hungary|Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako,, Hodmezovasarhely, 6800, Hungary|Netra Diagnostics (P) Ltd, Abids, Hyderabad, Andhra Pradesh, 500 001, India|Krishna Institute of Medical Sciences Ltd., Secunderabad, Andhra Pradesh, 500 003, India|King George Hospital, Visakhapatnam, Andhra Pradesh, 530002, India|M.S. Ramaiah Medical College and Hospitals,, Bangalore,, Karnataka, 560054, India|St. John's Medical College Hospital, Bangalore, Karnataka, 560034, India|Mallikatta Neuro Center, Mangalore, Karnataka, 575002, India|Kasturba Medical College and Hospital,, Manipal, Karnataka, 576 104, India|Eye Site,, Indore, Madhya Pradesh, 452 001, India|M.G.M. Medical College & M. Y. Hospitals,, Indore, Madhya Pradesh, 452 001, India|T.N.M.C and B.Y.L Nair Charitable Hospital,, Mumbai, Maharashtra, 400 008, India|Kelkar Nursing Home, Pune, Maharashtra, 411004, India|Sahyadri Clinical Research Development Centre, A unit of Sahyadri Hospitals Ltd,, Pune, Maharashtra, 411004, India|Sahyadri Speciality Hospital, Pune, Maharashtra, 411004, India|Vijaya Health Centre, Chennai, Tamil NADU, 600 026, India|Yashoda Hospital, Hyderabad, Telangana, 500 082, India|Dr. Ram Manohar Lohia Hospital, New Delhi, 110 001, India|All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India|Keimyung University Dongsan Hospital, Daegu, 41931, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Yonsei University Health System Severance Hospital, Seoul, 03722, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Instituto Biomedico de Investigacion AC, Aguascalientes, Aquascalientes, 20127, Mexico|Dr. Ruben Munoz Flores de la Torre Ophthalmic Office, Aquascalientes, 20000, Mexico|Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, 78240, Mexico|Niepubliczny Zaklad Opieki Zdrowotnej ""OKOmed"" s.c., Goczalkowice Zdroj, 43-230, Poland|NZOZ Tommed, Katowice, 40-662, Poland|Centrum Medyczne Dendryt, Katowice, 40-683, Poland|Prywatny Gabinet Psychiatryczny dr Ewa Dereszak-Kozanecka, Krakow, 30-040, Poland|Prywatny Gabinet Okulistyczny dr. n.med. Teresa Gedliczka, Krakow, 30-319, Poland|NZOZ Centrum Leczenia Padaczki i Migreny, Krakow, 31-209, Poland|Khon Kaen University, Faculty of Medicine, Neurology Unit, Department of Medicine, Muang, Khon Kaen, 40002, Thailand|Phramongkutklao hospital,, Bangkok, 10400, Thailand",
Epilepsy,NCT00567268,Drug Use Investigation Of Gabapentin,https://clinicaltrials.gov/study/NCT00567268,YES,"Epilepsies, Partial",DRUG: Gabapentin,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00603473,A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00603473,YES,"Epilepsies, Partial",DRUG: gabapentin,ALL,CHILD,PHASE3,"Pfizer Investigational Site, Obu-shi,Morioka-machi, Aichi, Japan|Pfizer Investigational Site, Jonan-ku, Fukuoka, Japan|Pfizer Investigational Site, Sapporo, Hokkaido, Japan|Pfizer Investigational Site, Kobe, Hyogo, Japan|Pfizer Investigational Site, Suma-Ku, Kobe, Hyogo, Japan|Pfizer Investigational Site, Kanazawa, Ishikawa, Japan|Pfizer Investigational Site, Zentsuuji, Kagawa, Japan|Pfizer Investigational Site, Yokohama, Kanagawa Pref., Japan|Pfizer Investigational Site, Sendai-shi, Miyagi-ken, Japan|Pfizer Investigational Site, Showa-Ku, Nagoya, Japan|Pfizer Investigational Site, Niigata-shi, Niigata, Japan|Pfizer Investigational Site, Kurashiki-City, Okayama Pref., Japan|Pfizer Investigational Site, Okayama-shi, Okayama, Japan|Pfizer Investigational Site, Izumi-shi, Osaka, Japan|Pfizer Investigational Site, Miyakojima-ku, Osaka, Japan|Pfizer Investigational Site, Suita, Osaka, Japan|Pfizer Investigational Site, Higashimatsuyama, Saitama, Japan|Pfizer Investigational Site, Shizuoka-shi, Shizuoka, Japan|Pfizer Investigational Site, Kiyose-shi, Tokyo, Japan|Pfizer Investigational Site, Kodaira, Tokyo, Japan|Pfizer Investigational Site, Setagaya-ku, Tokyo, Japan|Pfizer Investigational Site, Shinjuku-ku, Tokyo, Japan|Pfizer Investigational Site, Hiroshima, Japan|Pfizer Investigational Site, Saitama, Japan|Pfizer Investigational Site, Yamagata, Japan|Pfizer Investigational Site, Yamanashi, Japan","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00552305,To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00552305,YES,Partial Epilepsies,DRUG: lacosamide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Birmingham, Alabama, United States|Huntsville, Alabama, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Little Rock, Arkansas, United States|Los Angeles, California, United States|Englewood, Colorado, United States|Gainesville, Florida, United States|Hollywood, Florida, United States|Miami, Florida, United States|Ponte Vedra Beach, Florida, United States|Chicago, Illinois, United States|Springfield, Illinois, United States|Indianapolis, Indiana, United States|Iowa City, Iowa, United States|Wichita, Kansas, United States|Crestview Hills, Kentucky, United States|Lexington, Kentucky, United States|Baltimore, Maryland, United States|Frederick, Maryland, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Saint Paul, Minnesota, United States|Chesterfield, Missouri, United States|Saint Louis, Missouri, United States|Somerset, New Jersey, United States|New York, New York, United States|Durham, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|Irving, Texas, United States|Lubbock, Texas, United States|Wichita Falls, Texas, United States|Bennington, Vermont, United States|Charlottesville, Virginia, United States|Marshfield, Wisconsin, United States|Milwaukee, Wisconsin, United States|Bonn, Germany|Erlangen, Germany|Kehl Kork, Germany|Schwalmstedt-Treysa, Germany|Budapest, Hungary|Zalaegerszeg, Hungary|Kaunas, Lithuania|Vilnius, Lithuania|Poznan, Poland|Goteborg, Sweden|Stockholm, Sweden|Bern/Biel, Switzerland|Zurich, Switzerland|Bucks/London, United Kingdom|Glasgow, United Kingdom|Liverpool, United Kingdom","Study Director : UCB Clinical Trial Call Center , +1 877 822 9493 (UCB)"
Epilepsy,NCT04515316,A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures,https://clinicaltrials.gov/study/NCT04515316,NO,Epilepsy,DEVICE: OPM sensors|DEVICE: SQUID sensors,ALL,"ADULT, OLDER_ADULT",,"University of Colorado School of Medicine - Anschutz Medical Campus, Aurora, Colorado, 80045, United States","University of Colorado, Boulder"
Epilepsy,NCT05257915,A China RWS to Evaluate the Effectiveness and Safety of Perampanel as an add-on Treatment for Epileptic Seizure,https://clinicaltrials.gov/study/NCT05257915,NO,Epilepsy,DRUG: Perampanel,ALL,"CHILD, ADULT, OLDER_ADULT",,"Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, 100045, China|Beijing TianTan Hospital, Capital Medical University, Beijing, Beijing, China|Beijing University First Hospital, Beijing, Beijing, China|Peking Union Medical College Hospital, Beijing, Beijing, China|Peking University People's Hospital, Beijing, Beijing, China",
Epilepsy,NCT04102254,Thalamic Stimulation for Epilepsy Study,https://clinicaltrials.gov/study/NCT04102254,NO,Seizures|Epilepsy|Seizure Disorder,PROCEDURE: ANT recording and stimulation,ALL,"ADULT, OLDER_ADULT",,"Duke University Health System, Durham, North Carolina, 27710, United States","Principal Investigator : Derek Southwell, M.D., Ph.D. , Duke Health"
Epilepsy,NCT00151879,Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures,https://clinicaltrials.gov/study/NCT00151879,NO,"Epilepsies, Partial",DRUG: SPM 927,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,"Schwarz, RTP, North Carolina, United States","Study Director : UCB Clinical Trial Call Center , UCB Pharma"
Epilepsy,NCT05873062,"Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK",https://clinicaltrials.gov/study/NCT05873062,NO,"Myoclonus Epilepsies, Progressive",DRUG: AUT00201|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1,"University of Pennsylvania, Penn Epilepsy Center, Philadelphia, Pennsylvania, 19104, United States","Principal Investigator : Michael Gelfand, MD , Penn Epilepsy Center, Department of Neurology"
Epilepsy,NCT05274035,A Multi-center RWS of Perampanel as an add-on Treatment for Epileptic Seizures in Chinese Children,https://clinicaltrials.gov/study/NCT05274035,NO,Epilepsy,DRUG: Perampanel,ALL,CHILD,,"Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, 100045, China|Wuhan Children's Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, 430015, China|XuZhou Children's Hospital, XuZhou, Jiangsu, 221002, China|Jinan Children's Hospital, Jinan, Shandong, 250022, China|Tianjin Children's Hospital, Tianjin, Tianjin, 300134, China","Study Chair : Fang Fang , Beijing Children's Hospital"
Epilepsy,NCT06210022,Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy,https://clinicaltrials.gov/study/NCT06210022,NO,Epilepsy|Focal Epilepsy,DIAGNOSTIC_TEST: Neuropsychological Assessment,ALL,ADULT,,"IRCCS San Raffaele, Milan, 20132, Italy",IRCCS San Raffaele
Epilepsy,NCT02441478,Co-operative Behavior and Decision-making in Frontal Lobe Epilepsy,https://clinicaltrials.gov/study/NCT02441478,NO,Frontal Lobe Epilepsies,RADIATION: functional magnetic resonance imaging exam,ALL,ADULT,,"Hospices Civils de Lyon, Lyon, 69002, France",Hospices Civils de Lyon
Epilepsy,NCT00210652,An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00210652,NO,"Epilepsy|Epilepsies, Partial",DRUG: RWJ 333369:,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,,"Study Director : Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial , Johnson & Johnson Pharmaceutical Research & Development, L.L.C."
Epilepsy,NCT04457687,Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies,https://clinicaltrials.gov/study/NCT04457687,NO,"Epilepsies, Myoclonic|Drug Resistant Epilepsy",DRUG: Lorcaserin,ALL,"CHILD, ADULT, OLDER_ADULT",,,Eisai Inc.
Epilepsy,NCT00210522,An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00210522,NO,"Epilepsy|Epilepsies, Partial",DRUG: RWJ 333369,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Study Director : Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial , Johnson & Johnson Pharmaceutical Research & Development, L.L.C."
Epilepsy,NCT05518578,Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy,https://clinicaltrials.gov/study/NCT05518578,NO,"Epilepsy|Seizures, Epileptic",DRUG: SPN-817,ALL,"ADULT, OLDER_ADULT",PHASE2,"Alfred Hospital, Melbourne, Australia",
Epilepsy,NCT04284072,Clinical Scenarios for Long-term Monitoring of Epileptic Seizures With a Wearable Biopotential Technology,https://clinicaltrials.gov/study/NCT04284072,NO,Epilepsy,DEVICE: Sensor Dot,ALL,"CHILD, ADULT, OLDER_ADULT",,"University Hospitals Leuven, department of Neurology, Leuven, 3000, Belgium|Department of Epileptology and Neurology, Aachen, Germany|Epilepsy Center, University Medical Center, Freiburg University, Freiburg, Germany|Division of Neurology, Coimbra University Hospital, Coimbra, Portugal|Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden|Division of Neuroscience, King's College London, London, United Kingdom|Nuffield Department of Clinical Neurosciences, Oxford University Hospital, Oxford, United Kingdom","Principal Investigator : Wim Van Paesschen, MD, PhD , UZ Leuven and KU Leuven"
Epilepsy,NCT05066880,Yoga and Aerobic Exercise in Epilepsy,https://clinicaltrials.gov/study/NCT05066880,NO,Epilepsy|Epilepsy; Seizure|Epilepsy Idiopathic,OTHER: Exercise training,ALL,"ADULT, OLDER_ADULT",,"Dokuz Eylul University, Izmir, Turkey",Dokuz Eylul University
Epilepsy,NCT00150293,Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00150293,NO,"Seizure Disorder, Partial",DRUG: Pregabalin,ALL,"ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Deakin, Australian Capital Territory, 2600, Australia|Pfizer Investigational Site, Camperdown, New South Wales, 2050, Australia|Pfizer Investigational Site, Chastwood, New South Wales, 2067, Australia|Pfizer Investigational Site, Cairns, Queensland, 4870, Australia|Pfizer Investigational Site, Maroochydore, Queensland, 4558, Australia|Pfizer Investigational Site, Footscray, Victoria, 3011, Australia|Pfizer Investigational Site, Parkville, Victoria, 3050, Australia|Pfizer Investigational Site, Perth, Western Australia, 6001, Australia|Pfizer Investigational Site, Auenbruggerplatz 22, A-8035 GRAZ, Austria|Pfizer Investigational Site, Graz, 8020, Austria|Pfizer Investigational Site, Innsbruck, A6020, Austria|Pfizer Investigational Site, Linz, 4020, Austria|Pfizer Investigational Site, Wien, 1220, Austria|Pfizer Investigational Site, Leuven, 3000, Belgium|Pfizer Investigational Site, Calgary, Alberta, T2N 2T9, Canada|Pfizer Investigational Site, Edmonton, Alberta, T5G 0B7, Canada|Pfizer Investigational Site, Penticton, British Columbia, V2A 4V8, Canada|Pfizer Investigational Site, Vancouver, British Columbia, V5Z 1M9, Canada|Pfizer Investigational Site, Halifax, Nova Scotia, B3H 3A7, Canada|Pfizer Investigational Site, Barrie, Ontario, L4M 4S5, Canada|Pfizer Investigational Site, London, Ontario, N6A 5A5, Canada|Pfizer Investigational Site, Ottawa, Ontario, K1L 8L6, Canada|Pfizer Investigational Site, Toronto, Ontario, M5T 2S8, Canada|Pfizer Investigational Site, Windsor, Ontario, N8X5A6, Canada|Pfizer Investigational Site, Montreal, Quebec, H1T 2M4, Canada|Pfizer Investigational Site, Montreal, Quebec, H2L 4M1, Canada|Pfizer Investigational Site, Montreal, Quebec, H3A 2B4, Canada|Pfizer Investigational Site, Regina, Saskatchewan, S4T 1A5, Canada|Pfizer Investigational Site, Saskatoon, Saskatchewan, S7N 0W8, Canada|Pfizer Investigational Site, Quebec, G1J 1Z4, Canada|Pfizer Investigational Site, Ulm, BW, 89081, Germany|Pfizer Investigational Site, Berlin, BE10362, Germany|Pfizer Investigational Site, Bernau, 16321, Germany|Pfizer Investigational Site, Bonn, 53127, Germany|Pfizer Investigational Site, Dresden, 01307, Germany|Pfizer Investigational Site, Erlangen, 91054, Germany|Pfizer Investigational Site, Essen, 45147, Germany|Pfizer Investigational Site, Frankfurt, HE 60528, Germany|Pfizer Investigational Site, Freiburg, 79106, Germany|Pfizer Investigational Site, Goettingen, D-37075, Germany|Pfizer Investigational Site, Hamburg, D-22337, Germany|Pfizer Investigational Site, Mainz, 55101, Germany|Pfizer Investigational Site, Muenchen, 81377, Germany|Pfizer Investigational Site, AE Breda, 4836, Netherlands|Pfizer Investigational Site, Blaricum, 1261 AN, Netherlands|Pfizer Investigational Site, Ve Heeze, 5591, Netherlands|Pfizer Investigational Site, Bialystok, 15-276, Poland|Pfizer Investigational Site, Bydgoszcz, 85-826, Poland|Pfizer Investigational Site, Choroszcz, 16-070, Poland|Pfizer Investigational Site, Gdansk, 80-211, Poland|Pfizer Investigational Site, Gdansk, 82-803, Poland|Pfizer Investigational Site, Grudziadz, 86-300, Poland|Pfizer Investigational Site, Katowice, 46-645, Poland|Pfizer Investigational Site, Krakow, 31-112, Poland|Pfizer Investigational Site, Lublin, 20-718, Poland|Pfizer Investigational Site, Mosina, 62-050, Poland|Pfizer Investigational Site, Olsztyn, 10-561, Poland|Pfizer Investigational Site, Plock, 09-402, Poland|Pfizer Investigational Site, Poznan, 60-780, Poland|Pfizer Investigational Site, Poznan, 61-285, Poland|Pfizer Investigational Site, Torun, 87-100, Poland|Pfizer Investigational Site, Warsaw, 00-909, Poland|Pfizer Investigational Site, Warsaw, 02-957, Poland|Pfizer Investigational Site, Warszawa, 00-909, Poland|Pfizer Investigational Site, Warszawa, Poland|Pfizer Investigational Site, Coimbra, 3000-075, Portugal|Pfizer Investigational Site, Porto, 4099, Portugal|Pfizer Investigational Site, Barcelona, 08036, Spain|Pfizer Investigational Site, Girona, 17007, Spain|Pfizer Investigational Site, Granada, 18013, Spain|Pfizer Investigational Site, Madrid, 28034, Spain|Pfizer Investigational Site, Madrid, 28040, Spain|Pfizer Investigational Site, Malaga, 29010, Spain|Pfizer Investigational Site, Zaragoza, 50009, Spain|Pfizer Investigational Site, Middlesborough, N. York, TS5 5AZ, United Kingdom|Pfizer Investigational Site, Washington, Tyne & Wear, NE38 9JZ, United Kingdom|Pfizer Investigational Site, Blackpool, FY3 8BP, United Kingdom|Pfizer Investigational Site, Dundee, DD1 9SY, United Kingdom|Pfizer Investigational Site, Glasgow, G11 6NT, United Kingdom|Pfizer Investigational Site, Leeds, LS9 7TF, United Kingdom|Pfizer Investigational Site, London, E1 1BB, United Kingdom|Pfizer Investigational Site, Northampton, NN1 5BD, United Kingdom|Pfizer Investigational Site, Wolverhampton, WV10 0QP, United Kingdom|Pfizer Investigational Site","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00141388,To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures,https://clinicaltrials.gov/study/NCT00141388,NO,"Seizure Disorder, Partial",DRUG: Pregabalin,ALL,"ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Birmingham, Alabama, 35249, United States|Pfizer Investigational Site, Birmingham, Alabama, 35255, United States|Pfizer Investigational Site, Birmingham, Alabama, 35294-0021, United States|Pfizer Investigational Site, Phoenix, Arizona, 85006, United States|Pfizer Investigational Site, Tucson, Arizona, 85712-2809, United States|Pfizer Investigational Site, Tucson, Arizona, 85712, United States|Pfizer Investigational Site, Little Rock, Arkansas, 72205, United States|Pfizer Investigational Site, Los Angeles, California, 90033, United States|Pfizer Investigational Site, Pasadena, California, 91105, United States|Pfizer Investigational Site, Gainesville, Florida, 32608-1197, United States|Pfizer Investigational Site, Gainesville, Florida, 32610, United States|Pfizer Investigational Site, Miami, Florida, 33136, United States|Pfizer Investigational Site, Plantation, Florida, 33317, United States|Pfizer Investigational Site, Spring Hill, Florida, 34609, United States|Pfizer Investigational Site, Tallahassee, Florida, 32308, United States|Pfizer Investigational Site, Chicago, Illinois, 60612, United States|Pfizer Investigational Site, Springfield, Illinois, 62702, United States|Pfizer Investigational Site, Springfield, Illinois, 62704, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46202, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46254, United States|Pfizer Investigational Site, Iowa City, Iowa, 52242, United States|Pfizer Investigational Site, Kansas City, Kansas, 66160-7314, United States|Pfizer Investigational Site, Kansas City, Kansas, 66160, United States|Pfizer Investigational Site, Louisville, Kentucky, 40205, United States|Pfizer Investigational Site, Baltimore, Maryland, 21201, United States|Pfizer Investigational Site, Baltimore, Maryland, 21224, United States|Pfizer Investigational Site, Greenbelt, Maryland, 20770, United States|Pfizer Investigational Site, Boston, Massachusetts, 02130, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48108, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48109, United States|Pfizer Investigational Site, St. Paul, Minnesota, 55102, United States|Pfizer Investigational Site, Chesterfield, Missouri, 63017, United States|Pfizer Investigational Site, Columbia, Missouri, 65212, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110-1092, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110, United States|Pfizer Investigational Site, Lebanon, New Hampshire, 03756, United States|Pfizer Investigational Site, New York, New York, 10016, United States|Pfizer Investigational Site, New York, New York, 10032, United States|Pfizer Investigational Site, Rochester, New York, 14642, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 27157, United States|Pfizer Investigational Site, Cleveland, Ohio, 44195, United States|Pfizer Investigational Site, Columbus, Ohio, 43210, United States|Pfizer Investigational Site, Portland, Oregon, 97227, United States|Pfizer Investigational Site, Nashville, Tennessee, 37232, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, Bennington, Vermont, 05201, United States|Pfizer Investigational Site, Edmonton, Alberta, T5H 3V9, Canada|Pfizer Investigational Site, Edmont, Alberta, T5G 0B7, Canada|Pfizer Investigational Site, Vancouver, British Columbia, V52 1M9, Canada|Pfizer Investigational Site, Vancouver, British Columbia, V67 1Y6, Canada|Pfizer Investigational Site, London, Ontario, N6A 5A5, Canada|Pfizer Investigational Site, Ottawa, Ontario, K1H 8L6, Canada|Pfizer Investigational Site, Toronto, Ontario, M4Y 1J3, Canada|Pfizer Investigational Site, Montreal, Quebec, H3A 2B4, Canada","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00141336,To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00141336,NO,"Seizure Disorder, Partial",DRUG: Pregabalin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Phoenix, Arizona, 85013, United States|Pfizer Investigational Site, Tucson, Arizona, 85724, United States|Pfizer Investigational Site, Bakersfield, California, 93301, United States|Pfizer Investigational Site, Berkeley, California, 94705, United States|Pfizer Investigational Site, Concord, California, 94520, United States|Pfizer Investigational Site, Covina, California, 91723, United States|Pfizer Investigational Site, El Cajon, California, 92021, United States|Pfizer Investigational Site, Encino, California, 91436, United States|Pfizer Investigational Site, La Mesa, California, 91942, United States|Pfizer Investigational Site, Marina del Ray, California, 90292, United States|Pfizer Investigational Site, Martinez, California, 94553, United States|Pfizer Investigational Site, Northridge, California, 91325, United States|Pfizer Investigational Site, Pinole, California, 94564, United States|Pfizer Investigational Site, Redondo Beach, California, 90277, United States|Pfizer Investigational Site, Sacramento, California, 95816, United States|Pfizer Investigational Site, Sacramento, California, 95823, United States|Pfizer Investigational Site, San Diego, California, 92120, United States|Pfizer Investigational Site, Santa Monica, California, 90404, United States|Pfizer Investigational Site, Walnut Creek, California, 94598, United States|Pfizer Investigational Site, Denver, Colorado, 80218, United States|Pfizer Investigational Site, Englewood, Colorado, 80110, United States|Pfizer Investigational Site, Danbury, Connecticut, 06810, United States|Pfizer Investigational Site, Miami, Florida, 33173, United States|Pfizer Investigational Site, Miami, Florida, 33176, United States|Pfizer Investigational Site, Orlando, Florida, 32806, United States|Pfizer Investigational Site, Tampa, Florida, 33609, United States|Pfizer Investigational Site, Atlanta, Georgia, 30322, United States|Pfizer Investigational Site, Chicago, Illinois, 60611, United States|Pfizer Investigational Site, Chicago, Illinois, 60612, United States|Pfizer Investigational Site, Chicago, Illinois, 60640, United States|Pfizer Investigational Site, Crestview Hills, Kentucky, 41017, United States|Pfizer Investigational Site, Louisville, Kentucky, 40202, United States|Pfizer Investigational Site, Ruston, Louisiana, 71270, United States|Pfizer Investigational Site, Baltimore, Maryland, 21287, United States|Pfizer Investigational Site, Detroit, Michigan, 48202-2689, United States|Pfizer Investigational Site, Golden Valley, Minnesota, 55422, United States|Pfizer Investigational Site, Minneapolis, Minnesota, 55422, United States|Pfizer Investigational Site, Jackson, Mississippi, 39216, United States|Pfizer Investigational Site, St. Louis, Missouri, 63110, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89102, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89106, United States|Pfizer Investigational Site, Concord, New Hampshire, 03301, United States|Pfizer Investigational Site, Dover, New Hampshire, 03820, United States|Pfizer Investigational Site, New Brunswick, New Jersey, 08901, United States|Pfizer Investigational Site, New Brunswick, New Jersey, 08903, United States|Pfizer Investigational Site, Ridgewood, New Jersey, 07450, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87131-5021, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87131-5281, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87131, United States|Pfizer Investigational Site, Bronx, New York, 10467, United States|Pfizer Investigational Site, Brooklyn, New York, 11203, United States|Pfizer Investigational Site, New York, New York, 10021, United States|Pfizer Investigational Site, Asheville, North Carolina, 28803, United States|Pfizer Investigational Site, Asheville, North Carolina, 28806, United States|Pfizer Investigational Site, Raleigh, North Carolina, 27607, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 27103, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 37103, United States|Pfizer Investigational Site, Cincinnati, Ohio, 45219, United States|Pfizer Investigational Site, Cincinnati, Ohio, 45242, United States|Pfizer Investigational Site, Columbus, Ohio, 43210, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73104-5068, United States|Pfizer Investigational Site, Medford, Oregon, 97504, United States|Pfizer Investigational Site, Portland, Oregon, 97201, United States|Pfizer Investigational Site, Portland, Oregon, 97209, United States|Pfizer Investigational Site, Portland, Oregon, 97210, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19104, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, 19107, United States|Pfizer Investigational Site, Pittsburgh, Pennsylvania, 15212, United States|Pfizer Investigational Site, Ridley Park, Pennsylvania, 19078, United States|Pfizer Investigational Site, Upland, Pennsylvania, 19013, United States|Pfizer Investigational Site, Cranston, Rhode Island, 02920, United States|Pfizer Investigational Site, Knoxville, Tennessee, 37916, United States|Pfizer Investigational Site, Memphis, Tennessee, 38103, United States|Pfizer Investigational Site, Dallas, Texas, 75216, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Dallas, Texas, 75243, United States|Pfizer Investigational Site, Fort Worth, Texas, 76107-2699, United States|Pfizer Investigational Site, Fort Worth, Texas, 76107, United States|Pfizer Investigational Site, Houston, Texas, 77002, United States|Pfizer Investigational Site, Houston, Texas, 77025, United States|Pfizer Investigational Site, Houston, Texas, 77030, United States|Pfizer Investigational Site, Lubbock, Texas, 79410, United States|Pfizer Investigational Site, San Antonio, Texas, 78207, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, Alexandria, Virginia, 22304, United States|Pfizer Investigational Site, Alexandria, Virginia, 22311, United States|Pfizer Investigational Site, Charlottesville, Virginia, 22908, United States|Pfizer Investigational Site, Roanoke, Virginia, 24014, United States|Pfizer Investigational Site, Roanoke, Virginia, 24016, United States|Pfizer Investigational Site, Sterling, Virginia, 20165, United States|Pfizer Investigational Site, Bellevue, Washington, 98004, United States|Pfizer Investigational Site, Bellvue, Washington, 98004, United States|Pfizer Investigational Site, Spokane, Washington, 99202, United States|Pfizer Investigational Site, Spokane, Washington, 99204, United States|Pfizer Investigational Site, Morgantown, West Virginia, 26507, United States|Pfizer Investigational Site, Marshfield, Wisconsin, 54449, United States|Pfizer Investigational Site, Milwaukee, Wisconsin, 53226, United States|Pfizer Investigational Site, Calgary, Alberta, T2N 2T9, Canada|Pfizer Investigational Site, Edmonton, Alberta, T5G 0B7, Canada|Pfizer Investigational Site, Edmonton, Alberta, T5H 3V9, Canada|Pfizer Investigational Site, Barrie, Ontario, L4M 4S5, Canada|Pfizer Investigational Site, London, Ontario, N6A 5A5, Canada|Pfizer Investigational Site, Toronto, Ontario, M5C 1R6, Canada","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00141245,To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.,https://clinicaltrials.gov/study/NCT00141245,NO,"Seizure Disorder, Partial",DRUG: Pregabalin,ALL,"ADULT, OLDER_ADULT",PHASE3,"Pfizer Investigational Site, Deakin, Australian Capital Territory, 2600, Australia|Pfizer Investigational Site, Chatswood, New South Wales, 2067, Australia|Pfizer Investigational Site, Westmead, New South Wales, 2145, Australia|Pfizer Investigational Site, Maroochydore, Queensland, 4558, Australia|Pfizer Investigational Site, Heidelberg, VIC 3084, Australia|Pfizer Investigational Site, Woodville, 5011, Australia|Pfizer Investigational Site, Graz, A-8035, Austria|Pfizer Investigational Site, Innsbruck, A-6020, Austria|Pfizer Investigational Site, Duffel, 2570, Belgium|Pfizer Investigational Site, Helsinki, 00029, Finland|Pfizer Investigational Site, Turku, FIN-20521, Finland|Pfizer Investigational Site, Lyon, Cedex, 69694, France|Pfizer Investigational Site, Paris, Cedex, 75674, France|Pfizer Investigational Site, Tours, Cedex, 37044, France|Pfizer Investigational Site, Dijon, 21000, France|Pfizer Investigational Site, Paris Cedex 13, 75651, France|Pfizer Investigational Site, Roubaix, 59100, France|Pfizer Investigational Site, Erlangen, 91054, Germany|Pfizer Investigational Site, Freiburg, 79106, Germany|Pfizer Investigational Site, Goettingen, D-37075, Germany|Pfizer Investigational Site, Hamburg, 22292, Germany|Pfizer Investigational Site, Mainz, 55131, Germany|Pfizer Investigational Site, Moenchengladbach, 41179, Germany|Pfizer Investigational Site, Muenster, 48149, Germany|Pfizer Investigational Site, Munich, D-81377, Germany|Pfizer Investigational Site, Firenze, 50135, Italy|Pfizer Investigational Site, Pavia, 27100, Italy|Pfizer Investigational Site, Perugia, 06123, Italy|Pfizer Investigational Site, Pisa, 56126, Italy|Pfizer Investigational Site, Heemstede, 2103 SW, Netherlands|Pfizer Investigational Site, Heeze, 5591 VE, Netherlands|Pfizer Investigational Site, Parow, Cape Town, 7505, South Africa|Pfizer Investigational Site, Durban, 4052, South Africa|Pfizer Investigational Site, San Sebastian, Guipuzcoa, 20014, Spain|Pfizer Investigational Site, Barcelona, 08036, Spain|Pfizer Investigational Site, Gerona, 17007, Spain|Pfizer Investigational Site, Sevilla, 41013, Spain|Pfizer Investigational Site, Goteborg, S-413 45, Sweden|Pfizer Investigational Site, Lavigny, LE, CN-1775, Switzerland|Pfizer Investigational Site, Tschugg, CH-3233, Switzerland|Pfizer Investigational Site, Bimingham, B15 2QZ, United Kingdom|Pfizer Investigational Site, Bucks, SL9 ORJ, United Kingdom|Pfizer Investigational Site, Dundee, DD1 9ND, United Kingdom|Pfizer Investigational Site, Glasgow, G11 6NT, United Kingdom|Pfizer Investigational Site, Liverpool, L9 1AE, United Kingdom|Pfizer Investigational Site, York, Y03 7HE, United Kingdom","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT02286271,Preliminary Testing of a Novel Device to Detect Epileptic Seizures,https://clinicaltrials.gov/study/NCT02286271,NO,Epilepsy,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|Royal Hospital for Sick Children, Edinburgh, EH9 1LF, United Kingdom",
Epilepsy,NCT00067431,A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children,https://clinicaltrials.gov/study/NCT00067431,NO,Partial Seizure Disorder,DRUG: Divalproex Sodium (DepakoteÂ® Sprinkle Capsules),ALL,CHILD,PHASE3,"Pediatric Epilepsy & Neurology Specialist, Tampa, Florida, 33607, United States|Rainbow Babies Children's Hospital, Cleveland, Ohio, 44106, United States|University Hospital of Cleveland, Cleveland, Ohio, United States|PCTI / Children's Hospital, Columbus, Ohio, 43205, United States|Primary Physician's Research, Pittsburgh, Pennsylvania, United States|Texas Association of Pediatric Neurology, PA, San Antonio, Texas, 78258, United States|Virginia Commonwealth University, Richmond, Virginia, 23298-0211, United States","Study Director : Laura Redden, M.D., Ph.D. , Medical Director"
Epilepsy,NCT03949478,Treating Postictal Symptoms Using Ibuprofen and Nifedipine,https://clinicaltrials.gov/study/NCT03949478,NO,"Epilepsy|Epilepsies, Partial",DRUG: Ibuprofen|DRUG: Nifedipine|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Foothills Medical Centre, Calgary, Alberta, T2N T29, Canada|South Health Campus, Calgary, Alberta, T3M 1M4, Canada","Principal Investigator : Paolo Federico, MD, PhD , University of Calgary"
Epilepsy,NCT04291716,Study to Validate Novel Seizure-Detection Algorithm,https://clinicaltrials.gov/study/NCT04291716,NO,"Seizures, Motor|Seizures|Seizure Disorder|Epilepsy|Epileptic Seizures|Epileptic",DEVICE: Motor Seizure Detection Algorithm (mSDA),ALL,"ADULT, OLDER_ADULT",,"Covenant Hospital and Covenant Medical Group, Lubbock, Texas, 79410, United States","Principal Investigator : Haytham Elgammal, MD , Overwatch Digital Health Study Director : Subha Sarcar, PhD , Bracane Company"
Epilepsy,NCT00050934,Pediatric Epilepsy Study,https://clinicaltrials.gov/study/NCT00050934,NO,"Epilepsy|Epilepsies, Partial",DRUG: oxcarbazepine,ALL,CHILD,PHASE3,"Birmingham, Alabama, 35233, United States|Mobile, Alabama, 36693, United States|Los Angeles, California, 90027, United States|Los Angeles, California, 90095, United States|Madera, California, 93638, United States|Orange, California, 92868, United States|Wilmington, Delaware, 19806, United States|Miami, Florida, 33155, United States|Tampa, Florida, 33607, United States|Atlanta, Georgia, 30342, United States|Boise, Idaho, 83712, United States|Ann Arbor, Michigan, 48109, United States|Duluth, Minnesota, 55805, United States|St. Paul, Minnesota, 55102, United States|Chesterfields, Missouri, 63017, United States|Buffalo, New York, 14222, United States|New York, New York, 10016, United States|New York, New York, 10032, United States|Akron, Ohio, 44308, United States|Cincinnati, Ohio, 45229, United States|Cleveland, Ohio, 44106, United States|Portland, Oregon, 97201, United States|Philadelphia, Pennsylvania, 19104, United States|Fort Worth, Texas, 76104, United States|Houston, Texas, 77030, United States|Norfolk, Virginia, 23507, United States|Brigadeiro Hospital, Sao Paulo - SP, 01401-901, Brazil|Kehl-Kork, 77694, Germany|Kiel, 24105, Germany|Novartis, Mexico City, Mexico","Study Director : Novartis Pharmaceuticals , Novartis Pharmaceuticals"
Epilepsy,NCT01657084,Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask,https://clinicaltrials.gov/study/NCT01657084,NO,Epilepsy,DEVICE: CDA Mask|DEVICE: Dummy mask,ALL,"ADULT, OLDER_ADULT",,"Aarhus University Hospital, Aarhus, 8000, Denmark|The Epilepsy Hospital Filadelfia, Dianalund, Denmark","Principal Investigator : Jakob Christensen, M.D., Ph.d. , Aarhus University Hospital"
Epilepsy,NCT06366009,Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy With EEG Extended With Intra-auricular Electrodes,https://clinicaltrials.gov/study/NCT06366009,NO,Epilepsy|Focal Epilepsy|Drug Resistant Epilepsy,DEVICE: NaoX in-ear EEG system,ALL,"ADULT, OLDER_ADULT",,"Kliniki Neurochirurgii CSK UCK WUM, Warsaw, Poland",NaoX Technologies Warsaw Medical University Clinical Center Departments and Clinics of Emergency Medicine of the Medical University of GdaÅ„sk
Epilepsy,NCT03643016,Improving EPilepsy Surgery Management and progNOsis Using Virtual Epileptic Patient Software (VEP),https://clinicaltrials.gov/study/NCT03643016,NO,Epilepsy,OTHER: Surgical strategy based on a software,ALL,"CHILD, ADULT, OLDER_ADULT",,"Assistance Publique Hopitaux de Marseille, Marseille, 13354, France",
Epilepsy,NCT04649008,Localizing Epileptic Networks Using MRI and iEEG,https://clinicaltrials.gov/study/NCT04649008,NO,"Epilepsy|Epilepsy Intractable|Epilepsy, Temporal Lobe",DIAGNOSTIC_TEST: 3T Magnetic Resonance Imaging|DIAGNOSTIC_TEST: Intracranial electroencephalography recordings|DIAGNOSTIC_TEST: 7T Magnetic Resonance Imaging,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States","Principal Investigator : Kathryn A Davis, MD, MSTR , University of Pennsylvania"
Epilepsy,NCT03551431,Comparison of Efficacy Between Suggestion Method During Video EEG Recording by Verbal Suggestion in Isolation and Verbal Suggestion Along With Cotton Swab or Tuning Fork for Inducing the Paroxysmal Event in Children Aged 5 to 18 Years With Suspected Psychogenic Nonepileptic Events,https://clinicaltrials.gov/study/NCT03551431,NO,"EEG, Psychogenic Non Epileptic Events",DIAGNOSTIC_TEST: Video EEG with verbal suggestion,ALL,"CHILD, ADULT",,,"All India Institute of Medical Sciences, New Delhi"
Epilepsy,NCT01311440,Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy,https://clinicaltrials.gov/study/NCT01311440,NO,Epilepsy|Focal Epilepsy|Generalized Epilepsy,OTHER: Modified Atkins diet treatment,ALL,"CHILD, ADULT, OLDER_ADULT",,"Oslo University Hospital, The national Centre for epilepsy, Sandvika, BÃ¦rum Postterminal, 1306, Norway","Principal Investigator : Karl Otto Nakken , Oslo University Hospital"
Epilepsy,NCT05844696,Electrical Neuromodulation for Focal Epilepsy,https://clinicaltrials.gov/study/NCT05844696,NO,Epilepsy,DEVICE: Soterix MXN-5 HD-tES Model 5005A. Medtronic Percept DBS platform.,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,,
Epilepsy,NCT03403907,The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients,https://clinicaltrials.gov/study/NCT03403907,NO,Epilepsy|Epilepsy Intractable,OTHER: Probiotic,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : MarÃ­a GÃ³mez EguÃ­laz , FundaciÃ³n RiojaSalud"
Epilepsy,NCT05285059,Implicit Learning in Epileptic Children,https://clinicaltrials.gov/study/NCT05285059,NO,Epilepsy,BEHAVIORAL: ASRT task,ALL,CHILD,,"Agathe Marcastel, PhD, Bron, 69675, France|Dezso Nemeth, Bron, 69675, France|Service d'Epileptologie Clinique, des Troubles du sommeil et de Neurologie fonctionnelle de l'enfant, Ã HÃ´pital Femme MÃ¨re et Enfant,, Bron, France","Principal Investigator : Marcastel Agathe, PhD , Service d'Epileptologie Clinique, des Troubles du sommeil et de Neurologie fonctionnelle de l'enfant - HÃ´pital Femme MÃ¨re Enfant"
Epilepsy,NCT03013348,Automated Identification of Psychogenic Nonepileptic Seizures,https://clinicaltrials.gov/study/NCT03013348,NO,"Convulsion, Non-Epileptic",DEVICE: Brain Sentinel's sEMG Post-processing algorithm,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Principal Investigator : Jonathan Halford, MD , Medical University of South Carolina"
Epilepsy,NCT04158531,REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.,https://clinicaltrials.gov/study/NCT04158531,NO,Epileptic Seizure|Epilepsy Intractable|Motor Seizure,DEVICE: ECoG sensing and stimulation,ALL,"CHILD, ADULT, OLDER_ADULT",,"University Medical Center Utrecht, Utrecht, 3584 CX, Netherlands","Principal Investigator : Frans Leijten, MD, PhD , UMC Utrecht"
Epilepsy,NCT04607317,Exercise as Adjunctive Treatment for Refractory Epilepsy,https://clinicaltrials.gov/study/NCT04607317,NO,Refractory Epilepsy|Epilepsy,BEHAVIORAL: Exercise program|BEHAVIORAL: Health Coach|BEHAVIORAL: Health Information,ALL,"ADULT, OLDER_ADULT",,"Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States","Principal Investigator : Halley Alexander, MD , Wake Forest University Health Sciences"
Epilepsy,NCT00282854,Genetics of Rolandic Epilepsy,https://clinicaltrials.gov/study/NCT00282854,NO,Epilepsy,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Mailman School of Public Health, Columbia University Medical Center, 722 West 168th St, 6th Floor, New York, New York, 10032, United States","Principal Investigator : Deb K. Pal, MD, PhD , Associate Research Scientist, Mailman School of Public Health, Columbia University Medical Center"
Epilepsy,NCT00236730,A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy,https://clinicaltrials.gov/study/NCT00236730,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Study Director : Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial , Johnson & Johnson Pharmaceutical Research & Development, L.L.C."
Epilepsy,NCT05776745,Study of Speech Function in Epileptic Patients Based on Stereoelectroencephalography Signal,https://clinicaltrials.gov/study/NCT05776745,NO,Epilepsy,BEHAVIORAL: Speech|DEVICE: Stereoelectroencephalography,ALL,"CHILD, ADULT",,"Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, Zhejiang, 310009, China","Second Affiliated Hospital, School of Medicine, Zhejiang University"
Epilepsy,NCT02682927,A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome,https://clinicaltrials.gov/study/NCT02682927,YES,Dravet Syndrome|Seizure Disorder,DRUG: ZX008 (Fenfluramine Hydrochloride)|DRUG: Matching Placebo,ALL,"CHILD, ADULT",PHASE3,"Phoenix Children's, Phoenix, Arizona, 85016, United States|Center for Neurosciences - Tucson, Tucson, Arizona, 85718, United States|Rady Children's Hospital San Diego, San Diego, California, 92123, United States|University of California San Francisco, San Francisco, California, 94143, United States|The Children's Hospital Colorado, Aurora, Colorado, 80045, United States|NW FL Clinical Research Group, LLC, Gulf Breeze, Florida, 32561, United States|Miami Children's Hospital Brain Institute, Miami, Florida, 33155, United States|Neurology and Epilepsy Research Center, Orlando, Florida, 32819, United States|Panda Neurology, Atlanta, Georgia, 30328, United States|Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Boston Children's Hospital, Boston, Massachusetts, 02467, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Saint Barnabas Medical Center, Livingston, New Jersey, 07039, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Cook Children's Medical Center, Fort Worth, Texas, 76087, United States|University of Utah, Salt Lake City, Utah, 84113, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|MultiCare Institute for Research & Innovation, Tacoma, Washington, 98405, United States|Melbourne Brain Centre Austin Hospital, Melbourne, Australia|Children's Health Queensland Hospital and Health Service at Lady Cilento Children's Hospital, South Brisbane, Australia|The Children's Hospital Westmead Dept. of Neurology and Neurosurgery, Westmead, Australia|Universitair Ziekenhuis Antwerpen, Antwerp, Belgium|British Columbia Children's Hospital BCCH, Vancouver, British Columbia, V6H3V4, Canada|Centre Hospitalier Universitaire Sainte-Justine, MontrÃ©al, H3T 1C5, Canada|Danish National Epilepsy Centre, Dianalund, Denmark|French Ref centre Necker Hospital Paris, Paris, France|Epilepsiezentrum / NeuropÃ¤diatrie Hedwig-von-Rittberg-Zentrum FÃ¼r Kinder und Jugendliche, Berlin, Germany|Krankenhaus Mara Epilepsie-Zentrum Bethel, Bielefeld, Germany|Epilepsiezentrum Freiburg, Freiburg, Germany|Universitaetsklinikum Jena Klinik fuer Kinder- und Jugendmedizin Neuropaediatrie, Jena, Germany|Klinik fÃ¼r NeuropÃ¤diatrie UniversitÃ¤tsklinikum Schleswig Holstein Campus Kiel, Kiel, Germany|Kleinwachau Saechsisches Epilepsiezentrum Radeberggemeinnuetzige GmbH, Radeberg, Germany|Universitaetsklinik fuer Kinder- und Jugendmedizin Abteilung III, TÃ¼bingen, Germany|Schoen Klinik Vogtareuth Neuropaediatrie und Neurologische Rehabilitation, Epilepsiezentrum fuer Kinder und Jugendlische,Tagesklinik fuer Neuropaediatrie, Vogtareuth, Germany|AOU Anna Meyer, Firenze, 50139, Italy|Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia, Genova, Italy|A.O Carlo Poma, Mantova, 46100, Italy|Instituto Neurologica Carlo Besta, Milano, 20133, Italy|Ospedale Fatebenefratelli e Oftalmico, Milano, Italy|U.O. Neurologia Dipartimento di Neuroscienze Ospedale Pediatrico Bambino GesÃ¹, IRCS, Roma, 00165, Italy|Ospedal Policlinico Giambattista Rossi diBorga Roma, Verona, 37134, Italy|Okayama University Hospital, Okayama-shi, Okayama, Japan|Saitama Children's Medical Center, Saitama-shi, Saitama, Japan|National Epilepsy Center Shizuoka Institute, Shizuoka-city, Shizuoka, Japan|Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan|Hospital Sant Joande DÃ©u, Barcelona, Spain|Hospital Ruber Internacional Primera Planta Servicio de Neurologia, Madrid, Spain|Clinica Universitaria de Navarra Fase 4. Segunda planta, Consulta de Pediatria, Pamplona, Spain|Birmingham Children Hospital, Birmingham, United Kingdom|Institute of Neurosciences Queens Elizabeth University Hospital, Glasgow, United Kingdom|Alder Hey Hospital, Liverpool, United Kingdom|Evelina Hospital, London, United Kingdom|Great Ormonnd Street Hospital for Children NHS Foundation Trust, London, United Kingdom|Sheffield Children's Hospital, Sheffield, United Kingdom","Study Director : UCB Cares , 001 844 599 2273"
Epilepsy,NCT05015868,"Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies",https://clinicaltrials.gov/study/NCT05015868,NO,"Epilepsies, Partial|Epilepsy Intractable",DIAGNOSTIC_TEST: Standard of care|DIAGNOSTIC_TEST: Functional magnetic resonance imaging-Electroencephalogram combined analysis|DIAGNOSTIC_TEST: High density- electroencephalogram or 7 Tesla magnetic resonance imaging,ALL,"CHILD, ADULT",,"Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, 23842, Italy","Principal Investigator : Stefania Zambrano, MD , Scientific Institute IRCCS Eugenio Medea"
Epilepsy,NCT00236691,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.",https://clinicaltrials.gov/study/NCT00236691,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,,
Epilepsy,NCT00236873,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.",https://clinicaltrials.gov/study/NCT00236873,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Study Director : Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial , Johnson & Johnson Pharmaceutical Research & Development, L.L.C."
Epilepsy,NCT00236860,"A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures",https://clinicaltrials.gov/study/NCT00236860,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Study Director : Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial , Johnson & Johnson Pharmaceutical Research & Development, L.L.C."
Epilepsy,NCT05561166,EPIDREAM 1 : Study of Dreaming in Epilepsy,https://clinicaltrials.gov/study/NCT05561166,NO,Epilepsy,OTHER: EPIDREAM Questionnaire,ALL,"ADULT, OLDER_ADULT",,"Hospices Civils de Lyon, Bron, RhÃ´ne, 69500, France",Hospices Civils de Lyon
Epilepsy,NCT04716673,Stimulation of Sleep in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT04716673,NO,Epilepsy,OTHER: Down-phase targeted auditory stimulation,ALL,"CHILD, ADULT",,"University Children's Hospital Zurich, Zurich, 8032, Switzerland","Principal Investigator : Reto Huber, Prof. Dr. , University Children's Hospital, Zurich"
Epilepsy,NCT05269901,Association Between Ferroptosis and Epilepsy,https://clinicaltrials.gov/study/NCT05269901,NO,Epilepsy,"GENETIC: SLC7A11, GPX4, P53",ALL,CHILD,,"Affiliated Hospital of JiangNan University, Department of Pediatrics, Wuxi, Jiangsu, 226600, China","Study Director : YueYing Liu , Affiliated Hospital of JiangNan University, department of pediatrics"
Epilepsy,NCT05671575,Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life,https://clinicaltrials.gov/study/NCT05671575,NO,Epilepsy,OTHER: Questionnaire about Epilepsy,ALL,"CHILD, ADULT, OLDER_ADULT",,"Sohag university hospital, Sohag, 82611, Egypt",Mohamed Adel Abdellah
Epilepsy,NCT05450822,Precision Medicine in the Treatment of Epilepsy,https://clinicaltrials.gov/study/NCT05450822,NO,Epilepsy,DRUG: Levetiracetam|DRUG: Levetiracetam Tablets|DRUG: Lamotrigine tablet,ALL,"CHILD, ADULT",,"Neurobiology Research Unit, Rigshospitalet, Copenhagen, 2100, Denmark","Principal Investigator : Lars Hageman Pinborg, MD , Neurobiological Research Unit"
Epilepsy,NCT05698537,Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda,https://clinicaltrials.gov/study/NCT05698537,NO,Epilepsy,DIAGNOSTIC_TEST: EEG|DIAGNOSTIC_TEST: Neuroimaging|DIAGNOSTIC_TEST: Blood sample|OTHER: Risk factor questionnaire,ALL,"CHILD, ADULT, OLDER_ADULT",,"King Faisal Hospital, Kigali, Rwanda","Study Chair : Paul Boon, MD-PhD , University Hospital, Ghent Study Director : Dirk Teuwen, MD , University Hospital, Ghent Principal Investigator : Ieme Garrez, MD , University Hospital, Ghent"
Epilepsy,NCT04266990,Olfactive Discriminative Ability of Dogs When Confronted With Seizure and Non-seizure Samples // Identification of Potential Biomarkers for Epilepsy in Human Sweat.,https://clinicaltrials.gov/study/NCT04266990,NO,Epilepsy,OTHER: Planned Sweat collection|OTHER: Spontaneous Sweat collection|OTHER: Healthy volunteers sweat collection,ALL,"ADULT, OLDER_ADULT",,"UZ Gent, Gent, Belgie, 9000, Belgium",University Ghent
Epilepsy,NCT04526418,Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients With Temporal Lobe Epilepsy,https://clinicaltrials.gov/study/NCT04526418,NO,Epilepsy,DEVICE: 24/7 EEGâ„¢ SubQ system,ALL,"ADULT, OLDER_ADULT",,"Mayo Clinic, Phoenix, Arizona, 85054, United States|University of California, Los Angeles, California, 90095, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|University of Pennsylvenia, Philadelphia, Pennsylvania, 19104, United States|UniversitÃ¤t Klinikum Freibrug, Freiburg, 79106, Germany|Walton Centre NHS Foundation Trust, Fazakerley, Liverpool, L9 7LJ, United Kingdom","Principal Investigator : Michael Gelfand , University of Pennsylvania"
Epilepsy,NCT04705441,Self-management for People With Epilepsy,https://clinicaltrials.gov/study/NCT04705441,NO,Epilepsy,BEHAVIORAL: SMART 2,ALL,"ADULT, OLDER_ADULT",,"University of Iowa, Iowa City, Iowa, 52242, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States","Principal Investigator : Martha Sajatovic, MD , Case Western Reserve University Principal Investigator : Gena Ghearing, MD , University of Iowa"
Epilepsy,NCT03582345,Investigation of Human Epileptic Networks by fMRI,https://clinicaltrials.gov/study/NCT03582345,NO,Epilepsy,PROCEDURE: EEG/fMRI,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Anna Elisabetta Vaudano, MD , Azienda Unita' Sanitaria Modena"
Epilepsy,NCT05934786,Rehabilitation of Cognition and Psychosocial Well-being in Epilepsy,https://clinicaltrials.gov/study/NCT05934786,NO,Epilepsy,BEHAVIORAL: Cognitive rehabilitation,ALL,"ADULT, OLDER_ADULT",,,Vilnius University
Epilepsy,NCT05082181,Telephone-Based Support Programs for People With Epilepsy,https://clinicaltrials.gov/study/NCT05082181,NO,Epilepsy,BEHAVIORAL: UPLIFT (Using Practice and Learning to Increase Favorable Thoughts)|BEHAVIORAL: BOOST (Bringing Out Our Strength Together),ALL,"ADULT, OLDER_ADULT",,"NYU Langone Health, New York, New York, 10016, United States","Principal Investigator : Tanya Spruill , NYU Langone Health Principal Investigator : Daniel Friedman, MD , NYU Langone Health"
Epilepsy,NCT05683847,User Controlled Follow-up of Epilepsy,https://clinicaltrials.gov/study/NCT05683847,NO,Epilepsy,OTHER: User controlled epilepsy follow-up by means of patient reported outcome measures (PROM),ALL,"ADULT, OLDER_ADULT",,"Drammen Hospital, Drammen, 3004, Norway","Study Chair : Marte Syvertsen, PhD , Vestre Viken Hospital Trust"
Epilepsy,NCT05384782,Computational Decision Support in Epilepsy Using Retrospective EEG,https://clinicaltrials.gov/study/NCT05384782,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,"Cornwall Partnership NHS Foundation Trust, Bodmin, Cornwall, PL31 2QN, United Kingdom",Neuronostics Ltd
Epilepsy,NCT00236847,A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.,https://clinicaltrials.gov/study/NCT00236847,NO,"Epilepsy|Epilepsies, Partial|Seizures",DRUG: topiramate,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Study Director : Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial , Johnson & Johnson Pharmaceutical Research & Development, L.L.C."
Epilepsy,NCT05898438,The Role of Gut Microbiota in Children With Epilepsy Following Ketogenic Diet,https://clinicaltrials.gov/study/NCT05898438,NO,Epilepsy,,ALL,"CHILD, ADULT",,"Attikon Athens University Hospital, Athens, Haidari, 12462, Greece","Study Chair : Argirios Dinopoulos, Professor , 3rd Pediatric Clinic, Attikon Athens University Hospital"
Epilepsy,NCT06139198,Self-management Intervention for Reducing Epilepsy Burden Among Ugandans With Epilepsy.,https://clinicaltrials.gov/study/NCT06139198,NO,Epilepsy,BEHAVIORAL: Self-MAnagement intervention for Reducing The epilepsy burden among Ugandans,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Mark Kaddumukasa, MD , Makerere University Principal Investigator : Martha Sajatovic, MD , Case Western Reserve University"
Epilepsy,NCT06052605,Healthy Aging in People With Epilepsy Program,https://clinicaltrials.gov/study/NCT06052605,NO,Epilepsy,BEHAVIORAL: Healthy Aging in People with Epilepsy Program,ALL,"ADULT, OLDER_ADULT",,"University of Califonia, San Diego, San Diego, California, 92093, United States","University of California, San Diego"
Epilepsy,NCT05200455,Microelectrodes in Epilepsy,https://clinicaltrials.gov/study/NCT05200455,YES,Epilepsy,DEVICE: Microelectrodes,ALL,"ADULT, OLDER_ADULT",,"Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States","Principal Investigator : Barbara C Jobst, MD, PhD , Section Chief of Adult Neurology"
Epilepsy,NCT04944641,"Epilepsy Prevalence and Intervention Study in Zhejiang Province, China",https://clinicaltrials.gov/study/NCT04944641,NO,Epilepsy,BEHAVIORAL: education on epilepsy|DRUG: routine and proper antiepileptic drugs,ALL,"CHILD, ADULT, OLDER_ADULT",,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, China|Shengzhou People's Hospital, Shengzhou, China",Hangzhou Center of Disease Control and Prevention The Central Hospital of Lishui City The Second Affiliated Hospital of Jiaxing University Shengzhou People's Hospital Children's Hospital Affiliated to Zhejiang University School of Medicine
Epilepsy,NCT01281956,PRX-00023 Therapy in Localization-Related Epilepsy,https://clinicaltrials.gov/study/NCT01281956,YES,"Epilepsy|Epilepsy, Temporal Lobe|Partial Epilepsy",DRUG: PRX-00023|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States","Principal Investigator : William H Theodore, M.D. , National Institute of Neurological Disorders and Stroke (NINDS)"
Epilepsy,NCT06346262,Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care,https://clinicaltrials.gov/study/NCT06346262,NO,Epilepsy,BEHAVIORAL: SMART RM|DRUG: Valtoco Nasal Product,ALL,"ADULT, OLDER_ADULT",PHASE4,"University Hospitals Medical Center, Cleveland, Ohio, 44106, United States",
Epilepsy,NCT04692701,Pulvinar Stimulation in Epilepsy: a Pilot Study,https://clinicaltrials.gov/study/NCT04692701,NO,Epilepsy,DEVICE: Pulvinar deep brain stimulation,ALL,ADULT,,"Service de Neurologie, Nice, 13385, France","Study Director : Jean-Olivier Arnaud , Assistance Publique HÃ´pitaux de Marseille"
Epilepsy,NCT05335187,Hybrid Micro-macro Electrodes in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT05335187,NO,Epilepsy,DEVICE: micro-macro electrode implantation,ALL,"ADULT, OLDER_ADULT",,"HÃ´pitaux Universitaires de GenÃ¨ve, GenÃ¨ve, CH, 1205, Switzerland","Principal Investigator : Pierre MÃ©gevand, MD, PhD , University of Geneva"
Epilepsy,NCT01273129,Surgery as a Treatment for Medically Intractable Epilepsy,https://clinicaltrials.gov/study/NCT01273129,NO,"Epilepsy|Epilepsy, Temporal Lobe|Partial Epilepsy",,ALL,"CHILD, ADULT, OLDER_ADULT",,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States","Principal Investigator : Kareem A Zaghloul, M.D. , National Institute of Neurological Disorders and Stroke (NINDS)"
Epilepsy,NCT02952456,Phenomenological Approach of Epilepsy in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT02952456,NO,Epilepsy,OTHER: interview with a psychologist,ALL,"CHILD, ADULT, OLDER_ADULT",,"Uhmontpellier, Montpellier, 34295, France","Study Director : GERALD BOURREL, MD PhD , University of Montpellier"
Epilepsy,NCT04559919,Prospective Regional Epilepsy Database,https://clinicaltrials.gov/study/NCT04559919,NO,Epilepsy,OTHER: Seizure status|DIAGNOSTIC_TEST: Tests|OTHER: Epilepsy|OTHER: Demographics and psychosocial|OTHER: Health care,ALL,"ADULT, OLDER_ADULT",,"SÃ¶dra Ã„lvsborgs Sjukhus, BorÃ¥s, Sweden|Sahlgrenska University Hospital, Gothenburg, 41345, Sweden|Sjukhusen i VÃ¤ster, Gothenburg, Sweden","Principal Investigator : Johan Zelano, MD PhD , Sahlgrenska University Hospital, Sweden"
Epilepsy,NCT06082999,Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services,https://clinicaltrials.gov/study/NCT06082999,NO,Epilepsy,,ALL,CHILD,,"Boston Children's Hospital, Boston, Massachusetts, 02115, United States|Murdoch Childrens Research Institute, Parkville, Victoria, 3052, Australia|The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|UCL Great Ormond Street Institute of Child Health, London, WC1N 1DZ, United Kingdom","Principal Investigator : Amy McTague , UCL Great Ormond Street Institute of Child Health"
Epilepsy,NCT00594945,Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures,https://clinicaltrials.gov/study/NCT00594945,YES,Epilepsy,DRUG: Clonazepam,ALL,"ADULT, OLDER_ADULT",PHASE2,"Clinical Trials. inc., Little Rock, Arkansas, 72205, United States|Mid-Atlantic Epilepsy & Sleep Center, Bethesda, Maryland, 20817, United States|Columbia Comprehensive Epilepsy Center, Neurological Institute, New York, New York, 10032, United States|Ohio State University, Columbus, Ohio, 43210, United States|Neurological Clinic of Texas, PA, Dallas, Texas, 75232, United States|Tampere University Hospital, Tampere, 33521, Finland","Study Director : Beverly Benson, PhD , Jazz Pharmaceuticals"
Epilepsy,NCT05637086,Clinical Study Evaluating Safety of Pentoxifylline in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy,https://clinicaltrials.gov/study/NCT05637086,NO,Epilepsy,DRUG: Phenytoin|DRUG: Pentoxifylline 400 MG,ALL,"ADULT, OLDER_ADULT",PHASE2,"Mansoura University, Mansoura, 35516, Egypt","Sahar El-Haggar, Prof Clinical pharmacy Department- Tanta University Principal Investigator Maha Ahmed Younis, PhD Pharmacy Practice Department- Horus University Tarek Mohamed Mostafa, Prof Clinical pharmacy Department- Tanta University"
Epilepsy,NCT06202196,Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy,https://clinicaltrials.gov/study/NCT06202196,NO,Epilepsy,PROCEDURE: Risk prevention session|PROCEDURE: Usual Therapeutic Patient Education (TPE) management,ALL,ADULT,,"CHU Gui de Chauliac, Montpellier, France","University Hospital, Montpellier"
Epilepsy,NCT05096871,Association of Brain Derived Neurotrophic Factor (BDNF) rs6265 Gene Polymorphism With Susceptibility to Epilepsy,https://clinicaltrials.gov/study/NCT05096871,NO,Epilepsy,GENETIC: Genotyping by Real Time PCR,ALL,CHILD,,,Sohag University
Epilepsy,NCT05325047,Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy: A Case Study,https://clinicaltrials.gov/study/NCT05325047,NO,Epilepsy,PROCEDURE: Intensive speech rehabilitation,ALL,"ADULT, OLDER_ADULT",,"CHU Bordeaux, Bordeaux, 33000, France","Study Director : FranÃ§ois CREMIEUX , APHM"
Epilepsy,NCT00537940,Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures,https://clinicaltrials.gov/study/NCT00537940,YES,"Epilepsy|Partial Seizure Disorder|Epilepsies, Partial|Complex Partial Seizure Disorder",DRUG: Pregabalin|DRUG: Gabapentin,ALL,"ADULT, OLDER_ADULT",PHASE4,"Hospital Clinica Biblica, San Jose, Costa Rica|Instituto de Neurociencias, San Salvador, 01503, El Salvador|Clinica de Especialidades Neurologicas, San Salvador, El Salvador|Private Office, Guatemala Ciudad, 01014, Guatemala|Private Office, Guatemala, Guatemala|Clinica Anglo Americana, Lima, 27, Peru|Torre de Consultorios Clinica Anglo Americana, Lima, L-27, Peru|Hospital Nacional Guillermo Almenara Irigoyen - Essalud, Lima, L13, Peru","Study Director : Pfizer CT.gov Call Center , Pfizer"
Epilepsy,NCT00706160,Language Mapping in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT00706160,NO,"Epilepsy|Epilepsy, Temporal Lobe|Partial Epilepsy",,ALL,"CHILD, ADULT",,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States","Principal Investigator : William H Theodore, M.D. , National Institute of Neurological Disorders and Stroke (NINDS)"
Epilepsy,NCT04876820,Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients,https://clinicaltrials.gov/study/NCT04876820,NO,Epilepsy,OTHER: Pharmacist intervention|OTHER: Standard of care,ALL,"ADULT, OLDER_ADULT",,"Hopital Roger Salengro, CHU Lille, Lille, 59037, France","Principal Investigator : Philippe DERAMBURE, MD,PhD , University Hospital, Lille"
Epilepsy,NCT00522418,Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients,https://clinicaltrials.gov/study/NCT00522418,YES,Epilepsy|Partial Epilepsy,DEVICE: Vagal Nerve Simulation (VNS) Therapy|DRUG: Best Medical Practive,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"ULB-HÃ´pital Erasme, Centre de rÃ©fÃ©rence pour le traitement de l'Ã©pilepsie rÃ©fractaire - Neurologie, Brussels, 1070, Belgium|UZ Gent, Department of Neurology, 1K12/A, Gent, 9000, Belgium|Foothills Hospital, Neurology Department, Calgary, Alberta, T1Y6J4, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 3A7, Canada|Hopital Notre Dame, Montreal, Quebec, H2L 4M1, Canada|Montreal Neurological Institute, Clinical Research, Montreal, Quebec, H3A 2B4, Canada|CHU Grenoble, Neurology Department, Grenoble, 38043, France|Hopital Roger Salengro, Service de Neurologie, Lille, 59037, France|HÃ´pital Neurologique, UntitÃ© d'Ã©pileptologie, Lyon, 69003, France|HÃ´pital Gui De Chauliac, Service Explorations Neurologiques et Epileptologie, Montpellier, 34295, France|HÃ´pital Sainte-Anne, Service de Neurochirurgie, Paris, 75674, France|Service d'exploration des Ã©pilepsies, Strasbourg, 67091, France|CHU Tours, Service de neurologie, Tours, 37044, France|UniversitÃ¤tskliniken Bonn, Klinik fÃ¼r Epileptologie, Bonn, 53105, Germany|UniversitÃ¤tsklinik Erlangen, Zentrum fÃ¼r Epilepsie ZEE, Erlangen, 91054, Germany|Klinik der Ernst-Moritz-Arndt-UniversitÃ¤t, Neurologische Klinik, Greifswald, 17487, Germany|Epilepsiezentrum Kork, Kehl-Kork, 77694, Germany|Klinikum der Philips-UniversitÃ¤t Marburg, Fachbereich, 20 - Medizin / Klinik Neurologie / Epilepsie Zentrum, Marburg, 35039, Germany|SÃ¤chsisches Epilepsiezentrum Radeberg, Epilepsiezentrum Kleinwachau, Radeberg, 01465, Germany|Azienda Ospedaliero Universitaria - Ospedali Riuniti Umberto I - Lancisi - Salesi, NeuroPsichiatria Infantile, Ancona, 60100, Italy|Universita di Bologna, Clinica Neurologica, Bologna, 40123, Italy|Azienda Ospendaliero-Universitaria, Caressi Dep Neuroscience, Firenze, 50100, Italy|Ospedale San Paolo, Centro Epilessia, Milano, 20142, Italy|Universita degli Studi di Cagliari - Policlinico Monserrato, Clinica Neurologica, Monserrato, 09042, Italy|Universita di Pisa, Clinica Neurologica, Pisa, 56126, Italy|Ospedale F. Lotti, NeuroFisioPatalogia, Pontedera, 56025, Italy|Azienda Ospedaliera ""Bianchi Melacrino Morelli"", Centro Regionale Epilessie, Reggio Calabria, 89100, Italy|UniversitÃ Cattolica Del Sacro Cuore, Istituto di NeuroChirurgia, Roma, 00168, Italy|Centro Epilessia, Dipartimento di Neuroscienze, Torino, 10126, Italy|Tergooiziekenhuizen, Dienst Neurologie, Blaricum, 1261, AN, Netherlands|Medisch Spectrum Twente, Dienst Neurologie, Enschede, 7513 R, Netherlands|Stichting Epilepsie Instituut Nederland, Dienst Neurologie, Heemstede, 8025 BV, Netherlands|Kempenhaeghe, Dienst Neurologie, Oosterhout, 4901 ZG, Netherlands|Medisch Centrum Rijnmond-Zuid, locatie Clara, Dienst Neurologie, Rotterdam, 3078 HT, Netherlands|Spesialsykehuset for Epilepsi, Dep of Neurodiagnostics, Sandvika, 1306, Norway|Hospital Ruber Internacional, Servicio de neurologÃ­a, Madrid, 28034, Spain|Hospital ClÃ­nico de Santiago, Santiago de Compostela, 15706, Spain|Hospital ClÃ­nico Universitario, Servicio de neurologÃ­a, Valencia, 46010, Spain|Hospital General de Valencia, Neurology/Neurophisiology, Valencia, 46014, Spain|Hospital General Basico De La Defensa de Valencia, Servicio de neurologÃ­a, Valencia, 46930, Spain|Institute of Neuroscience and Physiology, Clinical Neuroscience and Rehabilitation, Goteborg, 41345, Sweden|Universitetssjukhuset i Lund, Neurologiska kliniken, Lund, 221 85, Sweden|Norrlands Universitetssjukhus, Neurocentrum, Umea, 901 85, Sweden|Akademiska sjukhuset, Neurocentrum, Uppsala, 751 85, Sweden|Addenbrookes Hospital, Dept of Neurosurgery, Cambridge, CB2 2QQ, United Kingdom|Walton Centre, Dept of Neurosciences, Clinical Sciences Centre, Fazakerley, L97LJ, United Kingdom|Kings College Hospital, Dept of Neurosurgery, London, SE5 9RS, United Kingdom|National Hospital for Neurology and Neurosurgery, London, WC1N3B, United Kingdom","Principal Investigator : Phillippe Ryvlin, MD , Hopital Neurologique, Lyon, France Study Director : Sophie Leyman, MD , Cyberonics Europe"
Epilepsy,NCT00851331,Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits,https://clinicaltrials.gov/study/NCT00851331,NO,Epilepsy,GENETIC: genome analyzes (genetic defects and pathophysiological mechanisms ),ALL,"CHILD, ADULT, OLDER_ADULT",,"HÃ´pital Femme MÃ¨re Enfant - Hospices Civils de Lyon, Service Epilepsie, Sommeil et Exploration fonctionnelle neurologique pÃ©diatrique, Bron, 69500, France|American Memorial Hospital, CHU de Reims, UnitÃ© de Neurologie PÃ©diatrique - Service PÃ©diatrie A, Reims, 51092, France|Clinique neurologique, HÃ´pitaux Universitaires de Strasbourg, Strasbourg, 67091, France|HÃ´pital de Hautepierre, Service de pÃ©diatrie 1, Strasbourg, 67098, France","Principal Investigator : Edouard HIRSCH, MD , University Hospital, Strasbourg, France"
Epilepsy,NCT06427967,A Novel Social Emotional Learning Curriculum for Youth With Epilepsy,https://clinicaltrials.gov/study/NCT06427967,NO,Epilepsy,BEHAVIORAL: Project Dream Team,ALL,"CHILD, ADULT",,"Boston Medical Center, Neurology and remote, Boston, Massachusetts, 02118, United States","Principal Investigator : Laurie Douglass, MD , Boston Medical Center, Department of Neurology"
Epilepsy,NCT05722951,Metformin Efficacy and Safety in Epileptic Patients,https://clinicaltrials.gov/study/NCT05722951,NO,Epilepsy,DRUG: Levetiracetam|DRUG: Metformin,ALL,"ADULT, OLDER_ADULT",PHASE3,"Omnia Ashraf Abd El Aziz Ahmed Kotb, Alexandria, Egypt",Tanta University
Epilepsy,NCT02358538,Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies,https://clinicaltrials.gov/study/NCT02358538,YES,Epilepsy,DRUG: Ganaxolone,ALL,"CHILD, ADULT",PHASE2,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|Sutter Institute for Medical Research, Sacramento, California, 95816, United States|University of California San Francisco, San Francisco, California, 94143, United States|Center for Rare Neurological Diseases, Norcross, Georgia, 30093, United States|JWM Neurology, Indianapolis, Indiana, 46239, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States|Northeast Regional Epilepsy Group, Hackensack, New Jersey, 07601, United States|Institute of Neurology and Neurosurgery at St. Barnabas, Livingston, New Jersey, 07039, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Bambino Gesu Children's Hospital, IRCCS, Rome, 00165, Italy",Marinus Pharmaceuticals
Epilepsy,NCT05491369,Effectiveness of an Epilepsy Application for Self-management in Viet Nam,https://clinicaltrials.gov/study/NCT05491369,NO,Epilepsy,OTHER: Epilepsy application,ALL,"ADULT, OLDER_ADULT",,"Nguyen Tri Phuong Hospital, Ho Chi Minh City, 700000, Vietnam|University Medical Center at Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam","Study Chair : Minh-An T Le, Master , University of Medicine and Pharmacy at HCMC"
Epilepsy,NCT05552924,Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients,https://clinicaltrials.gov/study/NCT05552924,NO,Epilepsy,OTHER: Self-Acupressure,ALL,"ADULT, OLDER_ADULT",,"Firat University, ElazÄ±g, Turkey","Study Director : GÃ¼lcan BahÃ§ecioÄŸlu Turan, PhD , Firat University"
Epilepsy,NCT06175247,Low-Glycemic (LGI) Diet in Pregnant People With Epilepsy,https://clinicaltrials.gov/study/NCT06175247,NO,Epilepsy,OTHER: Low Glycemic Index Diet,FEMALE,ADULT,,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States",Epilepsy Foundation
Epilepsy,NCT06352476,The Effect of Sleep Hygiene Given to Epilepsy Patients on Seizure Frequency and Sleep Quality,https://clinicaltrials.gov/study/NCT06352476,NO,Epilepsy,BEHAVIORAL: Sleep Hygiene Training,ALL,"ADULT, OLDER_ADULT",,"Marmara University, Istanbul, Turkey",Marmara University
Epilepsy,NCT06105645,Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy,https://clinicaltrials.gov/study/NCT06105645,NO,Epilepsy,DEVICE: DIXI Medical MicrodeepÂ® Micro- Macro Depth electrodes|DEVICE: Standard electrodes,ALL,"ADULT, OLDER_ADULT",,"CHU Amiens Picardie, Amiens, France|CHU de Lille, Lille, France|Hospices Civils de Lyon, Lyon, France|CHRU de Nancy, Nancy, France|CHU de Rennes, Rennes, France|HÃ´pitaux universitaires de Strasbourg, Strasbourg, France|University Hospital of Toulouse, Toulouse, 31059, France","Principal Investigator : Luc VALTON, MD , University Hospital, Toulouse"
Epilepsy,NCT05307146,Brain Activity in Epilepsy,https://clinicaltrials.gov/study/NCT05307146,NO,Epilepsy,DEVICE: macro/micro electrode recording,ALL,"ADULT, OLDER_ADULT",,"UZ Leuven, Leuven, 3000, Belgium",Universitaire Ziekenhuizen KU Leuven
Epilepsy,NCT05559060,Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction),https://clinicaltrials.gov/study/NCT05559060,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,,Assiut University
Epilepsy,NCT05992402,Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery,https://clinicaltrials.gov/study/NCT05992402,NO,Epilepsy,BEHAVIORAL: ReBOOT program,ALL,ADULT,,"Cleveland Clinic, Cleveland, Ohio, 44195, United States","Principal Investigator : Kayela Arrotta, PhD , The Cleveland Clinic"
Epilepsy,NCT05290610,Intracranial Stimulation Mapping In Epilepsy,https://clinicaltrials.gov/study/NCT05290610,NO,Epilepsy,OTHER: Functional mapping,ALL,"ADULT, OLDER_ADULT",,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","Principal Investigator : Alexander Herman, MD , UMN"
Epilepsy,NCT06334029,Observational Study of the Structural-functional Connectome in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT06334029,NO,Epilepsy,DIAGNOSTIC_TEST: Functional and structural Connectome,ALL,"CHILD, ADULT, OLDER_ADULT",,"IRCCS E.Medea, Conegliano, Treviso, 31015, Italy","Principal Investigator : Gian Marco Duma, PhD , IRCCS E. Medea"
Epilepsy,NCT05182437,Precision Radiation Treatment for Epilepsy (PRECISION),https://clinicaltrials.gov/study/NCT05182437,NO,Epilepsy,RADIATION: LINAC-based Stereotactic Radiotherapy,ALL,"ADULT, OLDER_ADULT",,"Maastricht Radiation Oncology, Maastricht, Limburg, 6202 AZ, Netherlands",
Epilepsy,NCT02318446,Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics,https://clinicaltrials.gov/study/NCT02318446,NO,Epilepsy,DRUG: Folic Acid|DRUG: Saccharine,ALL,"CHILD, ADULT",PHASE3,"Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, 411041, India","Principal Investigator : UMA A. BHOSALE, MD , Smt. Kashibai Navale Medical College and General Hospital"
Epilepsy,NCT04290975,Bridging the Childhood Epilepsy Treatment Gap in Africa,https://clinicaltrials.gov/study/NCT04290975,NO,Epilepsy,OTHER: Task-shifting of follow-up care for pediatric epilepsy|OTHER: Enhanced usual care for pediatric epilepsy,ALL,CHILD,,"Federal Neuro-Psychiatric Hospital, Kaduna, Nigeria|Aminu Kano Teaching Hospital, Kano, Nigeria|Ahmadu Bello University Teaching Hospital, Zaria, Nigeria","Principal Investigator : Edwin Trevathan, MD, MPH , Vanderbilt University Medical Center Principal Investigator : Aminu Taura, MBBS , Aminu Kano Teaching Hospital"
Epilepsy,NCT04967326,Role of Clinical Pharmacists in Epilepsy Management,https://clinicaltrials.gov/study/NCT04967326,NO,Epilepsy,"DRUG: Optimizing therapy with antiepileptic drugs (carbamazepine, phenytoin, valproic acid)",ALL,"ADULT, OLDER_ADULT",PHASE4,,Gia Dinh People Hospital
Epilepsy,NCT05359003,Steps for Epilepsy,https://clinicaltrials.gov/study/NCT05359003,NO,Epilepsy,BEHAVIORAL: 12-week physical activity program,ALL,"ADULT, OLDER_ADULT",,"Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, 27046, United States","Principal Investigator : Halley Alexander, MD , Wake Forest Health Sciences"
Epilepsy,NCT02726919,Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy,https://clinicaltrials.gov/study/NCT02726919,NO,Epilepsy,DRUG: Clobazam,ALL,"ADULT, OLDER_ADULT",PHASE4,"MidAtlantic Epilepsy and Sleep Center, Bethesda, Maryland, 20817, United States",
Epilepsy,NCT05944692,Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG),https://clinicaltrials.gov/study/NCT05944692,NO,Epilepsy,DEVICE: Tripolar electroencephalography,ALL,"CHILD, ADULT, OLDER_ADULT",,"Barrow Neurological Institute Dignity Health dba St. Joseph's Hospital and Medical Center, Phoenix, Arizona, 85013, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States",
Epilepsy,NCT03926273,Serum and Urine Ghrelin in Adult Epileptic Patients,https://clinicaltrials.gov/study/NCT03926273,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,"Nageeb, Zagazig, El Sharkia, 002, Egypt","Principal Investigator : nageeb rania, PI , zagazig U"
Epilepsy,NCT04749901,Symptoms of Post-traumatic Stress in Adult Drug-resistant Epilepsies,https://clinicaltrials.gov/study/NCT04749901,NO,Epilepsy,OTHER: Psycho-emotional and semiological measures,ALL,ADULT,,"Assistance Publique Hopitaux de Marseille, Marseille, 13354, France",
Epilepsy,NCT05741541,How Would the Creation of a Follow-up Methodology in Consultation Improve the Care of the Epileptic Patient?,https://clinicaltrials.gov/study/NCT05741541,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,"HÃ´pital Nord Franche-ComtÃ©, TrÃ©venans, 90400, France",Hopital Nord Franche-Comte
Epilepsy,NCT06388174,Idiopathic Generalized Epilepsy Syndromes,https://clinicaltrials.gov/study/NCT06388174,NO,"Epilepsy|Epilepsy, Idiopathic Generalized",,ALL,"CHILD, ADULT",,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, 310000, China","Principal Investigator : Chunhong Shen , Second Affiliated Hospital, School of Medicine, Zhejiang University"
Epilepsy,NCT04924933,Evaluation of Memory and Forgetting in Patients With Epilepsy,https://clinicaltrials.gov/study/NCT04924933,NO,Epilepsy,DIAGNOSTIC_TEST: Computerised associative memory task using abstract words and landscape photographs,ALL,ADULT,,"Hospices Civils de Lyon Service de Neurologie Fonctionnelle et d'Epileptologie, Bron, 69500, France","Principal Investigator : Victoria Guinet, PhD student , Service de Neurologie Fonctionnelle et d'Epileptologie"
Epilepsy,NCT04687904,Mindfulness Meditation for Epilepsy,https://clinicaltrials.gov/study/NCT04687904,NO,Epilepsy,BEHAVIORAL: Mindfulness meditation training|BEHAVIORAL: Therapeutic education,ALL,"CHILD, ADULT, OLDER_ADULT",,"Centre Hospitalier Universitaire, Rennes, 35033, France","Study Chair : Isabelle MERLET, PhD , LTSI - INSERM UMR 1099"
Epilepsy,NCT04106284,Comorbidities of Epilepsy,https://clinicaltrials.gov/study/NCT04106284,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,,
Epilepsy,NCT03738072,Intracerebral Electrical Stimulation and the Optimisation of Presurgical Planning in Drug-refractory Partial Epilepsy,https://clinicaltrials.gov/study/NCT03738072,NO,Epilepsy,DIAGNOSTIC_TEST: StiMiC stimulation condition,ALL,"CHILD, ADULT, OLDER_ADULT",,"CHU de Toulouse, Toulouse, 3100, France",
Epilepsy,NCT00165828,Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization,https://clinicaltrials.gov/study/NCT00165828,NO,Epilepsy,DRUG: Zonegran,ALL,"ADULT, OLDER_ADULT",PHASE4,"Epilepsieklinik Tabor, Bernau, Brandenburg, 16321, Germany|Universtitatsklinikum Bonn, Bonn, Nordrhein-Westphalen, 53105, Germany|Universtitatsklinikum Munster, Klinik und Poliklinik fur Neurologie, Munster, Nordrhein-Westphalen, 48129, Germany|Epilepsiezentrum Bethel/KSE, Beilefeld, 33617, Germany|Institut fur Diagnostik der Epilepsien Gmbh, Berlin, 10362, Germany|Charite Campus Virchow-Klinikum, Neurologische Klinik und Poliklinik, Berlin, 13353, Germany|St. Josephs Hospital, Neurologische Klinik, Bochum, 44791, Germany|Dr. Gunther Schumann, Bochum, 44805, Germany|Knappschaftskrankenhaus Bochum-Langendreer, Neurologische Klinik, Bochum, 44892, Germany|Dr. Hans Martin Kolbinger, Bonn, 53127, Germany|Neuro-Consil Gmbh, Dusseldorf, 40212, Germany|Neurologische Klinik der Universitat Erlangen, Erlangen, 91054, Germany|Universitatsklinik Essen, Klinik und Poliklinik fur Neurologie, Essen, 45147, Germany|Universitatsklinikum Freiburg, Neurozentrum, Freiburg, 79106, Germany|Universitatsklinikum Gottingen, Abt. fur klinische Neurophysiologie, Gottingen, 37075, Germany|Gemeinschaftpraxis fur Neurologie und Psychiatrie, Hamburg, 22083, Germany|Dr. Heinrich C. Braeuer, Hamburg, 22299, Germany|Ev. Krankenhaus Alsterdorf, Epilepsiezentrum Alsterdorf, Hamburg, 22337, Germany|Epilepsiezentrum Kork, Kehl, 77694, Germany|Epilepsiezentrum Kleinwachau, Epilepsieambulanz, Liegau-Augustusbad, 01465, Germany|Universitatsklinikum Mannheim, Neurologische Klinik, Ambulanz fur Anfallserkrankte, Mannheim, 68167, Germany|Universitatsklinikum, Interdisziplinares Epilepsiezentrum, Marburg, 35043, Germany|Klinikum Grosshadern, Neurologische Klinik und Poliklinik, Epilepsie-Ambulanz, Munchen, 81377, Germany|Klinikum Offenbach, Neurologie, Offenbach, 63069, Germany|Klinik Ernst von Bergmann, Potsdam, 14467, Germany|Universitat Regensburg, Klinik un Poliklinik fur Neurologie, Regensburg, 93053, Germany|Klinik ""Die Weissenau"", Anfallsambulanz, Revensburg, 88214, Germany|Universitat Rostock, Klinik fur Neurologie und Poliklinik, Rostock, 18147, Germany|Universitatsklinik Ulm Poliklinik fur Neurologie, Epilepsieambulanz, Ulm, 89075, Germany|Dr. Horst-Schmidt Klinik, Neurologie, Wiesbaden, 65199, Germany","Principal Investigator : Christian Elger , Universitatsklinikum Bonn, Klinik fur Epileptologie"
Epilepsy,NCT05127499,The Effect of Progressive Relaxation Exercises Applied to Patients With Epilepsy,https://clinicaltrials.gov/study/NCT05127499,NO,Epilepsy,OTHER: progressive relaxation exercises,ALL,ADULT,,"FÄ±rat Ãœniversitesi, ElazÄ±ÄŸ, Turkey","Study Chair : GÃ¼lcan Bahcecioglu Turan, PhD , Firat University"
Epilepsy,NCT05864612,Tools for Anxiety and Depression Screening in Epilepsy,https://clinicaltrials.gov/study/NCT05864612,NO,Epilepsy,BEHAVIORAL: Screening Questionnaires,ALL,"ADULT, OLDER_ADULT",,"Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, 27157, United States","Principal Investigator : Heidi M. Munger Clary, MD, MPH , Wake Forest University Health Sciences"
Epilepsy,NCT06180538,Exploring Patient Impact & Value in Epilepsy Wearables for Seizure Monitoring,https://clinicaltrials.gov/study/NCT06180538,NO,Epilepsy,,ALL,"ADULT, OLDER_ADULT",,,Beaumont Hospital
Epilepsy,NCT06321822,Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy,https://clinicaltrials.gov/study/NCT06321822,NO,Epilepsy,DIAGNOSTIC_TEST: Whole exome sequencing (WES),ALL,"CHILD, ADULT, OLDER_ADULT",,"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy","Principal Investigator : Robertino Dilena, MD , Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan"
Epilepsy,NCT04725162,Epileptogenic Focus Localization for Children With Epilepsy Using 18F-FDG PET Molecular Imaging,https://clinicaltrials.gov/study/NCT04725162,NO,Epilepsy,RADIATION: 18F-FDG,ALL,"CHILD, ADULT",,"Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China",
Epilepsy,NCT04569071,Clinical Trial of MgLiTT for Medical Refractory Epilepsy,https://clinicaltrials.gov/study/NCT04569071,NO,Epilepsy,DEVICE: Sinovation Laser Ablation System,ALL,"CHILD, ADULT, OLDER_ADULT",,"Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, 100070, China","Study Director : Kai Zhang, Dr. , Beijing Tiantan Hospital"
Vitiligo,NCT01206374,Questionnaire and Laboratory Data on Vitiligo Vulgaris,https://clinicaltrials.gov/study/NCT01206374,NO,Vitiligo Vulgaris,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Department of Dermatology, Beth Israel Medical Center, New York, New York, 10003, United States|Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, New York, 10025, United States",
Vitiligo,NCT01401374,Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo,https://clinicaltrials.gov/study/NCT01401374,NO,Vitiligo Vulgaris,,ALL,"CHILD, ADULT, OLDER_ADULT",,"St. Luke's-Roosevelt Hospital Center, New york, New York, 10025, United States",
Vitiligo,NCT00907062,Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents,https://clinicaltrials.gov/study/NCT00907062,NO,Vitiligo Vulgaris,DIETARY_SUPPLEMENT: Ginkgo biloba,ALL,"CHILD, ADULT",PHASE1,"Noumena Naturopathic Health Clinic, Mississauga, Ontario, L5H 1H2, Canada","Principal Investigator : Orest Szczurko, ND MSc(cand) , University of Toronto, Leslie Dan Faculty of Pharmacy Principal Investigator : Heather Boon, PhD , University of Toronto, Leslie Dan Faculty of Pharmacy"
Vitiligo,NCT00372307,Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris,https://clinicaltrials.gov/study/NCT00372307,NO,Vitiligo Vulgaris,DRUG: Application of pimecrolimus,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"University Hospital Ghent, Ghent, 9000, Belgium","Principal Investigator : Jean-Marie Naeyaert, MD, PhD , University Hospital, Ghent"
Vitiligo,NCT03234673,"The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo",https://clinicaltrials.gov/study/NCT03234673,NO,Vitiligo Vulgaris,DRUG: Tacrolimus ointment|DRUG: calcipotriol ointment|DRUG: NB-UVB,ALL,"CHILD, ADULT",PHASE1,,Assiut University
Vitiligo,NCT05607316,Evaluating the Efficacy and Safety of Metformin in Vitiligo,https://clinicaltrials.gov/study/NCT05607316,NO,Vitiligo,DRUG: Metformin Hydrochloride,ALL,"ADULT, OLDER_ADULT",PHASE2,"UMass Chan Medical School, Worcester, Massachusetts, 01605, United States","Principal Investigator : John E Harris, MD, PhD , Chair, Department of Dermatology"
Vitiligo,NCT05869942,Histochemical Study of Vitiligo in Sohag University Hospital Patients,https://clinicaltrials.gov/study/NCT05869942,NO,Vitiligo,DIAGNOSTIC_TEST: Light microscopic studies|DIAGNOSTIC_TEST: Immunohistochemical studies,ALL,ADULT,,"Sohag University Hospital, Sohag, Egypt","Study Chair : Doha S Mohamed, professor , Sohag University, Faculty of Medicine Study Director : Zeinab A Goda, lecturer , Sohag University, Faculty of Medicine"
Vitiligo,NCT05971381,Repigmentation of Stable Vitiligo Lesions Using Spray-On Skinâ„¢ Cells,https://clinicaltrials.gov/study/NCT05971381,NO,Vitiligo,DEVICE: RECELLÂ® Autologous Cell Harvesting Device,ALL,"ADULT, OLDER_ADULT",,"Affiliated Dermatology, Scottsdale, Arizona, 85225, United States|University of California, Irvine, Irvine, California, 92697, United States|West Dermatology Research Center, San Diego, California, 92121, United States|Sutter Health, Sunnyvale, California, 94086, United States|California Dermatology Institute, Thousand Oaks, California, 91320, United States|Clarity Dermatology, Castle Rock, Colorado, 80109, United States|Siperstein Dermatology Group, Boynton Beach, Florida, 33437, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|Dermatologic Surgery Center of Washington, Chevy Chase, Maryland, 20815, United States|Maryland Laser, Skin & Vein Institute, Hunt Valley, Maryland, 21030, United States|University Of Massachusetts, Worcester, Massachusetts, 01605, United States|Hamzavi Dermatology, Canton, Michigan, 48187, United States|Henry Ford Health, Detroit, Michigan, 48202, United States|Grekin Skin Institute, Warren, Michigan, 48088, United States|The Dermatology Specialist, New York, New York, 10012, United States|Mount Sinai, New York, New York, 10028, United States|Dermatology, Laser and Vein Specialists of the Carolinas, Charlotte, North Carolina, 28207, United States",Avita Medical
Vitiligo,NCT05706636,T Central Memory Cells in Early Localized Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT05706636,NO,Vitiligo,DRUG: oral mini pulse|DRUG: Topical cream|DEVICE: targeted phototherapy,ALL,"CHILD, ADULT",,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt","Study Chair : Samia Esmat, MD , Cairo University"
Vitiligo,NCT06209138,5-fluorouracil for Treatment of Stable Vitiligo,https://clinicaltrials.gov/study/NCT06209138,NO,Vitiligo,DRUG: 5 fluorouracil|OTHER: Saline,ALL,"CHILD, ADULT, OLDER_ADULT",,"Al-Azhar University, Assiut, No State, Egypt",
Vitiligo,NCT06446063,Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.,https://clinicaltrials.gov/study/NCT06446063,NO,Vitiligo,OTHER: Test product|OTHER: Control Product,ALL,"ADULT, OLDER_ADULT",,"COSDERMA, Bordeaux, Gironde, 33000, France","Principal Investigator : Julien SENESCHAL, Pr , CHU Bordeaux"
Vitiligo,NCT05233735,Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05233735,NO,Vitiligo,OTHER: Enhanced Transcutaneous Delivery of Topical Betamethasone after the treatment with Tixel|OTHER: Topical treatment,ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology, Tel Aviv Sourasky medical center, Tel Aviv, 64239, Israel","Principal Investigator : Mor Pavlovski, MD , Sourasky Medical Center"
Vitiligo,NCT06163326,A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo,https://clinicaltrials.gov/study/NCT06163326,NO,Vitiligo,DRUG: Ritlecitinib|DRUG: Ritlecitinib 100 mg|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Marvel Clinical Research, Huntington Beach, California, 92647, United States|Wallace Medical Group, Inc, Los Angeles, California, 90056, United States|Encore Medical Research of Boynton Beach, Boynton Beach, Florida, 33436, United States|Skin Care Research, Hollywood, Florida, 33021, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|DelRicht Research, Baton Rouge, Louisiana, 70809, United States|Visage Dermatology and Aesthetic Center, Largo, Maryland, 20774, United States|Accellacare - Wilmington, Wilmington, North Carolina, 28411, United States|Wilmington Health, PLLC, Wilmington, North Carolina, 28411, United States|Remington Davis Clinical Research, Columbus, Ohio, 43215, United States|Remington-Davis, Inc, Columbus, Ohio, 43215, United States|Austin Institute for Clinical Research, Houston, Texas, 77056, United States|CARe Clinic, Red Deer, Alberta, T4P 1K4, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|DermEdge Research, Mississauga, Ontario, L4Y 4C5, Canada|North York Research Inc, Toronto, Ontario, M2N3A6, Canada|Centre de Recherche Dermatologique du Quebec metropolitain, Quebec, G1V 4X7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W 4R4, Canada|Huashan Hospital Fudan University, Shanghai, Shanghai, 200040, China|Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen, 48455, Germany|Tohoku University Hospital, Sendai-shi, Miyagi, 980-8574, Japan|Dermatology and Ophthalmology Kume Clinic, Sakai City, Osaka, 593-8324, Japan|Nippon Medical School Hospital, Bunkyo-ku, Tokyo, 113-8603, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, 400-8506, Japan|Nippon Medical School Hospital, Tokyo, 113-8603, Japan|Ajou University Hospital, Suwon, KyÇ’nggi-do, 16499, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [seoul], 03722, Korea, Republic of|DermoDent Centrum Medyczne Aldona Czajkowska RafaÅ‚ Czajkowski s.c., Osielsko, Kujawsko-pomorskie, 86-031, Poland|Royalderm Agnieszka Nawrocka, Warszawa, Mazowieckie, 02-962, Poland|Twoja Przychodnia SCM, Szczecin, Zachodniopomorskie, 71-500, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, ÅšwiÄ™tokrzyskie, 27-400, Poland","Study Director : Pfizer CT.gov Call Center , Pfizer"
Vitiligo,NCT06097494,Investigating Healthcare Disparities in Vitiligo,https://clinicaltrials.gov/study/NCT06097494,NO,Vitiligo,OTHER: No intervention,ALL,"CHILD, ADULT, OLDER_ADULT",,"Momentum Data Limited, London, United Kingdom","Study Director : Andrew McGovern, MD , Momentum Data"
Vitiligo,NCT05577637,Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05577637,NO,Vitiligo,DRUG: 0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily,ALL,ADULT,PHASE1,"cmh Abbottabad, Abbottabad, Khyber Pakhtunkhwa, 22020, Pakistan",Combined Military Hospital Abbottabad
Vitiligo,NCT05991596,Vitiligo and Psychodrama Therapy,https://clinicaltrials.gov/study/NCT05991596,NO,Vitiligo,BEHAVIORAL: Psychodramatic psychotherapy|BEHAVIORAL: Self-help activities,ALL,ADULT,,"APSS Trento, Trento, Italy","Principal Investigator : Gabriella PravatÃ , MD , APSS Trento"
Vitiligo,NCT06394349,Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo,https://clinicaltrials.gov/study/NCT06394349,NO,Vitiligo,COMBINATION_PRODUCT: PRP+308nm|COMBINATION_PRODUCT: NS+308nm,ALL,"ADULT, OLDER_ADULT",,"Huashan Hospital, Shanghai, Shanghai, 200040, China",
Vitiligo,NCT06118411,A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo,https://clinicaltrials.gov/study/NCT06118411,NO,Vitiligo,DRUG: Upadacitinib|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Advanced Research Associates - Glendale /ID# 259915, Glendale, Arizona, 85308, United States|Alliance Dermatology and MOHs Center, PC /ID# 259926, Phoenix, Arizona, 85032, United States|Private Practice - Dr. Joseph Raoof /ID# 260055, Encino, California, 91436, United States|Vitiligo & Pigmentation Institute of Southern California /ID# 259970, Los Angeles, California, 90036-5679, United States|Dermatology Research Associates /ID# 260056, Los Angeles, California, 90045, United States|Integrative Skin Science and Research /ID# 260060, Sacramento, California, 95815, United States|Clinical Trials Research Institute /ID# 259910, Thousand Oaks, California, 91320-2130, United States|Skin Care Research - Boca Raton /ID# 260094, Boca Raton, Florida, 33486-2269, United States|Apex Clinical Trials /ID# 260096, Brandon, Florida, 33511, United States|Florida Academic Dermatology Center /ID# 259919, Coral Gables, Florida, 33134-5755, United States|Encore Medical Research LLC /ID# 259963, Hollywood, Florida, 33021-6476, United States|Skin Care Research - Hollywood /ID# 260101, Hollywood, Florida, 33021-6748, United States|Life Clinical Trials /ID# 260097, Margate, Florida, 33063-5704, United States|GSI Clinical Research, LLC /ID# 259918, Margate, Florida, 33063, United States|Savin Medical Group, LLC /ID# 259968, Miami Lakes, Florida, 33014-2490, United States|Advanced Clinical Research Institute /ID# 260058, Tampa, Florida, 33607, United States|Encore Medical Research of Weston LLC /ID# 260542, Weston, Florida, 33331-3642, United States|Cleaver Medical Group /ID# 259925, Dawsonville, Georgia, 30534, United States|DeNova Research /ID# 260611, Chicago, Illinois, 60611, United States|Dawes Fretzin, LLC /ID# 260068, Indianapolis, Indiana, 46256, United States|Oakland Hills Dermatology /ID# 260602, Auburn Hills, Michigan, 48326-4600, United States|Hamzavi Dermatology - Canton /ID# 260545, Canton, Michigan, 48187, United States|Michigan Center for Research Company /ID# 260069, Clarkston, Michigan, 48346, United States|Minnesota Clinical Study Center /ID# 260154, New Brighton, Minnesota, 55112, United States|DermResearchCenter of New York, Inc. /ID# 259906, Stony Brook, New York, 11790, United States|Schweiger Dermatology, P.C. /ID# 260152, Verona, New York, 07044-2946, United States|ClinOhio Research Services /ID# 260300, Columbus, Ohio, 43213-4440, United States|Oregon Dermatology and Research Center /ID# 259917, Portland, Oregon, 97210, United States|Bellaire Dermatology Associates /ID# 260044, Bellaire, Texas, 77401, United States|Dermatology Treatment and Research Center /ID# 260078, Dallas, Texas, 75230, United States|Derm Clin Res Ctr San Antonio /ID# 260047, San Antonio, Texas, 78229, United States|Progressive Clinical Research /ID# 260070, San Antonio, Texas, 78229, United States|Dermatology and Ophthalmology Kume Clinic /ID# 260555, Sakai-shi, Osaka, 5938324, Japan|Tokyo Medical University Hospital /ID# 260552, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamagata University Hospital /ID# 260553, Yamagata-shi, Yamagata, 990-9585, Japan|Yamanashi Prefectural Central Hospital /ID# 260554, Kofu-shi, Yamanashi, 400-8506, Japan|Dr. Samuel Sanchez PSC /ID# 260090, Caguas, 00727, Puerto Rico|Mindful Medical Research /ID# 260092, San Juan, 00918-3756, Puerto Rico",
Vitiligo,NCT06068218,Translational Assessment of Vitiligo According to Body Locations,https://clinicaltrials.gov/study/NCT06068218,NO,Vitiligo,OTHER: Biopsy for the patient group|OTHER: biopsy for the volunteer group,ALL,"ADULT, OLDER_ADULT",,"CHU de Nice - HÃ´pital de l'Archet, Nice, Alpes-maritimes, 06200, France","Principal Investigator : Passeron Thierry, PhD , CHU de Nice, Service de Dermatologie"
Vitiligo,NCT05549869,Assessment of Serum Leptin in Vitiligo Patients,https://clinicaltrials.gov/study/NCT05549869,NO,Vitiligo,DIAGNOSTIC_TEST: serum leptin,ALL,"ADULT, OLDER_ADULT",,"Sohag University Hospital, Sohag, Egypt",Sohag University
Vitiligo,NCT06454461,Efficacy of Upadacitinib After NECS in Vitiligo,https://clinicaltrials.gov/study/NCT06454461,NO,Vitiligo,DRUG: Upadacitinib 15 MG,ALL,ADULT,,,
Vitiligo,NCT05342519,Daily Topical Rapamycin for Vitiligo,https://clinicaltrials.gov/study/NCT05342519,NO,Vitiligo,DRUG: Rapamycin|DRUG: Rapamycin|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Medical University of South Carolina, Charleston, South Carolina, 29425, United States","Principal Investigator : Ahmad Aleisa, MD , Medical University of South Carolina"
Vitiligo,NCT06261073,Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients,https://clinicaltrials.gov/study/NCT06261073,NO,Vitiligo,DIAGNOSTIC_TEST: blood sample and tissue biopsy,ALL,ADULT,,,Sohag University
Vitiligo,NCT03611348,Microneedling and Latanoprost in Acrofacial Vitiligo,https://clinicaltrials.gov/study/NCT03611348,NO,Vitiligo,DRUG: Latanoprost|DEVICE: Microneedling,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,,"Study Director : Ramadan Saleh, MD , Sohag University"
Vitiligo,NCT05290077,Role of NGAL in Vitiligo,https://clinicaltrials.gov/study/NCT05290077,NO,Vitiligo,DIAGNOSTIC_TEST: NGAL,ALL,"ADULT, OLDER_ADULT",,"Sohag fuculty, Sohag, Egypt",Sohag University
Vitiligo,NCT05927272,Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions,https://clinicaltrials.gov/study/NCT05927272,NO,Vitiligo,PROCEDURE: SKIN SAMPLES|PROCEDURE: BLOOD SAMPLES|DEVICE: narrowband UVB|DRUG: Systemic Steroids,ALL,"ADULT, OLDER_ADULT",,"University Hospital of Bordeaux - St AndrÃ© Hospital, Bordeaux, 33000, France",
Vitiligo,NCT05836441,Improved Phototherapy in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT05836441,NO,Vitiligo,RADIATION: Exposure to white patches|RADIATION: Exposure to edge of white patches and normal skin around white patches,ALL,"CHILD, ADULT, OLDER_ADULT",,"The first Affiliated hospital with Nanjing medical university, Nanjing, Jiangsu, 210009, China","Study Chair : Lu Yan , The First Affiliated Hospital with Nanjing Medical University"
Vitiligo,NCT05917561,Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT05917561,NO,Vitiligo,DRUG: Anifrolumab Infusion Product|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Bordeaux, Bordeaux, 33075, France|Centre Hospitalier RÃ©gional Le Mans, Le Mans, 72037, France|Centre Hospitalier Universitaire de Nice, Nice, 06000, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, 31059, France",AstraZeneca
Vitiligo,NCT05506995,Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo,https://clinicaltrials.gov/study/NCT05506995,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,"Dermatology Department. Hospital Central ""Dr. Ignacio Morones Prieto"", San Luis PotosÃ­, 78290, Mexico","Principal Investigator : Juan P Castanedo-Cazares, MD , Universidad Autonoma de San Luis Potosi"
Vitiligo,NCT05298033,"Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo",https://clinicaltrials.gov/study/NCT05298033,NO,Vitiligo,DRUG: Crisaborole 2 % Topical Ointment|DRUG: PF-07038124 0.01% topical ointment|DEVICE: NBUVB phototherapy|DEVICE: Sham phototherapy|DRUG: Vehicle,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Colorado Anschutz - Clinical and Translational Research Centers, Aurora, Colorado, 80045, United States","Principal Investigator : Stanca Birlea, MD , University of Colorado, Denver"
Vitiligo,NCT04843059,ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation,https://clinicaltrials.gov/study/NCT04843059,NO,Vitiligo,OTHER: The resident memory T-cell infiltrate in perilesional vitiligo skin,ALL,ADULT,,"CHU de Nice, Nice, Alpes Maritimes, 06001, France|CHU Bordeaux, Bordeaux, 33440, France","Principal Investigator : Passeron Thierry, PhD , CHU de Nice, Service de Dermatologie"
Vitiligo,NCT05812079,Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo,https://clinicaltrials.gov/study/NCT05812079,NO,Vitiligo,DIAGNOSTIC_TEST: skin biopsy examined by ELISA technique,ALL,ADULT,,,Cairo University
Vitiligo,NCT05247489,A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT05247489,NO,Vitiligo,DRUG: Ruxolitinib 1.5% cream|DEVICE: NB-UVB phototherapy,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"First Oc Dermatology, Fountain Valley, California, 92708, United States|UC Davis Health, Sacramento, California, 95816, United States|Palo Alto Medical Foundation, Sunnyvale, California, 94086, United States|Delricht Clinical Research - Clinedge - Ppds Baton Rouge, Baton Rouge, Louisiana, 70809, United States|Aesthetic and Dermatology Center, Rockville, Maryland, 20850, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135, United States|University of Massachusetts Medical School, Worcester, Massachusetts, 01605, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, 48202, United States|Austin Institute For Clinical Research Aicr Pflugerville, Pflugerville, Texas, 78660, United States|Principle Research Solutions, Spokane, Washington, 99202, United States|Simcomed Health Ltd, Barrie, Ontario, L4M 7G1, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada","Study Director : Haq Nawaz, MD , Incyte Corporation"
Vitiligo,NCT05223738,Resident Memory T Cells in Vitiligo,https://clinicaltrials.gov/study/NCT05223738,NO,Vitiligo,,ALL,ADULT,,"Kasr El Ainy University hospital, Cairo, Egypt","Principal Investigator : Hilal , Kasr El Ainy University Hospital, Faculty of medicine, Cairo University"
Vitiligo,NCT04374435,Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT04374435,NO,Vitiligo,PROCEDURE: MKTP with Surgical blade|DEVICE: MKTP with Negative Pressure Instrument|DEVICE: Suction blister grafting without cell dissociation,ALL,"ADULT, OLDER_ADULT",,"University of California, Irvine, Irvine, California, 92697, United States","Principal Investigator : Anand K Ganesan, MD, PhD , University of California, Irvine"
Vitiligo,NCT04896385,A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA),https://clinicaltrials.gov/study/NCT04896385,YES,Vitiligo,DRUG: Ruxolitinib cream|DRUG: Vehicle Cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"First Oc Dermatology, Fountain Valley, California, 92708, United States|UC Irvine, Irvine, California, 92697, United States|George Washington Medical Faculty Associates, Washington, District of Columbia, 20037, United States|Suny Downstate Medical Center, Brooklyn, New York, 11203, United States|Mount Sinai Hospital, New York, New York, 10029, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Simcoderm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada|JRB Research Inc, Ottawa, Ontario, K1H 7X8, Canada|Hopital Saint Andre, Bordeaux, 33000, France|Centre Hospitalier Universitaire Henri Mondor, Creteil, 94010, France|Hopital Archet 2 Derm Dept, Nice, 06200, France",Incyte Corporation
Vitiligo,NCT06410898,Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT06410898,NO,Vitiligo,DEVICE: Punch Biopsy 5mm,ALL,"ADULT, OLDER_ADULT",,"Sohag University hospitals, Sohag, Egypt",Sohag University
Vitiligo,NCT04858152,Hair Transplantation for Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT04858152,NO,Vitiligo,PROCEDURE: Follicular Unit Extraction via punch biopsy,ALL,"ADULT, OLDER_ADULT",,"University of Massachusetts Medical School, Worcester, Massachusetts, 01605, United States","Principal Investigator : Mehdi Rashighi, MD , University of Massachusetts, Worcester"
Vitiligo,NCT04271501,Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions,https://clinicaltrials.gov/study/NCT04271501,NO,Vitiligo,PROCEDURE: Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB)|DEVICE: RECELL 1:5 and Ultraviolet Lamp (UVB)|DEVICE: RECELL 1:10 and Ultraviolet Lamp (UVB)|DEVICE: RECELL 1:20 and Ultraviolet Lamp (UVB),ALL,"ADULT, OLDER_ADULT",,"University of Massachusetts, Worcester, Massachusetts, 01655, United States",Avita Medical
Vitiligo,NCT04237103,Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT04237103,NO,Vitiligo,DRUG: Methotrexate|DRUG: Placebos,ALL,"ADULT, OLDER_ADULT",PHASE2,"Service de Dermatologie - HÃ´pital Saint-AndrÃ©, Bordeaux, 33075, France|Centre Hospitalier de Pau, Pau, 64000, France|Centre Hospitalier de PÃ©rigueux, PÃ©rigueux, 24000, France|Service de Dermatologie - CHU de Toulouse - Hopital Purpan, Toulouse, 31059 Toulouse Cedex, France","Principal Investigator : Julien SENESCHAL, MD, PhD , University of Bordeaux"
Vitiligo,NCT05513924,Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.,https://clinicaltrials.gov/study/NCT05513924,NO,Vitiligo,DRUG: Latanoprost 0.005% Ophthalmic Solution|DRUG: 5Fluorouracil,ALL,"CHILD, ADULT",PHASE2|PHASE3,"South Valley University, QinÄ, Qena Governorate, 83523, Egypt",
Vitiligo,NCT04822584,Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT04822584,NO,Vitiligo,DRUG: Baricitinib Oral Product|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Service de Dermatologie - HÃ´pital Saint-AndrÃ©, Bordeaux, 33075, France|Service de dermatologie - HÃ´pital Henri Mondor - EA EpiDermE (EpidÃ©miologie en Dermatologie et Evaluation des ThÃ©rapeutiques), CrÃ©teil, 94010, France|Centre Hospitalier Universitaire de Nice - Service de Dermatologie, Nice, 06000, France|Service de dermatologie Centre de RÃ©fÃ©rence des Maladies Rares de la Peau et des muqueuses d'origine gÃ©nÃ©tique - HÃ´pital Larrey, Toulouse, 31059 cedex 9, France",
Vitiligo,NCT05037981,Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo,https://clinicaltrials.gov/study/NCT05037981,NO,Vitiligo,,ALL,"CHILD, ADULT",,,"Principal Investigator : Samia Esmat, MD , Cairo University Principal Investigator : Rania Mogawer, MD , Cairo University Study Director : Dalia Bassiony, MD , Cairo University Study Chair : Suzan Shalaby, MD , Cairo University Study Chair : Rehab Hegazy, MD , Cairo University Study Chair : Nanis Ragab, MD , Cairo University Study Chair : Sarah Ibrahim , Cairo University Show fewer investigators"
Vitiligo,NCT04765826,"Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo",https://clinicaltrials.gov/study/NCT04765826,NO,Vitiligo,PROCEDURE: Autologous mini punch grafting,ALL,ADULT,,"Alexandria faculty of medicine, Alexandria, Egypt","Study Director : Carmen brahiem farid amin, Ph.D , Assistant professor of dermatology faculty of medicine .University of Alexandria Study Director : Ai Ahmed fouad El Eriny, Ph.D , Professor of dermatology faculty of medicine .University of Alexandria Study Director : Eman Hamed El Morsy, Ph.D , Professor of dermatology faculty of medicine .University of Alexandria"
Vitiligo,NCT04775979,Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo,https://clinicaltrials.gov/study/NCT04775979,NO,Vitiligo,DRUG: diphenylcyclopropenone (DPCP),ALL,"ADULT, OLDER_ADULT",PHASE4,"University hospitals faculty of medicine ain shams university, Cairo, Egypt","Study Chair : Marwa MA Abdallah , Ain Shams University Study Director : Rania M Elhusseiny , Ain Shams University"
Vitiligo,NCT05121532,Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05121532,NO,Vitiligo,DIAGNOSTIC_TEST: Interleukin-15 and Interleukin-22,ALL,"CHILD, ADULT, OLDER_ADULT",,,Sohag University
Vitiligo,NCT04030988,Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB,https://clinicaltrials.gov/study/NCT04030988,NO,Vitiligo,DRUG: Oral dexamethasone minipulse|DRUG: Placebo oral tablet,ALL,"CHILD, ADULT",PHASE1,"Ain Shams University, Cairo, Abbaseya, 00202, Egypt",
Vitiligo,NCT03872804,Punch Minigraft Versus Transverse Needling or Combination of Both in Treatment of Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT03872804,NO,Vitiligo,PROCEDURE: Autologous punch mini grafts:|PROCEDURE: Transverse needling|PROCEDURE: Punch minigrafts followed by transverse needling|OTHER: Oral pulse steroid with narrow band,ALL,"CHILD, ADULT, OLDER_ADULT",,"Omneya abd el aziz el zagh, Alexandria, 21500, Egypt","Study Director : Carmen Ibrahiem farid amin, Ph.D , Assistant Professor of dermatolog Faculty of Medicine. University of Alexandria. Study Director : Magdy Abd el aziz ragab, Ph.D , Professor of Dermatlolgy, Faculty of Medicine. University of Alexandria."
Vitiligo,NCT05287776,E-cadherin and Integrin Alpha v Beta 1 in Vitiligo,https://clinicaltrials.gov/study/NCT05287776,NO,Vitiligo,DEVICE: Narrow band UVB,ALL,ADULT,,"Kasr El Ainy university hospital, Faulty of medicine,Cairo university, Cairo, El Manial, 11956, Egypt",
Vitiligo,NCT04338581,Evaluation of AMG 714 for Vitiligo,https://clinicaltrials.gov/study/NCT04338581,NO,Vitiligo,BIOLOGICAL: AMG 714|BIOLOGICAL: Placebo|PROCEDURE: nbUVB phototherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of California, Irvine: Department of Dermatology, Irvine, California, 92697, United States|University of California Davis Health System: Department of Dermatology, Sacramento, California, 95816, United States|Yale University School of Medicine: Department of Dermatology, New Haven, Connecticut, 06824, United States|Tufts Medical Center: Department of Dermatology, Boston, Massachusetts, 02111, United States|University of Massachusetts Medical School, Worcester, Massachusetts, 01605, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Northwell Health, Lake Success, New York, 11042, United States|Perelman School of Medicine, University of Pennsylvania: Department of Dermatology, Philadelphia, Pennsylvania, 19104, United States",
Vitiligo,NCT03099304,A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo,https://clinicaltrials.gov/study/NCT03099304,YES,Vitiligo,DRUG: Ruxolitinib cream|DRUG: Vehicle cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"UNIVERSITY OF ALABAMA AT BIRMINGHAM (UAB), 1802 6th Ave S, Birmingham, Alabama, 35233, United States|BURKE PHARMACEUTICAL RESEARCH LLC, 3633 Central Ave, Hot Springs, Arkansas, 71913, United States|NORTHWEST AR CLINICAL TRIALS CENTER, PLLC/HULL DERMATOLOGY, PA, 500 S 52nd Street, Rogers, Arkansas, 72758, United States|THE VITILIGO & PIGMENTATION INSTITUE OF SOUTHERN CALIFORNIA, 5670 Wilshire Boulevard, Los Angeles, California, 90036, United States|DERMATOLOGY RESEARCH ASSOCIATES- LOS ANGELES, 8930 S Sepulveda Blvd, Los Angeles, California, 90045, United States|DERMATOLOGY SPECIALISTS, 3629 Vista Way, Oceanside, California, 92056, United States|CLINICAL RESEARCH CENTER OF CT, 27 Hospital Avenue, Danbury, Connecticut, 06810, United States|LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC/ AMERIDERM RESEARCH, 725 W Granada Blvd, Ormond Beach, Florida, 32174, United States|EMORY UNIVERSITY, 1525 Clifton Road, Atlanta, Georgia, 30322, United States|NORTHWESTERN UNIVERSITY, 676 N Saint Clair, Chicago, Illinois, 60611, United States|DAWES FRETZIN CLINICAL RESEARCH GROUP, 8103 Clearvista Parkway, Indianapolis, Indiana, 46256, United States|DS RESEARCH, 2241 Green Valley Road, New Albany, Indiana, 47150, United States|TULANE UNIVERSITY, 1415 Tulane Avenue, New Orleans, Louisiana, 70112, United States|Tufts Medical Center, 260 Tremont Street, Boston, Massachusetts, 02111, United States|UNIVERSITY OF MASSACHUESETTS, 364 Plantation Street, Worcester, Massachusetts, 01605, United States|HAMZAVI DERMATOLOGY, 3031 W Grand Blvd, Detroit, Michigan, 48059, United States|WASHINGTON UNIVERSITY SCHOOL OF MEDICINE DERMATOLOGY, 969 N. Mason Road, Saint Louis, Missouri, 63141, United States|ACTIVMED PRACTICES & RESEARCH, INC, 110 Corporate Drive, Portsmouth, New Hampshire, 03801, United States|ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI MEDICAL CENTER- DERMATOLOGY ASSOCIATES, 5 E 98th Street, New York, New York, 11209, United States|WAKE FOREST UNIVERSITY HEALTH SCIENCES, Medical Center Boulevard, Winston-Salem, North Carolina, 27157, United States|CENTRAL SOONER RESEARCH, 900 N Porter Ave, Norman, Oklahoma, 73071, United States|RHODE ISLAND HOSPITAL, 593 Eddy Street, Providence, Rhode Island, 02903, United States|ARLINGTON RESEARCH CENTER, INC., 711 East Lamar Boulevard, Arlington, Texas, 76011, United States|MENTER DERMATOLOGY RESEARCH INSTITUTE, 3900 Junius Street, Dallas, Texas, 75246, United States|UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, DEPARTMENT OF DERMATOLOGY, 5323 Harry Hines Blvd, Dallas, Texas, 75390, United States|THE DERMATOLOGY AND LASER CENTER OF SAN ANTONIO, 7810 Louis Pasteur, San Antonio, Texas, 78229, United States","Study Director : Kathleen Butler, MD , Incyte Corporation"
Vitiligo,NCT05053022,A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT05053022,NO,Vitiligo,DEVICE: Skinpen Precision System,ALL,ADULT,,"Crown Laboratories, Dallas, Texas, 75234, United States",
Vitiligo,NCT04738149,"Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment",https://clinicaltrials.gov/study/NCT04738149,NO,Vitiligo,DRUG: Bimatoprost|DEVICE: Excimer laser|DEVICE: Microneedling with a dermaroller,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Medical University of South Carolina, Charleston, South Carolina, 29407, United States",Medical University of South Carolina
Vitiligo,NCT03411135,Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) Score,https://clinicaltrials.gov/study/NCT03411135,NO,Vitiligo,OTHER: VES and VASI scores as assessment methods for vitiligo,ALL,"ADULT, OLDER_ADULT",,,Cairo University
Vitiligo,NCT02962180,Transplantation of Basal Cell Layer Suspension Using Derma-rolling System in Vitiligo,https://clinicaltrials.gov/study/NCT02962180,NO,Vitiligo,DEVICE: Dermabrasion with dermaroller,ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology, Ibn Sina University Hospital, Rabat, 10000, Morocco","Principal Investigator : laila benzekri , Mohammed V University"
Vitiligo,NCT01082393,Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis),https://clinicaltrials.gov/study/NCT01082393,NO,Vitiligo,DRUG: topical tacrolimus treatment|DRUG: topical pimecrolimus treatment|DRUG: local mometasone furoate treatment|DRUG: cold cream,ALL,"ADULT, OLDER_ADULT",PHASE4,"University Hospital Ghent, Ghent, Belgium","Principal Investigator : Nanny Van Geel, MD, PhD , University Hospital, Ghent"
Vitiligo,NCT05872477,Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas,https://clinicaltrials.gov/study/NCT05872477,NO,Vitiligo,DRUG: Ruxolitinib Topical|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Nice - HÃ´pital de l'Archet, Nice, Alpes-maritimes, 06200, France","Principal Investigator : Passeron Thierry, PhD , CHU de Nice, Service de Dermatologie"
Vitiligo,NCT03123016,Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03123016,NO,Vitiligo,DRUG: Apremilast|PROCEDURE: NB-UVB phototherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States","Principal Investigator : Mark Lebwohl, MD , Icahn School of Medicine at Mount Sinai"
Vitiligo,NCT03036995,Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO,https://clinicaltrials.gov/study/NCT03036995,NO,Vitiligo,DRUG: Apremilast|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Nice - Dermatologie - HÃ´pital Archet, Nice, Alpes-Maritimes, 06, France",
Vitiligo,NCT03864315,"To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study",https://clinicaltrials.gov/study/NCT03864315,NO,Vitiligo,DEVICE: HGM,ALL,"ADULT, OLDER_ADULT",,"National Taiwan University Hospital, Taipei, 10002, Taiwan",
Vitiligo,NCT05008887,Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05008887,NO,Vitiligo,DRUG: Methotrexate|DRUG: 5-fluorouracil|DEVICE: Fractional CO2 laser,ALL,"ADULT, OLDER_ADULT",PHASE4,,Assiut University
Vitiligo,NCT01051687,Botulinum Toxin Treatment for Localized Vitiligo,https://clinicaltrials.gov/study/NCT01051687,NO,Vitiligo,DRUG: Botulinum toxin A,ALL,ADULT,PHASE4,"King Khalid University Hospital, Riyadh, 11524, Saudi Arabia","Principal Investigator : Ghada Binsaif, MD , King Saud University"
Vitiligo,NCT06109649,A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT06109649,NO,Vitiligo,DRUG: Afamelanotide and NB-UVB Light|PROCEDURE: NB-UVB Light,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"CLINUVEL site, Los Angeles, California, 00000, United States|CLINUVEL site, Miami, Florida, 00000, United States|CLINUVEL site, Miramar, Florida, 00000, United States|CLINUVEL site, Baton Rouge, Louisiana, 00000, United States|CLINUVEL site, Detroit, Michigan, 00000, United States|CLINUVEL site, Roseville, Minnesota, 00000, United States|CLINUVEL Site, Lee's Summit, Missouri, 00000, United States|CLINUVEL Site, Charleston, South Carolina, 00000, United States|CLINUVEL site, Thompson's Station, Tennessee, 00000, United States|CLINUVEL Site, Cedar Park, Texas, 00000, United States|CLINUVEL site, Tyler, Texas, 00000, United States|CLINUVEL site, Charlottesville, Virginia, 00000, United States|CLINUVEL site, Manchester, United Kingdom","Clinuvel, Inc."
Vitiligo,NCT01787708,Efficacy of Red Light in Vitiligo,https://clinicaltrials.gov/study/NCT01787708,NO,Vitiligo,PROCEDURE: Red light,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada","Principal Investigator : Harvey Lui, MD, FRCPC , University of British Columbia"
Vitiligo,NCT03755830,Prostaglandin F2-alpha (PGF2Î±) in Vitiligo,https://clinicaltrials.gov/study/NCT03755830,NO,Vitiligo,OTHER: Skin biopsy,ALL,"ADULT, OLDER_ADULT",,,Cairo University
Vitiligo,NCT03859518,Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo,https://clinicaltrials.gov/study/NCT03859518,NO,Vitiligo,OTHER: blood and skin samples,ALL,"ADULT, OLDER_ADULT",,"CH de Frejus, FrÃ©jus, France","Principal Investigator : Thierry PASSERON, MD; PhD , Centre Hospitalier Universitaire de Nice"
Vitiligo,NCT01478945,HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home,https://clinicaltrials.gov/study/NCT01478945,NO,Vitiligo,DEVICE: 311 nm NB-UVB light,ALL,"CHILD, ADULT, OLDER_ADULT",,"Queens Medical Centre,Nottingham University Hospitals NHS Trust, Nottingham, East Midlands, NG7 2UH, United Kingdom|Leicester Royal Infirmary, Leicester, Leicestershire, LE1 5WW, United Kingdom","Study Chair : Hywel C. Williams, MSc PhD FRCP , Centre of Evidence Based Dermatology Study Director : Viktoria Eleftheriadou, MD , Centre of Evidence Based Dermatology Principal Investigator : Jane C Ravenscroft, MB ChB, MRCP , Queen's Medical Center Principal Investigator : Anton Alexandroff, PhD MRCP , University Hospitals, Leicester"
Vitiligo,NCT02625012,Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Migration in Vitiligo,https://clinicaltrials.gov/study/NCT02625012,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Diego Cortes-Garcia, PhD , Universidad Autonoma de San Luis Potosi"
Vitiligo,NCT02466997,Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC,https://clinicaltrials.gov/study/NCT02466997,NO,Vitiligo,DRUG: tacrolimus|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"University Hospital of Bordeaux - St AndrÃ© Hospital, Bordeaux, 33000, France|Regional Hospital Center of Le Mans -, Le Mans, 72000, France|University Hospital Center of Nice - HÃ´pital de l'Archet, Nice, 06000, France|University Hospital Center of Rennes - HÃ´pital Pontchaillou, Rennes, 35000, France",
Vitiligo,NCT03832751,Human Beta-defensin 1 in Vitiligo,https://clinicaltrials.gov/study/NCT03832751,NO,Vitiligo,OTHER: skin biopsy before and after NB-UVB phototherapy,ALL,"ADULT, OLDER_ADULT",,,Cairo University
Vitiligo,NCT05210582,A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face,https://clinicaltrials.gov/study/NCT05210582,NO,Vitiligo,DRUG: Afamelanotide,ALL,"ADULT, OLDER_ADULT",PHASE2,"CLINUVEL Investigational site, Detroit, Michigan, 48202, United States","Clinuvel, Inc."
Vitiligo,NCT04774809,Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo,https://clinicaltrials.gov/study/NCT04774809,NO,Vitiligo,DRUG: Low Dose SHR0302 Ointment BID|DRUG: High Dose SHR0302 Ointment BID|OTHER: Placebo Comparator: Vehicle,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, China|Wuhan No.1 Hospital, Wuhan, Hubei, China|The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China|Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China|Shanghai Skin Disease Hospital, Shanghai, Shanghai, 200071, China|West China School of Medicine, Chengdu, Sichuan, China|Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Tianjin, 300120, China|Hangzhou Third Hospital, Hangzhou, Zhejiang, China|Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Ningbo No.2 Hospital, Ningbo, Zhejiang, China|The First Hospital of Jillin University, Changchun, 130021, China|Sun. Yai- Sen Memorial Hospital, Sun. Yai- Sen University, Guangzhou, 51000, China|Zhejiang Provincial People's Hospital, Hangzhou, 310014, China|Jiangsu Province Hospital, Nanjing, 210006, China|Huashan Hospital Affiliated To Fudan University, Shanghai, China",Reistone Biopharma Company Limited
Vitiligo,NCT01517893,Clinical Trial of Simvastatin to Treat Generalized Vitiligo,https://clinicaltrials.gov/study/NCT01517893,YES,Vitiligo,DRUG: Simvastatin|DRUG: Placebo,MALE,ADULT,PHASE2,"University of Massachusetts Medical School Clinical Research Center, Worcester, Massachusetts, 01655, United States","Principal Investigator : John E. Harris, MD, PhD , University of Massachusetts, Worcester"
Vitiligo,NCT03608917,Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo,https://clinicaltrials.gov/study/NCT03608917,NO,Vitiligo,DRUG: Total Glucosides of Paeony(TGP)|DEVICE: Narrow band-ultraviolet bï¼ˆNB-UVBï¼‰|DRUG: Total Glucosides of Paeony(TGP) analogue,ALL,"ADULT, OLDER_ADULT",,"Xijing Hospital, Xi'an, Shaanxi, 710032, China","Principal Investigator : Tianwen Gao, Prof , Dermatology Derpartment of Xijing Hospital"
Vitiligo,NCT03367273,Thymic Stromal Lymphopoietin (TSLP) in Vitiligo,https://clinicaltrials.gov/study/NCT03367273,NO,Vitiligo,OTHER: skin biopsy,ALL,"ADULT, OLDER_ADULT",,,Cairo University
Vitiligo,NCT03497208,Comparative Study of Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03497208,NO,Vitiligo,PROCEDURE: Microneedling|PROCEDURE: Cell suspension|RADIATION: Phototherapy,ALL,"CHILD, ADULT, OLDER_ADULT",,"HCPA, Porto Alegre, RS, 90035903, Brazil","Study Director : Tania Cestari, Dr , Federal University of Health Science of Porto Alegre"
Vitiligo,NCT04811131,Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo,https://clinicaltrials.gov/study/NCT04811131,NO,Vitiligo,DRUG: ARQ-252 cream 0.3%|DRUG: ARQ-252 Vehicle cream|DEVICE: NB-UVB phototherapy active treatment|DEVICE: NB-UVB phototherapy sham treatment,ALL,"ADULT, OLDER_ADULT",PHASE2,"Arcutis Site 123, San Diego, California, 92123, United States|Arcutis Site 167, Coral Gables, Florida, 33134, United States|Arcutis Clinical Site 102, Rolling Meadows, Illinois, 60008, United States|Arcutis Site 162, Austin, Texas, 78759, United States|Arcutis Clinical Site 163, Pflugerville, Texas, 78660, United States","Study Director : David Berk, MD , Arcutis Biotherapeutics, Inc."
Vitiligo,NCT03973073,Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT03973073,NO,Vitiligo,COMBINATION_PRODUCT: CapulinTM|OTHER: topical applications and NB-UVB,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,"Peking university people's hospital, Beijing, Beijing, 100044, China","Principal Investigator : Juan Du, Doctor , Peking University People's Hospital"
Vitiligo,NCT01259986,Treatment of Vitiligo With Low-energy Visible Light Laser,https://clinicaltrials.gov/study/NCT01259986,NO,Vitiligo,PROCEDURE: Laser treatment,ALL,"ADULT, OLDER_ADULT",,,
Vitiligo,NCT04530344,Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT04530344,YES,Vitiligo,DRUG: ruxolitinib|DRUG: Vehicle,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Cahaba Dermatology, Hoover, Alabama, 35244, United States|Desert Sky Dermatology, Gilbert, Arizona, 85295, United States|First Oc Dermatology, Fountain Valley, California, 92708, United States|Center For Dermatology Cosmetic and Laser Surgery, Fremont, California, 94538, United States|Marvel Clinical Research Llc, Huntington Beach, California, 92647, United States|Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Acrc Studies, San Diego, California, 92119, United States|University of California San Francisco, San Francisco, California, 94158, United States|Colorado Medical Research Center Inc, Denver, Colorado, 80210, United States|Harmony Medical Research Institute, Hialeah, Florida, 33016, United States|San Marcus Research Clinic Inc., Miami Lakes, Florida, 33014, United States|Advanced Pharma, Miami, Florida, 33147, United States|Leavitt Medical Associates of Florida, Ormond Beach, Florida, 32174, United States|Avita Clinical Research, Tampa, Florida, 33613, United States|Olympian Clinical Research, Tampa, Florida, 33614, United States|Forcare Clinical Research Fcr Forward Clinical Trials, Inc, Tampa, Florida, 33624, United States|Metabolic Research Institute Inc, West Palm Beach, Florida, 33401, United States|Northwestern University, Chicago, Illinois, 60611, United States|Randall Dermatology, West Lafayette, Indiana, 47906, United States|Delricht Clinical Research - Clinedge - Ppds Baton Rouge, Baton Rouge, Louisiana, 70809, United States|Tufts Medical Center, Boston, Massachusetts, 02116, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135, United States|Great Lakes Research Group Inc, Bay City, Michigan, 48706, United States|Henry Ford Medical Center, Detroit, Michigan, 48202, United States|Minnesota Clinical Study Center, Minneapolis, Minnesota, 55432, United States|Jdr Dermatology Research, Las Vegas, Nevada, 89148, United States|Suny Downstate Medical Center, Brooklyn, New York, 11203, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|The Dermatology Specialists Greenwich, New York, New York, 10012, United States|Icahn School of Medicine At Mount Sinai, New York, New York, 10029, United States|Derm Research Center of New York Inc, Stony Brook, New York, 11790, United States|Wake Research Associates Llc, Raleigh, North Carolina, 27612, United States|Wake Forest University, Winston-Salem, North Carolina, 27104, United States|Central Sooner Research, Norman, Oklahoma, 73071, United States|Kgl Skin Study Center, Broomall, Pennsylvania, 19008, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|Palmetto Clinical Trial Services, Anderson, South Carolina, 29621, United States|International Clinical Research Tennessee Llc, Murfreesboro, Tennessee, 37130, United States|Innovative Dermatology, Plano, Texas, 75024, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|The Dermatology and Laser Center of San Antonio, San Antonio, Texas, 78229, United States|Clinical Research Partners Llc, Richmond, Virginia, 23226, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Medical Center Unimed Eood, Sevlievo, 05400, Bulgaria|Diagnostic Consultative Center Ii Sofia Eood, Sofia, 01000, Bulgaria|University Multiprofile Hospital For Active Treatment Aleksandrovska, Sofia, 01431, Bulgaria|Diagnostic Consultative Center Xxviii - Sofia - Eood, Sofia, 01592, Bulgaria|Medical Center Eurohealth, Sofia, 01606, Bulgaria|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Simcoderm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada|Skin Centre For Dermatology, Peterborough, Ontario, K9J 5K2, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Xlr8 Medical Research, Windsor, Ontario, N8W 1E6, Canada|Siena Medical Research Corporation, Westmount, Quebec, H3Z 2S6, Canada|Le Bateau Blanc, Martigues, 13500, France|Hopital Archet 2 Derm Dept, Nice, 06200, France|Centre Hospitalier Universitaire de Bordeaux - Hospital Haut-Leveque, Pessac, 33604, France|Hopital Charles Nicolle Chu Rouen Hospital de Bois-Guillaume, Rouen, 76031, France|Chu de Toulouse Hopital Larrey Centre de Reference Des Maladies Rares de La Peau Service de Dermatol, Toulouse, 31059, France|Universitaetsklinikum Carl Gustav Carus, Dresden, 01307, Germany|Hautarztpraxis Mahlow, Mahlow, 15831, Germany|Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz, 55131, Germany|Universitatsklinik Munster Dermatologie, Muenster, 48149, Germany|Amsterdam University Medical Centre, Amsterdam, 1100 DD, Netherlands|Synexus - Polska Sp Z Oo Oddzial W Gdansk, Gdansk, 80-382, Poland|Synexus Polska Sp. Z O.O. Oddzial W Gdyni, Gdynia, 81-537, Poland|Synexus - Sp Z Oo Oddzial W Katowice, Katowice, 40-040, Poland|Synexus Affiliate - Krakowskie Centrum Medyczne, Krakow, 31-501, Poland|Synexus Polska Sp Z Oo Oddzial W Lodzi, Lodz, 90-127, Poland|Synexus Polska Sp Z Oo Oddzial W Czestochowie, Lublin, 20-081, Poland|Dermedic Dr. Zdybski, OSTROWIEC Swietokrzyski, 27-400, Poland|Synexus Polska Sp. Z O.O. Oddzial W Poznaniu, Poznan, 60-702, Poland|Lubeskie Centrum Diagnostyczne, Swidnik, 21-040, Poland|Poradnia Dermatologiczno-Wenerologiczna Mediderm S.C. Nzoz, Torun, 87-100, Poland|Synexus Polska Sp. Z O.O. Oddzial Warszawie, Warsaw, 01-192, Poland|High-Med Przychodnia Specjalistycza, Warsaw, 01-817, Poland|Synexus Polska Sp. Z O.O. Oddzial We Wroclawiu, Wroclaw, 50-381, Poland|Dermmedica Sp. Z O.O., Wroclaw, 51-318, Poland|Ico Hospital Germans Trias I Pujol, Badalona, 08916, Spain|Dermomedic, Madrid, 28001, Spain|Clinica Universidad de Navarra (Cun), Pamplona, 31008, Spain","Study Chair : Kathleen Butler, MD , Incyte Corporation"
Vitiligo,NCT03762551,Janus Kinase 1 in Vitiligo & Psoriasis,https://clinicaltrials.gov/study/NCT03762551,NO,Vitiligo,OTHER: skin biopsy,ALL,"CHILD, ADULT, OLDER_ADULT",,,Cairo University
Vitiligo,NCT02432534,Atorvastatin in Active Vitiligo,https://clinicaltrials.gov/study/NCT02432534,NO,Vitiligo,DRUG: Atorvastatin|OTHER: UVB,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Nice, Nice, Alpes-Maritimes, 06001, France|National Skin center - 1 Mandalay Rd, Bedok, Singapore, 308205, Indonesia",
Vitiligo,NCT04547998,Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions,https://clinicaltrials.gov/study/NCT04547998,YES,Vitiligo,DEVICE: Control Intervention (UVB)|DEVICE: Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB),ALL,"ADULT, OLDER_ADULT",,"University of California, Irvine, Irvine, California, 92697, United States|University of California, Davis, Sacramento, California, 95817, United States|West Dermatology, San Diego, California, 92121, United States|DMR Research, Westport, Connecticut, 06880, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|Miami Dermatology and Laser Institute, Miami, Florida, 33173, United States|University of Massachusetts, Worcester, Massachusetts, 01581, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Dermatology, Laser & Vein Specialists of the Carolinas, Charlotte, North Carolina, 28207, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|University of Texas at Austin Dell Medical School, Austin, Texas, 78712, United States|Heights Dermatology, Houston, Texas, 77008, United States",Avita Medical
Vitiligo,NCT03133871,Evaluation of Scanoskin for the Assessment of Vitiligo,https://clinicaltrials.gov/study/NCT03133871,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,"Chelsea and Westminster Hospital, London, SW10 9NH, United Kingdom","Principal Investigator : Lucy J Thomas, MBChB , Chelsea and Westminster Hospital NHS Trust Study Director : Declan Colllins, MBBS , Chelsea and Westminster Hospital NHS Trust"
Vitiligo,NCT02510651,Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02510651,NO,Vitiligo,PROCEDURE: Melanocyte-keratinocyte suspension,ALL,"ADULT, OLDER_ADULT",PHASE1,,Cairo University
Vitiligo,NCT01732965,NB-UVB and PUVA Vitiligo Study,https://clinicaltrials.gov/study/NCT01732965,NO,Vitiligo,OTHER: Phototherapy|OTHER: Phototherapy and Photochemotherapy,ALL,"ADULT, OLDER_ADULT",PHASE4,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States","Principal Investigator : Iltefat Hamzavi, MD , Henry Ford Dermatology"
Vitiligo,NCT02797574,Stress Response Pathways in Vitiligo,https://clinicaltrials.gov/study/NCT02797574,NO,Vitiligo,PROCEDURE: Punch Biopsy at a Lesional Site|PROCEDURE: Punch Biopsy at a Non- Lesional site,ALL,ADULT,,"New York University School of Medicine, New York, New York, 10016, United States","Principal Investigator : Prashiela Manga, MD , New York University Medical School"
Vitiligo,NCT00830713,Vitiligo Skin Transplantation,https://clinicaltrials.gov/study/NCT00830713,NO,Vitiligo,PROCEDURE: Melanocyte-keratinocyte transplantation procedure (MKTP),ALL,"ADULT, OLDER_ADULT",PHASE3,"Henry Ford Medical Center, New Center One, Detroit, Michigan, 48202, United States","Principal Investigator : Iltefat H Hamzavi, MD , Henry Ford Health Systems Dermatology Department"
Vitiligo,NCT02290717,Fractional Laser in Combination With UVB Therapy in Vitiligo Patients,https://clinicaltrials.gov/study/NCT02290717,NO,Vitiligo,DEVICE: Fractional CO2 laser|OTHER: NB-UVB therapy|DRUG: Fluticasone Propionate Cream 0.05%,ALL,"ADULT, OLDER_ADULT",,"Academic Medical Centre, Amsterdam, Netherlands",Netherlands Institute for Pigment Disorders
Vitiligo,NCT04103060,"Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo",https://clinicaltrials.gov/study/NCT04103060,NO,Vitiligo,DRUG: Cerdulatinib 0.37% gel|DRUG: Vehicle gel,ALL,"ADULT, OLDER_ADULT",PHASE2,"Dermavant Investigational Site, Irvine, California, 92617, United States|Dermavant Investigational Site, Worcester, Massachusetts, 01605, United States","Study Director : Michael McLaughlin , Dermavant Sciences GmbH"
Vitiligo,NCT01766609,Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01766609,NO,Vitiligo,DRUG: Triamcinolone Acetonide,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada",
Vitiligo,NCT04171427,Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT04171427,NO,Vitiligo,OTHER: Lithium liposome|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",,"Hbib thamer Hospital, Tunis, Tunisia",
Vitiligo,NCT03941808,Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.,https://clinicaltrials.gov/study/NCT03941808,NO,Vitiligo,DRUG: Glisodin tablet|DRUG: Placebo tablet,ALL,"ADULT, OLDER_ADULT",,"Passeron, Nice, Alpes-Maritime, 06001, France","Principal Investigator : Passeron Thierry, PhD , Centre Hospitalier Universitaire de Nice"
Vitiligo,NCT03717025,Comparison of Surgical Methods on Resistant Sites in Stable Vitiligo Patients,https://clinicaltrials.gov/study/NCT03717025,NO,Vitiligo,PROCEDURE: SUCTION BLISTER EPIDERMAL GRAFTING|PROCEDURE: MINI PUNCH GRAFTING|PROCEDURE: NON CULTURED EPIDERMAL CELL SUSPENSION,ALL,"ADULT, OLDER_ADULT",,"Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India",
Vitiligo,NCT04525157,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV),https://clinicaltrials.gov/study/NCT04525157,YES,Vitiligo,DRUG: Afamelanotide|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,,Clinuvel Pharmaceuticals Limited
Vitiligo,NCT04320160,Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo,https://clinicaltrials.gov/study/NCT04320160,NO,Vitiligo,PROCEDURE: Platelet rich plasma|PROCEDURE: Fractional CO2 laser,ALL,ADULT,,,"Principal Investigator : Amal T. ELghait, Professor , Assiut University"
Vitiligo,NCT00696358,Excimer Lamp Versus Excimer Laser in Vitiligo Treatment,https://clinicaltrials.gov/study/NCT00696358,NO,Vitiligo,RADIATION: 308nm excimer lamp|RADIATION: 308nm excimer laser,ALL,"ADULT, OLDER_ADULT",PHASE3,"Department of Dermatology, University Hospital of Nice, Nice, 06200, France",Centre Hospitalier Universitaire de Nice
Vitiligo,NCT02809976,Topical Ruxolitinib for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02809976,YES,Vitiligo,DRUG: Ruxolitinib 1.5% Phosphate Cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"Tufts Medical Center, Boston, Massachusetts, 02111, United States",
Vitiligo,NCT01923142,Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01923142,NO,Vitiligo,BIOLOGICAL: Outer-Root-Sheath Melanocytes Suspension|BIOLOGICAL: Placebo,ALL,ADULT,PHASE2,"Papa Giovanni XXIII Hospital, Bergamo, 24127, Italy|Spedali Civili, Brescia, 25123, Italy","Principal Investigator : Luigi Naldi, MD , Centro Studi Gised"
Vitiligo,NCT03468855,A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03468855,YES,Vitiligo,DRUG: ATI-50002 topical solution,ALL,"ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Encinitas, California, 92024, United States|Aclaris Investigator Site, Los Angeles, California, 90036, United States|Aclaris Investigator Site, Worcester, Massachusetts, 01655, United States|Aclaris Investigator Site, Dallas, Texas, 75390, United States|Aclaris Investigator Site, Lynchburg, Virginia, 24501, United States","Aclaris Therapeutics, Inc."
Vitiligo,NCT03155698,Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma,https://clinicaltrials.gov/study/NCT03155698,NO,Vitiligo,COMBINATION_PRODUCT: microneedling and Platelet rich plasma|RADIATION: NB-UVB phototherapy,ALL,ADULT,,"Assiut university, Assiut, Egypt","Principal Investigator : Lamiaa Ahmad Abd El-khalek , Assiut University"
Vitiligo,NCT01419964,Efficacy and Safety of ACH24 in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01419964,NO,Vitiligo,DRUG: Group 01|DRUG: Group 02,ALL,"ADULT, OLDER_ADULT",PHASE3,"Irmandade da Santa Casa de MisericÃ³rdia de Curitiba, Curitiba, ParanÃ¡, 80010-030, Brazil","Principal Investigator : CAIO CASTRO, PHYSICIAN , PUNTIFÃCIA UNIVERSIDADE CATÃ“LICA"
Vitiligo,NCT02925767,Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo,https://clinicaltrials.gov/study/NCT02925767,NO,Vitiligo,DEVICE: 311-nm Ti:Sapphire laser|DEVICE: 308-nm excimer laser,ALL,"ADULT, OLDER_ADULT",,"St. Vincent's Hospital, Suwon, Gyeonggi-do, 16247, Korea, Republic of",The Catholic University of Korea
Vitiligo,NCT01992185,Photocil (Topical) for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01992185,YES,Vitiligo,DRUG: Photocil for Vitiligo|OTHER: Placebo - Sunscreen (SPF 2),ALL,"ADULT, OLDER_ADULT",,"Physicians Institute, Tucson, Arizona, 85719, United States","Study Director : John McCoy, PhD , Applied Biology, Inc."
Vitiligo,NCT03199664,Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo,https://clinicaltrials.gov/study/NCT03199664,NO,Vitiligo,RADIATION: NB-UVB|COMBINATION_PRODUCT: NB-UVB & Tacrolimus 0.03%,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"South valley university, QinÄ, Egypt","Study Director : Ramdan Saleh, MD , Sohag Faculty of Medicine, Sohag university"
Vitiligo,NCT03158675,"Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo",https://clinicaltrials.gov/study/NCT03158675,NO,Vitiligo,PROCEDURE: fractional carbon dioxide(CO2) laser|DRUG: Topical corticosteroid|RADIATION: Ultraviolet B narrow band,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Principal Investigator : Muna Abdullah , Assiut University"
Vitiligo,NCT02281058,Open-label Pilot Study of Abatacept for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02281058,NO,Vitiligo,DRUG: Abatacept,ALL,"ADULT, OLDER_ADULT",PHASE1,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States",Bristol-Myers Squibb
Vitiligo,NCT03013049,A Novel Surgical Method in the Treatment of Unstable Vitiligo,https://clinicaltrials.gov/study/NCT03013049,NO,Vitiligo,PROCEDURE: Non cultured epidermal cell suspension|PROCEDURE: Non cultured dermal cell suspension,ALL,"ADULT, OLDER_ADULT",,"PGIMER, Chandigarh, 160012, India",
Vitiligo,NCT01382589,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo,https://clinicaltrials.gov/study/NCT01382589,NO,Vitiligo,DRUG: Afamelanotide|DEVICE: NB-UVB,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Principal Investigator : Giovanni Leone, MD , San Gallicano Dermatological Institute, Photodermatology Unit, Roma, ITALY"
Vitiligo,NCT01430195,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV),https://clinicaltrials.gov/study/NCT01430195,NO,Vitiligo,DRUG: Afamelanotide|PROCEDURE: Narrow-Band UVB Light Treatment,ALL,"ADULT, OLDER_ADULT",PHASE1,"Henry Ford Medical Center, Detroit, Michigan, 48202, United States|The Mount Sinai School of Medicine, New York, New York, 10029, United States",
Vitiligo,NCT01333410,Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo,https://clinicaltrials.gov/study/NCT01333410,NO,Vitiligo,DRUG: tacrolimus ointment|DRUG: Mometasone furoate,ALL,"ADULT, OLDER_ADULT",PHASE4,"Department of Dermatology, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand","Principal Investigator : Chanisada Wongpraparut, M.D. , Faculty of Medicine Siriraj Hospital"
Vitiligo,NCT01629979,Epidermal Cell Transplantation in Vitiligo Skin,https://clinicaltrials.gov/study/NCT01629979,NO,VITILIGO,PROCEDURE: Grafting with epidermal cells|RADIATION: UVB treatment,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Centre hospitalier Universitaire de Nice, Nice, 06000, France","Principal Investigator : philippe bahadoran, doctor , Centre Hospitalier Universitaire de Nice"
Vitiligo,NCT03249064,Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo,https://clinicaltrials.gov/study/NCT03249064,NO,VITILIGO,DIAGNOSTIC_TEST: CD 91 levels|DIAGNOSTIC_TEST: Tregs,ALL,"ADULT, OLDER_ADULT",,"Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain",FundaciÃ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Vitiligo,NCT03741738,"The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity",https://clinicaltrials.gov/study/NCT03741738,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, 03722, Korea, Republic of",Yonsei University
Vitiligo,NCT00807690,Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo,https://clinicaltrials.gov/study/NCT00807690,NO,Vitiligo,DRUG: Tacrolimus ointment,ALL,"ADULT, OLDER_ADULT",PHASE3,,"Principal Investigator : Eli Johanne Nordal, MD , Rikshospitalet HF, Dept. of Dermatology"
Vitiligo,NCT02191748,Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT02191748,NO,Vitiligo,PROCEDURE: Needling|DRUG: Triamcinolone,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"RWJUH Dermatology office, Somerset, New Jersey, 08873, United States",
Vitiligo,NCT03668834,"Comparing Recipient Site Preparation Using Dermabrasion, Dermaroller and Liquid Nitrogen Induced Blister in Non Cultured Epidermal Cell Suspension in Stable Vitiligo",https://clinicaltrials.gov/study/NCT03668834,NO,Vitiligo,PROCEDURE: Dermabrasion with NCES|PROCEDURE: Dermaroller with NCES|PROCEDURE: Liquid nitrogen induced blister with NCES,ALL,"ADULT, OLDER_ADULT",,"PGIMER, Chandigarh, 160012, India","Post Graduate Institute of Medical Education and Research, Chandigarh"
Vitiligo,NCT00615355,Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment,https://clinicaltrials.gov/study/NCT00615355,NO,Vitiligo,RADIATION: UVB 311 nm radiation|DEVICE: UVB 311nm,ALL,"ADULT, OLDER_ADULT",,"Medical University, Department of Dermatology, Graz, 8036, Austria","Principal Investigator : Angelika Hofer , Medical Univsersity of Graz, Department of Dermatology, Austria"
Vitiligo,NCT00134368,Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo,https://clinicaltrials.gov/study/NCT00134368,NO,Vitiligo,DRUG: Etanercept,ALL,"ADULT, OLDER_ADULT",PHASE2,"UMDNJ Psoriasis Center of Excellence, New Brunswick, New Jersey, 08903, United States","Principal Investigator : Alice Gottlieb, MD, PhD , UMDNJ-RWJMS"
Vitiligo,NCT00367224,Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT00367224,NO,Vitiligo,PROCEDURE: 6 to 9 ultraviolet B treatments|PROCEDURE: Skin biopsies,ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology/Henry Ford Hospital, Detroit, Michigan, 48202, United States",
Vitiligo,NCT01787695,UVA 1 Phototherapy for Vitiligo,https://clinicaltrials.gov/study/NCT01787695,NO,Vitiligo,PROCEDURE: UVA1,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada","Principal Investigator : Harvey Lui, MD, FRCPC , University of British Columbia"
Vitiligo,NCT01459055,Long-term Follow-up in Patients Affected With Acrofacial Vitiligo,https://clinicaltrials.gov/study/NCT01459055,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,"Irmandade da Santa Casa de MisericÃ³rdia de Curitiba, Curitiba, Parana, 80730000, Brazil","Principal Investigator : Caio C Silva de Castro, MD, PhD , Irmandade da Santa Casa de MisericÃ³rdia de Curitiba"
Vitiligo,NCT00368407,Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck,https://clinicaltrials.gov/study/NCT00368407,NO,Vitiligo,DEVICE: 308-nm excimer laser,ALL,"CHILD, ADULT",,"Department of dermatology, Xijing Hospital, Xi'an, SHANNXI, 710032, China","Study Director : gao tianwen, MD,PHD , Ddepartment of Dermatology"
Vitiligo,NCT01262547,A New Micrografting Technique for Vitiligo,https://clinicaltrials.gov/study/NCT01262547,YES,Vitiligo,DEVICE: Dermabrasion-Micrografting|PROCEDURE: Dermabrasion,ALL,"ADULT, OLDER_ADULT",PHASE2,"Mgh Curtis, Boston, Massachusetts, 02114, United States",
Vitiligo,NCT00622180,The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands,https://clinicaltrials.gov/study/NCT00622180,YES,Vitiligo,DEVICE: NBUVB|DEVICE: Monochromacitc Excimer light,ALL,"ADULT, OLDER_ADULT",,"UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials, Dallas, Texas, 75390-8802, United States","Principal Investigator : Amit Pandya, M.D. , UT Southwestern Medical Center at Dallas - Department of Dermatology"
Vitiligo,NCT01822379,Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01822379,NO,Vitiligo,PROCEDURE: Melanocyte Keratinocyte transplantation,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Henry Ford Hospital Department of Dermatology, Detroit, Michigan, 48202, United States","Principal Investigator : Iltefat H Hamzavi, MD , Henry Ford Dermatology"
Vitiligo,NCT00631865,Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin,https://clinicaltrials.gov/study/NCT00631865,NO,Vitiligo,BIOLOGICAL: Melanocyte transplantation,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Royan Institute, Tehran, 1665659911, Iran, Islamic Republic of","Principal Investigator : Hossein Baharvand, PhD , Head of Royan stem cell department Principal Investigator : Saeeid Shafieian, MD , Firoozgar Hospital Study Director : Nasser Aghdami, MD., PhD , Head of Royan transplantation Lab"
Vitiligo,NCT00380471,Treatment and Complication of Bath PUVA in Vitiligo,https://clinicaltrials.gov/study/NCT00380471,NO,Vitiligo,DEVICE: Bath PUVA,ALL,"ADULT, OLDER_ADULT",PHASE2,"Skin Research Center, Shaheed Beheshti Medical University, Tehran, 19899, Iran, Islamic Republic of","Study Chair : Parviz Toossi, M.D. , Shahid Beheshti University of Medical Sciences"
Vitiligo,NCT03022019,ReNovaCell in Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT03022019,NO,Non-segmental Vitiligo|Vitiligo,DEVICE: ReNovaCell,ALL,"ADULT, OLDER_ADULT",,"Nipd / Amc, Amsterdam, 1105AZ, Netherlands",
Vitiligo,NCT00398723,Narrowband UVB Treatment in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT00398723,NO,Vitiligo,DEVICE: Narrowband UVB,ALL,"ADULT, OLDER_ADULT",,"Rockefeller University Hospital, New York, New York, 10021, United States",
Vitiligo,NCT06261086,Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study,https://clinicaltrials.gov/study/NCT06261086,NO,Vitiligo,"DIAGNOSTIC_TEST: evaluate serum levels pyroptosis-related indicators (GASDM-D, IL 1Î² & IL-18)",ALL,"ADULT, OLDER_ADULT",,,Sohag University
Vitiligo,NCT01006421,Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01006421,NO,Vitiligo,DIETARY_SUPPLEMENT: GINGKO BILOBA,ALL,"CHILD, ADULT, OLDER_ADULT",,"King Khalid University Hospital, Riyadh, Central, Saudi Arabia","Study Chair : KHALID M ALGHAMDI, MD , KSU"
Vitiligo,NCT05467839,Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients,https://clinicaltrials.gov/study/NCT05467839,NO,Vitiligo,DEVICE: derma pen,ALL,"CHILD, ADULT, OLDER_ADULT",,"Sohag University Hospital, Sohag, Egypt",Sohag University
Vitiligo,NCT00525395,Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol,https://clinicaltrials.gov/study/NCT00525395,NO,Vitiligo,GENETIC: Sequential phototherapy|PROCEDURE: Continuous phototherapy,ALL,ADULT,PHASE3,"Istituto San Gallicano -, Rome, 00100, Italy","Study Chair : Mauro Picardo, MD , Istituto San Gallicano - Rome - Italy"
Vitiligo,NCT00172939,Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model,https://clinicaltrials.gov/study/NCT00172939,NO,Vitiligo,PROCEDURE: foreskin from healthy adults,MALE,ADULT,PHASE1,"National Taiwan University Hospital, Taipei, Taiwan","Study Director : Hsin-Su Yu, MD PHD , National Taiwan University Hospital"
Vitiligo,NCT05256147,Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters,https://clinicaltrials.gov/study/NCT05256147,NO,Vitiligo,DRUG: Ibuprofen,ALL,"ADULT, OLDER_ADULT",,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States",
Vitiligo,NCT00177034,Examination Of Vitiligo Skin Samples Before and After UVB Treatment,https://clinicaltrials.gov/study/NCT00177034,NO,Vitiligo,DRUG: Narrow Band UVB Treatment,ALL,"ADULT, OLDER_ADULT",,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","Principal Investigator : Mimi Cho, MD, PhD , University of Minnesota"
Vitiligo,NCT01511965,Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01511965,NO,Vitiligo,OTHER: autologous (cellular therapy),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"service de Dermatologie - HÃ´pital l'Archet, Nice, 06200, France","Principal Investigator : Philippe Bahadoran, PH , Centre Hospitalier Universitaire de Nice"
Vitiligo,NCT01087216,Interest of the Dermabrasion by Laser Erbium in the Treatment of the Vitiligo,https://clinicaltrials.gov/study/NCT01087216,NO,Vitiligo,DEVICE: Group Laser = Arm A|DRUG: Bras B : The group control,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"CHU de Nice - 4 avenue Reine Victoria - HÃ´pital de Cimiez, Nice, Alpes-Maritimes, 06001, France","Principal Investigator : PASSERON Ph Thierry, Md , CHU de Nice - Service de Dermatologie - HÃ´pital de l'Archet - 151 Route de saint-antoine de ginestiÃ¨re 06200 Nice"
Vitiligo,NCT03933774,"PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation",https://clinicaltrials.gov/study/NCT03933774,YES,Vitiligo,DRUG: Tretinoin 0.05% cream|DRUG: Placebo cream,ALL,"ADULT, OLDER_ADULT",,"St. Vincent's Hospital, Suwon, Gyeonggi-do, 16247, Korea, Republic of","Principal Investigator : Jung Min Bae, MD, PhD , Department of Dermatology, College of Medicine, Catholic University of Korea"
Vitiligo,NCT01792245,Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand,https://clinicaltrials.gov/study/NCT01792245,NO,Vitiligo,DEVICE: Phototherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada","Principal Investigator : Harvey Lui, MD, FRCPC , University of British Columbia"
Vitiligo,NCT05676333,Secukinumab in Active Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05676333,NO,Vitiligo|Secukinumab,DRUG: Secukinumab,ALL,"ADULT, OLDER_ADULT",PHASE4,"Department of Dermatology, Ghent University Hospital, Gent, Oost-Vlaanderen, 9000, Belgium","Principal Investigator : van Geel Nanja, MD, PhD , Department of Dermatology, Ghent University Hospital"
Vitiligo,NCT05980390,IL35 Level in Vitiligo,https://clinicaltrials.gov/study/NCT05980390,NO,"IL35, Vitiligo",DIAGNOSTIC_TEST: IL 35 in tissue biopsy,ALL,ADULT,,,Cairo University
Vitiligo,NCT05503368,Autologous Cellular Graft in Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05503368,NO,"Vitiligo, Generalized",PROCEDURE: surgical treatment of vitiligo using NCES,ALL,"ADULT, OLDER_ADULT",,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt","Principal Investigator : Rania M Mogawer , Kasr Alainy, Cairo University Hospitals Study Director : Samia M Esmat , Kasr Alainy, Cairo University Hospitals"
Vitiligo,NCT06327321,Vitiligo Treatment by Targeting TYK2 Mediated Responses,https://clinicaltrials.gov/study/NCT06327321,NO,"Vitiligo, Generalized",DRUG: Deucravacitinib|OTHER: Volunteer without treatment,ALL,"ADULT, OLDER_ADULT",PHASE3,"CHU de Nice - HÃ´pital de l'Archet, Nice, Alpes-Maritimes, 06200, France|APHP, Henri Mondor, Paris, Creteil, France|CHU de Bordeaux, Bordeaux, Talence, 33000, France|CHU de Lille, Lille, France|HCL, Lyon, France","Principal Investigator : PASSERON Thierry, PhD , CHU de Nice, Service de Dermatologie"
Vitiligo,NCT06113471,A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2),https://clinicaltrials.gov/study/NCT06113471,NO,NonSegmental Vitiligo,DRUG: Povorcitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"University of Alabama At Birmingham Hospital-Whitaker Clinic, Birmingham, Alabama, 35294-0007, United States|C2 Research Center, Llc, Montgomery, Alabama, 36117, United States|Tien Q Nguyen Md Inc, Fountain Valley, California, 92708-3701, United States|Center For Dermatology Clinical Research, Inc, Fremont, California, 94538, United States|Marvel Clinical Research Llc, Huntington Beach, California, 92647, United States|Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036-5609, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Clinical Trials Research Institute, Thousand Oaks, California, 91320, United States|Skin Care Research, Llc, Boca Raton, Florida, 33486, United States|Total Vein and Skin Llc, Boynton Beach, Florida, 33437, United States|Driven Research Llc, Coral Gables, Florida, 33134, United States|Florida Academic Centers Research and Education Llc, Coral Gables, Florida, 33134, United States|Pediatric Skin Research Llc, Coral Gables, Florida, 33146, United States|Metabolic Research Institute Inc, West Palm Beach, Florida, 33401, United States|Advanced Medical Research Pc, Sandy Springs, Georgia, 30328, United States|Dundee Dermatology, West Dundee, Illinois, 60118, United States|Indiana University School of Medicine Iusm Indianapolis, Indianapolis, Indiana, 46202-3082, United States|Delricht Research, Baton Rouge, Louisiana, 70809, United States|Callender Dermatology and Cosmetic Center, Glenn Dale, Maryland, 20769, United States|Aesthetic and Dermatology Center, Rockville, Maryland, 20850, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Allcutis Research, Inc Portsmouth, Portsmouth, New Hampshire, 03801, United States|Weill Cornell Medicine, New York, New York, 10065, United States|Accellacare Wilmington, Wilmington, North Carolina, 28401, United States|Remington-Davis Clinical Research, Columbus, Ohio, 43215, United States|Oregon Medical Research Center, Pc, Portland, Oregon, 97223, United States|Health Concepts Rapid City, Rapid City, South Dakota, 57702, United States|Dermatology Treatment and Research Center, Dallas, Texas, 75230, United States|Heights Dermatology and Aesthetic Center, Houston, Texas, 77008, United States|University of Texas, Md Anderson Cancer, Houston, Texas, 77030, United States|Austin Institute For Clinical Research Aicr Pflugerville, Pflugerville, Texas, 78660, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Premier Clinical Research, Spokane, Washington, 99202, United States|Medical Center Asklepii Ood, Dupnitsa, 02600, Bulgaria|Mc Unimed, Sliven, 05308, Bulgaria|Ambulatory For Specialized Medical Care - Individual Practice For Specialized Medical Care - Skin An, Sofia, 01407, Bulgaria|Aleksandrovska University Hospital, Sofia, 01431, Bulgaria|28 Diagnostic and Consultative Center, Sofia, 01528, Bulgaria|British Columbia'S Centre For Dermatologic Science - the Skin Care Centre, Vancouver, British Columbia, V5Z 4E8, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada|DERMEDGE, Mississauga, Ontario, L4Y 4C5, Canada|Research Toronto, Toronto, Ontario, M3H 5Y8, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Centre de Recherche Dermatologique de Quebec, Quebec City, Quebec, G1V4X7, Canada|Chru Morvan/Chu Brest Hopital Morvan, Brest, 29200, France|Centre Hospitalier - Le Mans, Le Mans, 72037, France|Hopital Edouard Herrio, Lyon Cedex 03, 69003, France|Cabinet Medical- Chemin de Paradis, Martigues, 13500, France|Centre Hospitalier Universitaire de Nice,Hopital L Archet, Nice, 06200, France|Hopital Charles Nicolle, Rouen Cedex, 76031, France|Fachklinik Bad Bentheim Dermatologie, Bad Bentheim, 481455, Germany|Charite Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin, 10117, Germany|University Hospital Carl Gustav Carus, Dresden, 01307, Germany|Universitatsklinikum Hamburg, Hamburg, 20246, Germany|Dermatologische Gemeinschaftspraxis, Mahlow, 15831, Germany|Universitatsklinikum Munster, Muenster, 48149, Germany|Clinexpert Egeszsegugyi Szolgaltato Es Kereskedelmi Kft., Budapest, 01033, Hungary|Orvostudomanyi Kutato Es Fejleszto Kft, Debrecen, 04027, Hungary|Debreceni Egyetem, Debrecen, 04032, Hungary|Obudai Egeszsegugyi Centrum - Dunaujvaros, Dunaujvaros, H-2400, Hungary|Markusovszky Teaching Hospital, Szombathely, Hungary|Azienda Ospedaliera Spedali Civili Di Brescia-Universita Degli Studi Di Brescia, Brescia, 25123, Italy|Azienda Ospedaliero-Universitaria Policlinico Vittorio Emanuele Ospedale Gaspare Rodolico Di Catania, Catania, 95123, Italy|Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Fondazione Policlinico Universitario Agostino Gemelli Irccs, Rome, 00168, Italy|Irccs Istituto Clinico Humanitas, Rozzano, 20089, Italy|Synexus - Polska Sp Z Oo Oddzial W Gdansksynexus Affiliate - Bialystok - Clinicmed Daniluk Nowak Spo, Gdansk, 80-382, Poland|Synexus Gdynia, Gdynia, 81-537, Poland|Provita Sp.Zo.O. Centrum Medyczne Angelius, Katowice, 40-611, Poland|Pro Familia Altera Sp. Z O.O., Katowice, 40-648, Poland|Prywatny Gabinet Dermatologiczny Elzbieta Klujszo, Kielce, 25-316, Poland|Niepubliczny Zaklad Opieki Zdrowotnej Dermed Centrum Medyczne Sp. Z O.O., Lodz, 90-265, Poland|Dermoklinika Centrum Medyczne S.C., M. Kierstan, J. Narbutt, A. Lesiak, Lodz, 90-436, Poland|Etg Skierniewice, Skierniewice, 96-100, Poland|Laser Clinic, Szczecin, 70-332, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. Z O.O., Tarnow, 33-100, Poland|Centrum Medyczne Evimed, Warsaw, 02-625, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-692, Poland|Klinika Ambroziak Sp. Z O.O., Warszawa, 02-953, Poland|Futuremeds Targowek Centrum Medyczne Amed Warszawa Targowek, Wrocaw, 03-291, Poland|Synexus Polska Sp. Z O.O. Oddzial We Wroclawiu, Wroclaw, 50-088, Poland|Dermmedica Sp. Z O.O., Wroclaw, 51-318, Poland|Centrum Medyczne Oporow, Wroclaw, 52-416, Poland|Ipswich Hospital, East Suffolk and North Essex Nhs Foundation Trust, Ipswich, IP4 5PD, United Kingdom|University Hospitals of Leicester-Leicester Royal Infirmary (Lri), Leicester, LE1 5WW, United Kingdom|Barts Health Nhs Trust - Whipps Cross University Hospital, London, E11 1NR, United Kingdom|Nottingham University Hospitals - Treatment Center, Nottingham, NG7 2FT, United Kingdom|Royal Wolverhampton Nhs Trust, Walsall, WS2 9PS, United Kingdom","Study Director : Incyte Medical Monitor , Incyte Corporation"
Vitiligo,NCT06113445,A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1),https://clinicaltrials.gov/study/NCT06113445,NO,NonSegmental Vitiligo,DRUG: Povorcitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Cahaba Dermatology, Hoover, Alabama, 35244, United States|University of California Irvine, Irvine, California, 92697, United States|Clinical Science Institute Clinical Research Specialists Inc, Santa Monica, California, 90404, United States|Cura Clinical Research, Sherman Oaks, California, 91403, United States|Sutter Health Palo Alto Medical Foundation Pamf Sunnyvale Center, Sunnyvale, California, 94086, United States|Renaissance Research, Cape Coral, Florida, 33991, United States|Encore Medical Research, Llc Hollywood, Hollywood, Florida, 33021, United States|San Marcus Research Clinic Inc., Miami Lakes, Florida, 33014, United States|Savin Medical Group, Rc, Miami, Florida, 33156, United States|Skin Research of South Florida, Llc, Miami, Florida, 33173, United States|Olympian Clinical Research, Tampa, Florida, 33609, United States|Forcare Clinical Research, Tampa, Florida, 33613, United States|Cleaver Medical Group, Cumming, Georgia, 30040, United States|Pivotal Research Solutions, Stonecrest, Georgia, 30038, United States|Options Research Group, Llc, Kokomo, Indiana, 46901, United States|Allcutis Research Inc Beverly, Beverly, Massachusetts, 01915, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135-3511, United States|Great Lakes Research Group Inc, Bay City, Michigan, 48706, United States|Wayne State University Physician Group Dermatology, Dearborn, Michigan, 48124, United States|Revival Research Institute, Llc Dermatology, Troy, Michigan, 48084, United States|Grekin Skin Institute Warren, Warren, Michigan, 48088, United States|Medisearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Jdr Dermatology Research, Las Vegas, Nevada, 89148, United States|Schweiger Dermatology Group - Verona, Verona, New Jersey, 07044, United States|Empire Dermatology, East Syracuse, New York, 13057, United States|Sadick Dermatology Sadick Research Group, New York, New York, 10075, United States|Derm Research Center of New York Inc, Stony Brook, New York, 11790, United States|Bexley Dermatology, Bexley, Ohio, 43209, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|International Clinical Research Tennessee Llc, Murfreesboro, Tennessee, 37130, United States|University of Texas Physicians - Bellaire Station, Bellaire, Texas, 77401, United States|Center For Clinical Studies, Houston, Texas, 77004, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Jordan Valley Dermatology Center, West Jordan, Utah, 84088, United States|Clinical Research Partners Llc Crp Richmond Forest Avenue Office Building Location, Richmond, Virginia, 23226, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Hopital Universitaire de Bruxelles (H.U.B)/ Academisch Ziekenhuis Brussel, Brussels, 01070, Belgium|Universitair Ziekenhuis Gent, Gent, 09000, Belgium|Centre Hospitalier Universitaire de Liege - Sart Tilman, Liege, 04000, Belgium|Cliniques Universitaires Ucl Saint-Luc, Woluwe-saint-lambert, 01200, Belgium|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|Dr. Chih-Ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Leader Research, Burlington, Ontario, L7R 4H9, Canada|Dermeffects, London, Ontario, N6H 5L5, Canada|North York Research Inc., North York, Ontario, M2M 4J5, Canada|Care Clinic, Ottawa, Ontario, K1A 0K9, Canada|Siena Medical Research Corporation, Ottawa, Ontario, K1A 0K9, Canada|Skin Health, Peterborough, Ontario, K9J 5K2, Canada|Alliance Clinical Trials, Waterloo, Ontario, N2J 1C4, Canada|Bordeaux Chu Hopital Saint - Andre, Bordeaux Cedex, 33075, France|Centre Hospitalier Universitaire (Chu) - Hopital Henri Mondor, Bordeaux Cedex, 33075, France|Clinique de Courlancy, Reims, 51100, France|Hopital Larrey, Toulouse, 31059, France|Universitatsklinikum Erlangen Hautklinik, Erlangen, 91054, Germany|Klinikum Der Johann Wolfgang Goethe University, Frankfurt Am Main, 60590, Germany|Derma-Study-Center Friedrichshafen Gmbh, Friedrichshafen, 88045, Germany|Dermatologische Gemeinschaftspraxis Dres. Quist, Mainz, 55128, Germany|Beldio Research Gmbh, Dr. Schwinn,, Memmingen, 87700, Germany|Hamamatsu University Hospital, Hamamatsu, 431-3192, Japan|St. Marianna University School of Medicine Hospital, Kawasaki, 216-8511, Japan|Kobe University Hospital, Kobe, 6500017, Japan|University Hospital Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan|Dokkyo Medical University Saitama Medical Center, Minamikoshigaya, 343-8555, Japan|Nagasaki University Hospital, Nagasaki-shi, 852-8501, Japan|Nagoya City University Hospital, Nagoya, 467-8602, Japan|Kochi Medical School Hospital, Nankoku, 783-8505, Japan|Niigata University Medical and Dental Hospital, Niigata, 9518520, Japan|National Hospital Organization Okayama Medical Center, Okayama-shi, 701-1192, Japan|Tohoku University Hospital, Sendai, 980-8574, Japan|Ntt Medical Center Tokyo, Shinagawa-ku, 141-8625, Japan|Tokyo Medical University Hospital, Shinjuku-ku, 160-0023, Japan|Osaka University Hospital, Suita, 565-0871, Japan|National University Corporation - Tokyo Medical and Dental University (Tmdu), Tokyo, 113-8519, Japan|Juntendo University Urayasu Hospital, Urayasu, 279-0021, Japan|Yamagata University Hospital, Yamagata-shi, 990-9585, Japan|Trials in Medicine S.C., Cuauhtemoc, 06700, Mexico|Instituto de Investigaciones Aplicadas A La Neurociencia A.C, Durango, 34000, Mexico|Grupo ClÃ­nico Catei Sc, Guadalajara, 44600, Mexico|Centro de Dermatologia de Monterrey, Monterrey, 64460, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, 64660, Mexico|Clinica de Enfermedades Cronicas Y de Procedimientos Especiales (Cecype), Morelia, 58249, Mexico|Uva - Amc - Stichting Nederlands Instituut Voor Pigmentstoornissen (Snip) (Netherlands Institute For, Amsterdam, 1105 AZ, Netherlands|Bravis Ziekenhuis, Bergen Op Zoom, 4624 VT, Netherlands|Dermapolis Medical Dermatology Center Dr N. Med. Edyta Gebska, Chorzow, 41-516, Poland|Synexus Polska Sp Z Oo Oddzial W Czestochowie, Czestochowa, 42-202, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-214, Poland|Synexus Polska Sp. Z O.O. Oddzial W Katowicach, Katowice, 40-040, Poland|Synexus Polska Sp Z Oo Oddzial W Lodzi, Lodz, 90-127, Poland|Dermodent Centrum Medyczne Aldona Czajkowska RafaÂ¿ Czajkowski, Osielsko, 86-031, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, 27-400, Poland|Uniwersytecki Szpital Kliniczny Im. Fryderyka Chopina W Rzeszowie, Rzeszow, 35-055, Poland|Etg Warszawa, Warsaw, 02-777, Poland|Csk Mswia Centralny Szpital Kliniczny Mswia, Warszawa, 02-507, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszawa, 02-661, Poland|Synexus Polska Sp. Z O.O. Oddzial Warszawie, Warszawa, 02-672, Poland|Emc Instytut Medyczny Spolka Akcyjna-Euromedicare Szpital Specjalistyczny Z Przychodnia, Wrocaw, 54144, Poland|Hospital Universitario Fundacion Alcorcon, Alcorcon, 28922, Spain|Germans Trias I Pujol, Badalona, 08916, Spain|Hospital Clinic I Provincial, Barcelona, 08036, Spain|Hospital Universitario Ramon Y Cajal, Madrid, 28034, Spain|Clinical Universidad de Navarra Madrid, Madrid, 31008, Spain|Hospital de Manises, Manises, 46940, Spain","Study Director : Incyte Medical Monitor , Incyte Corporation"
Vitiligo,NCT05950542,"Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo",https://clinicaltrials.gov/study/NCT05950542,NO,"Vitiligo, Generalized",DRUG: Baricitinib,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Study Director : Yasmin mostafa Tawfik, Doctor , Assiut University"
Vitiligo,NCT05511493,Efficacy of PRP With Er-YAG Laser Versus With Microneedling in Localized Stable Vitiligo,https://clinicaltrials.gov/study/NCT05511493,NO,Localized Vitiligo,DEVICE: fractional Erbium-YAG laser|DEVICE: microneedling,ALL,"CHILD, ADULT",,,
Vitiligo,NCT04440371,Phototherapy Combination With Topicals in Vitiligo,https://clinicaltrials.gov/study/NCT04440371,NO,"Vitiligo, Generalized",COMBINATION_PRODUCT: Tacrolimus 0.1% ointment twice daily plus NBUVB 3 times weekly|COMBINATION_PRODUCT: Calcipotriol/Betamethasone ointment plus NBUVB,ALL,"ADULT, OLDER_ADULT",,"Diala Alshiyab, Irbid, Jordan","Principal Investigator : Diala Alshiyab, MD , Jordan University of Science and Technology"
Vitiligo,NCT04803461,Catecholamines Level in Vitiligo Patients Before and After Excimer Light,https://clinicaltrials.gov/study/NCT04803461,NO,"Vitiligo, Generalized",DIAGNOSTIC_TEST: serum and urinary catecholamines,ALL,"CHILD, ADULT, OLDER_ADULT",,,Assiut University
Vitiligo,NCT05238077,Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo,https://clinicaltrials.gov/study/NCT05238077,NO,Generalized Vitiligo,PROCEDURE: Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy,ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard,, Detroit, Michigan, 48202, United States","Principal Investigator : Iltefat Hamzavi, M.D. , Henry Ford HS"
Vitiligo,NCT03378011,UVA1 Phototherapy in Acral Vitiligo,https://clinicaltrials.gov/study/NCT03378011,NO,Acral Vitiligo,OTHER: phototherapy,ALL,"CHILD, ADULT, OLDER_ADULT",,"Maha Fathy Elmasry, Cairo, Egypt","Principal Investigator : Maha Elmasry , Cairo University"
Vitiligo,NCT04039451,"Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt",https://clinicaltrials.gov/study/NCT04039451,NO,Psoriasis|Vitiligo,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Assiut University, Assiut, Egypt",Assiut University
Vitiligo,NCT03535051,Efficiency of Fractional-Laser Resurfacing Followed by Topical Tacrolimus 0.03% Cream vs Tacrolimus Alone in Vitiligo,https://clinicaltrials.gov/study/NCT03535051,NO,Stable Vitiligo,DEVICE: fractional carbon dioxide laser|DRUG: Tacrolimus Oint 0.03%,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Study Director : Ola M AbuZeid, MD , Kasr Al Aini dermatology department Study Director : Dina ElSharkawy, MD , Kasr Al Aini dermatology department"
Vitiligo,NCT04818346,A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT04818346,YES,NonSegmental Vitiligo,DRUG: INCB054707|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigative Site 010, Hoover, Alabama, 35244, United States|Investigative Site 015, Gilbert, Arizona, 85295, United States|Investigative Site 028, Scottsdale, Arizona, 85260, United States|Investigative Site 006, Irvine, California, 92697, United States|Investigative Site 009, Los Angeles, California, 90036, United States|Investigative Site 018, Los Angeles, California, 90045, United States|Investigative Site 017, Sacramento, California, 95815, United States|Investigative Site 032, Orange Park, Florida, 32073, United States|Investigative Site 005, Tampa, Florida, 33613, United States|Investigative Site 022, Tampa, Florida, 33614, United States|Investigative Site 011, West Palm Beach, Florida, 33401, United States|Investigative Site 024, Covington, Louisiana, 70433, United States|Investigative Site 002, Brighton, Massachusetts, 02135, United States|Investigative Site 023, Saint Paul, Minnesota, 55112, United States|Investigative Site 027, Verona, New Jersey, 07044, United States|Investigative Site 003, Columbus, Ohio, 43215, United States|Investigative Site 007, Norman, Oklahoma, 73071, United States|Investigative Site 001, Portland, Oregon, 97223, United States|Investigative Site 021, Plymouth Meeting, Pennsylvania, 19462, United States|Investigative Site 004, Murfreesboro, Tennessee, 37130, United States|Investigative Site 033, Dallas, Texas, 75230, United States|Investigative Site 012, San Antonio, Texas, 78213, United States|Investigative Site 030, Spokane, Washington, 99202, United States|Investigative Site 020, Winnipeg, Manitoba, R3M 3Z4, Canada|Investigative Site 014, Etobicoke, Ontario, M8X 1Y9, Canada|Investigative Site 034, London, Ontario, N6H 5LR, Canada|Investigative Site 025, Mississauga, Ontario, L5H 1G9, Canada|Investigative Site 026, North York, Ontario, M2M4J5, Canada|Investigative Site 031, Oakville, Ontario, L6J 7W5, Canada|Investigative Site 008, Peterborough, Ontario, K9J 5K2, Canada|Investigative Site 029, Quebec, Q1V 4X7, Canada",Incyte Corporation
Vitiligo,NCT03358082,Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT03358082,NO,Vitiligo|Tacrolimus,DRUG: Tacrolimus 0.03% Ointment|DRUG: Hydrocortisone Acetate 1% Ointment,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,"Sohag University, Sohag, Egypt","Study Director : Ramadan Saleh, MD , Sohag Faculty of Medicine, Sohag University"
Vitiligo,NCT03577327,The Gut and Skin Microbiome in Vitiligo Disease Progression,https://clinicaltrials.gov/study/NCT03577327,NO,Vitiligo|Healthy,,ALL,"ADULT, OLDER_ADULT",,"Northwestern University, Chicago, Illinois, 60611, United States","Principal Investigator : I. Caroline Le Poole , Northwestern University"
Vitiligo,NCT01701648,Melanocyte Transplantation for Patients With Stable Vitiligo.,https://clinicaltrials.gov/study/NCT01701648,NO,Stable Vitiligo,OTHER: Laser CO2,ALL,ADULT,PHASE1|PHASE2,"University Clinic of Navarre, Pamplona, Navarre, 31008, Spain",Spanish Clinical Research Network - SCReN
Vitiligo,NCT03487042,Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo,https://clinicaltrials.gov/study/NCT03487042,NO,Generalized Vitiligo,DRUG: Bimatoprost 0.03% ophthalmic solution,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,,Assiut University
Vitiligo,NCT01202513,Topical Bimatoprost Solution 0.03%in Stable Vitiligo,https://clinicaltrials.gov/study/NCT01202513,NO,Vitiligo|Repigmentation,DRUG: Bimatoprost 0.03% topical ophthalmic solution,ALL,"CHILD, ADULT",PHASE4,,"Study Director : Rajeev Jain, M.D. , PP Principal Investigator : Tarun Narang, MD , GSMCH"
Vitiligo,NCT02156427,Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism,https://clinicaltrials.gov/study/NCT02156427,NO,Vitiligo|Piebaldism,DEVICE: VITICELL|DEVICE: PLACEBO,ALL,"ADULT, OLDER_ADULT",PHASE3,"Department of Dermatology - Ghent University Hospital, Ghent, Belgium|University Hospital Center of Bordeaux, Bordeaux, France|CHU Le Mans, Le Mans, France|Dr Michel PASCAL, Paris, France|San Gallicano Dermatological Institute, Roma, Italy","Principal Investigator : Nanja Van Geel, Pr , Gent hospital"
Vitiligo,NCT06072183,A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2,https://clinicaltrials.gov/study/NCT06072183,NO,Stable Nonsegmental Vitiligo|Active Nonsegmental Vitiligo,DRUG: Ritlecitinib|DRUG: Ritlecitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Total Dermatology, Birmingham, Alabama, 35203, United States|Total Skin & Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States|Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States|Dermatology Trial Associates, Bryant, Arkansas, 72022, United States|First OC Dermatology Research Inc, Fountain Valley, California, 92708, United States|L.A. Universal Research Center, Inc., Los Angeles, California, 90057, United States|Cura Clinical Research - Oxnard, Oxnard, California, 93030, United States|Mission Dermatology Center, Rancho Santa Margarita, California, 92688, United States|Mission Dermatology Center, Rancho Santa Margarita, California, 92688, United States|Peninsula Research Associates, Rolling Hills Estates, California, 90274, United States|University of California San Diego - La Jolla, San Diego, California, 92122, United States|Wolverine Clinical Trials, Santa Ana, California, 92705, United States|Wolverine Clinical Trials, Tustin, California, 92780, United States|Gamma Diagnostic Lab, Doral, Florida, 33172, United States|FXM Clinical Research - Fort Lauderdale, Fort Lauderdale, Florida, 33308, United States|Hear 4 U, Hialeah, Florida, 33015, United States|Harmony Medical Research Institute, Hialeah, Florida, 33016, United States|Unlimited Diagnostic Center, Hialeah, Florida, 33016, United States|Wellness Clinical Research, Miami Lakes, Florida, 33016, United States|SouthCoast Research Center, Miami, Florida, 33136, United States|Bio-Medical Research LLC, Miami, Florida, 33144, United States|All Hearing Aid, LLC, Miami, Florida, 33155, United States|Health and Life Research Institute, Miami, Florida, 33155, United States|South Miami Medical & Research Group, Miami, Florida, 33155, United States|New Horizon Research Center, Miami, Florida, 33165, United States|Miami Dermatology and Laser Research, Miami, Florida, 33173, United States|Skin Research of South Florida, Miami, Florida, 33173, United States|Well Pharma Medical Research, Corp., Miami, Florida, 33173, United States|FXM Clinical Research - Miami, Miami, Florida, 33175, United States|JD Medical Group, Miami, Florida, 33176, United States|Floridian Research Institute Llc, Miami, Florida, 33179, United States|Sanitas Research, Miami, Florida, 33186, United States|FXM Clinical Research - Miramar, Miramar, Florida, 33027, United States|GCP Research, Global Clinical professionals, Saint Petersburg, Florida, 33705, United States|NorthShore University Health System, Skokie, Illinois, 60077, United States|The South Bend Clinic, LLC, South Bend, Indiana, 46617, United States|Dermatology & Advanced Aesthetics, Lake Charles, Louisiana, 70605, United States|Concentra Urgent Care, Auburn Hills, Michigan, 48326, United States|Oakland Hills Dermatology, Auburn Hills, Michigan, 48326, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, 48202, United States|Great Lakes Hearing Care, Rochester, Michigan, 48307, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Canfield Scientific Inc., Parsippany, New Jersey, 07054, United States|Juva Skin & Laser Center, New York, New York, 10022, United States|OptiSkin Medical, New York, New York, 10128, United States|OptiSkin Medical, New York, New York, 10128, United States|DermResearchCenter of New York, Inc., Stony Brook, New York, 11790, United States|Darst Dermatology, Charlotte, North Carolina, 28277, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Centricity Research Dublin Multispeciality, Dublin, Ohio, 43016, United States|Centricity Research Dublin Multispecialty, Dublin, Ohio, 43016, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|Columbia Dermatology & Aesthetics, Columbia, South Carolina, 29212, United States|Palmetto Clinical Trial Services - Greenville, Greenville, South Carolina, 29615, United States|International Clinical Research - Tennessee LLC, Murfreesboro, Tennessee, 37130, United States|Center for Clinical Studies, Houston, Texas, 77004, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Global Imaging, Sugar Land, Texas, 77478, United States|Complete Dermatology, Sugar Land, Texas, 77479, United States|Fort Bend Hearing, Sugar Land, Texas, 77479, United States|Springville Dermatology - Springville/CCT Research, Springville, Utah, 84663, United States|The Education & Research Foundation, Inc., Lynchburg, Virginia, 24501, United States|Virginia Dermatology and Skin Cancer Center, Norfolk, Virginia, 23502, United States|Diagnostic - Consultative Center XXVIII - Sofia, Sofia, 1528, Bulgaria|""Diagnostic - Consultative Center XX - Sofia"" EOOD, Sofia, 1618, Bulgaria|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|DermEffects, London, Ontario, N6H 5L5, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|Medicor Research Inc, Sudbury, Ontario, P3C 1X3, Canada|Sudbury Skin Clinique, Sudbury, Ontario, P3C 1X8, Canada|North York Research Inc, Toronto, Ontario, M2N 3A6, Canada|Dermatology on Bloor - Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Innovaderm Research Inc., MontrÃ©al, Quebec, H2X 2V1, Canada|Centre de Recherche Saint-Louis, Sherbrooke, Quebec, J1G 1X9, Canada|Diex Recherche sherbrooke Inc., Sherbrooke, Quebec, J1L 0H8, Canada|Skinsense Medical Research, Saskatoon, Saskatchewan, S7K 2C1, Canada|Diex Recherche Quebec Inc., Quebec, G1V 4T3, Canada|Alpha Recherche Clinique, Quebec, G2J 0C4, Canada|Beijing Friendship Hospital Affiliate of Capital University, Beijing, Beijing, 100050, China|Peking Union Medical College Hopital, Beijing, Beijing, 100730, China|Peking Union Medical College Hospital, Beijing, Beijing, 100730, China|The First Affiliated Hospital Of Fujian Medical University, Fuzhou, Fujian, 350005, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, 510091, China|Guangzhou First People's Hospital, Guangzhou, Guangdong, 510180, China|The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550004, China|The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China|The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050030, China|NanYang First people's hospital, Nanyang, Henan, 473000, China|The First Hospital of Wuhan, Wuhan, Hubei, 430022, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China|The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, 014010, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China|Huashan Hospital, Fudan University, Shanghai, Shanghai, 200040, China|Chengdu second people's hospital, Chengdu, Sichuan, 610017, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, 300052, China|First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Sheng, 650032, China|Hangzhou Third Hospital, Hangzhou, Zhejiang, 310009, China|Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China|The First Affiliated Hospital Of Fujian Medical University, Fuzhou, 350005, China|Shanghai General Hospital, Shanghai, 200080, China|The First Hospital of Hebei Medical University, Shijiazhuang, 050030, China|Hautzentrum im Jahrhunderthaus, Bochum, Nordrhein-westfalen, 44793, Germany|BAG Drs. Med. Quist PartG, Mainz, Rheinland-pfalz, 55128, Germany|HNO-Praxis Dr. Kugler in Magdeburg, Magdeburg, Sachsen-anhalt, 39104, Germany|Magdeburger Company for Medical Studies and Services, Magdeburg, Sachsen-anhalt, 39104, Germany|Radiologie Ulrichshaus, Magdeburg, Sachsen-anhalt, 39104, Germany|PÃ©csi TudomÃ¡nyegyetem Klinikai KÃ¶zpont, PÃ©cs, Baranya, 7632, Hungary|Synexus Magyarorszag Kft. (Gyula DRS), Gyula, BÃ©kÃ©s, 5700, Hungary|Szegedi TudomÃ¡nyegyetem Szent-GyÃ¶rgyi Albert Klinikai KÃ¶zpont, Szeged, CsongrÃ¡d, 6720, Hungary|Allergo-Derm Bakos Kft, Szolnok, JÃ¡sz-nagykun-szolnok, 5000, Hungary|Ã“budai EgÃ©szsÃ©gÃ¼gyi Centrum, Budapest, 1036, Hungary|Orvostudomanyi Kutato es Fejleszto Kft, Debrecen, 4027, Hungary|DERMA-B EgÃ©szsÃ©gÃ¼gyi Ã©s SzolgÃ¡ltatÃ³, Debrecen, 4031, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, 4032, Hungary|Derm-Surg Kft., KaposvÃ¡r, 7400, Hungary|Istituto Dermopatico Immacolata, Rome, Roma, 00167, Italy|Japan Community Health Care Organization Chukyo Hospital, Nagoya, Aichi, 457-8510, Japan|Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Aichi, 457-8510, Japan|Toho University Sakura Medical Center, Sakura, Chiba, 285-8741, Japan|Juntendo University Urayasu Hospital, Urayasu, Chiba, 279-0021, Japan|Takarazuka City Hospital, Takarazuka, HyÅgo, 665-0827, Japan|Tokyo Medical University Ibaraki Medical Center, Inashiki-gun, Ibaraki, 300-0395, Japan|Tokyo Medical University Ibaraki Medical Center, Inashiki, Ibaraki, 300-0395, Japan|Kindai University Nara Hospital, Ikoma City, Nara, 630-0293, Japan|Osaka Habikino Medical Center, Habikino, Osaka, 583-8588, Japan|Hamamatsu University Hospital, Hamamatsu-shi, Shizuoka, 431-3192, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Tokyo Medical And Dental University Hospital, BunkyÅ, Tokyo, 113-8519, Japan|Yamaguchi University Hospital, Ube, Yamaguchi, 755-8505, Japan|Wromedica I Bielicka A Strzalkowska s.c., Wroclaw, DolnoÅ›lÄ…skie, 51-685, Poland|Clinica Dermatoestetica Prywatny Gabinet Dermatologiczny I Alergologiczny Prof.Dr Hab.Med. Barbara Z, Bydgoszcz, Kujawsko-pomorskie, 85-650, Poland|ETG Warszawa, Warszawa, Mazowieckie, 02-677, Poland|Klinika Ambroziak Dermatologia, Warszawa, Mazowieckie, 02-953, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszaw, Mazowieckie, 02-661, Poland|Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Marek Brzewski, PaweÅ‚ Brzewski spÃ³Å‚ka, KrakÃ³w, MaÅ‚opolskie, 30-002, Poland|Specderm Poznanska sp.j., Bialystok, Podlaskie, 15-375, Poland|ClinicMed Daniluk, Nowak SpÃ³Å‚ka komandytowa, Bialystok, Podlaskie, 15-879, Poland|""DERMED"" Centrum Medyczne Sp. z o.o., Lodz, ÅÃ³dzkie, 90-265, Poland|Clinmedica Research Sp. z. o. o., Skierniewice, ÅÃ³dzkie, 96-100, Poland|Centrum Medyczne Angelius Provita, Katowice, ÅšlÄ…skie, 40-611, Poland|Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica, Banska Bystrica, BanskobystrickÃ½ KRAJ, 97517, Slovakia|SANARE, s.r.o, Svidnik, PreÅ¡ovskÃ½ KRAJ, 089 01, Slovakia|Fakultna nemocnica Trnava, Trnava, TrnavskÃ½ KRAJ, 917 75, Slovakia|CLINIQ s.r.o., Bratislava, 811 09, Slovakia|BeneDerma, Bratislava, 841 02, Slovakia|Derma therapy spol. s.r.o., Bratislava, 851 01, Slovakia|Topskin pro s.r.o., Kosice, 040 01, Slovakia|Poliklinika ProCare Kosice s.r.o., Kosice, 040 23, Slovakia|Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya [cataluÃ±a], 08041, Spain|Hospital Universitario Infanta Leonor, Madrid, Madrid, Comunidad DE, 28031, Spain|Clinica Universidad de Navarra, Madrid, 28027, Spain|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitari i Politecnic La Fe, ValÃ¨ncia, 46026, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan","Study Director : Pfizer CT.gov Call Center , Pfizer"
Vitiligo,NCT05583526,A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo,https://clinicaltrials.gov/study/NCT05583526,NO,Stable Nonsegmental Vitiligo|Active Nonsegmental Vitiligo,DRUG: Ritlecitinib|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|University of Alabama at Birmingham Faculty Office Towers (Regulatory, Birmingham, Alabama, 35294, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Center For Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|Marvel Clinical Research, Huntington Beach, California, 92647, United States|Wallace Medical Group, Inc, Los Angeles, California, 90056, United States|Audiology, Washington, District of Columbia, 20007, United States|MedStar Washington Hospital Center, Washington, District of Columbia, 20010, United States|Center for Dermatology and Dermatologic Surgery, Washington, District of Columbia, 20037, United States|Encore Medical Research of Boynton Beach, Boynton Beach, Florida, 33436, United States|Skin Care Research, Hollywood, Florida, 33021, United States|JC Audiology, Lutz, Florida, 33548, United States|Millennium Clinical Research, Miami, Florida, 33125, United States|Clever Medical Research, Miami, Florida, 33126, United States|Tory Sullivan, MD PA, North Miami Beach, Florida, 33162, United States|Tory Sullivan, Md Pa, North Miami Beach, Florida, 33162, United States|Ziaderm Research, LLC, North Miami Beach, Florida, 33162, United States|Olympian Clinical Research, Saint Petersburg, Florida, 33709, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Tower Imaging, LLC dba TGH Imaging powered by Tower, Tampa, Florida, 33618, United States|Marietta Dermatology Clinical Research, Inc, Marietta, Georgia, 30060, United States|Advanced Medical Research, PC., Sandy Springs, Georgia, 30328, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|Velocity Clinical Research at The Dermatology Clinic, Baton Rouge, Baton Rouge, Louisiana, 70808, United States|DelRicht Research, Baton Rouge, Louisiana, 70809, United States|The NeuroMedical Center (XRay), Baton Rouge, Louisiana, 70810, United States|DelRicht Research, New Orleans, Louisiana, 70115, United States|Prairieville Family Hospital (XRay), Prairieville, Louisiana, 70769, United States|Callender Center for Clinical Research, Glenn Dale, Maryland, 20769, United States|Visage Dermatology and Aesthetic Center, Largo, Maryland, 20774, United States|Lawrence J Green, MD LLC, Rockville, Maryland, 20850, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|MetroBoston Clinical Partners, LLC, Brighton, Massachusetts, 02135, United States|University of Massachusetts Chan Medical School, Worcester, Massachusetts, 01655, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Hamzavi Dermatology - Canton, Canton, Michigan, 48187, United States|Skin Specialists, PC, Omaha, Nebraska, 68144, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, 87102, United States|SUNY Downstate Health Sciences University, Brooklyn, New York, 11203, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|University of North Carolina Medical Center, Chapel Hill, North Carolina, 27516, United States|Clinical & Translational Research Center (CTRC), Chapel Hill, North Carolina, 27599, United States|Accellacare - Wilmington, Wilmington, North Carolina, 28411, United States|Accellacare, Wilmington, North Carolina, 28411, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, 28411, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Remington Davis Clinical Research, Columbus, Ohio, 43215, United States|Remington-Davis, Inc, Columbus, Ohio, 43215, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|Modern Research Associates, PLLC, Dallas, Texas, 75231, United States|Alpesh D. Desai, DO PLLC - Research, Houston, Texas, 77008, United States|Alpesh D. Desai, DO PLLC, Houston, Texas, 77008, United States|Austin Institute for Clinical Research, Houston, Texas, 77056, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|The Skin Hospital, Darlinghurst, New South Wales, 2010, Australia|North Eastern Health Specialists, Campbelltown, South Australia, 5074, Australia|Skin Health Institute Inc., Carlton, Victoria, 3053, Australia|Dr Rodney Sinclair Pty Ltd, East Melbourne, Victoria, 3002, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|MC ""Asklepiy"" OOD, Dupnitsa, 2600, Bulgaria|DCC Aleksandrovska EOOD, Sofia, 1431, Bulgaria|UMHAT ""Prof. dr. Stoyan Kirkovich"" AD, Stara Zagora, 6000, Bulgaria|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|CARe Clinic, Red Deer, Alberta, T4P 1K4, Canada|SKiN Health, Cobourg, Ontario, K9A 0Z4, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|DermEdge Research, Mississauga, Ontario, L4Y 4C5, Canada|Oshawa Clinic Dermatology Trials, Oshawa, Ontario, L1H 1B9, Canada|North York Research Inc, Toronto, Ontario, M2N3A6, Canada|Centre de Recherche Dermatologique du Quebec metropolitain, Quebec, G1V 4X7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W 4R4, Canada|Fujian Medical University Affiliated First Hospital, Fuzhou, Fujian, 350005, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, 510091, China|Guangzhou First People's Hospital, Guangzhou, Guangdong, 510180, China|The First Hospital of Wuhan, Wuhan, Hubei, 430022, China|The First Hospital of China Medical University/Dermatology and STD Department, Shenyang, Liaoning, 110001, China|Huashan Hospital Fudan University, Shanghai, Shanghai, 200040, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, 300052, China|First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Sheng, 650032, China|Zhejiang Provincial People's Hospital/Dermatology Department, Hangzhou, Zhejiang, 310014, China|Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China|The first Affiliated hospital of Wenzhou medical University, Wenzhou, Zhejiang, 325000, China|The first Affiliated hospital of Wenzhou medical University, Wenzhou, Zhejiang, 325000, China|Praxis Leitz und Kollegen, Stuttgart, Baden-wÃ¼rttemberg, 70178, Germany|Universitaetsklinikum Erlangen, Erlangen, Bayern, 91054, Germany|Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen, 48455, Germany|UniversitÃ¤tsklinikum MÃ¼nster, MÃ¼nster, Nordrhein-westfalen, 48149, Germany|Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UniversitÃ Cattolica del Sacro Cuore, Roma, Lazio, 00168, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Lombardia, 25123, Italy|Istituto Clinico Humanitas IRCCS, Rozzano, Milano, 20089, Italy|Istituto Clinico Humanitas IRCSS - UOC di Dermatologia, Rozzano, Milano, 20089, Italy|Istituto Clinico Humanitas, IRCCS, Rozzano, Milano, 20089, Italy|Istituti Fisioterapici Ospitalieri (IFO) - Roma, Roma, RM, 00144, Italy|Istituti Fisioterapici Ospitalieri (IFO), Roma, RM, 00144, Italy|Policlinico S. Orsola- Malpighi, Bologna, 40138, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, 25123, Italy|Nagoya City University Hospital, Nagoya, Aichi, 467-8602, Japan|Tohoku University Hospital, Sendai-shi, Miyagi, 980-8574, Japan|Dermatology and Ophthalmology Kume Clinic, Sakai City, Osaka, 593-8324, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Sugamo Kobayashi Derma Clinic, Toshima-Ku, Tokyo, 170-0002, Japan|Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, 400-8506, Japan|Nippon Medical School Hospital, Tokyo, 113-8603, Japan|Nippon Medical School Hospital, Tokyo, 113-8603, Japan|Dongguk University Ilsan Hospital, Goyang-si, KyÇ’nggi-do, 10326, Korea, Republic of|The Catholic University Of Korea St. Vincent's Hospital, Suwon-si, KyÇ’nggi-do, 16247, Korea, Republic of|Ajou University Hospital, Suwon, KyÇ’nggi-do, 16499, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [seoul], 03722, Korea, Republic of|Hospital Infantil de Mexico Federico Gomez, Mexico City, Distrito Federal, 06720, Mexico|Centro de Dermatologia de Monterrey, Monterrey, Nuevo LEÃ“N, 64460, Mexico|Sociedad de Metabolismo y Corazon S.C., Veracruz, 91900, Mexico|Sociedad de Metabolismo Y Corazon Sc, Veracruz, 91900, Mexico|ArkÃ© SMO S.A de C.V, Veracruz, 91910, Mexico|DermoDent Centrum Medyczne Aldona Czajkowska RafaÅ‚ Czajkowski s.c., Osielsko, Kujawsko-pomorskie, 86-031, Poland|Royalderm Agnieszka Nawrocka, Warszawa, Mazowieckie, 02-962, Poland|Twoja Przychodnia SCM, Szczecin, Zachodniopomorskie, 71-500, Poland|Twoja Przychodnia SCM, Szczecin, Zachodniopomorskie, 71-500, Poland|Dermoklinika - Centrum Medyczne spÃ³Å‚ka cywilna M. Kierstan, J. Narbutt, A. Lesiak, Lodz, ÅÃ³dzkie, 90-436, Poland|Dermedic Jacek Zdybski, Ostrowiec Witokrzyski, ÅšwiÄ™tokrzyskie, 27-400, Poland|Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern CAPE, 5099, South Africa|Phoenix Pharma, Port Elizabeth, Eastern CAPE, 6001, South Africa|Clinresco Centres, Kempton Park, Gauteng, 1619, South Africa|Botho Ke Bontle Health Services, Pretoria, Gauteng, 0184, South Africa|Task Central, Cape Town, Western CAPE, 7530, South Africa|Hospital Universitario Reina Sofia, Cordoba, AndalucÃ­a, 14004, Spain|Hospital Universitario de Gran Canaria Doctor NegrÃ­n, Las Palmas de Gran Canaria, Canarias, 35010, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|AUDIKA, CÃ³rdoba, 14001, Spain|Hospital Universitario RamÃ³n y Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Istanbul Universitesi- Cerrahpasa, Cerrahpasa Tip Fakultesi, Istanbul, 34098, Turkey|Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, 34890, Turkey|Erciyes Universitesi TÄ±p Fakultesi Hastaneleri, Kayseri, 38039, Turkey|Celal Bayar Universitesi Hafta Sultan Hastanesi, Manisa, 45030, Turkey|Guy's & St Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom","Study Director : Pfizer CT.gov Call Center , Pfizer"
Vitiligo,NCT01377077,Punchgrafting Techniques for Vitiligo,https://clinicaltrials.gov/study/NCT01377077,NO,Non-segmental Vitiligo|Segmental Vitiligo|Piebaldism,PROCEDURE: punchgrafting|PROCEDURE: punchgrafting,ALL,"ADULT, OLDER_ADULT",PHASE4,"Netherlands Institute for Pigmentdisorders, Amsterdam, Noord-Holland, 1105 AZ, Netherlands",Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Vitiligo,NCT05335746,Ocular Changes in Vitiligo Patients on Therapy,https://clinicaltrials.gov/study/NCT05335746,NO,Vitiligo|Chorioretinopathy|Chorioretinitis,DIAGNOSTIC_TEST: Optical coherence tomography angiography (OCT-A),ALL,"ADULT, OLDER_ADULT",,"Benha University, BanhÄ, QA, 13511, Egypt","Principal Investigator : Amal A Yousif, MD , Benha University"
Vitiligo,NCT00509314,The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis,https://clinicaltrials.gov/study/NCT00509314,NO,Melanocyte|Vitiligo,BEHAVIORAL: melanocyte self-assembly and functional analysis,ALL,ADULT,,"National Taiwan University Hospital, Taipei, 100, Taiwan","Principal Investigator : Sung-Jan Lin, MD PhD , National Taiwan University Hospital"
Vitiligo,NCT04057573,Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2),https://clinicaltrials.gov/study/NCT04057573,YES,Non-segmental Vitiligo,DRUG: Ruxolitinib cream|DRUG: Vehicle,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Desert Sky Dermatology, Gilbert, Arizona, 85295, United States|Center For Dermatology Cosmetic and Laser Surgery, Fremont, California, 94538, United States|Uci Beckman Laser Institute and Medical Clinic, Irvine, California, 92617, United States|UCI Health Beckman Laser Institute and Medical Center, Irvine, California, 92697, United States|Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Dermatology Specialists Inc, Murrieta, California, 92562, United States|Dermatology Specialists Inc, Oceanside, California, 92056, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States|Acrc Studies, San Diego, California, 92119, United States|Central Sooner Research, San Diego, California, 92123, United States|Colorado Medical Research Center Inc, Denver, Colorado, 80210, United States|Advanced Pharma Cr, Miami, Florida, 33147, United States|Leavitt Medical Associates of Florida, Ormond Beach, Florida, 32174, United States|Avita Clinical Research, Tampa, Florida, 33613, United States|Olympian Clinical Research, Tampa, Florida, 33614, United States|Ashira Dermatology Llc, Gurnee, Illinois, 60031, United States|Randall Dermatology of West Lafayette, West Lafayette, Indiana, 47096, United States|Randall Dermatology, West Lafayette, Indiana, 47906, United States|Delricht Clinical Research - Clinedge - Ppds Baton Rouge, Baton Rouge, Louisiana, 70809, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Tufts Medical Center, Boston, Massachusetts, 02116, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135, United States|University of Massachusetts, Worcester, Massachusetts, 01655, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Henry Ford Medical Center, Detroit, Michigan, 48202, United States|Minnesota Clinical Study Center, Minneapolis, Minnesota, 55432, United States|Jdr Dermatology Research, Las Vegas, Nevada, 89148, United States|Northwell Physician Partners, New Hyde Park, New York, 11042, United States|Icahn School of Medicine At Mount Sinai, New York, New York, 10029, United States|Derm Research Center of New York Inc, Stony Brook, New York, 11790, United States|Central Sooner Research, Norman, Oklahoma, 73071, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|Clinical Research Partners Llc, Richmond, Virginia, 23220, United States|Medical Center Unimed Eood, Sevlievo, 05400, Bulgaria|Medical Center Unimed EOOD, Sevlievo, 5300, Bulgaria|Diagnostic Consultative Center Ii Sofia Eood, Sofia, 01000, Bulgaria|University Multiprofile Hospital For Active Treatment Aleksandrovska, Sofia, 01431, Bulgaria|Diagnostic Consultative Center II Sofia EOOD, Sofia, 1000, Bulgaria|Diagnostic Consultative Center II Sofia EOOD, Sofia, 1407, Bulgaria|University Hospital Prof Dr Stoyan Kirkovich, Stara Zagora, 06003, Bulgaria|University Hospital "" Prof. Dr Stoyan Kirkovich"", Stara Zagora, 6003, Bulgaria|Simcoderm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Xlr8 Medical Research, Windsor, Ontario, N8W 1E6, Canada|Centre Hospitalier Universitaire de Besancon, Besancon, 25000, France|CHU Besancon, Besancon, 25030, France|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, 33000, France|CHU de Bordeaux, Hospital Saint Andre, Bordeaux, 33075, France|University Hospital Henri Mondor, Creteil, 94000, France|CENTRE HOSpITALIER UNIVERSITAIRE HENRI MONDOR, Creteil, 94010, France|Le Bateau Blanc, Martigues, 13500, France|Emovis GMBH, Berlin, 10629, Germany|Universitatsklinikum Bonn Aoer, Bonn, 53127, Germany|Hautarztpraxis Mahlow, Mahlow, 15831, Germany|Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz, 55131, Germany|University Medical Center (UniversitÃ¤tsmedizin der Johannes Gutenberg-UniversitÃ¤t Mainz), Mainz, 55131, Germany|Policlinico S. Orsola Malpighi, Bologna, 40138, Italy|Istituto Dermatologico San Gallicano, Rome, 00163, Italy|Amsterdam University Medical Centre, Amsterdam, 1105 AZ, Netherlands|Synexus Polska Sp. Z o.o. OddziaÅ‚ w CzÄ™stochowie, Czestochowa, 42-202, Poland|Synexus Affiliate - Krakowskie Centrum Medyczne, Krakow, 31-501, Poland|Synexus Polska Sp Z Oo Oddzial W Lodzi, Lodz, 90-127, Poland|Synexus Polska Sp Z Oo Oddzial W Czestochowie, Lublin, 20-081, Poland|Lubeskie Centrum Diagnostyczne, Swidnik, 21-040, Poland|High-Med Przychodnia Specjalistycza, Warsaw, 01-817, Poland|Synexus Polska Sp. Z O.O. Oddzial Warszawie, Warszawa, 01-192, Poland|Dermmedica Sp. Z O.O., Wroclaw, 51-318, Poland|Ico Hospital Germans Trias I Pujol, Badalona, 08916, Spain|Hospital Universitari Germans Trias i Pujol, Barcelona, 8916, Spain|Dermomedic, Madrid, 28001, Spain|IDEI (Instituto de DermatologÃ­a Integral)., Madrid, 28010, Spain|Hospital La Paz (Hospital Universitario La Paz ), Madrid, 28046, Spain|Hospital Universitario de La Paz, Madrid, 28046, Spain","Study Director : Kathleen Butler, MD , Incyte Corporation"
Vitiligo,NCT04052425,Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1),https://clinicaltrials.gov/study/NCT04052425,YES,Non-segmental Vitiligo,DRUG: Ruxolitinib cream|DRUG: Vehicle,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Cahaba Dermatology, Hoover, Alabama, 35244, United States|Cognitive Clinical Trials Scottsdale Btc Ppds, Scottsdale, Arizona, 85260, United States|Burke Pharmaceutical Research, Hot Springs National Park, Arkansas, 71913, United States|First Oc Dermatology, Fountain Valley, California, 92708, United States|Marvel Clinical Research Llc, Huntington Beach, California, 92647, United States|Rady Children'S Hospital - San Diego, San Diego, California, 92123, United States|University of California San Francisco Sub Location, San Francisco, California, 94158, United States|Clinical Research Center of Ct, Danbury, Connecticut, 06810, United States|Harmony Medical Research Institute, Hialeah, Florida, 33016, United States|San Marcus Research Clinic Inc., Miami Lakes, Florida, 33014, United States|ForCare Medical Center, Tampa, Florida, 33613, United States|Forcare Clinical Research Fcr Forward Clinical Trials, Inc, Tampa, Florida, 33624, United States|Metabolic Research Institute Inc, West Palm Beach, Florida, 33401, United States|Northwestern University, Chicago, Illinois, 60611, United States|Clinical Trials Management Llc, Metairie, Louisiana, 70006, United States|Great Lakes Research Group Inc, Bay City, Michigan, 48706, United States|Dermatology Specialists of Brighton, Brighton, Michigan, 48114, United States|Suny Downstate Medical Center, Brooklyn, New York, 11203, United States|Forest Hills Dermatology Group, Forest Hills, New York, 11375, United States|The Dermatology Specialists Greenwich, New York, New York, 10012, United States|Wake Research Associates Llc, Raleigh, North Carolina, 27612, United States|Wake Forest University, Winston-Salem, North Carolina, 27157, United States|Kgl Skin Study Center, Broomall, Pennsylvania, 19008, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|Palmetto Clinical Trial Services, Anderson, South Carolina, 29621, United States|International Clinical Research Tennessee Llc, Murfreesboro, Tennessee, 37130, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Multiprofile Hospital For Active Treatement - Clinic of Dermatology and Venerology, Pleven, 05800, Bulgaria|DCC 28, Sofia, 01592, Bulgaria|Medical Center Eurohealth, Sofia, 01606, Bulgaria|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Institute For Skin Advancement, Calgary, Alberta, T3A 2N1, Canada|Skin Centre For Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Windsor Clinical Research Inc, Windsor, Ontario, N8W 5L7, Canada|McGill University Health Centre / Carey/Wang Clinic, Montreal, Quebec, H3Z2S6, Canada|Siena Medical Reserch Corporation, Westmount, Quebec, H3Z 2S6, Canada|Centre Hospitalier Universitaire de Nantes, Nantes, 44000, France|Chu de Nice - Hopital L'Archet 1, Nice Cedex 3, 06202, France|Hopital Charles Nicolle Chu Rouen - Hopital de Bois-Guillaume, Rouen, 76031, France|Chu de Toulouse Hopital Larrey Centre de Reference Des Maladies Rares de La Peau Service de Dermatol, Toulouse, 31059, France|University Clinic Carl Gustav Carus, Technical University Dresden, Dresden, 01307, Germany|Universitatsklinik Munster Dermatologie, Muenster, 48149, Germany|Presidio Ospedaliero Piero Palagi, Firenze, 50125, Italy|Istituto Dermatologico San Gallicano, Rome, 00144, Italy|Synexus - Polska Sp Z Oo Oddzial W Gdansk, Gdansk, 80-382, Poland|Synexus Polska Sp. Z O.O. Oddzial W Gdyni, Gdynia, 81-537, Poland|Synexus - Sp Z Oo Oddzial W Katowice, Katowice, 40-040, Poland|Dermedic Dr. Zdybski, Ostrowiec, 27-400, Poland|Synexus Polska Sp. Z O.O. Oddzial W Poznaniu, Poznan, 60-702, Poland|Poradnia Dermatologiczno-Wenerologiczna Mediderm S.C. Nzoz, Torun, 87-100, Poland|Synexus Polska Sp. Z O.O. Oddzial We Wroclawiu, Wroclaw, 50-381, Poland|Hospital Cima Sanitas, Barcelona, 08034, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario San Cecilio, Granada, 18016, Spain|Clinica Universidad de Navarra (Cun), Pamplona, 31008, Spain","Study Director : Kathleen Butler, MD , Incyte Corporation"
Vitiligo,NCT06218082,Vitiligo Registry for Adults and Children in the UK,https://clinicaltrials.gov/study/NCT06218082,NO,Dermatologic Disease|Vitiligo,,ALL,"CHILD, ADULT, OLDER_ADULT",,"The Royal Wolverhampton NHS Trust, Wolverhampton, WV10 0QP, United Kingdom","Principal Investigator : Viktoria Eleftheriadou , The Royal Wolverhampton NHS Trust"
Vitiligo,NCT05990309,ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO,https://clinicaltrials.gov/study/NCT05990309,NO,Non-segmental Vitiligo,DIAGNOSTIC_TEST: skin biopsy,ALL,"ADULT, OLDER_ADULT",,,Sohag University
Vitiligo,NCT04927975,Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT04927975,NO,Non-Segmental Vitiligo,DRUG: Upadacitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of California Irvine /ID# 229390, Irvine, California, 92697-1385, United States|Stanford University /ID# 228000, Redwood City, California, 94063, United States|Clearlyderm Dermatology /ID# 227993, Boca Raton, Florida, 33428, United States|New Horizon Research Center /ID# 229403, Miami, Florida, 33165-3372, United States|Park Avenue Dermatology, PA /ID# 229400, Orange Park, Florida, 32073, United States|ForCare Clinical Research /ID# 228010, Tampa, Florida, 33613-1244, United States|Dawes Fretzin, LLC /ID# 227996, Indianapolis, Indiana, 46256, United States|Tufts Medical Center /ID# 228087, Boston, Massachusetts, 02111-1552, United States|UMass Chan Medical School /ID# 228066, Worcester, Massachusetts, 01655, United States|Michigan Center for Research Company /ID# 228054, Clarkston, Michigan, 48346, United States|Hamzavi Dermatology /ID# 228056, Fort Gratiot, Michigan, 48059, United States|Remington-Davis Clinical Research /ID# 229401, Columbus, Ohio, 43215, United States|Essential Medical Research, LLC /ID# 228074, Tulsa, Oklahoma, 74137-2842, United States|Oregon Dermatology and Research Center /ID# 228007, Portland, Oregon, 97210, United States|Oregon Medical Res Center PC /ID# 228073, Portland, Oregon, 97223, United States|Medical University of South Carolina /ID# 228067, Charleston, South Carolina, 29425, United States|International Clinical Research - Tennessee LLC /ID# 228059, Murfreesboro, Tennessee, 37130-2450, United States|Bellaire Dermatology Associates /ID# 228004, Bellaire, Texas, 77401, United States|University of Texas Health Science Center at Houston /ID# 229399, Houston, Texas, 77030-1501, United States|Virginia Clinical Research, Inc. /ID# 228050, Norfolk, Virginia, 23507, United States|Dr. Chih-ho Hong Medical Inc. /ID# 228403, Surrey, British Columbia, V3R 6A7, Canada|Wiseman Dermatology Research /ID# 228410, Winnipeg, Manitoba, R3M 3Z4, Canada|Research Toronto /ID# 228401, Toronto, Ontario, M4W 2N4, Canada|K. Papp Clinical Research /ID# 228877, Waterloo, Ontario, N2J 1C4, Canada|Centre de Recherche dermatologique du Quebec Metropolitain /ID# 228388, QuÃ©bec, Quebec, G1V 4X7, Canada|Chu de Nice-Hopital L'Archet Ii /Id# 228192, Nice, Alpes-Maritimes, 06200, France|Hopital Saint-Andre /ID# 228193, Bordeaux, Gironde, 33075, France|HCL - Hopital Edouard Herriot /ID# 228194, Lyon, Rhone, 69003, France|Hopital Henri Mondor /ID# 228198, Creteil, 94000, France|CHU Toulouse - Hopital Larrey /ID# 228196, Toulouse, 31400, France|Nagoya City University Hospital /ID# 228725, Nagoya shi, Aichi, 467-8602, Japan|Nippon Medical School Hospital /ID# 230361, Bunkyo-ku, Tokyo, 113-8602, Japan|Tokyo Medical University Hospital /ID# 230288, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamagata University Hospital /ID# 230362, Yamagata-shi, Yamagata, 990-9585, Japan|Yamanashi Prefectural Central Hospital /ID# 229441, Kofu-shi, Yamanashi, 400-8506, Japan","Study Director : ABBVIE INC. , AbbVie"
Vitiligo,NCT06113328,A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007),https://clinicaltrials.gov/study/NCT06113328,NO,Non-segmental Vitiligo,BIOLOGICAL: MK-6194|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Cahaba Dermatology & Skin Health Center ( Site 0127), Birmingham, Alabama, 35244, United States|Burke Pharmaceutical Research ( Site 0124), Hot Springs, Arkansas, 71913, United States|The Vitiligo & Pigmentation Institute of Southern California ( Site 0115), Los Angeles, California, 90036, United States|Indiana University Health University Hospital-Indiana University School of Medicine, Department of (, Indianapolis, Indiana, 46202, United States|Dawes Fretzin Clinical Research Group, LLC ( Site 0106), Indianapolis, Indiana, 46250, United States|Metro Boston Clinical Partners ( Site 0110), Brighton, Massachusetts, 02135, United States|Hamzavi Dermatology - Canton ( Site 0101), Canton, Michigan, 48187, United States|Remington Davis Clinical Research-Outpatient ( Site 0104), Columbus, Ohio, 43215, United States|Medical University of South Carolina-Dermatology Research ( Site 0114), Charleston, South Carolina, 29425, United States|International Clinical Research - Tennessee LLC ( Site 0120), Murfreesboro, Tennessee, 37130, United States|Progressive Clinical Research ( Site 0108), San Antonio, Texas, 78213, United States|Virginia Clinical Research, Inc. ( Site 0109), Norfolk, Virginia, 23502, United States|Dermatology Specialists of Spokane ( Site 0126), Spokane, Washington, 99202, United States|Psoriahue ( Site 0205), Ciudad Autonoma de Buenos Aires, Buenos Aires, C1425DKG, Argentina|Stat Research S.A. ( Site 0204), Buenos Aires, Caba, C1023AAB, Argentina|Centro de Investigaciones MetabÃ³licas (CINME)-Dermatology ( Site 0203), Ciudad AutÃ³noma de Buenos Aires, Caba, C1027AAP, Argentina|Instituto Medico Strusberg ( Site 0208), CÃ³rdoba, Cordoba, X5000EDC, Argentina|Hospital Aleman-Dermatologia ( Site 0209), Buenos Aires, C1118AAT, Argentina|Paratus Clinical Research Woden ( Site 1703), Phillip, Australian Capital Territory, 2606, Australia|Westmead Hospital-Dermatology ( Site 1701), Westmead, New South Wales, 2145, Australia|Skin Health Institute Inc.-Trials ( Site 1702), Carlton, Victoria, 3053, Australia|Sinclair Dermatology ( Site 1704), Melbourne, Victoria, 3002, Australia|UZ Gent ( Site 0604), Gent, Oost-Vlaanderen, 9000, Belgium|Enverus Medical Research ( Site 0006), Surrey, British Columbia, V3V 0C6, Canada|Diex Recherche sherbrooke Inc. ( Site 0007), Sherbrooke, Quebec, J1L 0H8, Canada|Diex Recherche Quebec Inc. ( Site 0008), Quebec, G1V 4T3, Canada|Centre de Recherche Dermatologique du Quebec metropolitain ( Site 0002), Quebec, G1V 4X7, Canada|Dermisur ( Site 0305), Osorno, Los Lagos, 5310644, Chile|Clinical Research Chile SpA ( Site 0304), Valdivia, Los Rios, 5110683, Chile|Clinica Dermacross ( Site 0301), Santiago, Region M. De Santiago, 7640881, Chile|Pontificia Universidad Catolica de Chile-CICUC ( Site 0308), Santiago, Region M. De Santiago, 8330034, Chile|Centro Internacional de Estudios Clinicos (CIEC) ( Site 0302), Santiago, Region M. De Santiago, 8420383, Chile|Centre Hospitalier Universitaire de Nice - HÃ´pital l'Archet ( Site 0803), Nice, Alpes-Maritimes, 06202, France|CHU de Bordeaux Hop St ANDRE ( Site 0804), Bordeaux, Aquitaine, 33075, France|HÃ´pital Edouard Herriot ( Site 0802), Lyon, Rhone-Alpes, 69003, France|HENRI MONDOR HOSPITAL ( Site 0801), CrÃ©teil, Val-de-Marne, 94000, France|Universitaetsklinikum Erlangen-Hautklinik Studienambulanz ( Site 0905), Erlangen, Bayern, 91054, Germany|UniversitÃ¤tsklinikum MÃ¼nster-Hautklinik ( Site 0904), MÃ¼nster, Nordrhein-Westfalen, 48149, Germany|CharitÃ© Universitaetsmedizin Berlin - Campus Mitte ( Site 0901), Berlin, 10117, Germany|Rambam Health Care Campus-Dermatology ( Site 1002), Haifa, 3109601, Israel|Sheba Medical Center-Dermatology ( Site 1001), Ramat Gan, 5265601, Israel|Nagoya City University Hospital-Dermatology ( Site 2002), Nagoya, Aichi, 467-8602, Japan|Osaka University Hospital ( Site 2004), Suita, Osaka, 565-0871, Japan|Tokyo Medical University Hospital ( Site 2001), Shinjuku-ku, Tokyo, 160-0023, Japan|Inha University Hospital ( Site 1992), Incheon, 22332, Korea, Republic of|Seoul National University Hospital-Dermatology ( Site 1991), Seoul, 03080, Korea, Republic of|Severance Hospital, Yonsei University Health System-Department of Dermatology ( Site 1993), Seoul, 03722, Korea, Republic of|Amsterdam UMC, locatie AMC-Dermatology ( Site 1101), Amsterdam, Noord-Holland, 1105 AZ, Netherlands|Hospital Universitario Puerta del Mar ( Site 1302), CÃ¡diz, Andalucia, 11009, Spain|Hospital Universitari de Bellvitge-Dermatology ( Site 1307), L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Clinica Universidad de Navarra ( Site 1305), Madrid, Madrid, Comunidad De, 28027, Spain|Cantonal Hospital St.Gallen ( Site 1402), st.Gallen, Sankt Gallen, 9007, Switzerland|New Cross Hospital ( Site 1601), Wolverhampton, WV10 0QP, United Kingdom","Study Director : Medical Director , Merck Sharp & Dohme LLC"
Vitiligo,NCT04811326,Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation,https://clinicaltrials.gov/study/NCT04811326,NO,Non-segmental Vitiligo,RADIATION: NB-UVB|DRUG: Latanoprost,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"faculty of medicine, Aswan University, Aswan, Aswan Governorate, 81528, Egypt","Study Chair : Moustafa A El Taieb, prof. , Prof. and Head of Dermatology, Venereology and Andrology department, Aswan University, Egypt"
Vitiligo,NCT04942860,The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo,https://clinicaltrials.gov/study/NCT04942860,NO,Non-segmental Vitiligo,DRUG: 1% Methotrexate gel|DRUG: 0.5% Methotrexate gel,ALL,"ADULT, OLDER_ADULT",PHASE3,"Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz, Bydgoszcz, Cuiavian-Pomeranian, 85094, Poland","Principal Investigator : RafaÅ‚ Czajkowski, Prof. , Head of Chair and Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College in Bydgoszcz"
Vitiligo,NCT04920162,Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma,https://clinicaltrials.gov/study/NCT04920162,NO,Melanoma and Vitiligo,OTHER: Biospecimen into patients who had skin diseases,ALL,"ADULT, OLDER_ADULT",,"CHU de Nice, Nice, Provence Alpes Cote d'Azur, 06000, France",Centre Hospitalier Universitaire de Nice
Vitiligo,NCT03047733,Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT03047733,NO,Dermatologic Disease|Vitiligo,DEVICE: The XTRAC Excimer Laser System|DRUG: Topical tacrolimus 0.1% ointment,ALL,"CHILD, ADULT, OLDER_ADULT",,"Ajou university hospital, Suwon-si, Gyeonggi-do, 16499, Korea, Republic of","Study Director : HEE YOUNG KANG, M.D., Ph.D. , Ajou University School of Medicine"
Vitiligo,NCT04487860,Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT04487860,NO,Non-segmental Vitiligo,DRUG: AS012|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Sun Pharma Site 15, Phoenix, Arizona, 85018, United States|Sun Pharma Site 02, Bryant, Arkansas, 72022, United States|Sun Pharma Site 09, Fremont, California, 94538, United States|Sun Pharma Site 01, Brandon, Florida, 33511., United States|Sun Pharma Site 06, Fort Lauderdale, Florida, 33308, United States|Sun Pharma Site 04, Miami, Florida, 33175, United States|Sun Pharma Site 05, Miramar, Florida, 33027, United States|Sun Pharma Site 10, Ormond Beach, Florida, 32174, United States|Sun Pharma Site 14, West Lafayette, Indiana, 47906, United States|Sun Pharma Site 12, Baton Rouge, Louisiana, 70809, United States|Sun Pharma Site 13, New Orleans, Louisiana, 70115, United States|Sun Pharma Site 07, Troy, Michigan, 48084, United States|Sun Pharma Site 08, Warwick, Rhode Island, 02886, United States|Sun Pharma Site 03, Dallas, Texas, 75234, United States|Sun Pharma Site 16, Pflugerville, Texas, 78660, United States|Sun Pharma Site 11, Mill Creek, Washington, 98012, United States|Sun Pharma Site 19, Ahmedabad, Gujrat, 380016, India|Sun Pharma Site 20, Gandhinagar, Gujrat, 382428, India|Sun Pharma Site 28, Rajkot, Gujrat, 360005, India|Sun Pharma Site 23, Bangalore, Karnataka, 560074, India|Sun PharmaSite 24, Mysuru, Karnataka, 570001, India|Sun Pharma Site 21, Aurangabad, Maharashtra, 431001, India|Sun Pharma Site 25, Nashik, Maharashtra, 422101, India|Sun Pharma Site 26, Pune, Maharashtra, 411005, India|Sun Pharma Site 17, Rajsamand, Rajasthan,, 313202, India|Sun Pharma Site 27, Lucknow, Uttar Pradesh, 226003, India|Sun Pharma Site 18, Lucknow, Uttar Pradesh, 226005, India|Sun Pharma Site 22, Chandigarh, 160012, India",Sun Pharmaceutical Industries Limited
Vitiligo,NCT02458417,Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients,https://clinicaltrials.gov/study/NCT02458417,NO,Segmental Vitiligo|Piebaldism,"DEVICE: ReCell|DEVICE: Full surface CO2 laser 200 mJ|DEVICE: Full surface CO2 laser 150 mJ|DEVICE: Fractional CO2 laser 7.5 mJ, 20%",ALL,"ADULT, OLDER_ADULT",PHASE4,"Netherlands Institute for Pigment disorders, Amsterdam, 1105 AZ, Netherlands","Principal Investigator : Albert Wolkerstorfer, MD, PhD , Netherlands Institute for Pigment Disorders, Department of Dermatology, Academic Medical Center, University of Amsterdam Study Director : Menno A. De Rie, MD, PhD , Department of Dermatology, Academic Medical Center, University of Amsterdam"
Vitiligo,NCT03622320,Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo,https://clinicaltrials.gov/study/NCT03622320,NO,Metabolic Syndrome|Vitiligo,OTHER: Blood sample,ALL,"CHILD, ADULT, OLDER_ADULT",,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt","Principal Investigator : Samar El-Tahlawi, MD , Cairo university, dermatology department"
Vitiligo,NCT04734704,Defining the Role of the Skin Microbiome in Immune-related Adverse Events,https://clinicaltrials.gov/study/NCT04734704,NO,Vitiligo|Skin Melanoma,PROCEDURE: skin swabs at lesional and non-lesional sites|PROCEDURE: skin swabs on skin,ALL,"ADULT, OLDER_ADULT",,"Service de Dermatologie - HÃ´pital Saint-AndrÃ©, Bordeaux, 33075, France","Principal Investigator : Julien SENESCHAL, MD, PhD , University Hospital, Bordeaux"
Vitiligo,NCT02506101,"Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo",https://clinicaltrials.gov/study/NCT02506101,YES,Vitiligo|Pigmentation|Dyschromia,DEVICE: narrow-band ultraviolet B phototherapy,ALL,"ADULT, OLDER_ADULT",,"Johns Hopkins Dept. of Dermatology, Baltimore, Maryland, 21287, United States","Principal Investigator : Ginette Okoye, MD , Johns Hopkins School of Medicine"
Vitiligo,NCT02660320,"Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin",https://clinicaltrials.gov/study/NCT02660320,NO,Vitiligo - Macular Depigmentation,DEVICE: Dermabrasion|DEVICE: Laser placebo,ALL,"ADULT, OLDER_ADULT",,"CHU de Nice, Nice, Alpes-Maritimes, 06200, France|CH Creteil, Paris, Ile De France, France|CHU de Bordeaux, Bordeaux, 33 000, France","Principal Investigator : Passeron Thierry, PhD , Dermatology, CHU de Nice"
Vitiligo,NCT03247400,The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo,https://clinicaltrials.gov/study/NCT03247400,NO,Non-segmental Vitiligo,DRUG: 1% simvastatin-acid sodium salt ointment|DRUG: 1% atorvastatin calcium salt ointment,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz, Bydgoszcz, Cuiavian-Pomeranian, 85094, Poland","Principal Investigator : Rafal Czajkowski, Prof NCU , Head of Chair and Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College in Bydgoszcz"
Vitiligo,NCT01640678,Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients,https://clinicaltrials.gov/study/NCT01640678,NO,Piebaldism|Segmental Vitiligo,PROCEDURE: ReCell epidermal cell suspension grafting|PROCEDURE: CO2 laser abrasion + UV-therapy,ALL,"ADULT, OLDER_ADULT",PHASE4,"The Netherlands Institute for pigment disorders, AMC, Amsterdam, 1105 AZ, Netherlands",Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Vitiligo,NCT01841008,Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control,https://clinicaltrials.gov/study/NCT01841008,NO,Pigmentation Disorders|Vitiligo,DRUG: Protopic|DRUG: Placebo : Diprobase,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"CHU de Nice - HÃ´pital de l'Archet, Nice, Alpes-Maritimes, 06200, France|CHU de Bordeaux, Bordeaux, Gironde, 33 404, France","Principal Investigator : PASSERON Thierry, Pu-Ph , CHU de Nice - Service de Dermatologie - HÃ´pital de l'Archet - 151 Route de saint-antoine de ginestiÃ¨re 06200 Nice"
Vitiligo,NCT05554523,How Does Skin Tone Affect Quantitative Photoacoustic Imaging,https://clinicaltrials.gov/study/NCT05554523,NO,Vitiligo|Skin Abnormalities,DEVICE: Photoacoustic imaging,ALL,"ADULT, OLDER_ADULT",,,Cancer Research UK
Vitiligo,NCT00484224,Audiological Disturbances in Vitiligo,https://clinicaltrials.gov/study/NCT00484224,NO,Vitiligo|Hearing Loss,,ALL,"CHILD, ADULT",,"Hadassah Medical Organization, Jerusalem, Israel","Principal Investigator : Arieh Ingber, Prof. , Hadassah Medical Organization"
Vitiligo,NCT05293119,Role of Tofacitinib in Vitiligo Patients,https://clinicaltrials.gov/study/NCT05293119,NO,Vitiligo|Effect of Drug,DRUG: JAK-2 inhibitor|DRUG: Topical corticosteroid,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,,"Study Chair : Mohammad Jahid Hasan, MPH , Pi Research Consultancy Center, Dhaka, Bangladesh"
Vitiligo,NCT04872257,Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT04872257,NO,"Vitiligo|Vitiligo, Generalized|Autoimmune|Autoimmune Diseases|Autoimmune Disease Skin",DRUG: Oral Vitamin D|PROCEDURE: NB-UVB Phototherapy|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",,"Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Monterrey, Nuevo Leon, 64460, Mexico","Principal Investigator : Adrian B Cuellar-Barboza, MD , Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"""
Vitiligo,NCT03270241,Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy,https://clinicaltrials.gov/study/NCT03270241,YES,Vitiligo|Dermatology/Skin - Other,DEVICE: Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet,ALL,"ADULT, OLDER_ADULT",,"Johns Hopkins Outpatient Center, Baltimore, Maryland, 21287, United States","Principal Investigator : Noori Kim, M.D , Johns Hopkins University"
Vitiligo,NCT06370650,Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study,https://clinicaltrials.gov/study/NCT06370650,NO,Management of Stable Vitiligo,"PROCEDURE: platelet rich plasma, narrow band UVB",ALL,"CHILD, ADULT",,"Faculty of Medicine, Sohag University, Sohag, 82515, Egypt",Sohag University
Vitiligo,NCT05364567,Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency,https://clinicaltrials.gov/study/NCT05364567,NO,Vitamin D Deficiency|Vitiligo,DRUG: cholecalciferol (vitamin D3)|PROCEDURE: Phototherapy,ALL,"ADULT, OLDER_ADULT",,"Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of","Study Chair : Bo Young Chung, M.D., PhD , Department of Dermatology, Kangnam Sacred Heart Hospital"
Vitiligo,NCT05316987,Effect of NB-UVB on the Tissue Level of IL 15 and IL-15RÎ± in Active Non Segmental Vitiligo Cases.,https://clinicaltrials.gov/study/NCT05316987,NO,Active Non Segmental Vitiligo,RADIATION: Narrow band ultraviolet B,ALL,"ADULT, OLDER_ADULT",,"Nourhan Emad, Cairo, Helwan, Egypt","Principal Investigator : Nourhan Emad , Faculty of medicine kasr Elainy"
Vitiligo,NCT03185312,Cutaneous JAK in Vitiligo and Acne Vulgaris.,https://clinicaltrials.gov/study/NCT03185312,NO,Vitiligo and Acne Vulgaris,DIAGNOSTIC_TEST: skin biopsy,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Principal Investigator : Amira Abdel Motaleb, MD , Assiut University"
Vitiligo,NCT03715829,A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects,https://clinicaltrials.gov/study/NCT03715829,YES,Active Non-segmental Vitiligo,DRUG: PF-06651600|DRUG: PF-06651600|DRUG: PF-06651600|DRUG: PF-06651600|DRUG: PF-06651600|DRUG: placebo|DRUG: PF06700841|DEVICE: narrow-band UVB phototherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"Marvel Research, LLC, Huntington Beach, California, 92647, United States|University of California, Irvine, Dermatology Clinical Research Center, Irvine, California, 92697, United States|Vitiligo and Pigmentation Institute Of Southern California, Los Angeles, California, 90036, United States|Dermatology Specialist, Inc., Murrieta, California, 92562, United States|Dermatology Specialists, Inc., Oceanside, California, 92056, United States|UC Davis Health, Sacramento, California, 95816, United States|Brookside Dermatology Associates, Bridgeport, Connecticut, 06606, United States|New England Research Associates, LLC, Bridgeport, Connecticut, 06606, United States|New Horizon Research Center, Miami, Florida, 33165, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Advanced Skin and MOHS Surgery Center, c/o TrialSpark, Inc., Chicago, Illinois, 60657, United States|Chevy Chase Dermatology Center (TrialSpark, Inc.), Chevy Chase, Maryland, 20815, United States|TrialSpark - Samantha Toerge, MD, Chevy Chase, Maryland, 20815, United States|TrialSpark - Ronald Shore, MD, Rockville, Maryland, 20852, United States|Tobias & Battite, Inc., Boston, Massachusetts, 02111, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|UMass Memorial Medical Center, Hahnemann Campus, Worcester, Massachusetts, 01605, United States|Investigational Drug Service Pharmacy, Worcester, Massachusetts, 01655, United States|UMass Memorial Medical Center Ear Nose and Throat, Worcester, Massachusetts, 01655, United States|University of Massachusetts Medical School, Worcester, Massachusetts, 01655, United States|Henry Ford Hospital Department of Dermatology, Detroit, Michigan, 48202, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|The Dermatology Group, P.C., Verona, New Jersey, 07044, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10003, United States|Upper West Side Dermatology c/o TrialSpark, Inc, New York, New York, 10023, United States|MDCS: Medical Dermatology & Cosmetic Surgery (TrialSpark, Inc.), New York, New York, 10065, United States|South Nassau Dermatology, Oceanside, New York, 11572, United States|TrialSpark, Inc. - Russell W. Cohen, MD, Oceanside, New York, 11572, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, 28411, United States|Remington-Davis, Inc. Clinical Research, Columbus, Ohio, 43215, United States|ForeFront Dermatology, Columbus, Ohio, 43220, United States|Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma, 74136, United States|University Physicians Group, Austin, Texas, 78701, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390-9191, United States|Pickens Academic Tower, Houston, Texas, 77030, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Virginia Clinical Research, Inc, Norfolk, Virginia, 23502, United States|Tamjidi Skin Institute (TrialSpark, Inc.), Vienna, Virginia, 22182, United States|The Skin Hospital, Darlinghurst, New South Wales, 2010, Australia|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3052, Australia|HÃ´pital Erasme Dermatology, Brussels, 1070, Belgium|UZ Brussel - Dermatology, Brussel, 1090, Belgium|UZ Gent - Dermatology, Gent, 9000, Belgium|Dr. Chih-ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|University of British Columbia, Vancouver, British Columbia, V5Z 4E8, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|CCA Medical Research, Ajax, Ontario, L1S 7K8, Canada|Guenther Research Inc., London, Ontario, N6A 3H7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|DermEdge Research, Mississauga, Ontario, L5H 1G9, Canada|North York Research Inc., North York, Ontario, M2M 4J5, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|K.Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada|Diex Research Sherbrooke Inc., Sherbrooke, Quebec, J1L 0H8, Canada|Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Quebec, G1V 4X7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W 4R4, Canada|Centre de Recherche Saint-Louis, Quebec, G1W1S2, Canada|Fachklinik Bad Bentheim, Fachbereich Dermatologie und Allergologie, Dermatologische Ambulanz, Bad Bentheim, 48455, Germany|Universitaetsklinikum Erlangen Hautklinik Studienambulanz, Erlangen, 91054, Germany|UniversitÃ¤tsklinikum Frankfurt, Klinik fÃ¼r Dermatologie, Venerologie und Allergologie, Frankfurt am Main, 60590, Germany|Universitaetsklinikum Schleswig-Holstein, Campus Luebeck CCIM, Luebeck, 23538, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, 55131, Germany|Universitaetsklinikum Muenster, Muenster, 48149, Germany|Istituti Fisioterapici Ospitalieri, Istituto di Ricovero e Cura a Carattere Scientifico,, Roma, RM, 00144, Italy|Nagoya City University Hospital - Dermatology, Nagoya, Aichi, 467-8602, Japan|Tohoku University Hospital, Sendai, Miyagi, 980-8574, Japan|Nippon Medical School Hospital, Bunkyo-ku, Tokyo, 113-8603, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, 400-8506, Japan|Dongguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, 10326, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Gyeonggi-do, 16247, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, 16499, Korea, Republic of|Inha University Hospital, Incheon, 22332, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 03722, Korea, Republic of|Hospital de la Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Universitario Reina Sofia, Cordoba, 14004, Spain|Hospital Universitario RamÃ³n y Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan|National Cheng Kung University Hospital, Tainan, 70403, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan","Study Director : Pfizer CT.gov Call Center , Pfizer"
Vitiligo,NCT05536856,Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05536856,NO,Vitiligo|Topical Fluorouracil|Effervescent Mixture,DRUG: a new effervescent mixture 5-florouracil formula|DRUG: 5-Fluorouracil plain powder,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Facualty of Pharmacy, Al Azhar University, Cairo, 11765, Egypt",Al-Azhar University
Vitiligo,NCT05750823,A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo,https://clinicaltrials.gov/study/NCT05750823,NO,Nonsegmental Vitiligo With Genital Involvement,DRUG: Ruxolitinib Cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"Center For Dermatology Clinical Research, Inc, Fremont, California, 94538, United States|Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059-3526, United States|Apex Clinical Research Center, Mayfield, Ohio, 44124, United States|Austin Institute For Clinical Research Aicr Pflugerville, Pflugerville, Texas, 78660, United States|Innovative Dermatology: Legacy Medical Village, Plano, Texas, 75024-4319, United States|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|Simcomed Health Ltd, Barrie, Ontario, L4M 7G1, Canada|Skin Centre For Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Research Toronto, Toronto, Ontario, M3H 5Y8, Canada|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, 33075, France|Hopital Henri Mondor Service de Dermatologie, Creteil, 94000, France|Chu Nice Hopital Archet 2, Nice, 06202, France",Incyte Corporation
Vitiligo,NCT03365141,Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03365141,NO,Vitiligo|Treatment|Intralesional Injection|Corticosteroid,DRUG: Triamcinolone acetonide 0.4mg/cc|DEVICE: Phototherapy (NBUVB or excimer laser)|DRUG: Topical tacrolimus,ALL,"ADULT, OLDER_ADULT",,"St. Vincent's Hospital, Suwon, Gyonggi-do, 16247, Korea, Republic of",The Catholic University of Korea
Vitiligo,NCT02038257,Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP,https://clinicaltrials.gov/study/NCT02038257,NO,Vitiligo|Depigmented Scars|Depigmentation,PROCEDURE: MKTP (melanocyte keratinocyte transplant procedure)|DEVICE: Collagen Dressing|DEVICE: Vaseline Impregnated Gauze|DEVICE: Carbon Dioxide Laser|DEVICE: Dermabrasion,ALL,"ADULT, OLDER_ADULT",,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States","Principal Investigator : Iltefat H Hamzavi, MD , Henry Ford Dermatology"
Hypothyroidism,NCT04953195,Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT04953195,NO,Subclinical Hypothyroidisms,DRUG: Levothyroxine Sodium Tablets,ALL,"ADULT, OLDER_ADULT",PHASE4,"Beijing Chao-Yang Hospital, Capital Medical University, Beijing, Beijing, China",
Hypothyroidism,NCT06083636,Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine,https://clinicaltrials.gov/study/NCT06083636,NO,Hypothyroidism,OTHER: Single extra blood draw and completion of single questionnaire|OTHER: Single blood draw and completion of single questionnaire,ALL,"ADULT, OLDER_ADULT",,"Amsterdam UMC, Amsterdam, Noord-Holland, 1105 AZ, Netherlands","Principal Investigator : Annemieke C Heijboer, Prof. dr. , Amsterdam UMC, VU Amsterdam and UvA, Endocrine Laboratory, Department of Laboratory Medicine"
Hypothyroidism,NCT05143918,Quality of Life Among Egyptian Hypothyroid Patients,https://clinicaltrials.gov/study/NCT05143918,NO,Hypothyroidism,OTHER: assessment of quality of life using questionnaire,ALL,ADULT,,,"Study Chair : Nabawia M Tawfik , Assiut University Study Director : Ghada Abd El Rahman , Assiut University Study Director : Doaa M Osman , Assiut University Principal Investigator : Noha F Radwan , Assiut University"
Hypothyroidism,NCT04795947,Correlation Between Thyroid Function and Quality of Life in Hypothyroidism,https://clinicaltrials.gov/study/NCT04795947,NO,Hypothyroidism,BEHAVIORAL: Behavioral,ALL,"ADULT, OLDER_ADULT",,"BeijingCYH, Beijing, Beijing, 100020, China","Principal Investigator : Guang Wang , Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China"
Hypothyroidism,NCT06345339,A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants,https://clinicaltrials.gov/study/NCT06345339,NO,Hypothyroidism,DRUG: Armour Thyroid|DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Central Research Associates /ID# 255719, Birmingham, Alabama, 35205, United States|John Muir Medical Center /ID# 257103, Concord, California, 94520, United States|Diagnamics Inc. /ID# 262680, Encinitas, California, 92024, United States|NorCal Medical Research /ID# 256512, Greenbrae, California, 94904, United States|Velocity Clinical Research - Huntington Park /ID# 259044, Huntington Park, California, 90255-2951, United States|Diabetes Associates Medical Group /ID# 256949, Orange, California, 92866-2862, United States|Care Access - Santa Clarita /ID# 262573, Santa Clarita, California, 91321, United States|Diablo Clinical Research /ID# 261329, Walnut Creek, California, 94598, United States|San Fernando Valley Health Institute /ID# 257363, West Hills, California, 91304-3837, United States|New England Research Associates - Bridgeport /ID# 262184, Bridgeport, Connecticut, 06606, United States|Innovative Research of West Florida /ID# 257356, Clearwater, Florida, 33756-2004, United States|ALL Medical Research /ID# 256748, Cooper City, Florida, 33024, United States|Northeast Research Institute (NERI) /ID# 261841, Fleming Island, Florida, 32003, United States|Northeast Research Institute (NERI) /ID# 261846, Fleming Island, Florida, 32003, United States|The Center for Diabetes and Endocrine Care /ID# 255721, Fort Lauderdale, Florida, 33312, United States|Encore Medical Research LLC /ID# 256758, Hollywood, Florida, 33021, United States|East Coast Institute For Research - LaVilla - West Monroe Street /ID# 256972, Jacksonville, Florida, 32204, United States|The University of Florida Heal /ID# 257361, Jacksonville, Florida, 32207-4966, United States|East Coast Research - Jacksonville /ID# 256971, Jacksonville, Florida, 32216, United States|Encore Research Group-Jacksonville Center for Clinical Research /ID# 256147, Jacksonville, Florida, 32216, United States|South Florida Wellness & Clinic /ID# 256513, Margate, Florida, 33063, United States|Med Research of Florida /ID# 257837, Miami, Florida, 33186, United States|Adult Medicine of Lake County - Mount Dora /ID# 257371, Mount Dora, Florida, 32757, United States|Suncoast Clinical Research Pasco County /ID# 257018, New Port Richey, Florida, 34652, United States|West Orange Endocrinology /ID# 256139, Ocoee, Florida, 34761-4547, United States|Suncoast Clinical Research - Palm Harbor /ID# 256741, Palm Harbor, Florida, 34684, United States|Comprehensive Medical & Research Center /ID# 261678, Plantation, Florida, 33317-2911, United States|Northeast Research institute /ID# 261857, Saint Augustine, Florida, 32080-6010, United States|Metabolic Research Inst /ID# 255729, West Palm Beach, Florida, 33401, United States|East Coast Institute for Research - Canton /ID# 256974, Canton, Georgia, 30114, United States|Columbus Regional Research Ins /ID# 255738, Columbus, Georgia, 31904, United States|Physicians Research Associates, LLC /ID# 255675, Lawrenceville, Georgia, 30046, United States|East Coast Institute for Research - Macon /ID# 256529, Macon, Georgia, 31210, United States|Endocrine Research Solutions /ID# 256784, Roswell, Georgia, 30076, United States|Rocky Mountain Clinical Research, LLC /ID# 256753, Idaho Falls, Idaho, 83404-7596, United States|West Broadway Clinic /ID# 256756, Council Bluffs, Iowa, 51501-3822, United States|Iowa Diabetes and Endocrinology Research Center /ID# 256750, West Des Moines, Iowa, 50265, United States|Cotton O'Neil Digestive Health Center /ID# 256749, Topeka, Kansas, 66606-1539, United States|L-MARC Research Center /ID# 255733, Louisville, Kentucky, 40213-1014, United States|Nola Care Clinical Research /ID# 260145, Metairie, Louisiana, 70006-2930, United States|Omega Clinical Research /ID# 260162, Metairie, Louisiana, 70006-2930, United States|NECCR PrimaCare Research, LLC /ID# 256531, Fall River, Massachusetts, 02721, United States|Metro Detroit Endocrinology Center /ID# 260862, Dearborn, Michigan, 48126, United States|Michigan Healthcare Professionals /ID# 260859, Farmington Hills, Michigan, 48334-1566, United States|Elite Clinical Research Center /ID# 256782, Flint, Michigan, 48532, United States|Diabetes and Endocrinology Specialists /ID# 259068, Chesterfield, Missouri, 63017, United States|Jefferson City Medical Group /ID# 257099, Jefferson City, Missouri, 65109, United States|Billings Clinic /ID# 258316, Billings, Montana, 59101-0733, United States|Mercury Street Medical /ID# 259632, Butte, Montana, 59701-1652, United States|Methodist Physicians Clinic /ID# 259276, Omaha, Nebraska, 68114, United States|Palm Research Center /ID# 256131, Las Vegas, Nevada, 89148, United States|Northern Nevada Endocrinology /ID# 259646, Reno, Nevada, 89511, United States|Southern New Hampshire Diabetes and Endocrinology /ID# 257841, Nashua, New Hampshire, 03060, United States|Research Foundation of SUNY - University of Buffalo /ID# 261019, Buffalo, New York, 14203, United States|NYC Research /ID# 258662, New York, New York, 10001, United States|Endocrine Assc Long Island PC /ID# 257357, Smithtown, New York, 11787, United States|Physician's East Endocrinology /ID# 256491, Greenville, North Carolina, 27834, United States|Carteret Medical Group /ID# 256869, Morehead City, North Carolina, 28557, United States|Lucas Research /ID# 256127, Morehead City, North Carolina, 28557, United States|Lucas Research /ID# 257061, Morehead City, North Carolina, 28557, United States|Accellacare Wilmington /ID# 256744, Wilmington, North Carolina, 28401, United States|Diabetes and Endocrinology Associates of Stark County Inc /ID# 256751, Canton, Ohio, 44718, United States|Lynn Institute of Norman /ID# 256785, Norman, Oklahoma, 73072, United States|Lynn Institute of Oklahoma City /ID# 263141, Oklahoma City, Oklahoma, 73112, United States|Diabetes & Endocrinology Consultants of Pennsylvania /ID# 259064, Feasterville-Trevose, Pennsylvania, 19053, United States|Jefferson Health - Roosevelt Boulevard /ID# 256837, Philadelphia, Pennsylvania, 19114-1025, United States|Trial Management Associates - Myrtle Beach /ID# 259800, Myrtle Beach, South Carolina, 29572, United States|Carolina Endocrine Associates Llc /ID# 259640, North Charleston, South Carolina, 29406-9823, United States|Chattanooga Medical Research /ID# 257631, Chattanooga, Tennessee, 37404-3239, United States|Mid State Endocrine Associates /ID# 259641, Nashville, Tennessee, 37203, United States|Texas Diabetes and Endocrinology - Central Austin /ID# 255728, Austin, Texas, 78731, United States|Texas Diabetes and Endocrinology - South Austin /ID# 255723, Austin, Texas, 78749, United States|Brusco, Corpus Christi, TX /ID# 256746, Corpus Christi, Texas, 78414, United States|North TX Endocrine Center /ID# 255737, Dallas, Texas, 75231, United States|Research Institute Dallas /ID# 256126, Dallas, Texas, 75231, United States|Academy of Diabetes, Thyroid and Endocrine /ID# 255735, El Paso, Texas, 79935, United States|Diabetes and Thyroid Center of Ft. Worth /ID# 256781, Fort Worth, Texas, 76132, United States|Juno Research /ID# 259238, Houston, Texas, 77040-5059, United States|Biopharma Informatic - Houston - Business Center Drive /ID# 256149, Houston, Texas, 77043, United States|PlanIt Research, PLLC /ID# 259221, Houston, Texas, 77079-2204, United States|Endocrine and Psychiatry Cente /ID# 259631, Houston, Texas, 77095, United States|Tekton Research /ID# 260988, Irving, Texas, 75039-2523, United States|Southern Endocrinology Associates /ID# 256795, Mesquite, Texas, 75149, United States|Texas Diabetes and Endocrinology /ID# 255722, Round Rock, Texas, 78681, United States|Northeast Clinical Research of San Antonio, LLC /ID# 256868, San Antonio, Texas, 78233, United States|Diabetes & Glandular Disease Clinic /ID# 255734, San Antonio, Texas, 78237, United States|Consano Clinical Research, LLC /ID# 256138, Shavano Park, Texas, 78231, United States|Texas Valley Clinical Research /ID# 261476, Weslaco, Texas, 78596, United States|Virginia Endocrinology Research /ID# 259623, Chesapeake, Virginia, 23321, United States|Rainier Clinical Research /ID# 255802, Renton, Washington, 98055, United States",
Hypothyroidism,NCT05334771,Early Detection of Endolymphatic Hydrops in Hypothyroid Patients,https://clinicaltrials.gov/study/NCT05334771,NO,Hypothyroidism,DEVICE: Dual band pure tune audiometer,ALL,ADULT,,,"Study Chair : Enas Mostafa Osman, lecturer , audiovestibular medicine, assiut university Study Director : mohamed salama bakr, professor , audiovestibular medicine, assiut university"
Hypothyroidism,NCT05015725,"The Relationship Between Serum rT3 Concentrations, T3/T4 Ratio, and Symptoms/Quality of Life in Treated Hypothyroid Patients",https://clinicaltrials.gov/study/NCT05015725,NO,Hypothyroidism,"DIAGNOSTIC_TEST: Quality of life assessment, biochemical measures",ALL,"ADULT, OLDER_ADULT",,"Semmelweis University - Departement Medicine and Oncology, Budapest, 1083, Hungary",Semmelweis University
Hypothyroidism,NCT05823012,Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism,https://clinicaltrials.gov/study/NCT05823012,NO,Hypothyroidism,DRUG: levothyroxine sodium,ALL,"ADULT, OLDER_ADULT",PHASE2,"ProSciento, Inc., Chula Vista, California, 91911, United States|Catalina Research Institute, L.L.C., Montclair, California, 91763, United States|Panax Clinical Research, LLC, Miami Lakes, Florida, 33014, United States|American Research Corporation, San Antonio, Texas, 78215, United States|Mt. Olympus Medical Research, LLC, Sugar Land, Texas, 77479, United States|Rainier Clinical Research Center, Renton, Washington, 98057, United States","Study Director : Valentina Conoscenti, MD , Xeris Pharmaceuticals, Inc."
Hypothyroidism,NCT04878614,Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding,https://clinicaltrials.gov/study/NCT04878614,NO,Hypothyroidism,DRUG: Levothyroxine Tablet|DRUG: Levothyroxine Sodium,ALL,"ADULT, OLDER_ADULT",PHASE4,"UCLA Center for Human Nutrition, Los Angeles, California, 90024, United States","Principal Investigator : Vijiya Surampudi, MD , University of California, Los Angeles"
Hypothyroidism,NCT04236232,The Impact of Subclinical Hypothyroidism on Cardiovascular System,https://clinicaltrials.gov/study/NCT04236232,NO,Hypothyroidism,DIAGNOSTIC_TEST: Thyroid function,ALL,ADULT,,,Assiut University
Hypothyroidism,NCT04332770,Biosignals by Wearable Devices in Hypothyroidism,https://clinicaltrials.gov/study/NCT04332770,NO,Hypothyroidism,OTHER: levothyroxine withdrawal,ALL,ADULT,,"Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea, Republic of",
Hypothyroidism,NCT03631771,Pediatric Risk of Hypothyroidism With Iodinated Contrast Media,https://clinicaltrials.gov/study/NCT03631771,NO,Hypothyroidism,DRUG: Iohexol|DRUG: Iodixanol|DRUG: Iopromide|DRUG: Ioversol,ALL,CHILD,PHASE4,,"Study Director : Paul F. Sherwin, MD, PhD , GE Healthcare Study Director : Zuzana Jirakova Trnkova, MD, PhD , Bayer Study Director : Philippe Bourrinet, PharmD , Guerbet"
Hypothyroidism,NCT02024906,Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants,https://clinicaltrials.gov/study/NCT02024906,NO,Cardiovascular Disease|Subclinical Hypothyroid,DIETARY_SUPPLEMENT: soy protein isolate (SPI)|DIETARY_SUPPLEMENT: milk protein isolate (MPI),ALL,"ADULT, OLDER_ADULT",,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States","Principal Investigator : Jill Hamilton-Reeves, PhD, RD, LD , University of Kansas Medical Center"
Hypothyroidism,NCT03342001,Hypothyroidism Treated With Calcitonin,https://clinicaltrials.gov/study/NCT03342001,YES,Hypothyroidism,DRUG: Calcitonin,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Maryland Center for Diabetes and Endocrinology, Baltimore, Maryland, 21201, United States","Principal Investigator : Kashif Munir, M.D. , University of Maryland"
Hypothyroidism,NCT02959827,Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States,https://clinicaltrials.gov/study/NCT02959827,YES,Hypothyroidism,DRUG: Iodinated contrast agents,ALL,CHILD,,"Oakland, Oakland, California, 94612, United States",Bayer
Hypothyroidism,NCT05314790,"Management of Patients With Diagnosis of Hypothyroidism, as Hospitalized and as Outpatients, in Internal Medicine Units: Observational Study Before & After Educational Programme",https://clinicaltrials.gov/study/NCT05314790,NO,Hypothyroidism,OTHER: intervening Educational Program,ALL,"ADULT, OLDER_ADULT",,"ULSS1 Belluno San Martino, Belluno, Italy|Ospedale Versilia, Camaiore, Italy|Ospedale di CanicattÃ¬, CanicattÃ¬, Italy|Ospedale di Castiglione del Lago, Medicina del Trasimeno, Castiglione Del Lago, Italy|Garibaldi Nesima, Catania, Italy|Ospedale G.B. Morgagni - P.L. Pierantoni, ForlÃ¬, Italy|Ospedale G.P. Delogu, Ghilarza, Italy|Ospedale Gubbio-Gualdo Tadino, Gubbio, Italy|Ospedale ""F. Veneziale"", Isernia, Italy|ASL Latina, Latina, Italy|Ospedale S. Andrea, Massa Marittima, Italy|Ospedale S. Croce di Moncalieri - ASL TO5, Moncalieri, Italy|Ospedale Del Mare, Napoli, Italy|Ospedale Fatebenefratelli, Napoli, Italy|Ospedale Maggiore di Novara, Novara, Italy|Ospedale Civico di Partinico, Palermo, Italy|Ospedale ""Bianchi-Melacrino-Morelli"", Reggio Calabria, Italy|Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|AOU di Sassari, Sassari, Italy|Ospedale San Paolo, Savona, Italy","Study Director : MAURO CAMPANINI , FADOI FOUNDATION"
Hypothyroidism,NCT03180892,Non-immune Related Hypothyroidism in Iodine Sufficient Area,https://clinicaltrials.gov/study/NCT03180892,NO,Hypothyroidism,OTHER: The investigators did not apply any intervention for the participants.,ALL,"ADULT, OLDER_ADULT",,,Samsung Medical Center
Hypothyroidism,NCT05712421,A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism,https://clinicaltrials.gov/study/NCT05712421,NO,Hypothyroidism,DRUG: North Star|DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE2,"Neuvosyn Investigational Site, Birmingham, Alabama, 35209, United States|Neuvosyn Investigational Site, Canoga Park, California, 91304, United States|Neuvosyn Investigational Site, Greenbrae, California, 94904, United States|Neuvosyn Investigational Site, Toluca Lake, California, 91602, United States|Neuvosyn Investigational Site, Boca Raton, Florida, 33434, United States|Neuvosyn Investigational Site, Miami, Florida, 33144, United States|Neuvosyn Investigational Site, Miami, Florida, 33145, United States|Neuvosyn Investigational Site, Miami, Florida, 33155, United States|Neuvosyn Investigational Site, Miami, Florida, 33174, United States|Neuvosyn Investigational Site, Miami, Florida, 33179, United States|Neuvosyn Investigational Site, Sunrise, Florida, 33351, United States|Neuvosyn Investigational Site, Acworth, Georgia, 30101, United States|Neuvosyn Investigational Site, Atlanta, Georgia, 30318, United States|Neuvosyn Investigational Site, Columbus, Georgia, 31904, United States|Neuvosyn Investigational Site, Sugar Hill, Georgia, 30024, United States|Neuvosyn Investigational Site, Saginaw, Michigan, 48602, United States|Neuvosyn Investigational Site, Gladstone, Missouri, 64118, United States|Neuvosyn Investigational Site, Williamsville, New York, 14221, United States|Neuvosyn Investigational Site, Denver, North Carolina, 28037, United States|Neuvosyn Investigational Site, Winston-Salem, North Carolina, 27103, United States|Neuvosyn Investigational Site, Beavercreek, Ohio, 45440, United States|Neuvosyn Investigational Site, Columbus, Ohio, 31904, United States|Neuvosyn Investigational Site, Georgetown, Texas, 78628, United States|Neuvosyn Investigational Site, Houston, Texas, 77040, United States|Neuvosyn Investigational Site, Katy, Texas, 77450, United States|Neuvosyn Investigational Site, Katy, Texas, 77494, United States|Neuvosyn Investigational Site, Lewisville, Texas, 75067, United States|Neuvosyn Investigational Site, Paris, Texas, 75462, United States|Neuvosyn Investigational Site, Pearland, Texas, 77584, United States|Neuvosyn Investigational Site, Stafford, Texas, 77477, United States","Neuvosyn Laboratories, LLC"
Hypothyroidism,NCT05412979,A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism,https://clinicaltrials.gov/study/NCT05412979,NO,Hypothyroidism,DRUG: ST-1891|DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE2,"Sention Investigational Site, Greenbrae, California, 94904, United States|Sention Investigational Site, Newhall, California, 91321, United States|Sention Investigational Site, Denver, Colorado, 80246, United States|Sention Investigational Site, Fort Lauderdale, Florida, 33312, United States|Sention Investigational Site, Jacksonville, Florida, 32258, United States|Sention Investigational Site, New Port Richey, Florida, 34652, United States|Sention Investigational Site, Palm Harbor, Florida, 34684, United States|Sention Investigational Site, Atlanta, Georgia, 30318, United States|Sention Investigational Site, Lawrenceville, Georgia, 30046, United States|Sention Investigational Site, Roswell, Georgia, 30076, United States|Sention Investigational Site, Evergreen Park, Illinois, 60805, United States|Sention Investigational Site, Newburgh, Indiana, 47630, United States|Sention Investigational Site, South Bend, Indiana, 46617, United States|Sention Investigational Site, Ankeny, Iowa, 50023, United States|Sention Investigational Site, Louisville, Kentucky, 40213, United States|Sention Investigational Site, Dearborn, Michigan, 48126, United States|Sention Investigational Site, Chesterfield, Missouri, 63017, United States|Sention Investigational Site, Jefferson City, Missouri, 65109, United States|Sention Investigational Site, Staten Island, New York, 10301, United States|Sention Investigational Site, Cary, North Carolina, 27518, United States|Sention Investigational Site, Greenville, North Carolina, 27834, United States|Sention Investigational Site, Hickory, North Carolina, 28601, United States|Sention Investigational Site, Morehead City, North Carolina, 28557, United States|Sention Investigational Site, Raleigh, North Carolina, 27609, United States|Sention Investigational Site, Rocky Mount, North Carolina, 27804, United States|Sention Investigational Site, Salisbury, North Carolina, 28144, United States|Sention Investigational Site, Wilmington, North Carolina, 28401, United States|Sention Investigational Site, Mount Pleasant, South Carolina, 29464, United States|Sention Investigational Site, Bristol, Tennessee, 37620, United States|Sention Investigational Site, Chattanooga, Tennessee, 37411, United States|Sention Investigational Site, Memphis, Tennessee, 38133, United States|Sention Investigational Site, Austin, Texas, 78731, United States|Sention Investigational Site, Austin, Texas, 78749, United States|Sention Investigational Site, Benbrook, Texas, 76132, United States|Sention Investigational Site, Live Oak, Texas, 78233, United States|Sention Investigational Site, Round Rock, Texas, 78681, United States|Sention Investigational Site, Webster, Texas, 77598, United States|Sention Investigational Site, Virginia Beach, Virginia, 23462, United States|Sention Investigational Site, Renton, Washington, 98057, United States",
Hypothyroidism,NCT03257566,Hypothyroidism in Patients With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT03257566,NO,Hypothyroidism,,ALL,CHILD,,,Assiut University
Hypothyroidism,NCT02993562,"Hypothyroidism, Metabolism and Food Intake",https://clinicaltrials.gov/study/NCT02993562,NO,Hypothyroidism,DRUG: Levothyroxine,FEMALE,"ADULT, OLDER_ADULT",,"Center for Diabetes Research, Herlev and Gentofte Hospitals, Copenhagen, Region Hovedstaden, 2900, Denmark","Principal Investigator : Bjarke B Medici, MD , Department of Internal Medicine, Herlev and Gentofte hospitals."
Hypothyroidism,NCT02577367,Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding,https://clinicaltrials.gov/study/NCT02577367,NO,Hypothyroidism,DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE4,"Maimonides Medical Center, Brooklyn, New York, 11219, United States",
Hypothyroidism,NCT00565864,Neurocognitive and Metabolic Effects of Mild Hypothyroidism,https://clinicaltrials.gov/study/NCT00565864,YES,Hypothyroidism,DRUG: L-thyroxine (L-T4),ALL,"ADULT, OLDER_ADULT",PHASE4,"Oregon Health and Science University, Portland, Oregon, 97201, United States","Principal Investigator : Mary Samuels, MD , Oregon Health and Science University"
Hypothyroidism,NCT03095963,Interaction Between Levothyroxine and Probiotics in Hypothyroid Patients,https://clinicaltrials.gov/study/NCT03095963,NO,Hypothyroidism,OTHER: a mixture of highly charged Lactobacilli and Bifidobacteria (VSL#3Â®)|DRUG: levothyroxin,ALL,"ADULT, OLDER_ADULT",,,Azienda USL Modena
Hypothyroidism,NCT00818896,Maternal Hypothyroidism in Pregnancy,https://clinicaltrials.gov/study/NCT00818896,NO,Hypothyroidism,,FEMALE,"CHILD, ADULT",,"Women & Infants Hospital, Providence, Rhode Island, 02905, United States","Principal Investigator : James E. Haddow, M.D. , Women & Infants Hospital"
Hypothyroidism,NCT02766283,Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure,https://clinicaltrials.gov/study/NCT02766283,YES,Hypothyroidism,DRUG: iodinated contrast agents,ALL,CHILD,,"Multiple Locations, Israel","Study Director : Bayer Study Director , Bayer"
Hypothyroidism,NCT06205303,Interventional Study to Improve Medication Adherence Using Patient Decision Aid,https://clinicaltrials.gov/study/NCT06205303,NO,Hypothyroidism,OTHER: Patient Decision Aid (Video),ALL,"ADULT, OLDER_ADULT",,"SingHealth Polyclinics, Singapore, Singapore","Principal Investigator : Kalaipriya Gunasekaran, MD , SingHealth Polyclinics"
Hypothyroidism,NCT00524238,Metabolic Changes in Hypothyroid Patients,https://clinicaltrials.gov/study/NCT00524238,NO,Hypothyroidism,DRUG: L-thyroxine,ALL,"ADULT, OLDER_ADULT",,"Aarhus University Hospital, Aarhus, 8000, Denmark",
Hypothyroidism,NCT02917863,Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism,https://clinicaltrials.gov/study/NCT02917863,NO,Hypothyroidism,"DRUG: L-Thyroxine (tablet, per os)|DRUG: L-Thyroxine (oral drops, solution)",ALL,"CHILD, ADULT",PHASE4,"Meyer Children's Hospital, Florence, Italy",Meyer Children's Hospital IRCCS
Hypothyroidism,NCT02364102,Effect of Hypothyroidism on Brown Adipose Tissue,https://clinicaltrials.gov/study/NCT02364102,NO,Hypothyroidism,,ALL,"ADULT, OLDER_ADULT",,"University Hospital Basel, Department of Endocrinology, Basel, BS, 4031, Switzerland","Principal Investigator : Mirjam Christ-Crain, MD , Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel"
Hypothyroidism,NCT02891668,"Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition",https://clinicaltrials.gov/study/NCT02891668,NO,Hypothyroidism,DRUG: Levothyroxine treatment,ALL,"ADULT, OLDER_ADULT",,"Department of internal Medicine, Herlev Hospital, Herlev, Region Hovedstaden, DK-2730, Denmark","Principal Investigator : Bjarke Medici, MD , Bjarke Medici"
Hypothyroidism,NCT01197183,"Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France",https://clinicaltrials.gov/study/NCT01197183,NO,Hypothyroidism,,ALL,ADULT,,"Merck Lipha SantÃ© Laboratories, Saint Romain, Lyon, 69008, France","Study Director : Dr. Frederic Landron, MD , Laboratoires Merck Lipha SantÃ©"
Hypothyroidism,NCT02567877,Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?,https://clinicaltrials.gov/study/NCT02567877,NO,Postsurgical Hypothyroidism|Hypothyroidism,PROCEDURE: thyroidectomy|DRUG: levothyroxine in thyroidectomy patients,ALL,"ADULT, OLDER_ADULT",,"University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States","Principal Investigator : Bryan R Haugen, M.D. , University of Colorado Denver Anschutz Medical Campus"
Hypothyroidism,NCT02467244,"Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism",https://clinicaltrials.gov/study/NCT02467244,NO,Hypothyroidism,DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",,"AIIMS, Bhubaneswar, Bhubaneshwar, Odisha, 751019, India","Study Director : DEBASISH HOTA, MD, DM , AIIMS, Bhubaneswar"
Hypothyroidism,NCT00206375,Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism,https://clinicaltrials.gov/study/NCT00206375,YES,Hypothyroidism,DRUG: Growth hormone|DRUG: Growth hormone treatment and puberty,ALL,CHILD,PHASE4,"Baylor college of Medicine, Houston, Texas, 77030, United States","Principal Investigator : Parvin Yazdani, MD , Baylor College of Medicine"
Hypothyroidism,NCT01769157,Effects of L-carnitine on Hypothyroidism,https://clinicaltrials.gov/study/NCT01769157,NO,Hypothyroidism,DRUG: L-carnitine|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE4,"Korea University Anam Hospital, Seoul, Korea, Republic of",IlDong Pharmaceutical Co Ltd
Hypothyroidism,NCT01800617,A Study of T3 Therapy in Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT01800617,NO,Hypothyroidism,"DRUG: Liothyronine, Sodium",ALL,"ADULT, OLDER_ADULT",PHASE2,"Georgetown University Hospital, Washington, District of Columbia, 20007, United States","Ipe, LLC"
Hypothyroidism,NCT00403390,Generic vs. Name-Brand Levothyroxine,https://clinicaltrials.gov/study/NCT00403390,YES,Congenital Hypothyroidism|Hypothyroidism,DRUG: Brand Name Levothyroxine (Synthroid)|DRUG: Generic formulation of Levothyroxine,ALL,"CHILD, ADULT",,"Children's Hospital Boston, Boston, Massachusetts, 02115, United States","Principal Investigator : Rosalind S Brown, MD , Boston Children's Hospital"
Hypothyroidism,NCT02094079,Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism,https://clinicaltrials.gov/study/NCT02094079,NO,Hypothyroidism,OTHER: biomedical outcomes,FEMALE,ADULT,,"Endocrine Unit O, Herlev Hospital, University of Copenhagen, Herlev, dk 2730, Denmark","Principal Investigator : Birte Nygaard, MD, phd , Endocrine Unit O, Herlev Hospital, University of Copenahgen"
Hypothyroidism,NCT05821881,REduction of LEvothyroxine in Adults; a SElf Controlled Study,https://clinicaltrials.gov/study/NCT05821881,NO,Hypothyroidism,OTHER: Discontinuation of levothyroxine treatment,ALL,"ADULT, OLDER_ADULT",,"Leiden University Medical Center, Leiden, 2300 RC, Netherlands","Principal Investigator : Jacobijn Gussekloo, MD, PhD , Leiden University Medical Center"
Hypothyroidism,NCT03926585,Variations in the DIO2 and MCT10 Genes and Effect of Triiodothyronine Treatment,https://clinicaltrials.gov/study/NCT03926585,NO,Hypothyroidism,,ALL,"ADULT, OLDER_ADULT",,"Herlev Hospital, Herlev, 2730, Denmark",
Hypothyroidism,NCT06073665,Dosing of LT4 in Older Individuals,https://clinicaltrials.gov/study/NCT06073665,NO,Hypothyroidism,DRUG: Levothyroxine Sodium,ALL,OLDER_ADULT,PHASE4,"Penn Medicine, Smilow Translational Research Center, Philadelphia, Pennsylvania, 19104, United States","Principal Investigator : Anne R. Cappola, M.D., Sc.M. , University of Pennsylvania"
Hypothyroidism,NCT00770016,Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT00770016,NO,Hypothyroidism,DRUG: Levothyroxin,ALL,"ADULT, OLDER_ADULT",,"Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus,, Aarhus, 8000, Denmark","MR Research Center, Skejby Sygehus, Brendstrupgaardsvej 100, 8200 Aarhus N"
Hypothyroidism,NCT03779906,Thyroid Function of Pediatric Subjects Following IsovueÂ® Administration,https://clinicaltrials.gov/study/NCT03779906,NO,Hypothyroidism,DRUG: Isovue,ALL,CHILD,PHASE4,"Children's Hospital and Medical Center, Omaha, Nebraska, 68114, United States",
Hypothyroidism,NCT05421468,Timing of Thyroxine Dose In Ramadan,https://clinicaltrials.gov/study/NCT05421468,NO,Hypothyroidism,OTHER: L-Thyroxine time B (5-15 minutes Before dawn),ALL,"ADULT, OLDER_ADULT",,"Reem Alamoudi, Jeddah, 21423, Saudi Arabia|KingAbullahIMRC, Jeddah, Saudi Arabia",
Hypothyroidism,NCT00715572,Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone,https://clinicaltrials.gov/study/NCT00715572,NO,Hypothyroidism,DRUG: thyroxine|DRUG: thyroxine and triiodothyronine,FEMALE,ADULT,,,"Principal Investigator : Valentin V Fadeyev , Moscow Medical Academy, Department of Endocrinology"
Hypothyroidism,NCT05033496,The Yield of Postnatal Thyroid Function Test in the Well Baby Nursery,https://clinicaltrials.gov/study/NCT05033496,NO,Hypothyroidism,DIAGNOSTIC_TEST: Thyroid function test,ALL,CHILD,,"Hillel Yaffe medical center, HÌ±adera, Hadera, 38100, Israel","Principal Investigator : Erez Nadir, MD , Hillel Yaffe Medical Center"
Hypothyroidism,NCT04877665,Establishing RIs for TSH in Children Under the Age of Two Years,https://clinicaltrials.gov/study/NCT04877665,NO,Hypothyroidism,,ALL,CHILD,,"The Aga Khan University, Karachi, Sindh, 3500, Pakistan","Principal Investigator : Siraj Muneer , The Aga Khan University"
Hypothyroidism,NCT02317926,Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism,https://clinicaltrials.gov/study/NCT02317926,NO,Hypothyroidism,DRUG: Levothyroxine|DRUG: Levothyroxine Plus Liothyronine|DRUG: Desiccated Thyroid Extract,ALL,"ADULT, OLDER_ADULT",,"Walter Reed National Military Medical Center, Besthesda, Maryland, 20889, United States",Walter Reed National Military Medical Center
Hypothyroidism,NCT04098991,Improving White Matter Integrity With Thyroid Hormone,https://clinicaltrials.gov/study/NCT04098991,NO,Hypothyroidism,DRUG: Levothyroxine,ALL,ADULT,,"University of Illinois at Chicago, Chicago, Illinois, 60612, United States","Principal Investigator : Olusola A Ajilore, MD/PhD , University of Illinois at Chicago"
Hypothyroidism,NCT03988517,Comparing Two-time Points of Thyroid Hormone Replacement During the Holy Month of Ramadan,https://clinicaltrials.gov/study/NCT03988517,NO,Hypothyroidism,OTHER: timing of receiving the drug,ALL,"ADULT, OLDER_ADULT",,"Hamad General Hospital, Doha, 3050, Qatar",
Hypothyroidism,NCT01744743,Preconceptional Thyroid Screening and Childhood Nerocognitive Function,https://clinicaltrials.gov/study/NCT01744743,NO,Hypothyroidism,PROCEDURE: levothyroxine,FEMALE,ADULT,,"Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, 200011, China","Principal Investigator : Xiaotian Li, MD, PhD , Obstetrics and Gynecology Hospital, Fudan University"
Hypothyroidism,NCT01921452,Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit,https://clinicaltrials.gov/study/NCT01921452,YES,Hypothyroidism,DEVICE: Quantitative POC TSH Kit|DEVICE: Qualitative POC TSH Kit|DEVICE: Third generation TSH Kit,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Research site, Shanghai, China","Study Director : Medical Responsible , Merck Serono Co. Ltd. an affiliate of Merck KGaA, Darmstadt, Germany"
Hypothyroidism,NCT03053115,Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients,https://clinicaltrials.gov/study/NCT03053115,NO,Hypothyroidism,DRUG: Liothyronine|DRUG: Levothyroxin|DRUG: Placebos,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"AziendaUSLModena, Modena, 41126, Italy",
Hypothyroidism,NCT01744769,Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer,https://clinicaltrials.gov/study/NCT01744769,NO,Hypothyroidism,,ALL,"ADULT, OLDER_ADULT",,"Konkuk University Medical Center, Seoul, 143-729, Korea, Republic of","Principal Investigator : Suk Kyeong Kim, MD, PhD , Konkuk University Medical Center"
Hypothyroidism,NCT00111735,Thyroxine Titration Study,https://clinicaltrials.gov/study/NCT00111735,NO,Hypothyroidism,DRUG: Thyroxine,ALL,"ADULT, OLDER_ADULT",PHASE4,"Sir Charles Gairdner Hospital, Nedlands, Western Australia, 6009, Australia",
Hypothyroidism,NCT01916304,Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation,https://clinicaltrials.gov/study/NCT01916304,YES,Hypothyroidism,DRUG: Levothyroxine sodium new formulation,ALL,"ADULT, OLDER_ADULT",PHASE2,"Leuven, Belgium","Study Director : Medical Responsible , Takeda"
Hypothyroidism,NCT01647750,Study of Optimal Replacement of Thyroxine in the Elderly,https://clinicaltrials.gov/study/NCT01647750,NO,Hypothyroidism,DRUG: Levothyroxine|DRUG: Levothyroxine,ALL,OLDER_ADULT,PHASE4,"Bensham Hospital, Gateshead, Tyne and Wear, NE8 4YL, United Kingdom|Clinical Research Facility, Newcastle upon Tyne, Tyne and Wear, NE1 4LP, United Kingdom","Principal Investigator : Salman Razvi , Gateshead Health NHS Foundation Trust"
Hypothyroidism,NCT01536678,Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers,https://clinicaltrials.gov/study/NCT01536678,NO,Hypothyroidism,DRUG: Levothyroxine|DRUG: Levothyroxine,MALE,ADULT,PHASE4,"GSK Investigational Site, Hyderabad, 500051, India","Study Director : GSK Clinical Trials , GlaxoSmithKline"
Hypothyroidism,NCT00287144,Post Partum Thyroiditis 2: Long Term Observations,https://clinicaltrials.gov/study/NCT00287144,NO,Hypothyroidism,,FEMALE,"CHILD, ADULT, OLDER_ADULT",,"Sykehuset Telemark HF, Skien, 3710, Norway","Principal Investigator : Janna Berg , Sykehuset Telemark HF, Skien, Norway"
Hypothyroidism,NCT03823859,Metabolomics of Thyroid Hormones,https://clinicaltrials.gov/study/NCT03823859,NO,Central Hypothyroidism|Hypothyroidism|Hyperthyroidism,DIAGNOSTIC_TEST: Indirect calorimetry|DIAGNOSTIC_TEST: Dual energy X-ray Absorptiometry (DXA)|DIAGNOSTIC_TEST: Blood sampling,ALL,"ADULT, OLDER_ADULT",,"University Hospital Basel, Department of Endocrinology, Basel, BS, 4031, Switzerland",
Hypothyroidism,NCT00747760,TSH Receptor Mutations Among a Consanguineous Community,https://clinicaltrials.gov/study/NCT00747760,NO,Hypothyroidism,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Samuell Refetoff, Chicago, Illinois, 60637-1470, United States|Ha'Emek Medical Center, Afula, 18101, Israel","Principal Investigator : Yardena Tenenbaum-Rakover, MD , Ha'Emelk Medical Center,Afula, Israel Principal Investigator : Samuel Refetoff, MD , The University of Chicago, Chicago, Il, USA"
Hypothyroidism,NCT00205348,Swallowing Function Before and After Surgery for Thyroid Goiter,https://clinicaltrials.gov/study/NCT00205348,YES,Hypothyroidism,,ALL,"ADULT, OLDER_ADULT",,,
Hypothyroidism,NCT04712760,Congenital Hypothyroidism in Children With Eutopic Gland or Thyroid Hemiagenesis: Predictive Factors for Transient vs Permanent Hypothyroidism.,https://clinicaltrials.gov/study/NCT04712760,NO,Congenital Hypothyroidism,,ALL,CHILD,,"CHRU Nancy, Nancy, 54000, France","Principal Investigator : Emeline Renard, MD , CHRU Nancy"
Hypothyroidism,NCT04831957,Hypothyroidism After the TAVI Procedure in Elderly Patients,https://clinicaltrials.gov/study/NCT04831957,NO,Hypothyroidism|TAVI,DIAGNOSTIC_TEST: Assesment of thyroÃ¯d function,ALL,OLDER_ADULT,,"UZ brussel, Brussel, 1090, Belgium",Universitair Ziekenhuis Brussel
Hypothyroidism,NCT05801822,Screening of Subclinical Hypothyroidism in Pregnant Women,https://clinicaltrials.gov/study/NCT05801822,NO,Subclinical Hypothyroidism,DIAGNOSTIC_TEST: serum T.S.H level test,FEMALE,ADULT,,,"Principal Investigator : Amira M Mahmoud, bachelor , Sohag University"
Hypothyroidism,NCT05276856,Recovery Rate in Secondary Hypothyroidism,https://clinicaltrials.gov/study/NCT05276856,NO,Secondary Hypothyroidism,DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",,,Nova Scotia Health Authority
Hypothyroidism,NCT03036956,The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan,https://clinicaltrials.gov/study/NCT03036956,NO,Subclinical Hypothyroidism,,FEMALE,ADULT,,"Isra University hospital, Hyderabad, 71800, Pakistan|Pakistam Insititute of Medical science, Islamabad, 144001, Pakistan|Atia Hospital Hospital, Karachi, 75100, Pakistan|Boluvard Hospital, Karachi, 75500, Pakistan|MediCell Hospital, Karachi, 75500, Pakistan|Services Hospital, Lahore, 54000, Pakistan|Sir Ganga Ram hospital, Lahore, 54000, Pakistan|Welcare Medical Centre, Muzafferabad, Azad Kashmir, 13100, Pakistan|Lady Reading hospital, Peshawar, 25000, Pakistan",
Hypothyroidism,NCT03465176,The Effect of Aroma on Fatigue Scores Among Women With Hypothyroidism,https://clinicaltrials.gov/study/NCT03465176,NO,Fatigue|Hypothyroidism,OTHER: Aromatherapy Blend|OTHER: Placebo,FEMALE,ADULT,,"Franklin Institute of Wellness, Franklin, Tennessee, 37067, United States",Franklin Health Research
Hypothyroidism,NCT05316922,TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients,https://clinicaltrials.gov/study/NCT05316922,NO,Hypothyroidism; Irradiation,DRUG: Levothyroxine,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy","Fondazione IRCCS Istituto Nazionale dei Tumori, Milano"
Hypothyroidism,NCT05371262,Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism,https://clinicaltrials.gov/study/NCT05371262,NO,Congenital Hypothyroidism,DRUG: Levothyroxin,ALL,CHILD,PHASE4,,"Principal Investigator : Mariacarolina Salerno, Professor , Federico II University"
Hypothyroidism,NCT02430857,Osteopathy and Latent Hypothyroidism,https://clinicaltrials.gov/study/NCT02430857,NO,Latent Hypothyroidism,OTHER: OMT,FEMALE,"ADULT, OLDER_ADULT",,,"Principal Investigator : Emanuel Diekmann, DO , Praxis fuer Osteopathy"
Hypothyroidism,NCT04288115,Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT04288115,YES,Subclinical Hypothyroidism,DRUG: Levothyroxine|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE4,"Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR, North Little Rock, Arkansas, 72114-1706, United States","Principal Investigator : Spyridoula Maraka, MD MS , Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR"
Hypothyroidism,NCT04784208,A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen for HYpothyroidism' (Q'SHY),https://clinicaltrials.gov/study/NCT04784208,NO,Hypothyroidism|Healthy,DIAGNOSTIC_TEST: Blood test for Thyroid stimulating hormone (TSH),ALL,"ADULT, OLDER_ADULT",,"Diabecare, Mumbai, Maharashtra, 400706, India|Center for Diabetes and Endocrine care, Bangalore, 560043, India|Apollo Excelcare Hospital, Guwahati, 781033, India|Care Outpatient Centre, Hyderabad, 500034, India|FS Endocrine and Diabetic Centre, Hyderabad, 500059, India|Dr. MV Rama Mohan, MD, DM, Hyderabad, India|Diabetes Thyroid Endocrine Center, Jaipur, 302006, India|Healthy Lifestyle Clinic, Kolkata, 700014, India|Ananda Clinic, Kolkata, 700034, India|Khandelwal Diabetes Thyroid & Endocrinology Clinic, New Delhi, 110063, India|Chellaram Diabetes Institute, Pune, 411021, India","Study Director : Shivani Acharya , Abbott"
Hypothyroidism,NCT05228184,Use of TirosintÂ®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH),https://clinicaltrials.gov/study/NCT05228184,NO,Congenital Hypothyroidism,DRUG: TirosintÂ®-SOL|DRUG: Levothyroxine Sodium,ALL,CHILD,PHASE4,"Children's Hospital of Los Angeles, Los Angeles, California, 90027, United States|CHOC Children's Hospital, Orange, California, 92868, United States|University of California San Francisco, San Francisco, California, 94143, United States|Yale University, New Haven, Connecticut, 06511, United States|Children's Hospital of Atlanta, Atlanta, Georgia, 30329, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|Boston Children's Hospital, Boston, Massachusetts, 02115, United States|Children's Mercy Hospital and Clinics, Kansas City, Missouri, 64111, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Cook Children's Health Care Systems, Fort Worth, Texas, 76104, United States","Study Director : Giuseppe Mautone , IBSA Head of R&D Scientific Affairs"
Hypothyroidism,NCT01997554,Validation of a New TSH Test,https://clinicaltrials.gov/study/NCT01997554,NO,Sub-clinical Hypothyroidism|Hypothyroidism|Euthyroidism,OTHER: Blood sample,ALL,"ADULT, OLDER_ADULT",,"Centre Hospitalier de ChambÃ©ry, ChambÃ©ry, 73000, France|Centre Hospitalier Lyon Sud, Pierre-BÃ©nite, 69495, France",Hospices Civils de Lyon
Hypothyroidism,NCT01280292,"Central Hypothyroidism, a Novel Laboratory Measurement",https://clinicaltrials.gov/study/NCT01280292,NO,Central Hypothyroidism,DRUG: Eltroxin,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Ruth Percik, M.D. , Sheba Medical Center"
Hypothyroidism,NCT05682482,LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients With Autoimmune Hypothyroidism.,https://clinicaltrials.gov/study/NCT05682482,NO,Autoimmune Hypothyroidism,DRUG: LT3 (liothyronine)|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Amsterdam UMC - Location AMC, Amsterdam, Netherlands|Rijnstate, Arnhem, Netherlands|Van Weel-Bethesda Hospital, Dirksland, Netherlands|Albert Schweitzer Hospital, Dordrecht, Netherlands|Admiraal de Ruyter Hospital, Goes, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Radboudumc, Nijmegen, Netherlands|Erasmus Medical Center, Rotterdam, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Franciscus Gasthuis & Vlietland, Schiedam, Netherlands|Zuyderland, Sittard, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|Maxima Medical Center, Veldhoven, Netherlands",
Hypothyroidism,NCT02090907,Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT02090907,NO,Subclinical Hypothyroidism,DRUG: Levothyroxine|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Khorshid endocrinology clinic, Isfahan, Iran, Islamic Republic of","Principal Investigator : Nasmi Niknam, M.D. , Isfahan University of Medical Sciences"
Hypothyroidism,NCT01801033,Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism,https://clinicaltrials.gov/study/NCT01801033,NO,Hypothyroidism|Thyroidectomy,,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Francesco S Celi, M.D. , National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)"
Hypothyroidism,NCT02399475,Mechanistic Study of Subclinical Hypothyroidism In the Elderly,https://clinicaltrials.gov/study/NCT02399475,YES,Subclinical Hypothyroidism,DRUG: Levothyroxine|DRUG: Liothyronine|DRUG: Thyrotropin-Releasing Hormone,ALL,OLDER_ADULT,,"University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States","Principal Investigator : Anne R Cappola, MD, ScM , The University of Pennsylvania"
Hypothyroidism,NCT00962221,Lipids Profile in Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT00962221,NO,Subclinical Hypothyroidism,PROCEDURE: laboratory analysis,ALL,"ADULT, OLDER_ADULT",,"Endocrine Institute, Haemek Medical Center, Afula, 18101, Israel","Study Director : Rafael Luboshitzky, MD , Endocrine Institute, Haemek Medical Center, Afula, Israel Study Chair : Manfredi Rizzo, MD , University of Palermo Study Chair : Giatgen Spinas, MD , University of Zurich Study Chair : Kaspar Berneis, MD , University of Zurich"
Hypothyroidism,NCT02689609,Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma,https://clinicaltrials.gov/study/NCT02689609,NO,Hypothyroidism|Complications,RADIATION: Intensity-modulated radiation therapy,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Victor HF Lee, MD , The University of Hong Kong"
Hypothyroidism,NCT02374593,Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism,https://clinicaltrials.gov/study/NCT02374593,YES,Congenital Hypothyroidism,DRUG: Levothyroxine|DEVICE: Ultrasound,ALL,CHILD,,"Riley Hospital for Children, Indianapolis, Indiana, 46202, United States","Principal Investigator : Erica Eugster, MD , Indiana University"
Hypothyroidism,NCT01660126,Thyroid Hormone Replacement for Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT01660126,NO,Subclinical Hypothyroidism,DRUG: Levothyroxine|DRUG: Placebo,ALL,OLDER_ADULT,PHASE4,"Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, Glasgow, G31 2ER, United Kingdom",
Hypothyroidism,NCT05019118,Dietary Intervention With Ãšnicla Dairy Products (DANTIAN),https://clinicaltrials.gov/study/NCT05019118,NO,Subclinical Hypothyroidism,OTHER: Experimental milk|OTHER: Experimental yogur|OTHER: Experimental fresh cheese|OTHER: Placebo milk|OTHER: Placebo yogur|OTHER: Placebo fresh cheese,FEMALE,"ADULT, OLDER_ADULT",,"Nursing University School of Ourense, Ourense, 32005, Spain","Principal Investigator : Maria Reyes PÃ©rez- FernÃ¡ndez, PhD , Galicia sur sanitary research institute"
Hypothyroidism,NCT02005250,Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism,https://clinicaltrials.gov/study/NCT02005250,YES,Hyperthyroidism|Hypothyroidism,,FEMALE,"ADULT, OLDER_ADULT",,"Odense University Hospital, Odense, 5000, Denmark","Principal Investigator : Steen Bonnema, phd, DMsci , Odense University Hospital"
Hypothyroidism,NCT00493103,TG Gene Mutations and Congenital Hypothyroidism,https://clinicaltrials.gov/study/NCT00493103,NO,Congenital Hypothyroidism,,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Principal Investigator : Viviane Pardo , University of SÃ£o Paulo Study Director : Geraldo Medeiros-Neto , University of SÃ£o Paulo"
Hypothyroidism,NCT04734457,Final Height in Patients With CH Diagnosed by the Screening,https://clinicaltrials.gov/study/NCT04734457,NO,Congenital Hypothyroidism,DRUG: Levothyroxin,ALL,"CHILD, ADULT, OLDER_ADULT",,"Ain Shams University, Cairo, Abbasiya, 1181, Egypt","Study Director : Wessam Mouharram, PhD , Ain Shams University Study Director : Rana Mahmoud, PhD , Ain Shams University"
Hypothyroidism,NCT01916018,Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis.,https://clinicaltrials.gov/study/NCT01916018,NO,Congenital Hypothyroidism,OTHER: Clinical and radiologic exams and blood samples,ALL,"CHILD, ADULT, OLDER_ADULT",,"Pediatric endocrinology gynecology and diabetology, HÃ´pital Necker Enfants Malades, Assistance Publique - HÃ´pitaux de Paris , UniversitÃ© Paris Descartes, INSERM unit U 845, Paris, 75015, France",Assistance Publique - HÃ´pitaux de Paris
Hypothyroidism,NCT01739972,Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment,https://clinicaltrials.gov/study/NCT01739972,NO,Primary Hypothyroidism.,DRUG: Levothyroxine|DRUG: Desiccated thyroid extract,ALL,"ADULT, OLDER_ADULT",,"Walter Reed National Military Medical Center, Endocrinology, Bethesda, Maryland, 20889-5600, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, 20889-5600, United States",Walter Reed National Military Medical Center
Hypothyroidism,NCT05733078,Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism,https://clinicaltrials.gov/study/NCT05733078,NO,Hypothyroidism|Primary Hypothyroidism|Vitamin C Deficiency,DRUG: Vitamin C|DRUG: Oral Rehydration Salt Formulations,ALL,"ADULT, OLDER_ADULT",PHASE2,"Internal Medicine, College of Medicine and Health Sciences, Al Ain, Abu Dhabi, 15551, United Arab Emirates","Principal Investigator : Adnan Agha , United Arab Emirates University"
Hypothyroidism,NCT03102177,"Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics",https://clinicaltrials.gov/study/NCT03102177,NO,Hypothyroidism Primary,DRUG: Administration of stable Isotope labeled levothyroxine,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,,Georgetown University
Hypothyroidism,NCT00921050,Subclinical Hypothyroidism and Mind in the Elderly,https://clinicaltrials.gov/study/NCT00921050,NO,Subclinical Hypothyroidism,DRUG: levothyroxine sodium|DRUG: excipient without levothyroxine (placebo),ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Endocrinology, Outpatient Hospital Clinic, Monterrey, Nuevo Leon, 64460, Mexico|Community Health Center (Fomerrey 19), Monterrey, Nuevo Leon, Mexico","Principal Investigator : Lilia Cardenas-Ibarra, M.D. , Endocrinology, University Hospital, Universidad Autonoma de Nuevo Leon Study Chair : Jesus Z Villarreal-Perez, M.D. , Endocrinology, University Hospital, Universidad Autonoma de Nuevo Leon"
Hypothyroidism,NCT03496363,Hypothyroidism With Congenital Heart Disease (CHD),https://clinicaltrials.gov/study/NCT03496363,NO,Hypothyroidism|CHD,"DIAGNOSTIC_TEST: TSH , T4",ALL,CHILD,,,Assiut University
Hypothyroidism,NCT04806269,Biosignals by Wearables in Thyroid Dysfunction,https://clinicaltrials.gov/study/NCT04806269,NO,Thyrotoxicosis|Hypothyroidism,DEVICE: Fitbit and Glandy,ALL,ADULT,,"Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea, Republic of",
Hypothyroidism,NCT00230802,Thyroid Hormone Dose Adjustment in Pregnancy,https://clinicaltrials.gov/study/NCT00230802,YES,Pregnancy|Hypothyroidism,DRUG: Anticipatory dose increase of levothyroxine|DRUG: levothyroxine|DRUG: levothyroxine,FEMALE,"CHILD, ADULT, OLDER_ADULT",,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States","Principal Investigator : Erik Alexander, MD , Brigham and Women's Hospital"
Hypothyroidism,NCT00498238,The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT00498238,NO,Subclinical Hypothyroidism,DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Ronit Koren, MD , Department of Internal Medicine A , Research & Development unit Assaf Harofeh Medical Center, Zerifin, affiliated to Sackler School of Medicine,"
Hypothyroidism,NCT04988802,The Effect of Dietary Supplements for Pregnant Women on Levothyroxine Absorption,https://clinicaltrials.gov/study/NCT04988802,NO,Hypothyroidism Primary,DIETARY_SUPPLEMENT: Prenatal Nutrients Solgar|OTHER: Placebo,FEMALE,"ADULT, OLDER_ADULT",,"Dubrava University Hospital, Zagreb, Grad Zagreb, 10000, Croatia",University Hospital Dubrava
Hypothyroidism,NCT04648722,Higher Levothyroxine Requirements After Right-side Hemithyroidectomy,https://clinicaltrials.gov/study/NCT04648722,NO,Hemithyroidectomy|Hypothyroidism,PROCEDURE: Hemithyroidectomy,ALL,"ADULT, OLDER_ADULT",,"Medical University of Vienna, Vienna, 1090, Austria","Principal Investigator : Lana Kosi-Trebotic , Medical University of Vienna"
Hypothyroidism,NCT04767763,Thyroid Function in Critically Ill Patients With Acute Kidney Injury,https://clinicaltrials.gov/study/NCT04767763,NO,Secondary Hypothyroidism,"DIAGNOSTIC_TEST: Assessment of TSH, fT3, fT4,TRH, TT3, TT4, rT3 in patients with CVVHDF",ALL,"CHILD, ADULT, OLDER_ADULT",,"Medical University of Gdansk - Departament of Anesthesiology and Intensive Care, GdaÅ„sk, Pomorskie, 80-214, Poland",Medical University of Gdansk
Hypothyroidism,NCT01838031,Thyroid Screening Protocol During Pregnancy: a Multi-center Prospective Controlled Study,https://clinicaltrials.gov/study/NCT01838031,NO,Subclinical Hypothyroidism,OTHER: thyroid screening,FEMALE,ADULT,,"Peking Union Medical College Hospital, Beijing, Beijing, 100730, China","Study Director : Liangkun Ma, MD , Peking Union Medical College Hospital"
Hypothyroidism,NCT03094416,Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors,https://clinicaltrials.gov/study/NCT03094416,YES,Hypothyroidism;Postablative,DRUG: levothyroxine sodium capsule|DRUG: Proton pump inhibitor (PPI)|DRUG: Levothyroxine Sodium (LT4) Tablets,ALL,"ADULT, OLDER_ADULT",PHASE4,"California Head and Neck Specialists, La Jolla, California, 92037, United States|Coastal Metabolic Research Centre, Ventura, California, 93003, United States|Washington Hospital Center, Washington, District of Columbia, 20010-2975, United States|MedStar Union Memorial Hospital, Baltimore, Maryland, 21218, United States|NYC Health + Hospitals/ Queens, New York, New York, 11432, United States|Diabetes & Endocrinology Consultants, PC, Morehead City, North Carolina, 28557, United States|Carolina Ear Nose and Throat Clinic, Orangeburg, South Carolina, 29118, United States|Virginia Commonwealth University, Richmond, Virginia, 23298, United States|Stonesifer Endocrine Care & Clinical Research Inc., PS, Federal Way, Washington, 98003, United States","Principal Investigator : Kenneth D Burman, MD , Medstar Health Research Institute"
Hypothyroidism,NCT01145040,NOMOTHETICOS: Nonlinear Modelling of Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed Open-loop Situation,https://clinicaltrials.gov/study/NCT01145040,NO,Hypothyroidism|Hyperthyroidism,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Klinikum Ludwigsburg-Bietigheim, Bietigheim, BW, D-74321, Germany|Institute for diagnostical radiology, interventional radiology and nuclear medicine, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, NRW, D-44789, Germany|Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, NRW, D-44789, Germany","Principal Investigator : Johannes W Dietrich, M.D. , Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum Study Chair : Harald H Klein, M.D. , Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum Study Director : Johannes W Dietrich, M.D. , Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum Principal Investigator : Bojana Bazika-Gerasch, M.D. , Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum"
Hypothyroidism,NCT01204359,The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions,https://clinicaltrials.gov/study/NCT01204359,NO,Hypothyroidism|Exophthalmos,RADIATION: Iodine 131,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, 510120, China|Ningyi Jiang, Guangzhou, China","Principal Investigator : SUN YAT-SEN UNIVERSITY ningyi jiang, professor , Sun Yat-sen University"
Hypothyroidism,NCT01379170,Thyroid Study Type 2 Diabetes Mellitus (T2DM),https://clinicaltrials.gov/study/NCT01379170,NO,Diabetes|Hypothyroidism,DRUG: Euthyrox (levothyroxine),ALL,"ADULT, OLDER_ADULT",PHASE4,"Maastricht University Medical Centre, Maastricht, Limburg, 6200MD, Netherlands",Maastricht University Medical Center
Hypothyroidism,NCT06096454,Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance,https://clinicaltrials.gov/study/NCT06096454,NO,Hypothyroidism|Insulin Resistance,DRUG: Metformin,ALL,"ADULT, OLDER_ADULT",PHASE4,,"Principal Investigator : Mohammad HM AbdEllah-Alawi, MD , Assiut University"
Hypothyroidism,NCT02512978,Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI),https://clinicaltrials.gov/study/NCT02512978,NO,Myocardial Infarction|Hypothyroidism,DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE4,"Fuwai Cardiovascular Hospital, Beijing, 100037, China",
Hypothyroidism,NCT04354896,The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT04354896,NO,Subclinical Hypothyroidism|Sarcopenia,DRUG: Levothyroxin|DRUG: Placebo,ALL,OLDER_ADULT,PHASE4,"Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, Netherlands|Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands|Institute for Evidence-Based Medicine in Old Age, Leiden, Netherlands|Department of General Internal Medicine, Lausanne, Vaud, 1011, Switzerland|Clinic for General Internal Medicine, Bern University Hospital Bern, Bern, 3010, Switzerland","Principal Investigator : Nicolas Rodondi, MD MAS , BIHAM UniBern"
Hypothyroidism,NCT03178253,Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT03178253,NO,Hypothyroidism in Diabetes,,ALL,"ADULT, OLDER_ADULT",,"Maria Hamdy, Assuit, Egypt",Assiut University
Hypothyroidism,NCT00488644,Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors,https://clinicaltrials.gov/study/NCT00488644,YES,Hypothyroidism|Brain Tumor,DRUG: Levothyroxine|DRUG: Liothyronine,ALL,"ADULT, OLDER_ADULT",,"UT MD Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : Victor Levin, MD , M.D. Anderson Cancer Center"
Hypothyroidism,NCT01853579,The TRUST Study - Depression Substudy,https://clinicaltrials.gov/study/NCT01853579,NO,Subclinical Hypothyroidism|Depression,DRUG: Levothyroxine|DRUG: Placebo,ALL,OLDER_ADULT,PHASE4,"Leiden University Medical Center, Leiden, 2300, Netherlands|Department of General Internal Medicine, Lausanne, Vaud, 1011, Switzerland|University Clinic for General Internal Medicine, Bern University Hospital, Bern, 3010, Switzerland",
Hypothyroidism,NCT00001730,Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.,https://clinicaltrials.gov/study/NCT00001730,NO,Hypothyroidism|Thyroid Neoplasms,DRUG: Thyrogen,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, 20892, United States",National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hypothyroidism,NCT04747275,Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients,https://clinicaltrials.gov/study/NCT04747275,YES,Hypothyroidism|Trisomy 21,DRUG: Liquid stable levothyroxine (L-T4) Tirosint-SOL|DRUG: Oral tablet levothyroxine (L-T4),ALL,CHILD,PHASE4,"Children's Mercy Hospital, Kansas City, Missouri, 64108, United States",Children's Mercy Hospital Kansas City
Hypothyroidism,NCT03120221,Iodine Status in Pregnant Women in Israel,https://clinicaltrials.gov/study/NCT03120221,NO,Iodine-Deficiency; Hypothyroidism,DIAGNOSTIC_TEST: Urine sample for iodine measurement,FEMALE,ADULT,,"Women Health Service, Ashdod, Israel|Women Health Center, Tel Aviv, Israel",
Hypothyroidism,NCT05760131,Awareness of Osteoporosis in Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT05760131,NO,Hypothyroidism|Osteoporosis|Osteoporosis Risk,OTHER: Patient Participation Form,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Mustafa H Temel, M.D. , Uskudar State Hospital"
Hypothyroidism,NCT02499471,Brown Adipose Tissue Activity and Thyroid Hormone,https://clinicaltrials.gov/study/NCT02499471,NO,Hypothyroidism|Hyperthyroidism|Obesity,OTHER: Levothyroxine therapy (137.75 Â± 23.75 Î¼g/day),ALL,"ADULT, OLDER_ADULT",,"Maastricht UMC, Maastricht, Limburg, 6229HX, Netherlands","Principal Investigator : Wouter van Marken Lichtenbelt, Professor , Maastricht University Medical Center"
Hypothyroidism,NCT01707056,The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma,https://clinicaltrials.gov/study/NCT01707056,NO,Thyroid Carcinoma|Hypothyroidism,OTHER: Black Coffee|OTHER: Coffee with Milk|OTHER: Black Tea|OTHER: Water,ALL,ADULT,,"Georgetown University Hospital, Washington, District of Columbia, 20007, United States|Washington Hospital Center, Washington, District of Columbia, 20010, United States|MedStar St. Mary's Hospital, Leonardtown, Maryland, 20650, United States","Principal Investigator : Dorota Krajewski, MD , Medstar"
Hypothyroidism,NCT06408909,Pharmacist Role in Thyroid Disorders,https://clinicaltrials.gov/study/NCT06408909,NO,Hypothyroidism|Hyperthyroidism|Thyroid Diseases,BEHAVIORAL: Clinical Pharmacist Intervention Group,ALL,"ADULT, OLDER_ADULT",,"Marmara University, Istanbul, 34854, Turkey",Prof. Dr. Cemil TascÄ±oglu Education and Research Hospital Organization Marmara University
Hypothyroidism,NCT05247476,Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.,https://clinicaltrials.gov/study/NCT05247476,NO,"Thyroid Cancer, Papillary|Hypothyroidism",DRUG: L-T4|DRUG: L-T4+T3 (thyroid tablet),ALL,"ADULT, OLDER_ADULT",PHASE4,"Yan Ling, Xiamen, Fujian, 361004, China","Study Director : Yilin Zhao , Zhongshan Hospital Xiamen University"
Hypothyroidism,NCT03096613,Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF),https://clinicaltrials.gov/study/NCT03096613,NO,Heart Failure|Subclinical Hypothyroidism,DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE4,"Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing, Beijing, 100037, China","Principal Investigator : Yi-Da Tang, MD, PhD , Chinese Academy of Medical Sciences, Fuwai Hospital"
Hypothyroidism,NCT02548715,Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery,https://clinicaltrials.gov/study/NCT02548715,NO,Hypothyroidism|Neoplasms|Postoperative Complications,DRUG: Levothyroxine|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,,University of Alberta
Hypothyroidism,NCT00360074,Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation,https://clinicaltrials.gov/study/NCT00360074,NO,Secondary Hypothyroidism|Hypopituitarism|Hyperlipidemias,"DRUG: Thyroxin, Triiodothyronine",ALL,"ADULT, OLDER_ADULT",PHASE4,"University Hospital Freiburg, Department of Medicine, Freiburg, Baden-WÃ¼rttemberg, 79104, Germany",
Hypothyroidism,NCT01358136,ThyrOp: A Study of Individual Subclinical Hypothyroidism After Hemithyroidectomy for Benign Nontoxic Goiter,https://clinicaltrials.gov/study/NCT01358136,NO,Goiter|Hypothyroidism|Weight Gain,,ALL,"ADULT, OLDER_ADULT",,"Slagelse Hospital, Hospital South, Slagelse, Region Zealand, 4200, Denmark","Denmark:Department of Otorhinolaryngology Slagelse Hospital, Hospital South Region Zealand"
Hypothyroidism,NCT01832753,Treatment Trial of Subclinical Hypothyroidism in Down Syndrome,https://clinicaltrials.gov/study/NCT01832753,YES,Down Syndrome|Subclinical Hypothyroidism,DRUG: Levothyroxine,ALL,"CHILD, ADULT",,"Children's National Medical Center, Washington, District of Columbia, 20010, United States|The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States","Principal Investigator : Andrea Kelly, MD, MSCE , Children's Hospital of Philadelphia"
Hypothyroidism,NCT01223638,The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism,https://clinicaltrials.gov/study/NCT01223638,NO,Congenital Hypothyroidism|Hearing Loss,OTHER: Audiometry,ALL,"CHILD, ADULT",,"Ha'Emek Medical Center, Afula, 18101, Israel","HaEmek Medical Center, Israel"
Hypothyroidism,NCT00388297,Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy,https://clinicaltrials.gov/study/NCT00388297,YES,Subclinical Hypothyroidism|Hypothyroxinemia|Pregnancy,DRUG: Levothyroxine|DRUG: Placebo for Levothyroxine,FEMALE,"CHILD, ADULT, OLDER_ADULT",PHASE3,"University of Alabama - Birmingham, Birmingham, Alabama, 35249, United States|Northwestern University, Chicago, Illinois, 60611, United States|Wayne State University, Detroit, Michigan, 48201, United States|Columbia University, New York, New York, 10032, United States|University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, 27599, United States|Case Western University, Cleveland, Ohio, 44109, United States|Ohio State University, Columbus, Ohio, 43210, United States|Oregon Health & Sciences University, Portland, Oregon, 97239, United States|University of Pittsburgh Magee Womens Hospital, Pittsburgh, Pennsylvania, 15213, United States|Brown University, Providence, Rhode Island, 02905, United States|University of Texas - Southwest, Dallas, Texas, 75235, United States|University of Texas Medical Branch - Galveston, Galveston, Texas, 77555, United States|University of Texas-Houston, Houston, Texas, 77030, United States|University of Utah Medical Center, Salt Lake City, Utah, 84132, United States","Study Chair : Brian Casey, MD , University of Texas Southwestern Medical Center Study Director : Menachem Miodovnik, MD , NICHD Project Scientist"
Hypothyroidism,NCT06455371,Patient-centered Dosage of Levothyroxine,https://clinicaltrials.gov/study/NCT06455371,NO,Hypothyroidism|Thyroid Cancer|Thyroid,OTHER: Decision support tool,ALL,"ADULT, OLDER_ADULT",,,SINTEF Health Research Helseapps Norinnova Helse Nord
Hypothyroidism,NCT03612908,TSHÎ²X1 and D2 THR92ALA in Pregnancy,https://clinicaltrials.gov/study/NCT03612908,NO,Pregnancy Related|Hypothyroidism|Hyperthyroidism,,FEMALE,ADULT,,"Materno-Perinatal Hospital ""MÃ³nica Pretelini"", Toluca, 50130, Mexico","Principal Investigator : Mendieta ZerÃ³n , Hospital Materno-Perinatal ""MÃ³nica Pretelini SÃ¡enz""."
Hypothyroidism,NCT03712683,Thyroxin in Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT03712683,NO,Sub Clinical Hypothyroidism|Pregnancy Loss,DRUG: Thyroxine,FEMALE,ADULT,,,"Principal Investigator : Ariana Kh. Jawad, CABOG , Hawler Medical University"
Hypothyroidism,NCT05240911,Individual Dosing of Levothyroxine After Thyroidectomy,https://clinicaltrials.gov/study/NCT05240911,NO,Thyroid Neoplasms|Hypothyroidism|Surgery,DRUG: Levothyroxine Sodium Tablets,ALL,"ADULT, OLDER_ADULT",,"Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China",
Hypothyroidism,NCT06276205,Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism,https://clinicaltrials.gov/study/NCT06276205,NO,Hypothyroidism Primary|Lipid Disorder|Dyslipidemias,DRUG: Vitamin D|DRUG: Levothyroxin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"King Edward Medical University, Lahore, Punjab, 54000, Pakistan",
Hypothyroidism,NCT05385029,Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19,https://clinicaltrials.gov/study/NCT05385029,NO,Thyroid Dysfunction|Hypothyroidism|Hyperthyroidism,DRUG: Thyroxine,,"CHILD, ADULT, OLDER_ADULT",,"Security Forces Hospital, Riyadh, Central, 11481, Saudi Arabia",OMER B ABDELBASIT
Hypothyroidism,NCT01985204,Iodine Supplementation in Obesity,https://clinicaltrials.gov/study/NCT01985204,NO,Iodine Deficiency|Subclinical Hypothyroidism,DIETARY_SUPPLEMENT: Iodine tablet|DIETARY_SUPPLEMENT: Placebo tablet,FEMALE,ADULT,,"Universite Caddi Ayad, Faculte de Medecine et de Pharmacie, Marrakech, Morocco|University Cadi Ayyad, Faculte des Sciences, Marrakech, Morocco",
Hypothyroidism,NCT02946918,Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy,https://clinicaltrials.gov/study/NCT02946918,YES,Thyroid Cancer|Postsurgical Hypothyroidism,DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States","Principal Investigator : Alex Tessnow, MD , University of Texas Southwestern Medical Center"
Hypothyroidism,NCT04528225,A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer,https://clinicaltrials.gov/study/NCT04528225,NO,Breast Neoplasms|Hypothyroidism|Radiation Toxicity,,FEMALE,"ADULT, OLDER_ADULT",,"Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, 100021, China","Principal Investigator : Shu-lian Wang, M.D. , Cancer Institute and Hospital, Chinese Academy of Medical Sciences"
Hypothyroidism,NCT00336102,Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers,https://clinicaltrials.gov/study/NCT00336102,NO,Breast Cancer|Fatigue|Hypothyroidism,OTHER: physiologic testing|PROCEDURE: fatigue assessment and management|PROCEDURE: management of therapy complications,FEMALE,"ADULT, OLDER_ADULT",,"CCOP - Western Regional, Arizona, Phoenix, Arizona, 85006-2726, United States|North Colorado Medical Center, Greeley, Colorado, 80631-5199, United States|McKee Medical Center, Loveland, Colorado, 80538, United States|Cancer Centers of Central Florida, PA, Leesburg, Florida, 34788, United States|H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, 33612-9497, United States|Northeast Georgia Cancer Care, LLC - Medical Oncology, Athens, Georgia, 30607, United States|Medical College of Georgia Cancer Center, Augusta, Georgia, 30912-3500, United States|MBCCOP - Medical College of Georgia Cancer Center, Augusta, Georgia, 30912-4000, United States|Saint Anthony's Hospital at Saint Anthony's Health Center, Alton, Illinois, 62002, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, 62864, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, 70112, United States|Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport, Louisiana, 71130-3932, United States|CCOP - Beaumont, Royal Oak, Michigan, 48073-6769, United States|William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, 48073, United States|William Beaumont Hospital - Troy Campus, Troy, Michigan, 48085, United States|MeritCare Bemidji, Bemidji, Minnesota, 56601, United States|Southeast Cancer Center, Cape Girardeau, Missouri, 63701, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|David C. Pratt Cancer Center at St. John's Mercy, Saint Louis, Missouri, 63141, United States|St. John's Regional Health Center, Springfield, Missouri, 65804-2263, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, 65804, United States|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, 65807, United States|CCOP - St. Louis-Cape Girardeau, St. Louis, Missouri, 63141, United States|Newark Beth Israel Medical Center, Newark, New Jersey, 07112, United States|MBCCOP - Our Lady of Mercy Comprehensive Cancer Center, Bronx, New York, 10466, United States|Our Lady of Mercy Medical Center Comprehensive Cancer Center, Bronx, New York, 10466, United States|Mission Hospitals - Memorial Campus, Asheville, North Carolina, 28801, United States|Rutherford Internal Medicine Associates, PA, Forest City, North Carolina, 28043, United States|CCOP - Southeast Cancer Control Consortium, Goldsboro, North Carolina, 27534-9479, United States|Southeastern Medical Oncology Center - Goldsboro, Goldsboro, North Carolina, 27534, United States|Moses Cone Regional Cancer Center at Wesley Long Community Hospital, Greensboro, North Carolina, 27403-1198, United States|Pardee Memorial Hospital, Hendersonville, North Carolina, 28791, United States|Iredell Memorial Hospital, Statesville, North Carolina, 28687-1828, United States|Southeastern Medical Oncology Center - Wilson, Wilson, North Carolina, 27893, United States|Forsyth Regional Cancer Center at Forsyth Medical Center, Winston-Salem, North Carolina, 27103, United States|CCOP - MeritCare Hospital, Fargo, North Dakota, 58122, United States|Roger Maris Cancer Center at MeritCare Hospital, Fargo, North Dakota, 58122, United States|AnMed Cancer Center, Anderson, South Carolina, 29621, United States|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, 29303, United States|CCOP - Scott and White Hospital, Temple, Texas, 76508, United States|Scott and White Cancer Institute, Temple, Texas, 76508, United States",
Hypothyroidism,NCT00001159,Natural History of Thyroid Function Disorders,https://clinicaltrials.gov/study/NCT00001159,NO,Hyperthyroidism|Hypothyroidism|Grave's Disease,,ALL,"CHILD, ADULT, OLDER_ADULT",,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States","Principal Investigator : Sriram M Gubbi, M.D. , National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)"
Hypothyroidism,NCT02824016,Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation,https://clinicaltrials.gov/study/NCT02824016,NO,Irradiation; Adverse Effect|Irradiation Hypothyroidism,BIOLOGICAL: biological sample|RADIATION: supraclavicular irradiation,FEMALE,"ADULT, OLDER_ADULT",,"Institut Jean Godinot, Reims, 51100, France|Centre Paul Strauss, Strasbourg, 67000, France|Institut de Cancerologie de Lorraine, Vandoeuvre-les-nancy, 54519, France","Study Director : Yacine MERROUCHE, MD , Institut Jean-Godinot"
Hypothyroidism,NCT06112886,Identification of Important Symptoms and Diagnostic Hypothyroidism Patients Using Machine Learning Algorithms,https://clinicaltrials.gov/study/NCT06112886,NO,Prediction Hypothyroidism Patients Using Machine Learning Algorithms|Identification of Important Symptoms of Hypothyroidism,OTHER: There was no intervention in this study,ALL,"ADULT, OLDER_ADULT",,"Faculty of Health, Kerman University of Medical Sciences, Kerman, 7616913555, Iran, Islamic Republic of",Kerman University of Medical Sciences
Hypothyroidism,NCT00535561,Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT00535561,NO,Iron Deficiency Anemia|Subclinical Hypothyroidism,"DRUG: Ferrous sulfate tablets 325 mg, po, TID|DRUG: Ferrous sulfate plus levothyroxine",ALL,"ADULT, OLDER_ADULT",PHASE1,"Duzce University School of Medicine, Duzce, 81620, Turkey","Study Director : Hakan Cinemre, Assit. Prof. , Duzce University School of Medicine"
Hypothyroidism,NCT00505479,Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy?,https://clinicaltrials.gov/study/NCT00505479,NO,Congenital Hypothyroidism|Pregnancy|Iodine Deficiency,,FEMALE,ADULT,,"Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China","Study Director : zhengyan Zhao, M.D. , Children's Hospital Zhejiang University School of Medicine"
Hypothyroidism,NCT05975866,"The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato",https://clinicaltrials.gov/study/NCT05975866,NO,Thyroid Diseases|Hypothyroidism|Hashimoto Disease,DIETARY_SUPPLEMENT: curcumin|BEHAVIORAL: Anti-inflammatory diet,ALL,"ADULT, OLDER_ADULT",,"Golbon Sohrab, Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of",National Nutrition and Food Technology Institute
Hypothyroidism,NCT05581147,Thyroid Function and Structure IN Klinefelter Syndrome,https://clinicaltrials.gov/study/NCT05581147,NO,"Klinefelter Syndrome|Thyroiditis, Autoimmune|Hypothyroidism",,MALE,"CHILD, ADULT, OLDER_ADULT",,"Sapienza' University of Rome, Roma, 00161, Italy","Principal Investigator : Andrea M Isidori, MD, PhD , andrea.isidori@uniroma1.it"
Hypothyroidism,NCT05804149,Effect of Acupuncture and Low Caloric Diet on Primary Hypothyroidism and Irregular Menstruation in Infertile Women,https://clinicaltrials.gov/study/NCT05804149,NO,Primary Hypothyroidism|Acupuncture|Irregular Menstruation|PCO,DEVICE: acupuncture|DRUG: Thyroxine|DIETARY_SUPPLEMENT: low caloric diet,FEMALE,ADULT,PHASE2,"Eman Sedky, Cairo, Maadi, 002, Egypt",Cairo University
Hypothyroidism,NCT06268600,The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma,https://clinicaltrials.gov/study/NCT06268600,NO,Nasopharyngeal Carcinoma|Nasopharyngeal Cancer|Hypothyroidism,RADIATION: Modified neck target volume delineation,ALL,"ADULT, OLDER_ADULT",,"Department of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital, Nanchang, None Selected, 330029, China",Jiangxi Provincial Cancer Hospital
Hypothyroidism,NCT04782856,Energy Metabolism in Thyroidectomized Patients,https://clinicaltrials.gov/study/NCT04782856,YES,Thyroid Goiter|Hypothyroidism|Thyroid Cancer,DRUG: Levothyroxine|DRUG: Liothyronine|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Virginia Commonwealth University, Richmond, Virginia, 23298, United States",
Hypothyroidism,NCT01862510,Detection of Celiac Disease in Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT01862510,NO,Celiac Disease|Hypothyroidism|Celiac Sprue|Malabsorption,,ALL,"ADULT, OLDER_ADULT",,"Fletcher Allen Health Care, Burlington, Vermont, 05405, United States","Principal Investigator : Richard Zubarik, MD , University of Vermont"
Hypothyroidism,NCT03977207,A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients,https://clinicaltrials.gov/study/NCT03977207,NO,Thyroid; Functional Disturbance|Hypothyroidism|Hemodialysis,DRUG: Levothyroxine Sodium|DRUG: Placebos,ALL,"ADULT, OLDER_ADULT",,"University of California Irvine, Orange, California, 92868, United States",
Hypothyroidism,NCT03627611,Identification of Non-responders to Levothyroxine Therapy,https://clinicaltrials.gov/study/NCT03627611,NO,Hypothyroidism|Biomarkers|Endocrine System Diseases,DRUG: Levothyroxin|DRUG: Liothyronine,FEMALE,"ADULT, OLDER_ADULT",PHASE2,"Oslo University Hospital, Oslo, Norway","Principal Investigator : Erik Fink Eriksen, Professor , Department of Endocrinology, Morbid Obesity and Preventive Medicine"
Hypothyroidism,NCT03898622,Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.,https://clinicaltrials.gov/study/NCT03898622,NO,Chronic Kidney Diseases|Subclinical Hypothyroidism,DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE3,"Kidney health clinic, Civil Hospital of Guadalajara, Guadalajara, Jalisco, 44280, Mexico","Study Director : Jonathan Chavez , Hospital Civil de Guadalajara"
Hypothyroidism,NCT02307175,A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication,https://clinicaltrials.gov/study/NCT02307175,NO,Autoimmune Thyroid Disease|Congenital Hypothyroidism,,ALL,"ADULT, OLDER_ADULT",,"Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada","Principal Investigator : Eric Turcotte, MD , Centre de recherche du Centre hospitalier universitaire de Sherbrooke"
Hypothyroidism,NCT00147433,The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children,https://clinicaltrials.gov/study/NCT00147433,NO,Child Development Disorders|Pregnancy|Subclinical Hypothyroidism,,FEMALE,"CHILD, ADULT, OLDER_ADULT",,"Foundation for Blood Research, Scarborough, Maine, 04021, United States","Principal Investigator : Wendy Y. Craig, Ph.D. , Foundation for Blood Research"
Hypothyroidism,NCT00437931,Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction,https://clinicaltrials.gov/study/NCT00437931,NO,Subclinical Hypothyroidism|Hyperthyroidism|Thyroid Dysfunction,,ALL,"ADULT, OLDER_ADULT",,"Haemek Medical Center, Department of Radiology, Afula, 18101, Israel","Principal Investigator : Avraham Ishay, MD , Haemek Medical Center, Endocrine Institute, Afula, Israel Study Chair : Leonid Chervinsky , Haemek Medical Center, Department of Radiology, Afula , Israel Study Chair : Rafael Luboshitzky, MD , Haemek Medical Center, Endocrine Institute, Afula, Israel"
Hypothyroidism,NCT05813301,NAFLD in Patient of Hypothyroidism,https://clinicaltrials.gov/study/NCT05813301,NO,NAFLD,,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Study Director : wael ahmed abbas, prof , Assiut University Study Director : walaa anwer shehata, prof , Assiut University Principal Investigator : mena sawerss fathy, residant , Assiut University"
Hypothyroidism,NCT01574859,Central Hypothyroidism and Cardiovascular Risk,https://clinicaltrials.gov/study/NCT01574859,NO,Hypopituitarism,OTHER: levothyroxine,ALL,"CHILD, ADULT, OLDER_ADULT",,"Rigshospitalet, Copenhagen, 2100, Denmark","Principal Investigator : Ulla Feldt-Rasmussen, Professor , Rigshospitalet, Denmark"
Hypothyroidism,NCT01335802,Relation Between Subclinical Hypothyroidism and Outcome of Pregnancy,https://clinicaltrials.gov/study/NCT01335802,NO,"Abortion, Spontaneous|Pregnancy Complications|Subclinical Hypothyroidism",GENETIC,FEMALE,ADULT,,"Naestved Hospital, Naestved, 4700, Denmark","Principal Investigator : Jan Kvetny, MD, DMSc , Department of Internal Medicine & Faculty of Health Sciences, University of Copenhagen"
Hypothyroidism,NCT05782725,Subclinical Hypothyroidism and Normogonadotropic Anovulation,https://clinicaltrials.gov/study/NCT05782725,NO,Polycystic Ovary Syndrome|Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder),OTHER: Comparison of laboratory test results in women in the 4 study arms,FEMALE,ADULT,,"Jagiellonian University Medical College, Department of Gynecology and Obstetrics, Krakow, 31-501, Poland","Study Chair : Robert Jach, Prof. , Jagiellonian University"
Hypothyroidism,NCT01831869,Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT01831869,NO,Hypothyroidism|Thyroid Diseases|Endocrine System Diseases,DRUG: L-thyroxine,ALL,ADULT,PHASE4,"Shandong Provincial Hospital, Jinan, Shandong, 250021, China","Study Chair : Jiajun Zhao , Shandong Provincial Hospital"
Hypothyroidism,NCT01848171,Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism,https://clinicaltrials.gov/study/NCT01848171,NO,Hypothyroidism|Thyroid Diseases|Endocrine System Diseases,DRUG: L-thyroxine,ALL,"ADULT, OLDER_ADULT",PHASE4,"Shandong Provincial Hospital, Jinan, Shandong, 250021, China","Study Chair : Zhao jiajun , Shandong Province Hospital"
Hypothyroidism,NCT02316743,Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT02316743,NO,Systolic Heart Failure|Sub-clinical Hypothyroidism,DRUG: Levothyroxine supplementation,ALL,"ADULT, OLDER_ADULT",PHASE4,"Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, J1H 5N4, Canada","Study Director : Michel Nguyen, MD , Centre de recherche du Centre hospitalier universitaire de Sherbrooke"
Hypothyroidism,NCT05708456,The Effect of Mobile Application on Hypothyroid Patients,https://clinicaltrials.gov/study/NCT05708456,NO,Hypothyroidism|Symptom Management|Symptoms and Signs|Mobile Application|Digital Health,OTHER: Mobile application with symptom management,ALL,"ADULT, OLDER_ADULT",,"Seyma Trabzon, Sakarya, 54100, Turkey",Sakarya University
Hypothyroidism,NCT03614988,Evaluation of Evening Versus Morning Levothyroxine Intake in Elderly,https://clinicaltrials.gov/study/NCT03614988,NO,Aging|Primary Hypothyroidism|Interaction Drug Food,OTHER: Evening Levothyroxine Administration|OTHER: Morning Levothyroxine Administration,ALL,"ADULT, OLDER_ADULT",,"Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-903, Brazil","Principal Investigator : Renato Gorga Bandeira de Mello , Professor of the Post Graduate Program in Endocrinology at the Hospital de Clinicas de Porto Alegre"
Hypothyroidism,NCT00497575,Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT00497575,NO,Congenital Hypothyroidism|L-Thyroxine|Follow-Up,,ALL,CHILD,,,
Hypothyroidism,NCT06051279,Pattern of Congenital Hypothyroidism in Newborns.,https://clinicaltrials.gov/study/NCT06051279,NO,Pattern of CH,,ALL,CHILD,,,
Hypothyroidism,NCT06452823,Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization,https://clinicaltrials.gov/study/NCT06452823,NO,Atrial Fibrillation and Flutter|Hyperthyroidism|Hypothyroidism,PROCEDURE: Catheter Ablation,ALL,"ADULT, OLDER_ADULT",,"Cardiovascular Medicine Department of Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, 314000, China",The Second Affiliated Hospital of Jiaxing University
Hypothyroidism,NCT02280330,Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months,https://clinicaltrials.gov/study/NCT02280330,NO,Iodine Deficiency|Iodine Deficiency Disorder|Hypothyroidism,DIETARY_SUPPLEMENT: MNP group|OTHER: Placebo group,ALL,CHILD,PHASE4,"La Trinidad Benguet Day Care Centers, La Trinidad, Benguet, 2601, Philippines","Principal Investigator : Imelda O Degay , University of the Philippines Los Banos"
Hypothyroidism,NCT03754621,Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey,https://clinicaltrials.gov/study/NCT03754621,NO,Thyroid|Thyroid Dysfunction|Hypothyroidism|Pregnancy Early,DIAGNOSTIC_TEST: Serum thyroid functions tests,FEMALE,"ADULT, OLDER_ADULT",,"Bartin State Hospital, Bartin, Turkey",
Hypothyroidism,NCT06373523,MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin,https://clinicaltrials.gov/study/NCT06373523,NO,Hepatic Steato-Fibrosis|Non-Alcoholic Fatty Liver Disease,DRUG: Dapagliflozin 10mg Tab|DRUG: Placebo|DRUG: Levothyroxine Replacement daily,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"PGIMER, Chandigarh, Punjab, 160012, India","Principal Investigator : Ashu Rastogi, MD,DM , PGIMER, Chandigarh"
Hypothyroidism,NCT04682340,Analysis of BPA Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid Disease,https://clinicaltrials.gov/study/NCT04682340,NO,Hypothyroidism|Hyperthyroidism|Hashimoto Disease|Graves Disease,DIAGNOSTIC_TEST: Serum BPA,FEMALE,ADULT,,"Jagiellonian University Medical College, KrakÃ³w, Malopolska, 31-591, Poland",Jagiellonian University
Hypothyroidism,NCT06399796,Insulin Resistance in Relation to Hyperthyroidism and Hypothyroidism,https://clinicaltrials.gov/study/NCT06399796,NO,Insulin Resistance,,ALL,"ADULT, OLDER_ADULT",,,Assiut University
Hypothyroidism,NCT05842096,Subclinical Hypothyroidism and Chronic Inflammation in PCOS,https://clinicaltrials.gov/study/NCT05842096,NO,PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries|Subclinical hypothyroÃ¯dism|Hypothalamic-Pituitary-Gonadal Axis Dysfunction,"DIAGNOSTIC_TEST: Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms|DIAGNOSTIC_TEST: Evaluation of the impact of subclinical hypothyroidism, with present/ absent antithyroid antibodies, on the balance between anti- and pro-inflammatory factors in women in both study arms|DIAGNOSTIC_TEST: Assessment of the impact of imbalance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes on ovarian reserve indices",FEMALE,ADULT,,"Jagiellonian University Medical College, Department of Gynecology and Obstetrics, Krakow, 31-501, Poland|Jagiellonian University Medical College, Department of Gynecology and Obstetrics, KrakÃ³w, 31-501, Poland",
Hypothyroidism,NCT02190214,Thyroid Disorders in Malaysia: A Nationwide Multicentre Study,https://clinicaltrials.gov/study/NCT02190214,NO,Hypothyroidism|Subclinical Hypothyroidism|Hyperthyroidism|Subclinical Hyperthyroidism|Graves Disease|Hashimoto's Thyroiditis|Iodine Deficiency|Genetic Susceptibility,,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Nor Azmi Kamaruddin, MBBS, MMed , National University of Malaysia Principal Investigator : Norlela Sukor, MMed, Phd , National University of Malaysia Principal Investigator : Norhanita Othman , National University of Malaysia Principal Investigator : Johari Ali , University of Malaya Principal Investigator : Shirenee Vethakkan , University of Malaya Principal Investigator : Siew Kim Kwa , International Medical University Principal Investigator : Kuck Meng Chong, MD , Malaysian Endocrine and Metabolic Society Principal Investigator : Lecthuman Ramanathan , Malaysian Endocrine and Metabolic Society Principal Investigator : Hussein Zanariah , Malaysian Endocrine and Metabolic Society Principal Investigator : Nurain Mohd Noor , Malaysian Endocrine and Metabolic Society Principal Investigator : Norhaliza Mohd Ali , Malaysian Endocrine and Metabolic Society Principal Investigator : Norhayati Yahya , Malaysian Endocrine and Metabolic Society Principal Investigator : Nor Azizah Aziz , Malaysian Endocrine and Metabolic Society Show fewer investigators"
Hypothyroidism,NCT06272721,Hypothyroidism in Pregnancy and Neuropsychological Development in Children,https://clinicaltrials.gov/study/NCT06272721,NO,Thyroid Dysfunction|Pregnancy Related|Language Development,DIAGNOSTIC_TEST: Griffiths Scale,ALL,"CHILD, ADULT",,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, 00168, Italy",
Hypothyroidism,NCT04860622,Normal Range of TSH and FT4 in Pregnancy,https://clinicaltrials.gov/study/NCT04860622,NO,Hypothyroidism|Pregnancy Related|Thyroid|Dysfunction|Iodine Deficiency,DIAGNOSTIC_TEST: Serum thyroid function tests,FEMALE,ADULT,,"Sehit Prof Dr Ilhan Varank Sancaktepe Training and Research Hospital, Istanbul, Turkey",
Hypothyroidism,NCT06154382,Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit,https://clinicaltrials.gov/study/NCT06154382,NO,Thyroid; Functional Disturbance,DRUG: Eltroxin administration,ALL,"ADULT, OLDER_ADULT",,"Meir Medical Center, Kfar Saba, Israel",Meir Medical Center
Hypothyroidism,NCT06179368,Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome,https://clinicaltrials.gov/study/NCT06179368,NO,Hepatic Encephalopathy|Hepatic Impairment|Hypothyroidism|Hepatic Failure,DIAGNOSTIC_TEST: hypothroidism|DIAGNOSTIC_TEST: euothyroid,ALL,ADULT,,"Emad Zarief Kamel Said, Assiut, 71111, Egypt",Assiut University
Hypothyroidism,NCT05918497,Comparison Between Variable Time Regimen of Dosing L-Thyroxine for Treatment Hypothyroid Fasting Ramadan,https://clinicaltrials.gov/study/NCT05918497,NO,Different Regimens in Treatment of Hypothyroidism During Fasting in Ramadan,,ALL,ADULT,,"Sohag Faculty of Medicine, Sohag, Egypt",Sohag University
Hypothyroidism,NCT05643365,Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease,https://clinicaltrials.gov/study/NCT05643365,NO,Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients,RADIATION: Radioactive Iodine therapy,ALL,"CHILD, ADULT, OLDER_ADULT",,"Nuclear medicine unit, department of clinical oncology and nuclear medicine, Assiut university hospital, Assiut, Egypt","Study Director : Hemat A Mahmoud, M.D , Lecturer Study Chair : Hanan G Mostafa, M.D , Professor"
Hypothyroidism,NCT01528904,Maternal Autoimmune Thyroid Disease and Fetal Thyroxin,https://clinicaltrials.gov/study/NCT01528904,NO,Pregnancy Complicated by Hyperthyroidism|Hypothyroidism in Pregnancy,,FEMALE,ADULT,,"Clinic for Gynecology and Obstetrics, Belgrade, 11000, Serbia","Principal Investigator : Svetlana Spremovic-Radjenovic, MD PhD , Medical School of the University of Belgrade"
Hypothyroidism,NCT05803967,Baduanjin Exercising Effects on Sub-clinical Hypothyroidism and Cognitive Problems,https://clinicaltrials.gov/study/NCT05803967,NO,Subclinical hypothyroÃ¯dism|Cognitive Impairment,BEHAVIORAL: Baduanjin exercising,FEMALE,OLDER_ADULT,,"Cairo Unoversity, Giza, Egypt","Principal Investigator : Ali MA Ismail , Cairo University"
Hypothyroidism,NCT04270110,Assessment of Bone Mineral Density in Patients With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT04270110,NO,Subclinical hypothyroÃ¯dism,,ALL,"CHILD, ADULT",,"Assiut university Hospital, Assuit, 71511Assuit, Egypt",Assiut University
Hypothyroidism,NCT04124705,A Study of ArmourÂ® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants,https://clinicaltrials.gov/study/NCT04124705,YES,Hypothyroidism|Thyroid Disease|Euthyroid|Thyroid Gland|Thyroid Hormones,DRUG: ArmourÂ® Thyroid|DRUG: Levothyroxine,ALL,"ADULT, OLDER_ADULT",PHASE2,"Sponsor Site /ID# 237950, Birmingham, Alabama, 35205, United States|Sponsor Site /ID# 237986, Little Rock, Arkansas, 72209-7040, United States|Sponsor Site /ID# 235210, Greenbrae, California, 94904, United States|Sponsor Site /ID# 235716, Huntington Beach, California, 92648, United States|Sponsor Site /ID# 238120, Sacramento, California, 95821-2123, United States|Sponsor Site /ID# 238026, Santa Clarita, California, 91321, United States|Sponsor Site /ID# 238258, Van Nuys, California, 91405-3605, United States|Sponsor Site/ID# 235866, Denver, Colorado, 80246, United States|Sponsor Site /ID# 235853, Fort Lauderdale, Florida, 33312, United States|Sponsor Site /ID# 236809, West Palm Beach, Florida, 33401, United States|Sponsor Site /ID# 235032, Atlanta, Georgia, 30318, United States|Sponsor Site /ID# 237199, Columbus, Georgia, 31904, United States|Sponsor Site /ID# 238088, Lawrenceville, Georgia, 30046, United States|Sponsor Site /ID# 235714, Lexington, Kentucky, 40503, United States|Sponsor Site /ID# 236701, Louisville, Kentucky, 40213-1014, United States|Sponsor Site /ID# 235202, Asheville, North Carolina, 28803, United States|Sponsor Site/ID# 235204, Greenville, North Carolina, 27834, United States|Sponsor Site /ID# 238023, Hickory, North Carolina, 28601, United States|Sponsor Site /ID# 237137, Austin, Texas, 78731, United States|Sponsor Site/ID# 238071, Austin, Texas, 78749, United States|Sponsor Site/ID# 237652, Dallas, Texas, 75231, United States|Sponsor Site/ID# 237655, Dallas, Texas, 75231, United States|Sponsor Site /ID# 235870, El Paso, Texas, 79935, United States|Sponsor Site /ID# 235860, Round Rock, Texas, 78681, United States|Sponsor Site /ID# 235894, San Antonio, Texas, 78229, United States|Sponsor Site /ID# 235211, Renton, Washington, 98057, United States|Sponsor Site /ID# 236022, Spokane, Washington, 99202, United States|Sponsor Site/ID# 236977, Tacoma, Washington, 98405, United States",
Hypothyroidism,NCT03574051,the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism,https://clinicaltrials.gov/study/NCT03574051,NO,Microbiota,DRUG: Probiotic,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"First affiliated hospital of Harbin medical university, Harbin, Heilongjiang, 150001, China","Study Director : Yunwei Wei , First Affiliated Hospital of Harbin Medical University"
Hypothyroidism,NCT02017080,Fetal Thyroid Ultrasound And Fetal Thyroid Hormones,https://clinicaltrials.gov/study/NCT02017080,NO,Pregnancy Complicated by Hyperthyroidism|Hypothyroidism in Pregnancy,,FEMALE,ADULT,,"Clinic for Gynecology and Obstetrics , Clinical Center of Serbia, Belgrade, 11000, Serbia",
Hypothyroidism,NCT01488721,Clinical Evaluation of NeoPlex4 Assay and NeoPlex System,https://clinicaltrials.gov/study/NCT01488721,NO,"Adrenal Hyperplasia, Congenital|Congenital Hypothyroidism|Cystic Fibrosis",,ALL,CHILD,,"New York State Department of Health, Albany, New York, 12201, United States|Tennessee Department of Health, Nashville, Tennessee, 37243, United States|Unified State Laboratories: Public Health, Taylorsville, Utah, 84129, United States","Study Director : Dennis Smith, PhD , Luminex Corporation"
Hypothyroidism,NCT06135948,Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism,https://clinicaltrials.gov/study/NCT06135948,NO,L-thyroxine,"DRUG: Extra dose of L-thyroxine, 25 mcg during Ramadan",ALL,"ADULT, OLDER_ADULT",PHASE4,"Family Promotion Centre, Endocrinology Clinic, Sharjah, United Arab Emirates",
Hypothyroidism,NCT06377826,"Comparison of Aerobic and Resistance Training on Exercise Capacity, Depression and Quality of Life in Hypothyroidism.",https://clinicaltrials.gov/study/NCT06377826,NO,Comparison of Aerobic Exercise and Resistance Training,OTHER: aerobic exercises|OTHER: resistance training|DRUG: medication,ALL,ADULT,,"Abbottabad medical complex, AbbottÄbÄd, Khyber Pakhtunkhwa, 21300, Pakistan","Principal Investigator : saira jahan , Riphah International University"
Hypothyroidism,NCT02186405,Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT02186405,NO,Subclinical hypothyroÃ¯dism,DRUG: LEVOTHYROXINE,ALL,"ADULT, OLDER_ADULT",PHASE4,"Nephrology Department, Nice, 06202, France","Principal Investigator : Guillaume FAVRE, PhD , Centre Hospitalier Universitaire de Nice"
Hypothyroidism,NCT06036576,Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women,https://clinicaltrials.gov/study/NCT06036576,NO,Recurrent Early Pregnancy Loss|Thyroid Diseases,DRUG: Levothyroxine Pill,FEMALE,ADULT,PHASE3,"AL-Elwiyah Maternity Teaching Hospital, Baghdad, 10011, Iraq","Study Chair : Sarah Al-Musawi, C.A.B.O.G , Al-Kindy College of Medicine"
Hypothyroidism,NCT03115515,Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy,https://clinicaltrials.gov/study/NCT03115515,NO,Pregnancy Related|Thyroid,DRUG: levothyroxine,FEMALE,ADULT,,"Medstar Washington Hospital Center, Washington, District of Columbia, 20010, United States",Medstar Health Research Institute
Hypothyroidism,NCT04178928,Can Levothyroxine Treatment Reduce the Development of Cardio-metabolic Disorder in Subclinical Hypothyroidism?,https://clinicaltrials.gov/study/NCT04178928,NO,Subclinical hypothyroÃ¯dism,DRUG: Levothyroxine,ALL,CHILD,PHASE1|PHASE2,,Ain Shams University
Hypothyroidism,NCT02710799,Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List,https://clinicaltrials.gov/study/NCT02710799,NO,Diabetes Mellitus|Hypothyroidism|Hyperthyroidism|Goiter|Thyroid Nodule|Obesity,OTHER: Teleconsultation|OTHER: Protocol,ALL,"ADULT, OLDER_ADULT",,"Secretaria Estadual da SaÃºde, Porto Alegre, Rio Grande do Sul, 90110-150, Brazil","Study Chair : Erno Harzheim, MD , Hospital de ClÃ­nicas de Porto Alegre"
Hypothyroidism,NCT06353555,Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage,https://clinicaltrials.gov/study/NCT06353555,NO,Intracerebral Hemorrhage|Low T3 Syndrome|Neurocritical Care|Hormone Replacement Therapy,DRUG: Euthyrox|DRUG: Euthyrox,ALL,"ADULT, OLDER_ADULT",,"Peking union medical college hospital, Beijing, Beijing, 100730, China",Peking Union Medical College Hospital
Hypothyroidism,NCT06041204,Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT06041204,NO,PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries|Subclinical Hypothyroidism|Female Infertility,DRUG: Letrozole 2.5mg|DRUG: Levothyroxine 25 Mcg (0.025 Mg) Oral Tablet,FEMALE,ADULT,,"Al-Hussein University Hospital, Cairo, 11633, Egypt","Principal Investigator : Muhamed Alhagrasy, M.D. , Al-Azhar University"
Hypothyroidism,NCT04663451,An Assessment of the Occurrence of Hypothyroidism in Patients Treated With RAI for Hyperthyroidism.,https://clinicaltrials.gov/study/NCT04663451,NO,Nodule Solitary Thyroid|Toxic Multinodular Goiter|Radioactive Iodine-Induced Hypothyroidism,RADIATION: radioacive iodine therapy,ALL,"ADULT, OLDER_ADULT",,"Universitair Ziekenhuis Brussel, Brussels, 1090, Belgium","Principal Investigator : Corina Andreescu, Doctorate , Universitair Ziekenhuis Brussel"
Hypothyroidism,NCT03699098,The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up,https://clinicaltrials.gov/study/NCT03699098,NO,Head and Neck Cancer,"DIAGNOSTIC_TEST: TSH, T3, T4 and thyroid gland DVH",ALL,"ADULT, OLDER_ADULT",,"Department of clinical oncology and nuclear medicine, Cairo university, Cairo, 11311, Egypt",Cairo University
Hypothyroidism,NCT01950260,Early Levothyroxine Post Radioactive Iodine,https://clinicaltrials.gov/study/NCT01950260,YES,Graves' Disease,DRUG: Levothyroxine|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States","Principal Investigator : Marius Stan, MD , Mayo Clinic"
Hypothyroidism,NCT02500342,Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism,https://clinicaltrials.gov/study/NCT02500342,NO,Thyroid Dysfunction|Mental Fatigue|Fatigue,DRUG: Levothyroxine|DRUG: Placebo,ALL,OLDER_ADULT,PHASE4,"University College Cork, National University of Ireland, Cork, Cork, Ireland|Department of General Internal Medicine, Lausanne, Vaud, 1011, Switzerland|Clinic for General Internal Medicine, Bern University Hospital Bern, Bern, 3010, Switzerland","Principal Investigator : Nicolas Rodondi, MD MAS , Clinic for General Internal Medicine, Bern University Hospital Bern"
Hypothyroidism,NCT03372772,Effect of Levocarnitine Supplementation for the Management of Fatigue in Levothyroxine-Treated Hypothyroid Patients,https://clinicaltrials.gov/study/NCT03372772,NO,Patient Compliance,DRUG: Levocarnitine,ALL,ADULT,,"Phamacology Department, BSMMU, Dhaka, Shahbag, 1000, Bangladesh","Principal Investigator : Farjana Akhter, MBBS , Resident ,Phase-B"
Atopic Dermatitis,NCT06230991,A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema,https://clinicaltrials.gov/study/NCT06230991,NO,Atopic Eczema,DIETARY_SUPPLEMENT: SIM05,ALL,"ADULT, OLDER_ADULT",,"Prince of Wales Hospital, Hong Kong, Hong Kong",
Atopic Dermatitis,NCT05454722,A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.,https://clinicaltrials.gov/study/NCT05454722,NO,Atopic Eczema,DEVICE: ADEX Gel,ALL,CHILD,,"Cripps Health Centre, Nottingham, Nottinghamshire, United Kingdom|Atherstone Surgery, Atherstone, Warwickshire, CV9 1EU, United Kingdom",Dermal Laboratories Ltd
Atopic Dermatitis,NCT06453512,A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema,https://clinicaltrials.gov/study/NCT06453512,NO,Atopic Eczema,DEVICE: Doublebase Once,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Principal Investigator : Simon T Royal, BMedSci BM BS , Dermal Laboratories Ltd"
Atopic Dermatitis,NCT03143504,A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study,https://clinicaltrials.gov/study/NCT03143504,NO,Atopic Eczema,DIAGNOSTIC_TEST: Skin Testing for Atopic eczema,ALL,CHILD,,"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, South Yorkshire, S10 SJF, United Kingdom","Study Director : Simon G Danby, PhD, BSc , University of Sheffield"
Atopic Dermatitis,NCT02915146,Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema,https://clinicaltrials.gov/study/NCT02915146,NO,Atopic Eczema,RADIATION: combined ultraviolet phototherapy (NB-UVB + UVA1) vs. NB-UVB monotherapy,ALL,"CHILD, ADULT, OLDER_ADULT",,"Ninewells Hospital, Dundee, DD1 9SY, United Kingdom","Principal Investigator : Robert S Dawe , NHS Tayside and University of Dundee"
Atopic Dermatitis,NCT00576238,Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser,https://clinicaltrials.gov/study/NCT00576238,NO,Atopic Eczema,DRUG: betamethasone valerate|DRUG: betamethasone valerate|DRUG: urea,ALL,"ADULT, OLDER_ADULT",PHASE3,"Nacka hudmottagning, Nacka, 13183, Sweden|Nacka nÃ¤rsjukhus, Nacka, 13183, Sweden|Sophiahemmet, Stockholm, 11486, Sweden|Hudkliniken, Danderyds sjukhus, Stockholm, 18288, Sweden|LÃ¤karhuset VÃ¤llingby, VÃ¤llingby, 16862, Sweden","Principal Investigator : Berit Berne, MD , Hudkliniken, Akademiska sjukhuset, Uppsala"
Atopic Dermatitis,NCT05624112,Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China,https://clinicaltrials.gov/study/NCT05624112,NO,Atopic Dermatitis|Dermatitis Atopic,DRUG: Dupilumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Dermatology Hospital of Southern Medical University (Guangdong Provincial Dermatology Hospital), Guangzhou, Guangdong, 510091, China","Study Director : Clinical Sciences & Operations , Sanofi"
Atopic Dermatitis,NCT00676884,A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema,https://clinicaltrials.gov/study/NCT00676884,NO,Atopic Eczema,"DRUG: Aeroderm (also known as pitrakinra, AER 001, BAY 16-9996)|DRUG: placebo",ALL,"ADULT, OLDER_ADULT",PHASE2,"Guy's Drug Research unit, Quintiles Limited, London, SE1 1YR, United Kingdom","Principal Investigator : Darren Wilbraham, MBBS , Guy's Drug Research Unit, Quintiles Limited Principal Investigator : Richard Groves, FRCP , St. Johns Institute of Dermatology St. Thomas' Hospital London"
Atopic Dermatitis,NCT02381028,Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children,https://clinicaltrials.gov/study/NCT02381028,NO,Atopic Eczema,OTHER: Human milk and emollient: Apobase cremeÂ® (Actavis Norway AS)|OTHER: Emollient: Apobase cremeÂ® (Actavis Norway AS),ALL,CHILD,,,"Principal Investigator : Teresa L Berents, MD , Oslo University Hospital"
Atopic Dermatitis,NCT03270566,Softened Water for Eczema Prevention Pilot Trial,https://clinicaltrials.gov/study/NCT03270566,NO,Atopic Eczema,DEVICE: Domestic ion-exchange water softener,ALL,"CHILD, ADULT, OLDER_ADULT",,"St Thomas' Hospital, London, SE1 7EH, United Kingdom","Principal Investigator : Carsten Flohr, PhD, FRCPCH , King's College London"
Atopic Dermatitis,NCT06469385,Topical ENS-002 for Atopic Dermatitis in Adults,https://clinicaltrials.gov/study/NCT06469385,NO,Atopic Dermatitis|Atopic Dermatitis Eczema,BIOLOGICAL: ENS-002,ALL,"ADULT, OLDER_ADULT",PHASE1,"Derm Research, Austin, Texas, 78759, United States","Study Chair : Bernardo Cervantes, PhD , Concerto Biosciences"
Atopic Dermatitis,NCT00354510,Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis,https://clinicaltrials.gov/study/NCT00354510,NO,"Atopic Dermatitis|Dermatitis, Atopic",DRUG: GW842470X cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"GSK Investigational Site, Augsburg, Bayern, 86179, Germany|GSK Investigational Site, Mahlow, Brandenburg, 15831, Germany|GSK Investigational Site, Duelmen, Niedersachsen, 48249, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 51063, Germany|GSK Investigational Site, Schenefeld, Schleswig-Holstein, 22869, Germany|GSK Investigational Site, Berlin, 10117, Germany|GSK Investigational Site, Berlin, 13125, Germany|GSK Investigational Site, Hamburg, 20246, Germany|GSK Investigational Site, Hamburg, 20249, Germany|GSK Investigational Site, Hamburg, 22143, Germany|GSK Investigational Site, Nijmegen, 6531 LB, Netherlands|GSK Investigational Site, Rotterdam, 3015 GD, Netherlands|GSK Investigational Site, Utrecht, 3584 CJ, Netherlands","Study Director : GSK Clinical Trials , GlaxoSmithKline"
Atopic Dermatitis,NCT05578482,Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05578482,NO,Atopic Dermatitis|Atopic Dermatitis Eczema|Atopic Dermatitis Flare,DRUG: Dicloxacillin Oral Capsule|DRUG: Elocon 0.1 % Topical Cream,ALL,"ADULT, OLDER_ADULT",PHASE4,"Department of Dermatology, Copenhagen NV, 2100, Denmark","Principal Investigator : Jacob Thyssen, Professor, MD, DMSc , Professor, Department of Dermatology, Bispebjerg Hospital"
Atopic Dermatitis,NCT01119313,Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema,https://clinicaltrials.gov/study/NCT01119313,NO,Atopic Eczema,DRUG: LAS 41002|DRUG: Active,ALL,"ADULT, OLDER_ADULT",PHASE2,"Almirall Investigational Sites#1, Hamburg, Germany","Study Director : Christoph Willers, MD, MBA , Almirall Hermal GmbH"
Atopic Dermatitis,NCT05704205,The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema),https://clinicaltrials.gov/study/NCT05704205,NO,Atopic Dermatitis Eczema|Atopic Dermatitis,DEVICE: NB-UVB phototherapy|COMBINATION_PRODUCT: Optimal topical therapy,ALL,"ADULT, OLDER_ADULT",,"Flevoziekenhuis, Almere, Flevoland, 1315RA, Netherlands|Medisch Centrum Leeuwarden, Leeuwarden, Friesland, 8934 AD, Netherlands|Jeroen Bosch Ziekenhuis, Den Bosch, Noord-Brabant, 5223 GZ, Netherlands|Centrum Oosterwal, Alkmaar, Noord-Holland, 1817 MS, Netherlands|OLVG, Amsterdam, Noord-Holland, 1061 AE, Netherlands|Amsterdam Universitair Medische Centra, Amsterdam, Noord-Holland, 1105 AZ, Netherlands|Huid Medisch Centrum, Amsterdam, Noord-Holland, 1105 BJ, Netherlands|Bergman Clinics, Haarlem, Noord-Holland, 2015 BJ, Netherlands|Spaarne Gasthuis, Hoofddorp, Noord-Holland, 2134 TM, Netherlands|Dijklander Ziekenhuis, Purmerend, Noord-Holland, 1441 RN, Netherlands|Isala Klinieken, Zwolle, Overijssel, Netherlands|Meander Medisch Centrum, Amersfoort, Utrecht, 3813 TZ, Netherlands|Reinier de Graaf Gasthuis, Delft, Zuid-Holland, 2625 AD, Netherlands|Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, 2333 ZA, Netherlands|Alrijne Ziekenhuis, Leiderdorp, Zuid-Holland, Netherlands|Erasmus Medisch Centrum, Rotterdam, Zuid-Holland, 3015 GD, Netherlands","Principal Investigator : Louise AA Gerbens, MD PhD , Amsterdam University Medical Centers"
Atopic Dermatitis,NCT04800185,Characterizing Skin Microbiome Change in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04800185,NO,Atopic Dermatitis|Atopic Dermatitis Eczema,DRUG: Crisaborole 2% Top Oint|GENETIC: Skin Microbiome Swabs,ALL,"CHILD, ADULT, OLDER_ADULT",EARLY_PHASE1,"University of California, Irvine - Dermatology Clinical Research, Irvine, California, 92697, United States","Principal Investigator : Natasha Atanaskova Mesinkovska, MD, PhD , University of California, Irvine"
Atopic Dermatitis,NCT03667014,The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT03667014,YES,Atopic Dermatitis|Atopic Dermatitis Eczema,DRUG: Dupilumab,ALL,"ADULT, OLDER_ADULT",PHASE4,"UCSF Psoriasis and Skin Treatment Center, San Francisco, California, 94118, United States","Principal Investigator : Tina Bhutani, MD , University of California, San Francisco"
Atopic Dermatitis,NCT05719649,The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical Trial,https://clinicaltrials.gov/study/NCT05719649,NO,Atopic Dermatitis|Atopic Dermatitis Eczema,DIETARY_SUPPLEMENT: Lactic acid bacteria NTU 101|DIETARY_SUPPLEMENT: Placebo,ALL,CHILD,,,
Atopic Dermatitis,NCT06174493,Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials,https://clinicaltrials.gov/study/NCT06174493,NO,Atopic Dermatitis,,ALL,"ADULT, OLDER_ADULT",,"Power Life Sciences, San Francisco, California, 94107, United States","Study Director : Michael B Gill , Power Life Sciences Inc."
Atopic Dermatitis,NCT06004986,DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema,https://clinicaltrials.gov/study/NCT06004986,NO,Atopic Dermatitis|Atopic Dermatitis Eczema,DRUG: Dupilumab,ALL,"ADULT, OLDER_ADULT",PHASE4,"Amsterdam University Medical Centers, Amsterdam, Noord-Holland, 1105 AZ, Netherlands|Erasmus Medical Center, Rotterdam, Zuid-Holland, 3015 GD, Netherlands","Study Chair : Louise AA Gerbens, MD PhD , Amsterdam University Medical Centers Principal Investigator : Phyllis I Spuls, MD PhD , Amsterdam University Medical Centers Principal Investigator : DirkJan Hijnen, MD PhD , Erasmus Medical Center"
Atopic Dermatitis,NCT05502185,Targeting Staphylococci in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05502185,NO,Atopic Dermatitis,,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Alan IRVINE, MD , Clinical Research Facility in Trinity College of Dublin/St. James Hospital"
Atopic Dermatitis,NCT06455891,MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement,https://clinicaltrials.gov/study/NCT06455891,NO,Atopic Dermatitis,,ALL,"ADULT, OLDER_ADULT",,"Tenon Hospital APHP dermatology and allergology department, Paris, 75020, France","Principal Investigator : AngÃ¨le SORIA, PU-PH , Assistance Publique - HÃ´pitaux de Paris"
Atopic Dermatitis,NCT06395948,A Study Evaluating APG777 in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06395948,NO,Atopic Dermatitis,DRUG: APG777|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigational Site #14, Fountain Valley, California, 92708, United States|Investigational Site # 8, San Diego, California, 92123, United States|Investigational Site # 1, Coral Gables, Florida, 33134, United States|Investigational Site # 2, Rockville, Maryland, 20850, United States|Investigational Site #10, Troy, Michigan, 48084, United States|Investigational Site #16, Portsmouth, New Hampshire, 13801, United States|Investigational Site # 3, Wilmington, North Carolina, 28403, United States|Investigational Site #12, Mason, Ohio, 45040, United States|Investigational Site # 4, Nashville, Tennessee, 37215, United States|Investigational Site # 18, San Antonio, Texas, 78213, United States|Investigational Site # 5, Norfolk, Virginia, 23502, United States|Investigational Site # 7, Mill Creek, Washington, 98012, United States|Investigational Site #19, Winnipeg, Manitoba, R3M 3Z4, Canada|Investigational Site #15, Fredericton, New Brunswick, E3B 1G9, Canada|Investigational Site # 9, Markham, Ontario, L3P1X3, Canada|Investigational Site #13, Peterborough, Ontario, K9J 5K2, Canada|Investigational Site #11, Toronto, Ontario, M4W 2N4, Canada|Investigational Site # 6, Montreal, Quebec, H2X 2V1, Canada|Investigational Site #17, QuÃ©bec, Quebec, G1V4X7, Canada","Apogee Therapeutics, Inc."
Atopic Dermatitis,NCT05467046,Clinical Relevance of Scratching and Sleep in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05467046,NO,Atopic Dermatitis,DEVICE: Smartwatch system,ALL,"ADULT, OLDER_ADULT",,"University of Utrecht, Utrecht, Netherlands","Principal Investigator : Marjolein de Buin-Weller, MD, PhD , University Medical Center Utrecht (UMC Utrecht)"
Atopic Dermatitis,NCT04715087,Staphylococcus Aureus in Atopic Dermatitis Immunopathology,https://clinicaltrials.gov/study/NCT04715087,NO,Atopic Dermatitis,"OTHER: Blood sample (Day -42 to Day -28, Day 3),Skin swab sampling (Day -42 to Day -28, Day 0, Day 13) , patch test application (Day 0) , skin biopsies (Day 13)|OTHER: Blood sample (Day 0 ,Day 3),Skin swab sampling (Day 0,Day 13), patch test application (Day 1), skin biopsies (Day 13)",ALL,"ADULT, OLDER_ADULT",,"Centre Hospitalier Lyon Sud, Pierre-BÃ©nite, 69495, France","Principal Investigator : Audrey NOSBAUM, MD, PhD , Allergy and Clinical Immunology Department - Centre Hospitalier Lyon Sud"
Atopic Dermatitis,NCT05904509,Insulin Resistance in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT05904509,NO,Atopic Dermatitis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Bezmialem Vakif University Hospital, Istanbul, Turkey",Bezmialem Vakif University
Atopic Dermatitis,NCT06244212,Topical Treatment for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06244212,NO,Atopic Dermatitis,OTHER: Demonstration of applying triamcinolone cream|BEHAVIORAL: Mobile App Use|OTHER: Standard of Care,ALL,"CHILD, ADULT, OLDER_ADULT",,"Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States",
Atopic Dermatitis,NCT05286047,Probiotic on Atopic Dermatitis in Infant,https://clinicaltrials.gov/study/NCT05286047,NO,Atopic Dermatitis,DIETARY_SUPPLEMENT: Bifidobacterium longum CCFM1029|DIETARY_SUPPLEMENT: Placebo,ALL,CHILD,,"Glac Biotech Co., Ltd., Tainan City, 74442, Taiwan","Glac Biotech Co., Ltd"
Atopic Dermatitis,NCT06316609,Prenatal Exposure to Emerging Contaminants and Children's Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06316609,NO,Atopic Dermatitis,OTHER: Gestational Exposure to Emerging Contaminants (ECs),ALL,"CHILD, ADULT, OLDER_ADULT",,"Children Hospital of Fudan University, Shanghai, Shanghai, 201102, China",
Atopic Dermatitis,NCT05969730,Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05969730,NO,Atopic Dermatitis,DRUG: Baricitinib 4 MG|DRUG: Azathioprine 1.5-2.5 mg/kg,ALL,"ADULT, OLDER_ADULT",,"Iran, Sari, Mazandaran, Iran, Islamic Republic of",
Atopic Dermatitis,NCT05971355,Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05971355,NO,Atopic Dermatitis,"DEVICE: LimpiAD cream 2,5% plus|OTHER: Vehicle|OTHER: Emollient",ALL,CHILD,,"University of Bari Hospital, Bari, Italy|University of Modena e Reggio Emilia, Modena, Italy|University of Naples Hospital, Naples, Italy|S. Gallicano Hospital, Rome, Italy|University Rome La Sapienza (Hospital Umberto I), Rome, Italy",
Atopic Dermatitis,NCT05783453,CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS,https://clinicaltrials.gov/study/NCT05783453,NO,Atopic Dermatitis,OTHER: Cosmetic study,ALL,"CHILD, ADULT, OLDER_ADULT",,"CIDP, Rio de Janeiro, 20231-048, Brazil","Study Director : Daniele Miranda, MD , CIDP Brasil"
Atopic Dermatitis,NCT05523986,Vitamin D Treatment Effect for Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT05523986,NO,Atopic Dermatitis,OTHER: Vitamin D|OTHER: Placebo,ALL,"CHILD, ADULT",,"China Medical University Hospital, Taichung, 404, Taiwan",China Medical University Hospital
Atopic Dermatitis,NCT06447506,Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT06447506,NO,"Dermatitis, Atopic",DRUG: GSK1070806,ALL,"ADULT, OLDER_ADULT",PHASE2,"GSK Investigational Site, Phoenix, Arizona, 85006, United States|GSK Investigational Site, North Little Rock, Arkansas, 72117, United States|GSK Investigational Site, Canoga Park, California, 91303, United States|GSK Investigational Site, Fountain Valley, California, 92708, United States|GSK Investigational Site, Santa Monica, California, 90404, United States|GSK Investigational Site, Pompano Beach, Florida, 33060, United States|GSK Investigational Site, Fayetteville, Georgia, 30214, United States|GSK Investigational Site, Thomasville, Georgia, 31792, United States|GSK Investigational Site, Methuen, Massachusetts, 01844, United States|GSK Investigational Site, Troy, Michigan, 48084, United States|GSK Investigational Site, New York, New York, 10075, United States|GSK Investigational Site, Dublin, Ohio, 43016, United States|GSK Investigational Site, W. Lake Hills, Texas, 78746, United States|GSK Investigational Site, Springville, Utah, 84663, United States|GSK Investigational Site, Caba, Buenos Aires, C1055AAO, Argentina|GSK Investigational Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1207AAP, Argentina|GSK Investigational Site, Cordoba, CÃ³rdova, X5000AAW, Argentina|GSK Investigational Site, Rosario, Santa Fe, S2002, Argentina|GSK Investigational Site, Buenos Aires, C1181ACH, Argentina|GSK Investigational Site, Mendoza, 5500, Argentina|GSK Investigational Site, Pleven, 5800, Bulgaria|GSK Investigational Site, Sofia, 1510, Bulgaria|GSK Investigational Site, Sofia, Bulgaria|GSK Investigational Site, Barrie, Ontario, Canada|GSK Investigational Site, London, Ontario, N6H 5L5, Canada|GSK Investigational Site, Markham, Ontario, L3P1X2, Canada|GSK Investigational Site, Quebec, G1W 4R4, Canada|GSK Investigational Site, Chongqing, Chongqing, 400016, China|GSK Investigational Site, Shanghai, Shanghai, China|GSK Investigational Site, Hangzhou, Zhejiang, 310000, China|GSK Investigational Site, Yiwu City, Zhejiang, 322000, China|GSK Investigational Site, Beijing, 100044, China|GSK Investigational Site, Fu Zhou, 350014, China|GSK Investigational Site, Guangzhou, China|GSK Investigational Site, Shanghai, 200025, China|GSK Investigational Site, Yinchuan, China|GSK Investigational Site, Prague, 10034, Czechia|GSK Investigational Site, Praha 2, 128 08, Czechia|GSK Investigational Site, Praha, Czechia|GSK Investigational Site, La Rochelle cedex 1, 17019, France|GSK Investigational Site, Nice, 06200, France|GSK Investigational Site, Paris cedex 10, 75475, France|GSK Investigational Site, Essen, Nordrhein-Westfalen, 45122, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, 48149, Germany|GSK Investigational Site, Kiel, Schleswig-Holstein, 24105, Germany|GSK Investigational Site, Berlin, 10789, Germany|GSK Investigational Site, Hamburg, 22391, Germany|GSK Investigational Site, Athens, Greece|GSK Investigational Site, Thessaloniki, 546 43, Greece|GSK Investigational Site, Bologna, Emilia Romagna, 40138, Italy|GSK Investigational Site, Modena, Emilia-Romagna, 41124, Italy|GSK Investigational Site, Roma, Lazio, 00128, Italy|GSK Investigational Site, Bari, 70124, Italy|GSK Investigational Site, Firenze, Italy|GSK Investigational Site, Roma, 00168, Italy|GSK Investigational Site, Chiba, 272-0033, Japan|GSK Investigational Site, Chiba, 279-0021, Japan|GSK Investigational Site, Fukuoka, 807-8556, Japan|GSK Investigational Site, Fukuoka, 812-8582, Japan|GSK Investigational Site, Gunma, 370-0829, Japan|GSK Investigational Site, Hokkaido, 060-0033, Japan|GSK Investigational Site, Hokkaido, 080-0013, Japan|GSK Investigational Site, Kanagawa, 211-0063, Japan|GSK Investigational Site, Osaka, 583-8588, Japan|GSK Investigational Site, Osaka, 593-8324, Japan|GSK Investigational Site, Saitama, 343-8555, Japan|GSK Investigational Site, Gyeonggi-do, 15355, Korea, Republic of|GSK Investigational Site, Seoul, 03722, Korea, Republic of|GSK Investigational Site, Seoul, 04763, Korea, Republic of|GSK Investigational Site, Seoul, 100 799, Korea, Republic of|GSK Investigational Site, Seoul, 150-950, Korea, Republic of|GSK Investigational Site, Durango., Durango, 34000, Mexico|GSK Investigational Site, Guadalajara, Jalisco, 44628, Mexico|GSK Investigational Site, Chihuahua, 31000, Mexico|GSK Investigational Site, Monterrey, 64718, Mexico|GSK Investigational Site, Ciudad de Panama, 7099, Panama|GSK Investigational Site, Chojnice, 89-600, Poland|GSK Investigational Site, Elblag, 82-300, Poland|GSK Investigational Site, Katowice, 40-600, Poland|GSK Investigational Site, Poznan, 60-569, Poland|GSK Investigational Site, Szczecin, 70-332, Poland|GSK Investigational Site, Warsaw, 03-291, Poland|GSK Investigational Site, Majadahonda, Madrid, 28222, Spain|GSK Investigational Site, Vigo, Pontevedra, 36206, Spain|GSK Investigational Site, Alicante, ?03010, Spain|GSK Investigational Site, CÃ³rdoba, 14004, Spain|GSK Investigational Site, Granada, 18016, Spain|GSK Investigational Site, Valencia, 46026, Spain|GSK Investigational Site, Zaragoza, 50009, Spain|GSK Investigational Site, Bangkok, Pathum Wan, 10330, Thailand|GSK Investigational Site, Khlong Luang, 12120, Thailand",GlaxoSmithKline
Atopic Dermatitis,NCT05466877,A Study of MG-K10 in Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05466877,NO,Atopic Dermatitis,DRUG: MG-K10|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"The First Affiliated Hospital of Bengbu Medical College, Bengbu, China|Huashan Hospital Affiliated to Fudan University, Shanghai, China","Principal Investigator : Jinhua Xu, Medical Ph.D , Huashan Hospital"
Atopic Dermatitis,NCT05833880,Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05833880,NO,Atopic Dermatitis,BEHAVIORAL: Self-administered questionnaire,ALL,"CHILD, ADULT, OLDER_ADULT",,"University Hospital of Nancy, Nancy, France","Principal Investigator : Anne-Claire Bursztejn , University Hospital of Nancy, France"
Atopic Dermatitis,NCT06026891,Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06026891,NO,Atopic Dermatitis,DRUG: MG-K10/Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Peking University People's Hospital, Beijing, China","Principal Investigator : Jianzhong Zhang, Medical Ph.D , Feking University People's Hospital"
Atopic Dermatitis,NCT02087943,Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02087943,YES,"Dermatitis, Atopic Dermatitis",DRUG: Apremilast|DRUG: Apremilast|DRUG: Placebo|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Arizona Research Center, Phoenix, Arizona, 85023, United States|Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, California, 93309, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Renstar Medical Research, Ocala, Florida, 34471, United States|Emory Clinic, Atlanta, Georgia, 30322, United States|Advanced Medical Research, Atlanta, Georgia, 30342, United States|Northwestern University Northwestern Medical Faculty Foundation, Chicago, Illinois, 60611, United States|Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, 60045, United States|Dermatology Specialists, PSC, Louisville, Kentucky, 40202, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|NYU Department of Dermatology, New York, New York, 10016, United States|Mount Sinai Medical Center, New York, New York, 10029, United States|PMG Research of Winston-Salem LLC, Winston-Salem, North Carolina, 27103-3914, United States|Oregon Health and Science University, Portland, Oregon, 97201-3098, United States|Virginia Clinical Research Inc, Norfolk, Virginia, 23507, United States|Chih-Ho Hong Medical, Inc., Surrey, British Columbia, V3R 6A7, Canada|Eastern Canada Cutaneous Research Associates Ltd, Halifax, Nova Scotia, B3H 1Z2, Canada|Ultranova Skincare, Barrie, Ontario, L4M 6L2, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research, Montreal, Quebec, H2K 4L5, Canada|Centre Dermatologique du Quebec Metropolitain, Ste-Foy, Quebec, G1V 4X7, Canada|Kokubu Abashiri Dermatology Clinic, Abashiri-shi, Hokkaido, 093-0016, Japan|Asanuma Dermatology Clinic, Chitose-shi, Hokkaido, 066-0064, Japan|Fukuoka University Hospital Dermatology, Fukuoka-shi, Fukuoka, 814-0180, Japan|Hatamoto Dermatology Clinic, Fukuoka-shi, Fukuoka, 815-0075, Japan|Tashiro Clinic, Iizuka-shi, Fukuoka, 820-0040, Japan|Kokubu Dermatology, Kitami-shi, Hokkaido, 090-0832, Japan|University Hospital, Kyoto Prefectural University of Medicine, Kyoto-City, 602-8566, Japan|Kyoto University Hospital, Kyoto, 606-8507, Japan|Sapporo Skin Clinic, Sapporo-shi, Hokkaido, 060-0063, Japan|NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, 141-8625, Japan","Study Director : MD , Amgen"
Atopic Dermatitis,NCT02906475,Atopic Dermatitis in Atopy Predisposed Infants,https://clinicaltrials.gov/study/NCT02906475,NO,"Dermatitis, Atopic",OTHER: standardized skin care regimen,ALL,CHILD,,"Charite UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany","Principal Investigator : Ulrike Blume-Peytavi, Prof. Dr. , Charite UniversitÃ¤tsmedizin Berlin"
Atopic Dermatitis,NCT05399368,An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05399368,NO,Atopic Dermatitis,DRUG: RPT193|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States|Perseverance Research Center, Scottsdale, Arizona, 85254, United States|Arkansas Research Trials, LLC, North Little Rock, Arkansas, 72117, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Grimes Center, Los Angeles, California, 90036, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Wallace Medical Group, Los Angeles, California, 90056, United States|Velocity Clinical Research, North Hollywood, California, 91606, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Clinical Trials Research Institute, Thousand Oaks, California, 91320, United States|Foxhall Research Center, Washington, District of Columbia, 20016, United States|Driven Research LLC, Coral Gables, Florida, 33134, United States|Florida Academic Centers Research and Education, LLC, Coral Gables, Florida, 33134, United States|Palm Beach Dermatology Group, Delray Beach, Florida, 33484, United States|GSI Clinical Research, Margate, Florida, 33063, United States|Lenus Research & Medical Group, LLC, Sweetwater, Florida, 33172, United States|Forcare Clinical Research, Tampa, Florida, 33613, United States|Skin Care Physicians of Georgia, Macon, Georgia, 31217, United States|Marietta Dermatology Clinical Research, Inc., Marietta, Georgia, 30060, United States|Georgia Skin & Cancer Clinic, Savannah, Georgia, 31419, United States|University Dermatology and Vein Clinic, Darien, Illinois, 60561, United States|Indiana Clinical and Translational Sciences Institute (CTSI) Clinical Research Center, Indianapolis, Indiana, 46202, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|The Indiana Clinical Trials Center PC, Plainfield, Indiana, 46168, United States|Skin Sciences PLLC, Louisville, Kentucky, 40217', United States|DelRicht Research, Baton Rouge, Louisiana, 70809, United States|Schweiger Dermatology Group, PC Research Division, Columbia, Maryland, 21044, United States|MetroBoston Clinical Partners, Brighton, Massachusetts, 02135, United States|Beacon Clinical Research, LLC, Quincy, Massachusetts, 02169, United States|Fivenson Dermatology, Ann Arbor, Michigan, 48103, United States|St. Joseph Dermatology and Vein Clinic, Saint Joseph, Michigan, 49085, United States|Grekin Skin Institute, Warren, Michigan, 48088, United States|Medisearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Advanced Dermatology of the Midlands, Omaha, Nebraska, 68144, United States|Skin Specialists PC (Schlessinger MD), Omaha, Nebraska, 68144, United States|Schweiger Dermatology Group, Verona, New Jersey, 07044, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|JUVA Skin & Laser Center, New York, New York, 10022, United States|Ichan School of Medicine at Mount Sinai, New York, New York, 10029, United States|Markowitz Medical, PLLC, New York, New York, 10128, United States|Optima Research - Boardman, Boardman, Ohio, 44512, United States|Apex Clinical Research Center, Mayfield Heights, Ohio, 44124, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|Arlington Research Center Inc., Arlington, Texas, 76011, United States|DermResearch, Austin, Texas, 78759, United States|Studies in Dermatology, LLC, Cypress, Texas, 77433, United States|Dermatology Treatment and Research Center, Dallas, Texas, 75230, United States|Clinical Trial Network, Houston, Texas, 77074, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Acclaim Dermatology, Sugar Land, Texas, 77479, United States|Complete Dermatology, Sugar Land, Texas, 77479, United States|Jordan Valley Dermatology Center, South Jordan, Utah, 84095, United States|West End Dermatology Associates, Richmond, Virginia, 23233, United States|Premier Clinical Research, Spokane, Washington, 99202, United States|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M7G1, Canada|LEADER Research, Hamilton, Ontario, L8L 3C3, Canada|Red Maple Trials Inc., Ottawa, Ontario, K1H 1E4, Canada","RAPT Therapeutics, Inc."
Atopic Dermatitis,NCT06116526,Dupilumab De-escalation in Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06116526,NO,Atopic Dermatitis,DRUG: Dupilumab - Discontinuation|DRUG: Dupilumab - Dose Reduction|DRUG: Dupilumab - Standard Dose,ALL,CHILD,PHASE4,"Johns Hopkins Univerisity, Baltimore, Maryland, 21210, United States","Principal Investigator : Joy Wan, MD MSCE , Johns Hopkins University"
Atopic Dermatitis,NCT06492902,Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06492902,NO,Atopic Dermatitis,OTHER: Auricular acupuncture|OTHER: Sham auricular acupuncture,ALL,"ADULT, OLDER_ADULT",,"University of Medical Center HCMC - Branch no.3, Ho Chi Minh City, 700000, Vietnam|Traditional Medicine Hospital of Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam","Principal Investigator : Nga Th Tran, MD,MSc , University of Medicine and Pharmacy at Ho Chi Minh City"
Atopic Dermatitis,NCT05844618,Short-Term Efficacy of Triamcinolone Acetonide (AristocortÂ® C) in Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05844618,NO,Atopic Dermatitis,DRUG: Triamcinolone Acetonide (AristocortÂ® C)|DRUG: Vehicle,ALL,"ADULT, OLDER_ADULT",PHASE4,"Innovaderm Research Inc., MontrÃ©al, Quebec, H2X 2V1, Canada","Principal Investigator : Robert Bissonnette, MD , Innovaderm Research Inc."
Atopic Dermatitis,NCT05090982,Creation of a Shared Medical Decision-making Tool for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05090982,NO,Atopic Dermatitis,OTHER: Audio recordings during the consultations|OTHER: Audio recordings during the consultations and test of the shared medical decision-making tool for modification|OTHER: Audio recordings during the consultations and test of the shared medical decision-making tool for validation,ALL,"ADULT, OLDER_ADULT",,"Hospital Henri Mondor, CrÃ©teil, 64010, France","Study Director : Pierre-AndrÃ© Natella, PhD , Assistance Publique - HÃ´pitaux Paris"
Atopic Dermatitis,NCT06238817,"A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06238817,NO,Atopic Dermatitis,DRUG: Ruxolitinib Cream|DRUG: Vehicle Cream,ALL,"ADULT, OLDER_ADULT",PHASE3,"Lynn Institute of the Ozarks, Little Rock, Arkansas, 72204, United States|First Oc Dermatology, Fountain Valley, California, 92708, United States|Center For Dermatology Cosmetic and Laser Surgery, Fremont, California, 94538, United States|Medderm Associates, Inc, San Diego, California, 92103, United States|Encore Medical Research, Llc Hollywood, Hollywood, Florida, 33021, United States|Entrust Clinical Research, Miami, Florida, 33176, United States|Lane Dermatology and Dermatologic Surgery, Columbus, Georgia, 31904, United States|Marietta Dermatology the Skin Cancer Center Marietta, Marietta, Georgia, 30060-1047, United States|Arlington Dermatology, Rolling Meadows, Illinois, 60008, United States|Northshore University Healthsystem, Skokie, Illinois, 60077, United States|Oakland Hills Dermatology Pc, Auburn Hills, Michigan, 48326, United States|Revival Research Institute, Llc Troy, Troy, Michigan, 48084, United States|Ohio State University-Wexner Medical Center, Gahanna, Ohio, 43230, United States|Dermdox Center For Dermatology, Sugarloaf, Pennsylvania, 18249, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|International Clinical Research Tennessee Llc, Murfreesboro, Tennessee, 37130, United States|Texas Dermatology Research Center, Plano, Texas, 75025, United States|Rainey and Finklea Dermatology, San Antonio, Texas, 78212, United States|Center For Clinical Studies Webster, Webster, Texas, 77598, United States|North Sound Dermatology, Mill Creek, Washington, 98012, United States|Premier Specialists Pty Ltd, Kogarah, New South Wales, 02217, Australia|Australian Clinical Research Network, Maroubra, New South Wales, 02035, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 04102, Australia|Clinical Trials Sa, Campbelltown, South Australia, 05074, Australia|Skin Health Institute Inc., Carlton, Victoria, 03053, Australia|Paratus Clinical Research, Woden, Phillip, 02606, Australia|Cliniques Universitaires Ucl Saint-Luc, Brussels, 01200, Belgium|Ulb Hospital Erasme, Bruxelles, 01070, Belgium|Universitair Ziekenhuis Antwerpen (Uza), Edegem, 02650, Belgium|Universitair Ziekenhuis Gent, Gent, 09000, Belgium|Dermatologie Handelskaai, Kortrijk, 08500, Belgium|Grand Hopital de Charleroi, Loverval, 06280, Belgium|Mhat Dr. Tota Venkova Ad, Gabrovo, 05300, Bulgaria|Dcc 'Sveti Georgi' Eood, Haskovo, 06300, Bulgaria|Medical Center Medconsult Pleven Ood, Pleven, 05800, Bulgaria|Ambulatory For Specialized Medical Help - Skin and Venereal Diseases, Sofia, 01407, Bulgaria|Dcc 'Alexandrovska', Eood, Sofia, 01431, Bulgaria|Medical Center Hera Eood, Sofia, 01510, Bulgaria|Dcc Xxviii, Sofia, 01592, Bulgaria|Medical Center Assoc. Prof. Vasilev, Sofia, 01618, Bulgaria|Dermatology Research Institute Inc., Calgary, Alberta, T2J 7E1, Canada|Dr. Chih-Ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Wiseman Dermatology Research Inc, Winnipeg, Manitoba, R3M 3Z4, Canada|Brunswick Dermatology Center, Fredericton, New Brunswick, E3B 1G9, Canada|Skincare Studio Dermatology Centre, St. John's, Newfoundland and Labrador, A1E 1V4, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X3, Canada|Skin Centre For Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Centre de Recherche Dermatologique Du Quebec Metropolitain, Quebec, G1V 4X7, Canada|Centre Hospitalier Du Mans, Le Mans Cedex, 72037, France|Ghicl - HÃ´pital Saint-Vincent de Paul, Lille Cedex, 59020, France|Chru de Lille Hopital Claude Huriez, Lille Cedex, 59037, France|Centre Hospitalier Universitaire de Nantes (Chu de Nantes) - Hotel-Dieu, Nantes, 44093, France|Hospices Civils de Lyon Centre Hospitalier Lyon Sud, Pierre BÃ©nite Cedex, 69495, France|Chu de Rouen - Hospital Charles Nicolle, Rouen, 76000, France|University Hospital of Saint Etienne, Saint Etienne Cedex 2, 42055, France|Universitaetsklinikum Augsburg Sued, Augsburg, 86179, Germany|Fachklinik Bad Bentheim Dermatologie, Bad Bentheim, 48455, Germany|Praxis Fuer Haut- Und Geschlechtskrankheiten Dr. Med. Thomas Wildfeuer Und Partner, Berlin, 13055, Germany|Universitaetsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitatsklinikum Munster, Muenster, 48149, Germany|Dermatologie Potsdam Mvz Gmbh, Potsdam, 14467, Germany|Clinexpert Kft., Budapest, 01033, Hungary|Obudai Egeszsegugyi Centrum Kft., Budapest, 01036, Hungary|Semmelweis Egyetem, Budapest, 01085, Hungary|Debreceni Egyetem Klinikai Kozpon Belgyogy Klinika, Debrecen, 04032, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, 06720, Hungary|Azienda Ospedaliero Universitaria Consorziale Policlinico Di Bari, Bari, 70124, Italy|Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Azienda Ospedaliera Universitaria Federico Ii., Naples, 80131, Italy|Azienda Ospedaliera Universitaria University Degli Studi Della Campania Luigi Vanvitelli, Napoli, 80131, Italy|Fondazione Policlinico Universitario Agostino Gemelli Irccs, Rome, 00168, Italy|Irccs Istituto Clinico Humanitas, Rozzano, 20089, Italy|Soon Chun Hyang University Hospital (Schuh) Bucheon, Bucheon, 420-767, Korea, Republic of|Konkuk University Medical Center, Seoul, 05030, Korea, Republic of|Bravis Ziekenhuis, Bergen Op Zoom, 4624 VT, Netherlands|Amphia Ziekenhuis, Molengracht, Breda, 4818 CK, Netherlands|Universitair Medisch Centrum Groningen, Groningen, 9713GZ, Netherlands|Centrum Badan Klinicznych Pi-House Sp. Z O.O., Gdansk, 80-546, Poland|Centrum Medyczne Pratia Katowice I, Katowice, 40-081, Poland|Centrum Medyczne Pratia Krakow, Krakow, 30-002, Poland|Centrum Medyczne All-Med, Krakow, 30-033, Poland|Santa Familia Centrum Badan, Profilaktyki I Leczenia, Lodz, 90-302, Poland|Etg Lublin, Lublin, 20-412, Poland|Dermedic Dr. Zdybski, Ostrowiec, 27-400, Poland|Solumed Centrum Medyczne, Poznan, 60-529, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|Centrum Medyczne Evimed, Warszawa, 02-625, Poland|Klinika Ambroziak, Warszawa, 02-953, Poland|Dermmedica Sp. Z O.O., WrocÅ‚aw, 51-503, Poland|Ceim Hospital Universitari Germans Trias I Pujol, Badalona, 08916, Spain|Hospital de La Santa Creu I Sant Pau, Barcelona, 08041, Spain|Hospital Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario de La Paz, Madrid, 28046, Spain|Hospital de Manises, Manises, 46940, Spain|Hospital Marina Baixa, Villajoyosa, 03570, Spain|Universitatsspital Basel, Basel, CH-4055, Switzerland|Inselspital Universitatsklinik Fur Medizinische Onkologie, Bern, 03010, Switzerland|Dermatology & Skin Care Clinic, Buochs, 06374, Switzerland|Universitatsspital Zurich, Zuerich, 08091, Switzerland|Bristol Royal Infirmary, Bristol, BS2 8ED, United Kingdom|West Middlesex University Hospital, Isleworth, TW7 6AF, United Kingdom|Guys Hospital, London, SE1 9RT, United Kingdom|Northampton General Hospital, Northampton, NN1 5BD, United Kingdom|University Hospital Plymouth, Plymouth, PL6 8DH, United Kingdom|Walsall Manor Hospital, Walsall, WS2 9PS, United Kingdom","Study Director : Incyte Medical Monitor , Incyte Corporation"
Atopic Dermatitis,NCT05439941,A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials,https://clinicaltrials.gov/study/NCT05439941,YES,Atopic Dermatitis,DRUG: EDP1815,ALL,"ADULT, OLDER_ADULT",PHASE2,"USA-131, Birmingham, Alabama, 35244, United States|USA 112, Fountain Valley, California, 92708, United States|USA 123, Fremont, California, 94538, United States|USA -101, Fort Lauderdale, Florida, 33308, United States|USA-124, Jacksonville, Florida, 32216, United States|USA-108, Miami, Florida, 33165, United States|USA-120, Miami, Florida, 33175, United States|USA-105, Miramar, Florida, 33027, United States|USA-102, Orlando, Florida, 32801, United States|USA-115, Sweetwater, Florida, 33172, United States|USA-106, Tampa, Florida, 33613, United States|USA-126, Tampa, Florida, 33613, United States|USA-111, Clarksville, Indiana, 47129, United States|USA-116, Louisville, Kentucky, 40241, United States|USA-119, Baton Rouge, Louisiana, 70806, United States|USA-109, Metairie, Louisiana, 70006, United States|USA-125, Silver Spring, Maryland, 20902, United States|USA-121, Columbus, Ohio, 43221, United States|USA-128, Concord, Ohio, 44077, United States|USA-104, Portland, Oregon, 97239, United States|USA-127, Memphis, Tennessee, 38119, United States|USA-117, Frisco, Texas, 75034, United States|USA-110, Pflugerville, Texas, 78660, United States|USA-113, Bellevue, Washington, 98004, United States|AUS-102, Carlton, Australia|AUS-104, Kogarah, Australia|AUS-101, Melbourne, Australia|AUS-106, Woolloongabba, Australia|BGR-105, Pleven, Bulgaria|BGR-104, Sevlievo, Bulgaria|BGR-101, Sofia, Bulgaria|BGR-103, Sofia, Bulgaria|CAN-109, Barrie, Canada|CAN-108, Edmonton, Canada|CAN-105, Markham, Canada|CAN-104, Mississauga, Canada|CAN-101, Ottawa, Canada|CAN-107, Richmond Hill, Canada|CAN-103, Surrey, Canada|CAN-106, Waterloo, Canada|CAN-111, Winnipeg, Canada|DEU-105, Berlin, Germany|DEU-106, Erlangen, Germany|DEU-102, Frankfurt am Main, Germany|DEU-104, Gera, Germany|DEU-101, Hamburg, Germany|DEU-103, Heidelberg, Germany|POL-104, GdaÅ„sk, Poland|POL-106, Gdynia, Poland|POL-107, Katowice, Poland|POL-101, Lublin, Poland|POL-102, Warszawa, Poland|POL-103, WrocÅ‚aw, Poland|POL-105, ÅÃ³dÅº, Poland",
Atopic Dermatitis,NCT04826744,Frequency of Palpebral Involvement in Adult With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04826744,NO,Atopic Dermatitis,OTHER: Standard dermatology consultation,ALL,"ADULT, OLDER_ADULT",,"Hop Claude Huriez Chu Lille, Lille, 59037, France|Hopital Charles Nicolle Chu Rouen, Rouen, France","Principal Investigator : Delphine Staumont-Salle, MD,PhD , University Hospital, Lille"
Atopic Dermatitis,NCT04218877,The Factors Affecting Atopic Dermatitis in Children Age 1-3,https://clinicaltrials.gov/study/NCT04218877,NO,Atopic Dermatitis,OTHER,ALL,CHILD,,"Amedclinic, Moscow, 129626, Russian Federation",Akusherstvo Pro
Atopic Dermatitis,NCT06444165,Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06444165,NO,Atopic Dermatitis,DRUG: Lebrikizumab Pen,ALL,"ADULT, OLDER_ADULT",PHASE3,"Concentrics Research, Indianapolis, Indiana, 46240, United States","Study Director : Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 : Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) , Eli Lilly and Company"
Atopic Dermatitis,NCT04435392,Jaktinib Hydrochloride Cream For Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04435392,NO,Atopic Dermatitis,DRUG: Jaktinib Hydrochloride Cream|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China","Principal Investigator : Qianjin Lu, PhD , Central South University"
Atopic Dermatitis,NCT05437887,Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05437887,NO,Atopic Dermatitis,DIETARY_SUPPLEMENT: Fucoidan,ALL,"CHILD, ADULT",,"Chang Gung Memorial Hospital, Taoyuan, Taiwan","Study Director : Sien-hung Yang, Ph.D. , Chang Gung Memorial Hospital"
Atopic Dermatitis,NCT06024499,Phase 2 Trial of HY209gel in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT06024499,NO,Atopic Dermatitis|Atopic Dermatitis Eczema|Atopic Dermatitis of Scalp,DRUG: HY209GEL Active|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Cahaba Dermatology Skin Health Center, Birmingham, Alabama, 35244, United States|RAOOF MD Dermatology, Encino, California, 16133, United States|Continental Clinical Solutions, LLC, Towson, Maryland, 21204, United States|Sadick Dermatology, New York, New York, 10075, United States",
Atopic Dermatitis,NCT05509023,Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD),https://clinicaltrials.gov/study/NCT05509023,NO,Atopic Dermatitis,DRUG: ADX-914|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Cahaba Dermatology Skin Health Center, Birmingham, Alabama, 35244, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|California Allergy and Asthma Medical Group- Los Angeles, Los Angeles, California, 90025, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States|Dermatology Institute and Skin Care Center, Santa Monica, California, 90404, United States|Torrance Clinical Research Institute Inc., Torrance, California, 90505, United States|Integrated Research of Inland, Inc., Upland, California, 91786, United States|RM Medical Research Inc., Homestead, Florida, 33175, United States|Medical Research Center of Miami, Miami, Florida, 33134, United States|Well Pharma Medical Research Corporation, Miami, Florida, 33173, United States|Clinical Neurosciences Solutions Inc., Orlando, Florida, 32801, United States|GCP Research, Saint Petersburg, Florida, 33705, United States|Avita Clinical Trials, Tampa, Florida, 33613, United States|Alliance Clinical Research (Tampa), Tampa, Florida, 33615, United States|TruDerm, Wellington, Florida, 33449, United States|Metabolic Research Institute Inc, West Palm Beach, Florida, 33401, United States|Advanced Medical Research, PC, Sandy Springs, Georgia, 30328, United States|Treasure Valley Medical Research, Boise, Idaho, 83706, United States|Sneeze wheeze and Itch Associates LLC, Normal, Illinois, 61761, United States|Southern Indiana Clinical Trials, New Albany, Indiana, 47150, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|Randall Dermatology, West Lafayette, Indiana, 47906, United States|Visage Clinical Research, Largo, Maryland, 20774, United States|DermAssociates, PC., Rockville, Maryland, 20850, United States|Contemporary Dermatology, Marstons Mills, Massachusetts, 02648, United States|Great Lakes Research Group, Bay City, Michigan, 48706, United States|Revival Research Corporation- Clinedge, Troy, Michigan, 48084, United States|Grekin Skin Institute, Warren, Michigan, 48088, United States|Schweiger Dermatology Group, Hackensack, New Jersey, 07601, United States|Optima Research, Boardman, Ohio, 44512, United States|Apex Clinical Research Center, Painesville, Ohio, 33612, United States|Central Sooner Research, Oklahoma City, Oklahoma, 73170, United States|Clinical Partners, LLC, Johnston, Rhode Island, 02919, United States|North Texas Center for Clinical Research, Frisco, Texas, 75034, United States|Clinical Trial Network, Houston, Texas, 77074, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|JBR Clinical Research, Salt Lake City, Utah, 84107, United States|Advanced Research Institute- South Ogden, South Ogden, Utah, 84405, United States|Dermatology of Seattle & Bellevue, Seattle, Washington, 98004, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States",Q32 Bio Inc.
Atopic Dermatitis,NCT05868824,Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE),https://clinicaltrials.gov/study/NCT05868824,NO,Atopic Dermatitis,OTHER: Blood sample,ALL,"ADULT, OLDER_ADULT",,"Nice University Hospital, Nice, 06200, France",Centre Hospitalier Universitaire de Nice
Atopic Dermatitis,NCT05391061,A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05391061,NO,"Dermatitis, Atopic",DRUG: Abrocitinib,ALL,"CHILD, ADULT, OLDER_ADULT",,"Pfizer Tower, Seoul, 04631, Korea, Republic of",
Atopic Dermatitis,NCT06361992,Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT06361992,NO,Atopic Dermatitis|Atopic Dermatitis and Related Conditions|Atopic Dermatitis Eczema|Atopic Dermatitis \(AD\),OTHER: Blue Cap Foam,ALL,"CHILD, ADULT",PHASE3,"University of NiÅ¡ Faculty of Medicine, Department of Dermatology and Venereology, University Clinical Center of NiÅ¡, NiÅ¡, NiÅ¡ava, 18108, Serbia|City Institute for Skin and Venereal Diseases Belgrade, Belgrade, 11000, Serbia|University of Belgrade Faculty of Medicine, University Clinical Center of Serbia, Belgrade, 11000, Serbia",Catalysis SL
Atopic Dermatitis,NCT05276323,MedihoneyÂ® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study,https://clinicaltrials.gov/study/NCT05276323,NO,Atopic Dermatitis,DRUG: Medihoney Derma Cream|DRUG: Hydrocortisone 1% cream,ALL,"CHILD, ADULT",PHASE2,"Soroka University Medical Center, Beer Sheva, Israel",Soroka University Medical Center
Atopic Dermatitis,NCT06035835,Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature Infants,https://clinicaltrials.gov/study/NCT06035835,NO,Atopic Dermatitis,COMBINATION_PRODUCT: Lacticaseibacillus rhamnosus|COMBINATION_PRODUCT: Lactobacillus acidophilus + Bifidobacterium bifidum,ALL,CHILD,,,"Principal Investigator : JosÃ© Uberos-FernÃ¡ndez, Mr , Hospital Clinico Universitario San Cecilio"
Atopic Dermatitis,NCT04556461,Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function,https://clinicaltrials.gov/study/NCT04556461,NO,Atopic Dermatitis,DRUG: Tralokinumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"UKSH, Campus Kiel, Kiel, Schleswig-Holstein, 24105, Germany",Prof. Dr. Stephan Weidinger
Atopic Dermatitis,NCT06129136,The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.,https://clinicaltrials.gov/study/NCT06129136,NO,Atopic Dermatitis,OTHER: Nature-based exposure by biodiversity component in lotion.|OTHER: Placebo group using colored lotion.,ALL,"ADULT, OLDER_ADULT",,"Uute Scientific Oy, Helsinki, 00290, Finland","Principal Investigator : Olli Laitinen, PhD , Uute Scientific and Tampere University"
Atopic Dermatitis,NCT05644691,Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05644691,NO,Atopic Dermatitis,OTHER: Lipikar Baume AP+M|OTHER: Usual emollient,ALL,"CHILD, ADULT, OLDER_ADULT",,"DOST, SvidnÃ­k, 08901, Slovakia",
Atopic Dermatitis,NCT06238765,CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry,https://clinicaltrials.gov/study/NCT06238765,NO,Atopic Dermatitis,,ALL,CHILD,,"CorEvitas, LLC, Waltham, Massachusetts, 02451, United States",CorEvitas
Atopic Dermatitis,NCT05023668,China Atopic Dermatitis Registry Study,https://clinicaltrials.gov/study/NCT05023668,NO,"Dermatitis, Atopic",OTHER: No intervention,ALL,"CHILD, ADULT, OLDER_ADULT",,"Peking University People's Hospital, Beijing, Beijing, 100044, China","Principal Investigator : Jianzhong Zhang , Peking University People's Hospital"
Atopic Dermatitis,NCT04310189,The Role of IL-22/IL-22BP Axis in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04310189,NO,Atopic Dermatitis,PROCEDURE: Biopsy,ALL,"ADULT, OLDER_ADULT",,"Nantes University Hospital, Nantes, France","Principal Investigator : SÃ©bastien BARBAROT , Nantes University Hospital"
Atopic Dermatitis,NCT05455060,Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05455060,NO,Atopic Dermatitis,DRUG: Chinese herbal formula (CHF)|DRUG: Placebo,ALL,"CHILD, ADULT",PHASE3,,"National Yang Ming Chiao Tung University Taipei Veterans General Hospital, Taiwan Taipei Medical University"
Atopic Dermatitis,NCT05034822,Study of Ruxolitinib Cream in Children With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05034822,NO,Atopic Dermatitis,DRUG: Ruxolitinib cream,ALL,CHILD,PHASE1,"Desert Sky Dermatology, Gilbert, Arizona, 85295, United States|Burke Pharmaceutical Research, Hot Springs National Park, Arkansas, 71913, United States|Orange County Research Center, Anaheim, California, 92801, United States|Skin Care Research, Llc Scr Hollywood, Hollywood, Florida, 33021, United States|Accel Clinical Research, Lake Mary, Florida, 32746, United States|San Marcus Research Clinic Inc., Miami Lakes, Florida, 33014, United States|Forward Clinical Trials, Tampa, Florida, 33624, United States|Advanced Medical Research Pc, Sandy Springs, Georgia, 30328, United States|Aeroallergy Research Lab of Savannah, Savannah, Georgia, 31406, United States|Oakland Hills Dermatology Pc, Auburn Hills, Michigan, 48326, United States|Skin Cancer and Dermatology Institute, Reno, Nevada, 89509, United States|Forest Hills Dermatology Group, Forest Hills, New York, 11375, United States|Ohio Pediatric Research Association, Dayton, Ohio, 45414, United States|Cyn3Rgy Research - Clinedge - Ppds, Gresham, Oregon, 97030, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States","Study Director : Haq Nawaz, MD, MPH, MBA, MS , Incyte Corporation"
Atopic Dermatitis,NCT04444726,Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.,https://clinicaltrials.gov/study/NCT04444726,NO,Atopic Dermatitis,"DEVICE: Ultra Violet A Device.+ Topical medical treatment|DEVICE: Iontophoresis device + Topical medical treatment|DRUG: Topical medical treatment (Betamethasone dipropionate 0.05% "" diprolene "" )",ALL,CHILD,,"Banha University, BanhÄ, Egypt",Cairo University
Atopic Dermatitis,NCT06363461,Study of TDM-180935 in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT06363461,NO,Atopic Dermatitis,DRUG: TDM-180935 topical ointment 1.0%|DRUG: TDM-180935 topical ointment 2.0%|DRUG: TDM-180935 topical vehicle ointment 1|DRUG: TDM-180935 topical vehicle ointment 2,ALL,"ADULT, OLDER_ADULT",PHASE2,"Site 5, Rolling Meadows, Illinois, 60008, United States|Site 8, Covington, Louisiana, 70433, United States|Site 4, New Brighton, Minnesota, 55112, United States|Site 7, Anderson, South Carolina, 29621, United States|Site 3, Austin, Texas, 78759, United States|Site 1, College Station, Texas, 77845, United States|Site 2, Norfolk, Virginia, 23502, United States","Study Director : Daniel J. Piacquadio, M.D. , Therapeutics Incorporated"
Atopic Dermatitis,NCT05669794,An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World,https://clinicaltrials.gov/study/NCT05669794,NO,Atopic Dermatitis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Ch Saint Quentin /Id# 249270, St Quentin CEDEX, Aisne, 02321, France|CHU Clermont-Ferrand /ID# 248611, Clermont, Auvergne-Rhone-Alpes, 63100, France|Hopital Saint Joseph /ID# 255537, Marseille, Bouches-du-Rhone, 13008, France|Hopital Ponchaillou /ID# 251225, Rennes, Bretagne, 35000, France|CHU Dijon /ID# 248984, Dijon, Cote-d Or, 21000, France|CH Georges Renon /ID# 248976, Niort CEDEX, Deux-Sevres, 79028, France|CHU de Besancon - Jean Minjoz /ID# 248642, Besancon, Doubs, 25030, France|Hopitaux Drome Nord /ID# 248207, Romans Sur Isere, Drome, 26100, France|CH Valence /ID# 250693, Valence, Drome, 26000, France|Centre Hospitalier de Quimper /ID# 251119, Quimper CEDEX, Finistere, 29107, France|CHU Montpellier - Hopital Saint Eloi /ID# 251877, Montpellier Cedex 5, Herault, 34295, France|Hopital Prive d'Antony /ID# 247324, Antony, Ile-de-France, 92160, France|CHU nord - hopital Felix Guyon /ID# 250694, St Denis, Le Reunion, 97400, France|Polyclinique Courlancy /ID# 250476, Reims, Marne, 51100, France|Hopital du Scorff /ID# 251226, Lorient, Morbihan, 56100, France|Centre Hospitalier de Valenciennes /ID# 258642, Valenciennes, Nord, 59300, France|Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 247209, Creteil, Paris, 94010, France|Hopitaux Universitaires Paris Centre-Hopital Cochin /ID# 250807, Paris CEDEX 14, Paris, 75679, France|CHU de Nantes, Hotel Dieu -HME /ID# 262563, Nantes, Pays-de-la-Loire, 44000, France|HCL - Hopital Lyon Sud /ID# 248864, Pierre Benite CEDEX, Rhone, 69495, France|Centre Hospitalier du Mans /ID# 250510, Le Mans CEDEX 9, Sarthe, 72037, France|Centre Hospitalier MÃ©tropole Savoie - Site HÃ´pital de ChambÃ©ry /ID# 252012, Chambery CEDEX, Savoie, 73007, France|CH Pontoise - Hopital RenÃ© Dubos /ID# 248843, Pontoise, Val-d Oise, 95300, France|CH Avignon /ID# 251198, Avignon, Vaucluse, 84902, France|CHI POISSY - Saint-Germain-en-Laye /ID# 248612, St Germain en Laye, Yvelines, 78100, France|Hopital Nord Amiens /ID# 250300, Amiens, 80080, France|Chu Angers /Id# 248674, Angers, 49933, France|CH Victor Dupouy /ID# 247216, Argenteuil, 95100, France|Hopital Ambroise Pare /ID# 253337, Boulogne Billancourt, 92104, France|Centre Hospitalier de BÃ©ziers /ID# 264454, BÃ©ziers, 34525, France|CHU de CAEN - Hopital de la Cote de Nacre /ID# 252127, Caen, 14033, France|CH de Cahors /ID# 251190, Cahors CEDEX 9, 46005, France|Centre Hospitalier de Calais /ID# 249449, Calais, 62100, France|Cabinet Dermatologie et Esthetique /ID# 247972, Cannes, 06400, France|CH William Morey /ID# 256417, Chalon Sur Saone, 71321, France|CH Annecy Genevois - Site Annecy /ID# 249024, Epagny Metz Tessy, 74370, France|CH la Rochelle /ID# 252128, La Rochelle CEDEX 1, 17019, France|CH Emile Roux Le Puy en Velay /ID# 248983, Le Puy en Velay, 43000, France|Hopital Saint Vincent de Paul /ID# 247218, Lille Cedex, 59020, France|CHU Limoges - Dupuytren 2 /ID# 251224, Limoges, 87000, France|Hopital Femme Mere Enfant /ID# 258682, Lyon, 69500, France|HÃ´pital EuropÃ©en Marseille /ID# 257643, Marseille, 13003, France|Cideazur /ID# 247905, Nice, 06000, France|Hopital Saint Louis /ID# 251228, Paris, 75010, France|Cabinet libÃ©ral du Dr KURIHARA /ID# 249664, Paris, 75011, France|Hopital Pitie Salpetriere /ID# 253464, Paris, 75013, France|Hopital Bichat-Claude Bernard /ID# 251274, Paris, 75018, France|CH de PAU /ID# 248567, Pau, 64000, France|CHU de Rouen /ID# 250648, Rouen CEDEX, 76031, France|HÃ´pital Charles-Nicolle /ID# 247215, Rouen, 76000, France|CH de St Nazaire /ID# 251200, Saint Nazaire, 44600, France|HÃ´pital d'instruction des armÃ©es BÃ©gin /ID# 247751, Saint-MandÃ© cedex, 94163, France|Ch Salon de Provence /Id# 248829, Salon de Provence, 13300, France|Centre Hospitalier Universitaire de Saint Ã‰tienne - HÃ´pital Nord /ID# 251117, St-Priest-en-Jarez, 42270, France|CHR Metz-Thionville - Hopital Bel-Air /ID# 252267, Thionville, 57100, France|HÃ´pital d'Instruction des ArmÃ©es Sainte-Anne /ID# 247908, Toulon CEDEX 9, 83800, France|CHU Toulouse - Hopital Larrey /ID# 247219, Toulouse, 31400, France|Hopital Nord Franche ComtÃ© /ID# 261628, Trevenans, 90400, France|Cabinet Liberal /ID# 251195, Villeurbanne, 69100, France","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT06397781,Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT06397781,NO,Atopic Dermatitis,DRUG: Skin Cleanser Combination No.1,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,,Boston Children's Hospital
Atopic Dermatitis,NCT06022874,The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06022874,NO,Atopic Dermatitis,OTHER: Phoilex Releaf Gel,ALL,"ADULT, OLDER_ADULT",,"Phoenix Medical Spa X Peak Human, Brampton, Ontario, L6W 3E1, Canada","Principal Investigator : Sanjeev Goel, MD , Phoenix Medical Spa X Peak Human"
Atopic Dermatitis,NCT05694884,Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab,https://clinicaltrials.gov/study/NCT05694884,NO,Atopic Dermatitis,DRUG: Placebo|DRUG: ASLAN004,ALL,"ADULT, OLDER_ADULT",PHASE2,"ASLAN Investigative Site, Birmingham, Alabama, 35244, United States|ASLAN Investigative Site, Encino, California, 91436, United States|ASLAN Investigative Site, Fountain Valley, California, 92708, United States|ASLAN Investigative Site, Long Beach, California, 90806, United States|ASLAN Investigative Site, Los Angeles, California, 90025, United States|ASLAN Investigative Site, Sherman Oaks, California, 91403, United States|ASLAN Investigative Site, Boca Raton, Florida, 33486, United States|ASLAN Investigative Site, Hollywood, Florida, 33021, United States|ASLAN Investigative Site, Hollywood, Florida, 33436, United States|ASLAN Investigative Site, Miami Lakes, Florida, 33014, United States|ASLAN Investigative Site, North Miami Beach, Florida, 33162, United States|ASLAN Investigative Site, Orange City, Florida, 32720, United States|ASLAN Investigative Site, Saint Augustine, Florida, 32080, United States|ASLAN Investigative Site, Saint Petersburg, Florida, 33705, United States|ASLAN Investigative Site, New Albany, Indiana, 47150, United States|ASLAN Investigative Site, Louisville, Kentucky, 40217, United States|ASLAN Investigative Site, Quincy, Massachusetts, 02169, United States|ASLAN Investigative Site, Auburn Hills, Michigan, 48326, United States|ASLAN Investigative Site, Las Vegas, Nevada, 89148, United States|ASLAN Investigative Site, E. Amherst, New York, 14051, United States|ASLAN Investigative Site, Charlotte, North Carolina, 28277, United States|ASLAN Investigative Site, Oklahoma City, Oklahoma, 73118, United States|ASLAN Investigative Site, Johnston, Rhode Island, 02919, United States|ASLAN Investigative Site, Charleston, South Carolina, 29407, United States|ASLAN Investigative Site, Hamilton, Ontario, L8LCC3, Canada|ASLAN Investigative Site, Ottawa, Ontario, K1H1E4, Canada|ASLAN Investigative Site, Toronto, Ontario, Canada","Study Director : Chief Medical Officer , ASLAN Pharmaceuticals"
Atopic Dermatitis,NCT06412094,Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06412094,NO,Atopic Dermatitis,"OTHER: Standard care|BEHAVIORAL: Access to the ""AtopicApp"" mobile application|BEHAVIORAL: Virtual oversight through the AtopicApp",ALL,CHILD,,"Samara State Medical University, Samara, 443079, Russian Federation","Principal Investigator : Natalia Migacheva, MD, PhD , Samara State Medical University"
Atopic Dermatitis,NCT05158023,Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05158023,NO,Atopic Dermatitis,DRUG: Placebo Comparator|BIOLOGICAL: ASLAN004|BIOLOGICAL: ASLAN004|BIOLOGICAL: ASLAN004|BIOLOGICAL: ASLAN004,ALL,"ADULT, OLDER_ADULT",PHASE2,"ASLAN Investigative Site, Birmingham, Alabama, 35209, United States|ASLAN Investigative Site, Birmingham, Alabama, 35244, United States|ASLAN Investigative Site, Little Rock, Arkansas, 72205, United States|Tooraj Raoof, MD, Encino, California, 91436, United States|ASLAN Investigative Site, Fountain Valley, California, 92708, United States|Center for Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|ASLAN Investigative Site, Los Angeles, California, 90033, United States|ASLAN Investigative Site, Los Angeles, California, 90057, United States|MedDerm Associates, San Diego, California, 92103, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Skin Care Research, LLC, Boca Raton, Florida, 33486, United States|Encore Medical Research of Boynton Beach, Boynton Beach, Florida, 33436, United States|Driven Research, LLC, Coral Gables, Florida, 33134, United States|Aby's New Generation Research, Inc., Hialeah, Florida, 33016, United States|ASLAN Investigative Site, Hollywood, Florida, 33021, United States|Skin Research of South Florida, Miami, Florida, 33173, United States|ASLAN Investigative Site, Miami, Florida, 33176, United States|ASLAN Investigative Site, North Miami Beach, Florida, 33162, United States|ASLAN Investigative Site, Saint Augustine, Florida, 32080, United States|ASLAN Investigative Site, Tampa, Florida, 33607, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|ASLAN Investigative Site, Columbus, Georgia, 31904, United States|Skin Care Physicians of Georgia, Macon, Georgia, 31217, United States|ASLAN Investigative Site, Meridian, Idaho, 83642, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|ASLAN Investigative Site, Louisville, Kentucky, 40217, United States|ASLAN Investigative Site, Baton Rouge, Louisiana, 70808, United States|Allcutis Research LLC, Beverly, Massachusetts, 01915, United States|ASLAN Investigative Site, Quincy, Massachusetts, 02169, United States|ASLAN Investigative Site, Ann Arbor, Michigan, 48103, United States|ASLAN Investigative Site, Las Vegas, Nevada, 89148, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|Bobby Buka MD, PC, New York, New York, 10012, United States|ASLAN Investigative Site, New York, New York, 10075, United States|ASLAN Investigative Site, Medford, Oregon, 97504, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Clinical Partners, LLC, Johnston, Rhode Island, 02919, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|ASLAN Investigative Sites, Rapid City, South Dakota, 57702, United States|ASLAN Investigative Site, Nashville, Tennessee, 37215, United States|Dermatology Treatment and Research Center, Dallas, Texas, 75230, United States|Modern Research Associates, Dallas, Texas, 75231, United States|Menter Dermatology Research Institute, Dallas, Texas, 75246, United States|Center for Clinical Studies LTD, LLP, Houston, Texas, 77004, United States|ASLAN Investigative Site, San Antonio, Texas, 78209, United States|ASLAN Investigative Site, South Jordan, Utah, 84095, United States|Premier Specialist, Kogarah, New South Wales, 2217, Australia|Holdsworth House Medical Practice, Sydney, New South Wales, 2010, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 4102, Australia|Eastern Clinical Research, Box Hill, Victoria, 3128, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Fremantle Dermatology, Fremantle, Western Australia, 6160, Australia|Wiseman Dermatology Research, Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|DermEffects, London, Ontario, N6H 5L5, Canada|ASLAN Investigative Site, Markham, Ontario, L3P 1X3, Canada|Gordon Sussman Clinical Research Inc., North York, Ontario, M3B 3S6, Canada|Skin Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Centre de Recherche dermatologique du Quebec Metropolitain, Quebec City, Quebec, G1V 4X7, Canada|Centre de Recherche Saint-Louis (Quebec), Quebec, 1W4R4, Canada|ASLAN Investigative Site, Santo Domingo, 00000, Dominican Republic|B. J. Medical College and Civic Hospital, Asarwa, Ahmedabad, 380016, India|Nirmal Hospital Pvt Ltd., SÅ«rat, Gujarat, 395002, India|NKP Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur, Maharashtra, 440019, India|D Y Patil Hospital, Navi Mumbai, Maharashtra, 400706, India|Calcutta School of Tropical Medicine, Kolkata, West Bengal, 700073, India|Sir Ganga Ram Hospital, New Delhi, 110060, India|Lifepoint Multispeciality Hospital, Pune, 411057, India|King George Hospital, Visakhapatnam, 530002, India|Clinical Trials NZ, Hamilton, 3204, New Zealand|ASLAN Investigative Site, Bydgoszcz, 85231, Poland|ASLAN Investigative Site, Katowice, 40611, Poland|ASLAN Investigative Site, KrakÃ³w, 30033, Poland|ASLAN Investigative Site, KrakÃ³w, 31011, Poland|ASLAN Investigative Site, TarnÃ³w, 33100, Poland|ASLAN Investigative Site, Warsaw, 02953, Poland|ASLAN Investigative Site, Warszawa, 01817, Poland|ASLAN Investigative Site, WrocÅ‚aw, 50566, Poland|ASLAN Investigative Site, ÅÃ³dÅº, 90436, Poland|ASLAN Investigative Site, Singapore, 119260, Singapore|ASLAN Investigative Site, Singapore, 169608, Singapore|KK Women's and Children's Hospital, Singapore, 229899, Singapore|National Skin Centre, Singapore, 308205, Singapore","Study Director : Chief Medical Officer , ASLAN Pharmaceuticals"
Atopic Dermatitis,NCT05717920,A Clinical Trial in Subjects With Atopic Dermatitis (Part 1),https://clinicaltrials.gov/study/NCT05717920,NO,Atopic Dermatitis,DRUG: Part 1 ADX-629 (Open-label),ALL,"ADULT, OLDER_ADULT",PHASE2,"Bexley Dermatology Research, Bexley, Ohio, 43209, United States","Aldeyra Therapeutics, Inc."
Atopic Dermatitis,NCT05398445,A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE),https://clinicaltrials.gov/study/NCT05398445,NO,Atopic Dermatitis,DRUG: Rocatinlimab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States|Alliance Dermatology and Mohs Center, Phoenix, Arizona, 85032, United States|Anaheim Clinical Trials, Anaheim, California, 92801, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Kaiser Permanente - Glendale Medical Center, Glendale, California, 91203, United States|Long Beach Research Institute, Long Beach, California, 90805, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, 90027, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Cura Clinical Research, Sherman Oaks, California, 91403, United States|IMMUNOe Research Centers, Centennial, Colorado, 80112, United States|Skin Care Research Incorporated, Boca Raton, Florida, 33486, United States|Palm Beach Dermatology Group, Delray Beach, Florida, 33484, United States|Global Research Associates, Homestead, Florida, 33030, United States|Savin Medical Group LLC, Miami Lakes, Florida, 33014, United States|Healthy Life Research, Miami, Florida, 33175, United States|Kirsch Dermatology LLC, Naples, Florida, 34102, United States|Pure Skin Dermatology and Aesthetics, Orlando, Florida, 32819, United States|Industrial Medicine Associates Ima Clinical Research Inc, Saint Petersburg, Florida, 33709, United States|Genesis Clinical Research LLC, Tampa, Florida, 33606, United States|Treasure Valley Medical Research, Boise, Idaho, 83706, United States|DeNova Research, Chicago, Illinois, 60611, United States|Dundee Dermatology, West Dundee, Illinois, 60118, United States|The Indiana Clinical Trials Center PC, Plainfield, Indiana, 46168, United States|Institute for Asthma and Allergy, Chevy Chase, Maryland, 20815, United States|Continental Clinical Solutions, LLC, Towson, Maryland, 21204, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Onyx Clinical Research, Flint, Michigan, 48532, United States|Dermatology and Skin Cancer Center of Lees Summit, Lee's Summit, Missouri, 64064, United States|Jubilee Clinical Research Inc, Las Vegas, Nevada, 89106, United States|Allcutis Research, Llc - Portsmouth, Portsmouth, New Hampshire, 03801, United States|Continental Clinical Solutions - Cherry Hill, Cherry Hill, New Jersey, 08034, United States|Industrial Medicine Associates Ima Clinical Research Inc, Hartsdale, New York, 10530, United States|Sadick Research Group, New York, New York, 10075, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|Onsite Clinical Solutions, Charlotte, North Carolina, 28277, United States|Wilmington Dermatology Center, Wilmington, North Carolina, 28405, United States|The Skin Surgery Center for Clinical Research, Winston-Salem, North Carolina, 27103, United States|Optima Research, Boardman, Ohio, 44512, United States|ClinOhio Research Services, Columbus, Ohio, 43213, United States|Unity Clinical Research, Oklahoma City, Oklahoma, 73118, United States|Dermatology Research Center of Oklahoma, PLLC, Tulsa, Oklahoma, 74132, United States|Essential Medical Research LLC, Tulsa, Oklahoma, 74137, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|DermDox Dermatology, LLC, Sugarloaf, Pennsylvania, 18249, United States|Cumberland Skin Center, Hermitage, Tennessee, 37076, United States|Dermatology Treatment and Research Center PA, Dallas, Texas, 75230, United States|The Woodlands Dermatology Associates, The Woodlands, Texas, 77380, United States|Education and Research Foundation Inc, Lynchburg, Virginia, 24501, United States|Frontier Derm Partners, Mill Creek, Washington, 98012, United States|West Virginia Research Institute, Morgantown, West Virginia, 26505, United States|Cinme - Centro de Investigaciones Metabolicas, Caba, Buenos Aires, C1027AAP, Argentina|Fundacion Respirar, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1426ABP, Argentina|Hospital Universitario Austral, Derqui, Pilar, Buenos Aires, B1629ODT, Argentina|Centro DermatolÃ³gico Schejtman, San Miguel, Buenos Aires, 1663, Argentina|Conexa Investigacion Clinica SA, Caba, Distrito Federal, C1012AAY, Argentina|InAER - Investigaciones en Alergia y Enfermedades Respiratorias, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1425, Argentina|Instituto de Neumonologia y Dermatologia, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1425, Argentina|Fundacion Estudios Clinicos, Rosario, Santa Fe, 2000, Argentina|Instituto de Diagnostico Abc American British Cowdray, Rosario, Santa Fe, 2000, Argentina|Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-903, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Rio Grande Do Sul, 90160-093, Brazil|Upeclin-Pesq Clin FacMed Botucatu, Botucatu, SÃ£o Paulo, 18618-686, Brazil|Hosp e Maternidade Dr Christovao da Gama, Santo Andre, SÃ£o Paulo, 09030-010, Brazil|Fundacao Abc - Centro Univ Fmabc, Santo Andre, SÃ£o Paulo, 09060-870, Brazil|Consultoria Medica e Pesquisa Clinica Cmpc, Sorocaba, SÃ£o Paulo, 18040-425, Brazil|IBPClin Instituto Brasil de Pesquisa Clinica, Rio de Janeiro, 20241-180, Brazil|Alergoalfa Nucleo Diagnostico Tratamento e Pesquisa Clinica em Alergia, SÃ£o Paulo, 06454-010, Brazil|Alberta Derma Surgery Centre, Edmonton, Alberta, T6G 1C3, Canada|Vida Clinical Research, Edmonton, Alberta, T6H 4J8, Canada|CCA Medical Research Corporation, Ajax, Ontario, L1S 7K8, Canada|SimcoDerm Medical and Surgical Dermatology Centre, Barrie, Ontario, L4M 7G1, Canada|LEADER Research, Hamilton, Ontario, L8L 3C3, Canada|DermEdge Research Incorporated, Mississauga, Ontario, L4Y 4C5, Canada|Canadian Dermatology Centre, North York, Ontario, M3B 0A7, Canada|Gordon Sussman Clinical Research Incorporated, North York, Ontario, M3B 3S6, Canada|Oak Ridges Aesthetics Centre, Richmond Hill, Ontario, L4E 4L6, Canada|Innovaderm Research Inc, Montreal, Quebec, H2X 2V1, Canada|Skinsense Medical Research, Saskatoon, Saskatchewan, S7K 2C1, Canada|Recherche Clinique Sigma Incorporated, Quebec, G1G 3Y8, Canada|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350000, China|The First Affiliated Hospital ,Sun-Yat Sen University, Guangzhou, Guangdong, 510080, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, 510091, China|Sun Yat-sen Memorial Hospital Sun Yat-sen University, Guangzhou, Guangdong, 510120, China|The First Hospital Of Hebei Medical University, Shijiazhuang, Hebei, 050000, China|Nanyang First Peoples Hospital, Nanyang, Henan, 473002, China|Sanmenxia Central Hospital, Sanmenxia, Henan, 472099, China|Union Hospital Tongji Medical College Huazhong University of science and Technology, Wuhan, Hubei, 430022, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China|Jiangyin Hospital of Traditional Chinese Medicine, Jiangyin, Jiangsu, 214400, China|Wuxi Peoples Hospital, Wuxi, Jiangsu, 241023, China|Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, 330000, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China|Chengdu Second Peoples Hospital, Chengdu, Sichuan, 610021, China|the First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|Zhejiang Provincial Peoples Hospital, Hangzhou, Zhejiang, 310004, China|Affiliated Hangzhou First Peoples Hospitalï¼ŒZhejiang University School of Medicine, Hangzhou, Zhejiang, 310020, China|Taizhou Central Hospital, Taizhou, Zhejiang, 318000, China|Peking University Peoples Hospital, Beijing, 100044, China|Shanghai Skin Disease Hospital, Shanghai, 200443, China|Special Hospital for Medical Rehabilitation Naftalan, Ivanic-Grad, 10310, Croatia|Sestre milosrdnice University Hospital Center, Zagreb, 10000, Croatia|University Hospital Centre Zagreb, Zagreb, 10000, Croatia|Dermamedica, sro, Nachod, 547 01, Czechia|CCR Ostrava sro, Ostrava, 702 00, Czechia|Pratia Pardubice as, Pardubice, 530 02, Czechia|Clintrial sro, Praha 10, 100 00, Czechia|Pratia Prague sro, Praha 3, 130 00, Czechia|Fakultni nemocnice Bulovka, Praha 8, 180 81, Czechia|Krajska zdravotni as - Masarykova nemocnice Usti nad Labem oz, Usti nad Labem, 401 13, Czechia|Charite - Universitaetsmedizin Berlin, Campus Mitte, Berlin, 10117, Germany|Dermatologische Gemeinschaftspraxis-Mahlow, Blankenfelde-Mahlow, 15831, Germany|Hautarztpraxis Dr Niesmann und Dr Othlinghaus, Bochum, 44793, Germany|Rosenpark Research GmbH, Darmstadt, 64283, Germany|Universitaetsklinikum Dresden, Dresden, 01307, Germany|Heinrich-Heine-Universitaet Duesseldorf - Universitaetsklinikum Duesseldorf, Duesseldorf, 40225, Germany|Universitaetsklinikum Essen, Essen, 45174, Germany|Institute for Health Services Research in Dermatology and Nursing, Hamburg, 20246, Germany|Universitaetsklinikum Heidelberg, Heidelberg, 69120, Germany|Hautarztpraxis Dres Leitz und Kollegen, Stuttgart, 70178, Germany|Universitaetsklinikum Tuebingen, Tuebingen, 72076, Germany|CentroDerm GmbH, Wuppertal, 42287, Germany|Athens Naval Hospital, Athens, 11521, Greece|Thoracic General Hospital Of Athens Sotiria, Athens, 11527, Greece|University General Hospital Attikon, Athens, 12462, Greece|Andreas Syngros Hospital Of Venereal And Dermatological Diseases, Athens, 16121, Greece|University General Hospital of Ioannina, Ioannina, 45500, Greece|General University Hospital of Larissa, Larissa, 41110, Greece|Papageorgiou General Hospital, Thessaloniki, 56403, Greece|Medmare Bt, Veszprem, 8200, Hungary|Universita degli Studi Gabriele D Annunzio di Chieti e Pescara, Chieti, 66100, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia, Perugia, 06156, Italy|Azienda Ospedaliera Policlinico Umberto I, Roma, 00161, Italy|Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino, 10126, Italy|Aichi Medical University Hospital, Nagakute-shi, Aichi, 480-1195, Japan|Japan Community Healthcare Organization Chukyo Hospital, Nagoya-shi, Aichi, 457-8510, Japan|Central Clinic, Nagoya-shi, Aichi, 464-0821, Japan|Nagoya City University Hospital, Nagoya-shi, Aichi, 467-8602, Japan|Fukuoka University Hospital, Fukuoka-shi, Fukuoka, 814-0180, Japan|Matsuo Clinic, Fukuoka-shi, Fukuoka, 819-0373, Japan|Fukushima Medical University Hospital, Fukushima-shi, Fukushima, 960-1295, Japan|Asahikawa City Hospital, Asahikawa-shi, Hokkaido, 070-8610, Japan|Tokyo Medical University Ibaraki Medical Center, Inashiki-gun, Ibaraki, 300-0395, Japan|Kaji Dermatology Clinic, Nonoichi-shi, Ishikawa, 921-8801, Japan|Iwate Medical University Uchimaru Medical Center, Morioka-shi, Iwate, 020-8505, Japan|Takeoka Dermatology Clinic, Marugame-shi, Kagawa, 763-0074, Japan|Nippon Medical School Musashikosugi Hospital, Kawasaki-shi, Kanagawa, 211-8533, Japan|University Hospital Kyoto Prefectural University of Medicine, Kyoto-shi, Kyoto, 602-8566, Japan|Rakuwakai Otowa Hospital, Kyoto-shi, Kyoto, 607-8062, Japan|Mochida Dermatology Clinic, Izumiotsu-shi, Osaka, 595-0025, Japan|Dokkyo Medical University Hospital, Shimotsuga-gun, Tochigi, 321-0293, Japan|Teikyo University Hospital, Itabashi-ku, Tokyo, 173-8606, Japan|Nihon University Itabashi Hospital, Itabashi-ku, Tokyo, 173-8610, Japan|Korea University Ansan Hospital, Ansansi, Gyeonggido, 15355, Korea, Republic of|The Catholic University of Korea Incheon St Marys Hospital, Incheon, 21431, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|National Medical Center, Seoul, 04564, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Korea University Guro Hospital, Seoul, 08308, Korea, Republic of|Outpatient clinic Veselibas Centrs 4, Riga, 1003, Latvia|Outpatient clinic Veselibascentrs 4, Riga, LV-1013, Latvia|Smite Aija practice in dermatology and venerology, Talsi, 3201, Latvia|PreCare Trial and Recruitment, Born, 6121 XK, Netherlands|AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy, Gdansk, 80-280, Poland|Centrum Medyczne Angelius Provita, Katowice, 40-611, Poland|Centrum Zdrowia i Urody Maxxmed, Lublin, 20-080, Poland|Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Spzoo, Malbork, 82-200, Poland|Twoja przychodnia Ncm, Nowa Sol, 67-100, Poland|Twoja przychodnia Pcm, Poznan, 61-293, Poland|Twoja Przychodnia Scm, Szczecin, 71-500, Poland|Alergo-Med Specjalistyczna Przychodnia Lekarska Spzoo, Tarnow, 33-100, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-962, Poland|Dermatologiczna Praktyka Lekarska Michal Torz Dermaceum Centrum Badan Klinicznych, Wroclaw, 50-450, Poland|Hospital Lusiadas Lisboa, Lisboa, 1500-458, Portugal|Hospital Cuf Descobertas, Lisboa, 1998-018, Portugal|Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano, Matosinhos, 4464-513, Portugal|Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio, Porto, 4099-001, Portugal|Clinical Research of Puerto Rico, San Juan, 00909, Puerto Rico|Fakultna Nemocnica s poliklinikou F D Roosevelta Banska Bystrica, Banska Bystrica, 975 17, Slovakia|Derma therapy, spol s ro, Bratislava, 851 01, Slovakia|Sanare spol sro, Svidnik, 089 01, Slovakia|Kaderma Majtan, sro, Topolcany, 955 01, Slovakia|Fakultna nemocnica Trnava, Trnava, 917 75, Slovakia|Hospital Universitario Reina Sofia, Cordoba, AndalucÃ­a, 14004, Spain|Hospital Universitario Miguel Servet, Zaragoza, AragÃ³n, 50009, Spain|Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Canarias, 35010, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, CataluÃ±a, 08916, Spain|Hospital Universitari de Bellvitge, Hospitalet de LLobregat, CataluÃ±a, 08907, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Comunidad Valenciana, 46026, Spain|Hospital Clinico Universitario de Santiago, Pontevedra, Galicia, 36001, Spain|Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon, Madrid, 28223, Spain|Hospital Universitario de La Princesa, Madrid, 28006, Spain|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain|Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan|National Cheng Kung University Hospital, Tainan, 70403, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Mackay Memorial Hospital Taipei Branch, Taipei, 10449, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Linkou Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan","Study Director : MD , Amgen"
Atopic Dermatitis,NCT03559075,Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03559075,NO,Atopic Dermatitis,,ALL,"ADULT, OLDER_ADULT",,"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, 27157, United States","Principal Investigator : Stevan Feldman, MD , Wake Forest University Health Sciences"
Atopic Dermatitis,NCT06176040,A Study of TAVO101 in Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT06176040,NO,Atopic Dermatitis,DRUG: TAVO101,ALL,"ADULT, OLDER_ADULT",PHASE2,"Optimal Clinical Trials, Auckland, New Zealand","Principal Investigator : Penelope Montgomery, MD , Optimal Clinical Trials"
Atopic Dermatitis,NCT04564755,Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04564755,NO,Atopic Dermatitis,DRUG: abrocitinib,ALL,"CHILD, ADULT, OLDER_ADULT",,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States|Antelope Valley Clinical Trials, Lancaster, California, 93534, United States|Allergy & Asthma Care Center, Long Beach, California, 90808, United States|ACRC Studies, San Diego, California, 92119, United States|Palm Beach Dermatology, Delray Beach, Florida, 33484, United States|Skin Care Research, Hollywood, Florida, 33021, United States|L&C Professional Medical Research Institute, Miami, Florida, 33144, United States|Sarasota Clinical Research, Sarasota, Florida, 34239, United States|Precision Clinical Research, Sunrise, Florida, 33351, United States|Dundee Dermatology, West Dundee, Illinois, 60118, United States|Qualmedica Research, LLC, Evansville, Indiana, 47715, United States|Bluegrass Allergy Research, Lexington, Kentucky, 40509, United States|Respiratory Medicine Research Institute of Michigan, PLC, Ypsilanti, Michigan, 48197, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Hightower Clinical Trial Services - Lam Dermatology, Norman, Oklahoma, 73072, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Memphis, Tennessee, 38119, United States|Center for Clinical Studies, LTD. LLP, Houston, Texas, 77004, United States|Houston Medical Imaging, Houston, Texas, 77072, United States|West Virginia Research Institute, Morgantown, West Virginia, 26505, United States|Woden Dermatology, Phillip, Australian Capital Territory, 2606, Australia|Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Dr Rodney Sinclair Pty Ltd, Melbourne, Victoria, 3995, Australia|Sinclair Dermatology, Melbourne, Victoria, 3995, Australia|Paratus Clinical Research Woden, Philip, 2606, Australia|Medizinische UniversitÃ¤t Wien, Vienna, Wien, 1090, Austria|Medical University of Vienna, Vienna, 1090, Austria|Cliniques universitaires Saint-Luc, Brussels, 1200, Belgium|Universitair Ziekenhuis Gent, Gent, 9000, Belgium|Grand HÃ´pital de Charleroi, Loverval, 6280, Belgium|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|DermEffects, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Centre de recherche Saint-Louis, Quebec, G1W 4R4, Canada|401 General Military Hospital of Athens, Athens, AttikÃ­, 11525, Greece|University General Hospital ""ATTIKON"", Athens, AttikÃ­, 12462, Greece|""Ippokrateio"" General Hospital of Thessaloniki interconnected with Hospital of Dermatology and Vener, Thessaloniki, KentrikÃ­ MakedonÃ­a, 54643, Greece|Centro de Dermatologia de Monterrey, Monterrey, Nuevo LEÃ“N, 64460, Mexico|Universitair Medisch Centrum (UMCU) Utrecht, Utrecht, 3584 CX, Netherlands|NRC Institute of Immunology FMBA of Russia, Moscow, 115522, Russian Federation|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Universitario de Gran Canaria Doctor NegrÃ­n, Las Palmas de Gran Canaria, LAS Palmas, 35010, Spain|Clinica Universidad de Navarra, Pamplona, Navarra, 31008, Spain|Complejo Hospitalario Universitario de Pontevedra Centro de Especialidades de Mollabao, Pontevedra, 36001, Spain|Consorcio Hospital General Universitario de Valencia, Valencia, 46014, Spain|UniversitÃ¤tsspital ZÃ¼rich, Zuerich, ZÃ¼rich, 8052, Switzerland|UniversitÃ¤tsspital ZÃ¼rich, Zuerich, ZÃ¼rich, 8091, Switzerland|Inselspital, UniversitÃ¤tsklinik fÃ¼r Dermatologie, Bern, 3010, Switzerland|Inselspital, UniversitÃ¤tsspital Bern (Radiology), Bern, 3010, Switzerland|University Hospital Geneva, Geneva 14, 1211, Switzerland|UniversitÃ¤tsspital ZÃ¼rich, ZÃ¼rich, CH-8091, Switzerland|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, 807, Taiwan|Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung, 83301, Taiwan|Taipei Veterans General Hospital, Taipei, 112, Taiwan","Study Director : Pfizer CT.gov Call Center , Pfizer"
Atopic Dermatitis,NCT05121480,"A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis",https://clinicaltrials.gov/study/NCT05121480,YES,Atopic Dermatitis,DRUG: EDP1815|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"USA-131, Birmingham, Alabama, 35244, United States|USA-112, Fountain Valley, California, 92708, United States|USA-123, Fremont, California, 94538, United States|USA-114, Newport Beach, California, 92660, United States|USA-101, Fort Lauderdale, Florida, 33308, United States|USA-124, Jacksonville, Florida, 32216, United States|USA-108, Miami, Florida, 33165, United States|USA-120, Miami, Florida, 33175, United States|USA-105, Miramar, Florida, 33027, United States|USA-102, Orlando, Florida, 32801, United States|USA-115, Sweetwater, Florida, 33172, United States|USA-126, Tampa, Florida, 33613, United States|USA-106, Tampa, Florida, 33624, United States|USA-118, Sandy Springs, Georgia, 30328, United States|USA-111, Clarksville, Indiana, 47129, United States|USA-116, Louisville, Kentucky, 40241, United States|USA-119, Baton Rouge, Louisiana, 70806, United States|USA-109, Metairie, Louisiana, 70006, United States|USA-125, Silver Spring, Maryland, 20902, United States|USA-130, Ann Arbor, Michigan, 48103, United States|USA-121, Columbus, Ohio, 43221, United States|USA-128, Concord, Ohio, 44077, United States|USA-104, Portland, Oregon, 97239, United States|USA-127, Memphis, Tennessee, 38119, United States|USA-117, Frisco, Texas, 75034, United States|USA-110, Pflugerville, Texas, 78660, United States|USA-113, Bellevue, Washington, 98004, United States|AUS-102, Carlton, Australia|AUS-104, Kogarah, Australia|AUS-101, Melbourne, Australia|AUS-106, Woolloongabba, Australia|BGR-105, Pleven, Bulgaria|BGR-104, Sevlievo, Bulgaria|BGR-101, Sofia, Bulgaria|BGR-102, Sofia, Bulgaria|BGR-103, Sofia, Bulgaria|CAN-109, Barrie, Canada|CAN-108, Edmonton, Canada|CAN-105, Markham, Canada|CAN-104, Mississauga, Canada|CAN-101, Ottawa, Canada|CAN-107, Richmond Hill, Canada|CAN-103, Surrey, Canada|CAN-106, Waterloo, Canada|CAN-111, Winnipeg, Canada|DEU-105, Berlin, Germany|DEU-107, Bochum, Germany|DEU-106, Erlangen, Germany|DEU-102, Frankfurt am Main, Germany|DEU-104, Gera, Germany|DEU-101, Hamburg, Germany|DEU-103, Heidelberg, Germany|POL-104, GdaÅ„sk, Poland|POL-106, Gdynia, Poland|POL-107, Katowice, Poland|POL-101, Lublin, Poland|POL-102, Warszawa, Poland|POL-103, WrocÅ‚aw, Poland|POL-105, ÅÃ³dÅº, Poland","Principal Investigator : Benjamin Ehst, MD, PhD , Oregon Medical Research Center Study Director : Yanislav Mihaylov, MD , Evelo Biosciences, Inc."
Atopic Dermatitis,NCT05436535,Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis,https://clinicaltrials.gov/study/NCT05436535,NO,Atopic Dermatitis,BIOLOGICAL: Dupilumab|DRUG: Vanicream- Dupilumab-naÃ¯ve|DRUG: Triamcinolone Acetonide|DRUG: Hydrocortisone|DRUG: Vanicream- Active|DRUG: Vanicream- Experienced Dupilumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"University of California, San Diego: Dermatology Clinical Trials Unit, La Jolla, California, 92093, United States|Children's Hospital Los Angeles: Division of Clinical Immunology & Allergy, Los Angeles, California, 90027, United States|National Jewish Health: Division of Pediatric Allergy and Clinical Immunology, Denver, Colorado, 80206, United States|Boston Children's Hospital: Department of Immunology, Boston, Massachusetts, 02215, United States|Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York, New York, 10029, United States|University of Rochester Medical Center: Department of Dermatology, Rochester, New York, 14642, United States|North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill, North Carolina, 27599, United States|Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati, Ohio, 45229, United States|Oregon Health & Science University: Department of Dermatology, Portland, Oregon, 97239, United States|University of Pennsylvania, Perelman Center for Advanced Medicine: Department of Dermatology, Philadelphia, Pennsylvania, 19104, United States",
Atopic Dermatitis,NCT05081557,"A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT05081557,NO,Atopic Dermatitis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Hospital Universitario Austral /ID# 241607, Pilar, Buenos Aires, 1629, Argentina|Buenos Aires Skin /ID# 241606, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1055, Argentina|CEDIC Centro de Investigaciones Clinicas /ID# 241605, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1425, Argentina|Instituto de Neumonologia y Dermatologia /ID# 241604, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1425, Argentina|Centro Respiratorio Infantil /ID# 241609, Rosario, Santa Fe, 2000, Argentina|Hospital Italiano /ID# 241608, Caba, C1199ABB, Argentina|Kingsway Dermatology & Aesthetics /ID# 242276, Miranda, New South Wales, 2228, Australia|Veracity Clinical Research /ID# 242275, Woolloongabba, Queensland, 4102, Australia|Flinders Medical Centre /ID# 242162, Bedford, Park, South Australia, 5042, Australia|Sinclair Dermatology - Melbourne /ID# 242163, East Melbourne, Victoria, 3002, Australia|Burswood Dermatology /ID# 243767, Victoria Park, Western Australia, 6100, Australia|Sydney Skin /ID# 242277, Newtown, 2042, Australia|Ordensklinikum Linz GmbH Elisabethinen /ID# 246565, Linz, Oberoesterreich, 4010, Austria|Klinikum Wels-Grieskirchen GmbH /ID# 247369, Wels, Oberoesterreich, 4600, Austria|Dr. Achim Schneeberger /ID# 247370, Nenzing, Vorarlberg, 6710, Austria|Medizin am Hauptbahnhof /ID# 246567, Vienna, Wien, 1100, Austria|EZW HAUT Entzuendungszentrum Wien /ID# 246566, Vienna, Wien, 1130, Austria|Rejuvenation Dermatology - Edmonton Downtown /ID# 240377, Edmonton, Alberta, T5J 3S9, Canada|Winnipeg Clinic /ID# 239603, Winnipeg, Manitoba, R3C 0N2, Canada|Dr. Irina Turchin PC Inc. /ID# 240358, Fredericton, New Brunswick, E3B 1G9, Canada|Karma Clinical Trials /ID# 239602, St. John's, Newfoundland and Labrador, A1A 4Y3, Canada|NewLab Clinical Research Inc. /ID# 239600, St. John's, Newfoundland and Labrador, A1C 2H5, Canada|Dr Melinda Gooderham Medicine Profession /ID# 239745, Cobourg, Ontario, K9A 0Z4, Canada|Lima's Excellence in Allergy and Dermatology Research Inc /ID# 239854, Hamilton, Ontario, L8L 3C3, Canada|Lynde Institute for Dermatology /ID# 240025, Markham, Ontario, L3P 1X2, Canada|Gordon Sussman Medicine Professional Corporation /ID# 243383, North York, Ontario, M3B 3S6, Canada|JRB Research /ID# 241862, Ottawa, Ontario, K1H 7X3, Canada|Dr. Michael Cecchini Medicine Professional Corporation /ID# 239605, Richmond Hill, Ontario, L4B 1L1, Canada|Dr. Lyne Giroux Medicine Professional Corporation /ID# 240084, Sudbury, Ontario, P3C 1X3, Canada|North York Research Inc /ID# 253191, Toronto, Ontario, M2N 3A6, Canada|Canadian Dermatology Centre /ID# 240585, Toronto, Ontario, M3B 0A7, Canada|Centricity Research - Toronto Dermatology /ID# 241019, Toronto, Ontario, M4C 1L1, Canada|Dr Maksym Breslavets Medicine Professional Corporation /ID# 239741, Whitby, Ontario, L1N 8M7, Canada|Clinique D /ID# 239601, Laval, Quebec, H7N 6L2, Canada|Roula Rassi MD Inc /ID# 252562, Laval, Quebec, H7P 4K7, Canada|Dre Angelique Gagne-Henley M.D. inc. /ID# 239604, Saint-Jerome, Quebec, J7Z 7E2, Canada|Clinique de Dermatologie du Haut-Richelieu /ID# 239742, St-Jean Sur Le Richelieu, Quebec, J3A 1B5, Canada|Nemocnice Na Bulovce /ID# 246482, Prague, Stredocesky Kraj, 180 81, Czechia|Nemocnice Ceske Budejovice a.s. /ID# 246479, Ceske Budejovice, 370 01, Czechia|Fakultni nemocnice Olomouc /ID# 251177, Olomouc, 779 00, Czechia|Duplicate_Fakultni Nemocnice v Motole /ID# 246480, Prague, 150 00, Czechia|Fakultni nemocnice Kralovske Vinohrady /ID# 250792, Praha, 100 34, Czechia|Olympion General Clinic /ID# 261694, Patras, Achaia, 25443, Greece|Hygeia Hospital /ID# 254188, Amaroussio, Attiki, 15123, Greece|401 GSNA - 401 Army General Hospital /ID# 253222, Athens, Attiki, 11527, Greece|401 GSNA - 401 Army General Hospital /ID# 253228, Athens, Attiki, 11527, Greece|University General Hospital Attikon /ID# 253221, Athens, Attiki, 12462, Greece|General Hospital Andreas Syggros /ID# 253220, Athens, Attiki, 16121, Greece|Tzaneio general hospital of Piraeus /ID# 253223, Piraeus, Attiki, 18536, Greece|Naval Hospital of Athens /ID# 253229, Athens, 11521, Greece|University General Hospital of Larissa /ID# 254216, Larissa, 41110, Greece|Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 253225, Thessaloniki, 54643, Greece|Papageorgiou General Hospital /ID# 253226, Thessaloniki, 56429, Greece|Debreceni Egyetem-Klinikai Kozpont /ID# 239949, Debrecen, Hajdu-Bihar, 4032, Hungary|Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 239951, Szombathely, Vas, 9700, Hungary|Semmelweis Egyetem /ID# 239948, Budapest, 1085, Hungary|Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 239950, Pecs, 7624, Hungary|Szegedi TudomÃ¡nyegyetem /ID# 239947, Szeged, 6720, Hungary|HaEmek Medical Center /ID# 247834, Afula, H_efa, 1834111, Israel|Rambam Health Care Campus /ID# 244904, Haifa, H_efa, 3109601, Israel|Maccabi /ID# 252598, Haifa, H_efa, 7176250, Israel|The Edith Wolfson Medical Center /ID# 244902, Ashkelon, HaDarom, 5822000, Israel|Duplicate_Kaplan Medical Center /ID# 244903, Rehovot, HaMerkaz, 7661041, Israel|Leumit /ID# 260022, Rehovot, HaMerkaz, 9458414, Israel|ZIV Medical Center /ID# 244908, Safed, HaTsafon, 13100, Israel|Sheba Medical Center /ID# 244905, Ramat Gan, Tel-Aviv, 52621, Israel|Tel Aviv Sourasky Medical Center /ID# 244907, Tel Aviv, Tel-Aviv, 6423906, Israel|Shaare Zedek Medical Center /ID# 247833, Jerusalem, Yerushalayim, 91031, Israel|Ospedale Policlinico San Martino /ID# 255081, Genoa, Genova, 16132, Italy|Ospedale San Raffaele IRCCS /ID# 255285, Milan, Milano, 20132, Italy|AOU Citta della Salute e della Scienza di Torino /ID# 254615, Torino, Piemonte, 10126, Italy|Universita Campus Biomedico /ID# 255283, Rome, Roma, 00128, Italy|AOU San Giovanni e Ruggi Salerno - Presidio Ospedaliero S.M.I. dell'Olmo /ID# 254689, Cava De' Tirreni, Salerno, 84013, Italy|Azienda Ospedaliera Universitaria Consorziale Policlinico /ID# 254612, Bari, 70124, Italy|Presidio Ospedaliero Gaspare Rodolico /ID# 255707, Catania, 95123, Italy|AOU Gaetano Martino /ID# 255080, Messina, 98122, Italy|Azienda Ospedaliero Universitaria Maggiore della Carita di Novara /ID# 254613, Novara, 28100, Italy|Azienda ULSS 8 Berica/Ospedale San Bortolo di Vicenza /ID# 255011, Vicenza, 36100, Italy|Centro de Investigacion Biologica y Terapia Avanzada SC (CIMBYTA) /ID# 243820, Guadalajara, Jalisco, 44130, Mexico|Centro Dermatologico Del Country S de Rl de Cv /Id# 243818, Guadalajara, Jalisco, 44610, Mexico|Grupo Clinico Catei Sociedad Civil /Id# 243809, Guadalajara, Jalisco, 44657, Mexico|Consultorio Medico Privado Alejandra Macias Weinmann /Id# 244159, Monterrey, Nuevo Leon, 64623, Mexico|Clinica Dermassad /Id# 264048, San Pedro Garza GarcÃ­a, Nuevo Leon, 66220, Mexico|Consultorio Medico Privado Cipactli Ariel Navarro Hernandez /Id# 244165, Oaxaca de JuÃ¡rez, Oaxaca, 68000, Mexico|Consultorio Medico Privado Yuri Igor Lopez Carrera /Id# 244164, San AndrÃ©s Cholula, Puebla, 72820, Mexico|Consultorio Privado Leslie Lourdes Rodriguez /Id# 243819, MÃ©rida, Yucatan, 97203, Mexico|Consultorio Medico Privado Desiree Larenas Linnemann /Id# 244150, Ciudad de Mexico, 14050, Mexico|Centro Especializado en Diabetes, Obesidad y Prevencion de Enfermedades Cardiova /ID# 243856, Mexico City, 11650, Mexico|Neki Servicios Medicos Profesionales S D Rl de Cv /Id# 243817, Toluca, 50120, Mexico|Dermoklinika Medical Center /ID# 251249, Lodz, Lodzkie, 90-436, Poland|Luxderm Specjalistyczny Gabinet Dermatologiczny, /ID# 253106, Lublin, Lubelskie, 20-573, Poland|Maciej Pastuszczak Indywidualna Praktyka Lekarska /ID# 253105, Cracow, Malopolskie, 30-383, Poland|Panstwowy Instytut Medyczny MSWiA w Warszawie /ID# 252447, Warszawa, Mazowieckie, 02-507, Poland|Prywatna Praktyka Lekarska Witold Owczarek /ID# 252448, Warszawa, Mazowieckie, 02-962, Poland|KSW nr1 w Rzeszowie /ID# 251251, Rzeszow, Podkarpackie, 35-055, Poland|Chelyabinsk Regional Clinical Dermatovenerologic Dispensary /ID# 248262, Chelyabinsk, Chelyabinskaya Oblast, 454048, Russian Federation|Clinical Dermatovenerology Dispensary /ID# 245225, Krasnodar, Krasnodarskiy Kray, 350020, Russian Federation|National Research Center "" Institute of Immunology"" of the FMBA of Russia /ID# 245221, Moscow, Moskva, 115522, Russian Federation|Research and Clinical Center for Hematology, Oncology and Immunology, Ryazan Sta /ID# 245220, Ryazan, Ryazanskaya Oblast, 390029, Russian Federation|LLC Scientific Medical Center for General Therapy and Pharmacology /ID# 245229, Stavropol, Stavropol Skiy Kray, 355000, Russian Federation|LLC ""Medical Center ABC of Health"" /ID# 244816, Kazan, Tatarstan, Respublika, 420111, Russian Federation|Republican hospital named after V.A. Baranov /ID# 245230, Petrozavodsk, 185019, Russian Federation|Hospital Universitario Germans Trias i Pujol /ID# 248512, Badalona, Barcelona, 08916, Spain|Hospital Universitari de Bellvitge /ID# 248513, L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Universitari MÃºtua Terrassa /ID# 254292, Terrassa, Barcelona, 08221, Spain|Hospital San Pedro /ID# 248538, LogroÃ±o, La Rioja, 26006, Spain|Hospital Universitario Dr. Negrin /ID# 248533, Las Palmas de Gran Canaria, Las Palmas, 35019, Spain|Hospital Santa MarÃ­a del Rosell /ID# 251956, Cartagena, Murcia, 30203, Spain|Hospital Universitario Canarias /ID# 251957, San CristÃ³bal de La Laguna, Santa Cruz De Tenerife, 38320, Spain|Hospital Universitario Basurto /ID# 248508, Bilbao, Vizcaya, 48013, Spain|Hospital Parc de Salut del Mar /ID# 258675, Barcelona, 08003, Spain|Hospital Santa Creu i Sant Pau /ID# 248511, Barcelona, 08041, Spain|Hospital Universitario Virgen de las Nieves /ID# 248528, Granada, 18014, Spain|Hospital Universitario Clinico San Cecilio /ID# 248530, Granada, 18016, Spain|Hospital Juan Ramon Jimenez /ID# 251960, Huelva, 21005, Spain|Hospital Universitario de Jaen /ID# 251959, Jaen, 23007, Spain|Hospital Universitario Lucus Augusti /ID# 248507, Lugo, 27003, Spain|Hospital Universitario Virgen de la Victoria /ID# 248531, Malaga, 29010, Spain|Hospital Universitario de Salamanca /ID# 253356, Salamanca, 37711, Spain|Hospital Universitario Nuestra SeÃ±ora de Candelaria /ID# 251961, Santa Cruz de Tenerife, 38010, Spain|Hospital Universitario Virgen del Rocio /ID# 248527, Sevilla, 41013, Spain|Hospital Clinico Universitario de Valladolid /ID# 253355, Valladolid, 47003, Spain|Kantonsspital Aarau AG /ID# 245517, Aarau, Aargau, 5001, Switzerland|Dermatology & Skin Care Clinic /ID# 238348, Buochs, Nidwalden, 6374, Switzerland|Kantonsspital St. Gallen /ID# 239244, St. Gallen, Sankt Gallen, 9007, Switzerland|Haut- und Laserzentrum Weinfelden /ID# 239248, Weinfelden, Telangana, 8570, Switzerland|EOC Ospedale Regionale di Bellinzona e Valli /ID# 239246, Bellinzona, Ticino, 6500, Switzerland|Basile Darbellay SA /ID# 239245, OrsiÃ¨res, Valais, 1937, Switzerland|University Hospital Zurich /ID# 240076, Zurich, Zuerich, 8006, Switzerland|National Taiwan University Hospital /ID# 244754, Taipei City, Taipei, 100, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 244758, Kaohsiung, 807, Taiwan|Chung Shan Medical University Hospital /ID# 244757, Taichung, 40201, Taiwan|Chang Gung Memorial Foundation-Taipei Branch /ID# 244760, Taipei City, 05406, Taiwan|Taipei Veterans General Hosp /ID# 244759, Taipei, 11217, Taiwan|Linkou Chang Gung Memorial Hospital /ID# 244756, Taoyuan City, 333, Taiwan|New Medical Center Hospital /ID# 245106, Abu Dhabi, United Arab Emirates|Tawam Hospital /ID# 249696, Abu Dhabi, United Arab Emirates|Safa Clinic /ID# 248492, Dubai, United Arab Emirates","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT04761978,Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04761978,NO,"Dermatitis, Atopic",,ALL,"ADULT, OLDER_ADULT",,"Hop Claude Huriez Chu Lille, Lisle-sur-Tarn, 59037, France","Principal Investigator : Delphine Staumont-Salle, MD,PhD , University Hospital, Lille"
Atopic Dermatitis,NCT06032403,Patient With Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations,https://clinicaltrials.gov/study/NCT06032403,NO,Atopic Dermatitis,BEHAVIORAL: flexible patient centred consultations,ALL,"CHILD, ADULT, OLDER_ADULT",,"Gentofte University Hospital, Hellerup, Copenhagen, 2900, Denmark","Aage Bangs Fond The Novo Nordic Foundation Herlev and Gentofte Hospital Sanofi Almirall, S.A."
Atopic Dermatitis,NCT05704738,A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT05704738,NO,Atopic Dermatitis,DRUG: Rocatinlimab|DRUG: Placebo,ALL,CHILD,PHASE3,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States|AllerVie Clinical Research- Cullman, Cullman, Alabama, 35058, United States|Eclipse Clinical Research, Tucson, Arizona, 85745, United States|Arkansas Research Trials, LLC, North Little Rock, Arkansas, 72117, United States|Center for Dermatology Clinical Research Inc, Fremont, California, 94538, United States|Doc1 Healthcare Systems Incorporated, Fullerton, California, 92831, United States|Axon Clinical Research, Inglewood, California, 90301, United States|Avance Clinical Trials, Laguna Niguel, California, 92677, United States|Cura Clinical Research, Palmdale, California, 93551, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States|University of California at Davis Medical Center, Sacramento, California, 95816, United States|Allergy and Asthma Medical Group and Research Center, San Diego, California, 92123, United States|University of California at San Diego Rady Childrens Hospital San Diego, San Diego, California, 92123, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Cura Clinical Research Sherman Oaks, Sherman Oaks, California, 91403, United States|Velocity Clinical Research - Denver, Denver, Colorado, 80209, United States|Childrens National Medical Center, Washington, District of Columbia, 20010, United States|Academic Alliance in Dermatology - Saint Petersburg Office, Clearwater, Florida, 33761, United States|Corazon United States of America, LLC doing business as Life Clinical Trials, Coral Springs, Florida, 33071, United States|Palm Beach Dermatology Group, Delray Beach, Florida, 33484, United States|Angels Clinical Research Institute, Doral, Florida, 33122, United States|Direct Helpers Research Center, Hialeah, Florida, 33012, United States|Glick Skin Institute, Margate, Florida, 33063, United States|Deluxe Health Care LLC, Miami Lakes, Florida, 33014, United States|Savin Medical Group LLC, Miami Lakes, Florida, 33014, United States|Miami Clinical Research, Miami, Florida, 33155, United States|ara Professionals Limited Liability Corporation, Miami, Florida, 33176, United States|Optimal Research Sites, LLC, Orange City, Florida, 32763, United States|Clinical Associates of Orlando Limited Liability Company, Orlando, Florida, 32819, United States|Clinical Research Investments, Orlando, Florida, 32819, United States|University of South Florida, Tampa, Florida, 33612, United States|Advanced Medical Research PC, Sandy Springs, Georgia, 30328, United States|Divine Dermatology and Aesthetics, Savannah, Georgia, 31419, United States|McIntosh Clinic PC, Thomasville, Georgia, 31792, United States|Treasure Valley Medical Research, Boise, Idaho, 83706-1345, United States|Velocity Clinical Research - Boise, Meridian, Idaho, 83642, United States|NorthShore University HealthSystem Clinical Trials Center, Skokie, Illinois, 60077, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|Southern Indiana Clinical Trials, New Albany, Indiana, 47150, United States|The Indiana Clinical Trials Center PC, Plainfield, Indiana, 46168, United States|Kentucky Advanced Medical Research LLC, Murray, Kentucky, 42071, United States|Industrial Medicine Associates Clinical Research Advanced Dermatology Care, Monroe, Louisiana, 71201, United States|Aesthetic and Dermatology Center, Rockville, Maryland, 20850, United States|Derm Associates, PC, Rockville, Maryland, 20850, United States|Oakland Hills Dermatology, Auburn Hills, Michigan, 48326, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, 48202, United States|Onyx Clinical Research, Flint, Michigan, 48532, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Saint Louis University, Saint Louis, Missouri, 63104, United States|Somnos Clinical Research, Lincoln, Nebraska, 68505, United States|Skin Cancer and Dermatology Institute, Reno, Nevada, 89509, United States|Allcutis Research, Portsmouth, New Hampshire, 03801, United States|The Dermatology Center of New Jersey, Bridgewater, New Jersey, 08807, United States|University of New Mexico, Albuquerque, New Mexico, 87102, United States|Yeshiva University - Montefiore Medical Center, Bronx, New York, 10467, United States|Ace Clinical Trials, Brooklyn, New York, 11211, United States|Empire Dermatology, East Syracuse, New York, 13057, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|Pioneer Clinical Research New York, New York, New York, 10016, United States|Cornell University - Weill Cornell Medicine, New York, New York, 10075, United States|Rochester Clinical Research, Rochester, New York, 14609, United States|Duke South Durham, Durham, North Carolina, 27713, United States|Optima Research, Boardman, Ohio, 44512, United States|Apex Clinical Research Center LLC, Mayfield Heights, Ohio, 44124, United States|Epic Medical Research - Oklahoma, Chickasha, Oklahoma, 73018, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, 73112, United States|Dermatology and Aesthetics of Oklahoma, Oklahoma City, Oklahoma, 73120, United States|Dermatology Research Center of Oklahoma, PLLC, Tulsa, Oklahoma, 74132, United States|Essential Medical Research LLC, Tulsa, Oklahoma, 74137, United States|Velocity Clinical Research - Grants Pass, Grants Pass, Oregon, 97527, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Paddington Testing Company Inc, Philadelphia, Pennsylvania, 19103, United States|Rhode Island Hospital, Lifespan, Providence, Rhode Island, 02903, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|National Allergy and Asthma Research, LLC, North Charleston, South Carolina, 29420, United States|Coastal Pediatric Research, Summerville, South Carolina, 29486, United States|HealthStar Physicians Dermatology, Morristown, Tennessee, 37813, United States|US Dermatology Partners Cedar Park, Cedar Park, Texas, 78613, United States|Studies in Dermatology LLC, Cypress, Texas, 77429, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|MedCare Pharma - Houston, Houston, Texas, 77037, United States|Tranquil Clinical Research, Houston, Texas, 77098, United States|Sante Clinical Research, Kerrville, Texas, 78028, United States|Long and Harris Dermatology, Lubbock, Texas, 79424, United States|Sms Clinical Research Limited Liability Company, Mesquite, Texas, 75149, United States|Sienna Dermatology Research, Missouri City, Texas, 77459, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Epiphany Dermatology, Southlake, Texas, 76092, United States|Pioneer Research Solutions, Sugar Land, Texas, 77479, United States|Tanner Clinic, Murray, Utah, 84107, United States|Dermatology Research of Utah, dba Providence Dermatology, Providence, Utah, 84332, United States|Jordan Valley Dermatology Center, South Jordan, Utah, 84095, United States|Maria M Ona MD PC, Franklin, Virginia, 23851, United States|Northwest Clinical Research Center, Bellevue, Washington, 98007, United States|Hopital Erasme, Bruxelles, 1070, Belgium|Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, 1200, Belgium|Universitair Ziekenhuis Gent, Gent, 9000, Belgium|Centre Hospitalier Universitaire de Liege - Sart Tilman, Liege, 4000, Belgium|Dermatologie Maldegem, Maldegem, 9990, Belgium|Clinica Instituto Bahiano de Imunoterapia - Medicina, Reumatologia e Dermatologia ltda, Salvador, Bahia, 41820-020, Brazil|Centro do Diagnostico e Pesquisa da Osteoporose do Espirito Santo, VitÃ³ria, EspÃ­rito Santo, 29055-450, Brazil|Centro de Pesquisa ClÃ­nica da Universidade de Belo Horizonte - Unibh, Belo Horizonte, Minas Gerais, 30575-180, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90020-090, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-903, Brazil|Cecip Centro Est Clin Int Paulista, Jau, SÃ£o Paulo, 17201-130, Brazil|Le Plume Dermatologia- Clinica de Dermatologia Dra Beatriz Elias Eirelli, RibeirÃ£o Preto, SÃ£o Paulo, 14026-020, Brazil|Instituto Pesquisa e Ensino em SaÃºde Infantil, Sao Paulo, SÃ£o Paulo, 01228-200, Brazil|Hospital das ClÃ­nicas da Faculdade de Medicina da Universidade de SÃ£o Paulo, Sao Paulo, SÃ£o Paulo, 05403-002, Brazil|Hospital de Base de Sao Jose do Rio Preto, SÃ£o JosÃ© do Rio Preto, SÃ£o Paulo, 15090-000, Brazil|IBPClin Instituto Brasil de Pesquisa Clinica, Rio de Janeiro, 20241-180, Brazil|Rejuvenation Dermatology Laser Calgary North, Calgary, Alberta, T3K 6B8, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X3, Canada|Dr SK Siddha Medicine Professional Corporation, Newmarket, Ontario, L3Y 5G8, Canada|Allergy Research Canada Incorporated, Niagara Falls, Ontario, L2H 1H5, Canada|XLR8 Medical Research, Incorporated, Windsor, Ontario, N8T 1E6, Canada|Skinsense Medical Research, Saskatoon, Saskatchewan, S7K 2C1, Canada|Centro Dermatologico Dermisur, Osorno, 5310644, Chile|Centro Medico Skinmed Spa, Santiago, 7580206, Chile|Clinica Dermacross SA, Santiago, 7640881, Chile|Fundacion Innovacion Cardiovascular, Santiago, 8380465, Chile|Centro Internacional de Estudios Clinicos, Santiago, 8420383, Chile|Childrens Hospital Capital Institute of Pediatrics, Beijing, Beijing, 100020, China|Beijing Childrens Hospital, Capital Medical University, Beijing, Beijing, 100045, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|Childrens Hospital of Chongqing Medical University, Chongqing, Chongqing, 400014, China|The First Affiliated Hospital ,Sun-Yat Sen University, Guangzhou, Guangdong, 510080, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, 510091, China|Sun Yat-sen Memorial Hospital Sun Yat-sen University, Guangzhou, Guangdong, 510120, China|Nanyang First Peoples Hospital, Nanyang, Henan, 473002, China|The Central Hospital of Wuhan, Wuhan, Hubei, 430014, China|Union Hospital Tongji Medical College Huazhong University of science and Technology, Wuhan, Hubei, 430022, China|Jiangyin Hospital of Traditional Chinese Medicine, Jiangyin, Jiangsu, 214400, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750003, China|Chengdu Second Peoples Hospital, Chengdu, Sichuan, 610021, China|Suining Central Hospital, Suining, Sichuan, 629099, China|Kunming Childrens Hospital, Kunming, Yunnan, 650103, China|Affiliated Hangzhou First Peoples Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310020, China|Ningbo NO 2 Hospital, Ningbo, Zhejiang, 315010, China|Taizhou Central Hospital, Taizhou, Zhejiang, 318000, China|Peking University Peoples Hospital, Beijing, 100044, China|Hunan Childrens Hospital, Changsha, 410007, China|Dalian Women and Childrens Medical Group, Dalian, 116011, China|Shanghai Skin Disease Hospital, Shanghai, 200443, China|Shenzhen Childrens Hospital, Shenzhen, 518038, China|Special Hospital for Medical Rehabilitation Naftalan, Ivanic-Grad, 10310, Croatia|University Hospital Centre Osijek, Osijek, 31000, Croatia|Children s Hospital Zagreb, Zagreb, 10000, Croatia|Sestre milosrdnice University Hospital Center, Zagreb, 10000, Croatia|University Hospital Centre Zagreb, Zagreb, 10000, Croatia|Hopital Prive d Antony, Antony, 92160, France|Centre Hospitalier Regional Universitaire Brest Hopital Morvan, Brest, 29200, France|HÃ´pital Saint-Joseph, Marseille Cedex 8, 13285, France|Centre Hospitalier Universitaire de Nantes HÃ´tel Dieu, Nantes, 44093, France|Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes Cedex 9, 35033, France|Centre Hospitalier Universitaire de Rouen - HÃ´pital Charles Nicolle, Rouen Cedex, 76031, France|Centre Hospitalier Universitaire de Toulouse, Hopital Larrey, Toulouse, 31059, France|Fachklinik Bad Bentheim, Bad Bentheim, 48455, Germany|Universitaetsklinikum Bonn, Bonn, 53127, Germany|Rosenpark Research GmbH, Darmstadt, 64283, Germany|Universitaetsklinikum Dresden, Dresden, 01307, Germany|Universitaetsklinikum Erlangen, Erlangen, 91054, Germany|Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-Universitaet Frankfurt am Main, Frankfurt am Main, 60590, Germany|Velocity Clinical Research, Leipzig, 04103, Germany|Johannes Gutenberg Universitaet Mainz, Mainz, 55101, Germany|Athens Naval Hospital, Athens, 11521, Greece|Athens General Childrens Hospital Panagioti And Aglaia Kyriakou, Athens, 11527, Greece|Thoracic General Hospital Of Athens Sotiria, Athens, 11527, Greece|Ippokratio General Hospital of Thessaloniki, Thessaloniki, 54643, Greece|Clinexpert Kft, Budapest, 1033, Hungary|Derma-B Egeszsegugyi es Szolgaltato Kft, Debrecen, 4031, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, 4032, Hungary|Somogy Varmegyei Kaposi Mor Oktato Korhaz, Kaposvar, 7400, Hungary|Sheba Medical Center, Ramat Gan, 5262000, Israel|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Azienda Ospedaliera Universitaria Luigi Vanvitelli, Napoli, 80131, Italy|Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia, Perugia, 06129, Italy|Presidio Molinette Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino, 10126, Italy|Central Clinic, Nagoya-shi, Aichi, 464-0821, Japan|Miyata Dermatology Clinic, Matsudo-shi, Chiba, 271-0092, Japan|Matsuo Clinic, Fukuoka-shi, Fukuoka, 819-0373, Japan|Asahikawa City Hospital, Asahikawa-shi, Hokkaido, 070-8610, Japan|Takagi Dermatological Clinic, Obihiro-shi, Hokkaido, 080-0013, Japan|Yoshimura Child Clinic, Akashi-shi, Hyogo, 674-0068, Japan|Katahira Dermatology Urology Clinic, Kagoshima-shi, Kagoshima, 890-0063, Japan|Nomura Dermatology Clinic, Yokohama-shi, Kanagawa, 221-0825, Japan|Yokohama City Minato Red Cross Hospital, Yokohama-shi, Kanagawa, 231-8682, Japan|Jouzan Hihuka Hinyoukika Clinic, Kumamoto-shi, Kumamoto, 860-0066, Japan|Suizenji Dermatology Clinic, Kumamoto-shi, Kumamoto, 862-0950, Japan|Yoshioka Dermatology Clinic, Neyagawa-shi, Osaka, 572-0838, Japan|Dermatology and Ophthalmology Kume Clinic, Sakai-shi, Osaka, 593-8324, Japan|Hamamatsu University Hospital, Hamamatsu-shi, Shizuoka, 431-3192, Japan|Naoko Dermatology Clinic, Setagaya-ku, Tokyo, 158-0097, Japan|NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, 141-8625, Japan|Korea University Ansan Hospital, Ansansi, Gyeonggido, 15355, Korea, Republic of|Nowon Eulji Medical Center, Eulji University, Seoul, 01830, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, 03722, Korea, Republic of|National Medical Center, Seoul, 04564, Korea, Republic of|Kyung Hee University Hospital at Gangdong, Seoul, 05278, Korea, Republic of|The Catholic University of Korea Seoul St Marys Hospital, Seoul, 06591, Korea, Republic of|Chung-Ang University Hospital, Seoul, 06973, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, 07441, Korea, Republic of|Ewha Womans University Seoul Hospital, Seoul, 07804, Korea, Republic of|Korea University Guro Hospital, Seoul, 08308, Korea, Republic of|Phylasis Clinicas Research Toluca, Toluca, 50090, Mexico|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-214, Poland|AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy, Gdansk, 80-280, Poland|GynCentrum Sp zoo NZOZ Holsamed, Katowice, 40-600, Poland|Centrum Medyczne Angelius Provita, Katowice, 40-611, Poland|Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy Marek Brzewski Pawel Brzewski SpCywilna, Krakow, 30-002, Poland|Diamond Clinic Spolka z Ograniczona Odpowiedzialnoscia Diamond Medical Center, Krakow, 31-559, Poland|AppleTreeClinics Network Spzoo, Lodz, 90-349, Poland|Amicare Spolka z ograniczona odpowiedzialnoscia Spolka Komandytowa Amicare Centrum Medyczne, Lodz, 91-495, Poland|Clinical Best Solutions Sp zoo Spolka Komandytowa, Lublin, 20-011, Poland|Centrum Zdrowia Dziecka i Rodziny Im Jana Pawla II w Sosnowcu Osrodek Badan Klinicznych, Sosnowiec, 41-200, Poland|Alergo-Med Specjalistyczna Przychodnia Lekarska Spzoo, Tarnow, 33-100, Poland|Klinika Osipowicz and Turkowski Sp zoo, Warszawa, 00-716, Poland|High Med Przychodnia Specjalistyczna, Warszawa, 01-817, Poland|Klinika Ambroziak Dermatologia, Warszawa, 02-953, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-962, Poland|Dermatologiczna Praktyka Lekarska Michal Torz Dermaceum Centrum Badan Klinicznych, Wroclaw, 50-450, Poland|Clinical Research of Puerto Rico, San Juan, 00909, Puerto Rico|GCM Medical Group, Psc, San Juan, 00917, Puerto Rico|Dr Leventer Centre Clinica Dermatologie Bucuresti, Bucharest, 011216, Romania|Derma Cluj, Cluj-Napoca, 400105, Romania|Institutul Regional de Gastroenterologie si Hepatologie Prof Dr Octavian Fodor, Cluj-Napoca, 400431, Romania|Hospital de la Santa Creu i Sant Pau, Barcelona, CataluÃ±a, 08041, Spain|Hospital Sant Joan de Deu, Esplugues de Llobregat, CataluÃ±a, 08950, Spain|Clinica Universidad de Navarra, Pamplona, Navarra, 31008, Spain|Hospital General Universitario Gregorio MaraÃ±on, Madrid, 28007, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Linkou Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan|King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand|Siriraj Hospital, Bangkok, 10700, Thailand|Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, 50200, Thailand","Study Director : MD , Amgen"
Atopic Dermatitis,NCT05014438,A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05014438,YES,"Dermatitis, Atopic",DRUG: BMS-986166|DRUG: Branebrutinib|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Local Institution - 0091, Fremont, California, 94538, United States|Local Institution - 0112, Brandon, Florida, 33511, United States|Local Institution - 0061, Coral Gables, Florida, 33134, United States|Local Institution - 0110, Margate, Florida, 33063, United States|Local Institution - 0006, Miami Lakes, Florida, 33014, United States|Local Institution, Tampa, Florida, 33613, United States|Local Institution - 0008, Skokie, Illinois, 60077, United States|Local Institution - 0081, Indianapolis, Indiana, 46250, United States|Local Institution - 0083, Louisville, Kentucky, 40217, United States|Dermatology and Skin Cancer Specialists, LLC, Rockville, Maryland, 20850, United States|Local Institution - 0051, Saint Joseph, Missouri, 64506, United States|Local Institution, New York, New York, 10029, United States|Local Institution - 0078, Philadelphia, Pennsylvania, 19103, United States|Local Institution - 0094, Pittsburgh, Pennsylvania, 15213, United States|The University of Texas Health Science Center at Houston, Bellaire, Texas, 77401, United States|Local Institution, San Antonio, Texas, 78213, United States|Local Institution - 0003, Morgantown, West Virginia, 26505, United States|Premier Dermatology, Kogarah, New South Wales, 2217, Australia|Holdsworth House Medical Practice, Sydney, New South Wales, 2010, Australia|Westmead Hospital-Dermatology, Westmead, New South Wales, 2145, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Local Institution, Linz, 4020, Austria|Local Institution, Markham, Ontario, L3P 1X2, Canada|York Dermatology Clinic and Research Centre, Richmond Hill, Ontario, L4C 9M7, Canada|SIMa Recherche, Verdun, Quebec, H4G 3E7, Canada|CharitÃ© Universitaetsmedizin Berlin - Campus Mitte, Berlin, 10117, Germany|Local Institution, Berlin, 12459, Germany|Local Institution - 0034, Bochum, 44793, Germany|UniversitÃ¤tsklinikum Bonn-Studienzentrum Dermatologie, Bonn, 53127, Germany|SRH Wald-Klinikum Gera-Zentrum fÃ¼r klinische Studien, Gera, 07548, Germany|Local Institution, Hannover, 30625, Germany|Universitatsklinikum Schleswig-Holstein, Kiel, 24105, Germany|Local Institution, Munich, 80337, Germany|KliFOs - Klinische Forschung OsnabrÃ¼ck, OsnabrÃ¼ck, 49074, Germany|Private Practice - Dr. Ralph von Kiedrowski, Selters, 56242, Germany|Royalderm Agnieszka Nawrocka, Warszawa, Mazowieckie, 02-962, Poland|NZOZ Centrum Medyczne KERmed, Bydgoszcz, 85-231, Poland|ETYKA Osrodek Badan Klinicznych, Olsztyn, 10-117, Poland|Local Institution - 0130, Cordoba, AndalucÃ­a, 14004, Spain|Hospital General Universitario de Alicante-Dermatology, Alicante, 03010, Spain|Hospital Universitario de Gran Canaria Doctor NegrÃ­n-DermatologÃ­a, Las, 35010, Spain|Hospital Universitario La Paz-UCICEC/DERMA, Madrid, 28046, Spain","Study Director : Bristol-Myers Squibb , Bristol-Myers Squibb"
Atopic Dermatitis,NCT05507580,A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05507580,NO,Atopic Dermatitis,DRUG: Upadacitinib,ALL,ADULT,PHASE4,"Holdsworth House Medical Practice /ID# 254028, Darlinghurst, New South Wales, 2010, Australia|Premier Specialist /ID# 246150, Kogarah, New South Wales, 2217, Australia|Veracity Clinical Research /ID# 246154, Woolloongabba, Queensland, 4102, Australia|North Eastern Health Specialists /ID# 246153, Campbelltown, South Australia, 5074, Australia|Skin Health Institute Inc /ID# 246146, Carlton, Victoria, 3053, Australia|UCL Saint-Luc /ID# 245842, Woluwe-Saint-Lambert, Bruxelles-Capitale, 1200, Belgium|Grand Hopital de Charleroi /ID# 245837, Charleroi, Hainaut, 6000, Belgium|Dermatologie Maldegem /ID# 245840, Maldegem, Oost-Vlaanderen, 9990, Belgium|AZ Sint-Lucas /ID# 253708, Gent, 9000, Belgium|CHU de Liege /ID# 245839, Liege, 4000, Belgium|UMHAT Alexandrovska EAD /ID# 246594, Sofiya, Sofia, 1431, Bulgaria|Medical center Cordis /ID# 253310, Pleven, 5800, Bulgaria|Acibadem City Clinic Tokuda University Hospital EAD /ID# 246395, Sofia, 1407, Bulgaria|Ambulatory for Specialized Medical Care for skin and venereal diseases /ID# 247027, Sofia, 1407, Bulgaria|Medical center EuroHealth /ID# 246305, Sofia, 1606, Bulgaria|Medical Center Euroderma /ID# 246736, Sofiya, 1606, Bulgaria|Dermatology Research Institute Inc. /ID# 246703, Calgary, Alberta, T2J 7E1, Canada|Beacon Dermatology Inc /ID# 246705, Calgary, Alberta, T3E 0B2, Canada|Laser Rejuvenation Clinics Edmonton D.T. Inc. /ID# 256790, Edmonton, Alberta, T5J 3S9, Canada|Alberta DermaSurgery Centre /ID# 247286, Edmonton, Alberta, T6G 1C3, Canada|Dr. Chih-ho Hong Medical Inc. /ID# 246700, Surrey, British Columbia, V3R 6A7, Canada|Lynderm Research Inc. /ID# 246699, Markham, Ontario, L3P 1X3, Canada|SKiN Centre for Dermatology /ID# 246702, Peterborough, Ontario, K9J 5K2, Canada|Alliance Clinical Trials /ID# 246698, Waterloo, Ontario, N2J 1C4, Canada|Beijing Friendship Hospital /ID# 247719, Beijing, Beijing, 100032, China|Peking University Third Hospital /ID# 247842, Beijing, Beijing, 100191, China|Dermatology Hospital of Southern Medical University /ID# 247951, Guangzhou, Guangdong, 510091, China|The First Hospital of China Medical University /ID# 247686, Shenyang, Liaoning, 110001, China|Huashan Hospital, Fudan University /ID# 247680, Shanghai, Shanghai, 200040, China|Universitaetsklinikum Frankfurt /ID# 245627, Frankfurt am Main, Hessen, 60590, Germany|Universitaetsklinikum Muenster /ID# 245623, Muenster, Nordrhein-Westfalen, 48149, Germany|Fachklinik Bad Bentheim /ID# 245634, Bad Bentheim, 48455, Germany|Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 245636, Bramsche, 49565, Germany|Elbe Klinikum Buxtehude /ID# 245626, Buxtehude, 21614, Germany|Klinikum Darmstadt /ID# 247028, Darmstadt, 64283, Germany|Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 248413, Dresden, 01307, Germany|Derma Study Center Friedrichshafen GmbH /ID# 245640, Friedrichshafen, 88045, Germany|Universitaetsklinikum Halle (Saale) /ID# 245637, Halle (Saale), 06120, Germany|Dermatologikum Hamburg GmbH /ID# 245635, Hamburg, 20354, Germany|Dermatologische Gemeinschaftspraxis Mahlow /ID# 245629, Mahlow, 15831, Germany|Dermatologie Quist-BAG Dres. med. Quist PartG /ID# 245628, Mainz, 55128, Germany|Gyongyosi Bugat Pal Korhaz /ID# 246422, Gyongyos, Heves, 3200, Hungary|Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 246428, KaposvÃ¡r, Somogy, 7400, Hungary|Clinexpert Kft /ID# 246427, Budapest, 1033, Hungary|Derma-B Egeszsegugyi es Szolgaltato Kft. /ID# 246426, Debrecen, 4031, Hungary|Istituto Clinico Humanitas /ID# 246630, Rozzano, Milano, 20089, Italy|Azienda Ospedaliera di Perugia /ID# 246632, Perugia, Umbria, 06129, Italy|Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 254355, Ancona, 60126, Italy|ASST Spedali civili di Brescia /ID# 246631, Brescia, 25123, Italy|Universita degli Studi Gabriele dAnnunzio /ID# 246629, Chieti, 66100, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 246634, Milan, 20122, Italy|Miyata Dermatology Clinic /ID# 255491, Matsudo-Shi, Chiba, 271-0092, Japan|Fukuoka University Hospital /ID# 255182, Fukuoka-shi, Fukuoka, 814-0180, Japan|Takagi Dermatological Clinic Branch /ID# 255181, Obihiro-shi, Hokkaido, 080-0013, Japan|Nomura Dermatology Clinic /ID# 255534, Yokohama-shi, Kanagawa, 221-0825, Japan|Tohoku University Hospital /ID# 255183, Sendai-shi, Miyagi, 9808574, Japan|Maruyama Dermatology Clinic /ID# 255441, Koto-ku, Tokyo, 136-0074, Japan|Korea University Ansan Hospital /ID# 245653, Ansan, Gyeonggido, 15355, Korea, Republic of|Soonchunhyang University Hospital Bucheon /ID# 245654, Bucheon, Gyeonggido, 14584, Korea, Republic of|Ajou University Hospital /ID# 245652, Suwon, Gyeonggido, 16499, Korea, Republic of|KonKuk University Medical Center /ID# 245657, Seoul, Seoul Teugbyeolsi, 05030, Korea, Republic of|Seoul National University Hospital /ID# 245651, Seoul, 03080, Korea, Republic of|Chung-Ang University Hospital /ID# 245655, Seoul, 06973, Korea, Republic of|Academisch Medisch Centrum /ID# 245673, Amsterdam, 1105 AZ, Netherlands|Amphia Ziekenhuis /ID# 246397, Breda, 4818 CK, Netherlands|Greenlane Clinical Centre /ID# 246556, Epsom, Auckland, 1051, New Zealand|Middlemore Hospital /ID# 246559, Otahuhu, Auckland, 2025, New Zealand|Clinical Trials New Zealand /ID# 246557, Hamilton, 3204, New Zealand|MICS Centrum Medyczne Torun /ID# 245749, Torun, Kujawsko-pomorskie, 87-100, Poland|Dermed Centrum Medyczne Sp. z o.o /ID# 246329, Lodz, Lodzkie, 90-265, Poland|Santa Sp. z o.o. Santa Familia Centrum Badan, Profilaktyki i Leczenia /ID# 253872, Lodz, Lodzkie, 90-302, Poland|Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o. /ID# 245836, Krakow, Malopolskie, 31-011, Poland|CenterMed Krakow Sp. z o.o. /ID# 253940, Krakow, Malopolskie, 31-530, Poland|Klinika Ambroziak Sp. z o.o. /ID# 245748, Warszawa, Mazowieckie, 02-953, Poland|Royalderm Agnieszka Nawrocka /ID# 245746, Warszawa, Mazowieckie, 02-962, Poland|Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 245741, Gdansk, Pomorskie, 80-546, Poland|Centrum Medyczne Pratia Gdynia /ID# 245835, Gdynia, Pomorskie, 81-338, Poland|Silmedic Sp. z o.o. /ID# 253863, Katowice, Slaskie, 40-282, Poland|Specjalistyczna Przychodnia Lekarska Alergo-Med sp. z o.o. /ID# 253846, Poznan, Wielkopolskie, 61-578, Poland|Specjalistyczny Niepubliczny Zaklad Opieki Zdrowotnej Alergologia Plus /ID# 253508, PoznaÅ„, Wielkopolskie, 60-693, Poland|OFTALMIKA Sp. z o.o. /ID# 253429, Bydgoszcz, 85-631, Poland|Centro Hospitalar Universitario Lisboa Central, EPE - Hospital dos Capuchos /ID# 246247, Lisboa, 1169-050, Portugal|Hospital CUF Descobertas /ID# 245702, Lisboa, 1998-018, Portugal|Centro Hospitalar Universitario do Porto, EPE - Hospital Santo Antonio /ID# 245701, Porto, 4099-001, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 245704, Porto, 4200-319, Portugal|Poliklinika Bezrucova (Cliniq s.r.o.) /ID# 247515, Bratislava, 811 09, Slovakia|BeneDerma s.r.o. /ID# 247513, Bratislava, 841 04, Slovakia|Univerzitna nemocnica Martin /ID# 246948, Martin, 036 01, Slovakia|Hospital Universitario Germans Trias i Pujol /ID# 246320, Badalona, Barcelona, 08916, Spain|Hospital Universitario de Bellvitge /ID# 246326, L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Universitario Puerta de Hierro, Majadahonda /ID# 253820, Majadahonda, Madrid, 28222, Spain|Hospital General Universitario de Alicante Doctor Balmis /ID# 246270, Alicante, 03010, Spain|Hospital Universitario Infanta Leonor /ID# 246272, Madrid, 28031, Spain|Hospital Universitario Ramon y Cajal /ID# 246273, Madrid, 28034, Spain|Complejo Hospitalario Universitario de Pontevedra /ID# 246323, Pontevedra, 36071, Spain|Hospital Universitario Virgen del Rocio /ID# 253822, Sevilla, 41013, Spain|Kaohsiung Chang Gung Memorial Hospital /ID# 245710, Kaohsiung City, Kaohsiung, 833, Taiwan|Chung Shan Medical University Hospital /ID# 245707, Taichung, 40201, Taiwan|National Taiwan University Hospital /ID# 245711, Taipei City, 100, Taiwan|Mackay Memorial Hospital /ID# 245713, Taipei City, 10449, Taiwan|Taipei Municipal Wan Fang Hospital /ID# 245712, Taipei, 116, Taiwan|Linkou Chang Gung Memorial Hospital /ID# 245709, Taoyuan City, 333, Taiwan|University Hospital Southampton NHS Foundation Trust /ID# 246393, Southampton, Hampshire, SO16 6YD, United Kingdom|NHS Greater Glasgow and Clyde /ID# 246253, Glasgow, Scotland, G12 0XH, United Kingdom|NHS Lothian /ID# 246245, Edinburgh, EH3 9HE, United Kingdom|Leeds Teaching Hospitals NHS Trust /ID# 246241, Leeds, LS9 7TF, United Kingdom","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT05250115,A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05250115,NO,"Dermatitis, Atopic",,ALL,"ADULT, OLDER_ADULT",,"Dermatologische Gemeinschaftspraxis Dres. Quist PartG, Mainz, Rheinland-pfalz, 55128, Germany|HautÃ¤rztliche Gemeinschaftspraxis, Ahaus, 48688, Germany|Praxis Dr. A. Magerl, Bensheim, 64625, Germany|Dr. Christiane Handrick Hautarztpraxis, Berlin, 10117, Germany|Dres. Ziethen-Stavermann GbR, Berlin, 12353, Germany|Hautarztpraxis an der Hase Studienzentrum, Bramsche, 49565, Germany|HautÃ¤rzte Braunschweig, Braunschweig, 38114, Germany|Cutaneum Praxis Dr. Buck, Hamburg, 20095, Germany|Hautarztpraxis Dr. med. Matthias LÃ¼tten, Hamburg, 20095, Germany|UniversitÃ¤tsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|dermaSANA, Karlsruhe, 76131, Germany|Dr. Beate Schwarz, Langenau, 89129, Germany|Dermatologie MÃ¶lln, Praxis Dr Segert, MÃ¶lln, 23879, Germany|ZENTderma, Dr. Rolf Ostendorf, MÃ¶nchengladbach, 41061, Germany|Hautarztpraxis Dorittke / Kardorff, MÃ¶nchengladbach, 41236, Germany|Dermatologische Praxis im Hautzentrum Johannis Dr. med. Esther VÃ¶lkel, NÃ¼rnberg, 90419, Germany|Hautarztpraxis Mortazawi, Remscheid, 42897, Germany|Dermatologische Spezialpraxis Dr. med. Ralph von Kiedrowski, Selters, 56242, Germany|Hautarztpraxis Dr. Hoffmann, Witten, 58453, Germany","Study Director : Pfizer CT.gov Call Center , Pfizer"
Atopic Dermatitis,NCT05502848,The Effect of Intervention and Mechanism of ICBT on Chronic Itching in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05502848,NO,Atopic Dermatitis,BEHAVIORAL: Internet Cognitive Behavior Therapy,ALL,ADULT,,,Xiangya Hospital of Central South University
Atopic Dermatitis,NCT05651711,A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon),https://clinicaltrials.gov/study/NCT05651711,NO,Atopic Dermatitis,DRUG: Rocatinlimab|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Research Solutions of Arizona, PC, Litchfield Park, Arizona, 85340, United States|Center for Dermatology and Plastic Surgery, Scottsdale, Arizona, 85260, United States|Clinical Trials Institute of Northwest Arkansas, Fayetteville, Arkansas, 72703, United States|Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|Velocity Clinical Research Chula Vista, Chula Vista, California, 91911, United States|West Coast Research LLC, Dublin, California, 94568, United States|California Dermatology and Clinical Research Institute, Encinitas, California, 92024, United States|Center for Dermatology Clinical Research Inc, Fremont, California, 94538, United States|Velocity Clinical Research - San Diego, La Mesa, California, 91942, United States|Velocity Clinical Research - North Hollywood, North Hollywood, California, 91606, United States|Cura Clinical Research, Palmdale, California, 93551, United States|University of California at San Francisco, Dermatology Clinic at Mount Zion, San Francisco, California, 94115, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Clarity Dermatology, Castle Rock, Colorado, 80109, United States|Velocity Clinical Research - Denver, Denver, Colorado, 80209, United States|Foxhall Research Center, Washington, District of Columbia, 20016, United States|Renaissance Research and Medical Group, Cape Coral, Florida, 33991, United States|Driven Research LLC, Coral Gables, Florida, 33134, United States|Saint Jude Clinical Research, Doral, Florida, 33172, United States|Direct Helpers Research Center, Hialeah, Florida, 33012, United States|Glick Skin Institute, Margate, Florida, 33063, United States|Miami Dade Medical Research Institute, LLC, Miami, Florida, 33176, United States|Innovation Medical Research Center Inc, Palmetto Bay, Florida, 33157, United States|University of South Florida Health Morsani Center for Advanced Healthcare, Tampa, Florida, 33612, United States|Advanced Medical Research PC, Sandy Springs, Georgia, 30328, United States|Sneeze, Wheeze, and Itch Associates, LLC, Normal, Illinois, 61761, United States|The South Bend Clinic LLP, South Bend, Indiana, 46617, United States|Options Research Group LLC, West Lafayette, Indiana, 47906, United States|Dermatology and Skin Cancer Center of Overland Park, Overland Park, Kansas, 66223, United States|DS Research, Louisville, Kentucky, 40241, United States|Kentucky Advanced Medical Research LLC, Murray, Kentucky, 42071, United States|MetroBoston Clinical Partners, Brighton, Massachusetts, 02135, United States|Wendy Sadoff MD Dermatology PC, Farmington Hills, Michigan, 48334, United States|Revival Research Institute LLC, Troy, Michigan, 48084, United States|Somerset Skin Centre, Troy, Michigan, 48084, United States|Advanced Dermatology of the Midlands, Omaha, Nebraska, 68144, United States|James Del Rosso Dermatology Research, Las Vegas, Nevada, 89117, United States|Skin Cancer and Dermatology Institute, Reno, Nevada, 89509, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03766, United States|Weiss Medical, Riverdale, New Jersey, 07457, United States|Montefiore Medical Center, Bronx, New York, 10467, United States|Corning Center For Clinical Research, Horseheads, New York, 14845, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|Crystal Run Healthcare, Monroe, New York, 10950, United States|Ace Clinical Trials, New York, New York, 10022, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|OptiSkin Medical, New York, New York, 10128, United States|Duke South Durham, Durham, North Carolina, 27713, United States|University of Cincinnati, Cincinnati, Ohio, 45219, United States|Bernstein Clinical Research Center LLC, Cincinnati, Ohio, 45236, United States|The Ohio State University Dermatology East, Gahanna, Ohio, 43230, United States|Velocity Clinical Research - Grants Pass, Grants Pass, Oregon, 97527, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|Asthma and Allergy Physicians of Rhode Island Clinical Research Institute, Warwick, Rhode Island, 02886, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|US Dermatology Partners Cedar Park, Cedar Park, Texas, 78613, United States|Alina Clinical Trials, LLC, Dallas, Texas, 75225, United States|Zenos Clinical Research, LLC, Dallas, Texas, 75230, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|MedCare Pharma - Houston, Houston, Texas, 77037, United States|FMCScience LLC, Lampasas, Texas, 76550, United States|Epic Clinical Research Incorporated, Lewisville, Texas, 75057, United States|Sienna Dermatology Research, Missouri City, Texas, 77459, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Andante Research, San Antonio, Texas, 78229, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|University of Utah MidValley Dermatology, Murray, Utah, 84107, United States|Eastern Virginia Medical School, Norfolk, Virginia, 23507, United States|MultiCare Institute for Research and Innovation, Spokane, Washington, 99202, United States|St George Dermatology and Skin Cancer Centre, Darlinghurst, New South Wales, 2010, Australia|Premier Specialists, Kogarah, New South Wales, 2217, Australia|Box Hill Hospital, Box Hill, Victoria, 3128, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Hopital Erasme, Bruxelles, 1070, Belgium|Clinique Andre Renard, Herstal, 4040, Belgium|Dermatologie Maldegem, Maldegem, 9990, Belgium|CETI - Centro de Estudo em Terapias Inovadoras, Curitiba, ParanÃ¡, 80030-110, Brazil|Centro Multidisciplinar de Estudos Clinicos - CEMEC, Sao Bernardo do Campo, SÃ£o Paulo, 09715-090, Brazil|ISPEM - Instituto SÃ£o JosÃ© dos Campos em Pesquisas MÃ©dicas, SÃ£o JosÃ© dos Campos, SÃ£o Paulo, 12243-280, Brazil|Beacon Dermatology, Calgary, Alberta, T3E 0B2, Canada|Doctor Chih-Ho Hong Medical Incorporated, Surrey, British Columbia, V3R 6A7, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials Inc, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|XLR8 Medical Research, Incorporated, Windsor, Ontario, N8T 1E6, Canada|Clinique Dermatologique de Sherbrooke, Sherbrooke, Quebec, J1G 1X9, Canada|Centre de Recherche Dermatologique du Quebec Metropolitain, Quebec, G1V 4X7, Canada|Kozni ambulance Kutna Hora sro, Kutna Hora, 284 01, Czechia|Nemocnice Novy Jicin as, Novy Jicin, 741 01, Czechia|CCR Czech as, Pardubice, 530 02, Czechia|Fakultni nemocnice Plzen, Plzen, 305 99, Czechia|CCR Prague sro, Praha 3, 130 00, Czechia|Praglandia sro, Praha 5, 150 00, Czechia|Kozni ambulance Fialova sro, Praha 6, 106 00, Czechia|Dermamedest sro, Praha, 120 00, Czechia|Dermatologicka ambulance MUDr Petr Trestik, Svitavy, 568 02, Czechia|Gentofte Hospital, Hellerup, 2900, Denmark|Odense University Hospital, Odense, 5000, Denmark|North Estonia Medical Centre, Tallinn, 13419, Estonia|Clinical Research Centre, Tartu, 50106, Estonia|CRST Helsinki, Helsinki, 00180, Finland|CRST Turku, Helsinki, 00180, Finland|Oulun Yliopistollinen sairaala (OYS), Oulu, 90029, Finland|Terveystalo Tampere, Tampere, 33100, Finland|Fachklinik Bad Bentheim, Bad Bentheim, 48455, Germany|Hautzentrum Friedrichshain - Dermatologie, Berlin, 10247, Germany|Clinical Research Services Berlin GmbH, Berlin, 13672, Germany|Klinikum der Medizinischen Fakultaet der Martin-Luther-Universitaet Halle-Wittenberg, Halle (Saale), 06120, Germany|Dermatologikum Hamburg, Hamburg, 20354, Germany|Universitaetsklinikum Schleswig-Holstein, Kiel, 24105, Germany|Velocity Clinical Research, Leipzig, 04103, Germany|Universitaetsklinikum Muenster, Muenster, 48149, Germany|KliFOs Klinische Forschung Osnabrueck, Osnabrueck, 49074, Germany|Hautarztpraxis Mortazawi, Remscheid, 42897, Germany|Helios Klinikum Wuppertal, Wuppertal, 42283, Germany|Miyata Dermatology Clinic, Matsudo-shi, Chiba, 271-0092, Japan|International University of Health and Welfare Narita Hospital, Narita-shi, Chiba, 286-8520, Japan|Kobe University Hospital, Kobe-shi, Hyogo, 650-0017, Japan|St Marianna University Hospital, Kawasaki-shi, Kanagawa, 216-8511, Japan|National Hospital Organization Sagamihara National Hospital, Sagamihara-shi, Kanagawa, 252-0392, Japan|Showa University Northern Yokohama Hospital, Yokohama-shi, Kanagawa, 224-8503, Japan|Nagasaki University Hospital, Nagasaki-shi, Nagasaki, 852-8501, Japan|Osaka Habikino Medical Center, Habikino-shi, Osaka, 583-8588, Japan|Dermatology and Ophthalmology Kume Clinic, Sakai-shi, Osaka, 593-8324, Japan|Hamamatsu University Hospital, Hamamatsu-shi, Shizuoka, 431-3192, Japan|Mita Dermatology Clinic, Minato-ku, Tokyo, 108-0014, Japan|Showa University Hospital, Shinagawa-ku, Tokyo, 142-8666, Japan|Seibo International Catholic Hospital, Shinjuku-ku, Tokyo, 161-8521, Japan|Sugamo Kobayashi Derma Clinic, Toshima-ku, Tokyo, 170-0002, Japan|Shirasaki Dermatology Clinic, Takaoka-shi, Toyama, 933-0871, Japan|Korea University Ansan Hospital, Ansansi, Gyeonggido, 15355, Korea, Republic of|Soon Chun Hyang University Bucheon Hospital, Bucheon-si, Gyeonggi-do, 14584, Korea, Republic of|Pusan National University Hospital, Busan, 49241, Korea, Republic of|Kyungpook National University Hospital, Daegu, 41944, Korea, Republic of|Chosun University Hospital, Gwangju, 61453, Korea, Republic of|The Catholic University of Korea Incheon St Marys Hospital, Incheon, 21431, Korea, Republic of|Inha University Hospital, Incheon, 22332, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea, Republic of|Korea University Anam Hospital, Seoul, 02841, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 03722, Korea, Republic of|National Medical Center, Seoul, 04564, Korea, Republic of|Konkuk University Medical Center, Seoul, 05030, Korea, Republic of|Kyung Hee University Hospital at Gangdong, Seoul, 05278, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|The Catholic Univ of Korea Seoul St Marys Hospital, Seoul, 06591, Korea, Republic of|Chung-Ang University Hospital, Seoul, 06973, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, 07441, Korea, Republic of|Ewha Womans University Seoul Hospital, Seoul, 07804, Korea, Republic of|Ajou University Hospital, Suwon-si, Gyeonggi-do, 16499, Korea, Republic of|ClÃ­nica de Enfermedades CrÃ³nicas y de Procedimientos Especiales, Morelia, MichoacÃ¡n, 58249, Mexico|Scientia Investigacion Clinica Sc, Chihuahua, 31203, Mexico|Phylasis ClÃ­nicas Research S. De R. L. De C. V., CuautitlÃ¡n Izcalli, 54750, Mexico|ClinicMed Daniluk Nowak Spolka komandytowa, Bialystok, 15-879, Poland|Dermapolis Medical Dermatology Center dr n med Edyta Gebska, Chorzow, 41-500, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-214, Poland|Centermed krakow sp zoo, Krakow, 31-530, Poland|Centrum Terapii Wspolczesnej J M Jasnorzewska Spolka Komandytowo Akcyjna, Lodz, 90-338, Poland|AppleTreeClinics Network Spzoo, Lodz, 90-349, Poland|Amicare Spolka z ograniczona odpowiedzialnoscia Spolka Komandytowa Amicare Centrum Medyczne, Lodz, 91-495, Poland|Clinical Best Solutions Sp zoo Spolka Komandytowa, Lublin, 20-078, Poland|Clinical Research Center Spzoo Medic-R Spolka Komandytowa, Poznan, 61-731, Poland|Evimed sp zoo centrum medyczne evimed, Warszawa, 02-625, Poland|Hospital Garcia de Orta, EPE, Almada, 2801-951, Portugal|Centro Hospitalar e Universitario de Coimbra, EPE, Coimbra, 3000-075, Portugal|Hospital Cuf Descobertas, Lisboa, 1998-018, Portugal|Centro Hospitalar Universitario do Porto, EPE - Hospital de Santo Antonio, Porto, 4099-001, Portugal|Centro Hospitalar de Sao Joao EPE - Hospital de Sao Joao, Porto, 4200-319, Portugal|Spitalul Clinic Colentina, Bucharest, 020125, Romania|Ryexo Clinical Research, Centurion, Gauteng, 0157, South Africa|About Allergy, Johannesburg, Gauteng, 2057, South Africa|Hiway Medical Centre, Durban, 3630, South Africa|Hospital Universitario Virgen Macarena, Sevilla, AndalucÃ­a, 41009, Spain|Hospital General Universitario de Alicante, Alicante, Comunidad Valenciana, 03010, Spain|Hospital de Manises, Manises, Comunidad Valenciana, 46940, Spain|Hospital Arnau de Vilanova de Valencia, Valencia, Comunidad Valenciana, 46015, Spain|Clinica Universidad de Navarra, Pamplona, Navarra, 31008, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, 28222, Spain|Karolinska Universitetssjukhuset Solna, Stockholm, 171 76, Sweden|Hacettepe Universitesi Tip Fakultesi Hastanesi, Ankara, 06230, Turkey|Gaziantep Universitesi Tip Fakultesi Hastanesi, Gaziantep, 27310, Turkey|Bezmialem Vakif Universitesi Hastanesi, Istanbul, 34093, Turkey|Bakircay Universitesi Cigli Egitim ve Arastirma Hastanesi, Izmir, 35620, Turkey|Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri, 38030, Turkey|Kocaeli Universitesi Tip Fakultesi Hastanesi, Kocaeli, 41380, Turkey|Sakarya Egitim ve Arastirma Hastanesi, Sakarya, 54050, Turkey|Lakeside Healthcare, Corby, NN17 2UR, United Kingdom|Guys Hospital, London, SE1 9RT, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom","Study Director : MD , Amgen"
Atopic Dermatitis,NCT05326672,Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05326672,NO,Atopic Dermatitis,DRUG: Benvitimod Cream|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Peking University People's Hospital, Beijing, China",Zhonghao Pharmaceutical
Atopic Dermatitis,NCT05882877,"A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)",https://clinicaltrials.gov/study/NCT05882877,NO,Atopic Dermatitis,DRUG: Rocatinlimab|OTHER: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Cahaba Dermatology and Skin Health Center, Birmingham, Alabama, 35244, United States|Medical Dermatology Specialists, Phoenix, Arizona, 85006, United States|Alliance Dermatology and Mohs Center, Phoenix, Arizona, 85032, United States|Affiliated Dermatology, Scottsdale, Arizona, 85255, United States|Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|Arkansas Research Trials, LLC, North Little Rock, Arkansas, 72117, United States|Kern Research Inc, Bakersfield, California, 93301, United States|Hope Clinical Research LLC, Canoga Park, California, 91303, United States|West Coast Research LLC, Dublin, California, 94568, United States|California Dermatology and Clinical Research Institute, Encinitas, California, 92024, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Antelope Valley Clinical Trials, Lancaster, California, 93534, United States|Chemidox Clinical Trials Incorporated, Lancaster, California, 93534, United States|Long Beach Research Institute, Long Beach, California, 90805, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Wallace Medical Group Inc, Los Angeles, California, 90056, United States|Havana Research Institute Inc, Pasadena, California, 91105, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States|University of California at Davis Medical Center, Sacramento, California, 95816, United States|Acclaim Clinical Research, San Diego, California, 92120, United States|Kaiser Permanente Medical Center - Oakland, San Francisco, California, 94118, United States|Kaiser Permanente Medical Center - San Francisco, San Francisco, California, 94118, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Wolverine Clinical Trials, Tustin, California, 92780, United States|IMMUNOe Research Centers, Centennial, Colorado, 80112, United States|Foxhall Research Center, Washington, District of Columbia, 20016, United States|Skin Care Research Incorporated, Boca Raton, Florida, 33486, United States|Renaissance Research and Medical Group, Cape Coral, Florida, 33991, United States|Driven Research LLC, Coral Gables, Florida, 33134, United States|Corazon United States of America, LLC doing business as Life Clinical Trials, Coral Springs, Florida, 33071, United States|D and H Doral Research Centers, Doral, Florida, 33122, United States|Saint Jude Clinical Research, Doral, Florida, 33172, United States|Direct Helpers Research Center, Hialeah, Florida, 33012, United States|Global Research Solutions, Homestead, Florida, 33030, United States|Nexus Clinical Research, Homestead, Florida, 33033, United States|Glick Skin Institute, Margate, Florida, 33063, United States|Meridian International Research, Miami Gardens, Florida, 33014, United States|Savin Medical Group LLC, Miami Lakes, Florida, 33014, United States|Gold Coast Health Research Center, Miami, Florida, 33155, United States|Healthy Life Research, Miami, Florida, 33175, United States|Anchor Medical Research, Miami, Florida, 33176, United States|Innovation Medical Research Center Inc, Palmetto Bay, Florida, 33157, United States|Olympian Clinical Research - Tampa, Tampa, Florida, 33615, United States|Atlanta Dermatology, Vein and Research Center, PC, Alpharetta, Georgia, 30022, United States|First Georgia Physicians Group, Fayetteville, Georgia, 30214, United States|Advanced Medical Research PC, Sandy Springs, Georgia, 30328, United States|Treasure Valley Medical Research, Boise, Idaho, 83706, United States|DeNova Research, Chicago, Illinois, 60602, United States|Sneeze, Wheeze, and Itch Associates, LLC, Normal, Illinois, 61761, United States|NorthShore University HealthSystem, Skokie, Illinois, 60077, United States|Dundee Dermatology, West Dundee, Illinois, 60118, United States|DS Research, Clarksville, Indiana, 47129, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|The Indiana Clinical Trials Center PC, Plainfield, Indiana, 46168, United States|Options Research Group LLC, West Lafayette, Indiana, 47906, United States|Dermatology and Skin Cancer Center Leawood, Leawood, Kansas, 66211, United States|DS Research, Louisville, Kentucky, 40241, United States|Kentucky Advanced Medical Research LLC, Murray, Kentucky, 42071, United States|Institute for Asthma and Allergy, Chevy Chase, Maryland, 20815, United States|Continental Clinical Solutions, LLC, Towson, Maryland, 21204, United States|MetroBoston Clinical Partners, Brighton, Massachusetts, 02135, United States|University of Michigan Medical Center, Ann Arbor, Michigan, 48109, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Onyx Clinical Research, Flint, Michigan, 48532, United States|Revival Research Institute LLC, Troy, Michigan, 48084, United States|Somerset Skin Centre, Troy, Michigan, 48084, United States|Dermatology and Skin Cancer Center of Lees Summit, Lee's Summit, Missouri, 64064, United States|Somnos Clinical Research, Lincoln, Nebraska, 68505, United States|Skin Specialists PC, Omaha, Nebraska, 68144, United States|Jubilee Clinical Research Inc, Las Vegas, Nevada, 89106, United States|Excel Clinical Research, Las Vegas, Nevada, 89109, United States|Las Vegas Clinical Trials, North Las Vegas, Nevada, 89030, United States|Skin Cancer and Dermatology Institute, Reno, Nevada, 89509, United States|Albuquerque Clinical Trials Incorporated, Albuquerque, New Mexico, 87102, United States|Chear Center LLC, Bronx, New York, 10455, United States|Ace Clinical Trials, Brooklyn, New York, 11211, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Sadick Research Group, New York, New York, 10075, United States|OptiSkin Medical, New York, New York, 10128, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|Wilmington Dermatology Center, Wilmington, North Carolina, 28405, United States|Accellacare of Wilmington, Wilmington, North Carolina, 28411, United States|The Skin Surgery Center, Winston-Salem, North Carolina, 27103, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Bernstein Clinical Research Center LLC, Cincinnati, Ohio, 45236, United States|The Ohio State University Dermatology East, Gahanna, Ohio, 43230, United States|Apex Clinical Research Center LLC, Mayfield Heights, Ohio, 44124, United States|Dermatologist of Central States Clinical Research - Springfield, Springfield, Ohio, 45505, United States|Unity Clinical Research, Oklahoma City, Oklahoma, 73118, United States|Dermatology Research Center of Oklahoma, PLLC, Tulsa, Oklahoma, 74132, United States|Essential Medical Research LLC, Tulsa, Oklahoma, 74137, United States|Velocity Clinical Research Inc, Medford, Oregon, 97504, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|Paddington Testing Company Inc, Philadelphia, Pennsylvania, 19103, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States|DermDox Dermatology, LLC, Sugarloaf, Pennsylvania, 18249, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|Cumberland Skin Center, Hermitage, Tennessee, 37076, United States|US Dermatology Partners Jollyville, Austin, Texas, 78759, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|US Dermatology Partners Cedar Park, Cedar Park, Texas, 78613, United States|Alina Clinical Trials, LLC, Dallas, Texas, 75225, United States|Dermatology Treatment and Research Center PA, Dallas, Texas, 75230, United States|Zenos Clinical Research, LLC, Dallas, Texas, 75230, United States|Newco 3A Research LLC, El Paso, Texas, 79925, United States|University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|Sante Clinical Research, Kerrville, Texas, 78028, United States|Sms Clinical Research Limited Liability Company, Mesquite, Texas, 75149, United States|Texas Dermatology Research Center, Plano, Texas, 75025, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|The Woodlands Dermatology Associates, The Woodlands, Texas, 77380, United States|Tanner Clinic, Murray, Utah, 84107, United States|University of Utah MidValley Dermatology, Murray, Utah, 84107, United States|Education and Research Foundation Inc, Lynchburg, Virginia, 24501, United States|Virginia Dermatology and Skin Cancer Center, Norfolk, Virginia, 23502, United States|Eastern Virginia Medical School, Norfolk, Virginia, 23507, United States|MultiCare Institute for Research and Innovation, Spokane, Washington, 99202, United States|Cinme - Centro de Investigaciones Metabolicas, Caba, Buenos Aires, C1027AAP, Argentina|Fundacion Respirar, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1426ABP, Argentina|Hospital Universitario Austral, Derqui, Pilar, Buenos Aires, B1629ODT, Argentina|Framingham Centro Medico, La Plata, Buenos Aires, B1902COS, Argentina|Conexa Investigacion Clinica SA, Caba, Distrito Federal, C1012AAY, Argentina|Buenos Aires Skin SA, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1054, Argentina|Fundacion Cidea, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1121, Argentina|Care- Centro de Alergia y Enfermedades Respiratorias, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1414, Argentina|InAER - Investigaciones en Alergia y Enfermedades Respiratorias, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1425, Argentina|Instituto de Neumonologia y Dermatologia, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1425, Argentina|Psoriahue Medicina Interdisciplinaria SRL, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1425, Argentina|Centro de Investigaciones Clinicas Instituto Especialidades De La Salud De Rosario, Rosario, Santa Fe, 2000, Argentina|Fundacion Estudios Clinicos, Rosario, Santa Fe, 2000, Argentina|Instituto de Diagnostico ABC, Rosario, Santa Fe, 2000, Argentina|Premier Specialists, Kogarah, New South Wales, 2217, Australia|St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Princess Alexandra Hospital, South Brisbane, Queensland, 4101, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 4102, Australia|Box Hill Hospital, Box Hill, Victoria, 3128, Australia|Emeritus Research Melbourne, Camberwell, Victoria, 3124, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Medizinische Universitaet Graz, Graz, 8036, Austria|Landeskrankenhaus Salzburg, Salzburg, 5020, Austria|Universitair Ziekenhuis Gent, Gent, 9000, Belgium|Clinique Andre Renard, Herstal, 4040, Belgium|Dermatologie Handelskaai, Kortrijk, 8500, Belgium|Grand Hopital de Charleroi, Loverval, 6280, Belgium|Dermatologie Maldegem, Maldegem, 9990, Belgium|Ceti Centro Est Terap Inovadoras, Curitiba, ParanÃ¡, 80030-110, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-903, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Rio Grande Do Sul, 90160-093, Brazil|Fundacao Abc - Centro Univ Fmabc, Santo Andre, SÃ£o Paulo, 09060-870, Brazil|Centro Multidisciplinar de Estudos Clinicos - Cemec, Sao Bernardo do Campo, SÃ£o Paulo, 09715-090, Brazil|Consultoria Medica e Pesquisa Clinica Cmpc, Sorocaba, SÃ£o Paulo, 18040-425, Brazil|Ispem-Instituto SÃ£o JosÃ© dos Campos em Pesquisas MÃ©dicas, SÃ£o JosÃ© dos Campos, SÃ£o Paulo, 12243-280, Brazil|IBPClin Instituto Brasil de Pesquisa Clinica, Rio de Janeiro, 20241-180, Brazil|Medical Center Asklepii OOD, Dupnitsa, 2600, Bulgaria|Medical Center Medconsult Pleven OOD, Pleven, 5800, Bulgaria|Medical Center Excelsior OOD, Sofia, 1407, Bulgaria|Diagnostic-Consultative Center Alexandrovska EOOD, Sofia, 1431, Bulgaria|Diagnostic-Consultative Center - Fokus-5 - Medical Institution for Outpatient Care OOD, Sofia, 1463, Bulgaria|Dermatology Research Institute Incorporated, Calgary, Alberta, T2J 7E1, Canada|Beacon Dermatology, Calgary, Alberta, T3E 0B2, Canada|Laser Rejuvenation Clinics Edmonton D T Incorporated, Edmonton, Alberta, T5J 3S9, Canada|Alberta Derma Surgery Centre, Edmonton, Alberta, T6G 1C3, Canada|Vida Clinical Research, Edmonton, Alberta, T6H 4J8, Canada|Skin Physicians Dermatology, Edmonton, Alberta, T6W 4V4, Canada|Interior Dermatology Centre, Kelowna, British Columbia, V1W 4V5, Canada|Doctor Chih-Ho Hong Medical Incorporated, Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research Incorporated, Winnipeg, Manitoba, R3M 3Z4, Canada|CCA Medical Research Corporation, Ajax, Ontario, L1S 7K8, Canada|SimcoDerm Medical and Surgical Dermatology Centre, Barrie, Ontario, L4M 7G1, Canada|SKiN Health, Coburg, Ontario, K9A 4J9, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L 0B7, Canada|LEADER Research, Hamilton, Ontario, L8L 3C3, Canada|Centricity Research London, London, Ontario, N6A 2C2, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X3, Canada|DermEdge Research Incorporated, Mississauga, Ontario, L4Y 4C5, Canada|Dr SK Siddha Medicine Professional Corporation, Newmarket, Ontario, L3Y 5G8, Canada|Allergy Research Canada Incorporated, Niagara Falls, Ontario, L2H 1H5, Canada|North Bay Dermatology Centre, North Bay, Ontario, P1B 3Z7, Canada|Canadian Dermatology Centre, North York, Ontario, M3B 0A7, Canada|The Centre for Clinical Trials Inc, Oakville, Ontario, L6J 7W5, Canada|Dermatology Ottawa Research Centre, Ottawa, Ontario, K2C 3N2, Canada|JRB Research Incorporated, Ottawa, Ontario, K2C 3N2, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|York Dermatology Clinic and Research Centre, Richmond Hill, Ontario, L4B 1L1, Canada|Oak Ridges Aesthetics Centre, Richmond Hill, Ontario, L4E 4L6, Canada|North York Research Incorporated, Toronto, Ontario, M2N 3A6, Canada|Toronto Research Centre Inc, Toronto, Ontario, M3H 5Y8, Canada|FACET Dermatology, Toronto, Ontario, M4E 1R7, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Evidence Based Medical Educator Inc, Toronto, Ontario, M5G 1E2, Canada|Alliance Clinical Trials, Waterloo, Ontario, N2J 1C4, Canada|XLR8 Medical Research, Incorporated, Windsor, Ontario, N8T 1E6, Canada|Clinique de Dermatologie Rosemont, Montreal, Quebec, H1Y 3L1, Canada|Innovaderm Research Inc, Montreal, Quebec, H2X 2V1, Canada|Clinique Medicale Saint Louis, Quebec City, Quebec, G1W 4R4, Canada|Skinsense Medical Research, Saskatoon, Saskatchewan, S7K 2C1, Canada|Saskatoon Dermatology Centre, Saskatoon, Saskatchewan, S7T 0G3, Canada|Recherche Clinique Sigma Incorporated, Quebec, G1G 3Y8, Canada|Centre de Recherche Dermatologique du Quebec Metropolitain, Quebec, G1V 4X7, Canada|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350000, China|The First Hospital Of Hebei Medical University, Shijiazhuang, Hebei, 050000, China|Nanyang First Peoples Hospital, Nanyang, Henan, 473002, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China|Wuxi Peoples Hospital, Wuxi, Jiangsu, 241023, China|Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, 330000, China|Zhejiang Provincial Peoples Hospital, Hangzhou, Zhejiang, 310014, China|Affiliated Hangzhou First Peoples Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310020, China|Peking University Peoples Hospital, Beijing, 100044, China|Special Hospital for Medical Rehabilitation Naftalan, Ivanic-Grad, 10310, Croatia|University Hospital Centre Zagreb, Zagreb, 10000, Croatia|Kozni ambulance Kutna Hora sro, Kutna Hora, 284 01, Czechia|Dermamedica, sro, Nachod, 547 01, Czechia|Nemocnice Novy Jicin as, Novy Jicin, 741 01, Czechia|CCR Ostrava sro, Ostrava, 702 00, Czechia|Pratia Pardubice as, Pardubice, 530 02, Czechia|Fakultni nemocnice Plzen, Plzen, 305 99, Czechia|Clintrial sro, Praha 10, 100 00, Czechia|Pratia Prague sro, Praha 3, 130 00, Czechia|Praglandia sro, Praha 5, 150 00, Czechia|Kozni ambulance Fialova sro, Praha 6, 106 00, Czechia|Fakultni nemocnice Bulovka, Praha 8, 180 81, Czechia|Dermamedest sro, Praha, 120 00, Czechia|Dermatologicka ambulance MUDr Petr Trestik, Svitavy, 568 02, Czechia|Krajska zdravotni as - Masarykova nemocnice Usti nad Labem oz, Usti nad Labem, 401 13, Czechia|Gentofte Hospital, Hellerup, 2900, Denmark|North Estonia Medical Centre, Tallinn, 13419, Estonia|Clinical Research Centre, Tartu, 50106, Estonia|Clinical Research Services Helsinki, Helsinki, 00180, Finland|Oulun Yliopistollinen sairaala, Oulu, 90029, Finland|Terveystalo Tampere, Tampere, 33100, Finland|Hopital Prive d Antony, Antony, 92160, France|Polyclinique de Courlancy, Bezannes, 51430, France|Centre Hospitalier Regional Universitaire Brest Hopital Morvan, Brest, 29200, France|Centre Hospitalier RÃ©gional Universitaire de Lille - HÃ´pital Claude Huriez, Lille, 59037, France|Centre Hospitalier de Bretagne Sud - Hopital du Scorff, Lorient Cedex, 56322, France|Cabinet du Docteur Ruer-Mulard Mireille, Martigues, 13500, France|Centre Hospitalier Universitaire Archet 2, Nice, 06202, France|Hopital Saint Louis, Paris Cedex 10, 75475, France|Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes Cedex 9, 35033, France|Centre Hospitalier Universitaire de Rouen - HÃ´pital Charles Nicolle, Rouen Cedex, 76031, France|Fachklinik Bad Bentheim, Bad Bentheim, 48455, Germany|Charite Universitaetsmedizin Berlin, Campus Mitte, Berlin, 10117, Germany|Clinical Research Services Berlin GmbH, Berlin, 13627, Germany|Dermatologische Gemeinschaftspraxis-Mahlow, Blankenfelde-Mahlow, 15831, Germany|Hautarztpraxis Dr Niesmann und Dr Othlinghaus, Bochum, 44793, Germany|Rosenpark Research GmbH, Darmstadt, 64283, Germany|Universitaetsklinikum Dresden, Dresden, 01307, Germany|Universitaetsklinikum Frankfurt, Frankfurt am Main, 60590, Germany|Universitaetsmedizin Goettingen - Georg-August-Universitaet, Goettingen, 37075, Germany|Institute for Health Services Research in Dermatology and Nursing, Hamburg, 20246, Germany|Hautaerzte Zentrum Hannover, Hannover, 30159, Germany|Universitaetsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitaetsklinikum Schleswig-Holstein, Kiel, 24105, Germany|Velocity Clinical Research, Leipzig, 04177, Germany|Universitaetsmedizin Mainz, Mainz, 55101, Germany|Beldio Research GmbH, Memmingen, 87700, Germany|Hautmedizin Saar, Merzing, 66663, Germany|Klinikum rechts der Isar der TUM, Muenchen, 80802, Germany|Universitaetsklinikum Muenster, Muenster, 48149, Germany|KliFOs Klinische Forschung Osnabrueck, Osnabrueck, 49074, Germany|Hautarztpraxis Mortazawi, Remscheid, 42897, Germany|Hautarztpraxis Dres Leitz und Kollegen, Stuttgart, 70178, Germany|Universitaetsklinikum Tuebingen, Tuebingen, 72076, Germany|Helios Klinikum Wuppertal, Wuppertal, 42283, Germany|CentroDerm GmbH, Wuppertal, 42287, Germany|University General Hospital Attikon, Athens, 12462, Greece|Andreas Syngros Hospital Of Venereal And Dermatological Diseases, Athens, 16121, Greece|University General Hospital of Ioannina, Ioannina, 45500, Greece|General University Hospital of Larissa, Larissa, 41110, Greece|General Hospital Of Nea Ionia Konstantopouleio Patision, Nea Ionia, 14233, Greece|Geniko Nosokomeio Peiraia Tzaneio, Piraeus, 18536, Greece|Papageorgiou General Hospital, Thessaloniki, 56429, Greece|Trial Pharma Kft, Bekescsaba, 5600, Hungary|Csalogany Orvosi Kozpont, Budapest, 1027, Hungary|Obudai Egeszsegugyi Centrum Kft, Budapest, 1036, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, 4032, Hungary|Gyongyosi Bugat Pal Korhaz, Gyongyos, 3200, Hungary|Somogy Varmegyei Kaposi Mor Oktato Korhaz, Kaposvar, 7400, Hungary|DermaMed Research Kft, Oroshaza, 5900, Hungary|Allergo-Derm Bakos Kft, Szolnok, 5000, Hungary|Medmare Bt, Veszprem, 8200, Hungary|Obudai Egeszsegugyi Centrum Kft, Zalaegerszeg, 8900, Hungary|Universita degli Studi Gabriele D Annunzio di Chieti e Pescara, Chieti, 66100, Italy|Ospedale San Salvatore, LAquila, 67100, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia, Perugia, 06156, Italy|Azienda Ospedaliera Policlinico Umberto I, Roma, 00161, Italy|IRCCS Istituto Clinico Humanitas, Rozzano MI, 20089, Italy|Aichi Medical University Hospital, Nagakute-shi, Aichi, 480-1195, Japan|Fukui Dermatology Clinic, Nagoya-shi, Aichi, 454-0803, Japan|Japan Community Healthcare Organization Chukyo Hospital, Nagoya-shi, Aichi, 457-8510, Japan|Central Clinic, Nagoya-shi, Aichi, 464-0821, Japan|Nagoya City University Hospital, Nagoya-shi, Aichi, 467-8602, Japan|Miyata Dermatology Clinic, Matsudo-shi, Chiba, 271-0092, Japan|International University of Health and Welfare Narita Hospital, Narita-shi, Chiba, 286-8520, Japan|Ekihigashi Dermatology Allergy Clinic, Fukuoka-shi, Fukuoka, 812-0013, Japan|Fukuoka University Hospital, Fukuoka-shi, Fukuoka, 814-0180, Japan|Matsuo Clinic, Fukuoka-shi, Fukuoka, 819-0373, Japan|Fukushima Medical University Hospital, Fukushima-shi, Fukushima, 960-1295, Japan|Asahikawa City Hospital, Asahikawa-shi, Hokkaido, 070-8610, Japan|Takagi Dermatological Clinic, Obihiro-shi, Hokkaido, 080-0013, Japan|Medical Corporation Kojinkai Sapporo Skin Clinic, Sapporo-shi, Hokkaido, 060-0063, Japan|Yoshimura Child Clinic, Akashi-shi, Hyogo, 674-0068, Japan|Kobe University Hospital, Kobe-shi, Hyogo, 650-0017, Japan|Tokyo Medical University Ibaraki Medical Center, Inashiki-gun, Ibaraki, 300-0395, Japan|Kaji Dermatology Clinic, Nonoichi-shi, Ishikawa, 921-8801, Japan|Iwate Medical University Uchimaru Medical Center, Morioka-shi, Iwate, 020-8505, Japan|Takeoka Dermatology Clinic, Marugame-shi, Kagawa, 763-0074, Japan|Katahira Dermatology Urology Clinic, Kagoshima-shi, Kagoshima, 890-0063, Japan|Kosugi Dermatology Clinic, Kawasaki-shi, Kanagawa, 211-0063, Japan|Nippon Medical School Musashikosugi Hospital, Kawasaki-shi, Kanagawa, 211-8533, Japan|St Marianna University Hospital, Kawasaki-shi, Kanagawa, 216-8511, Japan|National Hospital Organization Sagamihara National Hospital, Sagamihara-shi, Kanagawa, 252-0392, Japan|Nomura Dermatology Clinic, Yokohama-shi, Kanagawa, 221-0825, Japan|Showa University Northern Yokohama Hospital, Yokohama-shi, Kanagawa, 224-8503, Japan|Jouzan Hihuka Hinyoukika Clinic, Kumamoto-shi, Kumamoto, 860-0066, Japan|Suizenji Dermatology Clinic, Kumamoto-shi, Kumamoto, 862-0950, Japan|University Hospital Kyoto Prefectural University of Medicine, Kyoto-shi, Kyoto, 602-8566, Japan|Rakuwakai Otowa Hospital, Kyoto-shi, Kyoto, 607-8062, Japan|Nagasaki University Hospital, Nagasaki-shi, Nagasaki, 852-8501, Japan|Osaka Habikino Medical Center, Habikino-shi, Osaka, 583-8588, Japan|Mochida Dermatology Clinic, Izumiotsu-shi, Osaka, 595-0025, Japan|Yoshioka Dermatology Clinic, Neyagawa-shi, Osaka, 572-0838, Japan|Dermatology and Ophthalmology Kume Clinic, Sakai-shi, Osaka, 593-8324, Japan|JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu-shi, Shizuoka, 430-0929, Japan|Hamamatsu University Hospital, Hamamatsu-shi, Shizuoka, 431-3192, Japan|Dokkyo Medical University Hospital, Shimotsuga-gun, Tochigi, 321-0293, Japan|Mildix Skin Clinic, Adachi-ku, Tokyo, 120-0034, Japan|Teikyo University Hospital, Itabashi-ku, Tokyo, 173-8606, Japan|Nihon University Itabashi Hospital, Itabashi-ku, Tokyo, 173-8610, Japan|Mita Dermatology Clinic, Minato-ku, Tokyo, 108-0014, Japan|Naoko Dermatology Clinic, Setagaya-ku, Tokyo, 158-0097, Japan|NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, 141-8625, Japan|Showa University Hospital, Shinagawa-ku, Tokyo, 142-8666, Japan|Seibo International Catholic Hospital, Shinjuku-ku, Tokyo, 161-8521, Japan|Yamate Dermatology Clinic, Shinjuku-ku, Tokyo, 169-0075, Japan|Sugamo Kobayashi Derma Clinic, Toshima-ku, Tokyo, 170-0002, Japan|Shirasaki Dermatology Clinic, Takaoka-shi, Toyama, 933-0871, Japan|Korea University Ansan Hospital, Ansansi, Gyeonggido, 15355, Korea, Republic of|SoonChunHyang University Hospital Bucheon, Bucheon-si, Gyeonggi-do, 14584, Korea, Republic of|Chosun University Hospital, Gwangju, 61453, Korea, Republic of|The Catholic University of Korea Incheon St Marys Hospital, Incheon, 21431, Korea, Republic of|Inha University Hospital, Incheon, 22332, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea, Republic of|Korea University Anam Hospital, Seoul, 02841, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, 03722, Korea, Republic of|National Medical Center, Seoul, 04564, Korea, Republic of|Konkuk University Medical Center, Seoul, 05030, Korea, Republic of|Kyung Hee University Hospital at Gangdong, Seoul, 05278, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|The Catholic University of Korea Seoul St Marys Hospital, Seoul, 06591, Korea, Republic of|Chung-Ang University Hospital, Seoul, 06973, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, 07441, Korea, Republic of|Ewha Womans University Seoul Hospital, Seoul, 07804, Korea, Republic of|Ajou University Hospital, Suwon-si, Gyeonggi-do, 16499, Korea, Republic of|Outpatient clinic Veselibas Centrs 4, Riga, 1003, Latvia|Outpatient clinic Veselibascentrs 4, Riga, LV-1013, Latvia|Smite Aija practice in dermatology and venerology, Talsi, 3201, Latvia|Hospital Sultan Ismail, Johor Bahru, Johor, 81100, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, 30450, Malaysia|Hospital Pulau Pinang, Georgetown, Pinang, 10990, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Wilayah Persekutuan, 59100, Malaysia|ClÃ­nica de Enfermedades CrÃ³nicas y de Procedimientos Especiales, Morelia, MichoacÃ¡n, 58249, Mexico|Phylasis Clinical Research, CuautitlÃ¡n Izcalli, 54750, Mexico|Bravis Ziekenhuis, Bergen op Zoom, 4624 VT, Netherlands|Universitair Medisch Centrum Groningen, Groningen, 9700 RB, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, 3584 CX, Netherlands|ClinicMed Daniluk Nowak Spolka komandytowa, Bialystok, 15-879, Poland|Dermapolis Medical Dermatology Center dr n med Edyta Gebska, Chorzow, 41-500, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-214, Poland|AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy, Gdansk, 80-280, Poland|GynCentrum Spzoo NZOZ Holsamed - Oddzial Libero, Katowice, 40-600, Poland|Centrum Medyczne Angelius Provita, Katowice, 40-611, Poland|Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy Marek Brzewski Pawel Brzewski SpCywilna, Krakow, 30-002, Poland|Centrum Terapii Wspolczesnej J M Jasnorzewska Spolka Komandytowo Akcyjna, Lodz, 90-338, Poland|AppleTreeClinics Network Spzoo, Lodz, 90-349, Poland|Ip Clinic Sp zoo, Lodz, 90-752, Poland|Amicare Spolka z ograniczona odpowiedzialnoscia Spolka Komandytowa Amicare Centrum Medyczne, Lodz, 91-495, Poland|Clinical Best Solutions Sp zoo Spolka Komandytowa, Lublin, 20-011, Poland|Centrum Zdrowia i Urody Maxxmed, Lublin, 20-080, Poland|Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Spzoo, Malbork, 82-200, Poland|Twoja przychodnia Ncm, Nowa Sol, 67-100, Poland|Twoja przychodnia Pcm, Poznan, 61-293, Poland|Twoja Przychodnia Scm, Szczecin, 71-500, Poland|Alergo-Med Specjalistyczna Przychodnia Lekarska Spzoo, Tarnow, 33-100, Poland|Klinika Osipowicz and Turkowski Sp zoo, Warszawa, 00-716, Poland|Evimed sp zoo centrum medyczne evimed, Warszawa, 02-625, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-962, Poland|Dermatologiczna Praktyka Lekarska Michal Torz Dermaceum Centrum Badan Klinicznych, Wroclaw, 50-450, Poland|DermMedica Spzoo Centrum Columbus, Wroclaw, 51-503, Poland|Unidade de Saude Local de Almada-Seixal, EPE - Hospital Garcia de Orta, Almada, 2801-951, Portugal|Unidade Local de Saude de Coimbra, EPE, Coimbra, 3000-075, Portugal|Hospital Cuf Descobertas, Lisboa, 1998-018, Portugal|Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio, Porto, 4099-001, Portugal|Unidade Local de Saude de Sao Joao, EPE - Hospital de Sao Joao, Porto, 4200-319, Portugal|National University Hospital, Singapore, 119074, Singapore|Singapore General Hospital, Singapore, 168753, Singapore|National Skin Centre, Singapore, 308205, Singapore|Fakultna Nemocnica s poliklinikou F D Roosevelta Banska Bystrica, Banska Bystrica, 975 17, Slovakia|Maxderm, sro, Bardejov, 085 01, Slovakia|Univerzitna nemocnica Bratislava - Nemocnica Stare Mesto, Bratislava, 813 69, Slovakia|Derma therapy, spol s ro, Bratislava, 851 01, Slovakia|Sanare spol sro, Svidnik, 089 01, Slovakia|Kaderma Majtan, sro, Topolcany, 955 01, Slovakia|Univerzitetni klinicni center Ljubljana, Ljubljana, 1000, Slovenia|Univerzitetni Klinicni Center Maribor, Maribor, 2000, Slovenia|Hiway Medical Centre, Westville, Durban, KwaZulu-Natal, 3630, South Africa|Hospital Universitario Reina Sofia, Cordoba, AndalucÃ­a, 14004, Spain|Hospital Universitario Virgen Macarena, Sevilla, AndalucÃ­a, 41009, Spain|Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Canarias, 35010, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, CataluÃ±a, 08916, Spain|Hospital Universitari de Bellvitge, Hospitalet de LLobregat, CataluÃ±a, 08907, Spain|Hospital General Universitario de Alicante, Alicante, Comunidad Valenciana, 03010, Spain|Hospital de Manises, Manises, Comunidad Valenciana, 46940, Spain|Hospital Arnau de Vilanova de Valencia, Valencia, Comunidad Valenciana, 46015, Spain|Hospital Clinico Universitario de Santiago, Santiago de Compostela, Galicia, 15706, Spain|Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon, Madrid, 28223, Spain|Clinica Universidad de Navarra, Pamplona, Navarra, 31008, Spain|Hospital Universitario Basurto, Bilbao, PaÃ­s Vasco, 48013, Spain|Hospital Universitario de La Princesa, Madrid, 28006, Spain|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Inselspital Bern, Bern, 3010, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland|Universitaetsspital Zuerich, Zuerich, 8091, Switzerland|National Cheng Kung University Hospital, Tainan, 70403, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Ankara Bilkent Sehir Hastanesi, Ankara, 06800, Turkey|Gaziantep Universitesi Tip Fakultesi Hastanesi, Gaziantep, 27310, Turkey|Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul, 34390, Turkey|Acibadem Altunizade Hastanesi, Istanbul, 34662, Turkey|Marmara Universitesi Tip Fakultesi Hastanesi, Istanbul, 34899, Turkey|Bakircay Universitesi Cigli Egitim ve Arastirma Hastanesi, Izmir, 35620, Turkey|Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri, 38030, Turkey|Kocaeli Universitesi Tip Fakultesi Hastanesi, Kocaeli, 41380, Turkey|Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi, Samsun, 55200, Turkey|The Royal Free Hospital, London, NW3 2PF, United Kingdom|Guys Hospital, London, SE1 9RT, United Kingdom|Salford Care Organisation, Salford, M6 8HD, United Kingdom|Accellacare Yorkshire, Shipley, BD18 3SA, United Kingdom","Study Director : MD , Amgen"
Atopic Dermatitis,NCT05614817,CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05614817,NO,Atopic Dermatitis,DRUG: CBP-201|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,,"Study Director : Suzhou Connect , Suzhou Connect Biopharmaceuticals, Ltd."
Atopic Dermatitis,NCT05984420,Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05984420,NO,Atopic Dermatitis,"DEVICE: LimpiAD 2,5% plus cream|OTHER: Vehicle|OTHER: Emollient",ALL,CHILD,,"Dr. Chianese Pierluigi, Castellammare di Stabia, Napoli, 80053, Italy|Dr. Carlomagno Francesco, Nola, Napoli, 80035, Italy|Dr. D'Onofrio Antonietta, Pomigliano d'Arco, Napoli, 80038, Italy|Dr. Giuseppe Ruggiero, Battipaglia, Salerno, 84091, Italy|Dr. Occhinegro Aurelio, Salerno, 84090, Italy","Principal Investigator : Ruggiero Giuseppe, MD , ASL Salerno"
Atopic Dermatitis,NCT05099315,Microbiome in Atopic Dermatitis Under Systemic Therapy,https://clinicaltrials.gov/study/NCT05099315,NO,Atopic Dermatitis,"OTHER: not applicable, observational study",ALL,"ADULT, OLDER_ADULT",,"Dpt of Dermatology and Allergology, CharitÃ© - UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany","Charite University, Berlin, Germany"
Atopic Dermatitis,NCT05215808,SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects,https://clinicaltrials.gov/study/NCT05215808,NO,Atopic Dermatitis,DRUG: RBN-3143,ALL,"ADULT, OLDER_ADULT",PHASE1,"Veracity Clinical Research, Woolloongabba, Queensland, Australia|CMAX Clinical Research Pty Ltd, Adelaide, SA 5000, Australia|Optimal Clinical Trials, Auckland, New Zealand|Waitemata Clinical Research, Auckland, New Zealand|New Zealand Clinical Research (NZCR), Christchurch, 8011, New Zealand|Southern Clinical Trials Tasman, Nelson, New Zealand",
Atopic Dermatitis,NCT05916365,Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05916365,NO,Atopic Dermatitis,BIOLOGICAL: Lebrikizumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Investigator Site 7, Darmstadt, Hessen, 64283, Germany|Investigator Site 8, Frankfurt, Hessen, 60590, Germany|Investigator Site 9, OsnabrÃ¼ck, Lower Saxony, 49074, Germany|Investigator Site 10, Bad Bentheim, Niedersachsen, 48455, Germany|Investigator Site 11, MÃ¼nster, Nordrhein-Westfalen, 48149, Germany|Investigator Site 12, Leipzig, Saxony, 04103, Germany|Investigator Site 1, Augsburg, 86150, Germany|Investigator Site 2, Berlin, 10789, Germany|Investigator Site 3, Berlin, 13055, Germany|Investigator Site 4, Dresden, D-01307, Germany|Investigator Site 5, Hamburg, 20144, Germany|Investigator Site 6, Hamburg, 20537, Germany|Investigator Site 23, WrocÅ‚aw, DolnoÅ›lÄ…skie, 51-503, Poland|Investigator Site 24, ÅÃ³dÅº, Lodzkie, 90-436, Poland|Investigator Site 25, Krakow, Malopolskie, 31-559, Poland|Investigator Site 26, KrakÃ³w, Malopolskie, 30-033, Poland|Investigator Site 27, Warsaw, Mazowieckie, 02-625, Poland|Investigator Site 28, Warszawa, Mazowieckie, 02-507, Poland|Investigator Site 29, Ossy, Slaskie, 42-624, Poland|Investigator Site 30, GdaÅ„sk, Woj. Pomorskie, 80-344, Poland|Investigator Site 31, Iwonicz Zdroj, Wojewodztwo Podkarpackie, 38-440, Poland|Investigator Site 13, Gdansk, 80-462, Poland|Investigator Site 14, Katowice, 40-600, Poland|Investigator Site 15, Kielce, 25-155, Poland|Investigator Site 16, Lublin, 20-081, Poland|Investigator Site 17, Poznan, 60-214, Poland|Investigator Site 18, Rzeszow, 35-055, Poland|Investigator Site 19, Szczecin, 71-434, Poland|Investigator Site 20, Tarnow, 33-100, Poland|Investigator Site 21, Warszawa, 01-142, Poland|Investigator Site 22, Wroclaw, 50-566, Poland|Investigator Site 32, Katowice, ÅšlÄ…skie, 40-611, Poland","Principal Investigator : Aleksandra Stjepanovic , Almirall, S.A."
Atopic Dermatitis,NCT06194045,Nutritional Study to Determine the Effect of Fish Oil on Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06194045,NO,Atopic Dermatitis,DIETARY_SUPPLEMENT: LC-MUFA oil|DIETARY_SUPPLEMENT: Placebo,ALL,"ADULT, OLDER_ADULT",,"Helse MÃ¸re og Romsdal HF, Ã…lesund, MÃ¸re Og Romsdal, 6017, Norway","Principal Investigator : Dag Arne Lihaug Hoff , Helse MÃ¸re og Romsdal HF"
Atopic Dermatitis,NCT03710044,Investigation of Flare and Remission in Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03710044,NO,Atopic Dermatitis,DRUG: Cyclosporine A,ALL,"ADULT, OLDER_ADULT",PHASE4,"Investigational site, Rotterdam, 3015 GD, Netherlands","Study Director : Medical Expert , LEO Pharma"
Atopic Dermatitis,NCT06366932,Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models,https://clinicaltrials.gov/study/NCT06366932,NO,Atopic Dermatitis,DRUG: Second-line systemic treatment|OTHER: Folllow-up of second-line systemic treatment already started,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Hospital La Paz, Madrid, 28046, Spain","Principal Investigator : Irene GarcÃ­a, MD , Hospital La Paz"
Atopic Dermatitis,NCT05598762,The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape Strips,https://clinicaltrials.gov/study/NCT05598762,NO,Atopic Dermatitis,GENETIC: Tape strips,ALL,"CHILD, ADULT",,"Queen Sirikit National Institute of Child Health, Bangkok, 10400, Thailand",
Atopic Dermatitis,NCT06248814,"A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06248814,NO,"Dermatitis, Atopic",DRUG: BMS-986326|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1,"Local Institution - 0009, Pardubice, 530 02, Czechia|CHU Estaing, Clermont-Ferrand, 63003, France|CHU de Nice - L'Archet, Nice, 06200, France|Charite-Universitaetsmedizin Berlin - Campus Charite Mitte (CCM), Berlin, BE, 10117, Germany|Universitaetsklinikum Schleswig-Holstein -Campus Luebeck - Exzellenzzentrum Entzuendungsmedizin, Lubeck, SH, 23562, Germany|Local Institution - 0005, Chemnitz, SN, 09117, Germany|Malopolskie Centrum Kliniczne, Krakow, MA, 30-149, Poland|Local Institution - 0001, Rzeszow, Podkarpackie, 35-055, Poland|Centrum Medyczne Pratia - Katowice, Katowice, SL, 40-081, Poland|Hospital Universitario de Gran Canaria Doctor NegrÃ­n, Las Palmas de Gran Canaria, GC, 35010, Spain|Hospital Universitario Reina SofÃ­a, CÃ³rdoba, X, 14004, Spain","Study Director : Bristol-Myers Squibb , Bristol-Myers Squibb"
Atopic Dermatitis,NCT05004324,Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT05004324,NO,"Dermatitis, Atopic",BIOLOGICAL: FURESTEM-ADÂ® inj. 5.0 X 10^7 cells/1.5 mL|BIOLOGICAL: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Chosun University Hospital, Gwangju, Jeollanam-do, 61453, Korea, Republic of","Principal Investigator : Yeonglib Park, professor (CI) , Bucheon Hospital, Soonchunhyang University Principal Investigator : Yangwon Lee, professor , Konkuk University Hospital Principal Investigator : Sanguk Son, professor , Korea University Principal Investigator : Bakrin Yoo, professor , Gangdong Kyunghee University Hospital Principal Investigator : Jihyun Lee, professor , Seoul St. Mary's Hospital Principal Investigator : Donghoon Lee, professor , Seoul National University Hospital Principal Investigator : Chanho Na, professor , Chosun University Hospital Principal Investigator : Yooin Bae, professor , Hallym University Dongtan Seongsim Hospital Principal Investigator : Hyunchang Ko, professor , Yangsan Pusan National University Hospital Principal Investigator : Younghyun Jang, professor , Kyungpook National University Hospital Principal Investigator : Jeongeun Kim, professor , The Catholic University of Korea Eunpyeong St. Mary's Hospital Principal Investigator : Minkyung Shin, professor , Kyunghee University Hospital Principal Investigator : Sanghyun Cho, professor , Catholic University Incheon St. Mary's Hospital Principal Investigator : Cheonuk Park, professor , Hallym University Gangnam Seongsim Hospital Principal Investigator : Jooyeon Ko, professor , Hanyang University Principal Investigator : Taeyoung Han, professor , Nowon Eulji University Hospital Principal Investigator : Jiyoung Ahn, professor , National Medical Center Show fewer investigators"
Atopic Dermatitis,NCT05969717,Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05969717,NO,Atopic Dermatitis,DRUG: GD-iExo-001|OTHER: normal saline,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Chinese Academy of Medical Science & Peking Union Medical College Hospital, Beijing, Beijing, 100730, China","Principal Investigator : Hongzhong Jin, MD , Peking Union Medical College Hospital"
Atopic Dermatitis,NCT06169527,A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab,https://clinicaltrials.gov/study/NCT06169527,NO,Atopic Dermatitis,DRUG: Dupilumab,ALL,"CHILD, ADULT, OLDER_ADULT",,"Investigational Site Number: 2500021, Argenteuil, 95100, France|Investigational Site Number: 2500018, Arras, 62022, France|Investigational Site Number: 2500011, Ars Laquenexy, 57530, France|Investigational Site Number: 2500023, Avignon, 84000, France|Investigational Site Number: 2500001, BesanÃ§on, 25000, France|Investigational Site Number: 2500003, Bron, 69500, France|Investigational Site Number: 2500043, Caen, 14033, France|Investigational Site Number: 2500006, Clermont Ferrand, 63003, France|Investigational Site Number: 2500005, Dijon, 21079, France|Investigational Site Number: 2500004, Epagny Metz Tessy, 74374, France|Investigational Site Number: 2500045, La Tronche, 38700, France|Investigational Site Number: 2500032, Lille, 59037, France|Investigational Site Number: 2500002, Limoges, 87042, France|Investigational Site Number: 2500036, Lorient, 56100, France|Investigational Site Number: 2500029, Marseille, 13008, France|Investigational Site Number: 2500019, Montivilliers, 76290, France|Investigational Site Number: 2500028, Montpellier, 34295, France|Investigational Site Number: 2500024, Nantes, 44093, France|Investigational Site Number: 2500020, Nice, 06000, France|Investigational Site Number: 2500025, Nice, 06000, France|Investigational Site Number: 2500030, Paris, 75015, France|Investigational Site Number: 2500016, Pau, 64000, France|Investigational Site Number: 2500022, Pontoise, 95300, France|Investigational Site Number: 2500009, PÃ©rigueux, 24000, France|Investigational Site Number: 2500014, Romans sur IsÃ¨re, 26102, France|Investigational Site Number: 2500008, Rouen, 76038, France|Investigational Site Number: 2500015, Saint Germain en Laye, 78100, France|Investigational Site Number: 2500027, Saint MandÃ©, 94163, France|Investigational Site Number: 2500026, Saint Nazaire, 44600, France|Investigational Site Number: 2500035, Saint-Pierre, 97410, France|Investigational Site Number: 2500013, Saint-Pierre, 97448, France|Investigational Site Number: 2500012, Toulouse, 31059, France|Investigational Site Number: 2500010, Valence, 26953, France",Regeneron Pharmaceuticals
Atopic Dermatitis,NCT04836858,A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT04836858,YES,Atopic Dermatitis,BIOLOGICAL: CMK389|BIOLOGICAL: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Novartis Investigative Site, Pardubice, Czech Republic, 530 02, Czechia|Novartis Investigative Site, Praha 10, 100 34, Czechia|Novartis Investigative Site, Marseille, 13008, France|Novartis Investigative Site, Nice, 06202, France|Novartis Investigative Site, Rouen, 76031, France|Novartis Investigative Site, Bad Bentheim, 48455, Germany|Novartis Investigative Site, Berlin, 10117, Germany|Novartis Investigative Site, Frankfurt, 60596, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Muenchen, 81377, Germany|Novartis Investigative Site, Muenster, 48149, Germany|Novartis Investigative Site, Osnabrueck, 49074, Germany|Novartis Investigative Site, Budapest, 1085, Hungary|Novartis Investigative Site, Szeged, 6720, Hungary|Novartis Investigative Site, Gdansk, 80-546, Poland|Novartis Investigative Site, Lodz, 90-265, Poland|Novartis Investigative Site, Rzeszow, 35 055, Poland|Novartis Investigative Site, Cordoba, Andalucia, 14004, Spain",Novartis Pharmaceuticals
Atopic Dermatitis,NCT05048056,"Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis",https://clinicaltrials.gov/study/NCT05048056,NO,Atopic Dermatitis,DRUG: Placebo|DRUG: AK120|DRUG: AK120,ALL,"ADULT, OLDER_ADULT",PHASE2,"AkesoBio Investigative Site 2003, Little Rock, Arkansas, 72204, United States|AkesoBio Investigative Site 2010, Canoga Park, California, 91303, United States|AkesoBio Investigative Site 2021, San Diego, California, 92119, United States|AkesoBio Investigative Site 2023, San Diego, California, 92120, United States|AkesoBio Investigative Site 2017, San Francisco, California, 94127, United States|AkesoBio Investigative Site 2020, Sherman Oaks, California, 91043, United States|AkesoBio Investigative Site 2009, Hialeah, Florida, 33016, United States|AkesoBio Investigative Site 2001, Hollywood, Florida, 33021, United States|AkesoBio Investigative Site 2011, Miami, Florida, 33155, United States|AkesoBio Investigative Site 2002, Weston, Florida, 33331, United States|AkesoBio Investigative Site 2022, Ridgeland, Mississippi, 39157, United States|AkesoBio Investigative Site 2015, Las Vegas, Nevada, 89145, United States|AkesoBio Investigative Site 2013, Spartanburg, South Carolina, 29303, United States|AkesoBio Investigative Site 2005, Rapid City, South Dakota, 57702, United States|AkesoBio Investigative Site 2004, Houston, Texas, 77065, United States|AkesoBio Investigative Site 2018, Houston, Texas, 77074, United States|AkesoBio Investigative Site 3003, Sydney, New South Wales, 2145, Australia|AkesoBio Investigative Site 3002, Woolloongabba, Queensland, 4102, Australia|AkesoBio Investigative Site 3001, Camberwell, Victoria, 3145, Australia|AkesoBio Investigative Site 4003, Auckland, 0626, New Zealand|AkesoBio Investigative Site 4001, Auckland, 1010, New Zealand|AkesoBio Investigative Site 4005, Christchurch, 8013, New Zealand|AkesoBio Investigative Site 4004, Hamilton, 3204, New Zealand|AkesoBio Investigative Site 4004, Wellington, 6242, New Zealand",Akesobio Australia Pty Ltd
Atopic Dermatitis,NCT05633355,"A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)",https://clinicaltrials.gov/study/NCT05633355,NO,Atopic Dermatitis,DRUG: Rocatinlimab,ALL,CHILD,PHASE3,"Phoenix Childrens Hosptial, Phoenix, Arizona, 85016, United States|Medical Advancement Centers of Arizona, Tempe, Arizona, 85283, United States|Dermatology Trial Associates, Bryant, Arkansas, 72022, United States|Little Rock Allergy and Asthma Clinical Research Center, Little Rock, Arkansas, 72205, United States|University of California Irvine, Irvine, California, 92697, United States|University of California Los Angeles, Los Angeles, California, 90024, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Manlio Dermatology, Kissimmee, Florida, 34741, United States|Deluxe Health Care LLC, Miami Lakes, Florida, 33014, United States|Palm Springs Community Health Center, Miami, Florida, 33014, United States|ARA Professionals Limited Liability Corporation, Miami, Florida, 33176, United States|Bluegrass Allergy Care, Lexington, Kentucky, 40509, United States|Windsor Dermatology dba Eczema Treatment Center of New Jersey, East Windsor, New Jersey, 08520, United States|Smart Medical Research Inc, Jackson Heights, New York, 11372, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Auni Allergy, Findlay, Ohio, 45840, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|DermDox Dermatology, LLC, Sugarloaf, Pennsylvania, 18249, United States|Driscoll Childrens Hospital, Corpus Christi, Texas, 78411, United States|Modern Research Associates, Dallas, Texas, 75231, United States|Center for Clinical Studies, Houston, Texas, 77004, United States|University of Utah MidValley Dermatology, Murray, Utah, 84107, United States|Cinme - Centro de Investigaciones Metabolicas, Caba, Buenos Aires, C1027AAP, Argentina|Fundacion Cidea, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1121, Argentina|Instituto de Neumonologia y Dermatologia, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1425, Argentina|Centro de Investigaciones Clinicas Instituto Especialidades De La Salud De Rosario, Rosario, Santa Fe, 2000, Argentina|Fundacion Estudios Clinicos, Rosario, Santa Fe, 2000, Argentina|Instituto de Diagnostico ABC, Rosario, Santa Fe, 2000, Argentina|Woden Dermatology, Phillip, Australian Capital Territory, 2606, Australia|The Skin Hospital, Darlinghurst, New South Wales, 2010, Australia|Premier Specialists, Kogarah, New South Wales, 2217, Australia|Liverpool Hospital, Liverpool, New South Wales, 2170, Australia|Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 4102, Australia|Monash Childrens Hospital, Clayton, Victoria, 3168, Australia|Institute for Skin Health and Immunity, Mitcham, Victoria, 3132, Australia|Universidade Federal do Parana, Curitiba, ParanÃ¡, 80060-240, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Rio Grande Do Sul, 90160-093, Brazil|Fundacao Abc - Centro Univ Fmabc, Santo Andre, SÃ£o Paulo, 09060-870, Brazil|Sociedade Beneficente de Senhoras Hospital Sirio Libanes, Sao Paulo, SÃ£o Paulo, 01308-050, Brazil|Ispem-Instituto SÃ£o JosÃ© dos Campos em Pesquisas MÃ©dicas, SÃ£o JosÃ© dos Campos, SÃ£o Paulo, 12243-280, Brazil|Alergoalfa Nucleo Diagnostico Tratamento e Pesquisa Clinica em Alergia, SÃ£o Paulo, 06454-010, Brazil|Dermatology Research Institute Incorporated, Calgary, Alberta, T2J 7E1, Canada|Stratica Dermatology, Edmonton, Alberta, T5K 1X3, Canada|Vida Clinical Research, Edmonton, Alberta, T6H 4J8, Canada|Winnipeg Clinic Dermatology Research, Winnipeg, Manitoba, R3C 0N2, Canada|Skincare Studio, St. John's, Newfoundland and Labrador, A1E 1V4, Canada|SimcoDerm Medical and Surgical Dermatology Centre, Barrie, Ontario, L4M 7G1, Canada|Halton Pediatric Allergy, Burlington, Ontario, L7L 6W6, Canada|LEADER Research, Hamilton, Ontario, L8L 3C3, Canada|Triple A Lab, Hamilton, Ontario, L8S 1G5, Canada|JRB Research Incorporated, Ottawa, Ontario, K2C 3N2, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Toronto Research Centre Inc, Toronto, Ontario, M3H 5Y8, Canada|FACET Dermatology, Toronto, Ontario, M4E 1R7, Canada|University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong|Korea University Ansan Hospital, Ansansi, Gyeonggido, 15355, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 03722, Korea, Republic of|National Medical Center, Seoul, 04564, Korea, Republic of|Kyung Hee University Hospital at Gangdong, Seoul, 05278, Korea, Republic of|The Catholic University of Korea Seoul St Marys Hospital, Seoul, 06591, Korea, Republic of|Chung-Ang University Hospital, Seoul, 06973, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, 07441, Korea, Republic of|Ewha Womans University Seoul Hospital, Seoul, 07804, Korea, Republic of|Bezmialem Vakif Universitesi Hastanesi, Istanbul, 34093, Turkey|Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul, 34098, Turkey|Bakircay Universitesi Cigli Egitim ve Arastirma Hastanesi, Izmir, 35620, Turkey|Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri, 38030, Turkey|Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi, Samsun, 55200, Turkey|Bristol Royal Hospital for Children, Bristol, BS2 8BJ, United Kingdom|Velocity Clinical Research, High Wycombe, High Wycombe, HP11 2QW, United Kingdom|Alder Hey Childrens Hospital, Liverpool, L12 2AP, United Kingdom|Whipps Cross University Hospital, London, E11 1NR, United Kingdom|St Thomas Hospital, London, SE1 7EH, United Kingdom|Carn to Coast Health Centres, Redruth, TR16 4ET, United Kingdom","Study Director : MD , Amgen"
Atopic Dermatitis,NCT05375929,A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India,https://clinicaltrials.gov/study/NCT05375929,NO,Atopic Dermatitis,DRUG: Abrocitinib 100 mg|DRUG: Abrocitinib 200 mg,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"All India Institute of Medical Sciences, New Delhi, Delhi, 110029, India|Sir Ganga Ram Hospital, New Delhi, Delhi, 110060, India|Nirmal Hospital Pvt Ltd., Surat, Gujarat, 395002, India|Government Medical College & Shri Sayajirao General Hospital, Vadodara, Gujarat, 390001, India|RajaRajeswari Medical College and Hospital, Bengaluru, Karnataka, 560074, India|Father Muller Medical College Hospital, Mangalore, Karnataka, 575002, India|Mahatma Gandhi Mission's Medical College & Hospital, Aurangabad, Maharashtra, 431003, India|Orange City Hospital and Research Institute, Nagpur, Maharashtra, 440015, India|Assured Care Plus Hospital, Nashik, Maharashtra, 422101, India|Jehangir Clinical Development Centre Pvt. Ltd., Pune, Maharashtra, 411001, India|S. P. Medical College & A. G. Hospitals, Bikaner, Rajasthan, 334001, India|Apex Hospitals Pvt. Ltd., Jaipur, Rajasthan, 302017, India|Calcutta School of Tropical Medicine, Kolkata, WEST Bengal, 700073, India|Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India|Maharaja Agrasen Hospital, New Delhi, 110026, India","Study Director : Pfizer CT.gov Call Center , Pfizer"
Atopic Dermatitis,NCT05127421,Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement,https://clinicaltrials.gov/study/NCT05127421,NO,Atopic Dermatitis,DRUG: Ruxolitinib cream|DRUG: Vehicle,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Science37, Culver City, California, 90230, United States","Study Director : Haq Nawaz, MD , Incyte Corporation"
Atopic Dermatitis,NCT00484003,"A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT00484003,NO,Atopic Eczema,DRUG: Pimecrolimus cream 1%,ALL,CHILD,PHASE4,"Investigative Sites, Various Cities, South Africa","Study Director : Novartis Pharmaceuticals , Novartis Pharmaceuticals"
Atopic Dermatitis,NCT05155085,A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05155085,NO,Atopic Dermatitis,DRUG: AK002|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Allakos Investigational Site 218-034, Birmingham, Alabama, 35209, United States|Allakos Investigational Site 218-074, Cullman, Alabama, 35058, United States|Allakos Investigational Site 218-025, Gilbert, Arizona, 85018, United States|Allakos Investigational Site 218-041, Scottsdale, Arizona, 85258, United States|Allakos Investigational Site 218-072, Canoga Park, California, 91303, United States|Allakos Investigational Site 218-056, Los Angeles, California, 90057, United States|Allakos Investigational Site 218-073, San Diego, California, 92123, United States|Allakos Investigational Site 218-051, San Francisco, California, 94132, United States|Allakos Investigational Site 218-013, Santa Monica, California, 90404, United States|Allakos Investigational Site 218-033, Santa Monica, California, 90404, United States|Allakos Investigational Site 218-071, Colorado Springs, Colorado, 80923, United States|Allakos Investigational Site 218-045, Washington, District of Columbia, 20037, United States|Allakos Investigational Site 218-018, Doral, Florida, 33172, United States|Allakos Investigational Site 218-046, Greenacres City, Florida, 33467, United States|Allakos Investigational Site 218-049, Jacksonville, Florida, 78758, United States|Allakos Investigational Site 218-008, Miami, Florida, 33134, United States|Allakos Investigational Site 218-048, Sarasota, Florida, 34239, United States|Allakos Investigational Site 218-020, Tampa, Florida, 33607, United States|Allakos Investigational Site 218-007, Tampa, Florida, 33614, United States|Allakos Investigational Site 218-068, Lexington, Kentucky, 40509, United States|Allakos Investigational Site 218-055, Crowley, Louisiana, 70526, United States|Allakos Investigational Site 218-012, Towson, Maryland, 21204, United States|Allakos Investigational Site 218-069, White Marsh, Maryland, 21162, United States|Allakos Investigational Site 218-066, Boston, Massachusetts, 02111, United States|Allakos Investigational Site 218-058, Dilworth, Minnesota, 56529, United States|Allakos Investigational Site 218-063, Missoula, Montana, 59808, United States|Allakos Investigational Site 218-032, Omaha, Nebraska, 68144, United States|Allakos Investigational Site 218-026, Las Vegas, Nevada, 89030, United States|Allakos Investigational Site 218-050, Las Vegas, Nevada, 89119, United States|Allakos Investigational Site 218-029, Great Neck, New York, 11021, United States|Allakos Investigational Site 218-053, Rochester, New York, 14620, United States|Allakos Investigational Site 218-001, Cincinnati, Ohio, 45236, United States|Allakos Investigational Site 218-062, Fairborn, Ohio, 45324, United States|Allakos Investigational Site 218-003, Oklahoma City, Oklahoma, 73118, United States|Allakos Investigational Site 218-015, Oklahoma City, Oklahoma, 73120, United States|Allakos Investigational Site 218-061, Portland, Oregon, 97210, United States|Allakos Investigational Site 218-010, Philadelphia, Pennsylvania, 19103, United States|Allakos Investigational Site 218-052, Dallas, Texas, 75230, United States|Allakos Investigational Site 218-047, Murray, Utah, 84107, United States|Allakos Investigational Site 218-009, Seattle, Washington, 98115, United States|Allakos Investigational Site 218-201, Berlin, 12203, Germany|Allakos Investigational Site 218-215, Darmstadt, 64283, Germany|Allakos Investigational Site 218-216, Darmstadt, 64283, Germany|Allakos Investigational Site 218-208, Dresden, 01069, Germany|Allakos Investigational Site 218-207, Erlangen, 91054, Germany|Allakos Investigational Site 218-212, Frankfurt am main, 60590, Germany|Allakos Investigational Site 218-211, Gera, 07548, Germany|Allakos Investigational Site 218-203, Lohne, 49393, Germany|Allakos Investigational Site 218-210, Magdeburg, 39104, Germany|Allakos Investigational Site 218-204, Mainz, 55128, Germany|Allakos Investigational Site 218-213, Mainz, 55131, Germany|Allakos Investigational Site 218-218, Munich, 81369, Germany|Allakos Investigational Site 218-205, OsnabrÃ¼ck, 49074, Germany|Allakos Investigational Site 218-202, Recklinghausen, 45657, Germany|Allakos Investigational Site 218-209, Schwerin, 19055, Germany","Study Director : Chin Lee, MD, MPH , Allakos Inc."
Atopic Dermatitis,NCT04392154,Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin),https://clinicaltrials.gov/study/NCT04392154,NO,Atopic Dermatitis,BIOLOGICAL: Lebrikizumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Pinnacle Research Group, LLC, Anniston, Alabama, 36207, United States|Clinical Research Center of Alabama- Birmingham, Birmingham, Alabama, 35244, United States|Investigate MD, Scottsdale, Arizona, 85255, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|Arkansas Research Trials, North Little Rock, Arkansas, 72117, United States|Northwest Arkansas Clinical Trials Center, Rogers, Arkansas, 72758, United States|Orange County Research Institute, Anaheim, California, 92801, United States|Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, California, 93309, United States|Wallace Medical Group, Inc., Beverly Hills, California, 90211, United States|Hope Clinical Research, Inc., Canoga Park, California, 91303, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|MD Studies, Fountain Valley, California, 92708, United States|Center For Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|Axon Clinical Research, Inglewood, California, 90301, United States|Sunwise Clinical Research, Lafayette, California, 94549, United States|Avance Trials, Laguna Niguel, California, 92677, United States|California Allergy and Asthma Medical Group + Research Center, Los Angeles, California, 90025, United States|Keck School of Medicine University of Southern California, Los Angeles, California, 90033, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|LA Universal Research Center, INC, Los Angeles, California, 90057, United States|Ablon Skin Institute and Research Center, Manhattan Beach, California, 90266, United States|Dermatology Clinical Trials, Newport Beach, California, 92660, United States|Cura Clinical Research, Palmdale, California, 93551, United States|MD Strategies Research Centers MDSRC, Poway, California, 92064, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States|Integrative Skin Science and Research, Sacramento, California, 95825, United States|Therapeutics Clinical Research, San Diego, California, 92123, United States|University Clinical Trials, San Diego, California, 92123, United States|University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology, San Diego, California, 92123, United States|Synergy Dermatology, San Francisco, California, 94132, United States|Care Access Research, San Jose, California, 95117, United States|San Luis Dermatology & Laser Clinic, San Luis Obispo, California, 93405, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|IMMUNOe International Research Centers, Centennial, Colorado, 80112, United States|Asthma and Allergy Associates, PC, Colorado Springs, Colorado, 80907-6231, United States|Central Connecticut Dermatology, Cromwell, Connecticut, 06416, United States|Medical Faculty Associates, Inc., Washington, District of Columbia, 20016, United States|George Washington University Medical Center, Washington, District of Columbia, 20037, United States|St. Francis Medical Institute, Clearwater, Florida, 33765, United States|Florida Academic Centers Research and Education, LLC, Coral Gables, Florida, 33134, United States|Pediatric Skin Research, LLC, Coral Gables, Florida, 33146, United States|Clinical Physiology Associates, Fort Myers, Florida, 33912, United States|The University of Florida Health System, Gainesville, Florida, 32606, United States|Direct Helpers Research Center, Hialeah, Florida, 33012, United States|The Community Research of South Florida, Hialeah, Florida, 33016, United States|Encore Medical Research, Hollywood, Florida, 33021, United States|Solutions Through Advanced Research, Jacksonville, Florida, 32256, United States|GSI Clinical Research, LLC, Margate, Florida, 33063, United States|C & R Research Services USA, Miami Beach, Florida, 33169, United States|Wellness Clinical Research, Miami Lakes, Florida, 33016, United States|Vitae Research Center, LLC, Miami, Florida, 33135, United States|Acevedo Clinical Research Associates, Miami, Florida, 33142, United States|International Dermatology Research, Inc., Miami, Florida, 33144, United States|Community Research Foundation Inc, Miami, Florida, 33145, United States|Sanchez Clinical Research Inc, Miami, Florida, 33157, United States|Miami Dermatology and Laser Research, Miami, Florida, 33173, United States|Well Pharma Medical Research Corp., Miami, Florida, 33173, United States|Florida Research Center, Inc, Miami, Florida, 33174, United States|Tory Sullivan, MD PA, North Miami Beach, Florida, 33162, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|Riverchase Dermatology and Cosmetic Surgery, Pembroke Pines, Florida, 33028, United States|ForCare Clinical Research, Tampa, Florida, 33613-1244, United States|Olympian Clinical Research, Tampa, Florida, 33614, United States|University of South Florida College of Medicine, Tampa, Florida, 33620, United States|Georgia Pollens Clinical Research Centers, Inc, Albany, Georgia, 31707, United States|IACT Health - VHC, Columbus, Georgia, 31904, United States|Marietta Dermatology Clinical Research, Marietta, Georgia, 30060, United States|Advanced Medical Research, Sandy Springs, Georgia, 30328, United States|Georgia Skin & Cancer Clinic, Savannah, Georgia, 31419, United States|Northwestern University, Chicago, Illinois, 60611, United States|Sneeze, Wheeze, & Itch Associates LLC, Normal, Illinois, 61761, United States|Arlington Dermatology, Rolling Meadows, Illinois, 60008, United States|Northshore University Healthsystem, Skokie, Illinois, 60077, United States|Dundee Dermatology, West Dundee, Illinois, 60118, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|The Indiana Clinical Trials Center, Plainfield, Indiana, 46168, United States|Epiphany Dermatology of Kansas, LLC, Overland Park, Kansas, 66210, United States|Kansas Medical Clinic, an Elligo Health Research, Inc., Shawnee Mission, Kansas, 66216, United States|Kansas Medical Clinic, Topeka, Kansas, 66614, United States|Skin Sciences, PLLC, Louisville, Kentucky, 40217, United States|Meridian Clinical Research, Baton Rouge, Louisiana, 70808, United States|Tulane Univ School of Med, New Orleans, Louisiana, 70112, United States|Dermatology and Skin Cancer Specialists, LLC, Rockville, Maryland, 20850, United States|ActivMed Practices and Research, Beverly, Massachusetts, 01915, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135, United States|Beacon Clinical Research, LLC, Quincy, Massachusetts, 02169, United States|Fivenson Dermatology, Ann Arbor, Michigan, 48103, United States|Oakland Dermatology, Auburn Hills, Michigan, 48326, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|Michigan Center for Research Company, Clarkston, Michigan, 48346, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|St Joseph Dermatology and Vein Clinic, Saint Joseph, Michigan, 49085, United States|Associated Skin Care Specialists, Fridley, Minnesota, 55432, United States|Associated Skin Care Specialists, New Brighton, Minnesota, 55112, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Central Dermatology PC, Saint Louis, Missouri, 63117, United States|Advanced Dermatology of the Midlands, Omaha, Nebraska, 68144, United States|JDR Dermatology Research, Las Vegas, Nevada, 89148, United States|ALLCUTIS Research, Portsmouth, New Hampshire, 03801, United States|Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey, 08520, United States|Skin Laser and Surgery Specialists, a Division of Schweiger Dermatology, Hackensack, New Jersey, 07601, United States|Montefiore Medical Center, Bronx, New York, 10467-2490, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|JUVA Skin & Laser Center, New York, New York, 10022-3350, United States|Icahn Sch of Med at Mt. Sinai, New York, New York, 10029, United States|Sadick Research Group, New York, New York, 10075, United States|Advanced Asthma and Allergy, Watertown, New York, 13601, United States|OnSite Clinical Solutions, Charlotte, North Carolina, 28277, United States|Medication Management, Greensboro, North Carolina, 27408, United States|Wake Research Associates, Raleigh, North Carolina, 27612, United States|Wilmington Dermatology Center, Wilmington, North Carolina, 28405, United States|University Hospitals Case Medical Center, Cleveland, Ohio, 44106, United States|Ohio Pediatric Research Association, Dayton, Ohio, 45414, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, 73112, United States|Unity Clinical Research, Oklahoma City, Oklahoma, 73118, United States|Central States Research, Tulsa, Oklahoma, 74136, United States|Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma, 74136, United States|Crisor, LLC, Medford office, Medford, Oregon, 97504, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|OHSU Center for Health and Healing, Portland, Oregon, 97239, United States|The Pennsylvania Centre for Dermatology, LLC, Exton, Pennsylvania, 19341, United States|Paddington Testing Company Inc, Philadelphia, Pennsylvania, 19103, United States|University of Pennsylvania Hospital, Philadelphia, Pennsylvania, 19104, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States|DermDox Dermatology Centers, Sugarloaf, Pennsylvania, 18249, United States|Peak Research LLC, Upper Saint Clair, Pennsylvania, 15241, United States|Clinical Partners, LLC, Johnston, Rhode Island, 02919, United States|AAPRI Clinical Research Institute, Warwick, Rhode Island, 02886, United States|Palmetto Clinical Trial Services, LLC, Anderson, South Carolina, 29621, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Rivergate Dermatology Clinical Research Center PL, Goodlettsville, Tennessee, 37072, United States|Arlington Research Center, Inc, Arlington, Texas, 76011, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|Dermatology Treatment and Research Center, Dallas, Texas, 75230, United States|Modern Research Associates, Dallas, Texas, 75231, United States|Austin Institute for Clinical Research, Dripping Springs, Texas, 78620, United States|Innovate Research, LLC, Fort Worth, Texas, 76244, United States|Center for Clinical Studies, Houston, Texas, 77004, United States|Suzanne Bruce and Associates, PA, Houston, Texas, 77056, United States|Encore Imaging & Medical Research, Houston, Texas, 77065, United States|Cutis Wellness Dermatology, Laredo, Texas, 78041, United States|Laredo Dermatology Associates P.A., Laredo, Texas, 78041, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Acclaim Dermatology PLLC, Sugar Land, Texas, 77479, United States|Center for Clinical Studies, Webster, Texas, 77598, United States|University of Utah MidValley Dematology, Murray, Utah, 84107, United States|Velocity Clinical Research - Woseth Dermatology, Salt Lake City, Utah, 84117, United States|Jordan Valley Dermatology Center, West Jordan, Utah, 84088, United States|PI-Coor Clinical Research, LLC, Burke, Virginia, 22015, United States|Virginia Clinical Research, Inc., Norfolk, Virginia, 23502, United States|Dermatology Associates of Seattle, Seattle, Washington, 98101, United States|Premier Clinical Research, Spokane, Washington, 99202, United States|Woden Dermatology, Phillip, Australian Capital Territory, 2606, Australia|The Skin Hospital, Darlinghurst, New South Wales, 02010, Australia|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|The St. George Hospital, Kogarah, New South Wales, 2217, Australia|Holdsworth House Medical Practice, Sydney, New South Wales, 2010, Australia|Skin & Cancer Foundation Australia, Westmead, New South Wales, 2045, Australia|Westmead Hospital, Westmead, New South Wales, 2145, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|University of the Sunshine Coast Clinical Trial Centre, Sippy Downs, Queensland, 04556, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Clinical Trials SA Pty Ltd, Hectorville, South Australia, 5073, Australia|Emeritus Research, Camberwell, Victoria, 3124, Australia|Skin Health Institute Inc., Carlton, Victoria, 3053, Australia|Sinclair Dermatology, Melbourne, Victoria, 3002, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 03050, Australia|Royal Children's Hospital, Parkville, Victoria, 3052, Australia|Fremantle Dermatology, Fremantle, Western Australia, 6160, Australia|Burswood Dermatology, Victoria Park, Western Australia, 06100, Australia|Captain Stirling Medical Centre, Nedlands, 6009, Australia|DCC Sveti Georgi, Haskovo, 6300, Bulgaria|Diagnostic and Consultation Center 14, Sofia, 1408, Bulgaria|Alexandrovska University Hospital, Sofia, 1431, Bulgaria|Euro Derma clinic, Sofia, 1606, Bulgaria|Military Medical Academy, Sofia, 1606, Bulgaria|Medical centre Alitera-Med EOOD, Sofia, 1618, Bulgaria|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|CARe Clinic, Red Deer, Alberta, T4P1K4, Canada|Dr. Chih-ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|University of British Columbia, Vancouver, British Columbia, V5Z 4E8, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|CCA Medical Research, Ajax, Ontario, L1S7K8, Canada|Simcoderm Medical & Surgical Dermatology Centre, Barrie, Ontario, L4M 7G1, Canada|Skin Health, Cobourg, Ontario, K9A 0Z4, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|North York Research Inc., North York, Ontario, M2M4J5, Canada|The Centre for Clinical Trials, Inc, Oakville, Ontario, L6J7W5, Canada|Ottawa Allergy Research Corp, Ottawa, Ontario, K1G 6C6, Canada|Dermatology Ottawa Research Centre, Ottawa, Ontario, K2C 3N2, Canada|Skin Health, Peterborough, Ontario, K9J 5K2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|AvantDerm, Toronto, Ontario, M5A3R6, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|International Dermatology Research, Montreal, Quebec, H3H1V4, Canada|International Dermatology Research, MontrÃ©al, Quebec, H4A 3J1, Canada|Vahlberg & Pild OU, Talinn, 10134, Estonia|Kliiniliste uuringute Keskus OU, Tartu, 50160, Estonia|Tartu University Hospital, Tartu, 51417, Estonia|CHU de Bordeaux Hop St ANDRE, Bordeaux, Gironde, 33075, France|CHRU de Brest - HÃ´pital Morvan, Brest, 29200, France|CHU Dijonon, Dijon, 21079, France|CHD Vendee, La Roche sur Yon, 85000, France|Cabinet MÃ©dical, Martigues, 13500, France|Centre Hospitalier Universitaire de Nantes - L' Hopital l'hÃ´tel-Dieu, Nantes, 44093, France|CHU de Nice Hopital de L'Archet, Nice, 06202, France|Hopital Saint Louis, Paris, 75010, France|Hopital Larrey, Toulouse cedex 9, 31059, France|Studienzentrum Dr.Beate Schwarz, Langenau, Baden-WÃ¼rttemberg, 89129, Germany|Hautarztpraxis am LÃ¶wenmarkt, Stuttgart, Baden-WÃ¼rttemberg, 70499, Germany|Dermazentrum Augsburg, Augsburg, Bayern, 86179, Germany|Rosenpark Research GmbH, Darmstadt, Hessen, 64283, Germany|Klinikum der Johann Wolfgang Goethe-UniversitÃ¤t Frankfurt, Frankfurt am Main, Hessen, 60596, Germany|Klinikum der Johann Wolfgang Goethe-UniversitÃ¤t Frankfurt, Frankfurt, Hesse, 60590, Germany|Klinische Forschung OsnabrÃ¼ck, OsnabrÃ¼ck, Lower Saxony, 49074, Germany|Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen, 48455, Germany|Elbe Klinikum Buxtehude, Buxtehude, Niedersachsen, 21614, Germany|Hautzentrum im Jahrhunderthaus, Bochum, Nordrhein-Westfalen, 44793, Germany|UniversitÃ¤tsklinikum MÃ¼nster - Albert Schweitzer Campus, MÃ¼nster, Nordrhein-Westfalen, 48149, Germany|Company for Medical Study & Service Selters GmbH, Selters, Rheinland-Pfalz, 56242, Germany|Hautarztpraxis Dr. Gerlach, Dresden, Sachsen, 01097, Germany|UniversitÃ¤t Leipzig - UniversitÃ¤tsklinikum, Leipzig, Sachsen, 04103, Germany|Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus - Klinik und Poliklinik fuer, Dresden, Saxony, 01307, Germany|Velocity Clinical Research Leipzig GmbH, Leipzig, Saxony, 04103, Germany|SRH Wald-Klinikum Gera, Gera, ThÃ¼ringen, 07548, Germany|Praxis Dr. med. Virgil-Oreste Mihaescu Facharzt fr Dermatologie und STD, Augsburg, 86150, Germany|CharitÃ© Campus Virchow-Klinikum, Berlin, 10117, Germany|ISA GmbH, Berlin, 10789, Germany|Praxis fÃ¼r Ganzheitliche Dermatologie im Ã„rztehaus, Berlin, 13055, Germany|Dermatologikum Hamburg, Hamburg, 20144, Germany|TFS Trial Support Form GmbH, Hamburg, 20537, Germany|Soon Chun Hyang University Bucheon Hospital, Bucheon, Gyeonggi-do, 14584, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, 16499, Korea, Republic of|Pusan National University Hospital, Busan, Korea, 49241, Korea, Republic of|Hanyang University Medical Center, Seoul, Korea, 04763, Korea, Republic of|Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 05505, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 07441, Korea, Republic of|Korea University Ansan Hospital, Gyeonggi-do, 15355, Korea, Republic of|Incheon St. Mary's Hospital, Incheon, 21431, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 03722, Korea, Republic of|Konkuk University Medical Center, Seoul, 05030, Korea, Republic of|Chung-Ang University Hospital, Seoul, 06973, Korea, Republic of|Clinic of Dermatology and STD, Riga, LV-1001, Latvia|Health and Aesthetics LTD, Riga, LV-1009, Latvia|Latvian Dermatology Institute, Riga, LV-1011, Latvia|Health Center 4, Affiliate Diagnostic Center, Riga, LV1003, Latvia|Smite Aija - Doctor Practice in Dermatology Venereology, Talsi, LV-3201, Latvia|JSC ""CD8 Alergology Clinic"", Kaunas, LT-44192, Lithuania|Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas, LT-50161, Lithuania|Children's Hospital, Affiliate of Vilnius University Hospital Santaros klinikos, Vilnius, 08406, Lithuania|Jsc Renmeda, Vilnius, LT-07195, Lithuania|JSC ""Center for Diagnosis and Treatment of Allergic Diseases"", Vilnius, LT-08109, Lithuania|JSC Inlita (Santaros CTC), Vilnius, LT-08406, Lithuania|Vilnius University Hospital Santaros Klinikos, Vilnius, LT-08441, Lithuania|Hospital Infantil de Mexico Federico Gomez, Ciudad de Mexico, Federal District, 06720, Mexico|Grupo Clinico CATEI Sociedad Civil, Guadalajara, Jalisco, 44657, Mexico|Clinica De Enfermedades Cronicas y Procedimientos Especiales, Morelia, Michoacan, 58249, Mexico|Cemdeicy S.C.P., Merida, YucatÃ¡n, 97130, Mexico|Derma Norte del Bajio, Aguascalientes, 20130, Mexico|Arke Estudios Clinicos S.A. de C.V., Veracruz, 91910, Mexico|dermMedica Sp. z o.o., WrocÅ‚aw, DolnoÅ›lÄ…skie, 51-503, Poland|Dermoklinika Centrum Medyczne s.c. M. Kierstan J. Narbutt A. Lesiak, Lodz, Lodzkie, 90-436, Poland|Grazyna Pulka Specjalistyczny Osrodek ""ALL-MED"", Krakow, Malopolskie, 30-033, Poland|Diamond Clinic, Krakow, Malopolskie, 31-559, Poland|Centrum Medyczne Evimed, Warsaw, Mazowieckie, 02-625, Poland|Centralny Szpital Kliniczny MSWiA, Warszawa, Mazowieckie, 02-507, Poland|Labderm s.c., Ossy, Slaskie, 42-624, Poland|Clinica Vitae Sp. z o.o., Gdansk, Woj. Pomorskie, 80-344, Poland|Zespol Naukowo - Leczniczy ""Iwolang"" Sp. z o.o., Iwonicz Zdroj, Wojewodztwo Podkarpackie, 38-440, Poland|Laser Clinic Dermatologia Laserowa Medycyna Estetyczna, Szczecin, Zachodniopomorskie, 70-332, Poland|Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny Anna Ploszczuk, Bialystok, 15-369, Poland|Wojewodzki Szpital Zespolony, Elblag, 82-300, Poland|Oddzial Dermatologii COPERNICUS, Gdansk, 80-462, Poland|Centrum Badan Klinicznych PI-House sp. z o.o., Gdynia, 81-553, Poland|Holsamed, Katowice, 40-600, Poland|Holsamed, Katowice, 40-851, Poland|Gabinet Dermatlogiczny. Beata Krecisz, Kielce, 25-155, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie, Lublin, 20-081, Poland|Centrum Alergologii Teresa Hofman, Poznan, 60-214, Poland|Kliniczny Szpital Wojewodzki nr. 1 Klinika Dermatologii, Rzeszow, 35-055, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71 500, Poland|Alergo-Med Specjalistyczna Przychodnia Lekarska Sp Z O.O., Tarnow, 33-100, Poland|Clinical Research Group Sp. z o.o., Warszawa, 01-142, Poland|High-Med Prywatny Gabinet Lekarski, Warszawa, 01-817, Poland|MTZ Clinical Research Sp.z.o.o., Warszawa, 02-106, Poland|Klinika Ambroziak Sp. Z.O.O., Warszawa, 02-953, Poland|CityClinic Przychodnia Lekarsko-Psychologiczna, Wroclaw, 50-566, Poland|Centrum Medyczne Angelius Provita, Katowice, ÅšlÄ…skie, 40-611, Poland|National University Hospital, Singapore, Central Singapore, 119074, Singapore|Singapore General Hospital, Singapore, 169078, Singapore|Kk Women'S and Childrens Hospital, Singapore, 229899, Singapore|National Skin Centre NSC, Singapore, 308205, Singapore|Hospital Sant Joan de DÃ©u, Esplugues de Llobregat, Barcelona [Barcelona], 8950, Spain|Hospital Germans Trias i Pujol, Badalona, Catalunya [CataluÃ±a], 08916, Spain|Hospital General Universitario de Alicante, Alicante, 03010, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Universitario Basurto, Bilbao (Bizkaia), 48013, Spain|Hospital Universitario Infanta Leonor-INTERNAL MED, Madrid, 28031, Spain|Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain|Kaohsiung Chang Gung Memorial Hospital, Niaosong, Kaohsiung City, 833, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, 80756, Taiwan|Taipei Medical University Shuang Ho Hospital, New Taipei, 23561, Taiwan|Chung Shan Medical University Hospital, Taichung, 402, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Chang Gung Memorial Hospital - Linkou, Taoyuan City, 33305, Taiwan|Community Institution Zaporizhzhya Regional Dermatovenereology Clinical Hospital of Zaporizhzhya Regional Council, Poshtova Square 2, Zaporizhzhya, 69063, Ukraine|Municipal Healthcare Institution Kharkiv City Dermatoverenologic Dispensary N2, Kharkiv, 61038, Ukraine|SE ""Institute of Dermatology and Venerology of NAMS of Ukraine"", Kharkiv, 61057, Ukraine|Rivne Regional Dermatology and Venereology Dispensary, Rivne, 33028, Ukraine|Treatment-diagnostic center PE ""Asclepius"", Uzhhorod, 88000, Ukraine","Study Director : Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) , Eli Lilly and Company"
Atopic Dermatitis,NCT06277245,A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT06277245,NO,Atopic Dermatitis,DRUG: LNK01001|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Dermatological Hospital of Southern Medical University, Guangzhou, China","Principal Investigator : Jianzhong Zhang , Peking University People's Hospital"
Atopic Dermatitis,NCT05566262,Bodewell Products for the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05566262,NO,Atopic Dermatitis,DRUG: Bodewell Calming Cream,ALL,"ADULT, OLDER_ADULT",PHASE4,"The University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States","Principal Investigator : Tiffany Mayo, MD , University of Alabama at Birmingham"
Atopic Dermatitis,NCT06216392,Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06216392,NO,Atopic Dermatitis,BIOLOGICAL: GR1802 injection|BIOLOGICAL: placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Huashan Hospital, Shanghai, Shanghai, 200000, China","Genrix (Shanghai) Biopharmaceutical Co., Ltd."
Atopic Dermatitis,NCT05692843,Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response,https://clinicaltrials.gov/study/NCT05692843,NO,Atopic Dermatitis,DRUG: Cyclosporin A|OTHER: Follow-up of Cyclospoin treatment already started,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Hospital La Paz, Madrid, 28046, Spain","Principal Investigator : Alberto M Borobia, MD, PhD , Hospital la Paz"
Atopic Dermatitis,NCT06309355,Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06309355,NO,Atopic Dermatitis,DRUG: YR001 ointment|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"DelRicht Research, Baton Rouge, Louisiana, 70809, United States","Hangzhou Yirui Pharmaceutical Technology Co., Ltd"
Atopic Dermatitis,NCT02091037,S. Aureus Colonization in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02091037,NO,Atopic Dermatitis,,ALL,"CHILD, ADULT",,"Columbia University Medical Center / Department of Dermatology, New York, New York, 10032, United States","Principal Investigator : Christine T Lauren, MD , Columbia University"
Atopic Dermatitis,NCT02001181,Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema),https://clinicaltrials.gov/study/NCT02001181,YES,"Dermatitis, Atopic",DRUG: Tofacitinib ointment 20mg/g|DRUG: Placebo ointment (Vehicle),ALL,ADULT,PHASE2,"SKiN Centre for Dermatology, Peterborough, Ontario, K9J 1Z2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2K 4L5, Canada|Centre de Recherche Dermatologique du Quebec metropolitain, Quebec, G1V 4X7, Canada","Study Director : Pfizer CT.gov Call Center , Pfizer"
Atopic Dermatitis,NCT05819463,Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland,https://clinicaltrials.gov/study/NCT05819463,NO,Atopic Dermatitis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"UniversitÃ¤tsspital Basel, Allergologie, Basel, 4031, Switzerland|Inselspital, Department of Dermatology, Bern, 3010, Switzerland|Dermatology & Skin Care Clinic, Buochs, 6374, Switzerland|HFR HÃ´pital Cantonal de Fribourg, Fribourg, 1752, Switzerland|Luzerner Kantonsspital, Zentrum fÃ¼r Dermatologie und Allergologie, Luzern, 6000, Switzerland|Kantonsspital St. Gallen - Klinik fÃ¼r Dermatologie, Venerologie und Allergologie, St. Gallen, 9007, Switzerland|PLAZA Kliniken, Uster, 8610, Switzerland","Principal Investigator : Dagmar Simon, Prof. Dr. med. , Department of Dermatology, Inselspital"
Atopic Dermatitis,NCT05363904,Atopic Dermatitis: Sub-Saharan Africa vs. Central Europe,https://clinicaltrials.gov/study/NCT05363904,NO,Atopic Dermatitis,OTHER: Observation,ALL,"ADULT, OLDER_ADULT",,"University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar|University Hospital Zurich, ZÃ¼rich, Switzerland|Regional Dermatology Training Centre (RDTC), Moshi, Tanzania","Principal Investigator : Marie-Charlotte BrÃ¼ggen, Prof. , University of Zurich Principal Investigator : Daudi Mavura, Prof. , RDTC Moshi Principal Investigator : John Masenga, Prof. , RDTC Moshi Principal Investigator : Fandresena Sendrasoa, Dr. , University Hospital Joseph Raseta Befelatanana"
Atopic Dermatitis,NCT05029895,A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT05029895,NO,Atopic Dermatitis,,ALL,CHILD,,"Takeo Skin Clinic /ID# 248095, Asahi Owari, Aichi, 488-0032, Japan|Ichinomiya Municipal Hospital /ID# 245070, Ichinomiya-shi, Aichi, 491-8558, Japan|Nagoya City University Hospital /ID# 250809, Nagoya shi, Aichi, 467-8602, Japan|NHO Nagoya Medical Center /ID# 245069, Nagoya-shi, Aichi, 460-0001, Japan|Aichi Children's Health and Medical Center /ID# 245357, Obu-shi, Aichi, 474-8710, Japan|Noriko Dermatology Clinic /ID# 246626, Akita City, Akita, 010-0062, Japan|Nippon Medical Chiba Hokusoh Hospital /ID# 246627, Inzai-shi, Chiba, 270-1613, Japan|National Hospital Organization Shimoshizu National Hospital /ID# 245064, Yotsukaido-shi, Chiba, 284-0003, Japan|Matsuyama Red Cross Hospital /ID# 248739, Matsuyama-shi, Ehime, 790-8524, Japan|Fukuoka Children's Hospital /ID# 245067, Fukuoka City, Fukuoka, 813-0017, Japan|Aso Iizuka Hospital /ID# 252145, Iizuka-shi, Fukuoka, 820-8505, Japan|Kurume University Hospital /ID# 248740, Kurume-shi, Fukuoka, 830-0011, Japan|Hoshi General Hospital /ID# 250959, Koriyama City, Fukushima, 963-8801, Japan|Central Japan International Medical Center /ID# 246625, Minokamo-shi, Gifu, 505-8510, Japan|Hiroshima University Hospital /ID# 245356, Hiroshima-shi, Hiroshima, 734-8551, Japan|Kitami Red Cross Hospital /ID# 250838, Kitami-shi, Hokkaido, 090-0026, Japan|Takagi Dermatological Clinic Branch /ID# 241160, Obihiro-shi, Hokkaido, 080-0013, Japan|Hosui General Medical Clinic /ID# 241881, Sapporo-shi, Hokkaido, 060-0063, Japan|Kobayashi Skin Clinic /ID# 248006, Sapporo, Hokkaido, 060-0807, Japan|Hayano Pediatrician Clinic /ID# 250960, Himeji City, Hyogo, 679-2151, Japan|Kobe City Medical Center General Hospital /ID# 244052, Kobe-shi, Hyogo, 650-0047, Japan|Kobe City Medical Center General Hospital /ID# 250836, Kobe-shi, Hyogo, 650-0047, Japan|Bito Dermatology Clinic /ID# 244093, Kobe-shi, Hyogo, 651-0095, Japan|Maekawa Kids Clinic /ID# 249521, Sichuan, Hyogo, 666-0017, Japan|Mito Kyodo General Hospital /ID# 243745, Mito-shi, Ibaraki, 310-0015, Japan|Takeoka Dermatology Clinic /ID# 240610, Marugame, Kagawa, 763-0074, Japan|Kagoshima City Hospital /ID# 252142, Kagoshima-shi, Kagoshima, 673-0886, Japan|Imamura General Hospital /ID# 249526, Kagoshima-shi, Kagoshima, 890-0064, Japan|Kagoshima University Hospital /ID# 248732, Kagoshima-shi, Kagoshima, 890-8520, Japan|Teikyo University Mizonokuchi Hospital /ID# 252146, Kawasaki, Kanagawa, 213-8507, Japan|National Hospital Organization Sagamihara National Hospital /ID# 243744, Sagamihara-shi, Kanagawa, 252-0392, Japan|Kanagawa Children's Medical Center /ID# 252144, Yokohama-shi, Kanagawa, 232-8555, Japan|National Mie Hospital /ID# 245066, Tsu-shi, Mie, 514-0125, Japan|Naha City Hospital /ID# 245065, Naha, Okinawa, 902-0061, Japan|Kansai Medical University Hospital /ID# 246020, Hirakata-shi, Osaka, 573-1191, Japan|Kansai Medical University Medical Center /ID# 250195, Moriguchi City, Osaka, 570-8507, Japan|Japanese Red Cross Osaka Hospital /ID# 249524, Osaka-shi, Osaka, 543-8555, Japan|Osaka Metropolitan University Hospital /ID# 245972, Osaka-shi, Osaka, 545-8586, Japan|Hino Clinic /ID# 245975, Sakai-shi, Osaka, 599-8272, Japan|Osaka Medical and Pharmaceutical University Hospital /ID# 251660, Takatsuki-shi, Osaka, 569-8686, Japan|Okada Kodomonomori Clinic /ID# 248096, Kasugabe City, Saitama, 344-0011, Japan|Saitama Medical Center /ID# 244695, Kawagoe-shi, Saitama, 350-8550, Japan|Dokkyo Medical University Saitama Medical Center /ID# 249525, Koshigaya, Saitama, 343-0845, Japan|Nagahama Red Cross Hospital /ID# 252136, Nagahama-shi, Shiga, 526-8585, Japan|Shiga University of Medical Science Hospital /ID# 245969, Otsu-shi, Shiga, 520-2192, Japan|Chutoen General Medical Center /Id# 248741, Kakegawa-shi, Shizuoka, 436-0040, Japan|Chutoen General Medical Center /Id# 249522, Kakegawa-shi, Shizuoka, 436-0040, Japan|Dokkyo Medical University Hospital /ID# 245068, Mibu, Tochigi, 321-0293, Japan|Tokyo Med Univ Hachioji Med Ct /ID# 250958, Hachioji-shi, Tokyo, 193-0998, Japan|National Center for Child Health and Development /ID# 244696, Setagaya-ku, Tokyo, 157-8535, Japan|Tokyo Metropolitan Hiroo Hospital /ID# 250837, Shibuya Ward, Tokyo, 150-0013, Japan|The Fraternity Memorial Hospital /ID# 245974, Sumida-ku, Tokyo, 1308587, Japan|Sugamo Sengoku Dermatology /ID# 247761, Toshima Ward, Tokyo, 170-0002, Japan|Tonami General Hospital /ID# 247760, Tonami-shi, Toyama, 939-1395, Japan|Suzuki Kids Clinic /ID# 243743, Shingu City, Wakayama, 647-0042, Japan|Yamaguchi Grand Medical Center /ID# 251659, Hohu-shi, Yamaguchi, 747-8511, Japan|Hiratsuka City Hospital /ID# 245071, Hiratsuka-shi, 254-0065, Japan|Okayama University Hospital /ID# 252141, Okayama, 700-8558, Japan|Takatsuki General Hospital /ID# 242334, Osaka, Japan","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT04212169,Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04212169,YES,Atopic Dermatitis,DRUG: MEDI3506|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Research Site, Birmingham, Alabama, 35209, United States|Research Site, Santa Monica, California, 90404, United States|Research Site, Jacksonville, Florida, 32256, United States|Research Site, Miami, Florida, 33180, United States|Research Site, Orlando, Florida, 32806, United States|Research Site, Baton Rouge, Louisiana, 70808, United States|Research Site, Charlotte, North Carolina, 28277, United States|Research Site, Tulsa, Oklahoma, 74136, United States|Research Site, Providence, Rhode Island, 02903, United States|Research Site, Spartanburg, South Carolina, 29303, United States|Research Site, Memphis, Tennessee, 38119, United States|Research Site, San Antonio, Texas, 78213, United States|Research Site, San Antonio, Texas, 78229, United States|Research Site, Box Hill, 3128, Australia|Research Site, Carlton, 3053, Australia|Research Site, East Melbourne, 3002, Australia|Research Site, Fremantle, 6160, Australia|Research Site, Berlin, 10117, Germany|Research Site, Dresden, 01307, Germany|Research Site, Hamburg, 20246, Germany|Research Site, Mahlow, 15831, Germany|Research Site, Bialystok, 15-453, Poland|Research Site, Kielce, 25-355, Poland|Research Site, Poznan, 60-681, Poland|Research Site, Skierniewice, 96-100, Poland|Research Site, Wroclaw, 50-566, Poland|Research Site, ÅÃ³dÅº, 90-436, Poland|Research Site, Alcobendas, 28100, Spain|Research Site, LeganÃ©s, 28915, Spain|Research Site, Sevilla, 41003, Spain|Research Site, Corby, NN18 9EZ, United Kingdom|Research Site, High Wycombe, HP11 2QW, United Kingdom|Research Site, Kenilworth, CV8 1JD, United Kingdom|Research Site, Northwood, HA6 2RN, United Kingdom|Research Site, Romford, RM1 3PJ, United Kingdom|Research Site, Shipley, BD18 3SA, United Kingdom|Research Site, Sidcup, DA14 6LT, United Kingdom|Research Site, Wokingham, RG40 1XS, United Kingdom",AstraZeneca
Atopic Dermatitis,NCT04921969,A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3),https://clinicaltrials.gov/study/NCT04921969,YES,Atopic Dermatitis,DRUG: Ruxolitinib|DRUG: Vehicle Cream,ALL,CHILD,PHASE3,"Clinical Research Center of Alabama, Birmingham, Alabama, 35209, United States|Cahaba Dermatology, Hoover, Alabama, 35244, United States|Physicians Research Group Ii, Gilbert, Arizona, 85295, United States|Cct Research With Center For Dermatology and Plastic Surgery, Scottsdale, Arizona, 85260, United States|Burke Pharmaceutical Research, Hot Springs National Park, Arkansas, 71913, United States|First Oc Dermatology, Fountain Valley, California, 92708, United States|Iact Health, Los Angeles, California, 90017, United States|Metropolis Dermatology, Los Angeles, California, 90017, United States|University of Southern California, Los Angeles, California, 90033, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Madera Family Medical Group, Madera, California, 93637, United States|Allergy & Asthma Associates of Southern California, Mission Viejo, California, 92691, United States|Palmtree Clinical Research-Clinedge-Ppds, Palm Springs, California, 92262, United States|Integrated Research of Inland, Inc, Riverside, California, 92506, United States|Clinical Science Institute Clinical Research Specialists Inc, Santa Monica, California, 90404, United States|Phdermatology, Clearwater, Florida, 33756, United States|Life Clinical Trials Margate, Margate, Florida, 33063, United States|Acevedo Clinical Research, Miami, Florida, 33142, United States|Pediatric Center of Excellence Pce Miami Pediatric Endocrinology, Llc, Miami, Florida, 33146, United States|The Childrens Skin Center Csc Miami, Miami, Florida, 33155, United States|Entrust Clinical Research, Miami, Florida, 33156, United States|Ciocca Dermatology Pa, Miami, Florida, 33173, United States|Forcare Clinical Research, Tampa, Florida, 33624, United States|Aeroallergy Research Lab of Savannah, Savannah, Georgia, 31406, United States|Northwestern Memorial Hospital-Arkes Pavilion, Chicago, Illinois, 60611, United States|Sneeze Wheeze and Itch Associates Llc, Normal, Illinois, 61761, United States|Northshore Medical Group Dermatology Skokie, Skokie, Illinois, 60076, United States|Dermatology Specialists Research Indiana, Clarksville, Indiana, 47129, United States|Dawes Fretzin Clinical Research Group Llc, Indianapolis, Indiana, 46250, United States|Kansas City Dermatology P.A., Lenexa, Kansas, 66215, United States|Office of Michael W. Simon, Md, Nicholasville, Kentucky, 40356, United States|Meridian Clinical Research, Baton Rouge, Louisiana, 70808, United States|Delricht Clinical Research-Clinedge-Ppds Baton Rouge, Baton Rouge, Louisiana, 70809, United States|Delricht Research-Touro Medical Center, New Orleans, Louisiana, 70115, United States|Lawrence J. Green, Md. Llc, Rockville, Maryland, 20850, United States|Henry Ford Medical Center-New Center One, Detroit, Michigan, 48202, United States|Michigan Dermatology Institute, Waterford, Michigan, 48328, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Skin Specialists Pc the Advanced Skin Research Center, Omaha, Nebraska, 68144, United States|Dr Bobby Buka, Md Greenwich Village, New York, New York, 10012, United States|New York University Langone Medical Center-Fink Children'S Ambulatory Care Center, New York, New York, 10016, United States|Ohio Pediatric Research Association, Dayton, Ohio, 45414, United States|Velocity Clinical Research Grants Pass Clinical Research Institute of Southern Oregon Pc, Grants Pass, Oregon, 97527, United States|Cyn3Rgy Research-Clinedge-Ppds, Gresham, Oregon, 97030, United States|Velocity Clinical Research-Medford, Medford, Oregon, 97504, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|Knight Cancer Institute At Oregon Health and Science University, Portland, Oregon, 97239, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Coastal Pediatric Associates, Charleston, South Carolina, 29414, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|International Clinical Research Tennessee Llc, Murfreesboro, Tennessee, 37130, United States|Arlington Research Center, Arlington, Texas, 76011, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Texas Dermatology Alamo Heights Office, San Antonio, Texas, 78218, United States|Allergy and Asthma Care of Waco, Pa, Waco, Texas, 76712, United States|Intermountain Clinical Research Icr Draper, Draper, Utah, 84020, United States|Springville Dermatology, Springville, Utah, 84663, United States|Jordan Valley Dermatology Center, West Jordan, Utah, 84088, United States|Skindc Clinic, Arlington, Virginia, 22209, United States|Pi Coor Clinical Research Llc, Burke, Virginia, 22015, United States|Clinical Research Partners Llc, Richmond, Virginia, 23220, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Children'S Hospital of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Dermatology Research Institute, Calgary, Alberta, T3A 2N1, Canada|Leader Research, Hamilton, Ontario, L8L 3C3, Canada|Dermatology Ottawa Research Centre, Ottawa, Ontario, K2C 3N2, Canada","Study Director : Brett Angel, MD , Incyte Corporation"
Atopic Dermatitis,NCT05696392,The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.,https://clinicaltrials.gov/study/NCT05696392,NO,Atopic Dermatitis,DRUG: ruxolitinib cream,ALL,"ADULT, OLDER_ADULT",PHASE4,"First Oc Dermatology, Fountain Valley, California, 92708, United States|Ark Clinical Research, Long Beach, California, 90815, United States|The Gw Medical Faculty Associates, Washington, District of Columbia, 20037, United States|Skin Care Research, Llc, Boca Raton, Florida, 33486, United States|Trueblue Clinical Research, Brandon, Florida, 33511, United States|Driven Research Llc, Coral Gables, Florida, 33134, United States|University of Florida Health Dermatology-Springhill, Gainesville, Florida, 32606, United States|Skin Care Research, Llc Scr Hollywood, Hollywood, Florida, 33021, United States|Ciocca Dermatology Pa, Miami, Florida, 33173, United States|Dermatology Specialists Research Indiana, Clarksville, Indiana, 47129, United States|Dawes Fretzin Clinical Research Group Llc, Indianapolis, Indiana, 46250, United States|Skin Sciences Pllc, Louisville, Kentucky, 40217, United States|Northeast Dermatology Associates, Beverly, Massachusetts, 01915, United States|Beth Israel Deaconess Medical Center (Bidmc), Boston, Massachusetts, 02215, United States|Essential Dermatology, Natick, Massachusetts, 01760, United States|Washington University School of Medicine Dermatology, Saint Louis, Missouri, 63110, United States|Suny Downstate Health Sciences University, Brooklyn, New York, 11203, United States|Empire Dermatology, East Syracuse, New York, 13057, United States|Sadick Dermatology, New York, New York, 10075, United States|Skin Search of Rochester, Rochester, New York, 14623, United States|Ohio Pediatric Research Association, Dayton, Ohio, 45414, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|Knight Cancer Institute At Oregon Health and Science University, Portland, Oregon, 97239, United States|University of Pittsburgh Medical Center Upmc Dermatology Clinic Oakland Falk Medical Building, Pittsburgh, Pennsylvania, 15213, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Arlington Research Center, Arlington, Texas, 76011, United States|Jordan Valley Dermatology Center, South Jordan, Utah, 84095, United States|Pi Coor Clinical Research Llc, Burke, Virginia, 22015, United States|Clinical Research Partners Llc, Richmond, Virginia, 23226, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States",Incyte Corporation
Atopic Dermatitis,NCT04178967,Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04178967,YES,Atopic Dermatitis,BIOLOGICAL: Lebrikizumab|OTHER: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Investigate MD, Scottsdale, Arizona, 85255, United States|Northwest Arkansas Clinical Trials Center, Rogers, Arkansas, 72758, United States|Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, California, 93309, United States|Center For Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|Woodward Centre, Fresno, California, 93720, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|LA Universal Research Center, INC, Los Angeles, California, 90057, United States|University Clinical Trials, Inc., San Diego, California, 92123, United States|San Luis Dermatology & Laser Clinic, San Luis Obispo, California, 93405, United States|Clinical Physiology Associates, Clinical Study Center, Fort Myers, Florida, 33916-9452, United States|Direct Helpers Medical Center, Hialeah, Florida, 33012, United States|The Community Research of South Florida, Hialeah, Florida, 33016, United States|Solutions Through Advanced Research, Inc., Jacksonville, Florida, 32256, United States|Georgia Pollens Clinical Research Centers, Inc, Albany, Georgia, 31707, United States|Marietta Dermatology Clinical Research, Marietta, Georgia, 30060, United States|Advanced Medical Research, Sandy Springs, Georgia, 30328, United States|Arlington Dermatology, Rolling Meadows, Illinois, 60008, United States|NorthShore University HealthSystem, Skokie, Illinois, 60077, United States|Kansas City Dermatology, PA, Overland Park, Kansas, 66215, United States|Meridian Clinical Research, Baton Rouge, Louisiana, 70808, United States|ActivMed Practices and Research, Beverly, Massachusetts, 01915, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|Associated Skin Care Specialists, Fridley, Minnesota, 55432, United States|Central Dermatology PC, Saint Louis, Missouri, 63117, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|OnSite Clinical Solutions, Charlotte, North Carolina, 28277, United States|Wilmington Dermatology Center, Wilmington, North Carolina, 28405, United States|Dermatology and Skin Surgery Center, Exton, Pennsylvania, 19341, United States|DermDOX, Hazleton, Pennsylvania, 18201, United States|Peak Research LLC, Upper Saint Clair, Pennsylvania, 15241, United States|Dermatology & Laser Center of Charleston, Charleston, South Carolina, 29407, United States|Palmetto Clinical Trial Services, Greenville, South Carolina, 29601, United States|Arlington Research Center, Inc, Arlington, Texas, 76011, United States|Innovate Research, LLC, Fort Worth, Texas, 76244, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|University of Utah MidValley Dematology, Murray, Utah, 84107, United States|Virginia Clinical Research, Inc., Norfolk, Virginia, 23502, United States|Dermatology Associates, Seattle, Washington, 98101, United States|DCC Sveti Georgi, Plovdiv, 4000, Bulgaria|Diagnostic and Consultation Center 14, Sofia, 1408, Bulgaria|Alexandrovska University Hospital, Sofia, 1432, Bulgaria|Euro Derma clinic, Sofia, 1606, Bulgaria|Military Medical Academy, Sofia, 1606, Bulgaria|Medical centre Alitera-Med EOOD, Sofia, 1618, Bulgaria|Dr. Chih-ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Simcoderm Medical & Surgical Dermatology Centre, Barrie, Ontario, L4M 7G1, Canada|Lynderm Research Inc., Markham, Ontario, L3P1X2, Canada|North York Research Inc., North York, Ontario, M2M4J5, Canada|Ottawa Allergy Research Corp, Ottawa, Ontario, K1G 6C6, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Derma-Study-Center Friedrichshafen GmbH, Friedrichshafen, Baden-WÃ¼rttemberg, 88045, Germany|Studienzentrum Dr.Beate Schwarz, Langenau, Baden-WÃ¼rttemberg, 89129, Germany|Hautarztpraxis am LÃ¶wenmarkt, Stuttgart, Baden-WÃ¼rttemberg, 70499, Germany|licca Fachklinik, Augsburg, Bayern, 86179, Germany|Rosenpark Research GeschÃ¤ftsbereich der Rosenparkklinik GmbH, Darmstadt, Hessen, 64283, Germany|Klinikum der Johann Wolfgang Goethe-UniversitÃ¤t Frankfurt, Frankfurt am Main, Hessen, 60590, Germany|Elbe Klinikum Buxtehude, Buxtehude, Niedersachsen, 21614, Germany|Klinische Forschung OsnabrÃ¼ck, OsnabrÃ¼ck, Niedersachsen, 49074, Germany|Fachklinik Bad Bentheim, Bad Bentheim, Nordrhein-Westfalen, 48455, Germany|Hautzentrum im Jahrhunderthaus, Bochum, Nordrhein-Westfalen, 44793, Germany|UniversitÃ¤tsklinikum MÃ¼nster, MÃ¼nster, Nordrhein-Westfalen, 48149, Germany|UniversitÃ¤t Leipzig - UniversitÃ¤tsklinikum, Leipzig, Sachsen, 04103, Germany|SIBAmed Studienzentrum GmbH & Co. KG, Leipzig, Saxony, 04103, Germany|UniversitÃ¤tsklinikum Schleswig-Holstein, LÃ¼beck, Schleswig-Holstein, 23538, Germany|Praxis Dr. Michael Dietlen, Augsburg, 86150, Germany|CharitÃ© UniversitÃ¤tsmedizin Berlin Campus Buch, Berlin, 10117, Germany|ISA GmbH, Berlin, 10789, Germany|Praxis fÃ¼r Ganzheitliche Dermatologie im Ã„rztehaus, Berlin, 13055, Germany|UniversitÃ¤tsklinikum Hamburg, Hamburg, 20246, Germany|TFS Trial Form Support GmbH, Hamburg, 20537, Germany|Clinica De Enfermedades Cronicas y Procedimientos Especiales, Morelia, Michoacan Morelia, CP 58249, Mexico|Derma Norte del BajÃ­o, S.C., Aguascalientes, 20130, Mexico|National University Hospital, Singapore, 119074, Singapore|Singapore General Hospital, Singapore, 169078, Singapore|Kk Women'S and Childrens Hospital, Singapore, 229899, Singapore|National Skin Centre NSC, Singapore, 308205, Singapore|Kaohsiung Chang Gung Memorial Hospital, Niaosong Dist, Kaohsiung City, 833, Taiwan|Kaohsiung Medical University Chung-Ho Institutional Review B, Kaohsiung, 807, Taiwan|Taipei Medical University- Shuang Ho Hospital, New Taipei City, 235, Taiwan|China Medical University Hospital, Taichung City, 40447, Taiwan|Chung Shan Medical University Hospital, Taichung, 402, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Chang Gung Memorial Hospital - Linkou, Taoyuan City, 33305, Taiwan|Municipal Healthcare Institution Kharkiv City Dermatoverenologic Dispensary N2, Kharkiv, 61038, Ukraine|Rivne Regional Dermatology and Venereology Dispensary, Rivne, 39028, Ukraine|Treatment-diagnostic center PE ""Asclepius"", Uzhhorod, 88002, Ukraine|Community Institution Zaporizhzhya Regional Dermatovenereology Clinical Hospital of Zaporizhzhya Regional Council, Zaporizhzhya, 69000, Ukraine","Study Director : Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) , Eli Lilly and Company"
Atopic Dermatitis,NCT03569293,Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema),https://clinicaltrials.gov/study/NCT03569293,YES,Atopic Dermatitis,DRUG: Placebo for Upadacitinib|DRUG: Upadacitinib,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Alliance Dermatology and MOHs /ID# 200375, Phoenix, Arizona, 85032, United States|Clear Dermatology & Aesthetics Center /ID# 201256, Scottsdale, Arizona, 85255-4134, United States|Bakersfield Derma & Skin Cance /ID# 200433, Bakersfield, California, 93309, United States|First OC Dermatology /ID# 201910, Fountain Valley, California, 92708-3701, United States|California Allergy and Asthma Medical Group /ID# 200727, Los Angeles, California, 90025-7014, United States|Allergy & Asthma Associates of Southern California /ID# 200733, Mission Viejo, California, 92691-6410, United States|Dermatology Clinical Trials /ID# 205876, Newport Beach, California, 92660-7853, United States|UC Davis /ID# 203622, Sacramento, California, 95817, United States|Synergy Dermatology /ID# 200842, San Francisco, California, 94132-1909, United States|San Luis Derm and Laser Clinic /ID# 200372, San Luis Obispo, California, 93405, United States|Stanford University /ID# 200440, Stanford, California, 94305, United States|Care Access Research - Walnut Creek /ID# 200940, Walnut Creek, California, 94598-2488, United States|Dermatology Physicians of Connecticut /ID# 200928, Shelton, Connecticut, 06484-6211, United States|Foxhall Research Center /ID# 213682, Washington, District of Columbia, 20016-4300, United States|Duplicate_George Washington Univ Med /ID# 200364, Washington, District of Columbia, 20037, United States|Clearlyderm Dermatology /ID# 208371, Boca Raton, Florida, 33428, United States|Skin Care Research, LLC /ID# 200811, Boca Raton, Florida, 33486-2269, United States|Olympian Clinical Research /ID# 202914, Clearwater, Florida, 33756, United States|Multi-Speciality Research Associates /ID# 213254, Lake City, Florida, 32055-8835, United States|GSI Clinical Research, LLC /ID# 200849, Margate, Florida, 33063, United States|Florida International Rsrch cr /ID# 218507, Miami, Florida, 33173, United States|Tory P Sullivan, MD PA /ID# 200671, North Miami Beach, Florida, 33162-4708, United States|Leavitt Medical Associates of Florida /ID# 200880, Ormond Beach, Florida, 32174, United States|Precision Clinical Research /ID# 209002, Sunrise, Florida, 33351-7311, United States|Integrated Clinical Research LLC /ID# 200900, West Palm Beach, Florida, 33406-6063, United States|Christie Clinic, LLC /ID# 200427, Champaign, Illinois, 61820, United States|Northwestern University Feinberg School of Medicine /ID# 201644, Chicago, Illinois, 60611-2927, United States|Dawes Fretzin, LLC /ID# 200366, Indianapolis, Indiana, 46256, United States|The South Bend Clinic Center /ID# 200371, South Bend, Indiana, 46617, United States|Clinical Trials Management, LLC - Covington /ID# 212658, Covington, Louisiana, 70433, United States|Clinical Trials Management, LLC - Metairie /ID# 212659, Metairie, Louisiana, 70006-4165, United States|Northeast Dermatology /ID# 201338, Beverly, Massachusetts, 01915, United States|Massachusetts General Hospital /ID# 200474, Boston, Massachusetts, 02114, United States|Integrated Dermatology of Massachusetts, LLC /ID# 209468, Quincy, Massachusetts, 02169, United States|Clin Res Inst of Michigan, LLC /ID# 208019, Chesterfield, Michigan, 48047, United States|Henry Ford Medical Center /ID# 204191, Detroit, Michigan, 48202-3046, United States|Cleaver Dermatology /ID# 202825, Kirksville, Missouri, 63501-5362, United States|Advanced Dermatology of the Midlands /ID# 201689, Omaha, Nebraska, 68144-1105, United States|Clinical Research Consortium /ID# 200734, Las Vegas, Nevada, 89119-5190, United States|AllCutis Research Inc /ID# 200981, Portsmouth, New Hampshire, 03801, United States|Montefiore Medical Center /ID# 200456, Bronx, New York, 10467, United States|Forest Hills Dermatology Group /ID# 209244, Kew Gardens, New York, 11415, United States|Icahn School of Medicine at Mount Sinai /ID# 200370, New York, New York, 10029-6504, United States|J. Schwartz, MD, PLLC /ID# 202121, Troy, New York, 12180-2323, United States|Velocity clinical research /ID# 202653, Cleveland, Ohio, 44122, United States|Lynn Health Science Institute (LHSI) /ID# 212676, Oklahoma City, Oklahoma, 73112, United States|Newton Clinical Research /ID# 204169, Oklahoma City, Oklahoma, 73120-5049, United States|Oregon Medical Res Center PC /ID# 200428, Portland, Oregon, 97223, United States|Oregon Health and Science University /ID# 200992, Portland, Oregon, 97239, United States|Dermdox Dermatology Centers, PC /ID# 213782, Hazleton, Pennsylvania, 18201, United States|Clinical Partners, LLC /ID# 200460, Johnston, Rhode Island, 02919, United States|Coastal Clinical Research Center of the Carolinas /ID# 200402, Charleston, South Carolina, 29414, United States|Arlington Research Center, Inc /ID# 200391, Arlington, Texas, 76011, United States|Orion Clinical Research /ID# 204703, Austin, Texas, 78759-4100, United States|Modern Research Associates, PL /ID# 200705, Dallas, Texas, 75231, United States|Menter Dermatology Res Inst /ID# 200390, Dallas, Texas, 75246, United States|Center for Clinical Studies - Webster TX /ID# 203185, Webster, Texas, 77598, United States|Dermatology Specialists of Spokane /ID# 202068, Spokane, Washington, 99202, United States|Framingham Centro Medico /ID# 202688, La Plata, Buenos Aires, 1902, Argentina|Instituto de NeumonologÃ­a y DermatologÃ­a /ID# 203444, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, 1425, Argentina|Psoriahue Med Interdisciplinar /ID# 202451, Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma De Buenos Aires, 1425, Argentina|Woden Dermatology /ID# 205799, Phillip, Australian Capital Territory, 2606, Australia|Holdsworth House Medical Practice /ID# 211236, Darlinghurst, New South Wales, 2010, Australia|North Eastern Health Specialists /ID# 205802, Hectorville, South Australia, 5073, Australia|Skin Health Institute Inc /ID# 204791, Carlton, Victoria, 3053, Australia|Fremantle Dermatology /ID# 205305, Fremantle, Western Australia, 6160, Australia|University Clinical Centre of the Republic of Srpska /ID# 202666, Banja Luka, Republika Srpska, 78000, Bosnia and Herzegovina|University Clinical Centre of the Republic of Srpska /ID# 202667, Banja Luka, Republika Srpska, 78000, Bosnia and Herzegovina|Clinical Center University of Sarajevo /ID# 202668, Sarajevo, 71000, Bosnia and Herzegovina|Clinical Center University of Sarajevo /ID# 202669, Sarajevo, 71000, Bosnia and Herzegovina|UMHAT Alexandrovska EAD /ID# 201519, Sofiya, Sofia, 1431, Bulgaria|UMHAT Dr Georgi Stranski EAD /ID# 201521, Pleven, 5800, Bulgaria|UMHAT Professor Stoyan Kirkovich /ID# 201522, Stara Zagora, 6000, Bulgaria|Kirk Barber Research, CA /ID# 200324, Calgary, Alberta, T2G 1B1, Canada|Dermatology Research Institute Inc. /ID# 200318, Calgary, Alberta, T2J 7E1, Canada|Dr. Chih-ho Hong Medical Inc. /ID# 200311, Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research /ID# 200307, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research /ID# 200323, Winnipeg, Manitoba, R3M 3Z4, Canada|Dr. Irina Turchin PC Inc. /ID# 200322, Fredericton, New Brunswick, E3B 1G9, Canada|Karma Clinical Trials /ID# 200316, St. John's, Newfoundland and Labrador, A1A 4Y3, Canada|Hamilton Health Sciences - McMaster University Medical Centre /ID# 200313, Hamilton, Ontario, L8S 4K1, Canada|Dr. Wei Jing Loo Medicine Prof /ID# 206051, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc. /ID# 200315, Markham, Ontario, L3P 1X2, Canada|Dermatology Ottawa Research Centre /ID# 200319, Ottawa, Ontario, K2C 3N2, Canada|K. Papp Clinical Research /ID# 200317, Waterloo, Ontario, N2J 1C4, Canada|Dr. David Gratton Dermat Inc. /ID# 200309, Montreal, Quebec, H3H 1V4, Canada|Innovaderm Research Inc. /ID# 200320, MontrÃ©al, Quebec, H2X 2V1, Canada|Dre Angelique Gagne-Henley M.D. inc. /ID# 200326, Saint-Jerome, Quebec, J7Z 7E2, Canada|Peking University People's Hospital /ID# 202549, Beijing, Beijing, 100044, China|Peking University Third Hospital /ID# 202612, Beijing, Beijing, 100191, China|Sun Yat-sen Memorial Hospital of Sun Yat-sen University /ID# 208597, Guangzhou, Guangdong, 510120, China|The Third Affiliated Hospital Of Sun Yat-Sen University /ID# 202548, Guangzhou, Guangdong, 510630, China|The First Hospital of China Medical University /ID# 202615, Shenyang, Liaoning, 110001, China|Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 202554, Shanghai, Shanghai, 200065, China|The second Affiliated hospital of Zhejiang University school of Medicine /ID# 202608, Hangzhou, Zhejiang, 310009, China|Beijing Friendship Hospital /ID# 202601, Beijing, 100032, China|Huashan Hospital of Fudan University /ID# 205760, Shanghai, 200040, China|Union Hospital affiliated to Tongji Medical College of Huazhong University of Sc /ID# 208598, Wuhan, 420022, China|Clinisalud del sur /ID# 218100, Medellin, Antioquia, 055422, Colombia|Fundacion Hospital San Vicente de Paul - Rionegro /ID# 202043, Rionegro, Antioquia, 054040, Colombia|Ctr Int de Reum del Caribe SAS /ID# 201620, Barranquilla, Atlantico, 80002, Colombia|Fundacion Centro de Excelencia en Enfermedades Cronicas no Transmisibles - FUNCE /ID# 201905, Monteria, Cordoba, 230002, Colombia|Klinicki bolnicki centar Zagreb /ID# 201879, Zagreb, Grad Zagreb, 10000, Croatia|Klinika za djeÄje bolesti Zagreb /ID# 203151, Zagreb, Grad Zagreb, 10000, Croatia|Duplicate_Klinicki bolnicki centar Osijek /ID# 201523, Osijek, Osjecko-baranjska Zupanija, 31000, Croatia|Klinicki bolnicki centar Rijeka /ID# 217423, Rijeka, Primorsko-goranska Zupanija, 51000, Croatia|Klinicki bolnicki centar Split /ID# 201527, Split, Splitsko-dalmatinska Zupanija, 21000, Croatia|Bispebjerg and Frederiksberg Hospital /ID# 200979, Copenhagen NV, Hovedstaden, 2400, Denmark|Herlev and Gentofte Hospital /ID# 200736, Hellerup, Hovedstaden, 2900, Denmark|Aarhus University Hospital /ID# 200737, Aarhus N, Midtjylland, 8200, Denmark|North Estonia Medical Centre /ID# 200951, MustamÃ¤e Linnaosa, Harjumaa, 13419, Estonia|Confido Private Medical Clinic /ID# 200846, Tallinn, Harjumaa, 11313, Estonia|Tartu University Hospital /ID# 200847, Tartu Linn, Tartumaa, 50406, Estonia|MehilÃ¤inen Neo /ID# 201116, Turku, Varsinais-Suomi, 20520, Finland|Kuopio University Hospital /ID# 202449, Kuopio, 70210, Finland|Terveystalo Tampere /ID# 201117, Tampere, 33100, Finland|HCL - HÃ´pital Lyon Sud /ID# 201529, Pierre Benite CEDEX, Auvergne-Rhone-Alpes, 69495, France|CHU de Nantes, Hotel Dieu -HME /ID# 206377, Nantes, Pays-de-la-Loire, 44000, France|Centre Hospitalier du Mans /ID# 205991, Le Mans CEDEX 9, Sarthe, 72037, France|Hopital Saint Vincent de Paul /ID# 218253, Lille Cedex, 59020, France|Le Bateau BLanc /ID# 206833, Martigues, 13500, France|AP-HP - Hopital Necker /ID# 218364, Paris, 75015, France|HÃ´pital Charles-Nicolle /ID# 201525, Rouen, 76000, France|CHU Toulouse - Hopital Larrey /ID# 201528, Toulouse, 31400, France|Duplicate_Klinikum rechts der Isar - Technische Universitaet Muenchen /ID# 202087, Munich, Bayern, 80802, Germany|Universitaetsklinikum Frankfurt /ID# 202089, Frankfurt am Main, Hessen, 60590, Germany|Universitaetsklinikum Muenster /ID# 202085, Muenster, Nordrhein-Westfalen, 48149, Germany|CMS3 Company for Medical Study /ID# 205193, Selters, Rheinland-Pfalz, 56242, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 202255, Kiel, Schleswig-Holstein, 24105, Germany|Universitaetsklinikum Bonn /ID# 202086, Bonn, 53127, Germany|TFS Trial Form Support GmbH /ID# 202083, Hamburg, 20537, Germany|Medizinische Hochschule Hannover /ID# 202091, Hannover, 30625, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz /ID# 205192, Mainz, 55131, Germany|Fondazione PTV Policlinico Tor Vergata /ID# 201136, Rome, Roma, 00133, Italy|Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 200692, Ancona, 60126, Italy|A.O.U. di Bologna Policlinico S.Orsola-Malpighi /ID# 200746, Bologna, 40138, Italy|A.O.U. Policlinico G. Rodolico S.Marco- Presidio G.Rodolico /ID# 200741, Catania, 95123, Italy|Azienda Ospedaliera Universitaria Federico II /ID# 200750, Napoli, 80131, Italy|Azienda Ospedaliero Universitaria Pisana-Stabilimento di Santa Chiara /ID# 200695, Pisa, 56126, Italy|Aichi Medical University Hospital /ID# 202833, Nagakute-shi, Aichi, 480-1195, Japan|Fukuoka University Hospital /ID# 201309, Fukuoka-shi, Fukuoka, 814-0180, Japan|Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers /ID# 202891, Fukuoka-shi, Fukuoka, 815-8588, Japan|Gifu University Hospital /ID# 201760, Gifu-shi, Gifu, 501-1194, Japan|Ogaki Municipal Hospital /ID# 203463, Ogaki-shi, Gifu, 503-8502, Japan|Takagi Dermatology Clinic /ID# 201238, Obihiro-shi, Hokkaido, 080-0013, Japan|Medical Cooperation Kojinkai Sapporo Skin Clinic /ID# 201239, Sapporo-shi, Hokkaido, 060-0063, Japan|University Hospital Kyoto Prefectural University of Medicine /ID# 201876, Kyoto-shi, Kyoto, 602-8566, Japan|Kume Clinic /ID# 201912, Sakai-shi, Osaka, 5938324, Japan|NTT Medical Center Tokyo /ID# 201759, Shinagawa-ku, Tokyo, 141-8625, Japan|University of Yamanashi Hospital /ID# 204174, Chuo-shi, Yamanashi, 409-3821, Japan|Hospital Raja Permaisuri Bainun /ID# 204375, Ipoh, Perak, 30450, Malaysia|Queen Elizabeth Hospital /ID# 204379, Division Pantai Barat Utara, Sabah, 88200, Malaysia|Hospital Selayang /ID# 204378, Batu Caves, Selangor, 68100, Malaysia|Clinical Trials NZ /ID# 205335, Hamilton, 3204, New Zealand|Cruz-Santana, Carolina, PR /ID# 201096, Carolina, 00985, Puerto Rico|Ponce Medical School Foundation /ID# 201821, Ponce, 00716-0377, Puerto Rico|Clinical Research Puerto Rico /ID# 203309, San Juan, 00909, Puerto Rico|Spitalul Clinic Colentina /ID# 205860, Bucuresti, 020121, Romania|Cabinet Medical de Dermatovenerologie Dr. Remus Orasan /ID# 205862, Cluj Napoca, 400105, Romania|Chelyabinsk Regional Clinical Dermatovenerologic Dispensary /ID# 201996, Chelyabinsk, Chelyabinskaya Oblast, 454048, Russian Federation|Clinical Dermatovenerology Dispensary /ID# 203439, Krasnodar, Krasnodarskiy Kray, 350020, Russian Federation|Saratov State Medical University n.a. V.I. Razumovskiy /ID# 201595, Saratov, Saratovskaya Oblast, 410012, Russian Federation|Ural Research Institute of dermatovenerology and immunopathology /ID# 201593, Yekaterinburg, Sverdlovskaya Oblast, 620076, Russian Federation|National Medical Research Center for Children's Health /ID# 203440, Moscow, 119296, Russian Federation|UniversitÃ¤tsspital Basel /ID# 201599, Basel, Basel-Stadt, 4031, Switzerland|HÃ´pitaux Universitaires GenÃ¨ve /ID# 201600, GenÃ¨ve, Geneve, 1205, Switzerland|CHUV, Centre hospitalier universitaire vaudois /ID# 200910, Lausanne, Vaud, 1011, Switzerland|CHUV, Centre hospitalier universitaire vaudois /ID# 206505, Lausanne, Vaud, 1011, Switzerland|Inselspital, UniversitÃ¤tsspital Bern /ID# 201598, Bern, 3010, Switzerland|Erciyes University Medical Fac /ID# 204098, Melikgazi, Kayseri, 38030, Turkey|Hacettepe University Faculty of Medicine /ID# 204099, Ankara, 06100, Turkey|Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty /ID# 204100, Istanbul, 34098, Turkey|Gazi Universitesi Tip Fakultes /ID# 204176, Yenimahalle, 06560, Turkey|Military Hospital of Military-Medical Clinical Center of Southern Region /ID# 201962, Zaporizhzhya, Zaporizka Oblast, 69063, Ukraine|ME ""Rivne Regional Dermatology and Venereology Dispensary"" of RRC /ID# 210504, Rivne, 33028, Ukraine|West Middlesex University Hospital /ID# 202273, Isleworth, London, City Of, TW7 6AF, United Kingdom|Barts Health NHS Trust /ID# 201043, London, London, City Of, E1 2ES, United Kingdom|Guy's and St Thomas' NHS Foundation Trust /ID# 201192, London, London, City Of, SE1 9RT, United Kingdom|Chelsea and Westminster Hospital NHS Foundation Trust9 /ID# 201971, London, SW10 9NH, United Kingdom|Northern Care Alliance NHS Group /ID# 201194, Salford, M6 8HD, United Kingdom","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT05098821,Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation,https://clinicaltrials.gov/study/NCT05098821,NO,Atopic Dermatitis,"OTHER: not applicable, observational study",ALL,"ADULT, OLDER_ADULT",,"Dpt of Dermatology and Allergology, CharitÃ© - UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany",Sanofi LEO Pharma
Atopic Dermatitis,NCT02594098,Secukinumab for Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02594098,YES,Atopic Dermatitis,DRUG: Secukinumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States","Principal Investigator : Emma Guttman, MD, PhD , Icahn School of Medicine at Mount Sinai"
Atopic Dermatitis,NCT05383378,"A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT05383378,NO,Atopic Dermatitis,DRUG: si-544|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1,"selectION Clinical Trial Site, Berlin, Germany|selectION Clinical Trial Site, Hamburg, Germany|selectION Clinical Trial Site, Magdeburg, Germany|selectION Clinical Trial Site, Mainz, Germany|selectION Clinical Trial Site, Wuppertal, Germany",
Atopic Dermatitis,NCT05671445,The Study of CM326 in Adult Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05671445,NO,Atopic Dermatitis,BIOLOGICAL: CM326,ALL,"ADULT, OLDER_ADULT",PHASE2,"Peking University People's hospital, Beijing, China",
Atopic Dermatitis,NCT05139836,A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting,https://clinicaltrials.gov/study/NCT05139836,NO,Atopic Dermatitis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Universitaetsklinik Heidelberg /ID# 245834, Heidelberg, Baden-Wuerttemberg, 69120, Germany|Beldio Research GmbH /ID# 245830, Memmingen, Bayern, 87700, Germany|Dermazent /Id# 268146, Munich, Bayern, 80331, Germany|Dermatologie Kleinmachnow /ID# 268383, Kleinmachnow, Brandenburg, 14532, Germany|Praxis Dr. Behnke /ID# 248870, Panketal, Brandenburg, 16341, Germany|Praxis Dr. Asadullah /ID# 243944, Potsdam, Brandenburg, 14467, Germany|HautÃ¤rzte am Nauener Tor /ID# 261533, Potsdam, Brandenburg, 14469, Germany|Universitaetsklinikum Frankfurt /ID# 241766, Frankfurt am Main, Hessen, 60590, Germany|Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 241658, Bramsche, Niedersachsen, 49565, Germany|Hautarztpraxis Dr. Kirschner /ID# 266738, Mainz, Rheinland-Pfalz, 55116, Germany|CMS3 Company for Medical Study /ID# 241659, Selters, Rheinland-Pfalz, 56242, Germany|HMS GmbH Zimmer /ID# 241657, Merzig, Saarland, 66663, Germany|Praxis Dr. Mempel /ID# 241827, Elmshorn, Schleswig-Holstein, 25335, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 240096, Kiel, Schleswig-Holstein, 24105, Germany|Dermatologie Moelln Praxis Dr. Bodo Segert /ID# 242280, MÃ¶lln, Schleswig-Holstein, 23879, Germany|Hoeller-Obrigkeit, Aachen, DE /ID# 245430, Aachen, 52064, Germany|Petri, Ahaus, DE /ID# 243452, Ahaus, 48683, Germany|Dr. Stoeber /ID# 251066, Ahlen, 59227, Germany|Bell, Andernach, DE /ID# 249154, Andernach, 56626, Germany|Praxis Dr. Mihaescu /ID# 241825, Augsburg, 86150, Germany|MVZ medicum.mittelhessen /ID# 266126, Bad Camberg, 65520, Germany|Mauer, Bad Kreuznach, DE /ID# 241990, Bad Kreuznach, 55543, Germany|Timmel/Timm/Vorwerk, Bergen /ID# 241661, Bergen, 18528, Germany|Hautarztpraxis Dr. med. Christiane Handrick /ID# 262667, Berlin, 10117, Germany|Praxis Dermatologie am Savigny /ID# 248846, Berlin, 10623, Germany|Dre. Gellrich/Klein/Soost /ID# 250301, Berlin, 12247, Germany|Schirmer, Berlin, DE /ID# 241684, Berlin, 12489, Germany|Kors, Berlin, DE /ID# 241847, Berlin, 13086, Germany|Dues/Manasterski, Berlin, DE /ID# 243885, Berlin, 13507, Germany|Hautarztzentrum Tegel /ID# 241826, Berlin, 13507, Germany|Haut Pur - Dermatologische Gemeinschaftspraxis /ID# 243943, Berlin, 13597, Germany|Klinikum Rosenhoehe /ID# 241601, Bielefeld, 33647, Germany|Hautarztpraxis Dr. Weid /ID# 265213, Bingen am Rhein, 55411, Germany|Praxis fuer Innere Medizin/Rheumatologie /ID# 241846, Blaubeuren, 89143, Germany|Praxis T. Schadeck /ID# 241768, Bogen, 94327, Germany|Barth, Borna, DE /ID# 248871, Borna, 04552, Germany|Schwichtenberg, Bremen, DE /ID# 241683, Bremen, 28779, Germany|Praxis P. Hausler-Mehlhorn /ID# 241527, Chemnitz, 09130, Germany|Dr. Hoffmann /ID# 245423, Cologne, 50674, Germany|Derma KÃ¶ln /ID# 241856, Cologne, 50737, Germany|Praxis Dr. Sbornik /ID# 241818, Deggendorf, 94469, Germany|Hautmedizin Delitzsch /ID# 251394, Delitzsch, 04509, Germany|Richter-Huhn, Dresden, DE /ID# 241822, Dresden, 01219, Germany|Praxis Dr. Korge /ID# 241531, Dueren, 52349, Germany|Praxis Dres. Freitag/Knoell /ID# 242278, Falkensee, 14612, Germany|Praxis Dr. Hong-Weldemann /ID# 248844, Freiburg im Breisgau, 79098, Germany|Kurzen, Freising, DE /ID# 241845, Freising, 85354, Germany|Hautarztpraxis Friedberg Dr. med. Wilfried Jungkunz /ID# 248851, Friedberg (Hessen), 61169, Germany|Rotterdam, Gelsenkirchen, DE /ID# 241819, Gelsenkirchen, 45897, Germany|Gemeinschaftspraxis Rietkoetter und Jablonka /ID# 241821, Gelsenkirchen, 45899, Germany|Praxis Dr. Lange /ID# 241829, Gera, 07548, Germany|Loth, Gernsbach, DE /ID# 241828, Gernsbach, 76593, Germany|Hautarztpraxis Dr. Budihardja /ID# 241851, GieÃŸen, 35392, Germany|Brinkmann & Partner, Gladbeck, /ID# 241850, Gladbeck, 45964, Germany|Dr. Krueger /ID# 265150, Goslar, 38640, Germany|Herrmann, Greifswald, DE /ID# 241889, Greifswald, 17489, Germany|Grossmann, Grossenhain, DE /ID# 250303, Grossenhain, 01558, Germany|Praxis Dr. Wegener /ID# 263731, Hamburg, 20095, Germany|Cutaneum /ID# 249104, Hamburg, 20249, Germany|Dermatologikum Hamburg /ID# 245431, Hamburg, 20354, Germany|Hautarztpraxis Luetten/Sack /ID# 241534, Hamburg, 21109, Germany|Praxis Dr. Kasche /ID# 249102, Hamburg, 22549, Germany|MVZ Prof. Dr. Ockenfels Haut- und Allergie-Praxisklinik GmbH /ID# 245395, Hanau, 63450, Germany|Praxis Dres. Kaspari /Schenck /ID# 241688, Hannover, 30159, Germany|Dr. Buerkle /ID# 250299, Haslach im Kinzigtal, 77716, Germany|Hautarztpraxis HaÃŸberge /ID# 257648, HaÃŸfurt, 97437, Germany|Durani & Durani, Heidelberg,DE /ID# 249172, Heidelberg, 69115, Germany|Gemeinschaftspraxis Dres. Anika HÃ¼nermund/Mario Pawlak /ID# 241908, Heilbad Heiligenstadt, 37308, Germany|Haut- u. Laserzentrum Heilbronn /ID# 250305, Heilbronn, 74072, Germany|Hausarztpraxis & Laserzentrum Dr. Zimmermann & Kollegen /ID# 251051, Heusenstamm, 63150, Germany|Praxis Dres. Bischoff/Danz /ID# 241852, Ilmenau, 98693, Germany|Stockmeier, Ingoldstadt, DE /ID# 248877, Ingolstadt, 85049, Germany|Hautarztpraxis Weidgang /ID# 248850, Juelich, 52428, Germany|Derma Sana /ID# 241854, Karlsruhe, 76133, Germany|Dermatologische Praxis Kempen /ID# 248852, Kempen, 47906, Germany|Grossmann, Koblenz, DE /ID# 242992, Koblenz, 56068, Germany|Praxis Dres. Bornemann/Reinerth /ID# 257649, Krefeld, 47798, Germany|Dres. Jacobs & Kollegen /ID# 241989, Kulmbach, 95326, Germany|Hautarztpraxis Langenau /ID# 242279, Langenau, 89129, Germany|Neubauer, Leipzig, DE /ID# 241823, Leipzig, 04209, Germany|Praxis Dres. Wiemers/Wiemers /ID# 241602, Leipzig, 04317, Germany|Haut- und Allergie-Zentrum Lippstadt /ID# 241929, Lippstadt, 59557, Germany|Hagemeier, Loehne, DE /ID# 241886, Loehne, 32584, Germany|Magdeburger Company for Medical Studies & Services GmbH /ID# 248849, Magdeburg, 39104, Germany|MVZ ""Im Altstadtquartier"" Magdeburg /ID# 261366, Magdeburg, 39104, Germany|Praxis Dr. Raschke /ID# 251398, Magdeburg, 39104, Germany|Universitaetsklinikum Magdeburg /ID# 249174, Magdeburg, 39120, Germany|HausÃ¤rzte am Fastnachtsbrunnen /ID# 250304, Mainz, 55116, Germany|Dermatologie Quist-BAG Dres. med. Quist PartG /ID# 243325, Mainz, 55128, Germany|Praxis A. Viculova /ID# 266133, Miltenberg, 63897, Germany|Dermatologie im Tal Praxis Dr.med. Maria Leibl /ID# 266128, Munich, 80331, Germany|Hautzentrum am Marienplatz /ID# 248847, Munich, 80331, Germany|Quack, Munich, DE /ID# 241536, Munich, 81539, Germany|Dr. GiÃŸler-Walter /ID# 248876, Mutterstadt, 67112, Germany|ZENTderma /ID# 241539, MÃ¶nchengladbach, 41061, Germany|Dr. Rezai /ID# 250298, MÃ¼nster, 48143, Germany|Dermatologie im Apfelgarten /ID# 263704, Neu Wulmstorf, 21629, Germany|Praxis Dr. Konstantin Ertner /ID# 249153, Nuremberg, 90402, Germany|Voelkel, Nuremberg, DE /ID# 252445, Nuremberg, 90419, Germany|MediCorium Zentrum fuer Dermatologie und Aesthetik /ID# 243328, Oberursel, 61440, Germany|Hockmann, Oelde, DE /ID# 241906, Oelde, 59302, Germany|Harzklinikum Dorothea Christiane Erxleben /ID# 251067, Quedlinburg, 06484, Germany|Kramer/Mortazawi, Remscheid /ID# 241824, Remscheid, 42897, Germany|Dr. Schaefers /ID# 255492, Reutlingen, 72764, Germany|Praxis Dr. FrÃ¤nken /ID# 241853, Schwelm, 58332, Germany|Haut- und Laserzentrum HunsrÃ¼ck /ID# 243882, Simmern, 55469, Germany|Karl, Soest, DE /ID# 241909, Soest, 59494, Germany|Gemeinschaftspraxis fur Dermatologie /ID# 245831, Stadtroda, 07646, Germany|Praxis Dr. Termeer /ID# 241662, Stuttgart, 70499, Germany|Flegl MD Stuttgart Germany /ID# 250302, Stuttgart, 70567, Germany|Jasnoch/Kock/Borrosch, Vechta, /ID# 252081, Vechta, 49377, Germany|Barnikol, Waltershausen, DE /ID# 241844, Waltershausen, 99880, Germany|Praxis Dehmel / Brand-Opitzer /ID# 243884, Wasserburg A. Inn, 83512, Germany|Dr. Barbara Kempkes, Werne /ID# 241910, Werne, 59368, Germany|Dr. med. Nicola MÃ¶ller & Thomas Kurtenbach GbR Dermatologie im Zentrum /ID# 266130, Wiesbaden, 65185, Germany|Hautarztpraxis Dr. med. Matthias Hoffmann /ID# 241907, Witten, 58453, Germany|Albrecht, Wurzen, DE /ID# 241988, Wurzen, 04808, Germany","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT04725136,Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04725136,NO,Atopic Dermatitis,BIOLOGICAL: FURESTEM-AD inj,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Dongguk University Medical Center, Ilsan, Korea, Republic of|Seoul National Hospital, Seoul, Korea, Republic of","Kang Stem Biotech Co., Ltd."
Atopic Dermatitis,NCT05372003,IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05372003,NO,Atopic Dermatitis,DRUG: Dupilumab|OTHER: Photo therapy,ALL,ADULT,EARLY_PHASE1,"Mayo Clinic Arizona, Scottsdale, Arizona, 85259, United States","Principal Investigator : Elena Anna De Filippis, MD, PhD , Mayo"
Atopic Dermatitis,NCT04110873,"A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT04110873,NO,Atopic Dermatitis,DRUG: Antroquinonol Capsule 50mg|DRUG: Antroquinonol Capsule 100mg|DRUG: Placebo oral capsule,ALL,"ADULT, OLDER_ADULT",PHASE2,"Chung Shan Medical University Hospital, Taichung, 402, Taiwan","Principal Investigator : Wei C- C, M.D. , Chung Shan Medical University"
Atopic Dermatitis,NCT05999799,A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05999799,NO,"Dermatitis, Atopic",DRUG: GSK1070806|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"GSK Investigational Site, Phoenix, Arizona, 85006, United States|GSK Investigational Site, North Little Rock, Arkansas, 72117, United States|GSK Investigational Site, Canoga Park, California, 91303, United States|GSK Investigational Site, Fountain Valley, California, 92708, United States|GSK Investigational Site, Santa Monica, California, 90404, United States|GSK Investigational Site, Pompano Beach, Florida, 33060, United States|GSK Investigational Site, Fayetteville, Georgia, 30214, United States|GSK Investigational Site, Thomasville, Georgia, 31792, United States|GSK Investigational Site, Methuen, Massachusetts, 01844, United States|GSK Investigational Site, Troy, Michigan, 48084, United States|GSK Investigational Site, New York, New York, 10029-6501, United States|GSK Investigational Site, New York, New York, 10075, United States|GSK Investigational Site, Dublin, Ohio, 43016, United States|GSK Investigational Site, W. Lake Hills, Texas, 78746, United States|GSK Investigational Site, Springville, Utah, 84663, United States|GSK Investigational Site, Caba, Buenos Aires, C1055AAO, Argentina|GSK Investigational Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1181ACH, Argentina|GSK Investigational Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1207AAP, Argentina|GSK Investigational Site, Cordoba, CÃ³rdova, X5000AAW, Argentina|GSK Investigational Site, Rosario, Santa Fe, S2002, Argentina|GSK Investigational Site, Mendoza, 5500, Argentina|GSK Investigational Site, Pleven, 5800, Bulgaria|GSK Investigational Site, Sofia, 1510, Bulgaria|GSK Investigational Site, Sofia, Bulgaria|GSK Investigational Site, Barrie, Ontario, Canada|GSK Investigational Site, London, Ontario, N6H 5L5, Canada|GSK Investigational Site, Markham, Ontario, L3P1X2, Canada|GSK Investigational Site, Quebec, G1W 4R4, Canada|GSK Investigational Site, Chongqing, Chongqing, 400016, China|GSK Investigational Site, Shanghai, Shanghai, China|GSK Investigational Site, Yiwu City, Zhejiang, 322000, China|GSK Investigational Site, Beijing, 100044, China|GSK Investigational Site, Fu Zhou, 350014, China|GSK Investigational Site, Guangzhou, China|GSK Investigational Site, Hangzhou, 310006, China|GSK Investigational Site, Shanghai, 200025, China|GSK Investigational Site, Yinchuan, China|GSK Investigational Site, Pardubice, Czechia|GSK Investigational Site, Prague, 10034, Czechia|GSK Investigational Site, Praha 2, 128 08, Czechia|GSK Investigational Site, Praha, Czechia|GSK Investigational Site, La Rochelle cedex 1, 17019, France|GSK Investigational Site, Nice, 06200, France|GSK Investigational Site, Paris cedex 10, 75475, France|GSK Investigational Site, Essen, Nordrhein-Westfalen, 45147, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, 48149, Germany|GSK Investigational Site, Kiel, Schleswig-Holstein, 24105, Germany|GSK Investigational Site, Berlin, 10789, Germany|GSK Investigational Site, Hamburg, 22391, Germany|GSK Investigational Site, Athens, Greece|GSK Investigational Site, Thessaloniki, 546 43, Greece|GSK Investigational Site, Bologna, Emilia Romagna, 40138, Italy|GSK Investigational Site, Modena, Emilia-Romagna, 41124, Italy|GSK Investigational Site, Roma, Lazio, 00128, Italy|GSK Investigational Site, Bari, 70124, Italy|GSK Investigational Site, Firenze, Italy|GSK Investigational Site, Roma, 00168, Italy|GSK Investigational Site, Chiba, 272-0033, Japan|GSK Investigational Site, Chiba, 279-0021, Japan|GSK Investigational Site, Fukuoka, 807-8556, Japan|GSK Investigational Site, Fukuoka, 812-8582, Japan|GSK Investigational Site, Gunma, 370-0829, Japan|GSK Investigational Site, Hokkaido, 060-0033, Japan|GSK Investigational Site, Hokkaido, 080-0013, Japan|GSK Investigational Site, Kanagawa, 211-0063, Japan|GSK Investigational Site, Osaka, 583-8588, Japan|GSK Investigational Site, Osaka, 593-8324, Japan|GSK Investigational Site, Saitama, 343-8555, Japan|GSK Investigational Site, Gyeonggi-do, 15355, Korea, Republic of|GSK Investigational Site, Seoul, 03722, Korea, Republic of|GSK Investigational Site, Seoul, 04564, Korea, Republic of|GSK Investigational Site, Seoul, 04763, Korea, Republic of|GSK Investigational Site, Seoul, 150-950, Korea, Republic of|GSK Investigational Site, Durango., Durango, 34000, Mexico|GSK Investigational Site, Guadalajara, Jalisco, 44628, Mexico|GSK Investigational Site, Chihuahua, 31000, Mexico|GSK Investigational Site, Monterrey, 64718, Mexico|GSK Investigational Site, Ciudad de Panama, 7099, Panama|GSK Investigational Site, Chojnice, 89-600, Poland|GSK Investigational Site, Elblag, 82-300, Poland|GSK Investigational Site, Katowice, 40-600, Poland|GSK Investigational Site, Poznan, 60-569, Poland|GSK Investigational Site, Szczecin, 70-332, Poland|GSK Investigational Site, Warsaw, 03-291, Poland|GSK Investigational Site, Majadahonda, Madrid, 28222, Spain|GSK Investigational Site, Vigo, Pontevedra, 36206, Spain|GSK Investigational Site, Alicante, ?03010, Spain|GSK Investigational Site, CÃ³rdoba, 14004, Spain|GSK Investigational Site, Granada, 18016, Spain|GSK Investigational Site, Valencia, 46026, Spain|GSK Investigational Site, Zaragoza, 50009, Spain|GSK Investigational Site, Bangkok, Pathum Wan, 10330, Thailand|GSK Investigational Site, Khlong Luang, 12120, Thailand","Study Director : GSK Clinical Trials , GlaxoSmithKline"
Atopic Dermatitis,NCT04146363,Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1),https://clinicaltrials.gov/study/NCT04146363,YES,Atopic Dermatitis,BIOLOGICAL: Lebrikizumab|OTHER: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|Wallace Medical Group, Inc., Beverly Hills, California, 90211, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Belle Aimee Skincare Clinic, Fountain Valley, California, 92708, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|ACRC Studies, San Diego, California, 92119, United States|Central Connecticut Dermatology, Cromwell, Connecticut, 06416, United States|St. Francis Medical Institute, Clearwater, Florida, 33765, United States|Community Research Foundation Inc, Miami, Florida, 33145, United States|ForCare Clinical Research, Tampa, Florida, 33613-1244, United States|IACT Health - VHC, Columbus, Georgia, 31903, United States|The Indiana Clinical Trials Center, Plainfield, Indiana, 46168, United States|Skin Sciences, PLLC, Louisville, Kentucky, 40217, United States|Beacon Clinical Research, LLC, Quincy, Massachusetts, 02169, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|St Joseph Dermatology and Vein Clinic, Saint Joseph, Michigan, 49085, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|JDR Dermatology Research, Las Vegas, Nevada, 89148, United States|ALLCUTIS Research, Portsmouth, New Hampshire, 03801, United States|Icahn Sch of Med at Mt. Sinai, New York, New York, 10029, United States|Sadick Research Group, New York, New York, 10075, United States|Wake Research Associates, Raleigh, North Carolina, 27612, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, 73112, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Clinical Research Institute, Medford, Oregon, 97504, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|Clinical Partners, LLC, Johnston, Rhode Island, 02919, United States|Bellaire Dermatology, Bellaire, Texas, 77401, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Premier Clinical Research, Spokane, Washington, 99202, United States|The St. George Hospital, Kogarah, New South Wales, 2217, Australia|Holdsworth House Medical Practice, Sydney, New South Wales, 2010, Australia|Skin & Cancer Foundation Australia, Westmead, New South Wales, 2145, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Eastern Clinical Research Unit, Box Hill, Victoria, 3128, Australia|Emeritus Research, Camberwell, Victoria, 3124, Australia|Skin Health Institute Inc., Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Fremantle Dermatology, Fremantle, Western Australia, 6160, Australia|Burswood Dermatology, Victoria Park, Western Australia, 06100, Australia|CARe Clinic, Red Deer, Alberta, T4P1K4, Canada|CCA Medical Research, Ajax, Ontario, L1S7K8, Canada|Skin Health, Cobourg, Ontario, K9A 0Z4, Canada|Dermatology and Dermatologic Surgery, Ottawa, Ontario, K2G6E2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|Kliiniliste uuringute Keskus OU, Tartu, 50160, Estonia|Hopital Saint-Louis, Paris, Cedex 10, 75475, France|CHU de Bordeaux Hopital Saint Andre, Bordeaux Cedex, 33075, France|CHU DIJON - Hopital le Bocage, Dijon Cedex, 21079, France|Cabinet MÃ©dical, Martigues, 13500, France|Hopital Larrey, Toulouse cedex 9, 31059, France|Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, 15355, Korea, Republic of|Pusan National University Hospital, Pusan, Korea, 49241, Korea, Republic of|Hanyang University Medical Center, Seoul, Korea, 04763, Korea, Republic of|Ulsan University Hospital, Ulsan, Korea, 44033, Korea, Republic of|Ajou University Hospital, Suwon-si, Kyung Gi-Do, Korea, 16499, Korea, Republic of|Soon Chun Hyang University Seoul Hospital, Seoul, Yongsan-gu, 04401, Korea, Republic of|Incheon St. Mary's Hospital, Incheon, 21431, Korea, Republic of|Severance Hospital, Seoul, 03722, Korea, Republic of|Konkuk University Medical Center, Seoul, 05030, Korea, Republic of|Chungang University Hospital, Seoul, 06973, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, 07441, Korea, Republic of|Clinic of Dermatology and STD, Riga, LV-1001, Latvia|Health Center 4, Affiliate Diagnostic Center, Riga, LV-1003, Latvia|Health and Aesthetics LTD, Riga, LV-1009, Latvia|Latvian Dermatology Institute, Riga, LV-1011, Latvia|Smite Aija - Practice in Dermatology Venereology, Talsi, LV-3201, Latvia|JSC ""CD8 Alergology Clinic"", Kaunas, LT-44192, Lithuania|Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas, LT-50161, Lithuania|Jsc Renmeda, Vilnius, LT-07195, Lithuania|JSC ""Center for Diagnosis and Treatment of Allergic Diseases"", Vilnius, LT-08109, Lithuania|Children's Hospital, Affiliate of Vilnius University Hospital Santaros klinikos, Vilnius, LT-08406, Lithuania|Inlita (Santaros CTC), Vilnius, LT-08406, Lithuania|Vilnius University Hospital Santaros klinikos, Vilnius, LT-08441, Lithuania|Alergo-Med Specjalistyczna Przychodnia Lekarska Sp Z O.O., Tarnow, Malopolska, 33100, Poland|Diamond Clinic, Krakow, Malopolskie, 31-559, Poland|Centralny Szpital Kliniczny MSWiA, Warszawa, Mazowieckie, 02-507, Poland|Centrum Medyczne Angelius Provita, Katowice, Slaskie, 40-611, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, West Pomeranian, 71-434, Poland|Zespol Naukowo - Leczniczy ""Iwolang"" Sp. z o.o., Iwonicz Zdroj, Wojewodztwo Podkarpackie, 38-440, Poland|GynCentrum Sp z o.o., Katowice, 40-851, Poland|Specjalistyczny Osrodek Alergologiczno-Internistyczny ALL-ME, Krakow, 31-023, Poland|Samodzielny Publiczny Szpital Kliniczny nr 1, Lublin, 20-081, Poland|Centrum Alergologii Teresa Hofman, Poznan, 60-214, Poland|Clinical Research Group Sp. z o.o., Warszawa, 01-142, Poland|CityClinic Przychodnia Lekarsko-Psychologiczna, Wroclaw, 50-566, Poland|Sant Joan de Deu Serveis En Salut Mental, SANT BOI DE Llobrega, Barcelona, 08830, Spain|Hospital De Basurto, Bilbao, Vizcaya, 48013, Spain|Hospital General Universitario Alicante, Alicante, 03010, Spain|Hospital Germans Trias i Pujol, Badalona, 08916, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain","Study Director : Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) , Eli Lilly and Company"
Atopic Dermatitis,NCT05891119,Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05891119,NO,Atopic Dermatitis,DIETARY_SUPPLEMENT: Caffeine|DRUG: Metoprolol|DRUG: Midazolam|DRUG: Warfarin|DIETARY_SUPPLEMENT: Vitamin K|DRUG: Omeprazole|DRUG: Rocatinlimab,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Velocity Clinical Research, North Hollywood, North Hollywood, California, 91606-1570, United States|Accel Research Sites (ACR), DeLand, Florida, 32720-3134, United States|Direct Helpers Research Center (DHRC), Hialeah, Florida, 33012-3618, United States|Axis Clinicals, LCC, Dilworth, Minnesota, 565294, United States|DermDox Dermatology Centers, PC - Camp Hill, Camp Hill, Pennsylvania, 17011, United States|Velocity Clinical Research -Spartanburg, Spartanburg, South Carolina, 29303-4225, United States|DermDox Dermatology Centers, PC - Sugarloaf, Nashville, Tennessee, 37203-1632, United States","Study Director : MD , Amgen"
Atopic Dermatitis,NCT03920852,A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03920852,NO,Atopic Dermatitis,DRUG: Ruxolitinib cream,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,"Orange County Research Center, Anaheim, California, 92801, United States|Encino Research Center, Encino, California, 91436, United States|San Marcus Research Clinic, Inc., Miami Lakes, Florida, 33014, United States|RM Medical Research, INC., Miami, Florida, 33174, United States|Pure Skin Dermatology Aesthetics at Accel Research, Orlando, Florida, 32819, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135, United States|Oakland Hills Dermatology PC, Auburn Hills, Michigan, 48326, United States|Clinical Research Institute of Southern Oregon - Crisor, Medford, Oregon, 97504, United States|Clinical Research Partners LLC, Richmond, Virginia, 23220, United States|Innovaderm Research Inc., MontrÃ©al, Quebec, H2K 4L5, Canada",
Atopic Dermatitis,NCT06116565,A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06116565,NO,Atopic Dermatitis,BIOLOGICAL: CM310,ALL,"ADULT, OLDER_ADULT",PHASE2,,Keymed Biosciences Co.Ltd
Atopic Dermatitis,NCT05324618,Tacrolimus Versus Hydrocortisone in Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05324618,NO,Atopic|Dermatitis,DRUG: Tacrolimus|DRUG: Hydrocortisone,ALL,CHILD,PHASE4,"Dermatology Clinic of National Hepatology and Tropical Medicine Research Institute, Cairo, 123456, Egypt","Principal Investigator : Amal A. Mohamed , Department of Biochemistry, National Hepatology and Tropical Medicine Research institute"
Atopic Dermatitis,NCT05059509,Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05059509,NO,Atopic Dermatitis,BIOLOGICAL: FB825,ALL,"ADULT, OLDER_ADULT",PHASE2,"National Taiwan University Hospital, Taipei, Taiwan","Oneness Biotech Co., Ltd."
Atopic Dermatitis,NCT05724199,A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT05724199,NO,Atopic Dermatitis,DRUG: Rocatinlimab|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"The University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|Medical Dermatology Specialists, Phoenix, Arizona, 85006, United States|Southwest Skin Specialists, Phoenix, Arizona, 85018, United States|US Dermatology Partners Sun City West, Sun City West, Arizona, 85375, United States|Arkansas Research Trials, LLC, North Little Rock, Arkansas, 72117, United States|Kern Research Inc, Bakersfield, California, 93301, United States|Keck Medicine of University of Southern California, Los Angeles, California, 90033, United States|Wallace Medical Group Inc, Los Angeles, California, 90056, United States|Antelope Valley Clinical Trials, Palmdale, California, 93551, United States|University of California at Davis Medical Center, Sacramento, California, 95816, United States|Kaiser Permanente South Sacramento Medical Center, Sacramento, California, 95823, United States|Acclaim Clinical Research, San Diego, California, 92120, United States|Kaiser Permanente Medical Center - Oakland, San Francisco, California, 94118, United States|Kaiser Permanente Medical Center - San Francisco, San Francisco, California, 94118, United States|Synergy Dermatology, San Francisco, California, 94132, United States|TrueBlue Clinical Research, Tampa, Florida, 33609, United States|Olympian Clinical Research - Tampa, Tampa, Florida, 33615, United States|Atlanta Dermatology, Vein and Research Center, PC, Alpharetta, Georgia, 30022, United States|Divine Dermatology and Aesthetics, Atlanta, Georgia, 30315, United States|NorthShore University HealthSystem, Skokie, Illinois, 60077, United States|DS Research, Clarksville, Indiana, 47129, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|Dermatology and Skin Cancer Center Leawood, Leawood, Kansas, 66211, United States|Industrial Medicine Associates Clinical Research Advanced Dermatology Care, Monroe, Louisiana, 71201, United States|Aesthetic and Dermatology Center, Rockville, Maryland, 20850, United States|University of Michigan Medical Center, Ann Arbor, Michigan, 48109, United States|Oakland Hills Dermatology, Auburn Hills, Michigan, 48326, United States|Somnos Clinical Research, Lincoln, Nebraska, 68505, United States|Skin Specialists PC, Omaha, Nebraska, 68144, United States|Vivida Dermatology, Las Vegas, Nevada, 89119, United States|Las Vegas Clinical Trials, North Las Vegas, Nevada, 89030, United States|Schweiger Dermatology Group, PC Research Division, Hackensack, New Jersey, 07601, United States|Albuquerque Clinical Trials Incorporated, Albuquerque, New Mexico, 87102, United States|Chear Center LLC, Bronx, New York, 10455, United States|Accellacare of Wilmington, Wilmington, North Carolina, 28401, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Velocity Clinical Research Inc, Medford, Oregon, 97504, United States|Paddington Testing Company Inc, Philadelphia, Pennsylvania, 19103, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|US Dermatology Partners Jollyville, Austin, Texas, 78759, United States|Newco 3A Research LLC, El Paso, Texas, 79925, United States|Sante Clinical Research, Kerrville, Texas, 78028, United States|Texas Dermatology Research Center, Plano, Texas, 75025, United States|Virginia Dermatology and Skin Cancer Center, Norfolk, Virginia, 23502, United States|Cinme - Centro de Investigaciones Metabolicas, Caba, Buenos Aires, C1027AAP, Argentina|Framingham Centro Medico, La Plata, Buenos Aires, B1902COS, Argentina|Dim Clinica Privada, Ramos Mejia, Buenos Aires, 1704, Argentina|Buenos Aires Skin SA, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1054, Argentina|Fundacion Cidea, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1121, Argentina|Care- Centro de Alergia y Enfermedades Respiratorias, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1414, Argentina|Psoriahue Medicina Interdisciplinaria SRL, Ciudad Autonoma de Buenos Aires, Distrito Federal, 1425, Argentina|Centro de Investigaciones Clinicas Instituto Especialidades De La Salud De Rosario, Rosario, Santa Fe, 2000, Argentina|Emeritus Research Sydney, Botany, New South Wales, 2019, Australia|Westmead Hospital, Westmead, New South Wales, 2145, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Princess Alexandra Hospital, South Brisbane, Queensland, 4101, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 4102, Australia|Emeritus Research Melbourne, Camberwell, Victoria, 3124, Australia|Medizinische Universitaet Graz, Graz, 8036, Austria|Medizinische Universitaet Innsbruck, Innsbruck, 6020, Austria|Landeskrankenhaus Salzburg, Salzburg, 5020, Austria|Klinik Landstrasse, Wien, 1030, Austria|Klinik Hietzing, Wien, 1130, Austria|Algemeen Ziekenhuis Sint-Jan Brugge-Oostende, Brugge, 8000, Belgium|Centre Hospitalier Universitaire Brugmann, Brussels, 1020, Belgium|Universitair Ziekenhuis Brussel, Brussel, 1090, Belgium|Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, 1200, Belgium|Universitair Ziekenhuis Gent, Gent, 9000, Belgium|Clinique Andre Renard, Herstal, 4040, Belgium|Dermatologie Handelskaai, Kortrijk, 8500, Belgium|Universitaire Ziekenhuizen Leuven Gasthuisberg, Leuven, 3000, Belgium|Centre Hospitalier Universitaire de Liege - Sart Tilman, Liege, 4000, Belgium|Grand Hopital de Charleroi, Loverval, 6280, Belgium|Medical Center Asklepii OOD, Dupnitsa, 2600, Bulgaria|Medical Center Medconsult Pleven OOD, Pleven, 5800, Bulgaria|Medical Center Excelsior OOD, Sofia, 1407, Bulgaria|Diagnostic-Consultative Center Alexandrovska EOOD, Sofia, 1431, Bulgaria|Diagnostic-Consultative Center - Fokus-5 - Medical Institution for Outpatient Care OOD, Sofia, 1463, Bulgaria|Dermatology Research Institute Incorporated, Calgary, Alberta, T2J 7E1, Canada|Laser Rejuvenation Clinics Edmonton D T Incorporated, Edmonton, Alberta, T5J 3S9, Canada|Alberta Derma Surgery Centre, Edmonton, Alberta, T6G 1C3, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research Incorporated, Winnipeg, Manitoba, R3M 3Z4, Canada|SKiN Health, Coburg, Ontario, K9A 4J9, Canada|Centricity Research London, London, Ontario, N6A 2C2, Canada|Dr SK Siddha Medicine Professional Corporation, Newmarket, Ontario, L3Y 5G8, Canada|Allergy Research Canada Incorporated, Niagara Falls, Ontario, L2H 1H5, Canada|North Bay Dermatology Centre, North Bay, Ontario, P1B 3Z7, Canada|Dermatology Ottawa Research Centre, Ottawa, Ontario, K2C 3N2, Canada|JRB Research Incorporated, Ottawa, Ontario, K2C 3N2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|North York Research Incorporated, Toronto, Ontario, M2N 3A6, Canada|Toronto Research Centre Inc, Toronto, Ontario, M3H 5Y8, Canada|Alliance Clinical Trials, Waterloo, Ontario, N2J 1C4, Canada|Clinique de Dermatologie Rosemont, Montreal, Quebec, H1Y 3L1, Canada|Innovaderm Research Inc, Montreal, Quebec, H2X 2V1, Canada|Saskatoon Dermatology Centre, Saskatoon, Saskatchewan, S7T 0G3, Canada|DIEX Recherche Quebec, Quebec, G1V 4T3, Canada|Centre de Recherche Saint-Louis, Quebec, G1W 4R4, Canada|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350000, China|The First Affiliated Hospital ,Sun-Yat Sen University, Guangzhou, Guangdong, 510080, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, 510091, China|Sun Yat-sen Memorial Hospital Sun Yat-sen University, Guangzhou, Guangdong, 510120, China|The Fist Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, 515041, China|Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangdong, 518101, China|Nanyang First Peoples Hospital, Nanyang, Henan, 473002, China|Union Hospital Tongji Medical College Huazhong University of science and Technology, Wuhan, Hubei, 430022, China|Wuxi Second Peoples Hospital, Wuxi, Jiangsu, 214001, China|Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, 330000, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|Chengdu Second Peoples Hospital, Chengdu, Sichuan, 610017, China|the First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China|Affiliated Hangzhou First Peoples Hospitalï¼ŒZhejiang University School of Medicine, Hangzhou, Zhejiang, 310020, China|The First Affiliation Hospital Of Ningbo University, Ningbo, Zhejiang, 315010, China|Taizhou Central Hospital, Taizhou, Zhejiang, 318000, China|Peking University Peoples Hospital, Beijing, 100044, China|Shanghai Skin Disease Hospital, Shanghai, 200443, China|Hopital Prive d Antony, Antony, 92160, France|Centre Hospitalier Universitaire de Bordeaux - HÃ´pital Saint AndrÃ©, Bordeaux, Cedex, France|Centre Hospitalier Regional Universitaire Brest Hopital Morvan, Brest, 29200, France|Centre Hospitalier RÃ©gional Universitaire de Lille - HÃ´pital Claude Huriez, Lille, 59037, France|Centre Hospitalier de Bretagne Sud - Hopital du Scorff, Lorient Cedex, 56322, France|HÃ´pital La Timone, Marseille cedex 05, 13385, France|Cabinet du Docteur Ruer-Mulard Mireille, Martigues, 13500, France|Centre Hospitalier Universitaire de Nantes HÃ´tel Dieu, Nantes, 44093, France|Centre Hospitalier Universitaire Archet 2, Nice, 06202, France|Hopital Saint Louis, Paris Cedex 10, 75475, France|Hopital Bichat Claude Bernard, Paris, 75018, France|Hopital Tenon, Paris, 75020, France|Polyclinique de Courlancy, Reims, 51100, France|Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes Cedex 9, 35033, France|Centre Hospitalier Universitaire de Rouen - HÃ´pital Charles Nicolle, Rouen Cedex, 76031, France|Centre Hospitalier Universitaire Saint Etienne Hopital Nord, Saint Priest en Jarez, 42270, France|Hopital d instruction des armees sainte anne, Toulon, 83800, France|Universitaetsklinikum Frankfurt, Frankfurt am Main, 60590, Germany|Universitaetsmedizin Goettingen - Georg-August-Universitaet, Goettingen, 37075, Germany|TFS Trial Form Support GmbH, Hamburg, 20537, Germany|MensingDerma research GmbH, Hamburg, 22391, Germany|Hautaerzte Zentrum Hannover, Hannover, 30159, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|Universitaetsmedizin Mainz, Mainz, 55101, Germany|Beldio Research GmbH, Memmingen, 87700, Germany|Hautmedizin Saar, Merzing, 66663, Germany|Klinikum rechts der Isar der TUM, Muenchen, 80802, Germany|401 General Military Hospital Of Athens, Athens, 11525, Greece|Andreas Syngros Hospital Of Venereal And Dermatological Diseases, Athens, 16121, Greece|University General Hospital of Heraklion, Heraklion, 71500, Greece|General Hospital Of Nea Ionia Konstantopouleio Patision, Nea Ionia, 14233, Greece|Geniko Nosokomeio Peiraia Tzaneio, Piraeus, 18536, Greece|Ippokratio General Hospital of Thessaloniki, Thessaloniki, 54642, Greece|Trial Pharma Kft, Bekescsaba, 5600, Hungary|Csalogany Orvosi Kozpont, Budapest, 1027, Hungary|Clinexpert Kft, Budapest, 1033, Hungary|Obudai Egeszsegugyi Centrum Kft, Budapest, 1036, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, 4032, Hungary|Gyongyosi Bugat Pal Korhaz, Gyongyos, 3200, Hungary|Somogy Varmegyei Kaposi Mor Oktato Korhaz, Kaposvar, 7400, Hungary|DermaMed Research Kft, Oroshaza, 5900, Hungary|Allergo-Derm Bakos Kft, Szolnok, 5000, Hungary|Obudai Egeszsegugyi Centrum Kft, Zalaegerszeg, 8900, Hungary|Ospedale Policlinico San Martino IRCCS, Genova, 16132, Italy|Ospedale San Salvatore, LAquila, 67100, Italy|Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, 00168, Italy|IRCCS Istituto Clinico Humanitas, Rozzano MI, 20089, Italy|Fukui Dermatology Clinic, Nagoya-shi, Aichi, 454-0803, Japan|Ekihigashi Dermatology Allergy Clinic, Fukuoka-shi, Fukuoka, 812-0013, Japan|Takagi Dermatological Clinic Branch, Obihiro-shi, Hokkaido, 080-0013, Japan|Medical Corporation Kojinkai Sapporo Skin Clinic, Sapporo-shi, Hokkaido, 060-0063, Japan|Katahira Dermatology Urology Clinic, Kagoshima-shi, Kagoshima, 890-0063, Japan|Kosugi Dermatology Clinic, Kawasaki-shi, Kanagawa, 211-0063, Japan|Nomura Dermatology Clinic, Yokohama-shi, Kanagawa, 221-0825, Japan|Jouzan Hihuka Hinyoukika Clinic, Kumamoto-shi, Kumamoto, 860-0066, Japan|Suizenji Dermatology Clinic, Kumamoto-shi, Kumamoto, 862-0950, Japan|Yoshioka Dermatology Clinic, Neyagawa-shi, Osaka, 572-0838, Japan|JA Shizuoka Kohseiren Enshu Hospital, Hamamatsu-shi, Shizuoka, 430-0929, Japan|Mildix Skin Clinic, Adachi-ku, Tokyo, 120-0034, Japan|Naoko Dermatology Clinic, Setagaya-ku, Tokyo, 158-0097, Japan|NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, 141-8625, Japan|Yamate Dermatology Clinic, Shinjuku-ku, Tokyo, 169-0075, Japan|Hospital Sultan Ismail, Johor Bahru, Johor, 81100, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, 30450, Malaysia|Hospital Pulau Pinang, Georgetown, Pinang, 10990, Malaysia|Queen Elizabeth Hospital, Kota Kinabalu, Sabah, 88586, Malaysia|Hospital Kuala Lumpur, Kuala Lumpur, Wilayah Persekutuan, 50586, Malaysia|Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Wilayah Persekutuan, 56000, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Wilayah Persekutuan, 59100, Malaysia|Bravis Ziekenhuis, Bergen op Zoom, 4624 VT, Netherlands|Universitair Medisch Centrum Groningen, Groningen, 9700 RB, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, 3584 CX, Netherlands|Dermapolis Medical Dermatology Center dr n med Edyta Gebska, Chorzow, 41-500, Poland|GynCentrum Spzoo NZOZ Holsamed - Oddzial Libero, Katowice, 40-600, Poland|Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy Marek Brzewski Pawel Brzewski SpCywilna, Krakow, 30-002, Poland|AppleTreeClinics Network Spzoo, Lodz, 90-349, Poland|Ip Clinic Sp zoo, Lodz, 90-752, Poland|Twoja Przychodnia Scm, Szczecin, 71-500, Poland|DermMedica Spzoo Centrum Columbus, Wroclaw, 51-503, Poland|Doctor Samuel Sanchez PSC, Caguas, 00727-9507, Puerto Rico|Theramed Healthcare SRL, Brasov, 500112, Romania|Institutul Regional de Gastroenterologie si Hepatologie Prof Dr Octavian Fodor, Cluj-Napoca, 400431, Romania|Spitalul Clinic Judetean Mures, Targu Mures, 540613, Romania|National University Hospital, Singapore, 117599, Singapore|Singapore General Hospital, Singapore, 168753, Singapore|National Skin Centre, Singapore, 308205, Singapore|Maxderm, sro, Bardejov, 085 01, Slovakia|Univerzitna nemocnica Bratislava - Nemocnica Stare Mesto, Bratislava, 813 69, Slovakia|Fakultna nemocnica s poliklinikou JA Reimana Presov, Presov, 081 81, Slovakia|Sanare spol sro, Svidnik, 089 01, Slovakia|Univerzitetni klinicni center Ljubljana, Ljubljana, 1000, Slovenia|Univerzitetni Klinicni Center Maribor, Maribor, 2000, Slovenia|Hospital Clinic i Provincial de Barcelona, Barcelona, CataluÃ±a, 08036, Spain|Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, 46014, Spain|Hospital Universitario Basurto, Bilbao, PaÃ­s Vasco, 48013, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Complexo Hospitalario Universitario de Pontevedra, Pontevedra, 36001, Spain|Inselspital Bern, Bern, 3010, Switzerland|Hopitaux Universitaires de Geneve, Geneve 14, 1211, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland|Kantonsspital Sankt Gallen, Sankt Gallen, 9007, Switzerland|Universitaetsspital Zuerich, Zuerich, 8091, Switzerland|Ankara Bilkent Sehir Hastanesi, Ankara, 06800, Turkey|Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul, 34390, Turkey|Acibadem Altunizade Hastanesi, Istanbul, 34662, Turkey|Marmara Universitesi Tip Fakultesi Hastanesi, Istanbul, 34899, Turkey|Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi, Samsun, 55200, Turkey|Royal United Hospitals Bath NHS Foundation Trust, Bath, BA1 3NG, United Kingdom|Russells Hall Hospital, Dudley, DY1 2HQ, United Kingdom|West Middlesex University Hospital, Isleworth, TW7 6AF, United Kingdom|The Royal Free Hospital, London, NW3 2PF, United Kingdom|Salford Royal Hospital, Salford, M6 8HD, United Kingdom|Accellacare Yorkshire, Shipley, BD18 3SA, United Kingdom","Study Director : MD , Amgen"
Atopic Dermatitis,NCT05394792,An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab,https://clinicaltrials.gov/study/NCT05394792,NO,Atopic Dermatitis,,ALL,"ADULT, OLDER_ADULT",,"Dermatology Research Institute Inc. /ID# 246344, Calgary, Alberta, T2J 7E1, Canada|Laser Rejuvenation Clinics Inc. /ID# 255303, Calgary, Alberta, T2W 4X9, Canada|Rejuvenation Dermatology Clinic Calgary North /ID# 255623, Calgary, Alberta, T3K 6B8, Canada|Laser Rejuvenation Clinics Edmonton D.T. Inc. /ID# 246298, Edmonton, Alberta, T5J 3S9, Canada|Stratica Medical /ID# 254940, Edmonton, Alberta, T5K 2V4, Canada|Rejuvaderm /ID# 255850, Edmonton, Alberta, T5N 1L5, Canada|Alpha Clinic Research Inc. /ID# 248015, Edmonton, Alberta, T6X 0N9, Canada|Dr. Chih-ho Hong Medical Inc. /ID# 246841, Surrey, British Columbia, V3R 6A7, Canada|Nova Scotia Health /ID# 248136, Halifax, Nova Scotia, B3H 1V7, Canada|Fiona Lovegrove Medicine Professional Corporation /ID# 255784, London, Ontario, N6A 5R9, Canada|Lynderm Research Inc. /ID# 246341, Markham, Ontario, L3P 1X3, Canada|Allergy Research Canada Inc. /ID# 251916, Niagara Falls, Ontario, L2H 1H5, Canada|SKiN Centre for Dermatology /ID# 246291, Peterborough, Ontario, K9J 5K2, Canada|York Dermatology Clinic and Research Centre /ID# 246921, Richmond Hill, Ontario, L4C 9M7, Canada|Canadian Dermatology Centre /ID# 246334, Toronto, Ontario, M3B 0A7, Canada|FACET Dermatology /ID# 254914, Toronto, Ontario, M4C 1L1, Canada|AvantDerm, Toronto, CA /ID# 250941, Toronto, Ontario, M5A 3R6, Canada|Evidence based medical educator Inc. /ID# 246687, Toronto, Ontario, M5G 1E2, Canada|Dr. Isabelle Delorme Inc. /ID# 246296, Drummondville, Quebec, J2B 5L4, Canada|Clinique D /ID# 247330, Laval, Quebec, H7N 6L2, Canada|Roula Rassi MD Inc /ID# 252563, Laval, Quebec, H7P 4K7, Canada|Centre de Recherche St-Louis /ID# 252223, Quebec City, Quebec, G1W 4R4, Canada|Diex Recherche QuÃ©bec Inc. /ID# 247696, QuÃ©bec, Quebec, G1V 4T3, Canada|Dre Angelique Gagne-Henley M.D. inc. /ID# 246457, Saint-Jerome, Quebec, J7Z 7E2, Canada|Sima Recherche inc. /ID# 248338, Verdun, Quebec, H4G 3E7, Canada","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT05442645,A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan,https://clinicaltrials.gov/study/NCT05442645,NO,Atopic Dermatitis,,ALL,"ADULT, OLDER_ADULT",,"Investigational site number TAIWAN, Taiwan, Taiwan",
Atopic Dermatitis,NCT06085521,A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06085521,NO,Atopic Dermatitis,DRUG: LNK01001 Dose A|DRUG: LNK01001 Dose B|DRUG: placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Jianzhong Zhang, Beijing, China","Principal Investigator : Jianzhong Zhang , Peking University People's Hospital"
Atopic Dermatitis,NCT03610386,Effects of an Anti-TRPM8 in the Atopic Dermatitis Pruritus,https://clinicaltrials.gov/study/NCT03610386,NO,Atopic Dermatitis,OTHER: Adding menthoxypropanediol to the biopsy|OTHER: No adding menthoxypropanediol to the biopsy,ALL,"ADULT, OLDER_ADULT",,"CHU Brest, Brest, France",Beiersdorf
Atopic Dermatitis,NCT04250350,Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04250350,YES,Atopic Dermatitis,BIOLOGICAL: Lebrikizumab,ALL,CHILD,PHASE3,"Pinnacle Research Group, Anniston, Alabama, 36207, United States|Arkansas Research Trials, LLC, North Little Rock, Arkansas, 72117, United States|Hope Clinical Research, Canoga Park, California, 91303, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|MD Studies, Fountain Valley, California, 92708, United States|Integrative Skin Science and Research, Sacramento, California, 95825, United States|University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology, San Diego, California, 92123, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|IMMUNOe International Research Centers, Centennial, Colorado, 80112, United States|C&R Research Services USA, Coral Gables, Florida, 33134, United States|Florida Academic Centers Research and Education, LLC, Coral Gables, Florida, 33134, United States|Pediatric Skin Research, LLC, Coral Gables, Florida, 33146, United States|Encore Medical Research, Hollywood, Florida, 33021, United States|Solutions Through Advanced Research, Inc., Jacksonville, Florida, 32256, United States|Well Pharma Medical Research Corp., Miami, Florida, 33143, United States|Sanchez Clinical Research Inc, Miami, Florida, 33157, United States|Miami Dermatology and Laser Research, Miami, Florida, 33173, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613-1244, United States|Georgia Pollens Clinical Research Centers, Inc, Albany, Georgia, 31707, United States|Advanced Medical Research, Sandy Springs, Georgia, 30328, United States|Georgia Skin & Cancer Clinic, Savannah, Georgia, 31419, United States|Northwestern University, Chicago, Illinois, 60611, United States|Sneeze, Wheeze, & Itch Associates LLC, Normal, Illinois, 61761, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|Kansas Medical Clinic, Topeka, Kansas, 66614, United States|Skin Sciences, PLLC, Louisville, Kentucky, 40217, United States|Tulane Univ School of Med, New Orleans, Louisiana, 70112, United States|Dermatology and Skin Cancer Specialists, Rockville, Maryland, 20850, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|St Joseph Dermatology and Vein Clinic, Saint Joseph, Michigan, 49085, United States|Central Dermatology PC, Saint Louis, Missouri, 63117, United States|ALLCUTIS Research, Portsmouth, New Hampshire, 03801, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|Advanced Asthma and Allergy, Watertown, New York, 13601, United States|Ohio Pediatric Research Association, Dayton, Ohio, 45414, United States|Central States Research, Tulsa, Oklahoma, 74136, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Paddington Testing Company Inc, Philadelphia, Pennsylvania, 19103, United States|Arlington Research Center, Inc, Arlington, Texas, 76011, United States|Encore Imaging & Medical Research, Houston, Texas, 77065, United States|Cutis Wellness Dermatology, Laredo, Texas, 78041, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Acclaim Dermatology, PLLC, Sugar Land, Texas, 77497, United States|Center for Clinical Studies, Webster, Texas, 77598, United States|PI-Coor Clinical Research, LLC, Burke, Virginia, 22015, United States|Virginia Clinical Research, Inc., Norfolk, Virginia, 23502, United States|Woden Dermatology, Phillip, Australian Capital Territory, 2606, Australia|The Skin Hospital, Sydney, New South Wales, 02010, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Royal Childrens Hospital Melbourne, Parkville, Victoria, 3052, Australia|Burswood Dermatology, Victoria Park, Western Australia, 06100, Australia|Captain Stirling Medical Centre, Nedlands, 6009, Australia|Institute for Skin Advancement, Calgary, Alberta, T3A 2N1, Canada|CARe Clinic, Red Deer, Alberta, T4N 6V7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Inc, Oakville, Ontario, L6J7W5, Canada|AvantDerm, Toronto, Ontario, M5A3R6, Canada|Dermoklinika Centrum Medyczne s.c. M. Kierstan J. Narbutt A. Lesiak, Lodz, Lodzkie, 90-436, Poland|Grazyna Pulka Specjalistyczny Osrodek ""ALL-MED"", Krakow, Malopolskie, 30-033, Poland|Diamond Clinic, Krakow, Malopolskie, 31-559, Poland|Centrum Medyczne Evimed, Warszawa, Mazowieckie, 02-625, Poland|Gabinet Dermatlogiczny. Beata Krecisz, Kielce, Swietokrzyskie, 25-155, Poland|Zespol Naukowo - Leczniczy ""Iwolang"" Sp. z o.o., Iwonicz Zdroj, Wojewodztwo Podkarpackie, 38-440, Poland|Provita Sp. z o.o, Katowice, 40-611, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie, Lublin, 20-081, Poland|CityClinic Przychodnia Lekarsko-Psychologiczna, Wroclaw, 50-566, Poland",
Atopic Dermatitis,NCT06487000,To Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate or Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06487000,NO,Atopic Dermatitis,DRUG: EC-18|DRUG: Placebo EC-18,ALL,"ADULT, OLDER_ADULT",PHASE2,,Enzychem Lifesciences Corporation
Atopic Dermatitis,NCT05601882,A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05601882,NO,Atopic Dermatitis,DRUG: Upadacitinib|DRUG: Dupilumab,ALL,"CHILD, ADULT",PHASE3,"Medical Dermatology Specialists /ID# 250212, Phoenix, Arizona, 85006, United States|Alliance Dermatology and MOHs Center, PC /ID# 249671, Phoenix, Arizona, 85032, United States|Clinical Trials Institute - Northwest Arkansas /ID# 249838, Fayetteville, Arkansas, 72703, United States|Arkansas Research Trials /ID# 250722, North Little Rock, Arkansas, 72217, United States|Joseph Raoof Md,Inc /Id# 250211, Encino, California, 91436, United States|First OC Dermatology /ID# 250686, Fountain Valley, California, 92708, United States|Antelope Valley Clinical Trials /ID# 249946, Lancaster, California, 93534, United States|Dermatology Research Associates /ID# 249829, Los Angeles, California, 90045, United States|University of California Davis Health /ID# 250044, Sacramento, California, 95817, United States|Clinical Trials Research Institute /ID# 250213, Thousand Oaks, California, 91320-2130, United States|Western States Clinical Res /ID# 250274, Wheat Ridge, Colorado, 80033-2896, United States|UConn Health /ID# 253807, Farmington, Connecticut, 06030, United States|Yale Center for Clinical Investigation /ID# 254791, New Haven, Connecticut, 06519, United States|Clearlyderm Dermatology /ID# 250457, Boca Raton, Florida, 33428, United States|Skin Care Research Boca Raton /ID# 250458, Boca Raton, Florida, 33486-2269, United States|Olympian Clinical Research /ID# 250453, Clearwater, Florida, 33756, United States|Skin Care Research - Hollywood /ID# 250459, Hollywood, Florida, 33021-6748, United States|Solutions Through Adv Rch /ID# 250455, Jacksonville, Florida, 32256, United States|GSI Clinical Research, LLC /ID# 250768, Margate, Florida, 33063, United States|Wellness Clinical Research - Miami Lakes /ID# 250236, Miami Lakes, Florida, 33016, United States|D&H National Research Centers /ID# 250734, Miami, Florida, 33155-3244, United States|Florida International Rsrch cr /ID# 249667, Miami, Florida, 33173, United States|Tory P Sullivan, MD PA /ID# 251136, North Miami Beach, Florida, 33162-4708, United States|Precision Clinical Research /ID# 250990, Sunrise, Florida, 33351-7311, United States|Advanced Clinical Research Institute /ID# 250460, Tampa, Florida, 33607, United States|Metabolic Research Inst /ID# 250046, West Palm Beach, Florida, 33401, United States|Treasure Valley Medical Research /ID# 250727, Boise, Idaho, 83706, United States|Dawes Fretzin, LLC /ID# 250276, Indianapolis, Indiana, 46256, United States|Randall Dermatology of West Lafayette /ID# 250234, West Lafayette, Indiana, 47906-1569, United States|Beth Israel Deaconess Medical Center /ID# 251212, Boston, Massachusetts, 02215-5400, United States|Beacon Clinical Research, LLC /ID# 251412, Quincy, Massachusetts, 02169, United States|Clarkston Dermatology /ID# 250225, Clarkston, Michigan, 48346, United States|Henry Ford Medical Center - New Center One /ID# 250228, Detroit, Michigan, 48202-3046, United States|Cleaver Dermatology /ID# 250725, Kirksville, Missouri, 63501-5362, United States|MediSearch Clinical Trials /ID# 250272, Saint Joseph, Missouri, 64506, United States|Duplicate_Allergy, Asthma & Immunology Associates, PC /ID# 250616, Lincoln, Nebraska, 68505-2343, United States|Physician Research Collaboration, LLC /ID# 251099, Lincoln, Nebraska, 68516, United States|Montefiore Medical Center - Moses Campus /ID# 251214, Bronx, New York, 10467, United States|Derm of Greater Columbus /ID# 250049, Bexley, Ohio, 43209-2422, United States|Univ Hosp Cleveland /ID# 250699, Cleveland, Ohio, 44106, United States|Wright State Physicians - Fairborn /ID# 254167, Fairborn, Ohio, 45324-2640, United States|Vital Prospects Clinical Research Institute, PC /ID# 249840, Tulsa, Oklahoma, 74136-7049, United States|Oregon Dermatology and Research Center /ID# 250726, Portland, Oregon, 97210, United States|Oregon Medical Research Center /ID# 249666, Portland, Oregon, 97223, United States|Oregon Medical Research Center /ID# 250712, Portland, Oregon, 97239, United States|University of Pittsburgh MC /ID# 251208, Pittsburgh, Pennsylvania, 15260, United States|Duplicate_Medical University of South Carolina /ID# 251218, Charleston, South Carolina, 29425-8903, United States|Health Concepts /ID# 250988, Rapid City, South Dakota, 57702, United States|International Clinical Research - Tennessee LLC /ID# 250724, Murfreesboro, Tennessee, 37130-2450, United States|Arlington Research Center, Inc /ID# 250468, Arlington, Texas, 76011, United States|Orion Clinical Research /ID# 250473, Austin, Texas, 78759-4100, United States|Bellaire Dermatology Associates /ID# 250739, Bellaire, Texas, 77401, United States|Modern Research Associates, PLLC /ID# 250688, Dallas, Texas, 75231, United States|Center for Clinical Studies - Houston - Northwest Freeway /ID# 250039, Houston, Texas, 77065, United States|Texas Dermatology and Laser Specialists /ID# 250367, San Antonio, Texas, 78218-3128, United States|University of Utah /ID# 250042, Murray, Utah, 84107, United States|University of Virginia - Dermatology /ID# 254166, Charlottesville, Virginia, 22903, United States|Virginia Clinical Research, Inc. /ID# 249908, Norfolk, Virginia, 23502, United States|Premier Specialist /ID# 250572, Kogarah, New South Wales, 2217, Australia|Veracity Clinical Research /ID# 249943, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute Inc /ID# 249938, Carlton, Victoria, 3053, Australia|Sinclair Dermatology - Melbourne /ID# 249937, East Melbourne, Victoria, 3002, Australia|Fremantle Dermatology /ID# 249941, Fremantle, Western Australia, 6160, Australia|Cliniques Universitaires UCL Saint-Luc /ID# 251403, Woluwe-Saint-Lambert, Bruxelles-Capitale, 1200, Belgium|Grand Hopital de Charleroi /ID# 251401, Charleroi, Hainaut, 6000, Belgium|Universitair Ziekenhuis Leuven /ID# 251399, Leuven, Vlaams-Brabant, 3000, Belgium|CHU de Liege /ID# 251400, Liege, 4000, Belgium|Diagnostic Consultative Center Aleksandrovska /ID# 251137, Sofiya, Sofia, 1431, Bulgaria|UMHAT Dr Georgi Stranski EAD /ID# 251268, Pleven, 5800, Bulgaria|DCC Pulmed AD /ID# 251271, Plovdiv, 4001, Bulgaria|ASMC-IPSMC-Skin and Venereal Diseases /ID# 251272, Sofia, 1407, Bulgaria|Medical center EuroHealth /ID# 251270, Sofia, 1606, Bulgaria|Military Medical Academy Multiprofile Hospital /ID# 251187, Sofia, 1606, Bulgaria|Diagnostic consultative center Focus-5 /ID# 251269, Sofiya, 1463, Bulgaria|Medical Center Euroderma /ID# 251267, Sofiya, 1606, Bulgaria|MC Zara-Med EOOD /ID# 251135, Stara Zagora, 6000, Bulgaria|Dermatology Research Institute - Blackfoot Trail /ID# 251642, Calgary, Alberta, T2J 7E1, Canada|Beacon Dermatology Inc /ID# 250336, Calgary, Alberta, T3A 2N1, Canada|Alberta DermaSurgery Centre /ID# 250217, Edmonton, Alberta, T6G 1C3, Canada|Dr. Chih-ho Hong Medical Inc. /ID# 251643, Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research /ID# 251645, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research /ID# 250219, Winnipeg, Manitoba, R3M 3Z4, Canada|Brunswick Dermatology Center /ID# 250220, Fredericton, New Brunswick, E3B 1G9, Canada|LEADER Research /ID# 251647, Hamilton, Ontario, L8L 3C3, Canada|DermEffects /ID# 250223, London, Ontario, N6H 5L5, Canada|Lynde Institute for Dermatology /ID# 251854, Markham, Ontario, L3P 1X2, Canada|DermEdge Research Inc. /ID# 250216, Mississauga, Ontario, L4Y 4C5, Canada|SKiN Centre for Dermatology /ID# 251853, Peterborough, Ontario, K9J 5K2, Canada|Toronto Dermatology Centre /ID# 252098, Toronto, Ontario, M3H 5Y8, Canada|Research Toronto /ID# 250222, Toronto, Ontario, M4W 2N4, Canada|Private Practice - Dr. Kim Papp Clinical Research /ID# 251644, Waterloo, Ontario, N2J 1C4, Canada|Centre de Recherche dermatologique du Quebec Metropolitain /ID# 250427, QuÃ©bec, Quebec, G1V 4X7, Canada|The First Affiliated Hospital Of Fujian Medical University /ID# 249674, Fuzhou, Fujian, 350005, China|Dermatology Hospital of Southern Medical University /ID# 250121, Guangzhou, Guangdong, 510091, China|Guangzhou First People's Hospital /ID# 249695, Guangzhou, Guangdong, 510180, China|The Second Affiliated Hospital of Guangzhou Medical University /ID# 249694, Guangzhou, Guangdong, 510260, China|The University of Hong Kong- Shenzhen Hospital /ID# 249436, Shenzhen, Guangdong, 518048, China|Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 251485, Wuhan, Hubei, 430022, China|The First Hospital of China Medical University /ID# 249638, Shenyang, Liaoning, 110001, China|Huashan Hospital, Fudan University /ID# 250025, Shanghai, Shanghai, 200040, China|Shanghai Skin Disease Hospital /ID# 249392, Shanghai, Shanghai, 200443, China|Tianjin Medical University General Hospital /ID# 250246, Tianjin, Tianjin, 300052, China|Hangzhou First People's Hospital /ID# 249437, Hangzhou, Zhejiang, 310003, China|The second affiliated hospital of Zhejiang University school of medicine /ID# 249655, Hangzhou, Zhejiang, 310009, China|Zhejiang Provincial People's Hospital /ID# 249653, Hangzhou, Zhejiang, 310014, China|The Second Xiangya Hospital of Central South University /ID# 249657, Changsha, 410011, China|DermaPlus - Poliklinika za dermatologiju i venerologiju /ID# 249591, Zagreb, Grad Zagreb, 10000, Croatia|Djecja bolnica Srebrnjak /ID# 249594, Zagreb, Grad Zagreb, 10000, Croatia|Klinicki bolnicki centar Zagreb /ID# 249596, Zagreb, Grad Zagreb, 10000, Croatia|Klinika za djecje bolesti Zagreb /ID# 249590, Zagreb, Grad Zagreb, 10000, Croatia|Klinicki bolnicki centar Rijeka /ID# 249593, Rijeka, Primorsko-goranska Zupanija, 51000, Croatia|Klinicki Bolnicki Centar (KBC) Split /ID# 249879, Split, Splitsko-dalmatinska Zupanija, 21000, Croatia|Poliklinika Solmed /ID# 252138, Grad Zagreb, 10000, Croatia|Bispebjerg and Frederiksberg Hospital /ID# 248902, Copenhagen NV, Hovedstaden, 2400, Denmark|Herlev and Gentofte Hospital /ID# 248900, Hellerup, Hovedstaden, 2900, Denmark|Aarhus Universitetshospital - Skejby /ID# 248899, Aarhus, Midtjylland, 8200, Denmark|Roskilde Sygehus /ID# 248901, Roskilde, SjÃ¦lland, 4000, Denmark|Hopital Saint Joseph /ID# 251053, Marseille, Bouches-du-Rhone, 13008, France|CHU de Nantes, Hotel Dieu -HME /ID# 251347, Nantes, Pays-de-la-Loire, 44000, France|HCL - Hopital Lyon Sud /ID# 251343, Pierre Benite CEDEX, Rhone, 69495, France|AP-HP - Hopital Saint-Louis /ID# 251052, Paris, 75010, France|HÃ´pital Charles-Nicolle /ID# 251055, Rouen, 76000, France|CHU Toulouse - Hopital Larrey /ID# 251344, Toulouse, 31400, France|Universitaetsklinikum Freiburg /ID# 249555, Freiburg, Baden-Wuerttemberg, 79106, Germany|Universitaetsklinik Heidelberg /ID# 251458, Heidelberg, Baden-Wuerttemberg, 69120, Germany|Universitaetsklinikum Tuebingen /ID# 249552, Tubingen, Baden-Wuerttemberg, 72076, Germany|Dermatologische Gemeinschaftspraxis Mahlow /ID# 250306, Blankenfelde-Mahlow, Brandenburg, 15831, Germany|Klinikum Darmstadt - Grafenstrasse /ID# 251391, Darmstadt, Hessen, 64283, Germany|Universitaetsklinikum Frankfurt /ID# 249544, Frankfurt am Main, Hessen, 60590, Germany|Studienzentrum an der Hase GbR Dr. Weyergraf/Dr. Frick/Thomas Heiber /ID# 251392, Bramsche, Niedersachsen, 49565, Germany|Universitaetsklinikum Muenster /ID# 249404, Muenster, Nordrhein-Westfalen, 48149, Germany|Universitaetsmedizin Mainz /ID# 249549, Mainz, Rheinland-Pfalz, 55131, Germany|Universitaetsklinikum Leipzig /ID# 249562, Leipzig, Sachsen, 04103, Germany|Universitaetsklinikum Schleswig-Holstein Campus Luebeck /ID# 249560, LÃ¼beck, Schleswig-Holstein, 23538, Germany|Fachklinik Bad Bentheim /ID# 249545, Bad Bentheim, 48455, Germany|Hautarztpraxis Dr. Niesmann und Dr. Othlinghaus /ID# 251566, Bochum, 44793, Germany|Universitaetsklinikum Bonn /ID# 250307, Bonn, 53127, Germany|Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 251844, Dresden, 01307, Germany|Derma Study Center Friedrichshafen GmbH /ID# 251460, Friedrichshafen, 88045, Germany|Universitaetsklinikum Hamburg-Eppendorf /ID# 249547, Hamburg, 20246, Germany|Dermatologikum Hamburg /ID# 251390, Hamburg, 20354, Germany|Klinikum rechts der Isar /ID# 249548, Munich, 81675, Germany|401 GSNA - 401 Army General Hospital /ID# 251843, Athens, Attiki, 11527, Greece|General Hospital Andreas Syggros /ID# 251842, Athens, Attiki, 16121, Greece|Papageorgiou General Hospital /ID# 251840, Thessaloniki, 56429, Greece|Debreceni Egyetem-Klinikai Kozpont /ID# 249849, Debrecen, Hajdu-Bihar, 4032, Hungary|Gyongyosi Bugat Pal Korhaz /ID# 251367, Gyongyos, Heves, 3200, Hungary|Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 249848, KaposvÃ¡r, Somogy, 7400, Hungary|Clinexpert Kft /ID# 249822, Budapest, 1033, Hungary|Semmelweis Egyetem /ID# 251368, Budapest, 1085, Hungary|UNO Medical Trials /ID# 249820, Budapest, 1135, Hungary|DERMA-B Egeszsegugyi es Szolgaltato - Debrecen - Gyepusor Utca /ID# 249819, Debrecen, 4031, Hungary|BÃ¡cs-Kiskun Megyei KÃ³rhÃ¡z Szegedi TudomÃ¡nyegyetem AOK OktatÃ³ KÃ³rhÃ¡za /ID# 249850, Kecskemet, 6000, Hungary|Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 250419, Pecs, 7624, Hungary|Szegedi TudomÃ¡nyegyetem /ID# 249818, Szeged, 6720, Hungary|Allergo-Derm Bakos Kft. /ID# 249821, Szolnok, 5000, Hungary|Hadassah Medical Center-Hebrew University /ID# 251576, Jerusalem, Yerushalayim, 91120, Israel|Rabin Medical Center /ID# 251578, Haifa, 4941492, Israel|Presidio Ospedaliero San Salvatore /ID# 250127, L'Aquila, L Aquila, 67100, Italy|Istituto Clinico Humanitas /ID# 251493, Rozzano, Milano, 20089, Italy|Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 250125, Rome, Roma, 00133, Italy|IRCCS Istituti Fisioterapici Ospitalieri-Istituto Dermatologico San Gallicano /ID# 250558, Rome, Roma, 00144, Italy|Azienda Ospedaliera di Perugia /ID# 251572, Perugia, Umbria, 06129, Italy|ASST Spedali civili di Brescia /ID# 250129, Brescia, 25123, Italy|CAST - Center for Advanced Studies and Technology /ID# 251495, Chieti, 66100, Italy|Ospedale Piero Palagi /ID# 250206, Florence, 50122, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 250123, Milan, 20122, Italy|Azienda Ospedaliero-Universitaria di Modena /ID# 250128, Modena, 41124, Italy|Azienda Ospedaliero Universitaria Pisana /ID# 250124, Pisa, 56126, Italy|Fondazione Policlinico Universitario Agostino Gemelli /ID# 251494, Roma, 00168, Italy|Medical Corporation Kojinkai Sapporo Skin Clinic /ID# 252549, Sapporo-shi, Hokkaido, 060-0063, Japan|Medical corporation Kojunkai Kosugi Dermatology Clinic /ID# 252554, Kawasaki-shi, Kanagawa, 211-0063, Japan|National Hospital Organization Sagamihara National Hospital /ID# 254518, Sagamihara-shi, Kanagawa, 252-0392, Japan|Queen's Square Medical Center, Dermatology and Allergology /ID# 252551, Yokohama-shi, Kanagawa, 220-6208, Japan|Osaka Habikino Medical Center /ID# 252550, Habikino-shi, Osaka, 583-8588, Japan|Dermatology and Ophthalmology Kume Clinic /ID# 254570, Sakai-shi, Osaka, 5938324, Japan|Naoko Dermatology Clinic /ID# 254571, Setagaya-ku, Tokyo, 158-0097, Japan|Kyungpook National University Hospital /ID# 249855, ì¤‘êµ¬, Daegu Gwang Yeogsi, 41944, Korea, Republic of|Korea University Ansan Hospital /ID# 249814, Ansan-si, Gyeonggido, 15355, Korea, Republic of|Soon Chun Hyang University Hospital Bucheon /ID# 249812, Bucheon-si, Gyeonggido, 14584, Korea, Republic of|Chungang University Hospital /ID# 251490, Dongjak-gu, Gyeonggido, 06973, Korea, Republic of|Ajou University Hospital /ID# 251491, Suwon-si, Gyeonggido, 16499, Korea, Republic of|Konkuk University Medical Center /ID# 249811, Seoul, Seoul Teugbyeolsi, 05030, Korea, Republic of|Pusan National University Hospital /ID# 249852, Busan, 49241, Korea, Republic of|Seoul National University Hospital /ID# 251492, Seoul, 03080, Korea, Republic of|Eukarya PharmaSite, SC /ID# 249702, Monterrey, Nuevo Leon, 64718, Mexico|Cryptex Investigacion Clinica S.A de C.V /ID# 249994, Mexico City, 06100, Mexico|Centro de Dermatologia de Monterrey /ID# 249126, Monterrey, 64640, Mexico|Clinical Research Institute SC /ID# 249647, Tlalnepantla de Baz, 54055, Mexico|ArkÃ© Estudios Clinicos Veracruz /ID# 250147, Veracruz, 91910, Mexico|Bravis Ziekenhuis /ID# 251395, Bergen op Zoom, Noord-Brabant, 4624 VT, Netherlands|Academisch Medisch Centrum /ID# 251397, Amsterdam, Noord-Holland, 1105 AZ, Netherlands|Nasz Lekarz Przychodnie Medyczne /ID# 251433, Torun, Kujawsko-pomorskie, 87-100, Poland|Dermed Centrum Medyczne Sp. z o.o /ID# 251429, Lodz, Lodzkie, 90-265, Poland|Lidia Rajzer - Specjalistyczny Gabinet Dermatologiczno-Kosmetyczny /ID# 252082, Cracow, Malopolskie, 30-438, Poland|Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o. /ID# 251437, Krakow, Malopolskie, 31-011, Poland|Royalderm Agnieszka Nawrocka /ID# 251432, Warsaw, Mazowieckie, 02-962, Poland|Klinika Ambroziak Sp. z o.o. /ID# 249406, Warszawa, Mazowieckie, 02-953, Poland|Bodyclinic Sp. z o.o. sp.k. /ID# 249599, Warszawa, Mazowieckie, 03-712, Poland|Zespol Naukowo-Leczniczy Iwolang Dermatologiczne Centrum Uzdrowiskowe Sp. z o.o /ID# 249598, Iwonicz-ZdrÃ³j, Podkarpackie, 38-440, Poland|INTER CLINIC Piotr Adrian Klimiuk /ID# 251430, Bialystok, Podlaskie, 15-077, Poland|Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 251431, Gdansk, Pomorskie, 80-546, Poland|Centrum Kliniczno-Badawcze J.Brzezicki, B. Gornikiewicz-Brzezicka Lekarze Spolka /ID# 251438, Elblag, Warminsko-mazurskie, 82-300, Poland|Solumed Centrum Medyczne /ID# 249641, Poznan, Wielkopolskie, 60-529, Poland|Centrum Medyczne ALL-MED Badania Kliniczne /ID# 249630, Cracow, 30-033, Poland|Hospital da Senhora da Oliveira Guimaraes, EPE /ID# 249196, Guimaraes, Braga, 4835-044, Portugal|Hospital Garcia de Orta /ID# 251455, Almada, Setubal, 2805-267, Portugal|2CA-Braga, Hospital de Braga /ID# 250480, Braga, 4710-243, Portugal|Unidade Local de Saude da Regiao de Leiria, EPE /ID# 249194, Leiria, 2410-197, Portugal|Hospital CUF Descobertas /ID# 249193, Lisboa, 1998-018, Portugal|Centro Hospitalar de Lisboa Central /ID# 249195, Lisbon, 1169-050, Portugal|Unidade Local de SaÃºde de Matosinhos, EPE /ID# 249197, Matosinhos, 4464-513, Portugal|Centro Hospitalar Universitario do Porto, EPE - Hospital Santo Antonio /ID# 249191, Porto, 4099-001, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 249192, Porto, 4200-319, Portugal|Dr. Samuel Sanchez PSC /ID# 250389, Caguas, 00727, Puerto Rico|Alma M. Cruz Santana, MD-Private practice /ID# 250393, Carolina, 00985, Puerto Rico|Clinical Research Puerto Rico /ID# 250394, San Juan, 00909-1711, Puerto Rico|GCM Medical Group PSC /ID# 250391, San Juan, 00917-3104, Puerto Rico|Bio Terra Med SRL /ID# 249624, Bucharest, Bucuresti, 010701, Romania|Private Practice - Dr. Orasan Remus /ID# 249625, Cluj Napoca, Cluj, 400006, Romania|Derma therapy spol /ID# 249783, Bratislava, Bratislavsky Kraj, 851 01, Slovakia|Poliklinika Bezrucova (Cliniq s.r.o.) /ID# 249746, Bratislava, 811 09, Slovakia|BeneDerma s.r.o. /ID# 251791, Bratislava, 841 04, Slovakia|University of Pretoria /ID# 250208, Pretoria, Gauteng, 0001, South Africa|About Allergy /ID# 249697, Pretoria, Gauteng, 0181, South Africa|Highway Medical Centre /ID# 250103, Durban, Kwazulu-Natal, 3630, South Africa|Spoke Research Inc /ID# 250091, CAPE TOWN Milnerton, Western Cape, 7441, South Africa|Allergy & Immunology (AIU) /ID# 249619, Cape Town, Western Cape, 7700, South Africa|Hospital Universitario Germans Trias i Pujol /ID# 251523, Badalona, Barcelona, 08916, Spain|Hospital Sant Joan de Deu /ID# 249602, Esplugues de Llobregat, Barcelona, 08950, Spain|Hospital Universitario Basurto /ID# 249784, Bilbao, Vizcaya, 48013, Spain|Hospital General Universitario de Alicante Doctor Balmis /ID# 251517, Alicante, 03010, Spain|Hospital Universitario Virgen de las Nieves /ID# 249785, Granada, 18014, Spain|Hospital Universitario La Paz /ID# 251518, Madrid, 28046, Spain|Hospital Universitario Virgen Macarena /ID# 249603, Sevilla, 41009, Spain|Hospital Universitario y Politecnico La Fe /ID# 251524, Valencia, 46026, Spain|Skane University hospital /ID# 250332, Malmo, Skane Lan, 214 28, Sweden|Karolinska University Hospital Solna /ID# 250328, Solna, Stockholms Lan, 171 64, Sweden|Norrlands University hospital /ID# 250329, Umea, Vasterbottens Lan, 581 85, Sweden|Malarsjukhuset /ID# 251908, Eskilstuna, 633 49, Sweden|Kantonsspital St. Gallen /ID# 250606, St. Gallen, Sankt Gallen, 9007, Switzerland|Inselspital, Universitaetsspital Bern /ID# 250577, Bern, 3010, Switzerland|Kaohsiung Chang Gung Memorial Hospital /ID# 249260, Kaohsiung City, Kaohsiung, 833, Taiwan|Mackay Memorial Hospital /ID# 249259, Taipei City, Taipei, 104217, Taiwan|National Taiwan University Hospital - Hsinchu branch /ID# 249265, Hsinchu City, 30059, Taiwan|Taipei Medical University Shuang Ho Hospital /ID# 249256, New Taipei City, 23561, Taiwan|Taichung Veterans General Hospital /ID# 249261, Taichung, 40705, Taiwan|National Taiwan University Hospital /ID# 249258, Taipei City, 100, Taiwan|Taipei Veterans General Hosp /ID# 249263, Taipei, 11217, Taiwan|Taipei Municipal Wan Fang Hospital /ID# 251500, Taipei, 116, Taiwan|Linkou Chang Gung Memorial Hospital /ID# 249257, Taoyuan City, 333, Taiwan|Ankara City Hospital /ID# 249870, Ankara, 06800, Turkey|Akdeniz Universitesi Tip Fakul /ID# 249866, Antalya, 07059, Turkey|Uludag University Medical Faculty /ID# 249864, Bursa, 16059, Turkey|Gaziantep Universitesi /ID# 249868, Gaziantep, 27310, Turkey|Erciyes University Medical Faculty /ID# 249863, Kayseri, 38039, Turkey|Ondokuz Mayis Universitesi Tip /ID# 249865, Samsun, 55139, Turkey","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT06192563,A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment,https://clinicaltrials.gov/study/NCT06192563,NO,Dermatitis Atopic,DRUG: Dupilumab,ALL,CHILD,,"Investigational Site Number: 002, Bologna, 40138, Italy|Investigational Site Number: 006, Brescia, 25123, Italy|Investigational Site Number: 004, Firenze, 50139, Italy|Investigational Site Number: 001, Milano, 20122, Italy|Investigational Site Number: 010, Napoli, 80131, Italy|Investigational Site Number: 011, Napoli, 80138, Italy|Investigational Site Number: 005, Roma, 00133, Italy|Investigational Site Number: 009, Roma, 00168, Italy|Investigational Site Number: 014, Verona, 37134, Italy","Study Director : Clinical Sciences & Operations , Sanofi"
Atopic Dermatitis,NCT06463353,Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT06463353,NO,Atopic Dermatitis,OTHER: trilinolein cream group|OTHER: cream base group,ALL,"CHILD, ADULT, OLDER_ADULT",,,
Atopic Dermatitis,NCT04686955,The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine,https://clinicaltrials.gov/study/NCT04686955,NO,Atopic Dermatitis,DRUG: Xiao-Xian-Gui-Fu-Tang,ALL,"CHILD, ADULT",,"Center for Traditional Medicine, Taipei VGH, Taipei, 11217, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan","Principal Investigator : Fang-Pey Chen, MD , Center for Traditional Medicine, Taipei Veterans General Hospital"
Atopic Dermatitis,NCT02889081,Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD),https://clinicaltrials.gov/study/NCT02889081,NO,Atopic Dermatitis,OTHER: maternal biological folate level|OTHER: maternal biological Vitamin D level,ALL,"CHILD, ADULT, OLDER_ADULT",,"Children Hospital of Fudan University, Shanghai, 201102, China","Principal Investigator : Guoying Huang, MD,PhD , Children's Hospital of Fudan University"
Atopic Dermatitis,NCT03843437,Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT03843437,NO,Atopic Dermatitis,DEVICE: Tencel Therapeutic Garments|DEVICE: Cotton Therapeutic Garments,ALL,CHILD,,"Johns Hopkins Pediatric Dermatology Clinic, Baltimore, Maryland, 21287, United States","Principal Investigator : Annie Grossberg, MD , Johns Hopkins University"
Atopic Dermatitis,NCT06058156,Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06058156,NO,Atopic Dermatitis,DRUG: SAR444656 (KT-474)|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Clear Dermatology & Aesthetics Center Site Number: 8400003, Scottsdale, Arizona, 85255-4140, United States|Encore Medical Research Site Number: 8400002, Boynton Beach, Florida, 33436-7245, United States|Encore Medical Research Site Number: 8400004, Hollywood, Florida, 33021-6467, United States|Tory Sullivan, MD, PA Site Number: 8400001, North Miami Beach, Florida, 33162-4708, United States|Encore Medical Research Site Number: 8400008, Weston, Florida, 33331-3643, United States|Revival Research Corporation Site Number: 8400007, Troy, Michigan, 48084-3536, United States|Investigational Site Number : 2760007, Heidelberg, Baden-WÃ¼rttemberg, 69120, Germany|Investigational Site Number : 2760009, MÃ¼nchen, Bayern, 80337, Germany|Investigational Site Number : 2760008, Frankfurt am Main, Hessen, 60590, Germany|Investigational Site Number : 2760002, Buxtehude, Niedersachsen, 21614, Germany|Investigational Site Number : 2760003, Bochum, Nordrhein-Westfalen, 44791, Germany|Investigational Site Number: 2760006, Remscheid, Nordrhein-Westfalen, 42897, Germany|Investigational Site Number : 2760010, Dessau-RoÃŸlau, Sachsen-Anhalt, 6847, Germany|Investigational Site Number : 2760001, Berlin, 1011, Germany|Investigational Site Number : 3000001, Pavlos Melas, Thessaloniki, 564 29, Greece|Investigational Site Number : 3000002, Thessaloniki, 546 43, Greece|Investigational Site Number : 6160002, Wroclaw, DolnoÅ›lÄ…skie, 50-566, Poland|Investigational Site Number : 6160001, LÃ³dz, LÃ³dzkie, 90-436, Poland|Investigational Site Number : 6160007, Warszawa, Mazowieckie, 00-874, Poland|Investigational Site Number: 6160005, Warszawa, Mazowieckie, 02-953, Poland|Investigational Site Number : 6160006, TarnÃ³w, MaÅ‚opolskie, 33-100, Poland|Investigational Site Number: 6160003, Chojnice, Pomorskie, 89-600, Poland|Investigational Site Number: 6160004, Gdansk, Pomorskie, 80-546, Poland","Kymera Therapeutics, Inc."
Atopic Dermatitis,NCT05285839,Dupixent and Narrowband UVB for Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05285839,NO,Atopic Dermatitis,DRUG: Dupixent,ALL,"ADULT, OLDER_ADULT",PHASE4,"Eczema Treatment Center of New Jersey, East Windsor, New Jersey, 08520, United States",Regeneron Pharmaceuticals
Atopic Dermatitis,NCT04352270,Clinic-Based Atopic Dermatitis Therapeutic Patient Education,https://clinicaltrials.gov/study/NCT04352270,NO,Atopic Dermatitis,OTHER: AD printed educational materials|OTHER: AD educational videos,ALL,CHILD,,"BMC Pediatric Dermatology Clinics, Boston, Massachusetts, 02118, United States","Principal Investigator : Margaret Lee, MD PhD , Boston University"
Atopic Dermatitis,NCT05613062,Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children,https://clinicaltrials.gov/study/NCT05613062,NO,Atopic Dermatitis,DRUG: Modified Huang-Lian-Jie-Du Decoction (MHLJDD)|DRUG: Placebo,ALL,CHILD,PHASE1|PHASE2,"School of Chinese Medicine, Hong Kong, Hong Kong","Principal Investigator : Zhixiu Lin , Integrative Medical Centre"
Atopic Dermatitis,NCT05200403,Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05200403,NO,Atopic Dermatitis,DRUG: Crisaborole 2%|DRUG: Vehicle treatment|DEVICE: Accelerometry device for children|DEVICE: Accelerometry device for adult caregivers,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"BU CAMed Laboratory for Human Neurobiology, Boston, Massachusetts, 02118, United States","Principal Investigator : Kevin C Thomas, PhD , BU School of Medicine, Anatomy and Neurobiology"
Atopic Dermatitis,NCT06009094,"Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06009094,NO,Atopic Dermatitis,DRUG: VC005|DRUG: VC005 Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1,"Chinese Academy of Medical Sciences Hospital of Skin Disease, Nanjing, Jiangsu, China","Principal Investigator : Qianjin Lu , Chinese Academy of Medical Sciences Hospital of Skin Disease"
Atopic Dermatitis,NCT06421740,An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China,https://clinicaltrials.gov/study/NCT06421740,NO,Atopic Dermatitis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 264193, Beijing, Beijing, 100730, China|The First Affiliated Hospital Of Fujian Medical University /ID# 268210, Fuzhou, Fujian, 350005, China|Changgeng Hospital /ID# 268209, Xiamen, Fujian, 361022, China|The Affiliated Hospital of Xuzhou Medical College /ID# 268208, Xuzhou, Jiangsu, 221006, China|The People's Hospital of Liaoning Province /ID# 268206, Shenyang, Liaoning, 110016, China|Sichuan Provincial People's Hospital /ID# 268314, Chengdu, Sichuan, 610072, China|The Affiliated Hospital Of Southwest Medical University /ID# 268207, Sichuan, Sichuan, 646000, China|Taizhou Central Hospital /ID# 268211, Taizhou, Zhejiang, 318000, China","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT02779426,Texting Atopic Dermatitis Patients to Optimize Learning and EASI Scores,https://clinicaltrials.gov/study/NCT02779426,NO,Atopic Dermatitis,BEHAVIORAL: Text messages,ALL,CHILD,,"Columbia University Medical Center, Department of Dermatology, New York, New York, 10032, United States","Principal Investigator : Christine Lauren, MD , Columbia University"
Atopic Dermatitis,NCT06101823,Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06101823,NO,Atopic Dermatitis,BIOLOGICAL: OpSCF|BIOLOGICAL: Placebo|BIOLOGICAL: OpSCF (Open Label Extension),ALL,"ADULT, OLDER_ADULT",PHASE2,"Cahaba Dermatology & Skin Health Center, Birmingham, Alabama, 33607, United States|First OC Dermatology Research, Fountain Valley, California, 92708, United States|Axon Clinical Research, Inglewood, California, 90301, United States|University Clinical Trials, San Diego, California, 92123, United States|Unison Clinical Trials, Sherman Oaks, California, 91403, United States|Skin Care Research, Boca Raton, Florida, 33456, United States|RM Medical Research, Miami Lakes, Florida, 33014, United States|Skin Research of South Florida, Miami, Florida, 33173, United States|Advanced Clinical Research Institute, Tampa, Florida, 33607, United States|Arlington Dermatology, Rolling Meadows, Illinois, 60008, United States|Options Research Group, West Lafayette, Indiana, 47906, United States|DS Research of Kentucky, Louisville, Kentucky, 40241, United States|Oakland Hills Dermatology P.C, Auburn Hills, Michigan, 48326, United States|Saginaw Bay Dermatology, Bay City, Michigan, 48706, United States|Skin Cancer and Dermatology Institute, Reno, Nevada, 89509, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|Rodgers Dermatology, Frisco, Texas, 75034, United States|Dermatology Of Seattle, Bellevue, Washington, 98004, United States|Oshawa Clinic Dermatology Trials, Oshawa, Ontario, L1H 1B9, Canada|Research Toronto, Toronto, Ontario, M4W 2N2, Canada|Innovaderm Research Inc, MontrÃ©al, Quebec, H2X 2V1, Canada|Centre de Recherche Saint-Louis, QuÃ©bec City, Quebec, G1W 4R4, Canada","Study Director : Martin Phillips , Opsidio, LLC"
Atopic Dermatitis,NCT04706559,Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04706559,NO,Atopic Dermatitis,"DRUG: Probiotic sachet containing mixture of four strains i.e.Lactobacillus rhamnosus, Lactobacillus acidophilus, Bifidobacterium longum, and Saccharomyces boulardii|DRUG: Conventional treatment",ALL,CHILD,,"B.P. Koirala Institute of Health Sciences, DharÄn BÄzÄr, 7053, Nepal",Nepal Health Research Council
Atopic Dermatitis,NCT04250337,Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT04250337,YES,Atopic Dermatitis,BIOLOGICAL: Lebrikizumab|OTHER: Placebo|OTHER: Topical Corticosteroid,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Investigate MD, Scottsdale, Arizona, 85255, United States|Orange County Research Institute, Anaheim, California, 92801, United States|Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, California, 93309, United States|Wallace Medical Group, Inc., Beverly Hills, California, 90211, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Center For Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|California Allergy and Asthma Medical Group + Research Center, Los Angeles, California, 90025, United States|Keck School of Medicine University of Southern California, Los Angeles, California, 90033, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|LA Universal Research Center, INC, Los Angeles, California, 90057, United States|ACRC Studies, San Diego, California, 92119, United States|University Clinical Trials, Inc., San Diego, California, 92123, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|Foxhall Dermatology, Washington, District of Columbia, 20016, United States|St. Francis Medical Institute, Clearwater, Florida, 33765, United States|University of Florida - Gainesville, Gainesville, Florida, 32606, United States|Direct Helpers Medical Center, Hialeah, Florida, 33012, United States|The Community Research of South Florida, Hialeah, Florida, 33016, United States|GSI Clinical Research, LLC, Margate, Florida, 33063, United States|Vitae Research Center, LLC, Miami, Florida, 33135, United States|Well Pharma Medical Research Corp., Miami, Florida, 33143, United States|ForCare Clinical Research, Tampa, Florida, 33613-1244, United States|Advanced Medical Research, Sandy Springs, Georgia, 30328, United States|The Indiana Clinical Trials Center, Plainfield, Indiana, 46168, United States|Dermatology and Skin Cancer Specialists, Rockville, Maryland, 20850, United States|ActivMed Practices and Research, Beverly, Massachusetts, 01915, United States|Beacon Clinical Research LLC, Quincy, Massachusetts, 02169, United States|Fivenson Dermatology, Ann Arbor, Michigan, 48103, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|ALLCUTIS Research, Portsmouth, New Hampshire, 03801, United States|Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey, 08520, United States|Sadick Research Group, New York, New York, 10075, United States|OnSite Clinical Solutions, Charlotte, North Carolina, 28277, United States|Wilmington Dermatology Center, Wilmington, North Carolina, 28405, United States|Clinical Research Institute, Medford, Oregon, 97504, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|OHSU Center for Health and Healing, Portland, Oregon, 97239, United States|Clinical Partners, LLC, Johnston, Rhode Island, 02919, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Arlington Research Center, Inc, Arlington, Texas, 76011, United States|Dermatology Treatment and Research Center, Dallas, Texas, 75230, United States|CARe Clinic, Red Deer, Alberta, T4N 6V7, Canada|Dr. Chih-ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|International Dermatology Research, Montreal, Quebec, H3H1V4, Canada|Klinikum der Johann Wolfgang Goethe-UniversitÃ¤t Frankfurt, Frankfurt am Main, Hessen, 60590, Germany|Elbe Klinikum Buxtehude, Buxtehude, Lower Saxony, 21614, Germany|Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus - Klinik und Poliklinik fuer, Dresden, Saxony, 01307, Germany|Praxis fÃ¼r Ganzheitliche Dermatologie im Ã„rztehaus, Berlin, 13055, Germany|TFS Trial Form Support GmbH, Hamburg, 20537, Germany|DermMEDICA Sp. z o.o., Wroclaw, Dolnoslaskie, 51-318, Poland|Alergo-Med Specjalistyczna Przychodnia Lekarska Sp Z O.O., Tarnow, Malopolska, 33100, Poland|Kliniczny Szpital Wojewodzki nr. 1 Klinika Dermatologii, Rzeszow, Podkarpackie, 35-055, Poland|COPERNICUS Podmiot Leczniczy sp. z o.o., Gdansk, Pomorskie, 80-219, Poland|Labderm s.c., Ossy, Slaskie, 42-624, Poland|Gabinet Dermatlogiczny. Beata Krecisz, Kielce, Swietokrzyskie, 25-155, Poland|Clinica Vitae Sp. z o.o., Gdansk, Woj. Pomorskie, 80-405, Poland|Clinical Research Group Sp. z o.o., Warszawa, 01-142, Poland|Centralny Szpital Kliniczny MSWiA, Warszawa, 02-507, Poland","Study Director : Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) , Eli Lilly and Company"
Atopic Dermatitis,NCT06397911,"Evaluate Efficacy, Pharmacokinetics, and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06397911,NO,Atopic Dermatitis,DRUG: FB825|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Principal Investigator : Chia-Yu Chu , Department of Dermatology National Taiwan University Hospital"
Atopic Dermatitis,NCT03921411,A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT03921411,YES,Atopic Dermatitis,BIOLOGICAL: Nemolizumab,ALL,CHILD,PHASE2,"Galderma Investigational Site, Fountain Valley, California, 92708, United States|Galderma Investigational Site, Fremont, California, 94538, United States|Galderma Investigational Site, Jacksonville, Florida, 32256, United States|Galderma Investigational Site, Tampa, Florida, 33607, United States|Galderma Investigational Site, Columbus, Georgia, 31904, United States|Galderma Investigational Site, Sandy Springs, Georgia, 30128, United States|Galderma Investigational Site, Gresham, Oregon, 97030, United States|Galderma Investigational Site, Dallas, Texas, 75230-5806, United States|Galderma Investigational Site, Frisco, Texas, 75034, United States|Galderma Investigational Site, Richmond, Virginia, 23220, United States",
Atopic Dermatitis,NCT04195698,Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04195698,NO,Atopic Dermatitis,DRUG: Upadacitinib,ALL,"ADULT, OLDER_ADULT",PHASE3,"University of Arkansas for Medical Sciences /ID# 221021, Little Rock, Arkansas, 72205, United States|First OC Dermatology Research Inc /ID# 218619, Fountain Valley, California, 92708-3701, United States|UCSF Fresno /ID# 218453, Fresno, California, 93701-2302, United States|California Allergy and Asthma Medical Group /ID# 218635, Los Angeles, California, 90025-7014, United States|Dermatology Research Associates /ID# 218637, Los Angeles, California, 90045, United States|Dermatology Clinical Trials /ID# 218627, Newport Beach, California, 92660-7853, United States|UC Davis Health /ID# 218582, Sacramento, California, 95816-3300, United States|Ucsd /Id# 218629, San Diego, California, 92103, United States|Clinical Science Institute /ID# 218632, Santa Monica, California, 90404-2102, United States|Miami Dermatology and Laser Institute /ID# 218664, Miami, Florida, 33173-3570, United States|Florida International Rsrch cr /ID# 218663, Miami, Florida, 33173, United States|GCP Research /ID# 218665, Saint Petersburg, Florida, 33705, United States|Clinical Research Trials of Florida, Inc. /ID# 218438, Tampa, Florida, 33607, United States|Georgia Pollens Clinical Research Centers, Inc /ID# 218441, Albany, Georgia, 31707-1282, United States|Medical Dermatology Associates of Chicago /ID# 218551, Chicago, Illinois, 60654-6903, United States|Sneeze, Wheeze, & Itch Associates, LLC /ID# 218552, Normal, Illinois, 61761, United States|Dawes Fretzin, LLC /ID# 218478, Indianapolis, Indiana, 46256, United States|Beacon Clinical Research, LLC /ID# 218636, Quincy, Massachusetts, 02169, United States|Michigan Center for Research Company /ID# 218577, Clarkston, Michigan, 48346, United States|Henry Ford Medical Center /ID# 218575, Detroit, Michigan, 48202-3046, United States|Duplicate_Allergy, Asthma & Immunology Associates, PC /ID# 218548, Lincoln, Nebraska, 68505-2343, United States|Skin Specialists, PC /ID# 218549, Omaha, Nebraska, 68144, United States|University Hospitals Case Medical Center /ID# 218574, Cleveland, Ohio, 44106, United States|Southside Dermatology /ID# 218477, Tulsa, Oklahoma, 74132, United States|Oregon Medical Res Center PC /ID# 218440, Portland, Oregon, 97223, United States|Oregon Medical Research Center /ID# 218578, Portland, Oregon, 97239, United States|Medical University of South Carolina /ID# 221072, Charleston, South Carolina, 29425, United States|Clinical Research Solutions, LLC /ID# 218447, Jackson, Tennessee, 38305-2163, United States|Orion Clinical Research /ID# 218565, Austin, Texas, 78759-4100, United States|Sante Clinical Research /ID# 218911, Kerrville, Texas, 78028-9640, United States|Clinical Research Partners, LLC /ID# 218480, Richmond, Virginia, 23220-4459, United States|Premier Clinical Research /ID# 218583, Spokane, Washington, 99202, United States|West Virginia Research Inst /ID# 218479, South Charleston, West Virginia, 25309, United States|Holdsworth House Medical Practice /ID# 218755, Darlinghurst, New South Wales, 2010, Australia|The Skin Hospital /ID# 218753, Darlinghurst, New South Wales, 2010, Australia|Veracity Clinical Research /ID# 218754, Woolloongabba, Queensland, 4102, Australia|Sinclair Dermatology /ID# 218751, East Melbourne, Victoria, 3002, Australia|Burswood Dermatology /ID# 218752, Victoria Park, Western Australia, 6100, Australia|Kirk Barber Research, CA /ID# 218727, Calgary, Alberta, T2G 1B1, Canada|Dermatology Research Institute Inc. /ID# 218728, Calgary, Alberta, T2J 7E1, Canada|Dr. Chih-ho Hong Medical Inc. /ID# 218725, Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research /ID# 218726, Surrey, British Columbia, V3V 0C6, Canada|Dr. Wei Jing Loo Medicine Prof /ID# 218722, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc. /ID# 218723, Markham, Ontario, L3P 1X2, Canada|DermEdge Research Inc. /ID# 218721, Mississauga, Ontario, L4Y 4C5, Canada|North York Research Inc /ID# 218729, Toronto, Ontario, M2N 3A6, Canada|K. Papp Clinical Research /ID# 218730, Waterloo, Ontario, N2J 1C4, Canada|Dre Angelique Gagne-Henley M.D. inc. /ID# 218724, Saint-Jerome, Quebec, J7Z 7E2, Canada|DermaPlus - Poliklinika za dermatologiju i venerologiju /ID# 218377, Zagreb, Grad Zagreb, 10000, Croatia|Klinicki bolnicki centar Zagreb /ID# 218375, Zagreb, Grad Zagreb, 10000, Croatia|Naftalan - Specijalna bolnica za medicinsku rehabilitaciju /ID# 218376, Ivanic-Grad, Zagrebacka Zupanija, 10310, Croatia|Fakultni nemocnice Hradec Kralove /ID# 214176, Hradec Kralove, 500 05, Czechia|Nemocnice Jihlava, prispevkova organizace /ID# 214178, Jihlava, 586 01, Czechia|Fakultni nemocnice Ostrava /ID# 214177, Ostrava, 708 52, Czechia|Fakultni Nemocnice v Motole /ID# 214179, Praha, 150 06, Czechia|Keski-pohjanmaa Central Hospital /ID# 214630, Kokkola, Keski-Pohjanmaa, 67200, Finland|Oulun yliopistollinen sairaala /ID# 214628, Oulu, Pohjois-Pohjanmaa, 90220, Finland|Mikkeli Central Hospital /ID# 214629, Mikkeli, 50100, Finland|AP-HM - Hopital de la Timone /ID# 218957, Marseille CEDEX 05, Bouches-du-Rhone, 13385, France|Polyclinique Courlancy /ID# 218955, Reims, Marne, 51100, France|CHU de Nantes, Hotel Dieu -HME /ID# 218959, Nantes, Pays-de-la-Loire, 44000, France|HÃ´pital Charles-Nicolle /ID# 218960, Rouen, 76000, France|CHU Toulouse - Hopital Larrey /ID# 218958, Toulouse, 31400, France|Universitaetsklinikum Frankfurt /ID# 214223, Frankfurt am Main, Hessen, 60590, Germany|Universitaetsklinikum Muenster /ID# 214222, Munster, Niedersachsen, 48149, Germany|Klinikum Darmstadt /ID# 214224, Darmstadt, 64283, Germany|Medizinische Hochschule Hannover /ID# 214226, Hannover, 30625, Germany|Dermatologische Gemeinschaftspraxis Mahlow /ID# 214225, Mahlow, 15831, Germany|Klinikum rechts der Isar - Technische Universitaet Muenchen /ID# 214221, Munich, 81675, Germany|Oroshazi Korhaz /ID# 214986, Oroshaza, Bekes, 5900, Hungary|Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 214984, KaposvÃ¡r, Somogy, 7400, Hungary|Uno Medical Trials Kft /ID# 214987, Budapest, 1135, Hungary|St Vincent's University Hospital /ID# 213558, Elm Park, Dublin, D04 T6F4, Ireland|The Chaim Sheba Medical Center /ID# 218522, Ramat Gan, Tel-Aviv, 5265601, Israel|HaEmek Medical Center /ID# 218520, Afula, 1834111, Israel|Rabin Medical Center /ID# 218521, Petakh Tikva, 4941492, Israel|Istituto Clinico Humanitas /ID# 215727, Rozzano, Milano, 20089, Italy|Fondazione PTV Policlinico Tor Vergata /ID# 214093, Rome, Roma, 00133, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 214095, Milan, 20122, Italy|Azienda Ospedaliero-Universitaria di Modena /ID# 214096, Modena, 41124, Italy|Hospital Sultan Ismail /ID# 218881, Johor Bahru, Johor, 81100, Malaysia|Hospital Pakar Sultanah Fatimah /ID# 218877, Muar, Johor, 84000, Malaysia|Universiti Kebangsaan Malaysia (UKM) Medical Centre /ID# 218879, Kuala Lumpur, Selangor, 56000, Malaysia|Hospital Putrajaya /ID# 218880, Putrajaya, Wilayah Persekutuan Putrajaya, 62250, Malaysia|University Malaya Med Ctr /ID# 218882, Kuala Lumpur, 59100, Malaysia|Hospital Pulau Pinang /ID# 218878, Penang, 10450, Malaysia|Bravis Ziekenhuis /ID# 218772, Bergen op Zoom, Noord-Brabant, 4624 VT, Netherlands|Erasmus Medisch Centrum /ID# 218770, Rotterdam, Zuid-Holland, 3015 GD, Netherlands|Universitair Medisch Centrum Groningen /ID# 218775, Groningen, 9713 GZ, Netherlands|Universitair Medisch Centrum Utrecht /ID# 218771, Utrecht, 3584 CX, Netherlands|Optimal Clinical Trials Ltd /ID# 218688, Grafotn, Auckland, 1010, New Zealand|Wellington Regional Hospital /ID# 218689, Newtown, Wellington, 6021, New Zealand|Clinical Trials NZ /ID# 218690, Hamilton, 3204, New Zealand|Universitetssykehuset N-Norge, Tromso /ID# 214634, Tromso, Troms, 9019, Norway|Dermoklinika Centrum Medyczne s.c. /ID# 214300, Lodz, Lodzkie, 90-436, Poland|Pratia MCM Krakow /ID# 214303, Krakow, Malopolskie, 30-727, Poland|Klinika Ambroziak Sp. z o.o. /ID# 214301, Warszawa, Mazowieckie, 02-953, Poland|Royalderm Agnieszka Nawrocka /ID# 214302, Warszawa, Mazowieckie, 02-962, Poland|ClinicMed Daniluk, Nowak Sp.k. /ID# 214299, Bialystok, Podlaskie, 15-879, Poland|National University Hospital /ID# 219093, Singapore, 119074, Singapore|Hospital Universitario de Bellvitge /ID# 214257, L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Universitario Dr. Negrin /ID# 214256, Las Palmas de Gran Canaria, Las Palmas, 35019, Spain|Hospital de Manises /ID# 214258, Manises, Valencia, 46940, Spain|Complejo Hospitalario Universitario de Pontevedra /ID# 214255, Pontevedra, 36071, Spain|Hospital Universitario Arnau Vilanova /ID# 214254, Valencia, 46015, Spain|Hospital Universitario y Politecnico La Fe /ID# 214252, Valencia, 46026, Spain|Chung Shan Medical University Hospital /ID# 218919, Taichung, 40201, Taiwan|China Medical University Hospital /ID# 218409, Taichung, 40447, Taiwan|National Taiwan University Hospital /ID# 218917, Taipei City, 100, Taiwan|Taipei Municipal Wan Fang Hospital /ID# 218918, Taipei, 116, Taiwan|Kyiv City Clinical Skin and Venereal Hospital /ID# 218382, Kyiv, Kyivska Oblast, 04209, Ukraine|ME ""Rivne Regional Dermatology and Venereology Dispensary"" of RRC /ID# 218385, Rivne, 33028, Ukraine|Victoria Hospital /ID# 213564, Kirkcaldy, Fife, KY2 5AH, United Kingdom|The Royal Free London NHS Foundation Trust /ID# 213560, London, London, City Of, NW3 2QG, United Kingdom|NHS Greater Glasgow and Clyde /ID# 213561, Glasgow, Scotland, G12 0XH, United Kingdom|University Hospitals Sussex NHS Foundation Trust /ID# 213562, Worthing, BN11 2DH, United Kingdom","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT05318300,Evaluation of an Adapted Formula on Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT05318300,NO,Atopic Dermatitis,DIETARY_SUPPLEMENT: tested formula with fiber|DIETARY_SUPPLEMENT: Control,ALL,CHILD,,"Center_13, Namur, Belgium|Center_14, Thuin, Belgium|Center_05, Nice, France","Principal Investigator : Fabienne Cahn-Sellem , Private Practice Study Chair : Sebastien Barbarot , Hotel Dieu Hospital, Nantes, France Principal Investigator : Elena Bradatan , Private Practice"
Atopic Dermatitis,NCT03901144,A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier,https://clinicaltrials.gov/study/NCT03901144,YES,"Dermatitis, Atopic",DRUG: 2% urea/20% glycerol cream|DRUG: MinidermÂ® 20% cream|DRUG: DiprobaseÂ® cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"The University of Sheffield Medical School, Sheffield, S10 2RX, United Kingdom",The University of Sheffield Medical School
Atopic Dermatitis,NCT04668066,Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04668066,YES,Atopic Dermatitis,DRUG: PF-07242813|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1,"Anaheim Clinical Trials, LLC, Anaheim, California, 92801, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Keck School of Medicine of USC, Los Angeles, California, 90033, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Orange County Research Center, Tustin, California, 92780, United States|Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma, 74136, United States|Aspen Clinical Research, Orem, Utah, 84058, United States",
Atopic Dermatitis,NCT06058000,A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06058000,NO,Atopic Dermatitis,DRUG: 1.5% QLM3003|DRUG: 2% QLM3003|DRUG: Vehicle (Placebo),ALL,"ADULT, OLDER_ADULT",PHASE2,"The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China|Dermatology Hospital of Shandong First Medical University, Jinan, Shandong, 276000, China","Principal Investigator : Xinghua Gao, Doctor , First Hospital of China Medical University Principal Investigator : Furen zhang, Doctor , Dermatology Hospital of Shandong First Medical University"
Atopic Dermatitis,NCT04613037,Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT04613037,NO,Atopic Dermatitis,BIOLOGICAL: Fecal Microbial Transplantation,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Department of Dermatology, Tel Aviv Sourasky medical center, Tel Aviv, 64239, Israel","Principal Investigator : Jacob Mashiah, MD , Tel-Aviv Sourasky Medical Center Principal Investigator : Nitsan Maharshak, MD , Tel-Aviv Sourasky Medical Center"
Atopic Dermatitis,NCT04193670,"Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis",https://clinicaltrials.gov/study/NCT04193670,NO,Atopic Dermatitis,OTHER: Clinical examination|PROCEDURE: Biopsies|OTHER: Blood test,ALL,"ADULT, OLDER_ADULT",,"CHU de TOULOUSE, Toulouse, 31059, France","Principal Investigator : Marie TAUBER , University Hospital, Toulouse"
Atopic Dermatitis,NCT05970432,A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05970432,NO,Atopic Dermatitis,DRUG: TQH2722 injection 300mg-150mg|DRUG: TQH2722 injection 600mg-300mg|DRUG: TQH2722 injection 900mg-450mg|DRUG: TQH2722 injection matching Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, 241000, China|Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, 510030, China|The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510260, China|Shenzhen People's Hospital, Shenzhen, Guangdong, 518020, China|Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, 541001, China|Affiliated Hospital of Hebei Engineering University, Handan, Hebei, 056002, China|The Forth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China|The second affiliated hospital of harbin medical university, Harbin, Heilongjiang, 150000, China|Puyang District Hospital of Anyang City, Anyang, Henan, 455000, China|The First People's Hospital of Nanyang, Nanyang, Henan, 473000, China|People's Hospital of Henan province, Zhengzhou, Henan, 450003, China|Shiyan Renmin Hospital, Shiyan, Hubei, 442000, China|Renmin Hospital of Wuhan University, Wuhan, Hubei, 430000, China|The third xiangya hospital of central south university, Changsha, Hunan, 410013, China|Qian-jin Lu, Nanjing, Jiangsu, 210042, China|Affiliated Hospital of Jiujiang University, Jiujiang, Jiangxi, 332000, China|The Second Hospital of Jilin University, Changchun, Jilin, 130041, China|Panjin Liaoyou Gem Flower Hospital, Panjin, Liaoning, 124000, China|The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110000, China|Air Force Medical University, Xi'an, Shaanxi, 710032, China|The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China|Shengli Oil Field Central Hospital, Dongying, Shandong, 25700, China|Shandong First Medical University Affiliated Dermatology Hospital, Jinan, Shandong, 250022, China|Qilu Hospital of Shandong University, Jinan, Shandong, 250063, China|The Affiliated Hospital Of Qingdao University, Qingdao, Shandong, 266000, China|Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, 200040, China|Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Tianjin, 300122, China|Xinjiang Uygur Autonomous Region People's Hospital, ÃœrÃ¼mqi, Xinjiang Uygur Autonomous Region, 830000, China|The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650000, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China|The First People's Hospital of Wenling, Wenling, Zhejiang, 317500, China","Chia Tai Tianqing Pharmaceutical Group Co., Ltd."
Atopic Dermatitis,NCT06477835,A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06477835,NO,Atopic Dermatitis,BIOLOGICAL: SIM0718 Injection,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,,"Principal Investigator : Jianzhong Zhang , Peking University People's Hospital Principal Investigator : Cheng Zhou , Peking University People's Hospital"
Atopic Dermatitis,NCT02865356,Topical Solution for the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02865356,NO,Atopic Dermatitis,DRUG: Cyclosporine 5% solution|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Sant Joan de DÃ©u, Esplugues de Llobregat, Barcelona, 08950, Spain|Hospital General Universitario de Alicante, Alicante, 03010, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitario de La Princesa, Madrid, 28006, Spain|Hospital Infantil Universitario NiÃ±o JesÃºs, Madrid, Spain|Hospital Universitario Virgen de la Victoria, MÃ¡laga, 29010, Spain|Hospital Universitario Virgen Macarena, Sevilla, 41009, Spain|Hospital Universitari i PolitÃ¨cnic La Fe, Valencia, 46026, Spain","Principal Investigator : Carlos FerrÃ¡ndiz, MD, PhD , Germans Trias i Pujol Hospital"
Atopic Dermatitis,NCT02949960,DMT210 Topical Gel in the Treatment of Atopic Dermatitis,https://clinicaltrials.gov/study/NCT02949960,NO,Atopic Dermatitis,DRUG: DMT210 Topical Gel|DRUG: Vehicle Control,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Dermata Investigational Site, Houston, Texas, 77056, United States|Dermata Investigational Site, Norfolk, Virginia, 23502, United States","Study Director : Christopher Nardo, PhD , Dermata Therapeutics"
Atopic Dermatitis,NCT06175143,A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.,https://clinicaltrials.gov/study/NCT06175143,NO,Atopic Dermatitis,BIOLOGICAL: GR2002 injection,ALL,"ADULT, OLDER_ADULT",PHASE1,"Peking University People's Hospital, Beijing, Beijing, 100044, China","Principal Investigator : Jianzhong Zhang, PHD , Peking University People's Hospital Principal Investigator : Cheng Zhou, PHD , Peking University People's Hospital"
Atopic Dermatitis,NCT02763722,Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy,https://clinicaltrials.gov/study/NCT02763722,NO,Atopic Dermatitis,OTHER: Emollient spray product,ALL,"CHILD, ADULT",,"Katarzyna Osinka, Warszawa, Å»wirki i Wigury 63A, 00-090, Poland","Principal Investigator : Wojciech Feleszko, MD PhD , Department of Pediatric Respiratory Diseases and Allergy, The Medical University of Warsaw"
Atopic Dermatitis,NCT02669888,Indigo Naturalis in Treating Atopic Dermatitis Topically,https://clinicaltrials.gov/study/NCT02669888,NO,Atopic Dermatitis,DRUG: Indigo naturalis ointment|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Chang Gung Memorial Hospital at Keelung, Kelung, 204, Taiwan|Chang Gung Memorial Hospital at Taipei, Taipei, 105, Taiwan|Chang Gung Memorial Hospital at Linkou, Taoyuan, 333, Taiwan","Principal Investigator : Yin-Ku Lin, MD., PhD. , Chang Gung Memorial Hospital"
Atopic Dermatitis,NCT06383468,A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06383468,NO,Atopic Dermatitis,DRUG: AK120,ALL,"ADULT, OLDER_ADULT",PHASE3,"Beijing Friendship Hospital Capital Medical University, Beijing, Beijing, China|Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, Beijing, China|Beijing Tongren Hospital, Beijing, Beijing, China|Peking University People's Hospital, Beijing, Beijing, China|Peking University Third Hospital, Beijing, Beijing, China|Chongqing Three Gorges Medical College Affiliated People's Hospital, Chongqing, Chongqing, China|Chongqing Traditional Chinese Medicine Hospital, Chongqing, Chongqing, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China|The Second Affiliated Hospital of Xiamen Medical College, Xiamen, Fujian, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China|Southern Medical University Dermatology Hospital/Guangdong Provincial Dermatology Hospital, Guangzhou, Guangdong, China|Southern Medical University Southern Hospital, Guangzhou, Guangdong, China|Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China|Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China|Yuebei People's hospital, Guangdong, China, Shaoguan, Guangdong, China|Shunde Hospital of Southern Medical University, Shunde, Guangdong, China|Guangdong Medical University Affiliated Hospital, Zhanjiang, Guangdong, China|The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China|Hainan General Hospital, Haikou, Hainan, China|Hainan Provincial Fifth People's Hospital, Haikou, Hainan, China|The First Affiliated Hospital of Hainan Medical College, Haikou, Hainan, China|Chengde Medical College Affiliated Hospital, Chengde, Hebei, China|The Second Affiliated Hospital of Xingtai Medical College, Xingtai, Hebei, China|Harbin Medical University Affiliated Second Hospital, Harbin, Heilongjiang, China|Heilongjiang Provincial Hospital, Harbin, Heilongjiang, China|The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China|Renmin Hospital of Wuhan University Hubei General Hospital, Wuhan, Hubei, China|Tongji Hospital, Wuhan, Hubei, China|Changde First People's Hospital, Changde, Hunan, China|Xiangya Hospital of Central South University, Changsha, Hunan, China|The First Affiliated Hospital of South China University, Hengyang, Hunan, China|Inner Mongolia Medical University Affiliated Hospital, Hohhot, Inner Mongolia, China|The First Affiliated Hospital of Bengbu Medical College, Bengbu, Jiangsu, China|Changzhou First People's Hospital, Changzhou, Jiangsu, China|Yancheng First People's Hospital, Yancheng, Jiangsu, China|Jiangsu University Affiliated Hospital, Zhenjiang, Jiangsu, China|The First Affiliated Hospital of Gannan Medical College, Ganzhou, Jiangxi, China|The First Bethune Hospital of Jilin University, Changchun, Jilin, China|Panjin Liaoyou Gemstone Flower Hospital, Panjin, Liaoning, China|Shenyang Integrated Traditional Chinese and Western Medicine Hospital, Shenyang, Liaoning, China|Zhongyi Northeast International Hospital, Shenyang, Liaoning, China|General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China|Shandong Provincial Dermatology Hospital, Jinan, Shandong, China|Shandong University Qilu Hospital, Jinan, Shandong, China|Qingdao Municipal Hospital, Qingdao, Shandong, China|Shanghai Dermatology Hospital, Shanghai, Shanghai, China|Baoji Central Hospital, Baoji, Shanxi, China|Sichuan Provincial People's Hospital, Chengdu, Sichuan, China|Tianjin Institute of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Tianjin, China|Xinjiang Uygur Autonomous Region People's Hospital, Urumqi, Xinjiang, China|The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China|Hangzhou First People's Hospital, Hangzhou, Zhejiang, China|Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Jiaxing First People's Hospital, Jiaxing, Zhejiang, China|Ningbo First Hospital, Ningbo, Zhejiang, China|Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China|Wenzhou Medical University First Affiliated Hospital, Wenzhou, Zhejiang, China",Akeso
Atopic Dermatitis,NCT05491447,A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05491447,NO,Atopic Dermatitis,DRUG: BMX-010|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Cahaba Dermatology & Skin Health Center, Birmingham, Alabama, 35244, United States|Dermatology Trial Associates, Bryant, Arkansas, 72022, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Axon Clinical Research, Inglewood, California, 90301, United States|Colorado Skin Care, Englewood, Colorado, 80113, United States|Skin Care Research, Boca Raton, Florida, 33486, United States|Driven Research LLC, Coral Gables, Florida, 33134, United States|RM Medical Research, Miami Lakes, Florida, 33014, United States|Lenus Research, Sweetwater, Florida, 33172, United States|Physicians Research Group, West Lafayette, Indiana, 47906, United States|Skin Sciences, Pllc, Louisville, Kentucky, 40241, United States|Clinical Trials Management, LLC, Mandeville, Louisiana, 70448, United States|Revival Research Institute, LLC, Troy, Michigan, 48084, United States|National Allergy and Asthma Research, LLC., North Charleston, South Carolina, 29420, United States|J&S Studies, Inc., College Station, Texas, 77845, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Jordan Valley Dermatology Center, South Jordan, Utah, 84095, United States|Dermatology Specialists of Spokane (Dermatology Specialists of Spokane, PLLC), Spokane, Washington, 99202, United States",Innovaderm Research Inc.
Atopic Dermatitis,NCT05531188,Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05531188,NO,Atopic Dermatitis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Insight Research, Quatre Bornes, Mauritius","Principal Investigator : Aslham Doarika ,"
Atopic Dermatitis,NCT05715320,Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05715320,NO,Atopic Dermatitis,BIOLOGICAL: CM310,ALL,"ADULT, OLDER_ADULT",PHASE2,"Hangzhou First People's Hospital, Hangzhou, Zhejiang, China",Keymed Biosciences Co.Ltd
Atopic Dermatitis,NCT03397979,Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03397979,NO,Atopic Dermatitis,BEHAVIORAL: Infrequent versus Frequent Soaking Baths,ALL,CHILD,,"Allergy and Asthma Associates of Maine, Portland, Maine, 04102, United States","Principal Investigator : Ivan D Cardona, M.D. , Allergy & Asthma Associates of Maine"
Atopic Dermatitis,NCT04345367,Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy,https://clinicaltrials.gov/study/NCT04345367,YES,Atopic Dermatitis,DRUG: Abrocitinib 200 mg|COMBINATION_PRODUCT: Dupilumab 300 mg,ALL,"ADULT, OLDER_ADULT",PHASE3,"Total Skin & Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States|Clinical Research Center Of Alabama, Birmingham, Alabama, 35209, United States|Alliance Dermatology & MOHS Center, PC, Phoenix, Arizona, 85032, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Ark Clinical Research, Long Beach, California, 90806, United States|Beach Allergy and Asthma Specialty Group, A Medical Corporation, Long Beach, California, 90808, United States|Wallace Medical Group, Inc, Los Angeles, California, 90056, United States|Empire Clinical Research, Pomona, California, 91767, United States|MedDerm Associates, San Diego, California, 92103, United States|University of California San Diego Dermatology, San Diego, California, 92122, United States|University Clinical Trials Inc., San Diego, California, 92123, United States|Synergy Dermatology, San Francisco, California, 94132, United States|Wolverine Clinical Trials, Llc, Santa Ana, California, 92705, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Skin Care Research, LLC, Boca Raton, Florida, 33486, United States|Olympian Clinical Research, Largo, Florida, 33770, United States|Miami Dermatology & Laser Research, LLC, Miami, Florida, 33173, United States|Clinical Neuroscience Solutions, Inc., Orlando, Florida, 32801, United States|Accel Research Sites - Pure Skin Dermatology & Aesthetics, Orlando, Florida, 32819, United States|Clinical Research Trials of Florida, Inc., Tampa, Florida, 33607, United States|Olympian Clinical Research, Tampa, Florida, 33614, United States|Integrated Clinical Research, West Palm Beach, Florida, 33406, United States|One Health Research Clinic, Norcross, Georgia, 30093, United States|Sneeze, Wheeze & Itch Associates, LLC, Normal, Illinois, 61761, United States|Dundee Dermatology, West Dundee, Illinois, 60118, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|The South Bend Clinic Center for Research, South Bend, Indiana, 46617, United States|Epiphany Dermatology of Kansas, LLC, Overland Park, Kansas, 66215, United States|Avant Research Associates, LLC, Crowley, Louisiana, 70526, United States|MetroBoston Clinical Partners, LLC, Brighton, Massachusetts, 02135, United States|Onyx Clinical Research, Flint, Michigan, 48507, United States|Linden Road Imaging Center, Flint, Michigan, 48532, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Regional Medical Imaging, P.C. ( Local X-Ray), Royal Oak, Michigan, 48067, United States|Revival Research Institute, LLC, Troy, Michigan, 48084, United States|Skin Specialists, PC, Omaha, Nebraska, 68144, United States|Vivida Dermatology, Las Vegas, Nevada, 89148, United States|Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey, 08520, United States|Boice-Willis Clinic, PA, Rocky Mount, North Carolina, 27804, United States|Carolina Research Center, Inc., Shelby, North Carolina, 28150, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|Paddington Testing Co, Inc., Philadelphia, Pennsylvania, 19103, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|Clinical Neuroscience Solutions, Inc., Memphis, Tennessee, 38119, United States|International Clinical Research - Tennessee LLC, Murfreesboro, Tennessee, 37130, United States|Center for Clinical Studies, LTD. LLP, Houston, Texas, 77004, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Acclaim Dermatology, PLLC, Sugar Land, Texas, 77479, United States|Jordan Valley Dermatology Center, West Jordan, Utah, 84088, United States|St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia|Box Hill Hospital, Box Hill, Victoria, 3128, Australia|Emeritus Research, Camberwell, Victoria, 3124, Australia|Skin Health Institute Inc., Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Melbourne Health Radiology, Pakrville, Victoria, 3050, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|MHAT Dobrich AD, Dobrich, 9300, Bulgaria|MC Asklepii OOD, Dupnitsa, 2600, Bulgaria|DCC Alexandrovska EOOD, Sofia, 1431, Bulgaria|DCC Fokus-5 - Medical Establishment for Outpatient Care EOOD, Sofia, 1463, Bulgaria|Military Medical Academy MHAT Sofia, Sofia, 1606, Bulgaria|Dermatology Research Institute, Calgary, Alberta, T2J7E1, Canada|Alberta DermaSurgery Centre, Edmonton, Alberta, T6G1C3, Canada|CARE Clinic Ltd, Red Deer, Alberta, T4P-1K4, Canada|Dr. Chih-ho Hong Medical Inc, Surrey, British Columbia, V3R 6A7, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|Karma Clinical Trials, Inc., St. John's, Newfoundland and Labrador, A1A 4Y3, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|DermEffects, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X2, Canada|DermEdge Research, Mississauga, Ontario, L5H 1G9, Canada|North Bay Dermatology Centre, North Bay, Ontario, P1B 3Z7, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|Dermatology Ottawa Research Centre, Ottawa, Ontario, K2C 3N2, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|Medicor Research Inc, Sudbury, Ontario, P3A 1W8, Canada|Sudbury Skin Clinique, Sudbury, Ontario, P3C 1X8, Canada|Toronto Research Centre, Toronto, Ontario, M3H5Y8, Canada|Intermed groupe santÃ©, Chicoutimi, Quebec, G7H 7Y8, Canada|Centre de Recherche Dermatologique du Quebec metropolitain, Quebec, G1V 4x7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W4R4, Canada|Medicien, Las Condes, Santiago, Region Metropolitana, 7580150, Chile|MIRES (M Y F Estudios Clinicos Limitada), Nunoa, Santiago, Region Metropolitana, 7750495, Chile|Vida lntegra, Nunoa, Santiago, Region Metropolitana, 7750495, Chile|Centro Radiologico Plaza Baquedano, Santiago, Region Metropolitana, 7500906, Chile|Centro Medico SkinMed Limitada, Santiago, Region Metropolitana, 7580206, Chile|Hospital Clinico Universidad de Chile, Santiago, Region Metropolitana, 8380456, Chile|Centro Internacional de Estudios Clinicos - CIEC, Santiago, Region Metropolitana, 8420383, Chile|ClÃ­nica Dermacross S.A., Santiago, RegiÃ³n Metropolitana, 7640881, Chile|Terveystalo Tampere, Tampere, 33100, Finland|MehilÃ¤inen Neo, Turku, 20520, Finland|Turun yliopistollinen keskussairaala, Turku, 20520, Finland|Fachklinik Bad Bentheim, Bad Bentheim, 48455, Germany|Klinikum Bielefeld RosenhÃ¶he, Bielefeld, 33647, Germany|Klinische Forschung Dresden GmbH, Dresden, 01069, Germany|IKF Pneumologie GmbH & Co KG, Frankfurt am Main, 60596, Germany|SRH Wald-Klinikum Gera GmbH, Gera, 07548, Germany|Studienzentrum Dr. med. Beate Schwarz, Langenau, 89129, Germany|SIBAmed GmbH, Leipzig, 04103, Germany|UniversitÃ¤tsklinikum Schleswig-Holstein, Campus LÃ¼beck, LÃ¼beck, 23538, Germany|Dermatologische Gemeinschaftspraxis Dres. Quist, Mainz, 55128, Germany|University of Muenster, Muenster, 48149, Germany|Clinexpert Kft., Budapest, 1033, Hungary|Debreceni Egyetem Klinikai KÃ¶zpont, Debrecen, 4032, Hungary|Trial Pharma Kft., KaposvÃ¡r, 7400, Hungary|Szegedi TudomÃ¡nyegyetem Szent-GyÃ¶rgyi Albert Klinikai KÃ¶zpont, Szeged, 6720, Hungary|Fondazione Policlinico Universitario A. Gemelli IRCCS Universita Cattolica del Sacro Cuore, Roma, 00168, Italy|Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, 15355, Korea, Republic of|Chonnam National University Hospital, Gwangju, 61469, Korea, Republic of|The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, 21431, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 03722, Korea, Republic of|Chung-Ang University Hospital, Seoul, 06973, Korea, Republic of|Health Centre 4 Ltd. Diagnostics Centre, Riga, LV-1003, Latvia|LLC J.Kisis, Riga, LV-1003, Latvia|Outpatient Clinic of Ventspils, Ventspils, LV-3601, Latvia|NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL s.c., Bialystok, 15-453, Poland|DERMAPOLIS Medical Dermatology Center, Chorzow, 41-500, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-214, Poland|MCBK, Grodzisk Mazowiecki, 05-825, Poland|Care Clinic Centrum Medyczne, Katowice, 40-568, Poland|Krakowskie Centrum Medyczne Sp. z o.o., Krakow, 31-501, Poland|Centrum Medyczne Promed, Krakow, 31-513, Poland|Centrum Terapii Wspolczesnej J.M. Jasnorzewska Spolka Komandytowo-Akcyjna, Lodz, 90-242, Poland|Niepubliczny Zaklad Opieki Zdrowotnej ""DERMED"" Centrum Medyczne, Lodz, 90-265, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, 27-400, Poland|Gabinety Lekarskie Rivermed, Poznan, 61-441, Poland|Spolka Cywilna Andrzej Krolicki, Tomasz Kochanowski, ,,Laser Clinic"", Szczecin, 70-332, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|Medycyna Kliniczna, Warszawa, 00-874, Poland|MTZ Clinical Research Sp. z o.o., Warszawa, 02-106, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszawa, 02-661, Poland|EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej, Wroclaw, 50-220, Poland|Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak SpÃ³Å‚ka Partnerska, Wroclaw, 50-566, Poland|Centrum Medyczne Oporow, Wroclaw, 52-416, Poland|Kliniczny Oddzial Chorob Wewnetrznych, Dermatologii i Alergologii, Zabrze, 41-800, Poland|SUMMIT CLINICAL RESEARCH, s.r.o., Bratislava, 831 01, Slovakia|SKINKLINIK s.r.o, Bratislava, 83103, Slovakia|BeneDerma s.r.o., Bratislava, 841 02, Slovakia|Derma therapy spol. s.r.o., Bratislava, 851 01, Slovakia|Dermatovenerologicka ambulancia, Nove Zamky, 940 34, Slovakia|SANARE spol.s.r.o., Svidnik, 089 01, Slovakia|Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Centro de Especialidades Mollabao (Area Sanitaria de Pontevedra e O Salnes), Pontevedra, 36001, Spain|Hospital de Montecelo, Pontevedra, 36071, Spain|Taipei Veterans General Hospital, Taipei City, Taiwan (r.o.c), 11217, Taiwan|Taipei Medical University-Shuang Ho Hospital, New Taipei City, 23561, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan","Study Director : Pfizer CT.gov Call Center , Pfizer"
Atopic Dermatitis,NCT06144424,"Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06144424,NO,Atopic Dermatitis,DRUG: Oral EP262|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Allervie Clinical Research, Birmingham, Alabama, 35209, United States|RM Medical Research, Inc., Miami Lakes, Florida, 33014, United States|Indiana Clinical Trials Center, Plainfield, Indiana, 46168, United States|Lawrence J. Green, MD LLC, Rockville, Maryland, 20850, United States|Revival Research Institute, LLC, Troy, Michigan, 48084, United States|Optima Research Boardman, Boardman, Ohio, 44512, United States|J&S Studies, Inc., College Station, Texas, 77845, United States|Jordan Valley Dermatology Center, South Jordan, Utah, 84095, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Innovaderm Research Inc., MontrÃ©al, Quebec, H2X 2V1, Canada","Escient Pharmaceuticals, Inc"
Atopic Dermatitis,NCT05602207,Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab,https://clinicaltrials.gov/study/NCT05602207,NO,Atopic Dermatitis,DRUG: Abrocitinib,ALL,"ADULT, OLDER_ADULT",PHASE4,"Inno-6050 Site 22, Birmingham, Alabama, 35244, United States|Inno-6050 Site 13, Fountain Valley, California, 92708, United States|Inno-6050 Site 21, Miami Lakes, Florida, 33014, United States|Inno-6050 Site 19, Saint Petersburg, Florida, 33709, United States|Inno-6050 Site 16, Quincy, Massachusetts, 02169, United States|Inno-6050 Site 17, Auburn Hills, Michigan, 48326, United States|Inno-6050 Site 15, Winnipeg, Manitoba, R3C 0N2, Canada|Inno-6050 Site 18, Newmarket, Ontario, L3Y 5G8, Canada|Inno-6050 Site 11, Toronto, Ontario, M4W 2N4, Canada|Inno-6050 Site 10, Montreal, Quebec, H2X 2V1, Canada|Inno-6050 Site 14, QuÃ©bec, Quebec, G1V 4X7, Canada|Inno-6050 Site 20, QuÃ©bec, Quebec, G1W 4R4, Canada","Principal Investigator : Robert Bissonnette, MD , Innovaderm Research Inc."
Atopic Dermatitis,NCT05680298,Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China,https://clinicaltrials.gov/study/NCT05680298,NO,Atopic Dermatitis,DRUG: Dupilumab,ALL,CHILD,PHASE4,"Beijing Children's hospital, Beijing, China","Study Director : Clinical Sciences & Operations , Sanofi"
Atopic Dermatitis,NCT03915496,Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03915496,YES,Atopic Dermatitis,DRUG: PF-04965842 200 mg|DRUG: PF-04965842 100 mg|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Keck School of Medicine of USC - IDS Pharmacy, Los Angeles, California, 90033, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Olympian Clinical Research, Largo, Florida, 33770, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|The Indiana Clinical Trials Center, PC - Dermatology Research, Plainfield, Indiana, 46168, United States|Wayne Health - Wayne State Dermatology, Dearborn, Michigan, 48124, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Menter Dermatology Research Institute, Dallas, Texas, 75246, United States|Beacon Dermatology, Calgary, Alberta, T3E 0B2, Canada|Innovaderm Research, Inc., Montreal, Quebec, H2X 2V1, Canada","Study Director : Pfizer CT.gov Call Center , Pfizer"
Atopic Dermatitis,NCT06280716,A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT06280716,NO,Atopic Dermatitis,DRUG: Placebo|DRUG: Lebrikizumab|DRUG: Topical Corticosteroid,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Wannan Medical College Yijishan Hospital, Wuhu, Anhui, 241001, China|China-Japan Friendship Hospital, Beijing, Beijing, 100029, China|Peking University People's Hospital, Beijing, Beijing, 100034, China|Beijing Children's hospital, Capital Medical University, Beijing, Beijing, 100045, China|Beijing Friendship Hospital, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100091, China|Beijing Tongren Hospital affiliated to Capital Medical University, Beijing, Beijing, 100730, China|Beijing Tsinghua Changgung Hospital, Beijing, Beijing, 102202, China|The Children's Hospital of Chongqing Medical University, Chongqing, Chongqing, 400065, China|Zhongshan Hospital Fudan University (Xiamen Branch), Xiamen, Fujian, 361015, China|Guangdong Province Dermatology Hospital, Guangzhou, Guangdong, 510018, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510180, China|Shenzhen Children's Hospital, Shenzhen, Guangdong, 518026, China|Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, China|The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, 518053, China|Hainan General Hospital, Haikou, Hainan, 570311, China|The First Hospital of Wuhan, Wuhan, Hubei, 430022, China|Wuhan Union Hospital, Wuhan, Hubei, 430022, China|Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China|Hunan Children's Hospital, Changsha, Hunan, 410007, China|Xiangya Hospital Central South University, Changsha, Hunan, 410008, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China|The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China|Wuxi No.2 People's Hospital, Wuxi, Jiangsu, 214000, China|Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China|The Second Hospital of Jilin University, Changchun, Jilin, 130000, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'An, Shaanxi, 710004, China|Huashan Hospital Affiliated Fudan University, Shanghai, Shanghai, 200040, China|Shanghai Tenth People's Hospital, Shanghai, Shanghai, 200072, China|Children's Hospital of Shanxi, Taiyuan, Shanxi, 030013, China|West China Hospital, Sichuan University, Cheng Du, Sichuan, 610041, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, 300052, China|The First People's Hospital of Hangzhou, Hangzhou, Zhejiang, 310000, China|The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, 310016, China|Zhejiang University School of Medicine - The Fourth Affiliated Hospital, Yiwu, Zhejiang, 322000, China|The First Affiliated Hospital Of Fujian Medical University, Fuzhou, 350005, China|Shanghai Skin Disease Hospital, Shanghai, 200071, China|The First Hospital of Hebei Medical University, Shijiazhuang, 050031, China|The Catholic University of Korea, Incheon St. Mary's Hospital, Bupyeong-gu, Incheon-gwangyeoksi [Incheon], 21431, Korea, Republic of|Korea University Ansan Hospital, Ansan-si, KyÇ’nggi-do, 15355, Korea, Republic of|National Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 01812, Korea, Republic of|Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 05505, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 07441, Korea, Republic of","Study Director : Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) , Eli Lilly and Company"
Atopic Dermatitis,NCT05525715,A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis,https://clinicaltrials.gov/study/NCT05525715,NO,Atopic Dermatitis,"DRUG: 2mg QY201 tablets or 2mg QY201 placebo,BID|DRUG: 5mg QY201 tablets or 5mg QY201 placebo,BID|DRUG: 10mg QY201 tablets or 10mg QY201 placebo,QD|DRUG: 10mg QY201 tablets or 10mg QY201 placebo,BID|DRUG: 15mg QY201 tablets or 15mg QY201 placebo,BID|DRUG: 20mg QY201 tablets or 20mg QY201 placebo,BID|DRUG: 5mg QY201 tabletsï¼ŒBID|DRUG: 10mg QY201 tabletsï¼ŒBID|DRUG: 20mg QY201 tabletsï¼ŒBID|DRUG: QY201 placeboï¼ŒBID",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,,"Principal Investigator : LiMing Wu, Ph.D, M.D , Affiliated Hangzhou First People's Hospital of Zhejiang University School of Medicine"
Atopic Dermatitis,NCT03327116,Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients,https://clinicaltrials.gov/study/NCT03327116,NO,Atopic Dermatitis,DRUG: Methotrexate,ALL,"ADULT, OLDER_ADULT",,"Hospital das ClÃ­nicas of the University of SÃ£o Paulo Medical School, Department of Dermatology, SÃ£o Paulo, SP, 05403900, Brazil",FUNADERSP (Foundation for Research Support of the State of SÃ£o Paulo)
Atopic Dermatitis,NCT06389136,A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab,https://clinicaltrials.gov/study/NCT06389136,NO,Atopic Dermatitis,DRUG: Upadacitinib Dose A|DRUG: Dupilumab Dose A|DRUG: Upadacitinib Dose B,ALL,ADULT,PHASE3,"Joseph Raoof Md,Inc /Id# 263849, Encino, California, 91436, United States|Integrative Skin Science and Research /ID# 264537, Sacramento, California, 95815, United States|Skin Care Research Boca Raton /ID# 263733, Boca Raton, Florida, 33486-2269, United States|Revival Research - Doral /ID# 263541, Doral, Florida, 33122, United States|GSI Clinical Research, LLC /ID# 263760, Margate, Florida, 33063-7011, United States|Cleaver Medical Group Dermatology /ID# 263788, Dawsonville, Georgia, 30534, United States|Treasure Valley Medical Research /ID# 263738, Boise, Idaho, 83706, United States|DeNova Research /ID# 264513, Chicago, Illinois, 60611, United States|Dawes Fretzin, LLC /ID# 264534, Indianapolis, Indiana, 46256, United States|Options Research Group /ID# 264564, West Lafayette, Indiana, 47906, United States|Skin Specialists /ID# 263345, Omaha, Nebraska, 68144, United States|Forest Hills Dermatology Group @ Union Turnpike /ID# 263755, Kew Gardens, New York, 11415, United States|Vital Prospects Clinical Research Institute - Tulsa /ID# 263645, Tulsa, Oklahoma, 74136, United States|Dermatology Partners /ID# 264972, Philadelphia, Pennsylvania, 19114, United States|Arlington Research Center, Inc /ID# 263665, Arlington, Texas, 76011, United States|Orion Clinical Research /ID# 263658, Austin, Texas, 78759, United States|Bellaire Dermatology Associates /ID# 263794, Bellaire, Texas, 77401, United States|Studies in Dermatology LLC /ID# 263335, Cypress, Texas, 77429, United States|Modern Research Associates /ID# 263852, Dallas, Texas, 75231, United States|Dermatology Associates of Tyler /ID# 264980, Tyler, Texas, 75703, United States","Study Director : ABBVIE INC. , AbbVie"
Atopic Dermatitis,NCT06035354,"A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis",https://clinicaltrials.gov/study/NCT06035354,NO,Atopic Dermatitis,DRUG: AK120|DRUG: AK120|DRUG: Placebo|DRUG: AK120|DRUG: AK120|DRUG: AK120|DRUG: Placebo|DRUG: AK120|DRUG: AK120|DRUG: AK120,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"AkesoBio Investigative Site 2037, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China|AkesoBio Investigative Site 2036, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China|AkesoBio Investigative Site 1001, Peking University People's Hospital, Beijing, Beijing, China|AkesoBio Investigative Site 2044, Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China|AkesoBio Investigative Site 2023, Xinqiao Hospital Medical University, Chongqing, Chongqing, China|AkesoBio Investigative Site 2024, Chongqing Three Gorges Medical College, Chongqing, Chongqing, China|AkesoBio Investigative Site 2040, Chongqing Traditional Chinese Medicine Hospital, Chongqing, Chongqing, China|AkesoBio Investigative Site 2052, The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China|AkesoBio Investigative Site 2038, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China|AkesoBio Investigative Site 2022, Dongguan People's Hospital, Dongguan, Guangdong, China|AkesoBio Investigative Site 1002, Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China|AkesoBio Investigative Site 2003, Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, China|AkesoBio Investigative Site 2049, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China|AkesoBio Investigative Site 2004, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China|AkesoBio Investigative Site 2001, Affiliated Hospital of Chengde medical university, Chengde, Hebei, China|AkesoBio Investigative Site 2010, Nanyang First People's Hospital National Third Class A Hospital, Nanyang, Henan, China|AkesoBio Investigative Site 2051, Jingzhou Central Hospital, Jingzhou, Hubei, China|AkesoBio Investigative Site 1005, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China|AkesoBio Investigative Site 2046, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China|AkesoBio Investigative Site 2008, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China|AkesoBio Investigative Site 2048, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China|AkesoBio Investigative Site 2050, Wuxi Second People's Hospital, Wuxi, Jiangsu, China|AkesoBio Investigative Site 2025, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China|AkesoBio Investigative Site 2032, The First Affiliated Hospital of Gannan Medical College, Ganzhou, Jiangxi, China|AkesoBio Investigative Site 2011, Northeast International Hospital, Shenyang, Liaoning, China|AkesoBio Investigative Site 2039, Shandong Provincial Dermatology Hospital, Jinan, Shandong, China|AkesoBio Investigative Site 2041, Qilu Hospital of Shandong University, Jinan, Shandong, China|AkesoBio Investigative Site 1003, Shanghai Skin Disease Hospital, Shanghai, Shanghai, China|AkesoBio Investigative Site 2027, Medical School of Yanan University, Xianyang, Shanxi, China|AkesoBio Investigative Site 2029, West China Hospitalï¼ŒSichuan University, Chengdu, Sichuan, China|AkesoBio Investigative Site 2034, Chengdu Second People's Hospital, Chengdu, Sichuan, China|AkesoBio Investigative Site 2013, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Tianjin, China|AkesoBio Investigative Site 2019, Tianjin Medical University General Hospital, Tianjin, Tianjin, China|AkesoBio Investigative Site 2043, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China|AkesoBio Investigative Site 1004, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China|AkesoBio Investigative Site 2006,Affiliated Hangzhou First People's Hospital, Hangzhou, Zhejiang, China|AkesoBio Investigative Site 2007, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China|AkesoBio Investigative Site 2035, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|AkesoBio Investigative Site 2009, The First Hospital of Jiaxing, Jiaxing, Zhejiang, China",Akeso
Atopic Dermatitis,NCT05674695,Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy,https://clinicaltrials.gov/study/NCT05674695,NO,"Dermatitis, Atopic",DRUG: Ciclosporin,ALL,"CHILD, ADULT, OLDER_ADULT",,"Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital del Mar IMIM, Barcelona, Spain|Hospital Universitario de Gran Canaria Dr NegrÃ­n, Las Palmas, Spain|Hospital Infanta Leonor, Madrid, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain|Hospital Universitario y PolitÃ©cnico la Fe, Valencia, Spain|Hospital Miguel Servet, Zaragoza, Spain",FundaciÃ³n Academia EspaÃ±ola de DermatologÃ­a
Atopic Dermatitis,NCT03745651,TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis,https://clinicaltrials.gov/study/NCT03745651,YES,Atopic Dermatitis,DRUG: Ruxolitinib cream|DRUG: Vehicle cream,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"University Of Alabama At Birmingham, Birmingham, Alabama, 35233, United States|Center For Dermatology Cosmetic And Laser Surgery, Fremont, California, 94538, United States|Marvel Clinical Research - Clinedge - PPDS, Huntington Beach, California, 92647, United States|Allergy And Asthma Associates Of Southern California - CRN, Mission Viejo, California, 92691, United States|Synexus Clinical Research US Inc. Santa Rosa, Santa Rosa, California, 95405, United States|Olympian Clinical Research, Largo, Florida, 33770, United States|San Marcus Research Clinic Inc, Miami Lakes, Florida, 33014, United States|Well Pharma Medical Research Corporation, South Miami, Florida, 33143, United States|Forward Clinical Trials Inc, Tampa, Florida, 33624, United States|Clinical Research Atlanta - ERN - PPDS, Stockbridge, Georgia, 30281, United States|Northwest Clinical Trials Clinedge, Boise, Idaho, 83704, United States|Randall Dermatology, West Lafayette, Indiana, 47906, United States|Derm Research LLC, Louisville, Kentucky, 40217, United States|Dermatology Specialists PSC, Louisville, Kentucky, 40241, United States|Michael W Simon MD Office, Nicholasville, Kentucky, 40356, United States|Delricht Clinical Research - Clinedge - PPDS Baton Rouge, Baton Rouge, Louisiana, 70809, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Jubilee Clinical Research - BTC - PPDS, Las Vegas, Nevada, 89106, United States|ActivMed Practices & Research Inc, Portsmouth, New Hampshire, 03801, United States|Hassman Research Institute, Berlin, New Jersey, 08009, United States|Skin Laser and Surgery specialists of New York and New Jersey LLC, Hackensack, New Jersey, 07601, United States|Derm Research Center Of New York Inc, Stony Brook, New York, 11790, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27516, United States|Synexus Clinical Research US, Inc. - Cincinnati, Cincinnati, Ohio, 45236, United States|Ohio Pediatric Research Association, Dayton, Ohio, 45414, United States|Synexus Clinical Research US, Inc. - Anderson, Anderson, South Carolina, 29621, United States|International Clinical Research Tennessee LLC, Murfreesboro, Tennessee, 37130, United States|Epiphany Dermatology Fort Worth, Fort Worth, Texas, 76244, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Center for Clinical Studies, Webster, Texas, 77598, United States|Tanner Clinic, Layton, Utah, 84041, United States|Advanced Research Institute, Ogden, Utah, 84405, United States|PI Coor Clinical Research LLC, Burke, Virginia, 22015, United States|Clinical Research Partners LLC, Richmond, Virginia, 23220, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Medical Center Unimed EOOD, Sevlievo, Gabrovo, 5400, Bulgaria|Medical Center Excelsior OOD - PPDS, Sofia, 1421, Bulgaria|Diagnostic Consultative Center XXVIII - Sofia - EOOD, Sofia, 1592, Bulgaria|Synexus - Medical Center Synexus Sofia EOOD, Sofia, 1784, Bulgaria|Synexus - Medical Centre Synexus Sofia EOOD (branch - Stara Zagora), Stara Zagora, 6000, Bulgaria|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|The Centre For Clinical Trials Inc., Oakville, L617W5, Canada|Dermatology Ottawa Research Centre, Ottawa, K2C 3N2, Canada|Dermamedica, s.r.o. - Kozni Ambulance Nachod, Nachod, 547 01, Czechia|CTCenter MaVe s.r.o., Olomouc, 779 00, Czechia|CCR Ostrava, s.r.o., Ostrava, 702 00, Czechia|Synexus Czech s.r.o., Prague 2, 120 00, Czechia|Synexus Affiliate - CLINTRIAL s.r.o., Praha, 100 00, Czechia|CharitÃ© - UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany|Hautarztpraxis Mahlow, Brandenburg, 15831, Germany|Universitatsklinikum Schleswig-Holstein, Kiel, 24105, Germany|Centrum Medyczne Matusiak, Wroclaw, Dolnoslaskie, 50-566, Poland|Synexus Affiliate - Bialystok - ClinicMed Daniluk, Nowak SpÃ³Å‚ka Jawna, Bialystok, 15-879, Poland|Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk, 80-546, Poland|Synexus - Gdynia, Gdynia, 81-537, Poland|Centrum Medyczne Angelius Provita, Katowice, 40-611, Poland|Synexus Affiliate - Krakowskie Centrum Medyczne, Krakow, 31-501, Poland|Twoja Przychodnia - SzczeciÅ„skie Centrum Medyczne, Szczecin, 71-434, Poland|Synexus - Warsaw, Warszawa, 01-192, Poland|EMC Instytut Medyczny S.A., Wroclaw, 50-220, Poland|Wro Medica, Wroclaw, 51-685, Poland|Hospital de Manises, Manises, Valencia, 46940, Spain|Hospital General Universitario de Alicante, Alicante, 3010, Spain|Hospital de La Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital General Universitario Reina Sofia, Cordoba, 14001, Spain|Hospital Universitario La Paz - PPDS, Madrid, 28046, Spain","Study Director : Michael E. Kuligowski, MD, PhD, MBA , Incyte Corporation"
Alopecia Areata,NCT05594316,New Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05594316,NO,Alopecia Areata,DRUG: Trichloroacetic acid,ALL,"CHILD, ADULT",,"Al-Azhar university, faculty of medicine, Cairo, Egypt|Al-Azhar university, Cairo, Egypt",Al-Azhar University
Alopecia Areata,NCT05744505,1565nm Non-ablative Fractional Laser Treat Alopecia Areata,https://clinicaltrials.gov/study/NCT05744505,NO,Alopecia Areata,PROCEDURE: 1565nm Non-ablative Fractional Laser|PROCEDURE: placebo,ALL,ADULT,,"Xianjie Wu, Hangzhou, Zhejiang, 310009, China","Second Affiliated Hospital, School of Medicine, Zhejiang University"
Alopecia Areata,NCT04833179,Fecal Transplant for Alopecia Areata,https://clinicaltrials.gov/study/NCT04833179,NO,Alopecia Areata,BIOLOGICAL: fecal transplant|OTHER: placebo,ALL,"ADULT, OLDER_ADULT",,,
Alopecia Areata,NCT06088147,Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata,https://clinicaltrials.gov/study/NCT06088147,NO,Alopecia Areata,DRUG: Methotrexate|DRUG: Triamcinolone Acetonide,ALL,"CHILD, ADULT, OLDER_ADULT",,"Al-Azhar University, Assiut, Egypt",Al-Azhar University
Alopecia Areata,NCT06087796,Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.,https://clinicaltrials.gov/study/NCT06087796,NO,Alopecia Areata,DRUG: Betamethasone Valerate 0.1% Cream|DRUG: Pentoxifylline|DRUG: Metformin,ALL,"CHILD, ADULT",PHASE1,"Assiut university, Assiut, 71515, Egypt","Principal Investigator : Nada K. Mostafa, bachelor , Assuit university hospital"
Alopecia Areata,NCT05865041,Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants,https://clinicaltrials.gov/study/NCT05865041,NO,Alopecia Areata,DRUG: Farudodstat|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"1 Site, Birmingham, Alabama, 35205, United States|1 Site, Fountain Valley, California, 92708, United States|1 Site, Santa Ana, California, 92701, United States|1 Site, New Haven, Connecticut, 06519, United States|1 Site, Washington, District of Columbia, 20037, United States|1 Site, Coral Gables, Florida, 33134, United States|1 Site, Indianapolis, Indiana, 46250, United States|1 Site, Louisville, Kentucky, 40241, United States|1 Site, Brighton, Massachusetts, 02135, United States|1 Site, Minneapolis, Minnesota, 55455, United States|1 Site, New Brighton, Minnesota, 55112, United States|1 Site, Saint Joseph, Missouri, 64506, United States|1 Site, Omaha, Nebraska, 68114, United States|1 Site, Cleveland, Ohio, 44195, United States|1 Site, Columbus, Ohio, 43215, United States|1 Site, Nashville, Tennessee, 37215, United States|1 Site, Pflugerville, Texas, 78660, United States|2 Sites, San Antonio, Texas, 78218, United States|1 Site, Webster, Texas, 77598, United States","Study Director : Chief Medical Officer , ASLAN Pharmaceuticals"
Alopecia Areata,NCT05600673,Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05600673,NO,Alopecia Areata,DRUG: Bimatoprost 0.03% solution|DEVICE: CO2 fractional laser,ALL,"CHILD, ADULT",PHASE1|PHASE2,"AL-Azhar University Hospital, Cairo, 11865, Egypt",Ahmed Hassan Nouh MD
Alopecia Areata,NCT04680234,Superficial Cryotherapy Versus Microneedling in Alopecia Areata,https://clinicaltrials.gov/study/NCT04680234,NO,Alopecia Areata,PROCEDURE: DMEP kit|DEVICE: Dermapen,ALL,"CHILD, ADULT, OLDER_ADULT",,"Sohag Faculty of Medicine, Sohag, 52324, Egypt",
Alopecia Areata,NCT05496426,A Study of KL130008 in Adults With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05496426,NO,Alopecia Areata,DRUG: KL130008/Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangzhou, 510080, China","Principal Investigator : Xingqi Zhang , First Affiliated Hospital, Sun Yat-Sen University"
Alopecia Areata,NCT05588310,Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors,https://clinicaltrials.gov/study/NCT05588310,NO,Alopecia Areata,,ALL,"ADULT, OLDER_ADULT",,"Toulouse University hospital, Toulouse, 31300, France","Principal Investigator : Juliette Mazereeuw-Hautier, Pr , Toulouse University Hospital"
Alopecia Areata,NCT05727306,Healthcare Disparities in Alopecia Areata,https://clinicaltrials.gov/study/NCT05727306,NO,Alopecia Areata,OTHER: No intervention,ALL,"CHILD, ADULT, OLDER_ADULT",,"Momentum Data Limited, London, United Kingdom",
Alopecia Areata,NCT03732807,PF-06651600 for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03732807,YES,Alopecia Areata,DRUG: PF-06651600 Induction Dose|DRUG: PF-06651600 Maintenance Dose #1|DRUG: PF-06651600 Maintenance Dose #2|DRUG: PF-06651600 Maintenance Dose #3|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,"The University of Alabama at Birmingham Hospital Outreach Lab, Birmingham, Alabama, 35233, United States|The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35233, United States|The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35294, United States|Mosaic Dermatology, Beverly Hills, California, 90211, United States|University of California, Irvine, Department of Dermatology, Dermatology Clinical Research Center, Irvine, California, 92697, United States|Dermatology Specialists, Inc., Murrieta, California, 92562, United States|University of California, San Francisco, San Francisco, California, 94115, United States|Kaiser Permanente Clinical Trials Unit, San Francisco, California, 94118, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States|University of Colorado Hospital Clinical and Translational Research Center, Aurora, Colorado, 80045, United States|University of Colorado Hospital Outpatient Pavillion, Aurora, Colorado, 80045, United States|Yale School of Medicine, New Haven, Connecticut, 06510, United States|Church Street Research Unit, New Haven, Connecticut, 06519, United States|Medstar Georgetown University Hospital Center-Department of Otolaryngology, Washington, District of Columbia, 20007, United States|Medstar Washington Hospital Center-Claude Nogay Research Pharmacy, Washington, District of Columbia, 20010, United States|Medstar Washington Hospital Center, Washington, District of Columbia, 20010, United States|Medstar Georgetown University Hospital Center-Department of Pediatrics, Washington, District of Columbia, 20016, United States|Siperstein Dermatology Group, Boynton Beach, Florida, 33472, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Advanced Clinical Research, Meridian, Idaho, 83642, United States|Northwestern Medical Group, Chicago, Illinois, 60611, United States|Northwestern Medicine Diagnostic Testing Center, Chicago, Illinois, 60611, United States|Northwestern Medicine, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Investigational Research Pharmacy, Chicago, Illinois, 60611, United States|Northwestern University, Chicago, Illinois, 60611, United States|NorthShore University HealthSystem, Skokie, Illinois, 60077, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|University of Iowa Hospitals and Clinics; Department of Pharmacy-IDS;, Iowa City, Iowa, 52242, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Medstar Georgetown University Hospital - Department of Dermatology, Chevy Chase, Maryland, 20815, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|University of Minnesota Medical Center, Investigational Drug Services Attn: Darlette Luke, Minneapolis, Minnesota, 55455, United States|Skin Specialists, PC, Omaha, Nebraska, 68144, United States|The Dermatology Group, P.C., Verona, New Jersey, 07044, United States|NYU School of Medicine, The Ronald O. Perelman Department of Dermatology, New York, New York, 10016, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|UNC CTRC, Chapel Hill, North Carolina, 27514, United States|UNC Hospitals, Investigational Drug Service, Chapel Hill, North Carolina, 27514, United States|UNC Dermatology Clinical Trials Unit, Chapel Hill, North Carolina, 27516, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Vital Prospects Clinical Research Institute, P.C, Tulsa, Oklahoma, 74136, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|CINME Centro de Investigaciones Metabolicas, Caba, Buenos Aires, C1027AAP, Argentina|Psoriahue Medicina Interdisciplinaria, Caba, C1425DKG, Argentina|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Royal Park Campus, Parkville, Victoria, 3052, Australia|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|Eastern Canada Cutaneous Research Associates Ltd., Halifax, Nova Scotia, B3H 1Z2, Canada|Guenther Research Inc, London, Ontario, N6A 3H7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|York Dermatology Clinic and Research Centre, Richmond Hill, Ontario, L4C 9M7, Canada|Medicor Research Inc, Sudbury, Ontario, P3A1W8, Canada|Sudbury Skin Clinique, Sudbury, Ontario, P3C 1X8, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada|Centre de Recherche Dermatologique du Quebec metropolitain, Quebec, G1V 4X7, Canada|Centro Internacional de Estudios Clinicos, CIEC, Santiago, Recoleta, 8420383, Chile|Centro Medico Skin Med, Santiago, RegiÃ³n Metropolitana, 7580206, Chile|Clinica Dermacross S.A., Santiago, RegiÃ³n Metropolitana, 7640881, Chile|Medical Skin Center, Vina del Mar, Valparaiso, 2530900, Chile|Peking University First Hospital, Beijing, Beijing, 100034, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China|The University of Hong Kong - Shenzhen Hospital, Shenzhen, Guangdong, 518053, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China|The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, 210029, China|Huashan Hospital, Fudan University/Dermatology Department, Shanghai, Shanghai, 200040, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|The Second Affiliated Hospital of College of Medicine, Zhejiang University/Dermatology Dept, Hangzhou, Zhejiang, 310009, China|Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China|Fundacion Centro de Investigacion Clinica CIC, Medellin, Antioquia, 050001, Colombia|Fundacion Hospitalaria San Vicente de Paul, Medellin, Antioquia, 050010, Colombia|Centro de InvestigaciÃ³n en ReumatologÃ­a y Especialidades MÃ©dicas SAS - CIREEM SAS, Bogota, D.c., 110221, Colombia|DERMAMEDICA s.r.o., Nachod, 54701, Czechia|Fakultni nemocnice Olomouc, Olomouc, 779 00, Czechia|Clintrial s.r.o., Praha 10, 100 00, Czechia|Sanatorium profesora Arenbergera, Praha 1, 11000, Czechia|Nemocnice Na Bulovce, Praha 8- Liben, 180 81, Czechia|Fachklinik Bad Bentheim, Bad Bentheim, 48455, Germany|Emovis GmbH, Berlin, 10629, Germany|Universitaetsklinikum Erlangen, Erlangen, 91054, Germany|University Hospital Frankfurt, Frankfurt am Main, 60590, Germany|University Hospital Schleswig-Holstein, Luebeck, 23538, Germany|University Hospital Muenster, Muenster, 48149, Germany|Semmelweis Egyetem, Budapest, 1085, Hungary|Debreceni Egyetem, Debrecen, 4032, Hungary|Bugat Pal Korhaz, Borgyogyaszat, Gyongyos, 3200, Hungary|Szegedi TudomÃ¡nyegyetem Altalanos Orvostudomanyi Kar, Szeged, 6720, Hungary|Nagoya City University Hospital - Dermatology, Nagoya, Aichi, 467-8602, Japan|Tohoku University hospital, Sendai, Miyagi, 980-8574, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, 136-0075, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Osaka City University Hospital, Osaka, 545-8586, Japan|Pusan National University Hospital, Busan, 49241, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Sociedad de Metabolismo y Corazon S.C., Veracruz, C.P. 91900, Mexico|Hospital D'Maria, Veracruz, CP. 91910, Mexico|Centermed Krakow Sp.z o.o., Krakow, 31-530, Poland|Medicover Sp.z.o.o, Lodz, 90-368, Poland|Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak, Lodz, 90-436, Poland|Sanova Audiological Care Polska Sp.z.o.o, Lodz, 91-867, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|RCMed Oddzial Warszawa, Warszawa, 02-657, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-962, Poland|Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak SpÃ³Å‚ka Partnerska, Wroclaw, 50-566, Poland|State Budgetary Healthcare Institution Chelyabinsk Regional Clinical Dermatovenerologic Dispensary, Chelyabinsk, 454092, Russian Federation|University Clinic of Kirov SMU, Kirov, 610035, Russian Federation|Clinical Medical Center of A.I. Yevdokimov MSMSU, Moscow, 111398, Russian Federation|Federal State Autonomous Institution National Medical Research Centre of Childrens Health, Moscow, 119991, Russian Federation|State Budgetary Institution of the Rostov Region ""Dermatovenerologic Dispensary"", Rostov-on-Don, 344002, Russian Federation|Limited Liability Company ""Pierre Volkenshtein Skin Diseases Clinic"", Saint Petersburg,, 191123, Russian Federation|Limited Liability Company ""Centre Vitiligo"" (""Centre Vitiligo"" LLC), Saint Petersburg, 191123, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""Dermatovenerologic Dispensary No. 10 -, Saint Petersburg, 194021, Russian Federation|State Autonomous Healthcare Institution of the Yaroslavl Region Clinical Emergency Hospital, Yaroslavl, 150003, Russian Federation|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitario Reina SofÃ­a, Servicio Dermatologia, Cordoba, 14004, Spain|Servicio Otorrinolaringologia, Hospital Universitario Reina Sofia, Cordoba, 14004, Spain|Servicio Radiologia, Hospital Universitario Reina Sofia, Cordoba, 14004, Spain|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Servicio de Dermatologia, Hospital Universitario y Politecnico La Fe, Valencia, 46026, Spain|Servicio de Otorrinolaringologia, Hospital Universitario y Politecnico La Fe, Valencia, 46026, Spain|Servicio de Radiologia, Hospital Universitario y Politecnico Le Fe, Valencia, 46026, Spain|CHANG GUNG MEMORIAL HOSPITAL Kaohsiung Branch, Kaohsiung City, 83301, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, 807, Taiwan|Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, 23561, Taiwan|Chung Shan Medical University Hospital, Taichung, 40201, Taiwan|Chung-Shan Medical University Hospital, Taichung, 40201, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Chang Gung Memorial Hospital-Linkou Branch, Taoyuan City, 333, Taiwan|Brighton and Sussex University Hospitals NHS Trust, Brighton, EAST Sussex, BN2 5BE, United Kingdom|Southampton University Hospital NHS Foundation Trust, Royal South Hants Hospital, Southampton, Hampshire, SO14 0YG, United Kingdom|Brighton and Sussex University Hospitals NHS Trust, Brighton, BN2 5BE, United Kingdom|NHS Tayside Ninewells Hospital, Dundee, DD1 9SY, United Kingdom|NHS Greater Glasgow and Clyde Queen Elizabeth University Hospital, Glasgow, G51 4TF, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, G51 4TF, United Kingdom|Southampton University Hospital NHS Foundation Trust, University Hospital Southampton, Hampshire, SO16 6YD, United Kingdom|Guy's and St.Thomas' Hospitals NHS Foundation Trust, St.Thomas' Hospital,, London,, SE1 7EH, United Kingdom|Guy's and St.Thomas' Hospitals NHS Foundation Trust, Guy's Hospital,, London,, SE1 9RT, United Kingdom|Harley Grove Medical Centre, London, E3 2AT, United Kingdom",
Alopecia Areata,NCT05866562,Dupilumab in the Treatment of Pediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT05866562,NO,Alopecia Areata,DRUG: Dupilumab|DRUG: Placebo,ALL,CHILD,PHASE2,"University of California, Irvine, Irvine, California, 92697, United States|Yale University, New Haven, Connecticut, 06511, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States","Principal Investigator : Emma Guttman-Yassky, MD, PhD , Icahn School of Medicine at Mount Sinai"
Alopecia Areata,NCT06149936,Excimer Light(308) Therapy for Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT06149936,NO,Alopecia Areata,DEVICE: excimer light,ALL,ADULT,,,Assiut University
Alopecia Areata,NCT06402630,"A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)",https://clinicaltrials.gov/study/NCT06402630,NO,Alopecia Areata,DRUG: STS01|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Queen Margaret Hospital, Glasgow, Dunfirmline, KY12 0SU, United Kingdom|St Lukes Hospital, Bradford, Little Horton Lane, BD5 0NA, United Kingdom|Royal Alexandra Children's Hospital, Brighton, BN2 5BE, United Kingdom|University Hospital Coventry & Warwickshire, Coventry, CV2 2DX, United Kingdom|Queen Elizabeth University Hospital, Glasgow, G51 4TF, United Kingdom|Gloucestershire Royal Hospital, Gloucester, GL1 3NN, United Kingdom|Queen Anne Street Medical Centre Limited, London, W1G 8HU, United Kingdom|Norfolk and Norwich University Hospital, Norwich, NR4 7UY, United Kingdom|Salford Royal Hospital, Salford, M6 8HD, United Kingdom",Soterios Ltd
Alopecia Areata,NCT05745389,CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry,https://clinicaltrials.gov/study/NCT05745389,NO,Alopecia Areata,,ALL,"ADULT, OLDER_ADULT",,"CorEvitas, LLC, Waltham, Massachusetts, 02451, United States",CorEvitas
Alopecia Areata,NCT01385839,Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata,https://clinicaltrials.gov/study/NCT01385839,NO,Alopecia Areata|Alopecia|Balding,PROCEDURE: Hair transplantation|PROCEDURE: Hypodermic needle irritation,ALL,"ADULT, OLDER_ADULT",,"Icahn School of Medicine at Mount Sinai, Department of Dermatology Clinical Trials Center, New York, New York, 10029, United States","Principal Investigator : Robin Unger, MD , Icahn School of Medicine at Mount Sinai"
Alopecia Areata,NCT06018428,"Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata",https://clinicaltrials.gov/study/NCT06018428,NO,Alopecia Areata,DRUG: ADX-914|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Scottsdale, Arizona, Scottsdale, Arizona, 85255, United States|Fayetteville, Arkansas, Fayetteville, Arkansas, 72703, United States|Hot Springs, Arkansas, Hot Springs, Arkansas, 71913, United States|Encinitas, California, Encinitas, California, 92024, United States|Fountain Valley, California, Fountain Valley, California, 92708, United States|Lomita, California, Lomita, California, 90717, United States|Miami, Florida, Miami, Florida, 33173, United States|Tampa, Florida, Tampa, Florida, 33613, United States|Clarksville, Indiana, Clarksville, Indiana, 47129, United States|Troy, Michigan, Troy, Michigan, 48084, United States|Warren, Michigan, Warren, Michigan, 48192, United States|New York, New York, New York, New York, 11211, United States|Wilmington, North Carolina, Wilmington, North Carolina, 28405, United States|Bexley, Ohio, Bexley, Ohio, 43209, United States|Mason, Ohio, Mason, Ohio, 45040, United States|Mayfield Heights, Ohio, Mayfield Heights, Ohio, 44124, United States|Portland, Oregon, Portland, Oregon, 97225, United States|Austin, Texas, Austin, Texas, 78759, United States|Frisco, Texas, Frisco, Texas, 75034, United States|Houston, Texas, Houston, Texas, 77056, United States|San Antonio, Texas, San Antonio, Texas, 78213, United States|Jordan, Utah, Jordan, Utah, 84095, United States|Spokane, Washington, Spokane, Washington, 99202, United States",Innovaderm Research Inc.
Alopecia Areata,NCT06012240,A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06012240,NO,Alopecia Areata,DRUG: Upadacitinib|DRUG: Placebo,ALL,"CHILD, ADULT",PHASE3,"Total Skin and Beauty Dermatology Center /ID# 259539, Birmingham, Alabama, 35205, United States|Advanced Research Associates - Glendale /ID# 259108, Glendale, Arizona, 85308, United States|Southwest Skin Specialists /ID# 258234, Phoenix, Arizona, 85018-3953, United States|Alliance Dermatology and Mohs Center /ID# 258111, Phoenix, Arizona, 85032, United States|Johnson Dermatology Clinic /ID# 259103, Fort Smith, Arkansas, 72916-6103, United States|Joseph Raoof Md,Inc /Id# 258031, Encino, California, 91436, United States|First OC Dermatology /ID# 259220, Fountain Valley, California, 92708, United States|University of California Irvine /ID# 259096, Irvine, California, 92697-1385, United States|Dermatology Research Associates /ID# 258033, Los Angeles, California, 90045, United States|Integrative Skin Science and Research /ID# 258114, Sacramento, California, 95815, United States|University of California Davis Health /ID# 258112, Sacramento, California, 95817, United States|Clinical Trials Research Institute /ID# 258021, Thousand Oaks, California, 91320-2130, United States|Skin Care Research Boca Raton /ID# 258012, Boca Raton, Florida, 33486-2269, United States|Apex Clinical Trials /ID# 259205, Brandon, Florida, 33511, United States|Florida Academic Dermatology Center /ID# 259353, Coral Gables, Florida, 33134-5755, United States|Revival Research /ID# 259213, Doral, Florida, 33122-1902, United States|Skin Care Research - Hollywood /ID# 259210, Hollywood, Florida, 33021-6748, United States|GSI Clinical Research, LLC /ID# 259352, Margate, Florida, 33063, United States|Life Clinical Trials /ID# 259358, Margate, Florida, 33063, United States|Lenus Research and Medical Group /ID# 259356, Miami, Florida, 33172, United States|International Clinical Research - Sanford /ID# 259547, Sanford, Florida, 32771, United States|Advanced Clinical Research Institute /ID# 259204, Tampa, Florida, 33607, United States|Avita Clinical Research /ID# 258011, Tampa, Florida, 33613-1825, United States|Cleaver Medical Group Dermatology /ID# 259801, Dawsonville, Georgia, 30534, United States|Marietta Dermatology /ID# 259818, Marietta, Georgia, 30060, United States|U.S. Dermatology Partners Leawood /ID# 259203, Leawood, Kansas, 66211-1453, United States|MetroBoston Clinical Partners /ID# 259559, Boston, Massachusetts, 02135-3511, United States|Lahey Hospital & Medical Center /ID# 260484, Burlington, Massachusetts, 01805, United States|Great Lakes Research Group - Bay City /ID# 259100, Bay City, Michigan, 48706, United States|Hamzavi Dermatology - Canton /ID# 260115, Canton, Michigan, 48187, United States|Clin Res Inst of Michigan, LLC /ID# 259802, Chesterfield, Michigan, 48047, United States|Clarkston Dermatology /ID# 258018, Clarkston, Michigan, 48346, United States|Henry Ford Medical Center - New Center One /ID# 258067, Detroit, Michigan, 48202-3046, United States|M Health Fairview University of Minnesota Medical Center - East Bank /ID# 260122, Minneapolis, Minnesota, 55455, United States|Minnesota Clinical Study Center /ID# 259218, New Brighton, Minnesota, 55112, United States|Dermatology and Skin Center of Lees Summit /ID# 259206, Lee's Summit, Missouri, 64064-2301, United States|Physician Research Collaboration, LLC /ID# 259354, Lincoln, Nebraska, 68516, United States|Skin Specialists, PC /ID# 259237, Omaha, Nebraska, 68144, United States|Skin Cancer and Dermatology Institute - Reno /ID# 259208, Reno, Nevada, 89509, United States|Schweiger Dermatology, P.C. /ID# 259531, Verona, New Jersey, 07044-2946, United States|Icahn School of Medicine at Mount Sinai /ID# 259808, New York, New York, 10029, United States|Schweiger Dermatology, P.C. /ID# 258007, Verona, New York, 07044-2946, United States|Remington-Davis Clinical Research /ID# 258106, Columbus, Ohio, 43215, United States|Dermatologists of Southwest Ohio, Inc /ID# 260116, Mason, Ohio, 45040-4520, United States|Oregon Dermatology and Research Center /ID# 258243, Portland, Oregon, 97210, United States|Oregon Medical Research Center /ID# 258107, Portland, Oregon, 97223, United States|Medical University of South Carolina /ID# 259828, Charleston, South Carolina, 29425, United States|International Clinical Research - Tennessee LLC /ID# 259552, Murfreesboro, Tennessee, 37130-2450, United States|Arlington Research Center, Inc /ID# 258028, Arlington, Texas, 76011, United States|Bellaire Dermatology Associates /ID# 259360, Bellaire, Texas, 77401, United States|U.S. Dermatology Partners - Cedar Park /ID# 259367, Cedar Park, Texas, 78613, United States|Dermatology Treatment and Research Center /ID# 259357, Dallas, Texas, 75230, United States|Modern Research Associates, PLLC /ID# 259349, Dallas, Texas, 75231, United States|Reveal Research Institute, Dallas /ID# 259361, Dallas, Texas, 75235-2519, United States|Center for Clinical Studies - Houston - Northwest Freeway /ID# 258036, Houston, Texas, 77065, United States|Progressive Clinical Research /ID# 259365, San Antonio, Texas, 78229, United States|Complete Dermatology /ID# 258025, Sugar Land, Texas, 77479-3794, United States|Buenos Aires Skin /ID# 258297, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1055, Argentina|Instituto de Neumonologia y Dermatologia /ID# 258640, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1425, Argentina|Psoriahue Med Interdisciplinar /ID# 258641, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, 1425, Argentina|Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 258639, Buenos Aires, 1061, Argentina|Instituto de Investigaciones Clinicas CÃ³rdoba /ID# 260244, Cordoba, 5000, Argentina|Holdsworth House Medical Practice /ID# 258571, Darlinghurst, New South Wales, 2010, Australia|St George Dermatology & Skin Cancer Centre /ID# 258567, Kogarah, New South Wales, 2217, Australia|Cornerstone Dermatology /ID# 258769, Coorparoo, Queensland, 4151, Australia|Veracity Clinical Research /ID# 258566, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute Inc /ID# 258570, Carlton, Victoria, 3053, Australia|Sinclair Dermatology - Melbourne /ID# 258565, East Melbourne, Victoria, 3002, Australia|The Royal Melbourne Hospital /ID# 258770, Parkville, Victoria, 3050, Australia|Fremantle Dermatology /ID# 260207, Fremantle, Western Australia, 6160, Australia|Irmandade da Santa Casa de Misericordia de Porto Alegre /ID# 258045, Porto Alegre, Rio Grande Do Sul, 90020-090, Brazil|Hospital e Maternidade Celso Pierro - PUC-Campinas /ID# 258105, Campinas, Sao Paulo, 13034-685, Brazil|Instituto Brasil de Pesquisa Clinica S.A - IBPClin /ID# 258750, Rio de Janeiro, 20241-180, Brazil|Hospital Alemao Oswaldo Cruz /ID# 258104, Sao Paulo, 01323-020, Brazil|Diagnostic Consultative Center Aleksandrovska /ID# 257049, Sofiya, Sofia, 1431, Bulgaria|UMHAT Sveti Georgi /ID# 257548, Plovdiv, 4002, Bulgaria|Ambulatory for Specialized Medical Care for skin and venereal diseases /ID# 257047, Sofia, 1407, Bulgaria|XX Diagnostic consultative center Sofia EOOD /ID# 257273, Sofiya, 1618, Bulgaria|UMHAT Professor Stoyan Kirkovich /ID# 257051, Stara Zagora, 6000, Bulgaria|Dr. Chih-ho Hong Medical Inc. /ID# 258814, Surrey, British Columbia, V3R 6A7, Canada|Wiseman Dermatology Research /ID# 258819, Winnipeg, Manitoba, R3M 3Z4, Canada|SimcoDerm Medical and Surgical Dermatology Center /ID# 258820, Barrie, Ontario, L4M 7G1, Canada|Lynde Institute for Dermatology /ID# 258815, Markham, Ontario, L3P 1X2, Canada|JRB Research /ID# 259248, Ottawa, Ontario, K1H 7X3, Canada|SKiN Centre for Dermatology /ID# 258813, Peterborough, Ontario, K9J 5K2, Canada|Medicor Research Inc /ID# 258810, Sudbury, Ontario, P3C 1X3, Canada|Private Practice - Dr. Kim Papp Clinical Research /ID# 259249, Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc. /ID# 258812, MontrÃ©al, Quebec, H2X 2V1, Canada|Centre de Recherche dermatologique du Quebec Metropolitain /ID# 258811, QuÃ©bec, Quebec, G1V 4X7, Canada|Centro Medico Skin Med SPA /ID# 259314, Las Condes, Region Metropolitana Santiago, 7580206, Chile|Clinica Dermacross /ID# 259311, Vitacura, Region Metropolitana Santiago, 7640881, Chile|Centro Internacional de Estudios Clinicos - CIEC /ID# 259312, Santiago, 8420383, Chile|Beijing Chaoyang Hospital,Capital Medical University /ID# 258912, Beijing, Beijing, 100020, China|China-Japan Friendship Hospital /ID# 258941, Beijing, Beijing, 100029, China|The First Affiliated Hospital, Sun Yat-sen University /ID# 257367, Guangzhou, Guangdong, 510080, China|Dermatology Hospital of Southern Medical University /ID# 257118, Guangzhou, Guangdong, 510091, China|The First Affiliated Hospital of Guangzhou Medical University /ID# 258663, Guangzhou, Guangdong, 510163, China|Zhujiang Hospital of Southern Medical University /ID# 258485, Guangzhou, Guangdong, 510280, China|Shenzhen People's Hospital /ID# 258208, Shenzhen, Guangdong, 518020, China|Shenzhen Second People's Hospital /ID# 258060, Shenzhen, Guangdong, 518039, China|Renmin Hospital of Wuhan University /ID# 260260, Wuhan, Hubei, 430060, China|Dermatology Hospital of Jiangxi Provincial /ID# 259488, Nanchang, Jiangxi, 330030, China|The First Hospital of Jilin University /ID# 257496, Changchun, Jilin, 130021, China|Second Affiliated Hospital of Xian Jiaotong University /ID# 257497, Xi'an, Shaanxi, 710004, China|Huashan Hospital, Fudan University /ID# 257758, Shanghai, Shanghai, 200040, China|First Affiliated Hospital of Shanxi Medical University /ID# 259647, Taiyuan, Shanxi, 030001, China|Chengdu Second Municipal People's Hospital /ID# 259492, Chengdu, Sichuan, 610017, China|West China Hospital, Sichuan University /ID# 259560, Chengdu, Sichuan, 610041, China|Tianjin Medical University General Hospital /ID# 259525, Tianjin, Tianjin, 300052, China|The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 257260, Hangzhou, Zhejiang, 310009, China|Sir Run Run Shaw Hospital Zhejiang University School of Medicine /ID# 257119, Hangzhou, Zhejiang, 310020, China|The First Affiliated Hospital of Wenzhou Medical University /ID# 257739, Wenzhou, Zhejiang, 325000, China|The Second Affiliated Hospital of Chongqing Medical University /ID# 260254, Chongqing, 400010, China|HCL - Hopital Edouard Herriot /ID# 256983, Lyon, Rhone, 69003, France|CHRU de Brest - Hopital Morvan /ID# 256979, Brest, 29200, France|Centre de Sante Sabouraud /ID# 257213, Paris, 75010, France|CHU Toulouse - Hopital Larrey /ID# 256980, Toulouse, 31400, France|Universitaetsklinikum Duesseldorf /ID# 257307, DÃ¼sseldorf, Nordrhein-Westfalen, 40225, Germany|Universitaetsklinikum Muenster /ID# 257306, Muenster, Nordrhein-Westfalen, 48149, Germany|Universitaetsklinikum Schleswig-Holstein Campus Luebeck /ID# 257305, LÃ¼beck, Schleswig-Holstein, 23538, Germany|Fachklinik Bad Bentheim /ID# 257741, Bad Bentheim, 48455, Germany|CharitÃ© UniversitÃ¤tsmedizin Berlin - Campus Mitte /ID# 257310, Berlin, 10117, Germany|Klinikum rechts der Isar /ID# 257609, Munich, 81675, Germany|DERMA-B Egeszsegugyi es Szolgaltato - Debrecen - Gyepusor Utca /ID# 257469, Debrecen, 4031, Hungary|Bagoly Egeszseghaz (Meditres Kft.) /ID# 258032, Kecskemet, 6000, Hungary|Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 257468, Pecs, 7624, Hungary|Rambam Health Care Campus /ID# 257769, Haifa, H_efa, 3525408, Israel|The Chaim Sheba Medical Center /ID# 257770, Ramat Gan, Tel-Aviv, 5265601, Israel|Tel Aviv Sourasky Medical Center /ID# 257771, Tel Aviv, Tel-Aviv, 6423906, Israel|Hadassah Medical Center-Hebrew University /ID# 257946, Jerusalem, Yerushalayim, 91120, Israel|Rabin Medical Center /ID# 257772, Haifa, 4941492, Israel|Kurume University Hospital /ID# 257255, Kurume-shi, Fukuoka, 830-0011, Japan|Kitasato University Hospital /ID# 257285, Sagamihara-shi, Kanagawa, 252-0375, Japan|Niigata University Medical & Dental Hospital /ID# 259425, Niigata-shi, Niigata, 951-8520, Japan|Osaka Metropolitan University Hospital /ID# 257256, Osaka-shi, Osaka, 545-8586, Japan|Hamamatsu University Hospital /ID# 257253, Hamamatsu-shi, Shizuoka, 431-3192, Japan|Tokyo Medical University Hospital /ID# 258132, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamaguchi University Hospital /ID# 257252, Ube-shi, Yamaguchi, 755-8505, Japan|Kyorin University - Mitaka Campus /ID# 257283, Mitaka, 181-8611, Japan|Pusan National University Hospital /ID# 257910, Busan, Busan Gwang Yeogsi, 49241, Korea, Republic of|Kyungpook National University Hospital /ID# 257908, ì¤‘êµ¬, Daegu Gwang Yeogsi, 41944, Korea, Republic of|Seoul National University Bundang Hospital /ID# 257906, Seongnam-si, Gyeonggido, 13620, Korea, Republic of|Inha University Hospital /ID# 257904, Incheon, Incheon Gwang Yeogsi, 21565, Korea, Republic of|Seoul National University Hospital /ID# 257903, Seoul, Seoul Teugbyeolsi, 03080, Korea, Republic of|Konkuk University Medical Center /ID# 257900, Seoul, Seoul Teugbyeolsi, 05030, Korea, Republic of|Kyung Hee University Hospital at Gangdong /ID# 257907, Seoul, Seoul Teugbyeolsi, 05278, Korea, Republic of|Hallym University Kangdong Sacred Heart Hospital /ID# 257905, Seoul, 05355, Korea, Republic of|Greenlane Clinical Centre /ID# 258563, Epsom, Auckland, 1051, New Zealand|Aotearoa Clinical Trials /ID# 258562, Auckland, 1640, New Zealand|Clinical Trials New Zealand /ID# 258564, Hamilton, 3204, New Zealand|P3 Research Ltd /ID# 259846, Wellington, 6021, New Zealand|Specjalistyczny Gabinet Dermatologiczny Aplikacyjno Badawczy /ID# 257534, Krakow, Malopolskie, 30-002, Poland|Klinika Osipowicz & Turkowski sp.z.o.o /ID# 257598, Warszawa, Mazowieckie, 00-716, Poland|Centrum Medyczne ALL-MED Badania Kliniczne /ID# 257590, Cracow, 30-033, Poland|Unidade Local de Saude de Almada-Seixal, EPE /ID# 257425, Almada, 2805-267, Portugal|Hospital CUF Descobertas /ID# 257419, Lisboa, 1998-018, Portugal|Unidade Local de Saude de Santo Antonio, E.P.E. /ID# 258554, Porto, 4099-003, Portugal|Santa Cruz Behavioral (SCB) Research Center /ID# 259350, Bayamon, 00961-6910, Puerto Rico|Dr. Samuel Sanchez PSC /ID# 259359, Caguas, 00727, Puerto Rico|Clinical Research Puerto Rico /ID# 259355, San Juan, 00909-1711, Puerto Rico|GCM Medical Group PSC /ID# 258013, San Juan, 00917-3104, Puerto Rico|Mindful Medical Research /ID# 260113, San Juan, 00918-3756, Puerto Rico|Hospital Universitario Reina Sofia /ID# 257035, CÃ³rdoba, Cordoba, 14004, Spain|Hospital Universitario de Fuenlabrada /ID# 257334, Fuenlabrada, Madrid, 28942, Spain|Hospital Santa Creu i Sant Pau /ID# 257034, Barcelona, 08041, Spain|Hospital Universitario Dr. Peset /ID# 257036, Valencia, 46017, Spain|Kaohsiung Chang Gung Memorial Hospital /ID# 258726, Kaohsiung City, Kaohsiung, 833, Taiwan|National Taiwan University Hospital /ID# 257407, Taipei City, Taipei, 100, Taiwan|National Cheng Kung University Hospital /ID# 257409, Tainan, 704, Taiwan|Taipei Veterans General Hosp /ID# 257413, Taipei, 11217, Taiwan|Velocity Clinical Research Ltd /ID# 257925, High Wycombe, Buckinghamshire, HP11 2QW, United Kingdom|Oxford University Hospitals NHS Foundation Trust /ID# 257948, Oxford, Oxfordshire, OX3 9DU, United Kingdom|University Hospitals Sussex NHS Foundation Trust /ID# 257912, Worthing, West Sussex, BN11 2DH, United Kingdom|Gloucestershire Royal Hospital /ID# 257953, Gloucester, GL1 3NN, United Kingdom|London North West University Healthcare NHS Trust /ID# 257914, Harrow, HA1 3UJ, United Kingdom|Chelsea and Westminster Hospital NHS Foundation Trust /ID# 259128, London, SW10 9NH, United Kingdom|Northern Care Alliance NHS Group /ID# 257952, Salford, M6 8HD, United Kingdom","Study Director : ABBVIE INC. , AbbVie"
Alopecia Areata,NCT05803070,Topical Cetirizine in Treatment of Localized Alopecia Areata,https://clinicaltrials.gov/study/NCT05803070,NO,Alopecia Areata,DRUG: Topical Cetirizine 1 %|DRUG: Topical betamethasone valerate 0.1%,ALL,"CHILD, ADULT, OLDER_ADULT",,,Assiut University
Alopecia Areata,NCT06399783,Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06399783,NO,Alopecia Areata,DRUG: Simvastatin|DRUG: Mometasone Furoate|PROCEDURE: Fractional CO2 laser,ALL,"CHILD, ADULT",PHASE4,"Assiut university, Assiut, 73333, Egypt",Assiut University
Alopecia Areata,NCT04006457,Long-Term PF-06651600 for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04006457,NO,Alopecia Areata,"DRUG: PF-06651600|BIOLOGICAL: Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine|BIOLOGICAL: Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"The University of Alabama at Birmingham Hosptial Outreach Lab, Birmingham, Alabama, 35233, United States|The University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|The University of Alabama at Birmingham, Department of Dermatology, Birmingham, Alabama, 35294, United States|Mosaic Dermatology, Beverly Hills, California, 90211, United States|Univ of California, Irvine, Dermatology Clinical Research Center, Irvine, California, 92697, United States|Dermatology Specialists Inc., Murrieta, California, 92562, United States|University of California, San Francisco, San Francisco, California, 94115, United States|Kaiser Permanente Clinical Trials Unit, San Francisco, California, 94118, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States|University of Colorado Hospital Clinical and Translational Research Center, Aurora, Colorado, 80045, United States|University of Colorado Hospital Outpatient Pavilion, Aurora, Colorado, 80045, United States|Yale School of Medicine, New Haven, Connecticut, 06510, United States|Investigational Drug Services, New Haven, Connecticut, 06511, United States|Yale School of Medicine, Yale Center for Clinical Investigations, New Haven, Connecticut, 06519, United States|Yale School of Medicine, Yale Center for Clinical Investigation, New Haven, Connecticut, 06519, United States|Medstar Georgetown University Hospital - Department of Otolaryngology, Washington, District of Columbia, 20007, United States|Medstar Georgetown University Hospital-Dept of Otolaryngology, Washington, District of Columbia, 20007, United States|Medstar Washington Hospital Center-Claude Nogay Research Pharmacy, Washington, District of Columbia, 20010, United States|MedStar Washington Hospital Center, Washington, District of Columbia, 20010, United States|Medstar Georgetown University Hospital - Department of Pediatrics, Washington, District of Columbia, 20016, United States|Siperstein Dermatology Group, Boynton Beach, Florida, 33472, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Velocity Clinical Research - Boise, Meridian, Idaho, 83642, United States|Northwestern Medical Group, Chicago, Illinois, 60611, United States|Northwestern Medicine Diagnostic Testing Center, Chicago, Illinois, 60611, United States|Northwestern Medicine, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital Investigational Drug Service Pharmacy, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|Summit Dermatology and Aesthetic Surgery (in c/o TrialSpark, Inc), Oakbrook Terrace, Illinois, 60181, United States|NorthShore University HealthSystem Dermatology Clinical Trials Unit, Skokie, Illinois, 60077, United States|Northshore University HealthSystem/Dermatology, Skokie, Illinois, 60077, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Medstar Georgetown University Hospital - Department of Dermatology, Chevy Chase, Maryland, 20815, United States|Massachusetts General Hospital - Clinical Unit for Research Trials in Skin (CURTIS), Boston, Massachusetts, 02114, United States|University of Minnesota Clinical Research Unit (CRU), Minneapolis, Minnesota, 55455, United States|University of Minnesota Lillehei Clinical Research Unit (LCRU), Minneapolis, Minnesota, 55455, United States|University of Minnesota Medical Center, Investigational Drug Services Attn: Darlette Luke, Minneapolis, Minnesota, 55455, United States|Skin Specialists PC, Omaha, Nebraska, 68144, United States|Schweiger Dermatology, P.C., Verona, New Jersey, 07044, United States|NYU School of Medicine, The Ronald O. Perelman Department of Dermatology, New York, New York, 10016, United States|Pura Dermatology (in c/o TrialSpark, Inc), New York, New York, 10018, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|UNC CTRC, Chapel Hill, North Carolina, 27514, United States|UNC Hospitals, Investigational Drug Service, Chapel Hill, North Carolina, 27514, United States|UNC Dermatology and Skin Cancer Center, Chapel Hill, North Carolina, 27516, United States|UNC Dermatology Clinical Trials Unit, Chapel Hill, North Carolina, 27516, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|The University of Texas Health Science Center at Houston, Bellaire, Texas, 77401, United States|Tamjidi Skin Institute (in c/o TrialSpark, Inc), Vienna, Virginia, 22182, United States|CINME Centro de Investigaciones Metabolicas, Caba, Buenos Aires, C1027AAP, Argentina|Psoriahue Medicina Interdisciplinaria, Caba, C1425DKG, Argentina|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|St George Dermatology & Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Royal Melbourne Hospital, Melbourne Health, Parkville, Victoria, 3050, Australia|Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Royal Melbourne Hospital, Melbourne Health, Parkville, Victoria, 3052, Australia|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|Eastern Canada Cutaneous Research Associates Ltd., Halifax, Nova Scotia, B3H 1Z2, Canada|Guenther Research Inc, London, Ontario, N6A 3H7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X2, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|York Dermatology Clinic and Research Centre, Richmond Hill, Ontario, L4C 9M7, Canada|Medicor Research Inc, Sudbury, Ontario, P3A 1W8, Canada|Medicor Research Inc, Sudbury, Ontario, P3C 1X3, Canada|Sudbury Skin Clinique, Sudbury, Ontario, P3C 1X8, Canada|Research Toronto, Toronto, Ontario, M4W 2N2, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada|Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Quebec, G1V 4X7, Canada|Centro Medico Skin Med, Santiago, LAS Condes, 7580206, Chile|Centro Internacional de Estudios Clinicos - CIEC, Santiago, Recoleta, 8420383, Chile|Medical Skin Center, Vina del Mar, Valparaiso, 2530900, Chile|Clinica Dermacross S.A., Santiago, Vitacura, 7640881, Chile|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China|The University of Hong Kong - Shenzhen Hospital, Shenzhen, Guangdong, 518053, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China|The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, 210029, China|Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, 200025, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Fundacion Centro de Investigacion Clinica CIC, Medellin, Antioquia, 050001, Colombia|Fundacion Hospitalaria San Vicente de Paul, Medellin, Antioquia, 050010, Colombia|Centro de Investigacion en Reumatologia y Especialidades Medicas S.A.S, CIREEM S.A.S, Bogota D.C., 110221, Colombia|DERMAMEDICA s.r.o., Nachod, 547 01, Czechia|Fakultni nemocnice Olomouc, Olomouc, 779 00, Czechia|Clintrial s.r.o., Praha 10, 100 00, Czechia|Sanatorium profesora Arenbergera, Praha 1, 110 00, Czechia|Fachklinik Bad Bentheim, Bad Bentheim, Lower Saxony, 48455, Germany|Fachklinik Bad Bentheim, Bad Bentheim, 48455, Germany|Emovis GmbH, Berlin, 10629, Germany|Universitaetsklinikum Erlangen, Erlangen, 91054, Germany|University Hospital Frankfurt, Frankfurt am Main, 60590, Germany|University Hospital Schleswig-Holstein, Luebeck, 23538, Germany|University Hospital Muenster, Muenster, 48149, Germany|Nagoya City University Hospital, Nagoya, Aichi, 467-8602, Japan|Tohoku University Hospital, Sendai, Miyagi, 980-8574, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, 136-0075, Japan|Kyorin University Hospital, Mitaka-shi, Tokyo, 181-8611, Japan|Osaka Metropolitan University Hospital, Osaka, 545-8586, Japan|Tokyo Medical University Hospital, Tokyo, 160-0023, Japan|Pusan National University Hospital, Busan, 49241, Korea, Republic of|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Sociedad de Metabolismo y Corazon S.C., Veracruz, 91900, Mexico|Hospital D Maria, Veracruz, 91910, Mexico|Twoja Przychodnia SCM, Szczecin, Zachodniopomorskie, 71-500, Poland|McBk S.C., Grodzisk Mazowiecki, 05-825, Poland|Centermed Krakow Sp.z o.o., Krakow, 31-530, Poland|Dermoklinika Centrum Medyczne s.c. M.Kierstan, J. Narbutt, A. Lesiak, Lodz, 90-436, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, 27-400, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|RCMed Oddzial Warszawa, Warszawa, 00-892, Poland|Magdalena Opadczuk Carpe Diem Centrum Medycyny Estetycznej, Warszawa, 02-661, Poland|ETG Warszawa, Warszawa, 02-793, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-962, Poland|EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej we Wroclawiu, Wroclaw, 50-220, Poland|Cityclinic Przychodnia Lekarsko Psychologiczna Matusiak SpÃ³Å‚ka Partnerska, Wroclaw, 50-566, Poland|Centrum Medyczne OPOROW, Wroclaw, 52-416, Poland|State Budgetary Healthcare Institution ""Chelyabinsk Regional Clinical Dermatovenerologic Dispensary"", Chelyabinsk, 454092, Russian Federation|University Clinic of Kirov SMU, Kirov, 610035, Russian Federation|Clinical Medical Center of Moscow State University of Medicine and Dentistry, Moscow, 111398, Russian Federation|Federal State Autonomous Institution ""National Medical Research Centre of Children's' Health"", Moscow, 119991, Russian Federation|State Budgetary Institution of the Rostov Region ""Dermatovenerologic Dispensary"", Rostov-on-Don, 344002, Russian Federation|Limited Liability Company ""Pierre Volkenshtein Skin Diseases Clinic"", Saint Petersburg,, 191123, Russian Federation|Limited Liability Company ""Centre Vitiligo"" (""Centre Vitiligo"" LLC), Saint Petersburg, 191123, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution ""Dermatovenerologic Dispensary No. 10 -, Saint Petersburg, 194021, Russian Federation|State Autonomous Healthcare Institution of the Yaroslavl Region ""Clinical Emergency Hospital, Yaroslavl, 150003, Russian Federation|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitario Reina Sofia, Cordoba, 14004, Spain|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario La Paz: Servicio de Farmacia, Madrid, 28046, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario y Politecnico La Fe, Valencia, 46026, Spain|Chung-Shan Medical University Hospital, Taichung, R.o.c., 40201, Taiwan|Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, 83301, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, 807, Taiwan|Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, 23561, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital, Taoyuan City, 333, Taiwan|University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, SO14 0YG, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, SO16 6YD, United Kingdom|University Hospitals Sussex NHS Foundation Trust (UHSussex), Brighton, BN2 1ES, United Kingdom|NHS Greater Glasgow and Clyde, Queen Elizabeth University Hospital, Glasgow, G51 4TF, United Kingdom|Guy's and St Thomas Hospitals NHS Foundation Trust, St Thomas Hospital, London, SE1 7EH, United Kingdom|Guy's and St Thomas' Hospitals NHS Foundation Trust, St Thomas' Hospital, London, SE1 7EH, United Kingdom|Guy's and St Thomas' Hospitals NHS Foundation Trust, Guy's Hospital, London, SE1 9RT, United Kingdom",
Alopecia Areata,NCT03800979,Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata,https://clinicaltrials.gov/study/NCT03800979,YES,Alopecia Areata,DRUG: Tofacitinib,ALL,ADULT,PHASE4,"Institute of Dermatology, Bangkok, Thailand","Principal Investigator : Chinmanat Lekhavat, MD , Institute of Dermatology"
Alopecia Areata,NCT03847441,Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03847441,NO,Alopecia Areata,DRUG: Calcipotriol|DEVICE: Narrow Band UVB|DIAGNOSTIC_TEST: vitamin D3 level,ALL,"CHILD, ADULT",,"Aswan University Hospital, Aswan, 81528, Egypt",Aswan University Hospital
Alopecia Areata,NCT05885269,Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata,https://clinicaltrials.gov/study/NCT05885269,NO,Alopecia Areata,DRUG: Group A applied topical Clobetasol Propionate|DRUG: Group B applied topical Tacrolimus,ALL,ADULT,PHASE1,"Danyal Sajjad, Abbottabad, Khyber Pakhtunkhwa, Pakistan",Combined Military Hospital Abbottabad
Alopecia Areata,NCT05485571,Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05485571,NO,Alopecia Areata,DEVICE: derma pen,ALL,ADULT,,"Sohag University Hospital, Sohag, Egypt",Sohag University
Alopecia Areata,NCT05910138,Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05910138,NO,Alopecia Areata,DIAGNOSTIC_TEST: Serum Interlukin-15|DIAGNOSTIC_TEST: Serum Interlukin-21,ALL,"CHILD, ADULT, OLDER_ADULT",,"Sohag University hospitals, Sohag, Egypt",
Alopecia Areata,NCT04660786,Intralesional Vitamin D in Alopecia Areata,https://clinicaltrials.gov/study/NCT04660786,NO,Alopecia Areata,DRUG: triamcinolone acetonide|DRUG: vitamin D,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,"Faculty of Medicine, Alexandria, 21521, Egypt",Alexandria University
Alopecia Areata,NCT02691117,Topical Garlic Concentrate for Alopecia Areata in Children,https://clinicaltrials.gov/study/NCT02691117,NO,Alopecia Areata,DRUG: garlic concentrate,ALL,"CHILD, ADULT",PHASE3,"Th Hospital for Sick Children, Toronto, Ontario, M5G1X8, Canada",
Alopecia Areata,NCT04412148,Modified SALT Score for Alopecia Areata,https://clinicaltrials.gov/study/NCT04412148,NO,Alopecia Areata,DRUG: Triamcinolone Acetonide|OTHER: saline,ALL,ADULT,PHASE4,"Kasr El Ainy university hospital, Faulty of medicine,Cairo university, Cairo, Egypt",Kasr El Aini Hospital
Alopecia Areata,NCT00167102,Alefacept in Patients With Severe Scalp Alopecia Areata,https://clinicaltrials.gov/study/NCT00167102,YES,Alopecia Areata,DRUG: Alefacept,ALL,"ADULT, OLDER_ADULT",,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",
Alopecia Areata,NCT05017454,Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids,https://clinicaltrials.gov/study/NCT05017454,NO,Alopecia Areata,DRUG: the optimized sodium valproate-loaded nanospanlastic dispersion|DRUG: mometasone furoate lotion,ALL,"CHILD, ADULT, OLDER_ADULT",EARLY_PHASE1,"Kasralainy Hospital, Dermatology Department, Cairo, Egypt","Principal Investigator : heba ahmed, Msc in dermatolo , Kasralainy Hospital, Faculty of Medicine, Cairo University"
Alopecia Areata,NCT02599129,A Study of Secukinumab for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT02599129,YES,Alopecia Areata,DRUG: Secukinumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",
Alopecia Areata,NCT04556734,Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04556734,YES,Alopecia Areata,DRUG: Etrasimod|DRUG: Etrasimod|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigate MD, Scottsdale, Arizona, 85255, United States|Dermatology Trial Associates, Bryant, Arkansas, 72022, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|University of California,Irvine, Irvine, California, 92697, United States|Prospect Optometry, Lomita, California, 90717, United States|Torrance Clinical Research Institute,Inc., Lomita, California, 90717, United States|Yale Eye Center, New Haven, Connecticut, 06511, United States|Yale Investigational Drug Services, New Haven, Connecticut, 06511, United States|Yale Center for Clinical Investigation, New Haven, Connecticut, 06519, United States|Yale New Haven Hospital Department of Respiratory Care, New Haven, Connecticut, 06519, United States|Advanced Sleep & Respiratory Institute, PA, Daytona Beach, Florida, 32117, United States|International Eye Associates, Ormond Beach, Florida, 32174, United States|Leavitt Medical Associates of Florida d/ba Ameriderm Research, Ormond Beach, Florida, 32174, United States|Advanced Clinical Research Institute, Tampa, Florida, 33607, United States|Advanced Medical Research PC, Sandy Springs, Georgia, 30328, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|Eye Surgeons of Indiana, Indianapolis, Indiana, 46260, United States|Magnante Eye Care (Ophthalmological Assessments), Lafayette, Indiana, 47905, United States|Physicians Research Group (Administrative Office Location), Noblesville, Indiana, 46060, United States|Physicians Research Group, West Lafayette, Indiana, 47906, United States|Randall Dermatology, PC, West Lafayette, Indiana, 47906, United States|Lawrence J. Green, MD LLC, Rockville, Maryland, 20850, United States|Michigan Center for Skin Care Research, Clinton Township, Michigan, 48038, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|NYC Retina- Manhattan, New York, New York, 10003, United States|Bobby Buka MD, PC, New York, New York, 10012, United States|Rochester Ophthalmological Group, Rochester, New York, 14623, United States|Skin Search of Rochester, Inc., Rochester, New York, 14623, United States|WDC Cosmetic and Research, PLLC, Wilmington, North Carolina, 28405, United States|NW Dermatology Institute, Portland, Oregon, 97210, United States|UPMC Department of Dermatology, Pittsburgh, Pennsylvania, 15213, United States|UPMC Eye Center, Pittsburgh, Pennsylvania, 15213, United States|International Clinical Research - Tennessee LLC, Murfreesboro, Tennessee, 37130, United States|Progressive Clinical Research, PA, San Antonio, Texas, 78213, United States|The Education & Research Foundation, Inc., Lynchburg, Virginia, 24501, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|PRINCIPLE RESEARCH SOLUTIONS (pulmonary function testing), Spokane, Washington, 99204, United States|SPOKANE EYE CLINIC (OCT and optical exam, Spokane, Washington, 99204, United States|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|Laser Rejuvenation Clinics Edmonton D.T. Inc., Edmonton, Alberta, T5J 3S9, Canada|Innovaderm Research, Montreal, Quebec, H2X 2V1, Canada","Study Director : Pfizer CT.gov Call Center , Pfizer"
Alopecia Areata,NCT05926882,"Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.",https://clinicaltrials.gov/study/NCT05926882,NO,Alopecia Areata,DRUG: Apremilast 30mg,ALL,"ADULT, OLDER_ADULT",PHASE4,"JPMC, Karachi, Sindh, Pakistan","Principal Investigator : Nazia Jabeen, FCPS , JPMC Principal Investigator : Khadija Asadullah, FCPS , JPMC Principal Investigator : Faiza Inam, FCPS , JPMC"
Alopecia Areata,NCT05861401,Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05861401,NO,Alopecia Areata,GENETIC: Janus Kinase 1 and 2,ALL,"CHILD, ADULT, OLDER_ADULT",,"Sohag University hospitals, Sohag, Egypt",
Alopecia Areata,NCT01802177,Excimer Light for Alopecia Areata,https://clinicaltrials.gov/study/NCT01802177,NO,Alopecia Areata,PROCEDURE: UVB excimer light,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada","Principal Investigator : Harvey Lui, MD FRCPC , University of British Columbia"
Alopecia Areata,NCT01736007,Childhood Alopecia Areata Study Using the 308-nm Excimer Laser,https://clinicaltrials.gov/study/NCT01736007,NO,Alopecia Areata,DEVICE: 308-nm excimer laser to alopecia patch|DEVICE: Liquid light guide tip on laser,ALL,CHILD,,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States","Principal Investigator : Harper N Price, MD , Phoenix Children's Hospital Principal Investigator : Judith AJ O'Haver, PhD , Phoenix Children's Hospital"
Alopecia Areata,NCT04517864,PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA,https://clinicaltrials.gov/study/NCT04517864,YES,Alopecia Areata,DRUG: PF-06651600|DRUG: Placebo,ALL,ADULT,PHASE2,"Marvel Clinical Research 002, LLC, Huntington Beach, California, 92647, United States|University of California, Irvine, Irvine, California, 92697, United States|Skin Care Research, LLC, Boca Raton, Florida, 33486, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|Skin Care Research, Hollywood, Florida, 33021, United States|Kendall Adkisson, MD - Intracoastal Dermatology, Jacksonville, Florida, 32224, United States|Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, 32256, United States|Y&L Advance Health Care Inc., d/b/a Elite Clinical Research, Miami, Florida, 33144, United States|BRCR Medical Center Inc, Miramar, Florida, 33027, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Orlando, Florida, 32801, United States|Orlando Dermatology & Skin Cancer Surgery Center, Oviedo, Florida, 32765, United States|USF Health Morsani Center For Advanced Healthcare, Tampa, Florida, 33612, United States|NorthShore University HealthSystem Dermatology Clinical Trials Unit, Skokie, Illinois, 60077, United States|NorthShore University HealthSystem Dermatology Clinic, Skokie, Illinois, 60077, United States|Washington University School of Medicine-Dermatology, Saint Louis, Missouri, 63108, United States|University of New Mexico Department of Dermatology, Albuquerque, New Mexico, 87102, United States|University of New Mexico Clinical & Translational Sciences Center, Albuquerque, New Mexico, 87106, United States|Stony Brook Dermatology, Stony Brook, New York, 11790, United States|M3 Wake Research, Inc., Raleigh, North Carolina, 27612, United States|Tekton Research, Inc., Austin, Texas, 78745, United States|Center for Clinical Studies, LTD. LLP, Houston, Texas, 77004, United States|Summit Clinical Research, LLC, Franklin, Virginia, 23851, United States|The Education & Research Foundation, Inc., Lynchburg, Virginia, 24501, United States|Virginia Dermatology and Skin Cancer Center, Norfolk, Virginia, 23502, United States|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|Eastern Health - Box Hill Hospital, Box Hill, Victoria, 3128, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Sima Recherche, Verdun, Quebec, H4G 3E7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W4R4, Canada|Niepubliczny Zaklad Opieki Zdrowotnej Specjalistyczny Osrodek Dermatologiczny ""DERMAL"", Bialystok, 15-453, Poland|Centrum Medyczne Angelius Provita, Katowice, 40-611, Poland|AWP Klinika Dermatologii Pod Fortem Anna Wojas-Pelc, Krakow, 31-302, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, 27-400, Poland|RCMed Oddzial Warszawa, Warszawa, 00-892, Poland|MTZ Clinical Research Sp. z o.o, Warszawa, 02-106, Poland|MTZ Clinical Research Powered by Pratia, Warszawa, 02-172, Poland|Przychodnia przy ul. Lowieckiej, Wroclaw, 50-220, Poland|Centrum Medyczne Matusiak, WrocÅ‚aw, 50-566, Poland","Study Director : Pfizer CT.gov Call Center , Pfizer"
Alopecia Areata,NCT04964349,Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04964349,NO,Alopecia Areata,DRUG: Corticosteroids Acting Locally,ALL,"CHILD, ADULT",EARLY_PHASE1,"Alazhar faculty of meidicine, Cairo, Egypt","Study Chair : Ahmed Elshahid, MD , Alazhar faculty of medicine"
Alopecia Areata,NCT05414266,Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata,https://clinicaltrials.gov/study/NCT05414266,NO,Alopecia Areata,DRUG: Placebo|DRUG: SADBE 5%,ALL,"CHILD, ADULT",EARLY_PHASE1,"The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States","Principal Investigator : Adelaide Hebert, MD , The University of Texas Health Science Center, Houston"
Alopecia Areata,NCT05278858,Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT05278858,YES,Alopecia Areata,COMBINATION_PRODUCT: MedJet Device with intralesional triamcinolone,ALL,CHILD,PHASE4,"University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States","Principal Investigator : Sonal Shah, MD , University Hospitals Cleveland Medical Center"
Alopecia Areata,NCT00176982,"Plaquenil for Alopecia Areata, Alopecia Totalis",https://clinicaltrials.gov/study/NCT00176982,NO,Alopecia Areata,DRUG: Hydroxychloroquine,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States|State University of New York at Stony Brook, Stonybrook, New York, 11790, United States","Principal Investigator : Maria Hordinsky, MD , University of Minnesota Principal Investigator : Richard Kalish, MD, PhD , State Universiyt of New York at Stony Brook"
Alopecia Areata,NCT05587257,Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT05587257,NO,Alopecia Areata,DEVICE: Fractional CO2 laser|DEVICE: Derma pen|DRUG: Niosome minoxidil|DRUG: Minoxidil Topical Spray,ALL,"CHILD, ADULT",,,Assiut University
Alopecia Areata,NCT06327581,Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06327581,NO,Alopecia Areata,DRUG: Lactic Acid|DRUG: vit D|DRUG: Triamcinolone Acetonide|DRUG: Saline,ALL,"CHILD, ADULT, OLDER_ADULT",,"Rana Ehab, Zagazig, 44519, Egypt",
Alopecia Areata,NCT06104839,Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06104839,NO,Alopecia Areata,DRUG: NXC736|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,,NEXTGEN Bioscience
Alopecia Areata,NCT05368103,Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05368103,NO,Alopecia Areata,BIOLOGICAL: Daxdilimab,ALL,"ADULT, OLDER_ADULT",PHASE2,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|First OC Dermatology Research, Inc., Fountain Valley, California, 92708, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|DS Research, Louisville, Kentucky, 40241, United States|Progressive Clinical Research, P.A., San Antonio, Texas, 78213, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Dr Dusan Sajic Medicine Professional Corporation, Guelph, Ontario, N1L 0B7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2,, Canada|Innovaderm Research, MontrÃ©al, Quebec, H2X 2V1, Canada|Centre de Recherche Saint-Louis (Quebec), Quebec, G1W 4R4, Canada","Study Director : MD , Amgen"
Alopecia Areata,NCT04793945,Excimer Light and Topical Steroid in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04793945,NO,Alopecia Areata,COMBINATION_PRODUCT: topical steroid and 308nm-Excimer light therapy,ALL,"CHILD, ADULT",PHASE4,,"Principal Investigator : Fatma m zidan, student , Assiut University"
Alopecia Areata,NCT04797650,Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2),https://clinicaltrials.gov/study/NCT04797650,YES,Alopecia Areata,DRUG: CTP-543 matching placebo|DRUG: CTP-543,ALL,"ADULT, OLDER_ADULT",PHASE3,"Alliance Dermatology & Mohs Center, Phoenix, Arizona, 85032, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|University of Miami Hospital, Miami, Florida, 33124, United States|Floridian Research Institute LLC, Miami, Florida, 33145, United States|MetroBoston Clinical Partners, LLC, Brighton, Massachusetts, 02135, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, 48087, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Galen Research, Chesterfield, Missouri, 63005, United States|Vivida Dermatology, Las Vegas, Nevada, 89148, United States|The Dermatology Group P.C., Verona, New Jersey, 07044, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Columbia University Medical Center - Department of Dermatology, New York, New York, 10032, United States|University of Rochester, Rochester, New York, 14642, United States|Dermatologists of Southwest Ohio, Mason, Ohio, 45040, United States|Oregon Medical Research, Portland, Oregon, 97223, United States|Velocity Clinical Research - Providence, Warwick, Rhode Island, 02886, United States|The Skin Wellness Center, Knoxville, Tennessee, 37922, United States|North Texas Center for Clinical Research, Frisco, Texas, 75034, United States|Elixir Research Group, Houston, Texas, 77077, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Velocity Clinical Research/Gateway, Salt Lake City, Utah, 84101, United States|Velocity Clinical Research/Swinyer-Woseth Dermatology, Salt Lake City, Utah, 84117, United States|Jordan Valley Dermatology Center, South Jordan, Utah, 84095, United States|The Rector and Visitors of the University of Virginia, Charlottesville, Virginia, 22903, United States|Care Clinic Ltd., Red Deer, Alberta, T4N6V7, Canada|Medical Arts Health Research Group, Kelowna, British Columbia, V1Y 4N7, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X1Y9, Canada|North Bay Dermatology Centre, North Bay, Ontario, P1B 3Z7, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B1A5, Canada|Centre de Recherche Saint-Louis, Quebec, G1W4R4, Canada|Centre de Recherche Dermatologique du Quebec Metropolitan, Quebec, L4B1A5, Canada|Centre Hospitalier Universitaire de Nice - HÃ´pital Archet 2, Nice, Alpes-maritimes, 06202 CEDEX 3, France|Chru de Brest - HÃ´pital Morvan, Brest, FinestÃ¨re, 29609 CEDEX, France|Universitaetsklinikum TÃ¼bingen, TÃ¼bingen, Baden-wÃ¼rttemberg, 72076, Germany|Klinikum Rechts Der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Bayern, 80802, Germany|UniversitÃ¤tsklinikum Frankfurt Klinik FÃ¼r Dermatologie, Venerologie Und Allergologie, Frankfurt am main, Hessen, 60590, Germany|Fachklinik Bad Bentheim - Dermatologische Studienambulanz, Bad Bentheim, Niedersachsen, 48455, Germany|Dermatologische Studienambulanz, Bochum, Nordrhein-Westfalen, 44791, Germany|University Hospital Muenster, MÃ¼nster, Nordrhein-westfalen, 48149, Germany|Clinical Research Center for Hair and Skin Science, Dept of Dermatology, CharitÃ© UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany|UniversitÃ¤tsklinikum Erlangen Hautklinik, Erlangen, 91054, Germany|PÃ©csi TudomÃ¡nyegyetem Klinikai KÃ¶zpont, BÅ‘r-, NemikÃ³rtani Ã‰s OnkodermatolÃ³giai Klinika, PÃ©cs, Baranya, 7632, Hungary|Szte Ãok Szent-GyÃ¶rgyi Albert Klinikai KÃ¶zpont BÅ‘rgyÃ³gyÃ¡szati Ã‰s AllergolÃ³giai Klinika, Szeged, CsongrÃ¡d-csanÃ¡d, 6720, Hungary|BugÃ¡t PÃ¡l KÃ³rhÃ¡z, GyÃ¶ngyÃ¶s, Heves, 3200, Hungary|Semmelweis Egyetem, ÃltalÃ¡nos OrvostudomÃ¡nyi Kar, BÅ‘r-, NemikÃ³rtani Ã‰s BÅ‘ronkolÃ³giai Klinika, Budapest, Pest, 1085, Hungary|Wromedica I. Bielicka, A. Strzalkowska S.C., WrocÅ‚aw, DolnoÅ›lÄ…skie, 50-685, Poland|Twoja Przychodnia - Centrum Medyczne Nowa SÃ³l, Nowa SÃ³l, Lubuskie, 67-100, Poland|Etg Siedlce, Siedlce, Mazowieckie, 08-110, Poland|Ot.Co Clinic Klinika Osipowicz & Turkowski Sp. Z O.O., Warszawa, Mazowieckie, 00-716, Poland|Rcmed Oddzial Warszawa, Warszawa, Mazowieckie, 00-892, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszawa, Mazowieckie, 02-664, Poland|Etg Warszawa, Warszawa, Mazowieckie, 02-793, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|Etg Skierniewice, Skierniewice, ÅÃ³dzkie, 96-100, Poland|Hospital Del Mar, Barcelona, CataluÃ±a, 08001, Spain|Hospital Santa Creu I Sant Pau, Barcelona, CataluÃ±a, 08041, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario Reina Sofia, CÃ³rdoba, 14004, Spain|Hospital Universitario RamÃ³n Y Cajal - Edificio Consultas Externas, Madrid, 28034, Spain|Hospital Doce de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario Infanta Leonor, Madrid, 28081, Spain",Concert Pharmaceuticals
Alopecia Areata,NCT04228029,Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids,https://clinicaltrials.gov/study/NCT04228029,NO,Alopecia Areata,DEVICE: Carboxytherapy|DRUG: Intralesional Steroid Injection,ALL,ADULT,PHASE4,"Kasr ElAiny Hospital, Cairo university, Cairo, El Manial, 11956, Egypt",Kasr El Aini Hospital
Alopecia Areata,NCT05502952,Combined Microneedling and Topical Pentoxifylline Vesrus Intalesional Pentoxifylline in Treatment of Alopecia Areata: Intra-indiviual Comparative Study,https://clinicaltrials.gov/study/NCT05502952,NO,Alopecia Areata,DRUG: Pentoxifylline,ALL,"ADULT, OLDER_ADULT",,"Sohag University Hospital, Sohag, Egypt",Sohag University
Alopecia Areata,NCT01950780,Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata,https://clinicaltrials.gov/study/NCT01950780,YES,Alopecia Areata,DRUG: Ruxolitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia University Medical Center, Department of Dermatology, New York, New York, 10032, United States","Principal Investigator : Julian Mackay-Wiggan, MD, MS , Columbia University"
Alopecia Areata,NCT04147845,Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT04147845,NO,Alopecia Areata,OTHER: Fractional Carbon Dioxide Laser|OTHER: Microneedling using dermapen|OTHER: Triamcinolone Acetonide|OTHER: Platelet-rich plasma,ALL,"CHILD, ADULT, OLDER_ADULT",,"Faculty of Medicine, Alexandria University, Alexandria, Egypt","Study Director : Khaled El Mulla, MBBCh, MS, Ph.D , Professor of Dermatology,Venereology and Andrology, Faculty of Medicine, University of Alexandria Study Director : Eman Elmorsy, MBBCh, MS, Ph.D , Professor of Dermatology,Venereology and Andrology, Faculty of Medicine, University of Alexandria"
Alopecia Areata,NCT03535233,Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03535233,NO,Alopecia Areata,DRUG: Triamcinolone Acetonide|DRUG: Minoxidil 5 % Topical Spray|DRUG: clobetasol propionate,ALL,"ADULT, OLDER_ADULT",PHASE4,,"Study Chair : Nermine H El-Eishi, MD , Cairo University Principal Investigator : Heba M Mashaly, MD , Cairo University Principal Investigator : Solwan I El-Samanoudy, MD , Cairo University Principal Investigator : Mona MI ElKalioby, MD , Cairo University Principal Investigator : Olfat G Shaker, MD , Cairo University Principal Investigator : Rania M Abdel-Hay, MD , Cairo University Show fewer investigators"
Alopecia Areata,NCT01520077,Vytorin in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01520077,NO,Alopecia Areata,DRUG: vytorin,ALL,"ADULT, OLDER_ADULT",PHASE1,"University of Miami, Miami, Florida, 33136, United States","Principal Investigator : Lawrence Schachner, M.D , University of Miami"
Alopecia Areata,NCT03651752,DPCP for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03651752,NO,Alopecia Areata,DRUG: Diphenylcyclopropenone (DPCP) Ointment,ALL,"ADULT, OLDER_ADULT",PHASE3,"University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States","Principal Investigator : Maria Hordinsky, MD , University of MN Department of Dermatology"
Alopecia Areata,NCT01328678,A Study of Vitamin D in Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT01328678,NO,Alopecia Areata,,ALL,"ADULT, OLDER_ADULT",,"Avera Research Institute, Sioux Falls, South Dakota, 57105, United States","Principal Investigator : Wael Eid, MD , Avera McKennan Hospital & University Health Center"
Alopecia Areata,NCT04299503,Topical Crisaborole in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04299503,NO,Alopecia Areata,DRUG: Crisaborole Topical Ointment|DRUG: Placebo Topical Ointment,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, 02111, United States","Principal Investigator : David Rosmarin, MD , Tufts Medical Center"
Alopecia Areata,NCT02684123,Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT02684123,YES,Alopecia Areata,DRUG: Apremilast|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",
Alopecia Areata,NCT02299297,"Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis",https://clinicaltrials.gov/study/NCT02299297,YES,Alopecia Areata,DRUG: Tofacitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia University Medical Center, New York, New York, 10032, United States","Principal Investigator : Julian Mackay-Wiggan, MD, MS , Columbia University"
Alopecia Areata,NCT05599607,Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT05599607,NO,Alopecia Areata,DIETARY_SUPPLEMENT: Probiotic mixture|DIETARY_SUPPLEMENT: Placebo,ALL,"ADULT, OLDER_ADULT",,"Centro DermatolÃ³gico EstÃ©tico, Alicante, 03014, Spain","Bionou Research, S.L."
Alopecia Areata,NCT04338295,Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling,https://clinicaltrials.gov/study/NCT04338295,NO,Alopecia Areata,DEVICE: Tattoo machine (SOL Nova Device),MALE,"ADULT, OLDER_ADULT",,"Yale University, New Haven, Connecticut, 06519, United States","Principal Investigator : Brett King, MD, PhD , Associate Professor of Dermatology, Yale University"
Alopecia Areata,NCT03359356,Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD),https://clinicaltrials.gov/study/NCT03359356,YES,Alopecia Areata,DRUG: Dupilumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|The Rockefeller University Laboratory for Investigative Dermatology, New York, New York, 10065-6399, United States","Principal Investigator : Emma Guttman, MD,PhD , Icahn School of Medicine at Mount Sinai"
Alopecia Areata,NCT04518995,Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1),https://clinicaltrials.gov/study/NCT04518995,YES,Alopecia Areata,DRUG: CTP-543 matching placebo|DRUG: CTP-543|DRUG: CTP-543,ALL,"ADULT, OLDER_ADULT",PHASE3,"Total Skin and Beauty Dermatology Center, Birmingham, Alabama, 35205, United States|Kern Research, Inc., Bakersfield, California, 93301, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|UC Irvine Dermatology Clinical Research Center, Irvine, California, 92697, United States|Quest Dermatology Research, Northridge, California, 91324, United States|Kaiser Permanente, Oakland, California, 94611, United States|Kaiser Permanente South Sacramento, Sacramento, California, 95823, United States|Kaiser Permanente, San Francisco, California, 94118, United States|Colorado Center for Dermatology and Skin Surgery, Centennial, Colorado, 80111, United States|Colorado Medical Research Center, Denver, Colorado, 80210, United States|Yale University, Church Street Research Unit, New Haven, Connecticut, 06519, United States|Lenus Research & Medical Group, LLC, Sweetwater, Florida, 33172, United States|Clinical Research Trials of Florida, Inc., Tampa, Florida, 33607, United States|Forward Clinical Trials Inc., Tampa, Florida, 33624, United States|Denova Research, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Department of Dermatology, Chicago, Illinois, 60611, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|DS Research, New Albany, Indiana, 47150, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|DS Research, Louisville, Kentucky, 40241, United States|Qualmedica Research LLC, Owensboro, Kentucky, 42301, United States|Massachusetts General Hospital - Clinic, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|Minnesota Clinical Study Center, Fridley, Minnesota, 55432, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|Skin Laser and Surgery Specialists of NJ, Hackensack, New Jersey, 07601, United States|Sadick Research Group, New York, New York, 10075, United States|Darst Dermatology, Charlotte, North Carolina, 28277, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|Wake Forest University Health Sciences, Department of Dermatology, Winston-Salem, North Carolina, 27157, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Northwest Dermatology Institute, Portland, Oregon, 97210, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Dermatology Associates Of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|PEAK Research, Upper Saint Clair, Pennsylvania, 15241, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Palmetto Clinical Trial Services, Fountain Inn, South Carolina, 29644, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|Dermatology Treatment and Research Center, Dallas, Texas, 75230, United States|Austin Institute for Clinical Research, Inc., Houston, Texas, 77056, United States|Austin Institute for Clinical Research, Inc., Pflugerville, Texas, 78660, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|West End Dermatology Associates, Richmond, Virginia, 23233, United States|Clinical Investigation Specialists, Inc., Kenosha, Wisconsin, 53144, United States|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Kirk Barber Research, Calgary, Alberta, T2G 1B1, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L 0B7, Canada|Dr Wei Jing Loo Medicine Professional Corporation, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|Dr. S. K. Siddha Medicine Professional Corporation, Newmarket, Ontario, L3Y 5G8, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|JRB Research Inc., Ottawa, Ontario, K1H 7X3, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|K. Papp Clinical Research Inc., Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc. - Clinic, Montreal, Quebec, H2X 2V1, Canada|HÃ´pital Saint-AndrÃ© - Chu de Bordeaux, Bordeaux, Nouvelle-aquitaine, 33075, France|HÃ´pital Saint-Louis - Gh de La Rochelle, La Rochelle, Nouvelle-aquitaine, 17000, France|HÃ´pital Hotel Dieu - Chu de Nantes, Nantes, PAYS DE LA Loire, 44093, France|HÃ´pital La Timone-Dermatologie, Marseille, 13385, France|HÃ´pital Saint Louis, Centre de SantÃ© Sabouraud, Paris, 75010, France|Vita Longa Sp.Zo.O, Katowice, 40-748, Poland|SGD S.C., Krakow, 31-147, Poland|My Clinic, Warsaw, 00-144, Poland|Royalderm Agnieszka Nawrocka, Warsaw, 02-962, Poland|Hospital ClÃ­nico Y Provincial de Barcelona, Barcelona, 8036, Spain|H. U. RamÃ³n y Cajal, Madrid, 28034, Spain",Concert Pharmaceuticals
Alopecia Areata,NCT01673789,Stem Cell Educator Therapy in Alopecia Areata,https://clinicaltrials.gov/study/NCT01673789,NO,Alopecia Areata,DEVICE: Stem Cell Educator,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050031, China","Study Chair : Yong Zhao, MD, PhD , Throne Biotechnologies Inc."
Alopecia Areata,NCT05556265,A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata,https://clinicaltrials.gov/study/NCT05556265,NO,Alopecia Areata,DRUG: Deucravacitinib|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Local Institution - 0016, Santa Monica, California, 90404-2120, United States|Local Institution - 0036, New Haven, Connecticut, 06510, United States|Local Institution - 0018, Tampa, Florida, 33624-2038, United States|Local Institution - 0023, Clinton Township, Michigan, 48038-1137, United States|Local Institution - 0024, New York, New York, 10029-6501, United States|Local Institution - 0019, Chapel Hill, North Carolina, 27516-4061, United States|Local Institution - 0011, Portland, Oregon, 97201-5134, United States|Local Institution - 0032, Pittsburgh, Pennsylvania, 15213-3403, United States|Local Institution - 0012, Austin, Texas, 78759, United States|Local Institution - 0013, Houston, Texas, 77004-8098, United States|Local Institution - 0014, San Antonio, Texas, 78213-2250, United States|Local Institution - 0017, South Jordan, Utah, 84095, United States|Local Institution - 0003, Kogarah, New South Wales, 2217, Australia|Local Institution - 0005, Carlton, Victoria, 3053, Australia|Local Institution - 0015, Winnipeg, Manitoba, R3M 3Z4, Canada|Local Institution - 0021, Markham, Ontario, L3P 1X2, Canada|Local Institution - 0009, Peterborough, Ontario, K9J 5K2, Canada|Local Institution - 0010, Richmond Hill, Ontario, L4C 9M7, Canada|Local Institution - 0034, Montreal, Quebec, H2X 2V1, Canada|Local Institution - 0027, QuÃ©bec, Quebec, G1V 4X7, Canada|Local Institution - 0033, Nice, 06200, France|Local Institution - 0020, Paris, 75010, France|Local Institution - 0031, Hamamatsu-Shi, 431-3192, Japan|Local Institution - 0028, Koto-Ku, 136-0075, Japan|Local Institution - 0030, Mitaka-Shi, 181-8611, Japan|Local Institution - 0029, Shinjuku-Ku, 160-0023, Japan|Local Institution - 0026, Wroclaw, DS, 50-566, Poland|Local Institution - 0025, Warsaw, 02-962, Poland","Study Director : Bristol-Myers Squibb , Bristol-Myers Squibb"
Alopecia Areata,NCT05470413,Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05470413,NO,Alopecia Areata,DRUG: SHR0302|DRUG: SHR0302|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China|Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China|China-Japan Friendship Hospital, Beijing, Beijing, China|Peking Union Medical College Hospital, Beijing, Beijing, China|Peking University People's Hospital, Beijing, Beijing, China|Chongqing Traditional Chinese Medicine Hospital, Chongqing, Chongqing, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China|Zhujiang Hospital of Southern Medical University, Guanzhou, Guangdong, China|Shenzhen People's Hospital, Shenzhen, Guangdong, China|Henan Provincial People's Hospital, Zhengzhou, Henan, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China|Wuhan No.1 Hospital, Wuhan, Hubei, China|The second xiangya hospital of central south university, Changsha, Hunan, China|Xiangya Hospital Of Central South University, Changsha, Hunan, China|Dermatology Hospital of Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China|Jiangsu Province People's Hospital, Nanjing, Jiangsu, China|Wuxi No.2 People's Hospital, Wuxi, Jiangsu, China|Jiangxi Provincial Hospital of Dermatology, Nanchang, Jiangxi, China|The First Hospital of Jilin University, Changchun, Jilin, China|Shengjing Hospital Of China Medical University, Shengyang, Liaoning, China|Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China|Shanghai Skin Disease Hospital, Shanghai, Shanghai, China|First Hospital Of Shanxi Medical University, Taiyuan, Shanxi, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China|West China Hospital Sichuan University, Chengdu, Sichuan, China|Hangzhou First People's Hospital, Hangzhou, Zhejiang, China|Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China|The First Affiliated Hospital Of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China|Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China|The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China",Reistone Biopharma Company Limited
Alopecia Areata,NCT01898806,Intralesional Steroids in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01898806,YES,Alopecia Areata,DRUG: Intralesional Triamcinolone 2.5 mg/ml|DRUG: Intralesional Triamcinolone 5 mg/ml|DRUG: Intralesional Triamcinolone 10 mg/ml|DRUG: Intralesional Saline,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States|Columbia University Medical Center, Department of Dermatology, New York, New York, 10032, United States",
Alopecia Areata,NCT01917058,A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT01917058,NO,Alopecia Areata,DRUG: Abatacept|DRUG: placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia University Medical Center, Dept of Dermatology, New York, New York, 10032, United States","Principal Investigator : Julian Mackay-Wiggan, MD, MS , Columbia University"
Alopecia Areata,NCT04740970,A Study of JNJ-64304500 in Participants With Alopecia Areata,https://clinicaltrials.gov/study/NCT04740970,NO,Alopecia Areata,DRUG: JNJ-64304500|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Forcare Clinical Research, Inc., Tampa, Florida, 33613, United States|Indiana Clinical Trial Center, Plainfield, Indiana, 46168, United States|Dermatology Specialists, Louisville, Kentucky, 40241, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Columbia University Medical Center, New York, New York, 10032, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|University of Pittsburgh Department of Dermatology, Pittsburgh, Pennsylvania, 15213, United States|Modern Research Associates, Dallas, Texas, 75231, United States|Center for Clinical Studies, Webster, Texas, 77598, United States|Sinclair Dermatology, East Melbourne, 3002, Australia|Fremantle Dermatology, Fremantle, 6160, Australia|St George Dermatology & Skin Cancer Centre, Kogarah, 2217, Australia|Veracity Clinical Research, Woolloongabba, 4102, Australia|CHU Bordeaux - Hopital St Andre, Bordeaux, 33000, France|CHU de Nice Hopital de l Archet, Nice, 06200, France|CHU Rouen - Hopital Charles Nicolle, Rouen, 76031, France|Hamamatsu University Hospital, Hamamatsu, 431-3192, Japan|Kyorin University Hospital, Mitaka, 181-8611, Japan|Osaka City University Hospital, Osaka, 545-8586, Japan|The Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, 136-0075, Japan|Tokyo Medical University Hospital, Tokyo, 160-0023, Japan|Yamaguchi University Hospital, Ube, 755-8505, Japan","Study Director : Janssen Research & Development, LLC Clinical Trial , Janssen Research & Development, LLC"
Alopecia Areata,NCT05255237,Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05255237,NO,Alopecia Areata,DRUG: Jaktinib,ALL,"ADULT, OLDER_ADULT",PHASE3,"11 Xizhimen South Street, Beijing, Beijing, China","Principal Investigator : Jianzhong Zhang, PhD , Peking University People's Hospital Principal Investigator : Qianjin Lu, PhD , Hospital for skin diseases, Chinese Academy of Medical Sciences"
Alopecia Areata,NCT06340360,A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA),https://clinicaltrials.gov/study/NCT06340360,NO,Alopecia Areata,DRUG: Rezpegaldesleukin|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Quest Dermatology Research, Northridge, California, 91324, United States|Atlanta Biomedical Clinical Research, Atlanta, Georgia, 30331, United States|Clinical Investigation Specialists, Inc., Gurnee, Illinois, 60031, United States|Michigan Center for Skin Care Research, Clinton Township, Michigan, 48038, United States|ALLCUTIS Research, LLC., Portsmouth, New Hampshire, 03801, United States|Sadick Research Group LLC, New York, New York, 10075, United States|DermDox Centers for Dermatology, Camp Hill, Pennsylvania, 17011, United States|North Texas Center for Clinical Research, Frisco, Texas, 75034, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 786660, United States|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X3, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|Centre de Recherche Saint-Louis SHERBROOKE, Sherbrooke, Quebec, J1G 1X9, Canada","Study Director : Study Director , Nektar Therapeutics"
Alopecia Areata,NCT02553330,A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA),https://clinicaltrials.gov/study/NCT02553330,YES,Alopecia Areata,DRUG: Placebo Cream|DRUG: Ruxolitinib Phosphate Cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"Birmingham, Alabama, United States|Hot Springs, Arkansas, United States|New Haven, Connecticut, United States|Trumbull, Connecticut, United States|Miami, Florida, United States|Beverly, Massachusetts, United States|Boston, Massachusetts, United States|Clinton Township, Michigan, United States|Fort Gratiot, Michigan, United States|Fridley, Minnesota, United States|Minneapolis, Minnesota, United States|Winston-Salem, North Carolina, United States|Cleveland, Ohio, United States|Portland, Oregon, United States|Austin, Texas, United States|Houston, Texas, United States|Katy, Texas, United States|Norfolk, Virginia, United States",
Alopecia Areata,NCT02350023,Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata,https://clinicaltrials.gov/study/NCT02350023,NO,Alopecia Areata,DRUG: Topical latanoprost 0.005%|DRUG: Topical betamethasone 0.05%,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Dept of Dermatology, PGIMER, Chandigarh, 160012, India","Post Graduate Institute of Medical Education and Research, Chandigarh"
Alopecia Areata,NCT04346316,A Phase II Study in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04346316,NO,Alopecia Areata,DRUG: SHR0302,ALL,"ADULT, OLDER_ADULT",PHASE2,"Quest Dermatology Research, Northridge, California, 91324, United States|Moore Clinical Research, Brandon, Florida, 33511, United States|Dawes Fretzin Clinical Research, Indianapolis, Indiana, 46250, United States|Skin Search of Rochester, Inc, Rochester, New York, 14623, United States|Dermatologists of Southwest Ohio, Mason, Ohio, 45040, United States|The Skin Wellness Center, Knoxville, Tennessee, 37922, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|Novatrials, Kogarah, New South Wales, 2289, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Sinclair Dermatology, Melbourne, Victoria, 3002, Australia|China-Japan Friendship Hospital, Beijing, Beijing, 100029, China|Peking University First Hospital, Beijing, Beijing, 100034, China|Peking University People's Hospital, Beijing, Beijing, 100044, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, 100730, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China|Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China|Peking University People's Hospital, Beijing, Beijing, China|Chongqing Traditional Chinese medicine Hospital, Chongqing, Chongqing, 400011, China|The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, 400016, China|The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350005, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, 510030, China|The Dermatology Hospital of Nanfang Medical University, Guangzhou, Guangdong, China|The Dermatology Hospital of Nanfang Medical University, Guangzhou, Guangzhou, China|Henan Provincial People's Hospital, Zhengzhou, Henan, 450003, China|Jiangsu Province People's Hospital, Nanjin, Jiangsu, 210029, China|The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China|Shanghai Skin Disease Hospital, Shanghai, Shanghai, 200071, China|Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Tianjin, 300120, China|The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310003, China|SIR RUN RUN Shaw Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310020, China",Reistone Biopharma Company Limited
Alopecia Areata,NCT06444451,A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT06444451,NO,Alopecia Areata,DRUG: Amlitelimab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Vital Prospects Clinical Research Institute, P.C. Site Number : 8400004, Tulsa, Oklahoma, 74136, United States|Health Concepts Site Number : 8400001, Rapid City, South Dakota, 57702, United States|Investigational Site Number : 0360003, East Melbourne, Victoria, 3002, Australia|Investigational Site Number : 1240001, Winnipeg, Manitoba, R3M 3Z4, Canada|Investigational Site Number : 1240006, Markham, Ontario, L3P 1X3, Canada",Sanofi
Alopecia Areata,NCT06060977,"A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants",https://clinicaltrials.gov/study/NCT06060977,NO,Alopecia Areata (AA),DRUG: IMG-007,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A., Rogers, Arkansas, 72758, United States|Torrance Clinical Research Institute Inc., Lomita, California, 90717, United States|Alliance Clinical Research of Tampa, Tampa, Florida, 33615, United States|Dawes Fretzin Clinical Resarch Group, LLC, Indianapolis, Indiana, 47906, United States|Options Research Group, West Lafayette, Indiana, 47906, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, 01803, United States|Great Lakes Research Group Inc., Bay City, Michigan, 48706, United States|Skin Cancer and Dermatology Institute, Reno, Nevada, 89509, United States|Skin Search of Rochester, Inc., Rochester, New York, 14623, United States|Stride Clinical Research LLC, Sugar Land, Texas, 77479, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|SimcoMed Health Ltd., Barrie, Ontario, L4M7G1, Canada|Skin Health, Cobourg, Ontario, K9A0Z4, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L0B7, Canada|Research Toronto, Toronto, Ontario, M2W2N4, Canada|Centre de Recherche Saint-Louis, QuÃ©bec, Quebec, G1W4R4, Canada|Innovaderm Research Inc., MontrÃ©al, Canada",Inmagene LLC
Alopecia Areata,NCT05051761,Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05051761,NO,Alopecia Areata,DRUG: Jaktinib|DRUG: placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Peking University People's Hospital, Beijing, Beijing, 100044, China|Hospital for Skin Diseases, Chinese Academy of medical Sciences, Nanjing, Jiangsu, 210042, China","Study Chair : Jason Wu , Suzhou Zelgen Biopharmaceuticals Co.,Ltd"
Alopecia Areata,NCT05041803,European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT05041803,NO,Alopecia Areata,DRUG: CTP-543,ALL,"ADULT, OLDER_ADULT",PHASE3,"Service de Dermatologie CHRU de Brest - Hopital Morvan, Brest Cedex, Finistere, 29609, France|Service de Dermatologie Centre Hospitalier Universitaire de Nice - Hopital Archet 2, Nice, Provence-Alpes-Cote d'Azur, 06202, France|CHU de Bordeaux, Hopital Saint-Andre, Bordeaux, 33000, France|Hopital Saint-Louis - GH De La Rochelle-Re-Aunis, La Rochelle, 17019, France|HÃ´pital La Timone-Dermatologie, Marseille, 13385, France|Hopital de l'Hotel Dieu - CHU de Nantes, Nantes, 22093, France|HÃ´pital Saint Louis, Centre de SantÃ© Sabouraud, Paris, 75010, France|Centre Hospitalier Universitaire de Toulouse - Hopital Larrey, Toulouse, 31059, France|UniversitÃ¤tsklinikum TÃ¼bingen UniversitÃ¤ts-Hautklinik, TÃ¼bingen, Baden-WÃ¼ttermberg, 72076, Germany|UniversitÃ¤tsklinikum Erlangen, Hautklinik, Erlangen, Bayern, 91054, Germany|Klinikum Rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Hautklinik, MÃ¼nchen, Bayern, 80802, Germany|Klinik fÃ¼r Dermatologie, Venerologie und Allergologie, Frankfurt am Main, Hessen, 60590, Germany|Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen, 48455, Germany|Klinik fÃ¼r Dermatologie und Venerologie, Zentrale Studienkoordination fÃ¼r innovative Dermatologie (ZiD), MÃ¼nster, Nordrhein-Westfalen, 48149, Germany|Clinical Research Center for Hair and Skin Science, Dept of Dermatology, CharitÃ© UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany|Pecsi Tudomanyegyetem Klinikai Kozpont, Bor-, Nemikortani es Onkodermatologiai Klinika, PÃ©cs, Baranya County, 7632, Hungary|SZTE AOK Szent-Gyorgyi Albert Klinikai Kozpont, Borgyogyaszati es Allergologiai Klinika, Szeged, Csongrad-Csanad County, 6720, Hungary|Semmelweis Egyetem AOK, Bor-, Nemikortani es Boronkologiai Klinika, Budapest, Pest, 1085, Hungary|Twoja Przychodnia Centrum Medyczne Nowa Sol, Nowa SÃ³l, Lubuskie, 67-100, Poland|ETG Siedlce, Siedlce, Mazowieckie, 08-110, Poland|ETG Skierniewice, Skierniewice, Mazowieckie, 96-100, Poland|RCMed Oddzial w Sochaczewie, Sochaczew, Mazowieckie, 96-500, Poland|ETG Warszawa, Warsaw, Mazowieckie, 02-793, Poland|OT.CO Clinic Klinika Osipowicz & Turkowski sp. z o.o, Warszawa, Mazowieckie, 00-716, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszawa, Mazowieckie, 02-661, Poland|NZOZ Specjalistyczny Osrodek Dermatologiczny DERMAL, BiaÅ‚ystok, 15-453, Poland|Vita Longa Sp.Zo.O, Katowice, 40-748, Poland|Specjalistyczny Gabinet Dermatologiczny s.c., KrakÃ³w, 30-002, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-500, Poland|My Clinic, Warsaw, 00-144, Poland|Royalderm Agnieszka Nawrocka, Warsaw, 02-962, Poland|WroMedica I. Bielicka, A. Strazalkowska s.c., Wroclaw, 51-685, Poland|Hospital ClÃ­nic de Barcelona, Barcelona, Barcelona/CataluÃ±a, 08036, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital de La Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Universitario Reina SofÃ­a, CÃ³rdoba, 14004, Spain|Hospital Universitario RamÃ³n y Cajal, Madrid, 28034, Spain|Hospital 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain",Concert Pharmaceuticals
Alopecia Areata,NCT05205070,A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05205070,NO,Alopecia Areata,BIOLOGICAL: Rosnilimab|BIOLOGICAL: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"10-105, Birmingham, Alabama, 35205, United States|Site10-103, Encinitas, California, 92024, United States|Site 10-113, Northridge, California, 91324, United States|Site 10-115, Chicago, Illinois, 60611, United States|10-104, Indianapolis, Indiana, 46250, United States|Site 10-109, Plainfield, Indiana, 46168, United States|Site 10-116, Louisville, Kentucky, 40241, United States|Site 10-117, Clarkston, Michigan, 48346, United States|Site 10-111, New York, New York, 10029, United States|Site 10-101, Charlotte, North Carolina, 28277, United States|Site 10-102, Bexley, Ohio, 43208, United States|Site 10-106, Tulsa, Oklahoma, 74136, United States|10-107, Upper Saint Clair, Pennsylvania, 15241, United States|10-110, Houston, Texas, 77056, United States|Site 10-108, San Antonio, Texas, 78229, United States|Site 10-114, Kenosha, Wisconsin, 53144, United States","Study Director : Bruce Randazzo, MD , AnaptysBio, Inc."
Alopecia Areata,NCT04784533,A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04784533,NO,Alopecia Areata,DRUG: CTP-543|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States|Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States|Kern Research, Inc., Bakersfield, California, 93301, United States|Hope Clinical Research, Canoga Park, California, 91303, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|University of California, Irvine, Irvine, California, 92697, United States|Quest Dermatology Research, Northridge, California, 91324, United States|Kaiser Permanente, Oakland, California, 94611, United States|Palmtree Clinical Research, Inc., Palm Springs, California, 92262, United States|Kaiser Permanente, San Francisco, California, 94118, United States|Colorado Center for Dermatology and Skin Surgery, Centennial, Colorado, 80111, United States|Colorado Medical Research Center, Inc., Denver, Colorado, 80210, United States|Yale University Church Street Research Unit, New Haven, Connecticut, 06519, United States|Skin Care Research, LLC, Boca Raton, Florida, 33486, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|DeNova Research, Chicago, Illinois, 60611, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|DS Research, Louisville, Kentucky, 40241, United States|Michigan Center for Research Company, LLC, Clarkston, Michigan, 48346, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|Minnesota Clinical Study Center, New Brighton, Minnesota, 55112, United States|Skin Specialists, PC, Omaha, Nebraska, 68144, United States|Skin Laser and Surgery Specialists of New Jersey, Hackensack, New Jersey, 07601, United States|Darst Dermatology, Charlotte, North Carolina, 28277, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|North Carolina Dermatology Associates, PLLC, Raleigh, North Carolina, 27617, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Remington Davis, Columbus, Ohio, 43215, United States|Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma, 74136, United States|Northwest Dermatology, Portland, Oregon, 97210, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|PEAK Research, LLC, Upper Saint Clair, Pennsylvania, 15241, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Dermatology Treatment and Research Center, PA, Dallas, Texas, 75230, United States|Austin Institute for Clinical Research, Houston, Texas, 77056, United States|Austin Institute for Clinical Research, Inc., Pflugerville, Texas, 78660, United States|Springville Dermatology/CCT Research, Springville, Utah, 84663, United States|West End Dermatology Associates, Richmond, Virginia, 23233, United States",Concert Pharmaceuticals
Alopecia Areata,NCT04003376,Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata,https://clinicaltrials.gov/study/NCT04003376,NO,Alopecia Areata,DEVICE: fractional carbon dioxide laser alone|DRUG: Triamcinolone Acetonide 10mg/mL|BIOLOGICAL: platelet rich plasma|DRUG: vitamin D solution,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Assiut University Hospital, Assiut, Egypt","Principal Investigator : Alaa Ghazally, MS , Assiut University"
Alopecia Areata,NCT02018042,An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata,https://clinicaltrials.gov/study/NCT02018042,YES,Alopecia Areata,DRUG: Abatacept,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia University Medical Center - Department of Dermatology, New York, New York, 10032, United States","Principal Investigator : Julian Mackay-Wiggan, MD, MS , Columbia University"
Alopecia Areata,NCT04034134,Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT04034134,NO,Alopecia Areata,DRUG: Jaktinib Hydrochloride Tablets|DRUG: Jaktinib Hydrochloride Tablets|DRUG: Jaktinib Hydrochloride Tablets,ALL,"ADULT, OLDER_ADULT",PHASE2,"Chongqing Chinese Traditional Medicine Hospital, Chongqing, Chongqing, 400011, China|The second xaingya hospital of central south university, Changsha, Hunan, 410011, China","Principal Investigator : qianjin Lu, MD , Central South University"
Alopecia Areata,NCT01453686,A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata,https://clinicaltrials.gov/study/NCT01453686,NO,Alopecia Areata,DRUG: Hydrocortisone 1%|DRUG: Clobetasol Propionate 0.05%,ALL,CHILD,PHASE3,"The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada","Principal Investigator : Colin Macarthur, MBChB, PhD , The Hospital for Sick Children, Toronto, Canada"
Alopecia Areata,NCT05650333,A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age,https://clinicaltrials.gov/study/NCT05650333,NO,Alopecia Areata,DRUG: Ritlecitinib 20 mg,ALL,CHILD,PHASE1,"California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Pediatric Skin Research,LLC, Coral Gables, Florida, 33146, United States|Nicklaus Children's Hospital, Miami, Florida, 33155, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, 87102, United States|UNMH, Albuquerque, New Mexico, 87106, United States|Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma, 74136, United States|Northwest Dermatology Institute, Portland, Oregon, 97210, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States","Study Director : Pfizer CT.gov Call Center , Pfizer"
Alopecia Areata,NCT02684097,A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT02684097,YES,Alopecia Areata,DRUG: Tralokinumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States","Principal Investigator : Emma Guttman, MD, PhD , ISMMS"
Alopecia Areata,NCT06157905,Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT06157905,NO,Extensive Alopecia Areata,DRUG: Oral Tofacitinib citrate,ALL,ADULT,EARLY_PHASE1,"Services Institute of Medical Sciences, Lahore, Punjab, 54000, Pakistan",
Alopecia Areata,NCT03898479,Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03898479,NO,Alopecia Areata,DRUG: CTP-543,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Total Skin and Beauty Dermatology Center, Birmingham, Alabama, 35203, United States|Alliance Dermatology & MOHS Center, Phoenix, Arizona, 85032, United States|Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|Northwest Arkansas Clinical Trials Center, PLLC, Rogers, Arkansas, 72758, United States|Kern Research Inc., Bakersfield, California, 93301, United States|Hope Clinical Research, Canoga Park, California, 91303, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|University of California, Irvine, Irvine, California, 92697, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Quest Dermatology Research, Northridge, California, 91324, United States|Kaiser Permanente Northern California - Oakland, Oakland, California, 94611, United States|Palmtree Clinical Research, Inc., Palm Springs, California, 92262, United States|Stanford University School of Medicine - Medical Dermatology Clinic, Redwood City, California, 94063, United States|Kaiser Permanente South Sacramento, Sacramento, California, 95823, United States|Kaiser Permanente Clinical Trials Unit, San Francisco, California, 94118, United States|Colorado Center for Dermatology, PLLC d/b/a CODerm Research, Centennial, Colorado, 80111, United States|Colorado Medical Research Center, Denver, Colorado, 80210, United States|Yale University Church Street Research Unit, New Haven, Connecticut, 06519, United States|Skin Care Research, LLC, Boca Raton, Florida, 33486, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|University of Miami Hospital, Miami, Florida, 33125, United States|Floridian Research Institute, LLC, Miami, Florida, 33179, United States|Lenus Research & Medical Group, LLC, Sweetwater, Florida, 33172, United States|Clinical Research Trials of Florida, Inc., Tampa, Florida, 33607, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|ASR, LLC, Boise, Idaho, 83702, United States|Denova Research, Chicago, Illinois, 60611, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|DS Research, New Albany, Indiana, 47150, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|DS Research, Louisville, Kentucky, 40241, United States|Qualmedica Research, Owensboro, Kentucky, 42301, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|Clinical Research Institute of Michigan, Clinton Township, Michigan, 48038, United States|Minnesota Clinical Study Center, Fridley, Minnesota, 55432, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55417, United States|Vivida Dermatology, Las Vegas, Nevada, 89119, United States|Skin Laser and Surgery Specialists of NJ, Hackensack, New Jersey, 07601, United States|Schweiger Dermatology, P.C., Verona, New Jersey, 07044, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Sadick Research Group, New York, New York, 10075, United States|UR Dermatology at College Town, Rochester, New York, 14620, United States|Darst Dermatology, Charlotte, North Carolina, 28277, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|North Carolina Dermatology Associates, PLLC, Raleigh, North Carolina, 27617, United States|Wake Forest University Health Sciences, Department of Dermatology, Winston-Salem, North Carolina, 27104, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Remington-Davis, Inc., Columbus, Ohio, 43215, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|NW Dermatology Institute, Portland, Oregon, 97210, United States|Hospital of the University of Pennsylvania Dept of Dermatology, Philadelphia, Pennsylvania, 19104, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|Peak Research - Pennsylvania, Upper Saint Clair, Pennsylvania, 15241, United States|Velocity Clinical Research-Providence, East Greenwich, Rhode Island, 02818, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Clinical Research Center of the Carolinas, Charleston, South Carolina, 29407, United States|Palmetto Clinical Trial Services, Fountain Inn, South Carolina, 29644, United States|Dermatology Treatment and Research Center - Dallas, Dallas, Texas, 75230, United States|North Texas Center for Clinical Research, Frisco, Texas, 75034, United States|Suzanne Bruce and Associates, PA, Houston, Texas, 77056, United States|Austin Institute for Clinical Research, Inc., Pflugerville, Texas, 78660, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Jordan Valley Dermatology, West Jordan, Utah, 84088, United States|University of Virginia Health System, Charlottesville, Virginia, 22903, United States|West End Dermatology Associates, Richmond, Virginia, 23233, United States|Clinical Investigation Specialists, Inc., Kenosha, Wisconsin, 53144, United States|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Kirk Barber Research, Calgary, Alberta, T2G 1B1, Canada|Care Clinic, Red Deer, Alberta, T4P 1K4, Canada|Medical Arts Health Research Group, Kelowna, British Columbia, V1Y 4N7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L 0B7, Canada|DermEffects, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|Dr. S. K. Siddha Medicine Professional Corporation, Newmarket, Ontario, L3Y 5G8, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|JRB research Inc., Ottawa, Ontario, K1H 7X3, Canada|Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Alliance Clinical Trials, Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada|Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), QuÃ©bec, G1V 4X7, Canada",Concert Pharmaceuticals
Alopecia Areata,NCT02561585,LEO 124249 Ointment in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT02561585,YES,Alopecia Areata,DRUG: LEO 124249|OTHER: Vehicle,ALL,"ADULT, OLDER_ADULT",PHASE2,"Northwestern University, Evanston, Illinois, 60208, United States|The Icahn School of Medicine, Mount Sinai Hospital, New York, New York, 10029, United States","Principal Investigator : Emma Guttman, MD, PhD , The Icahn School of Medicine, Mount Sinai Hospital"
Alopecia Areata,NCT03941548,Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03941548,YES,Alopecia Areata,DRUG: CTP-543|DRUG: CTP-543 Matching Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Colorado Center for Dermatology and Skin Surgery, Centennial, Colorado, 80111, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|The Indiana Clinical Trials Center, PC, Plainfield, Indiana, 46168, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Austin Institute for Clinical Research, Inc., Pflugerville, Texas, 78660, United States|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Guelph Dermatology Research, Guelph, Ontario, N1L 0B7, Canada|Dr Wei Jing Loo Medicine Professional Corporation, London, Ontario, N6H 5L5, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X2, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada",
Alopecia Areata,NCT00999869,The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata,https://clinicaltrials.gov/study/NCT00999869,NO,Alopecia Areata,DRUG: Botulinum toxin type A|DRUG: Triamcinolone acetonide,ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand|Siriraj hospital, Bangkok, 10700, Thailand","Study Chair : Rattapon Thoungtong, MD. , Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University,Thailand Study Director : Supenya Varothai, MD. , Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University,Thailand Principal Investigator : Rasthawathana Desomchoke, MD. , Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University,Thailand Principal Investigator : Kumpol Aiempanakit, M.D. , Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University,Thailand"
Alopecia Areata,NCT02557074,TREg Activation in the Treatment of the PELADE (Alopecia Areata),https://clinicaltrials.gov/study/NCT02557074,NO,Alopecia Areata,DRUG: IL2|DRUG: placebo,ALL,ADULT,PHASE3,"AP-HM - La timone - Dermatologie, Marseille, Bouche Du RhÃ´ne, 13005, France|AP-HP St Louis - Dermatologie, Paris, Ile De France, 75000, France|CHU de Nimes - Dermatologie, NÃ®mes, Languedoc-Roussillon, 30000, France|CHI St Raphael FrÃ©jus - Dermatologie, FrÃ©jus, Paca, 83000, France|CHU Montpellier - Dermatologie, Montpellier, 34000, France|CHU de Nice - dermatologie, Nice, 06200, France","Principal Investigator : Passeron Thierry, PUPH , Centre Hospitalier Universitaire de Nice"
Alopecia Areata,NCT03899259,A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03899259,YES,Alopecia Areata,DRUG: Baricitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States|Investigate MD, Scottsdale, Arizona, 85255, United States|First OC Dermatology, Fountain Valley, California, 92708, United States|Center For Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|Quest Dermatology Research, Northridge, California, 91324, United States|Kaiser Permanente Hospital, San Francisco, California, 94118, United States|New England Research Associates, Bridgeport, Connecticut, 06606, United States|Florida Academic Centers Research and Education, LLC, Coral Gables, Florida, 33134, United States|New Horizon Research Center, Miami, Florida, 33165, United States|ForCare Clinical Research, Tampa, Florida, 33613-1244, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|The South Bend Clinic Center for Research, South Bend, Indiana, 46617, United States|Qualmedica Research, LLC, Owensboro, Kentucky, 42303, United States|Dermatology and Skin Cancer Specialists, Rockville, Maryland, 20850, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|Clinical Research Institute of Michigan, LLC, Chesterfield, Michigan, 48047, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Associated Skin Care Specialists, New Brighton, Minnesota, 55112, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Joseph J. Schwartz, M.D., Troy, New York, 12180, United States|University of North Carolina Dermatology and Skin Cancer Cen, Chapel Hill, North Carolina, 27516, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|M3-Emerging Medical Research, Raleigh, North Carolina, 27612, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Dermatologists of Southwest Ohio, Mason, Ohio, 45040, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Northwest Dermatology Institute, Portland, Oregon, 97210, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|Velocity Clinical Research, Providence, East Greenwich, Rhode Island, 02818, United States|Center for Medical Research, LLC, Providence, Rhode Island, 02908, United States|Suzanne Bruce and Associates, PA, Houston, Texas, 77056, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Virginia Clinical Research, Inc., Norfolk, Virginia, 23502, United States|Stat Research, Caba, Buenos Aires, C1013AAB, Argentina|Centro de Investigaciones MetabÃ³licas (CINME), Ciudad AutÃ³noma de Buenos Aires, Buenos Aires, C1027AAP, Argentina|Buenos Aires Skin, Buenos Aires, Ciudad AutÃ³noma De Buenos Aires, 1055, Argentina|Centro Medico Privado de Reumatologia, SAN M. DE Tucuman, Tucuman, T4000AXL, Argentina|Fundacion Respirar, Buenos Aires, C1426ABO, Argentina|Instituto de NeumonologÃ­a y DermatologÃ­a, Ciudad Autonoma Buenos Aires, 1425, Argentina|Parra DermatologÃ­a, Mendoza, 5500, Argentina|Woden Dermatology, Phillip, Australian Capital Territory, 2606, Australia|Skin & Cancer Foundation Australia, Westmead, New South Wales, 2045, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Clinical Trials SA Pty Ltd, Adelaide, South Australia, 5073, Australia|Skin Health Institute Inc., Carlton, Victoria, 3053, Australia|Fremantle Dermatology, Perth, Western Australia, 6160, Australia|Sinclair Dermatology, Victoria, 3002, Australia|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90020-090, Brazil|IDERJ - Instituto de Dermatologia e EstÃ©tica do Brasil, Rio de Janeiro, RJ, 22470-220, Brazil|Faculdade de CiÃªncias MÃ©dicas - UNICAMP, Campinas, Sao Paulo, 13083-887, Brazil|FundaÃ§Ã£o Faculdade de Medicina do ABC, Santo AndrÃ©, Sao Paulo, 09060-870, Brazil|Centro de Pesquisa Sao Lucas, Campinas, SÃ£o Paulo, 13034-685, Brazil|IBPClin - Instituto Brasil de Pesquisa ClÃ­nica, Rio de Janeiro, 22241-180, Brazil|Hospital Central - Santa Casa de SÃ£o Paulo, SÃ£o Paulo, 01223-001, Brazil|Hospital de Servidor Publico Estadual, SÃ£o Paulo, 04039-901, Brazil|Beijing Chao-Yang Hospital, Capital Medical University, Beijing, Beijing, 100020, China|Beijing Friendship Hospital Affiliate of Capital University, Beijing, Beijing, 100050, China|Peking University Third Hospital, Beijing, Beijing, 100191, China|Guangdong Province Dermatology Hospital, Guangzhou, Guangdong, 510018, China|Xiangya Hospital Central South University, Changsha, Hunan, 410008, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'An, Shaanxi, 710004, China|1st affiliated Hospital of Shanxi Medical University, Tai Yuan, Shan XI, 030001, China|HuaShan Hospital Affiliated To Fudan University, Shanghai, Shanghai, 200040, China|Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310052, China|Chinese PLA General Hospital, Beijing, 100853, China|Shanghai Dermatology Hospital, Shanghai, 200071, China|Tianjin Medical University General Hospital, Tianjin, 300052, China|Emek Medical Center, Afula, 1834111, Israel|Soroka Medical Center, Beer Sheva, 8410101, Israel|Rambam Medical Center, Haifa, 3109601, Israel|Hadassah Medical Center, Jerusalem, 9112001, Israel|Rabin Medical Center, Petach Tikva, 4941492, Israel|Sheba Medical Center, Ramat Gan, 5262100, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel|Yokohama Rosai Hospital, Yokohama, Kanagawa, 222-0036, Japan|Hamamatsu University School of Medicine, University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, 113-8431, Japan|Kyorin University Hospital, Mitaka, Tokyo, 181-8611, Japan|Tokyo Medical Univ. Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamaguchi University Hospital, Ube, Yamaguchi, 755-8505, Japan|Osaka City University Hospital, Osaka, 545-8586, Japan|Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, 136-0075, Japan|Dankook University Hospital, Cheonan, Chungcheongnam-do, 31116, Korea, Republic of|Soonchunhyang University Bucheon Hospital, Bucheon, Gyeonggi-do, 14584, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, 16499, Korea, Republic of|Boramae Medical Center, Dongjak-gu, Seoul-teukbyeolsi [Seoul], 07061, Korea, Republic of|Kyunghee University Hospital at Gangdong, Seoul, Seoul-teukbyeolsi [Seoul], 134-090, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 03722, Korea, Republic of|Clinical Research Puerto Rico, San Juan, 00909, Puerto Rico|Chung Shan Medical University Hospital, Taichung City (r.o.c), 402, Taiwan|National Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei City, 10002, Taiwan|Chang Gung Medical Foundation-Linkou Branch, Taoyuan, 333, Taiwan","Study Director : Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM -5 PM Eastern time (UTC/GMT - 5 hours, EST) , Eli Lilly and Company"
Alopecia Areata,NCT03811912,Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata,https://clinicaltrials.gov/study/NCT03811912,YES,Alopecia Areata,DRUG: CTP-543|DRUG: CTP-543 Matching Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigative Site, Irvine, California, 92697, United States|Investigative Site, San Francisco, California, 94118, United States|Investigative Site, New Haven, Connecticut, 06519, United States|Investigative Site, Boynton Beach, Florida, 33472, United States|Investigative Site, Boston, Massachusetts, 02114, United States|Investigative Site, Boston, Massachusetts, 02115, United States|Investigative Site, Fridley, Minnesota, 55432, United States|Investigative Site, Portsmouth, New Hampshire, 03801, United States|Investigative Site, Winston-Salem, North Carolina, 27104, United States|Investigative Site, Portland, Oregon, 97210, United States","Study Director : Colleen E Hamilton, MS , Concert Pharmaceuticals, Inc."
Alopecia Areata,NCT01246284,The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01246284,NO,Alopecia Areata,DRUG: Triamcinolone acetonide|OTHER: Normal saline,ALL,"ADULT, OLDER_ADULT",,"The Skin Care Center, Vancouver General Hospital, 835 West 10th Ave, Vancouver, British Columbia, Canada","Principal Investigator : Jerry Shapiro, MD FRCPC , University of British Columbia"
Alopecia Areata,NCT02974868,Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT02974868,YES,Alopecia Areata,DRUG: PF-06651600|DRUG: PF-06700841|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Alabama at Birmingham, Dermatology at the Whitaker Clinic, Birmingham, Alabama, 35233, United States|University of Alabama at Birmingham, The Kirklin Clinic, Birmingham, Alabama, 35233, United States|Southern California Dermatology, Inc., Santa Ana, California, 92701, United States|Clinical Science Institute, Santa Monica, California, 90404, United States|Office of F. Monte Purcelli, Santa Monica, California, 90404, United States|Tower Saint John's Imaging, Santa Monica, California, 90404, United States|University of Colorado Hospital Clinical and Translational Research Center, Inpatient Unit, Aurora, Colorado, 80045, United States|University of Colorado Hospital Clinical and Translational Research Center, Outpatient Clinic, Aurora, Colorado, 80045, United States|University of Colorado Hospital, Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|Yale School of Medicine, New Haven, Connecticut, 06510, United States|Investigational Drug Services, New Haven, Connecticut, 06511, United States|Church Street Research Unit, New Haven, Connecticut, 06519, United States|Yale Hearing and Balance Center, New Haven, Connecticut, 06519, United States|Yale New Haven Hospital, New Haven, Connecticut, 06519, United States|Park Avenue Dermatology Administrative Annex, Orange Park, Florida, 32073, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|Edward B. Kampsen, MD, Tampa, Florida, 33609, United States|Olympian Clinical Research, Tampa, Florida, 33609, United States|Rose Radiology, Tampa, Florida, 33609, United States|Forward Clinical Trials, Inc, Tampa, Florida, 33624, United States|MedaPhase Inc., Newnan, Georgia, 30263, United States|NorthShore University HealthSystem Dermatology Clinical Trials Unit, Skokie, Illinois, 60077, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46256, United States|Dawes Fretzin Dermatology Group, LLC, Indianapolis, Indiana, 46256, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Massachusetts General Hospital Clinical Unit for Research Trials in Skin (CURTIS), Boston, Massachusetts, 02114, United States|Weill Cornell Medicine, New York, New York, 10021, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Mount Sinai Department of Otolaryngology, New York, New York, 10029, United States|Rockefeller University Hospital, New York, New York, 10065, United States|Investigational Drug Service, Rochester, New York, 14642, United States|University of Rochester Audiology, Rochester, New York, 14642, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|University of Rochester Radiology, Rochester, New York, 14642, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, 74136, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|University of Utah MidValley Dermatology, Murray, Utah, 84107, United States|University of Utah Medical Center, Salt Lake City, Utah, 84132, United States|Virginia Clinical Research, Inc., Norfolk, Virginia, 23502, United States|Hearing Life, Hurstville, New South Wales, 2220, Australia|Dr. Glen and Partners Medical Imaging, Kogarah, New South Wales, 2217, Australia|St George Dermatology and Skin Cancer Centre, Kogarah, New South Wales, 2217, Australia|St. George Hearing and Balance Clinic, Kogarah, New South Wales, 2217, Australia|The Skin Centre, Benowa, Queensland, 4217, Australia|Veracity Clinical Research, Woolloongabba, Queensland, 4102, Australia|Skin & Cancer Foundation Inc., Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|Bridge Road Imag ing, Richmond, Victoria, 3121, Australia|Richmond Audiology, Richmond, Victoria, 3121, Australia|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X2, Canada|Research by ICLS, Oakville, Ontario, L6J 7W5, Canada|SKiN Centre for Dermatology, Peterborough, Ontario, K9J 5K2, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|York Dermatology Center, Richmond Hill, Ontario, L4C 9M7, Canada","Study Director : Pfizer CT.gov Call Center , Pfizer"
Alopecia Areata,NCT02604888,Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females,https://clinicaltrials.gov/study/NCT02604888,NO,Alopecia Areata,OTHER: MEXIS/M6S Patent - lotion against alopecia,ALL,"ADULT, OLDER_ADULT",,"George Mexis, Athens, 11253, Greece","Study Chair : Markos Papakonstantis, Monitor , 401 General Military Hospital of Athens, Dermatology clinic"
Alopecia Areata,NCT01559584,Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01559584,NO,Alopecia Areata,RADIATION: ultraviolet A (UVA)|DRUG: Triamcinolone Acetonide,ALL,"CHILD, ADULT, OLDER_ADULT",,"Dermatology department - faculty of medicine- Cairo University, Cairo, Egypt",
Alopecia Areata,NCT00408798,Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin,https://clinicaltrials.gov/study/NCT00408798,NO,Alopecia Areata,"DRUG: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units",ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology, The Skin Care Centre, Vancouver, British Columbia, V5Z 4E8, Canada","Principal Investigator : Jerry Shapiro, MD, FRCPC , University of British Columbia"
Alopecia Areata,NCT03325296,Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.,https://clinicaltrials.gov/study/NCT03325296,NO,Alopecia Areata,DRUG: LEO 124249|OTHER: Ointment vehicle,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigational site, Aarhus, 8000, Denmark|Investigational site, Gentofte, 2820, Denmark","Study Director : Study Director , LEO Pharma"
Alopecia Areata,NCT00063076,Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata,https://clinicaltrials.gov/study/NCT00063076,NO,Alopecia Areata,DRUG: Targretin Gel 1%,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"UT MD Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : Madeleine Duvic, MD , UT MD Anderson Cancer Center"
Alopecia Areata,NCT03570749,A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03570749,NO,Alopecia Areata,DRUG: Baricitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|Coastal Clinical Research, Inc, Mobile, Alabama, 36608, United States|Johnson Dermatology, Fort Smith, Arkansas, 72916, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Tilda Research, Irvine, California, 92612, United States|University of California, Irvine, Irvine, California, 92697, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Stanford Medicine Outpatient Center, Redwood City, California, 94063, United States|University of California Davis Health, Sacramento, California, 95816, United States|University Clinical Trials, San Diego, California, 92123, United States|Mosaic Dermatology, Santa Monica, California, 90403, United States|Yale University School of Medicine, New Haven, Connecticut, 06519, United States|Solutions Through Advanced Research, Jacksonville, Florida, 32256, United States|University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Skin Care Physicians of Georgia, Macon, Georgia, 31217, United States|Medaphase Inc, Newnan, Georgia, 30263, United States|Northwestern University, Chicago, Illinois, 60611, United States|DS Research, Louisville, Kentucky, 40241, United States|Callender Center For Clinical Research, Glenn Dale, Maryland, 20769, United States|ActivMed Practices and Research, Beverly, Massachusetts, 01915, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Clarkston Skin Research, Clarkston, Michigan, 48346, United States|M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis, Minnesota, 55455, United States|ActivMed Practices & Research, Inc., Portsmouth, New Hampshire, 03801, United States|Montefiore Medical Center, Bronx, New York, 10467-2490, United States|University of Rochester School of Medicine, Rochester, New York, 14642, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Ohio State University, Columbus, Ohio, 43230, United States|Oregon Medical Research Center, Portland, Oregon, 97201, United States|Northwest Dermatology Institute, Portland, Oregon, 97210, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|The Pennsylvania Centre for Dermatology, LLC, Exton, Pennsylvania, 19341, United States|Penn State Univ. Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|Penn Medicine: University of Pennsylvania Health System, Philadelphia, Pennsylvania, 19104, United States|UPMC Clinical Trials, Pittsburgh, Pennsylvania, 15213, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|Modern Research Associates, Dallas, Texas, 75231, United States|Center for Clinical Studies, Houston, Texas, 77004, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Center for Clinical Studies, LTD.LLP, Webster, Texas, 77598, United States|University of Utah, Murray, Utah, 84107, United States|Dermatology Associates of Seattle, Seattle, Washington, 98101, United States|Kurume University Hospital, Kurume, Fukuoka, 830 0011, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Osaka City University Hospital, Osaka, 545-8586, Japan|Inha University Hospital, Incheon, Incheon-gwangyeoksi [Incheon], 22332, Korea, Republic of|Jeonbuk National University Hospital, Jeonju-si, Jeonrabugdo, 54907, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam, KyÇ’nggi-do, 13620, Korea, Republic of|Pusan National University Hospital, Busan, Pusan-KwangyÇ’kshi, 49241, Korea, Republic of|Chung-Ang University Hospital, Dongjak-gu, Seoul-teukbyeolsi [Seoul], 06973, Korea, Republic of|Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 03080, Korea, Republic of|The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 03312, Korea, Republic of|Konkuk University Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 05030, Korea, Republic of|Kyung-Hee University Hospital at Gangdong, Seoul, Seoul-teukbyeolsi [Seoul], 134-090, Korea, Republic of|Kyungpook National University Hospital, Jung-gu, Taegu-KwangyÇ’kshi, 41944, Korea, Republic of|Chungnam National University Hospital, Daejeon, TaejÇ’n-KwangyÇ’kshi, 35015, Korea, Republic of|RM Pharma Specialists, Mexico City, Distrito Federal, 3100, Mexico|Centro de AtenciÃ³n en Enfermedades Inflamatorias CATEI, Guadalajara, Jalisco, 44638, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S. C., Guadalajara, Jalisco, 44650, Mexico|Centro Regiomontano de Investigacion, Monterrey, Nuevo Leon, 64060, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo LeÃ³n, 64460, Mexico|B&B Investigaciones Medicas, SC, Mazatlan, Sinaloa, 82140, Mexico|Derma Norte del BajÃ­o, Aguascalientes, 20130, Mexico|Instituto de Investigaciones Aplicadas a la Neurociencia A.C, Durango, 34000, Mexico|Ponce Medical School Foundation Inc., Ponce, 00716, Puerto Rico|GCM Medical Group, PSC- Hato Rey Site, San Juan, 00917, Puerto Rico","Study Director : Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) , Eli Lilly and Company"
Alopecia Areata,NCT06239324,Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser,https://clinicaltrials.gov/study/NCT06239324,NO,Alopecia Areata,DRUG: Latanoprost,ALL,ADULT,PHASE1|PHASE2,"Qena Hospital, QinÄ, Egypt","Principal Investigator : Soheir AbdelHamid Ali, Assist. Prof. , Department of dermatology , Venerolgy and Andrology Faculty of Medicine Qena university"
Alopecia Areata,NCT02636244,Safety and Efficacy Study of SHAPE Gel in Alopecia Areata,https://clinicaltrials.gov/study/NCT02636244,NO,Alopecia Areata,DRUG: SHAPE Gel,ALL,"ADULT, OLDER_ADULT",PHASE2,,TetraLogic Pharmaceuticals
Alopecia Areata,NCT03354637,A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT03354637,YES,Alopecia Areata,DRUG: ATI-50002 high dose|DRUG: ATI-50002 low dose|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Encinitas, California, 92024, United States|Aclaris Investigator Site, Laguna Hills, California, 92653, United States|Aclaris Investigator Site, Redwood City, California, 94063, United States|Aclaris Investigator Site, Washington, District of Columbia, 20037, United States|Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States|Aclaris Investigator Site, Miami, Florida, 33136, United States|Aclaris Investigator Site, Boston, Massachusetts, 02115, United States|Aclaris Investigator Site, Clinton Township, Michigan, 48038, United States|Aclaris Investigator Site, Warren, Michigan, 48088, United States|Aclaris Investigator Site, Fridley, Minnesota, 55432, United States|Aclaris Investigator Site, Minneapolis, Minnesota, 55455, United States|Aclaris Investigator Site, Omaha, Nebraska, 68144, United States|Aclaris Investigator Site, New York, New York, 10155, United States|Aclaris Investigator Site, Durham, North Carolina, 27710, United States|Aclaris Investigator Site, Winston-Salem, North Carolina, 27104, United States|Aclaris Investigator Site, Portland, Oregon, 97210, United States|Aclaris Investigator Site, Fort Washington, Pennsylvania, 19034, United States|Aclaris Investigator Site, Knoxville, Tennessee, 37922, United States|Aclaris Investigator Site, Nashville, Tennessee, 37215, United States|Aclaris Investigator Site, Austin, Texas, 78745, United States|Aclaris Investigator Site, Austin, Texas, 78759, United States|Aclaris Investigator Site, San Antonio, Texas, 78229, United States|Aclaris Investigator Site, San Antonio, Texas, 78745, United States","Aclaris Therapeutics, Inc."
Alopecia Areata,NCT03137381,Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03137381,YES,Alopecia Areata,DRUG: CTP-543|DRUG: CTP-543 matching placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of California, Irvine, Irvine, California, 92697, United States|Contour Dermatology & Cosmetic Surgery Center, Rancho Mirage, California, 92270, United States|Stanford University School of Medicine, Redwood City, California, 94064, United States|Kaiser Permanente Northern California, San Francisco, California, 94118, United States|Yale School of Medicine, New Haven, Connecticut, 06519, United States|Siperstein Dermatology Group, Boynton Beach, Florida, 33472, United States|Northwestern University, Chicago, Illinois, 60611, United States|Minnesota Clinical Study Center, Fridley, Minnesota, 55432, United States|Icahn School of Medicine at Mt. Sinai, New York, New York, 10029, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27104, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Northwest Dermatology, Portland, Oregon, 97210, United States|Suzanne Bruce & Associates, PA, Houston, Texas, 77056, United States","Study Director : Colleen E. Hamilton , Concert Pharmaceuticals, Inc."
Alopecia Areata,NCT01797432,Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata,https://clinicaltrials.gov/study/NCT01797432,YES,Alopecia Areata,DRUG: Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10)|DEVICE: Restylane,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States",
Alopecia Areata,NCT01017510,Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata,https://clinicaltrials.gov/study/NCT01017510,NO,Alopecia Areata,DEVICE: Subcutaneous injection luer syringe|DEVICE: DERMOJET (a syringe without a needle),ALL,"ADULT, OLDER_ADULT",,"Sheba Medical Center, Rmat Gan, Israel","Principal Investigator : BOAZ AMI-CHI, MD , Sheba Medical Center"
Alopecia Areata,NCT00177021,Aldara for the Treatment of Extensive Alopecia Areata,https://clinicaltrials.gov/study/NCT00177021,NO,Alopecia Areata,DRUG: Aldara Cream 5%,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","Principal Investigator : Maria Hordinsky, MD , University of Minnesota Principal Investigator : Marna Ericson, Ph D , University of Minnesota"
Alopecia Areata,NCT00176969,Response of Topical Capsaicin in Alopecia Areata,https://clinicaltrials.gov/study/NCT00176969,NO,Alopecia Areata,DRUG: Capsaicin,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","Principal Investigator : Maria Hordinsky, MD , University of Minnesota Principal Investigator : Marna Ericson, Ph D , University of Minnesota"
Alopecia Areata,NCT00187577,Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT00187577,NO,Alopecia Areata,DRUG: Latanoprost (Xalatan)|DRUG: Bimatoprost (Lumigan)|DRUG: Topical application of latanoprost solution to eyelid,ALL,"ADULT, OLDER_ADULT",,"University of California, San Francisco, San Francisco, California, 94117, United States",
Alopecia Areata,NCT05551793,Regeneron AA Multicenter (Dupilumab),https://clinicaltrials.gov/study/NCT05551793,NO,Alopecia Areata,DRUG: Dupilumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|UR Dermatology at College Town, Rochester, New York, 14620, United States","Principal Investigator : Emma Guttman-Yassky, MD, PhD , Icahn School of Medicine at Mount Sinai"
Alopecia Areata,NCT03473600,Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation,https://clinicaltrials.gov/study/NCT03473600,NO,Alopecia Areata,PROCEDURE: Cryotherapy|DRUG: Triamcinolone acetonide injection,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Faculty of medicine, Assiut, 71111, Egypt",Assiut University
Alopecia Areata,NCT05954104,Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma,https://clinicaltrials.gov/study/NCT05954104,NO,Alopecia Areata,DRUG: Calcipotriol,ALL,"CHILD, ADULT",,"Faculty of Dentistary - Aswan University, Aswan, Egypt","Study Chair : Moustafa Adam, Professor , Department of dermatology , Venerolgy and Andrology Faculty of Medicine Aswan university"
Alopecia Areata,NCT06471114,Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA),https://clinicaltrials.gov/study/NCT06471114,NO,Alopecia Areata,,ALL,"ADULT, OLDER_ADULT",,"Chu Brest, Brest, 29609, France","University Hospital, Brest"
Alopecia Areata,NCT05251831,Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP,https://clinicaltrials.gov/study/NCT05251831,NO,Alopecia Areata,DRUG: Intradermal injection,ALL,ADULT,EARLY_PHASE1,"Al-Azhar University in Cairo, Cairo, 11311, Egypt","Principal Investigator : Ahmed Mohamed abdelaal, Prof , Al-Azhar University"
Alopecia Areata,NCT01840046,Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT01840046,NO,Alopecia Areata,DRUG: Interleukin-2,ALL,ADULT,PHASE1|PHASE2,"CHU de Nice - HÃ´pital Archet, Nice, Alpes-Maritimes, 06001, France","Principal Investigator : PASSERON Thierry, PhD , CHU de Nice - HÃ´pital de l'Archet - Dermatology"
Alopecia Areata,NCT05522556,Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600),https://clinicaltrials.gov/study/NCT05522556,NO,Alopecia Areata,DRUG: Ritlecitinib,ALL,"CHILD, ADULT, OLDER_ADULT",,,Pfizer
Alopecia Areata,NCT00484679,Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT00484679,YES,Alopecia Areata,DRUG: Triamcinolone Acetonide 10 mg/mL (Kenalog-10),ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","Study Director : Maria K Hordinsky, MD , University of Minnesota"
Alopecia Areata,NCT00176943,Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%,https://clinicaltrials.gov/study/NCT00176943,NO,Alopecia Areata,DRUG: Aldara Cream 5%,ALL,"ADULT, OLDER_ADULT",PHASE4,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","Principal Investigator : Maria Hordinsky, MD , University of Minnesota Principal Investigator : Marna Ericson, PhD , University of Minnesota"
Alopecia Areata,NCT06279221,Litfulo Capsules Special Investigation,https://clinicaltrials.gov/study/NCT06279221,NO,Alopecia Areata,DRUG: LITFULO,ALL,"CHILD, ADULT, OLDER_ADULT",,"Pfizer, Tokyo, Japan","Study Director : Pfizer CT.gov Call Center , Pfizer"
Alopecia Areata,NCT06045624,A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects,https://clinicaltrials.gov/study/NCT06045624,NO,Alopecia Areata,DRUG: OR-101 (Single ascending dose)|DRUG: OR-101 (Food effect)|DRUG: OR-101 (Multiple ascending dose)|DRUG: Placebo,ALL,ADULT,PHASE1,"SCIENTIA Clinical Research Ltd, Randwick, New South Wales, 2031, Australia","Ornovi, Inc."
Alopecia Areata,NCT04445363,A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata,https://clinicaltrials.gov/study/NCT04445363,NO,Alopecia Areata(AA),DRUG: Jaktinib hydrochloride cream|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"The Second Xaingya Hospitalï¼Œcentral south university, Changsha, Hunan, 410011, China","Study Chair : qianjin lu, M.D. , the Second Xiangya Hospital, Central South University"
Alopecia Areata,NCT05196711,A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects,https://clinicaltrials.gov/study/NCT05196711,NO,Alopecia Areata,DRUG: MAX-40070|DRUG: Placebo,ALL,ADULT,PHASE1,,"Maxinovel Pty., Ltd."
Alopecia Areata,NCT02037191,The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade,https://clinicaltrials.gov/study/NCT02037191,NO,ALOPECIA AREATA,DRUG: Methotrexate|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Head Dermatology Department, Rouen, Haute Normandie, 76031, France|CHU de Rouen - HÃ´pitaux de Rouen, Rouen, Seine Maritime, 76031, France","Principal Investigator : PASCAL JOLY, PROFESSOR , CHU - HÃ´pitaux de Rouen"
Alopecia Areata,NCT03078686,Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata,https://clinicaltrials.gov/study/NCT03078686,NO,Alopecia Areata|Scarring Alopecia,PROCEDURE: tSVF by lipoaspiration|PROCEDURE: PRP Concentration|PROCEDURE: Emulsification tSVF|PROCEDURE: cSVF isolation and concentration|PROCEDURE: cSVF in Normal Saline IV,ALL,"ADULT, OLDER_ADULT",,"Kenneth Williams, DO, Irvine, California, 92618, United States|Regeneris Medical, North Attleboro, Massachusetts, 02760, United States|Regenevita LLC, Stevensville, Montana, 59870, United States","Study Director : Robert W Alexander, MD , GARM-USA Principal Investigator : Ken Williams, DO , IIMSC"
Alopecia Areata,NCT06278402,"Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.",https://clinicaltrials.gov/study/NCT06278402,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: Tofacitinib,ALL,"CHILD, ADULT",PHASE3,"Misbah Zari Qadir, Karachi, Sindh, Pakistan",Jinnah Hospital
Alopecia Areata,NCT04238091,Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata,https://clinicaltrials.gov/study/NCT04238091,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: Fecal material transfer therapy|PROCEDURE: 4mm Punch Biopsy of Scalp|DIAGNOSTIC_TEST: Blood draw|PROCEDURE: Skin Microbiome sampling|PROCEDURE: Hair Microbiome Sampling|DRUG: Pre-FMT Antibiotic Cocktail|DRUG: Bowel Prep,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Principal Investigator : Lindsey Bordone, MD , Columbia University"
Alopecia Areata,NCT00069589,Alopecia Areata Registry,https://clinicaltrials.gov/study/NCT00069589,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis|Autoimmune Hair Loss|Alopecia Partialis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"University of California, San Francisco, San Francisco, California, 94143, United States|University of Colorado - UCHSC - Health Science Center at Fitzsimons, Aurora, Colorado, 80010-7163, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Columbia University, New York, New York, 10032, United States|M.D. Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : Madeleine Duvic, MD , M.D. Anderson Cancer Center"
Alopecia Areata,NCT05589610,Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT05589610,NO,Alopecia Areata|Alopecia|Alopecia Totalis|Alopecia Universalis,DRUG: EQ101,ALL,ADULT,PHASE2,"Sinclair Dermatology, East Melbourne, Australia|Fremantle Dermatology, Fremantle, Australia|Premier Specialists, Kogarah, Australia|Veracity Clinical Research, Woolloongabba, Australia|Optimal Clinical Trials Limited, Auckland, New Zealand",Equillium AUS Pty Ltd
Alopecia Areata,NCT04011748,Clinical Application of Stem Cell Educator Therapy in Alopecia Areata,https://clinicaltrials.gov/study/NCT04011748,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,COMBINATION_PRODUCT: Stem Cell Educator therapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"Throne Biotechnologies, Paramus, New Jersey, 07652, United States",Throne Biotechnologies Inc.
Alopecia Areata,NCT02812342,Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants,https://clinicaltrials.gov/study/NCT02812342,YES,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: Tofacitinib ointment,ALL,"ADULT, OLDER_ADULT",PHASE2,"Yale-New Haven Hospital, New Haven, Connecticut, 06510, United States","Principal Investigator : Brett King, MD, PhD , Yale University"
Alopecia Areata,NCT03759340,"ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)",https://clinicaltrials.gov/study/NCT03759340,YES,Alopecia Areata|Alopecia Universalis|Alopecia Totalis,DRUG: ATI 502 0.46% Topical Solution,ALL,"ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Rogers, Arkansas, 72758, United States|Aclaris Investigator Site, Denver, Colorado, 80210, United States|Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States|Aclaris Investigator Site, Snellville, Georgia, 30078, United States|Aclaris Investigator Site, Clinton Township, Michigan, 48038, United States|Aclaris Investigator SIte, Detroit, Michigan, 48202, United States|Aclaris Investigator Site, Fridley, Minnesota, 55432, United States|Aclaris Investigator Site, Minneapolis, Minnesota, 55455, United States|Aclaris Investigator Site, Saint Joseph, Missouri, 64506, United States|Aclaris Investigator Site, Omaha, Nebraska, 68144, United States|Aclaris Investigator Site, Las Vegas, Nevada, 89148, United States|Aclaris Investigator Site, New York, New York, 10075, United States|Aclaris Investigator Site, Rochester, New York, 14623, United States|Aclaris Investigator Site, Portland, Oregon, 97223, United States|Aclaris Investigator Site, Greenville, South Carolina, 29607, United States|Aclaris Investigator Site, Knoxville, Tennessee, 37922, United States|Aclaris Investigational Site, Nashville, Tennessee, 37215, United States|Aclaris Investigational Site, Austin, Texas, 78745, United States|Aclaris Investigator Site, Houston, Texas, 77056, United States|Aclaris Investigator Site, Lynchburg, Virginia, 24501, United States","Aclaris Therapeutics, Inc."
Alopecia Areata,NCT02312882,Tofacitinib for the Treatment of Alopecia Areata and Its Variants,https://clinicaltrials.gov/study/NCT02312882,YES,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: Tofacitinib,ALL,"ADULT, OLDER_ADULT",,"Stanford University, Stanford, California, 94305, United States",
Alopecia Areata,NCT03532958,Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata,https://clinicaltrials.gov/study/NCT03532958,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: BNZ-1|DRUG: Normal saline,ALL,"ADULT, OLDER_ADULT",PHASE2,,Equillium
Alopecia Areata,NCT03551821,Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata,https://clinicaltrials.gov/study/NCT03551821,YES,Alopecia Areata|Alopecia Totalis|Alopecia Universalis,DRUG: ATI-50002,ALL,"ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States",
Alopecia Areata,NCT03155958,Ocular Finding in Alopecia Areata,https://clinicaltrials.gov/study/NCT03155958,NO,Hair Loss,,ALL,"CHILD, ADULT, OLDER_ADULT",,,Assiut University
Alopecia Areata,NCT06283316,Systemic Treatments for Alopecia Areata Registry,https://clinicaltrials.gov/study/NCT06283316,NO,Alopecia Areata|Alopecia Totalis|Alopecia Universalis|Hair Loss|Hair Diseases|Alopecia|Alopecia Drugs|Autoimmune Diseases,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Erasmus University Medical Center, Rotterdam, Netherlands",Erasmus Medical Center
Alopecia Areata,NCT03240627,Efficacy and Safety of LH-8 in Paediatric Alopecia Areata,https://clinicaltrials.gov/study/NCT03240627,NO,Alopecia Areata|Pediatric Disorder,DRUG: LH-8|DRUG: Placebo,ALL,"CHILD, ADULT",PHASE2|PHASE3,"Multicenter Clinical Trials, Sofia, Bulgaria|Centre Sabourand - Hospital Saint-Louis, 1, Avenue Claude Vellefaux, Paris, 75010, France|Clinical Research Center for Hair and Skin Science, CharitÃ©-UniversitÃ¤tsmedizin Berlin, Berlin, Berlin,, 10117, Germany",
Alopecia Areata,NCT03873155,The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata,https://clinicaltrials.gov/study/NCT03873155,NO,Alopecia Areata|Social Anxiety,BEHAVIORAL: Mindfulness Based Cognitive Therapy,ALL,"CHILD, ADULT, OLDER_ADULT",,"The University of Sheffield, Sheffield, South Yorkshire, S12LT, United Kingdom|Royal Hallamshire Hospital (Sheffield Teaching Hospital), Sheffield, South Yorkshire, United Kingdom",Alopecia UK
Alopecia Areata,NCT02197455,Tofacitnib for the Treatment of Alopecia Areata and Variants,https://clinicaltrials.gov/study/NCT02197455,YES,Alopecia Areata (AA)|Alopecia Totalis (AT)|Alopecia Universalis (AU),DRUG: Tofacitinib Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,"Yale University, New Haven, Connecticut, United States","Principal Investigator : Brett King, MD , Yale University"
Alopecia Areata,NCT01167946,Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata,https://clinicaltrials.gov/study/NCT01167946,NO,Alopecia Totalis|Alopecia Universalis|Ophiasic Alopecia,DRUG: methylprednisolone sodium succinate|DRUG: methylprednisolone sodium succinate|DRUG: methylprednisolone sodium succinate,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"King Khalid University Hospital, Riyadh, 11472, Saudi Arabia","Principal Investigator : Ghada A Binsaif, MD , King Saud University"
Alopecia Areata,NCT02548689,PAI-1 Expression in Non-scarring Hair Loss,https://clinicaltrials.gov/study/NCT02548689,NO,Androgenetic Alopecia|Telogen Effluvium|Alopecia Areata,,ALL,ADULT,,"Northwestern University Department of Dermatology, Chicago, Illinois, 60611, United States","Principal Investigator : Maria Colavincenzo, MD , Northwestern University Feinberg School of Medicine"
Alopecia Areata,NCT01023841,Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children,https://clinicaltrials.gov/study/NCT01023841,YES,Eyelash Hypotrichosis|Alopecia Areata,DRUG: bimatoprost ophthalmic solution 0.03%|DRUG: Vehicle Sterile Solution,ALL,CHILD,PHASE4,"Newport Beach, California, United States|SÃ£o Paulo, Brazil","Study Director : Medical Director , Allergan"
Alopecia Areata,NCT06357169,Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias,https://clinicaltrials.gov/study/NCT06357169,NO,Lichen Planopilaris of Scalp|Alopecia Areata,DEVICE: Venus Glow,ALL,ADULT,,"University of Minnesota, Minneapolis, Minnesota, 55455, United States","Principal Investigator : Ronda Farah, MD , University of Minnesota Principal Investigator : Maria Hordinsky, MD , University of Minnesota"
Alopecia Areata,NCT03594227,"ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis",https://clinicaltrials.gov/study/NCT03594227,YES,Alopecia,DRUG: ATI-501 400mg BID (Low dose)|DRUG: ATI-501 600mg BID (Mid dose)|DRUG: ATI-501 800mg BID (High dose)|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Hot Springs, Arkansas, 71913, United States|Aclaris Investigator Site, Rogers, Arkansas, 72758, United States|Aclaris Investigator Site, Denver, Colorado, 80210, United States|Aclaris Investigator Site, Boynton Beach, Florida, 33472, United States|Aclaris Investigator Site, Miami, Florida, 33137, United States|Aclaris Investigator Site, Sanford, Florida, 32771, United States|Aclaris Investigator Site, Snellville, Georgia, 30078, United States|Aclaris Investigator Site, Clinton Township, Michigan, 48038, United States|Aclaris Investigator Site, Detroit, Michigan, 48202, United States|Aclaris Investigator Site, Fridley, Minnesota, 55432, United States|Aclaris Investigator Site, Minneapolis, Minnesota, 55455, United States|Aclaris Investigator Site, Saint Joseph, Missouri, 64506, United States|Aclaris Investigator Site, Omaha, Nebraska, 68144, United States|Aclaris Investigator Site, Las Vegas, Nevada, 89148, United States|Aclaris Investigator Site, New York, New York, 10075, United States|Aclaris Investigator Site, Rochester, New York, 14623, United States|Aclaris Investigator Site, Portland, Oregon, 97223, United States|Aclaris Investigator Site, Greenville, South Carolina, 29607, United States|Aclaris Investigator Site, Knoxville, Tennessee, 37922, United States|Aclaris Investigator Site, Nashville, Tennessee, 37215, United States|Aclaris Investigational Site, Austin, Texas, 78745, United States|Aclaris Investigator Site, Houston, Texas, 77056, United States|Aclaris Investigator Site, San Antonio, Texas, 78213, United States|Aclaris Investigator Site, Lynchburg, Virginia, 24501, United States|Aclaris Investigator Site, Norfolk, Virginia, 23502, United States",
Alopecia Areata,NCT06292533,Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study,https://clinicaltrials.gov/study/NCT06292533,NO,Androgenic Alopecia|Alopecia,DEVICE: Er:YAG laser,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Yang Mooi Lim, PhD , Universiti Tunku Abdul Rahman"
Alopecia Areata,NCT04341363,Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling,https://clinicaltrials.gov/study/NCT04341363,YES,Androgenic Alopecia,DEVICE: Tattoo machine,MALE,"ADULT, OLDER_ADULT",,"Yale University, New Haven, Connecticut, 06519, United States","Principal Investigator : Brett King, MD, PhD , Associate Professor of Dermatology, Yale University"
Alopecia Areata,NCT06319781,"A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo",https://clinicaltrials.gov/study/NCT06319781,NO,Alopecia Areata|Vitiligo|Atopic Dermatitis|Psoriasis,OTHER: Observational,ALL,"ADULT, OLDER_ADULT",,"Sanos Clinic, Gandrup, Gandrup, 9362, Denmark|Sanos Clinic, Herlev, Herlev, 2730, Denmark|Sanos Clinic, Vejle, Vejle, 7100, Denmark","Principal Investigator : Zarqa Ali, MD, PhD , Bispebjerg Hospital"
Alopecia Areata,NCT06409650,To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT06409650,NO,Alopecia,DRUG: KX-826 dosed at 2.5mg|DRUG: KX-826 dosed at 2.5mg|DRUG: KX-826 dosed at 5 mg|DRUG: KX-826 dosed at 5 mg|DRUG: Matching placebo to KX-826|DRUG: Matching placebo to KX-826,FEMALE,"ADULT, OLDER_ADULT",PHASE2,"Beijing Friendship Hospital, Capital Medical University, Beijing, China|Beijing Tongren Hospital, Capital Medical University, Beijing, China|China-Japan Friendship Hospital, Beijing, China|Peking University First Hospital, Beijing, China|Peking University People's Hospital, Beijing, China|Xiangya Hospital Central South University, Changsha, China|The First Affiliated Hospital of Chongqing Medical University, Chongqing, China|Dermatology Hospital of Southern Medical University, Guangzhou, China|Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China|Huashan Hospital, Fudan University, Shanghai, China|Shenzhen People's Hospital, Shenzhen, China|The First Hospital of Hebei Medical University, Shijiazhuang, China|Suining Central Hospital, Suining, China|The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China","Suzhou Koshine Biomedica, Inc."
Alopecia Areata,NCT03052413,Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females,https://clinicaltrials.gov/study/NCT03052413,NO,Hair Loss,DIETARY_SUPPLEMENT: Nutrafol|DIETARY_SUPPLEMENT: placebo,FEMALE,ADULT,,"New Jersey Plastic Surgery, Montclair, New Jersey, 07042, United States|Sadick Research Group, New York, New York, 10075, United States",Sadick Research Group
Alopecia Areata,NCT04205214,A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia,https://clinicaltrials.gov/study/NCT04205214,NO,Alopecia,BEHAVIORAL: Integrative Cognitive Behavioural Therapy,ALL,"ADULT, OLDER_ADULT",,"Royal Free Hospital, London, United Kingdom","Principal Investigator : Sharon Hart, Doctorate , Royal Free Hospital NHS Foundation Trust"
Alopecia Areata,NCT04884347,Evaluation of the Efficacy of a Food Supplement in Reducing Hair Loss in Male Subjects,https://clinicaltrials.gov/study/NCT04884347,NO,Hair Loss,DIETARY_SUPPLEMENT: Alline proMEN|DIETARY_SUPPLEMENT: Placebo,MALE,ADULT,,"Complife Italia S.r.l, Pavia, 27028, Italy","Study Director : Vincenzo Nobile, PhD , Complife Italia S.r.l"
Alopecia Areata,NCT03689452,The Effect of Platelet Rich Plasma on Non-scarring Alopecia,https://clinicaltrials.gov/study/NCT03689452,YES,Androgenetic Alopecia|Alopecia,DEVICE: Platelet Rich Plasma|DRUG: Normal saline,FEMALE,"ADULT, OLDER_ADULT",,"Icahn School of Medicine at Mount Sinai, New York, New York, 10028, United States","Principal Investigator : Hooman Khorasani, MD , Icahn School of Medicine at Mount Sinai"
Alopecia Areata,NCT02302053,Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair,https://clinicaltrials.gov/study/NCT02302053,NO,Hair Thinning,DIETARY_SUPPLEMENT: New Viviscal Professional Supplement|DIETARY_SUPPLEMENT: Placebo tablets,FEMALE,"ADULT, OLDER_ADULT",,,"Principal Investigator : Glynis Ablon, MD, FAAD , Director Ablon Skin Institute Research Center Principal Investigator : Steven Dayan, MD, FACS , Director DeNova Research"
Alopecia Areata,NCT03206567,Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair,https://clinicaltrials.gov/study/NCT03206567,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Supplement capsules|OTHER: Placebo capsules,FEMALE,"ADULT, OLDER_ADULT",,"Ablon Skin Institute & Research Center, Manhattan Beach, California, 90266, United States","Principal Investigator : Glynis Ablon, MD, FAAD , Ablon Skin Institute Research Center"
Alopecia Areata,NCT05970809,Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss,https://clinicaltrials.gov/study/NCT05970809,NO,Male Pattern Baldness|Androgenetic Alopecia|Hair Loss/Baldness|Hair Loss|Pattern Baldness,DEVICE: SAGA-001 (A)|DEVICE: SAGA-001 (B),MALE,ADULT,,"Ankara Bilkent Åžehir Hastanesi Dermatoloji Klini, Ankara, Turkey|Ä°stanbul Ãœniversitesi CerrahpaÅŸa TÄ±p FakÃ¼ltesi, Dahili TÄ±p Bilimleri BÃ¶lÃ¼mÃ¼ Deri ve ZÃ¼hrevi HastalÄ±klar Ana Bilim DalÄ± Kocamustafa PaÅŸa, Istanbul, Turkey","Principal Investigator : Server SerdaroÄŸlu, MD , Ä°stanbul Ãœniversitesi CerrahpaÅŸa TÄ±p FakÃ¼ltesi"
Alopecia Areata,NCT03976622,"Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata",https://clinicaltrials.gov/study/NCT03976622,NO,Vitiligo|Psoriasis|Alopecia Areata|Atopic Dermatitis,BIOLOGICAL: Blood samples|BIOLOGICAL: Skin biopsies,ALL,"ADULT, OLDER_ADULT",,"Service de Dermatologie - HÃ´pital Saint-AndrÃ©, Bordeaux, 33075, France","Principal Investigator : Julien SENESCHAL, MD, PhD , University Hospital, Bordeaux"
Alopecia Areata,NCT05210452,Treatment of Alopecia Using Follicular Stem Cells,https://clinicaltrials.gov/study/NCT05210452,NO,Alopecia,BIOLOGICAL: Follicular stem cells|OTHER: Standard treatment according to the clinical protocols,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,,"Study Director : Zinaida Kvacheva , the Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus"
Alopecia Areata,NCT06355856,Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss,https://clinicaltrials.gov/study/NCT06355856,NO,Alopecia,DRUG: DNN.22.17.036|DRUG: 10573048700,MALE,ADULT,PHASE4,,Ache Laboratorios Farmaceuticos S.A.
Alopecia Areata,NCT05339958,Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair,https://clinicaltrials.gov/study/NCT05339958,NO,Hair Thinning,DIETARY_SUPPLEMENT: NutrafolÂ® Men Hair Growth Nutraceutical|OTHER: Placebo Supplement,MALE,ADULT,,"Ablon Skin Institute and Research Center, Manhattan Beach, California, 90266, United States|Therapeutic Clinical Research, San Diego, California, 92123, United States",Nutraceutical Wellness Inc.
Alopecia Areata,NCT04558242,Low Level Light Device as a Primary Therapy for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT04558242,NO,Androgenetic Alopecia|Hair Loss|Thinning Hair|Balding,DEVICE: Genix|DEVICE: Sham,ALL,"ADULT, OLDER_ADULT",,"NST Consultants, Inc., Mendham, New Jersey, 07945, United States","Principal Investigator : Adam Bodian, MD , Bodian Dermatology Group"
Alopecia Areata,NCT04048031,Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning Hair,https://clinicaltrials.gov/study/NCT04048031,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Supplement Capsules|OTHER: Placebo Capsules,FEMALE,"ADULT, OLDER_ADULT",,"Ablon Skin Institute & Research Center, Manhattan Beach, California, 90266, United States","Principal Investigator : Glynis Ablon, MD, FAAD , Ablon Skin institute and Research Center"
Alopecia Areata,NCT05332743,Nutraceutical Supplement With Vegan Botanicals in Females With Self-Perceived Thinning Hair,https://clinicaltrials.gov/study/NCT05332743,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Vegan Women's Hair Supplement,FEMALE,ADULT,,"Ablon Skin Institute and Research Center, Manhattan Beach, California, 90266, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States",Nutraceutical Wellness Inc.
Alopecia Areata,NCT04459650,A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer,https://clinicaltrials.gov/study/NCT04459650,NO,Alopecia,PROCEDURE: Platelet Rich Plasma system,ALL,ADULT,EARLY_PHASE1,"Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, 10065, United States","Principal Investigator : Anthony M Rossi, MD , Memorial Sloan Kettering Cancer Center"
Alopecia Areata,NCT05213936,Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color,https://clinicaltrials.gov/study/NCT05213936,NO,Alopecia,DEVICE: Scalp cooling with hairstyle|DEVICE: Scalp cooling with conditioner and water emulsion,ALL,"ADULT, OLDER_ADULT",,"Montefiore Medical Center, Bronx, New York, 10461, United States","Principal Investigator : Beth McLellan, MD , Montefiore Medical Center"
Alopecia Areata,NCT04897555,LLLT for Alopecia of the Eyebrow in Women,https://clinicaltrials.gov/study/NCT04897555,NO,Alopecia,DEVICE: LLLT,FEMALE,"ADULT, OLDER_ADULT",,"NST Consultants, Inc., Mendham, New Jersey, 07945, United States|Bodian Dermatology, Great Neck, New York, 11021, United States","Principal Investigator : Adam Bodian, MD , Bodian Dermatology Group"
Alopecia Areata,NCT06362941,Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men,https://clinicaltrials.gov/study/NCT06362941,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Women's Hair Growth Supplemnt|DIETARY_SUPPLEMENT: Nutrafol Women's Balance Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Vegan Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Postpartum Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Men's Hair Growth Supplement,ALL,"ADULT, OLDER_ADULT",,"Dermatology Consulting Services, High Point, North Carolina, 27262, United States",Nutraceutical Wellness Inc.
Alopecia Areata,NCT06376409,Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females,https://clinicaltrials.gov/study/NCT06376409,NO,Hair Thinning,DIETARY_SUPPLEMENT: Nutrafol Women's Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Balance Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Vegan Hair Growth Supplement|DIETARY_SUPPLEMENT: Nutrafol Women's Postpartum Hair Growth Supplement,FEMALE,"ADULT, OLDER_ADULT",,"Integrative Skin Science and Research, Sacramento, California, 95815, United States",Nutraceutical Wellness Inc.
Alopecia Areata,NCT02297360,Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning Hair,https://clinicaltrials.gov/study/NCT02297360,NO,Hair Thinning,DIETARY_SUPPLEMENT: Viviscal Extra-Strength Supplement|OTHER: Placebo tablet,FEMALE,"ADULT, OLDER_ADULT",,,"Principal Investigator : Glynis Ablon, MD, FAAD , Director Ablon Skin Institute Research Center"
Alopecia Areata,NCT04721548,Treatment of Androgenetic Alopecia in Men for 24 Weeks,https://clinicaltrials.gov/study/NCT04721548,NO,Alopecia,DRUG: Minoxidil Topical Foam|DRUG: Placebo,MALE,"ADULT, OLDER_ADULT",PHASE3,"Eurofarma Laboratorios S.A, SÃ£o Paulo, 06696-000, Brazil",Eurofarma Laboratorios S.A.
Alopecia Areata,NCT03488108,Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women,https://clinicaltrials.gov/study/NCT03488108,YES,Alopecia,OTHER: Platelet Rich Plasma|DRUG: Minoxidil Foam,FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Mayo Clinic Florida, Jacksonville, Florida, 32224, United States","Principal Investigator : Alison Bruce, M.B. Ch.B , Mayo Clinic"
Alopecia Areata,NCT02288858,To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair,https://clinicaltrials.gov/study/NCT02288858,NO,Hair Thinning,DIETARY_SUPPLEMENT: Viviscal Oral Supplement Tablets,ALL,ADULT,,"Stephens Associates Inc., Richardson, Texas, 75081, United States","Principal Investigator : Ronald L Rizer, PhD , Stephens & Associates, Inc."
Alopecia Areata,NCT03284021,Fraxel Laser for Alopecia,https://clinicaltrials.gov/study/NCT03284021,NO,Alopecia,DEVICE: Fractional erbium-glass 1550 nm laser,ALL,"ADULT, OLDER_ADULT",,"Northwestern University Department of Dermatology, Chicago, Illinois, 60611, United States","Principal Investigator : Murad Alam, MD , Northwestern University"
Alopecia Areata,NCT02087319,Effect of PRP on the Therapy for Hair Growth,https://clinicaltrials.gov/study/NCT02087319,NO,Hair Loss/Baldness,"OTHER: hair loss, baldness (patient's own platelet-rich plasma)",ALL,"ADULT, OLDER_ADULT",,"China Medical University Hospital, Taichung, Taiwan","Study Chair : Jeng Long-Bin , organ transplantation center"
Alopecia Areata,NCT05391178,Improving Disease Severity,https://clinicaltrials.gov/study/NCT05391178,NO,Psoriasis|Alopecia Areata|Polymorphous Light Eruption,OTHER: Lumiton yarn sleeve|OTHER: Lumiton yarn hat|OTHER: Lumiton yarn shirt,ALL,"ADULT, OLDER_ADULT",,"Wake Forest University Health Sciences, Dermatology, Winston-Salem, North Carolina, 27157, United States","Principal Investigator : Joseph Jorizzo, M.D. , Wake Forest University Health Sciences"
Alopecia Areata,NCT05984862,Role of Bandage After FUE Hair Transplantation,https://clinicaltrials.gov/study/NCT05984862,NO,Hair Loss/Baldness,DEVICE: Bandage,ALL,"ADULT, OLDER_ADULT",,,"Study Director : Muhammad Sarfraz Khan, BSc, MBBS , Pak Medical and Diagnostic Center"
Alopecia Areata,NCT02676310,"Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)",https://clinicaltrials.gov/study/NCT02676310,NO,"Alopecia|Alopecia, Androgenetic|Baldness",DRUG: Bimatoprost,MALE,ADULT,PHASE1,"DermResearch, LLC, Austin, Texas, 78759, United States|J&S Studies Inc., College Station, Texas, 77845, United States|E&R Research Foundation, Lynchburg, Virginia, 24501, United States","Study Director : Medical Director , Allergan"
Alopecia Areata,NCT02014584,Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT02014584,YES,Alopecia,DRUG: Dutasteride|DRUG: Placebo,MALE,ADULT,PHASE3,"GSK Investigational Site, Santiago, RegiÃ³n Metro De Santiago, 7580206, Chile|GSK Investigational Site, Pokfulam, Hong Kong|GSK Investigational Site, Shatin, Hong Kong|GSK Investigational Site, Chungcheongnam-do, Korea, Republic of|GSK Investigational Site, Daejeon, 301-721, Korea, Republic of|GSK Investigational Site, Gwangju, 501-757, Korea, Republic of|GSK Investigational Site, Gyeonggi-do, 463-707, Korea, Republic of|GSK Investigational Site, Incheon, 400-711, Korea, Republic of|GSK Investigational Site, Jeonju-si, Jeollabuk-do, 561-712, Korea, Republic of|GSK Investigational Site, Kangwon-Do, 220-701, Korea, Republic of|GSK Investigational Site, Pusan, 602-739, Korea, Republic of|GSK Investigational Site, Seoul, 110-744, Korea, Republic of|GSK Investigational Site, Seoul, 134-090, Korea, Republic of|GSK Investigational Site, Seoul, 143-729, Korea, Republic of|GSK Investigational Site, Seoul, 156-755, Korea, Republic of|GSK Investigational Site, Singapore, 169608, Singapore|GSK Investigational Site, Taipei, 106, Taiwan|GSK Investigational Site, Taipei, Taiwan","Study Director : GSK Clinical Trials , GlaxoSmithKline"
Alopecia Areata,NCT02919735,"Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)",https://clinicaltrials.gov/study/NCT02919735,NO,Alopecia,DRUG: CG 428 cutaneous solution|DRUG: Placebo cutaneous solution,FEMALE,"ADULT, OLDER_ADULT",PHASE2,"CHUV Lausanne, Lausanne, 1011, Switzerland","Principal Investigator : Khalil KZ ZAMAN , Department Oncology - CHUV, 1011 Lausanne - CH"
Alopecia Areata,NCT01145625,Clinical Trial in Females With Female Pattern Hair Loss,https://clinicaltrials.gov/study/NCT01145625,YES,Alopecia,DRUG: 5% Minoxidil|DRUG: 2% Minoxidil,FEMALE,"ADULT, OLDER_ADULT",PHASE3,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Academic Dermatology Associates, Albuquerque, New Mexico, 87106, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Oregon Medical Research Center, P.C., Portland,, Oregon, 97223, United States|NW Dermatology and Research Center, Portland, Oregon, 97210, United States|DermResearch, Inc, Austin, Texas, 78759, United States|Dermatology Research Center, Inc., Salt Lake City, Utah, 84124, United States|The Skin Care Centre, Vancouver, British Columbia, V5Z 4E8, Canada|Centre de SantÃ© Sabouraud, Paris, ÃŽle-de-France, 75010, France|Klinik fÃ¼r Dermatologie, Venerologie und Allergologie, Clinical Research Center for Hair and Skin Science, Berlin, 10117, Germany|Royal Hallamshire Hospital, Sheffield, South Yorkshire, S10 2JF, United Kingdom","Study Director : Clare Kendall, MA , Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc."
Alopecia Areata,NCT01831791,A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT01831791,YES,Alopecia,DRUG: Dutasteride 0.5 mg,MALE,ADULT,PHASE3,"GSK Investigational Site, Fukuoka, 812-0025, Japan|GSK Investigational Site, Osaka, 530-0057, Japan|GSK Investigational Site, Osaka, 532-0003, Japan|GSK Investigational Site, Tokyo, 103-0028, Japan|GSK Investigational Site, Tokyo, 160-0022, Japan","Study Director : GSK Clinical Trials , GlaxoSmithKline"
Alopecia Areata,NCT00801086,Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain,https://clinicaltrials.gov/study/NCT00801086,NO,Alopecia,DRUG: 7% (w/v) Tempol alcohol-based gel (MTS-01)|DRUG: alcohol-based gel,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Arizona, Tucson, Arizona, 85724, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States","Study Chair : James Metz, MD , University of Pennsylvania"
Alopecia Areata,NCT02781311,A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males,https://clinicaltrials.gov/study/NCT02781311,YES,Alopecia,DRUG: Setipiprant|DRUG: Placebo|DRUG: Finasteride,MALE,ADULT,PHASE2,"Burke Pharmaceutical Research, Hot Springs, Arkansas, 71913, United States|Petrus Center for Aesthetic Surgery & Hair Transplantation, Little Rock, Arkansas, 72205, United States|Therapeutics Clinical Research, San Diego, California, 92123, United States|Radiant Research, Inc., Santa Rosa, California, 95405, United States|DeNova Research, Chicago, Illinois, 60611, United States|Heartland Research Associates, LLC, Wichita, Kansas, 67207, United States|Michigan Center for Skin Care Research, Clinton Township, Michigan, 48038, United States|Minnesota Clinical Study Center, Fridley, Minnesota, 55432, United States|University of Minnesota Department of Dermatology Division of Clinical research, Minneapolis, Minnesota, 55455, United States|Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard, Winston-Salem, North Carolina, 27157, United States|Cleveland Clinic, Dept of Dermatology, Cleveland, Ohio, 44195, United States|NW Dermatology and Research Center, Portland, Oregon, 97210, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|Penn State Hershey Medical Center Dermatology Research Office, Hershey, Pennsylvania, 17033, United States|Radiant Research, Inc., Greer, South Carolina, 29650, United States|DermResearch, Inc, Austin, Texas, 78759, United States|Suzzane Bruce and Associates P.A., The Center for Skin Research, Katy, Texas, 77494, United States|The Education & Research Foundation, Inc, Lynchburg, Virginia, 24501, United States","Study Director : Joan-En Lin , Allergan"
Alopecia Areata,NCT01111981,Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia,https://clinicaltrials.gov/study/NCT01111981,NO,Alopecia,DRUG: Clobetasol Propionate 0.05% Emollient Foam,FEMALE,"ADULT, OLDER_ADULT",PHASE4,"Callender Center for Clinical Research, Mitchellville, Maryland, 20721, United States","Principal Investigator : Valerie Callender, M.D. , Callender Skin for Clinical Research Study Director : Cherie Young, M.D. , Callender Center for Clinical Research"
Alopecia Areata,NCT06146166,"The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome",https://clinicaltrials.gov/study/NCT06146166,NO,Hair Thinning,DIETARY_SUPPLEMENT: Oral herbal supplement|DIETARY_SUPPLEMENT: Oral placebo supplement,FEMALE,"ADULT, OLDER_ADULT",,"Integrative Skin and Research, Sacramento, California, 95815, United States",
Alopecia Areata,NCT05296863,Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT05296863,NO,"Alopecia, Androgenetic|Hair Loss/Baldness",COMBINATION_PRODUCT: Non-concentrated adipose-derived stem cell conditioned media and 5% Minoxidil|COMBINATION_PRODUCT: Concentrated adipose-derived stem cell conditioned media and 5% Minoxidil|COMBINATION_PRODUCT: Placebo and 5% Minoxidil,MALE,ADULT,PHASE3,"Universitas Indonesia, Jakarta Pusat, Jakarta, 10430, Indonesia","Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia PT. Kimia Farma (Persero) Tbk"
Alopecia Areata,NCT00197379,The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT00197379,NO,Alopecia,DRUG: roxithromycin,ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan","Study Chair : Masahiro Takigawa, M.D. , Hamamatsu University"
Alopecia Areata,NCT05129800,Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study,https://clinicaltrials.gov/study/NCT05129800,NO,Androgenetic Alopecia|Hair Loss|Alopecia,OTHER: Platelet-rich plasma|OTHER: Mesotherapy,ALL,"CHILD, ADULT, OLDER_ADULT",,,"Principal Investigator : Athanasios J Stefanis , Faculty Hospital Kralovske Vinohrady"
Alopecia Areata,NCT05460611,1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia,https://clinicaltrials.gov/study/NCT05460611,NO,Scarring Alopecia|Androgenetic Alopecia,DEVICE: Sciton HALO 1470nm Non-ablative laser,ALL,"ADULT, OLDER_ADULT",,"Montefiore Einstein Advanced Care, Elmsford, New York, 10523, United States","Principal Investigator : Kseniya Kobets, MD , Albert Einstein College of Medicine Montefiore Medical Center"
Alopecia Areata,NCT00418249,Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women,https://clinicaltrials.gov/study/NCT00418249,NO,Alopecia,DRUG: AS101,FEMALE,"ADULT, OLDER_ADULT",PHASE2,"Tel Aviv, Israel","Principal Investigator : Danny Ben-Amitai, M.D. , Rabin Medical Center"
Alopecia Areata,NCT03427905,Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia,https://clinicaltrials.gov/study/NCT03427905,NO,Hair Loss/Baldness|Alopecia,PROCEDURE: Lipoaspiration|PROCEDURE: Transplantation,ALL,"ADULT, OLDER_ADULT",,"Lebanese University, faculty of Sciences, section II and III, Beirut, 99, Lebanon","Principal Investigator : Nehman Makdissy, PhD , Lebanese University Study Director : Rami Anderi, MD , Lebanese University"
Alopecia Areata,NCT01651689,Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia,https://clinicaltrials.gov/study/NCT01651689,NO,Alopecia,,ALL,"ADULT, OLDER_ADULT",,"Siriraj hospital, Bangkok, 10700, Thailand","Principal Investigator : Rattapon Thuangtong, MD , Department of Dermatology, Siriraj hospital, Faculty of Medicine, Mahidol University, Thailand"
Alopecia Areata,NCT03331003,"""iRestore"" Light Therapy Apparatus",https://clinicaltrials.gov/study/NCT03331003,NO,Alopecia,DEVICE: low level light therapy|DEVICE: non-LLLT wavelength group,ALL,ADULT,,,National Taiwan University Hospital Hsin-Chu Branch
Alopecia Areata,NCT01904721,A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA),https://clinicaltrials.gov/study/NCT01904721,YES,"Alopecia|Alopecia, Androgenetic|Baldness",DRUG: Bimatoprost Solution 1|DRUG: Bimatoprost Solution 2|DRUG: Bimatoprost Vehicle,MALE,ADULT,PHASE2,"Fridley, Minnesota, United States","Study Director : Medical Director , Allergan"
Alopecia Areata,NCT01004809,AVODARTÂ® Alopecia Post-marketing Surveillance (PMS),https://clinicaltrials.gov/study/NCT01004809,NO,Alopecia,DRUG: Dutasteride,MALE,ADULT,,"GSK Investigational Site, Daejeon, 301-721, Korea, Republic of","Study Director : GSK Clinical Trials , GlaxoSmithKline"
Alopecia Areata,NCT01325337,Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia,https://clinicaltrials.gov/study/NCT01325337,YES,"Alopecia|Alopecia, Androgenetic|Baldness",DRUG: bimatoprost Formulation A|DRUG: bimatoprost Formulation B|DRUG: bimatoprost Formulation C|DRUG: bimatoprost vehicle solution|DRUG: minoxidil 5% solution,MALE,ADULT,PHASE2,"Portland, Oregon, United States|Berlin, Germany","Study Director : Medical Director , Allergan"
Alopecia Areata,NCT00441116,A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia,https://clinicaltrials.gov/study/NCT00441116,YES,Alopecia,DRUG: Dutasteride 0.5mg oral tablets,MALE,ADULT,PHASE3,,"Study Director : GSK Clinical Trials , GlaxoSmithKline"
Alopecia Areata,NCT01189279,Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia,https://clinicaltrials.gov/study/NCT01189279,YES,"Alopecia|Alopecia, Androgenetic|Baldness",DRUG: bimatoprost Formulation A|DRUG: bimatoprost Formulation B|DRUG: bimatoprost Formulation C,ALL,ADULT,PHASE1,"Tempe, Arizona, United States",
Melanoma,NCT05928962,An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas,https://clinicaltrials.gov/study/NCT05928962,NO,Malignant Melanomas,DRUG: Recombinant Human Adenovirus Type 5 Injection,ALL,"ADULT, OLDER_ADULT",PHASE1,"Fujian Cancer Hospital, Department of Internal Medicine, Ward 19, Fuzhou, Fujian, China",Fujian Cancer Hospital
Melanoma,NCT01502696,Adjuvant PEG Intron in Ulcerated Melanoma,https://clinicaltrials.gov/study/NCT01502696,NO,Ulcerated Melanomas,BIOLOGICAL: PEG IFN alfa-2b,ALL,"ADULT, OLDER_ADULT",PHASE3,"Medical University of Graz, Graz, Austria|Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet, Brussels, Belgium|Universitair Ziekenhuis Gent, Ghent, Belgium|U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium|Aarhus University Hospital, Aarhus, 8000, Denmark|Herlev Hospital - University Copenhagen, Herlev, Denmark|Odense University Hospital, Odense, Denmark|Assistance Publique - Hopitaux de Paris - Hopital Avicenne, Bobigny, France|CHU de Bordeaux - Groupe Hospitalier Saint-AndrÃ© - Hopital Saint-Andre (Bordeaux, France, Bordeaux, France|CHU de Grenoble - La Tronche - HÃ´pital A. Michallon, Grenoble, France|CHRU de Lille, Lille, France|Centre Leon Berard, Lyon, France|Assistance Publique - Hopitaux de Marseille - HÃ´pital de La Timone, Marseille, France|CHU de Nice - CHU de Nice - Hopital De L'Archet, Nice, France|Assistance Publique - Hopitaux de Paris - CHU Ambroise Pare, Paris, France|Assitance Publique - Hopitaux de Paris - Hopital Bichat-Claude Bernard, Paris, France|Assitance Publique - Hopitaux de Paris - Hopital Saint-Louis, Paris, France|Institut Gustave Roussy, Paris, France|Centre Hospitalier De Pau, Pau, France|CHU de Reims - HÃ´pital Robert DebrÃ©, Reims, France|CHU d'Amiens - CHU Amiens - Hopital Sud, Salouel, France|Universitaetsklinikum, Essen, Germany|Universitaetsklinikum Heidelberg - Hautklinik / Dermatologic Department, Heidelberg, Germany|Universitaetsklinikum Heidelberg - Hautklinik, Heidelburg, Germany|Universitaetsklinikum Schleswig-Holstein, Kiel, Germany|Universitaetsklinikum Koeln, Koeln, Germany|Medizinische Universitaet Zu Luebeck, Luebeck, Germany|Johannes Gutenberg Universitaetskliniken - Mainz University Medical Center, Mainz, Germany|UniversitaetsMedizin Mannheim, Mannheim, Germany|Universitaetsklinikum Wuerzburg, Wuerzburg, Germany|IRCCS - Istituto Tumori ""Giovanni Paolo II"", Bari, Italy|Istituto Europeo di Oncologia, Milan, Italy|Istituto Nazionale Tumori IRCCS ""Fondazione G. Pascale"", Napoli, Italy|Istituto Dermopatico Dell'Immacolata, Roma, Italy|Azienda Ospedaliero-Universitaria ""Santa Maria della Misericordia"" di Udine, Udine, Italy|The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Netherlands|Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands|Leiden University Medical Centre, Leiden, Netherlands|Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland|I.P.O. Francisco Gentil - Centro De Lisboa, Lisboa, 1099-023, Portugal|I.P.O. Francisco Gentil - Centro De Lisboa, Lisboa, Portugal|Hospital Distrital De Santarem, Santarem, Portugal|Hospital Clinic Universitari, Barcelona, Spain|Hospital Universitario 12 De Octubre, Madrid, Spain|UniversitaetsSpital Zurich, Zurich, Switzerland|Clatterbridge Centre for Oncology NHS Trust - Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom|University Hospitals Birmingham NHS Foundation Trust (UHB) - Queen Elisabeth Medical Centre, Birmingham, United Kingdom|Mid Essex Hospitals - Broomfield Hospital, Broomfield, United Kingdom|Cambridge University Hospital NHS - Addenbrookes Hospital, Cambridge, United Kingdom|Cheltenham General Hospital, Cheltenham, United Kingdom|NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital, Glasgow, United Kingdom|Leeds Teaching Hospitals NHS Trust - St. James's University Hospital, Leeds, United Kingdom|St George's Hospital NHS Trust (6961), London, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom|Norfolk And Norwich Hospital, Norwich, United Kingdom|Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, United Kingdom|University Hospital Southampton NHS Foundation Trust - Southampton General Hospital, Southampton, United Kingdom|St Helens and Knowsley Teaching Hospitals, St Helens, United Kingdom","Study Chair : Alexander Eggermont, MD, PHD , Institut Gustave Roussy, Paris, France"
Melanoma,NCT03783325,Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma,https://clinicaltrials.gov/study/NCT03783325,NO,Nevi and Melanomas,BEHAVIORAL: UV Counseling|OTHER: UV Photo|OTHER: Biological Sample,ALL,"ADULT, OLDER_ADULT",,"University of Colorado, Aurora, Colorado, 80045, United States","Principal Investigator : Neil Box, PhD , University of Colorado, Denver"
Melanoma,NCT04020809,Neoadjuvant Atezolizumab in Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT04020809,NO,Cutaneous Melanoma,DRUG: Atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,"Houston Methodist Hospital, Houston, Texas, 77030, United States","Principal Investigator : Nestor Esnaola, M.D. , Houston Methodist Cancer Center"
Melanoma,NCT03541148,Evaluation of Oncoxin-ViusidÂ® in Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT03541148,NO,"Cutaneous Melanoma, Stage II|Malignant Cutaneous Melanoma|Cutaneous Melanoma, Stage III",DIETARY_SUPPLEMENT: Oncoxin-Viusid,ALL,"ADULT, OLDER_ADULT",PHASE2,"Manuel Fajardo Clinical Surgical University Hospital, La Habana, 10600, Cuba","Principal Investigator : Olaine R. Gray Lovio, Dr. , Manuel Fajardo Clinical Surgical University Hospital"
Melanoma,NCT04702854,Evaluation of Ultrasound Biomicroscopy in the Local Staging of Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT04702854,NO,Cutaneous Melanoma,DIAGNOSTIC_TEST: Ultrasound Biomicroscopy,ALL,"ADULT, OLDER_ADULT",,"CHU de Nice, Nice, France","Principal Investigator : Nicolas AZULAY , Centre Hospitalier Universitaire de Nice"
Melanoma,NCT05172232,Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions,https://clinicaltrials.gov/study/NCT05172232,NO,Malignant Melanoma,DIAGNOSTIC_TEST: Dermalyzer,ALL,"ADULT, OLDER_ADULT",,"Region Ã–stergÃ¶tland Primary Care, LinkÃ¶ping, Docent, 58185, Sweden|Region Stockholm Primary Care, Stockholm, Sweden|Region Kalmar and Kronoberg, VÃ¤xjÃ¶, Sweden","Principal Investigator : Magnus Falk, Ass.Prof. , Linkoeping University"
Melanoma,NCT05572463,A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT05572463,NO,Unresectable Cutaneous Melanoma|Metastatic Cutaneous Melanoma,COMBINATION_PRODUCT: Sintilimab + IBI110,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"University of California San Francisco Medical Center, San Francisco, California, 94143, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Princess Victoria Hospital, Woolloongabba, Queensland, 4102, Australia|Hospices Civil De Lyon Nord - Centre Hospitalier Lyon Sud - Dermatologie, Lyon, 69002, France|Hospital Saint Louis, Paris, 75010, France|Universitatsklinikum Carl Gustav Carus, Dresden, 01307, Germany|Universitatsklinikum Essen, Essen, 45147, Germany|Institut Catala d'Oncologia Hospital Universitari Germans Trials I Pujol, Barcelona, Barcelona, 8916, Spain|Hospital Universitario Reina Sofia, Cordoba, CÃ³rdoba, 14004, Spain|Universitaets Spital Zurich, ZÃ¼rich, 8091, Switzerland|Cambridge University Hospitals NHS Foundation Trust (Oxford), Cambridge, CB2 0QQ, United Kingdom|Lancashire Teaching Hospitals (Preston), Preston, PR2 9HT, United Kingdom","Innovent Biologics (USA), Inc."
Melanoma,NCT04253080,Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors,https://clinicaltrials.gov/study/NCT04253080,NO,Cutaneous Melanoma,BIOLOGICAL: Blood sample|BIOLOGICAL: Cutaneous melanoma biopsy,ALL,"ADULT, OLDER_ADULT",,"Dermatology department, Paris, Ile De France, 75014, France","Principal Investigator : Armelle Blondel, MD, PhD , Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France"
Melanoma,NCT02355587,Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes,https://clinicaltrials.gov/study/NCT02355587,NO,Cutaneous Melanoma,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Sutter Health, Santa Rosa, California, 95403, United States|Elizabeth Liotta Dermatology, Frederick, Maryland, 21702, United States|University of Nevada, Las Vegas, Nevada, 89102, United States|South Carolina Skin Care Center, Greenville, South Carolina, 29607, United States","Principal Investigator : Robert Cook, PhD , Castle Biosciences Inc."
Melanoma,NCT03313206,Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma,https://clinicaltrials.gov/study/NCT03313206,NO,Head and Neck Mucosal Melanomas,DRUG: Pembrolizumab|PROCEDURE: Surgery|RADIATION: IMRT|DRUG: Lenvatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Gustave Roussy, Villejuif, Val De Marne, 94805, France","Study Chair : Antoine MOYA PLANA, MD , Gustave Roussy, Cancer Campus, Grand Paris"
Melanoma,NCT05253872,The MELAcare Study: A New Method for Surveillance of Melanoma Patients,https://clinicaltrials.gov/study/NCT05253872,NO,Cutaneous Melanoma,OTHER: The MelaCare intervention,ALL,"ADULT, OLDER_ADULT",,"Herlev and Gentofte Hospital, Copenhagen, 2730, Denmark","Study Chair : Lisbet R HÃ¶lmich, Professor , Herlev and Gentofte Hospital"
Melanoma,NCT02288897,PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT02288897,YES,Cutaneous Melanoma,"DRUG: PV-10 (10% rose bengal disodium)|DRUG: Dacarbazine, temozolomide or talimogene laherparepvec",ALL,"ADULT, OLDER_ADULT",PHASE3,"Sharp Memorial Hospital - Clinical Oncology Research, San Diego, California, 92123, United States|Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States|Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States|Washington University School of Medicine - Dermatology, Saint Louis, Missouri, 63110, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|Atlantic Health System, Morristown, New Jersey, 07960, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, 27157, United States|Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma, 74146, United States|St Luke's University Hospital and Health Network, Easton, Pennsylvania, 18045, United States|Penn State Hershey Cancer Institute, Hershey, Pennsylvania, 17033, United States|M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|UnitÃ© CancÃ©ro-Dermatologie, HÃ´tel-Dieu CHU Nantes, Nantes, France|Institut Claudius Regaud, IUCT ONCOPOLE, Toulouse, 31059, France|Klinik fÃ¼r Dermatologie, Venerologie und Allergologie Charite UniversitÃ¤tsmedizin Berlin, Berlin, Germany|Klinik fÃ¼r Dermatologie UniversitÃ¤tsklinikum Essen Studienzentrum, Essen, Germany|Klinik fÃ¼r Dermatologie, Venerologie und Allergologie UniversitÃ¤tsklinikum Schleswig-Holstein Hautkrebszentrum, Kiel, Germany|Hautklinik Klinikum der Johannes Gutenberg UniversitÃ¤t Hautkrebszentrum, Mainz, Germany|IRCCS Instituto Nazionale Tumori ""Fondazione Giovanni Pascale"", Napoli, Italy|Istituto Dermopatico dell'Immacolata (IDI IRCCS), Rome, Italy|Azienda Sanitaria Azienda Ospedaliera Universitaria Senese, Siena, Italy|Centro de Estudios y PrevenciÃ³n del Cancer A.C., JuchitÃ¡n de Zaragoza, Oaxaca, 70000, Mexico|Neurociencias Estudios ClÃ­nicos S.C., CuliacÃ¡n, Sinaloa, 80020, Mexico","Study Director : Eric Wachter, Ph.D. , Provectus Biopharmaceuticals, Inc. Principal Investigator : Sanjiv Agarwala, M.D. , St Luke's University Hospital and Health Network"
Melanoma,NCT03396952,Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma,https://clinicaltrials.gov/study/NCT03396952,YES,Stage III Cutaneous Melanoma|Stage IIIA Cutaneous Melanoma|Stage IIIB Cutaneous Melanoma|Stage IIIC Cutaneous Melanoma|Stage IV Cutaneous Melanoma,DRUG: Aspirin|BIOLOGICAL: Ipilimumab|OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Califonia, San Francisco, San Francisco, California, 94143, United States","Principal Investigator : Adil Daud, MD , University of California, San Francisco"
Melanoma,NCT04884997,A Study of Toripalimab or Combining With Temozolomideï¼ˆivï¼‰ in the Treatment of Advanced/Metastatic Malignant Melanoma,https://clinicaltrials.gov/study/NCT04884997,NO,Malignant Melanoma,DRUG: toripalimab|DRUG: Temozolomide Injection,ALL,"ADULT, OLDER_ADULT",PHASE2,"Department of Medical Onocology, First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310003, China","Principal Investigator : Yulong Zheng, PhD , First Affiliated Hospital of Zhejiang University"
Melanoma,NCT02355574,5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results,https://clinicaltrials.gov/study/NCT02355574,NO,Cutaneous Melanoma,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Northside Hospital, Atlanta, Georgia, 30342, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Saint Louis University, Saint Louis, Missouri, 63103, United States","Principal Investigator : Robert Cook, PhD , Castle Biosciences Inc."
Melanoma,NCT04778449,"Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma",https://clinicaltrials.gov/study/NCT04778449,NO,Cutaneous Melanoma,OTHER: Medical Chart Review|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",,"M D Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : Jennifer L McQuade , M.D. Anderson Cancer Center"
Melanoma,NCT04274816,Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma,https://clinicaltrials.gov/study/NCT04274816,NO,Cutaneous Melanoma,DRUG: Tremelimumab,ALL,"ADULT, OLDER_ADULT",PHASE1,,"Principal Investigator : Tanja D de Gruijl , Amsterdam UMC, location VUmc Principal Investigator : Alfons JM van den Eertwegh , Amsterdam UMC, location VUmc"
Melanoma,NCT04253574,Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma,https://clinicaltrials.gov/study/NCT04253574,NO,Malignant Melanoma,DIAGNOSTIC_TEST: Imaging with 18F-FDG PET/CT and/or Ultrasound,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Joachim Hohmann, MD MSc , University of Basel"
Melanoma,NCT03842943,Neoadjuvant Combination Immunotherapy for Stage III Melanoma,https://clinicaltrials.gov/study/NCT03842943,NO,Cutaneous Melanoma,DRUG: Pembrolizumab|DRUG: Talimogene Laherparepvec,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Louisville, Louisville, Kentucky, 40202, United States","Principal Investigator : Michael Egger, MD , University of Louisville"
Melanoma,NCT00424515,Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma,https://clinicaltrials.gov/study/NCT00424515,YES,Mucosal Melanoma|Acral/Lentiginous Melanoma|Chronically Sun Damaged Melanomas,DRUG: Imatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Colorado at Denver Health Sciences Center, Denver, Colorado, 80045, United States|H. Lee Moffitt Cancer Center, Tampa, Florida, 33612, United States|University of Chicago, Chicago, Illinois, 60637, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : F. Stephen Hodi, MD , Dana-Farber Cancer Institute"
Melanoma,NCT03655756,pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT03655756,YES,"Cutaneous Melanoma, Stage III|Cutaneous Melanoma, Stage IV",BIOLOGICAL: IFx-Hu2.0,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"H. Lee Moffitt Cancer Center, Tampa, Florida, 33612, United States","Principal Investigator : Joseph Markowitz, MD, PhD , Collaborator"
Melanoma,NCT04924413,L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT04924413,NO,Malignant Melanoma,DRUG: Tislelizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China","Study Director : Quanli Gao, Ph.D , Henan Cancer Hospital"
Melanoma,NCT01729663,"Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients",https://clinicaltrials.gov/study/NCT01729663,NO,Cutaneous Melanoma,"BIOLOGICAL: CSF470 vaccine, BCG, Molgramostim|DRUG: interferon alpha 2b",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Instituto MÃ©dico Alexander Fleming, Buenos Aires, Capital Federal, 1426, Argentina","Principal Investigator : JosÃ© Mordoh, MD, PhD , Instituto MÃ©dico Alexander Fleming"
Melanoma,NCT00991250,SentoCloneÂ® Compared to Reference Treatment in Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00991250,NO,Malignant Melanoma,BIOLOGICAL: SentoCloneÂ®|DRUG: TemodalÂ® or Dacarbazine MedacÂ®,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Lunds Universitetssjukhus, Lund, SkÃ¥ne, 22185, Sweden|SÃ¶dersjukhuset, Stockholm, Stockholms LÃ¤n, 11883, Sweden|Karolinska Sjukhuset, Stockholm, Stockholms LÃ¤n, 17176, Sweden|Norrlands Universitetssjukhus, UmeÃ¥, VÃ¤sterbottens LÃ¤n, 90185, Sweden|Sahlgrenska Universitetssjukhuset, GÃ¶teborg, VÃ¤stra GÃ¶talands LÃ¤n, 41685, Sweden","Principal Investigator : Christian Ingvar, MD , Lund University Hospital"
Melanoma,NCT04123470,A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma,https://clinicaltrials.gov/study/NCT04123470,NO,Malignant Melanoma,GENETIC: delolimogene mupadenorepvec|BIOLOGICAL: atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Cedars-Sinai Medical Center, The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|Baylor St Luke's Medical Center, Houston, Texas, 77030, United States|Uppsala University Hospital, Uppsala, 75185, Sweden","Study Chair : Angelica Loskog, PhD , Lokon Pharma AB"
Melanoma,NCT04648163,Suction Drain in Axillary Lymph Node Dissection for Malignant Melanoma,https://clinicaltrials.gov/study/NCT04648163,NO,Malignant Melanoma,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Medical University of Graz, Graz, Styria, 8036, Austria","Study Chair : David B Lumenta, MD, Prof , Medical University of Graz"
Melanoma,NCT03649529,Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy,https://clinicaltrials.gov/study/NCT03649529,NO,Malignant Melanoma,BIOLOGICAL: GPA-TriMAR-T,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Hainan Cancer Hospital, Haikou, Hainan, 570100, China|The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570100, China","Principal Investigator : Haifeng Lin , The Second Affiliated Hospital of Hainan Medical University"
Melanoma,NCT00087477,A Pilot Study of Pivanex in Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT00087477,NO,Malignant Melanoma,DRUG: Pivanex,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Mt. Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States",Titan Pharmaceuticals
Melanoma,NCT01247623,Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT01247623,NO,Malignant Melanoma,BIOLOGICAL: GV1001,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Oslo University Hospital, Oslo, Postbox 4953, 0424, Norway",Oslo University Hospital
Melanoma,NCT04593485,Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract,https://clinicaltrials.gov/study/NCT04593485,NO,Malignant Melanoma,DRUG: Camrelizumab for injection,FEMALE,"ADULT, OLDER_ADULT",PHASE2,"Fudan University Shanghai Cancer Center, Shanghai, Shanghai, 200032, China|Fudan University Shanghai Cancer Center, Shanghai, China","Principal Investigator : Xiaohua Wu , Fudan University Shanghai Cancer Centre"
Melanoma,NCT02068196,A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.,https://clinicaltrials.gov/study/NCT02068196,NO,Malignant Melanoma,PROCEDURE: Blood sampling for Pre-existing immunity|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE4,"Haukeland University Hospital, Bergen, Norway|Nordland Hospital BodÃ¸, BodÃ¸, Norway|SÃ¸rlandet Hospital, Kristiansand, Kristiansand, Norway|Oslo University Hospital, Oslo, Norway|Stavanger University Hospital, Stavanger, Norway|University Hospital of North Norway, TromsÃ¸, Norway|Trondheim University Hospital, St.Olavs Hospital, Trondheim, Norway|Ã…lesund Hospital, Ã…lesund, Norway","Principal Investigator : Tormod K Guren, MD PhD , Oslo University Hospital"
Melanoma,NCT00323206,Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma,https://clinicaltrials.gov/study/NCT00323206,NO,Malignant Melanoma,BIOLOGICAL: IL-12p DNA|PROCEDURE: Intratumoral Electroporation,ALL,"ADULT, OLDER_ADULT",,"H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States","Principal Investigator : Adil Daud, MD , H. Lee Moffitt Cancer Center and Research Institute"
Melanoma,NCT05200143,"Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma",https://clinicaltrials.gov/study/NCT05200143,NO,Refractory Cutaneous Melanoma,DRUG: Ipilimumab|DRUG: Nivolumab|DRUG: Cabozantinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Providence Portland Medical Center, Portland, Oregon, 97213, United States","Principal Investigator : Matthew Taylor, MD , Providence Health & Services"
Melanoma,NCT00513604,Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00513604,YES,"Melanoma|Malignant Melanoma|Melanoma, Experimental|Experimental Melanomas",BIOLOGICAL: aldesleukin|BIOLOGICAL: therapeutic autologous lymphocytes|DRUG: Cyclophosphamide|DRUG: Fludarabine phosphate|RADIATION: Total body irradiation,ALL,"ADULT, OLDER_ADULT",PHASE2,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States","Principal Investigator : Deborah E Citrin, M.D. , National Cancer Institute (NCI)"
Melanoma,NCT00498836,"Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma",https://clinicaltrials.gov/study/NCT00498836,NO,Malignant Melanoma,DRUG: CP-4055|DRUG: Sorafenib (Nexavar),ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15232, United States|Cancer Therapy and Research Center, Institute for Drug Development, San Antonio, Texas, 78229, United States|The Norwegian Radium Hospital, Oslo, NO-0310, Norway|Lund University Hospital, Lund, SE-221 85, Sweden|UmeÃ¥ University Hospital, UmeÃ¥, Sweden|Uppsala University Hospital, Uppsala, SE-751 85, Sweden","Principal Investigator : Svein Dueland, MD , The Norwegian Radium Hospital, Oslo, Norway"
Melanoma,NCT01557114,Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT01557114,NO,Malignant Melanoma,DRUG: Ipilimumab|RADIATION: Radiotherapy,ALL,"ADULT, OLDER_ADULT",PHASE1,"Gustave Roussy Cancer Campus, Villejuif, Val de Marne, 94805, France|Institut Gustave Roussy, Villejuif, 94805, France","Gustave Roussy, Cancer Campus, Grand Paris"
Melanoma,NCT03116412,A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma,https://clinicaltrials.gov/study/NCT03116412,NO,Malignant Melanoma,PROCEDURE: CT or PET scans,ALL,"ADULT, OLDER_ADULT",,"SÃ¶dra Ã„lvsborgs sjukhus, Boras, Sweden|MÃ¤larsjukhuset Eskilstuna, Eskilstuna, Sweden|Falu lasarett, Falun, Sweden|GÃ¤vle sjukhus, Gavle, Sweden|Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden|Helsingborgs lasarett, Helsingborg, Sweden|LÃ¤nssjukhuset Ryhov, Jonkoping, Sweden|LÃ¤nssjukhuset i Kalmar, Kalmar, Sweden|Centralsjukhuset i Karlstad, Karlstad, Sweden|LinkÃ¶ping University Hospital, Linkoping, Sweden|SkÃ¥ne University Hospital, MalmÃ¶, Sweden|Ã–rebro University Hospital, Orebro, Sweden|Skaraborgs sjukhus SkÃ¶vde, Skovde, Sweden|Karolinska University Hospital, Stockholm, Sweden|LÃ¤nssjukhuset Sundsvall, Sundsvall, Sweden|Uddevalla sjukhus, Uddevalla, Sweden|UmeÃ¥ University Hospital, Umea, Sweden|Akademiska sjukhuset, Uppsala, Sweden|VÃ¤stmanlands sjukhus VÃ¤sterÃ¥s, Vasteras, Sweden|Visby lasarett, Visby, Sweden","Principal Investigator : Gustav Ullenhag, associate professor , Uppsala University Hospital"
Melanoma,NCT02275416,Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma,https://clinicaltrials.gov/study/NCT02275416,NO,Malignant Melanoma,DRUG: Ipilimumab|BIOLOGICAL: UV1 vaccine|BIOLOGICAL: GM-CSF,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Oslo University Hospital, Radiumhospitalet, Oslo, 0379, Norway","Principal Investigator : Tormod Guren, MD PhD , Oslo University Hospital"
Melanoma,NCT01227551,A Study of Intratumoral CAVATAKâ„¢ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM ),https://clinicaltrials.gov/study/NCT01227551,YES,Malignant Melanoma,BIOLOGICAL: Coxsackievirus A21 (CVA21),ALL,"ADULT, OLDER_ADULT",PHASE2,"Moores UCSD Cancer Center, La Jolla, California, 92093, United States|St Mary's Medical Center, San Francisco, California, 94117, United States|Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Oncology Specialists, SC, Niles, Illinois, 60714, United States|Investigative Clinical Research of Indiana, Indianapolis, Indiana, 46260, United States|Atlantic Melanoma Center, Morristown, New Jersey, 07962, United States|Providence Cancer Center, Portland, Oregon, 97213, United States|Mary Crowley Cancer Research Centers, Dallas, Texas, 75201, United States|Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States","Principal Investigator : Robert Andtbacka, MD , Associate Professor"
Melanoma,NCT04285749,Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas,https://clinicaltrials.gov/study/NCT04285749,NO,Malignant Melanoma,DRUG: Fluvastatin|OTHER: RNA-sequencing|OTHER: Gene expression profiling,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,,"Principal Investigator : Wesley Yu, MD , University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center"
Melanoma,NCT00535314,Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00535314,NO,Malignant Melanoma,DRUG: RTA 402 Dose1|DRUG: RTA 402 Dose2,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Reata, a wholly owned subsidiary of Biogen"
Melanoma,NCT00963261,Quality of Life and Psychological Well-being in Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT00963261,NO,Malignant Melanoma,BEHAVIORAL: psycho-oncological intervention,ALL,"ADULT, OLDER_ADULT",,"University Medical Center Freiburg, Department of Dermatology, Freiburg, 79104, Germany|University Medical Center Collogne, Department of Dermatology, KÃ¶ln, 50937, Germany","Principal Investigator : Katrin Reuter, PhD , University Medical Center Freiburg, Department of Psychiatry and Psychotherapy Principal Investigator : Dorothee Nashan, MD , University Medical Center, Department of Dermatology"
Melanoma,NCT00864253,A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma,https://clinicaltrials.gov/study/NCT00864253,YES,Malignant Melanoma,DRUG: ABI-007|DRUG: Dacarbazine,ALL,"ADULT, OLDER_ADULT",PHASE3,"University of Alabama at Birmingham, Birmingham, Alabama, 35243, United States|AZ Cancer Ctr, Scottsdale, Arizona, 85258, United States|Arizona Cancer Center, Tucson, Arizona, 85724, United States|Genesis Cancer Ctr - Hot Springs, Hot Springs, Arkansas, 71913, United States|University of Arkansa for Medical Sciences, Little Rock, Arkansas, 72205, United States|Tower Cancer Research Foundation, Beverly Hills, California, 90211, United States|San Diego Pacific Oncology and Hematology Associates, Encinitas, California, 92024, United States|Loma Linda University Cancer Center, Loma Linda, California, 92354, United States|University of Southern California/Norris Cancer Center, Los Angeles, California, 90033, United States|University of CA Los Angeles, Los Angeles, California, 90095, United States|St. Mary's Medical Center, San Francisco, California, 94117, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Baptist Cancer Institute, Jacksonville, Florida, 32207, United States|Lakeland Regional Cancer Center, Lakeland, Florida, 33805, United States|University of Miami Hospital and Clincs/SCCC, Miami, Florida, 33136, United States|Waren Billhartz Cancer Center, Maryville, Illinois, 62062, United States|Indiana University, Indianapolis, Indiana, 46202, United States|IA Blood and Cancer Care, PLC, Cedar Rapids, Iowa, 52402, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Wayne State University, Detroit, Michigan, 48201, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Saint Louis University, Saint Louis, Missouri, 63110, United States|St. John's Medical Research, Springfield, Missouri, 65807, United States|Nevada Cancer Institute, Las Vegas, Nevada, 89135, United States|Atlantic Melanoma Center, Morristown, New Jersey, 07962, United States|Piedmont Hematology, Winston-Salem, North Carolina, 27103, United States|OH State University Arthur G. James Cancer Hospital, Columbus, Ohio, 43210, United States|Integris Cancer Institute of OK, Oklahoma City, Oklahoma, 73142, United States|St. Luke's Hospital & Health Network, Bethlehem, Pennsylvania, 18015, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19131, United States|Mary Crowley Research Center, Dallas, Texas, 75246, United States|Univ of TX MD Anderson Cancer Ctr, Houston, Texas, 77030, United States|Univ of TX Med School at Houston, Houston, Texas, 77030, United States|Covenant Health System DBA Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, 79410, United States|Hope Oncology, Richardson, Texas, 75080, United States|Utah Cancer Specialist, Salt Lake City, Utah, 84106, United States|Univ. of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Evergreen Hematology & Oncology, Spokane, Washington, 99218, United States|Port Macquarie Base Hospital, Port Macquarie, New South Wales, 2444, Australia|Royal North Shore Hospital, Sydney, New South Wales, 2065, Australia|Sydney West Cancer Trials Centre/Westmead Hospital, Westmead, New South Wales, 2145, Australia|Royal Adelaide Hospital, Department of Medical Oncology, Adelaide, South Australia, 5000, Australia|Royal Hobart Hospital, Hobart, Tasmania, 7000, Australia|Alfred Hospital, Melbourne, Victoria, 3004, Australia|Sir Charles Gairdner Hospital, Nedlands Perth, Western Australia, Australia|Royal Perth Hospital, Perth, Western Australia, 6000, Australia|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|BCCA Centre for the Southern Interior, Kelowna, British Columbia, V1Y 5L3, Canada|BCCA, Centre for the Southern Interior, Kelowna, British Columbia, V1Y 5L3, Canada|BC Cancer Agency-Fraser Valley Ctr., Surrey, British Columbia, V3V 1Z2, Canada|BC Cancer Agency-Vancouver, Vancouver, British Columbia, V5Z4E6, Canada|BC Cancer Agency-Vancouver Island Ctr., Victoria, British Columbia, V8R 6V5, Canada|London Regional Cancer Program, London, Ontario, N6A 4L6, Canada|Credit Valley Hospital, Missiauga, Ontario, L5M 2N1, Canada|The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, K1H 8L6, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|McGill University Dept. of Oncology Clinical Research Program, Montreal, Quebec, H2W 1S6, Canada|Hopital Saint Andre' CHU de Bordeaux, Bordeaux, 33075, France|Centre Hospitaller Universitaire de Grenoble, Grenoble Cedex 09, 38043, France|CHRU Hopital Claude Huriez, Lile Cedax, France|Hopital Dypuytren-CHU de Limoges, Limoges cedex, France|Centre Leon Berad, Lyon, France|Hopital Sainte Marguerite, Marseille Cedex 9, France|CHU Hopital Saint Eloi, Montepellier Cedex 5, France|Centre Regional Val d' Aurelle Paul Lamarque, Montpellier, 34298, France|Hopital de 1 Archet 2, Nice Cedex 3, 06200, France|Hopital Saint-Louis, Paris Cedex, France|Hopital Bichat, Paris, 75018, France|Groupe hospitalier Cochin-St. Vincent de Paul, Paris, France|Institut Gustave Roussy (IGR) Centre de Lutte Contre le Canc, Villejuif Cedex, 94805, France|Charite Universitaetsmedizin Berlin, Berlin, BE, 10117, Germany|Universitaetsklinkum Heidelberg, Heidelberg, BW, Germany|Universitaetsklinkum Heidelberg, Heidelber, BW, Germany|Universitaetsklinkum Tuebingen, Tuebingen, BW, 72076, Germany|Universitaetsklinkum Wuerzburg PS, Wuerzburg, BY, 97080, Germany|Universitaetsklinkum Hamburg-Eppendorf, Hamburg, HH, Germany|Univeritaetsklinkum Goettingen, Gottington, NI, Germany|Medizinische Hochschuke Hannover, Hannover, NI, 30625, Germany|St. Josef-Hospital, Bochum, Northwest, 44791, Germany|Universitaetsklinkum Essen, Essen, Northwest, Germany|Universitaetklinkum Koeln, Koln, Northwest, Germany|Universitaetsklinkum Schegwig-Holstein, Keil, SH, 24105, Germany|Universitaetsklinkum Dresden, Dresden, SN, Germany|UniversitawtsklinKum Jena, Jena, Strasse 35, 07743, Germany|Universitaesklinkum Leipzig, Leipzig, Germany|Universitaetsklinkum Mainz, Mainz, Germany|Istituto Tumori ""Giovanni Paolo II"", Bari, BA, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei T, Meldola, FC, 47014, Italy|IST-Istituto Nazionale per la Ricera sul Cancro, Genova, GE, 16132, Italy|Istituto Europeo di Oncologia, Milano, MI, 20141, Italy|Istituto Nazionale Tumori, Milano, MI, Italy|IOV-Instituto Oncologico IRCCS, Padova, PD, 35128, Italy|Azienda Ospedaliera Universitaria Sense, Siena, SI, 53100, Italy|Ist. Naz. per lo studio e la cura dei tumori G. Pascale, Napoli, 80131, Italy|Ospedale S. Chiara, Pisa, 56100, Italy|Medisch Centrum Alkmaar, Alkmaar, 1815, Netherlands|Rijnstate ziekenhuis Arnhem, Amhem, 6800TA, Netherlands|Erasmus MC ae"" Daniel den Hoed, Rotterdam, Netherlands|H Clinic i Provincial, Barcelona, 08036, Spain|H CLINIC I Provincial, Barcelona, Spain|H Clinico San Carlos, Madrid, Spain|Corporacion Sanitaria Parc Tauli, Sabadell, 08208, Spain|Broomfield Hospital, Chelmsford, Essex, CM1 7ET, United Kingdom|Velindre Hospital, Cardiff, Glam, CF14 2TL, United Kingdom|St. George's Hospital, London, GT Lon, SW12 ORE, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, Nott, NG5 1PB, United Kingdom|Singleton Hospital, Sothwest Wales Inst., Swansea, S Glam, SA28QA, United Kingdom|Univ Hospital of North Staffordshire, Stroke On Kent, Staffs, ST4 6QB, United Kingdom|Weston Park Hospital, Sheffield, Syorks, S10 2SJ, United Kingdom|Newcross Hospital, Wolverhampton, Wstmid, SV10 0QP, United Kingdom|Royal Marsden Hospital London, London, SW3 6JJ, United Kingdom","Principal Investigator : Evan Hersh, MD , University of Arizona Study Director : Ileana Elias, MD , Celgene Corporation"
Melanoma,NCT00179608,Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy,https://clinicaltrials.gov/study/NCT00179608,NO,Malignant Melanoma,DRUG: CC-5013,ALL,"ADULT, OLDER_ADULT",PHASE1,"MD Anderson Cancer Center, Houston, Texas, 77030-4009, United States",Prologue Research International
Melanoma,NCT03860883,Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT03860883,NO,"Cutaneous Melanoma, Stage II",PROCEDURE: Wide Local Excision = 1cm Margin|PROCEDURE: Wide Local Excision = 2cm Margin,ALL,"ADULT, OLDER_ADULT",PHASE3,"University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, 36604, United States|Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Mayo Clinic Phoenix, Phoenix, Arizona, 85054, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|The Angeles (Cedars-Sinai Medical Center and its Affiliates), Los Angeles, California, 90048-1804, United States|UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|Stanford Cancer Institute, Palo Alto, California, 94304, United States|Kaiser Permanente - Vallejo Medical Center, Vallejo, California, 94589, United States|Kaiser Permanente - Walnut Creek Medical Center, Walnut Creek, California, 94596, United States|Smilow Hospital Care Center, Guilford, Guilford, Connecticut, 06437, United States|Yale University, New Haven, Connecticut, 06520, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, 20007, United States|MedStar Washington Hospital Center, Washington, District of Columbia, 20010, United States|Baptist MD Anderson Cancer Center, Jacksonville, Florida, 32207, United States|Mayo Clinic in Florida, Jacksonville, Florida, 32224, United States|Lakeland Regional Health Hollis Cancer Center, Lakeland, Florida, 33805, United States|Moffitt Cancer Center - McKinley Campus, Tampa, Florida, 33612, United States|Moffitt Cancer Center, Magnolia Campus, Tampa, Florida, 33612, United States|Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Emory University, Atlanta, Georgia, 30322, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, 30342, United States|Northside Hospital Atlanta, Atlanta, Georgia, 30342, United States|Northside Hospital Cancer Institute, Atlanta, Georgia, 30342, United States|Nancy N and JC Lewis Cancer & Research Pavilion St. Joseph's/Candler, Savannah, Georgia, 31405, United States|Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, 60115, United States|Northwestern University, Evanston, Illinois, 60208, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, 60134, United States|Northwestern Medicine Cancer Center Lake Forest Hospital, Lake Forest, Illinois, 60045, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, 60068, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, 60555, United States|University of Kansas Hospital - Indian Creek Campus, Overland Park, Kansas, 66211, United States|University of Kansas Hospital- Westwood Cancer Center, Westwood, Kansas, 66205, United States|University of Kentucky, Lexington, Kentucky, 40506, United States|MedStar Franklin Square Medical Center, Baltimore, Maryland, 21237, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, 49503, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, 49503, United States|West Michigan Cancer Centre, Kalamazoo, Michigan, 49007, United States|Siteman Cancer Centre, Barnes Jewish West County, Creve Coeur, Missouri, 63141, United States|University of Kansas Cancer Center, Kansas City, Missouri, 64154, United States|Cox South Hospital, Springfield, Missouri, 65807, United States|Nebraska Medicine - Bellevue, Bellevue, Nebraska, 68123, United States|Nebraska Medicine-Village Pointe, Omaha, Nebraska, 68118, United States|University of Nebraska Medicine, Omaha, Nebraska, 68198, United States|Cooperman Barnabas Medical Center, Livingston, New Jersey, 07039, United States|Rutgers Cancer Institute of New Jersey, Piscataway, New Jersey, 08854, United States|Northwell Health Imbert Cancer Center, Bay Shore, New York, 11706, United States|Roswell Park Cancer Institute, Buffalo, New York, 14203, United States|Northwell Health/Center for Advanced Medicine, Lake Success, New York, 11042, United States|NYU Langone Medical Center (Winthrop Hospital), Mineola, New York, 11501, United States|Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, 10016, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, 12601, United States|University of Rochester, Rochester, New York, 14642, United States|State University of New York Upstate Medical University, Syracuse, New York, 13210, United States|State University of New York Upstate Medical Center-Community Campus, Syracuse, New York, 13215, United States|Wilmont Cancer Institute at Webster, Webster, New York, 14580, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|East Carolina University, Greenville, North Carolina, 27858, United States|Sanford Broadway Medical Centre, Fargo, North Dakota, 58102, United States|Sanford Roger Maris Cancer Centre, Fargo, North Dakota, 58102, United States|University Hospitals Avon Health Center, Avon, Ohio, 44011, United States|Miami Valley Hospital South, Centerville, Ohio, 45459, United States|University Hospitals Geauga Medical Center, Chardon, Ohio, 44024, United States|University of Cincinnati, Cincinnati, Ohio, 45219, United States|University Hospitals Cleveland Medical Centre, Cleveland, Ohio, 44106, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|University Hospitals Chagrin Highlands Medical Centre, Orange Village, Ohio, 44122, United States|West Chester Hospital (OH394), West Chester, Ohio, 45069, United States|University Hospitals St. John Medical Center, Westlake, Ohio, 44145, United States|OUHSC Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Mercy Health Center - Oncology Hematology, Oklahoma City, Oklahoma, 73120-8362, United States|Kaiser Sunnyside Medical Center, Clackamas, Oregon, 97015, United States|Kaiser Permanente Northwest - Oncology Clinic, Portland, Oregon, 97227, United States|St. Luke's University Health Network - Allentown Cancer Center, Allentown, Pennsylvania, 18104, United States|St Luke's University Health Network, Bethlehem Campus, Bethlehem, Pennsylvania, 18015, United States|St Luke's University Health Network, Anderson Campus, Easton, Pennsylvania, 18045, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|St Luke's University Health Network Quakertown Campus, Quakertown, Pennsylvania, 18951, United States|St. Luke's University Health Network - Upper Bucks, Quakertown, Pennsylvania, 18951, United States|Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania, 18840, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Univ of Texas Health Science Center at San Antonio, San Antonio, Texas, 78284-7884, United States|Intermountain Medical Center, Murray, Utah, 84157, United States|Huntsman Cancer Institute (The University of Utah), Salt Lake City, Utah, 84112, United States|University of Vermont Medical Center, Burlington, Vermont, 05401, United States|University of Vermount and Sate Agricultural College, Burlington, Vermont, 05405, United States|University of Virginia Health System, Charlottesville, Virginia, 22903, United States|VCU Massey Cancer Center Peninsula Cancer Institute, Newport News, Virginia, 23601, United States|VCU Massey Cancer Center, Richmond, Virginia, 23298, United States|Carilion Roanoke Memorial Hospital, Roanoke, Virginia, 24014, United States|VCU Massey Cancer Center Affiliate Valley Health, Winchester, Virginia, 22601, United States|University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, 53792, United States|Marshfield Medical Center - Marshfield, Marshfield, Wisconsin, 54449, United States|Aurora St Luke's Medical Center, Milwaukee, Wisconsin, 53215, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Calvary Public Hospital Bruce, Bruce, Australian Capital Territory, 2617, Australia|The Canberra Hospital, Garran, Australian Capital Territory, 2605, Australia|Westmead Hospital, Sydney, New South Wales, 2145, Australia|Melanoma Institute Australia, Sydney, New South Wales, Australia|Royal Prince Alfred Hospital, Sydney, New South Wales, Australia|Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia|Robina Hospital, Gold Coast, Queensland, 4226, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia, V1Y 5L3, Canada|CancerCare Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada|Royal Victoria Regional Health Centre, Barrie, Ontario, L4M 6M2, Canada|Hamilton Health Sciences Centre, Hamilton, Ontario, L8V 1C3, Canada|Ottawa Hospital Research Institute, Ottawa, Ontario, K1Y 4E9, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|UHN - Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2C1, Canada|Hopital Maisonneuve-Rosemont, Montreal, Quebec, H1T 2M4, Canada|Hotel-Dieu de Quebec, QuÃ©bec City, Quebec, G1R2J6, Canada|IOV Istituto Oncologico Veneto IRCCS-Padova, Padova, 35128, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy|AOU CittÃ della Salute e della Scienza di Torino, Torino, 10126, Italy|Flevo Hospital, Almere, Flevoland, Netherlands|Ziekenhuis Gelderse Vallei, Ede, Gelderland, 6716 RP, Netherlands|Gelre Hospital, Zutphen, Gelderland, 7207 AE, Netherlands|University Medical Centre Groningen, Groningen, 9713, Netherlands|Zuyderland Medical Center, Heerlen, 6419, Netherlands|Maastricht University Medical Center, Maastricht, 6229 HX, Netherlands|North Shore Hospital, Auckland, 0620, New Zealand|Sahlgrenska University Hospital, Gothenburg, Sweden|Central Hospital Kristianstad, Kristianstad, 29133, Sweden|University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham, B15 2TH, United Kingdom|Royal Cornwall Hospital NHS Trust, Truro, Cornwall, TR1 3LJ, United Kingdom|Hull University Teaching Hospitals NHS Trust, Hull, East Yorkshire, HU3 2JZ, United Kingdom|MID & South Essex NHS Foundation Trust, Westcliff on Sea, Essex, SS0 0RY, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Headington, Oxford, OX3 9DU, United Kingdom|Imperial College Healthcare NHS Trust, London, The Bays, W2 1NY, United Kingdom|Queen Victoria Hospital NHS Foundation Trust, East Grinstead, West Sussex, RH19 3DZ, United Kingdom|North Bristol NHS Trust, Bristol, BS10 5NB, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, United Kingdom|The Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, United Kingdom|St. Helens & Knowsley Teaching Hospitals NHS Trust, Liverpool, United Kingdom|The Royal Marsden Hospital NHS Foundation Trust, London,, SW3 6JJ, United Kingdom|Royal Free London NHS Foundation Trust, London, NW3 2QG, United Kingdom|Guy's and St Thomas's NHS Foundation Trust, of St Thomas' Hospital, London, SE1 7EH, United Kingdom|St George's University Hospitals NHS Foundation Trust, London, SW17 0QT, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|South Tees Hospitals NHS Foundation Trust of The James Cook University Hospital, Middlesbrough, TS4 3BW, United Kingdom|Norfolk and Norwich University Hospital NHS Trust, Norwich, NR47UY, United Kingdom|Nottingham University Hospitals, NHS Trust, Trust HQ, City Hospital, Nottingham, NG5 1PB, United Kingdom","Study Chair : Michael Henderson , Peter MacCallum Cancer Centre, Australia Study Chair : Marc Moncrieff , Norfolk & Norwich University Hospital"
Melanoma,NCT01211262,Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma,https://clinicaltrials.gov/study/NCT01211262,YES,Malignant Melanoma,DRUG: IMCgp100,ALL,"ADULT, OLDER_ADULT",PHASE1,"The Angeles Clinic, Los Angeles, California, 90025, United States|Yale Cancer Center, New Haven, Connecticut, 06520-8028, United States|Memorial Slone Kettering Cancer Center, New York, New York, 10065, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Queen Elizabeth Hospital, Birmingham, United Kingdom|Addenbrooke's Hospital, Cambridge, United Kingdom|The Beatson Institute, Glasgow, United Kingdom|St James Hospital, Leeds, United Kingdom|NIHR Biomedical Research Centre, Oxford, United Kingdom","Study Director : Namir Hassan, PhD , Immunocore Ltd"
Melanoma,NCT00300612,Vaccine Treatment for Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00300612,NO,Malignant Melanoma,BIOLOGICAL: HyperAcute-Melanoma Vaccine,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States","Principal Investigator : Ronald C. DeConti, M.D. , University of South Florida Study Chair : Charles J. Link, M.D. , NewLink Genetics Corporation"
Melanoma,NCT04789421,"Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management",https://clinicaltrials.gov/study/NCT04789421,NO,Cutaneous Melanoma,"DEVICE: Clinical, dermoscopy and Reflective confocal microscopy evaluations|DEVICE: Clinical, dermoscopy evaluations",ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Giovanni Pellacani, MD , Azienda Ospedaliera Modena"
Melanoma,NCT01253096,Intratumoral Application of L19IL2 in Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT01253096,NO,Malignant Melanoma,DRUG: Intratumoral injections of L19IL2,ALL,"ADULT, OLDER_ADULT",PHASE2,"UniversitÃ¤tsklinik Graz, Graz, Austria|Medizinischen Hochschule Hannover, Hannover, Germany|University Hospital, Tuebingen, Germany","Principal Investigator : Claus Garbe, Prof. M.D. , University Hospital Tuebingen (Germany)"
Melanoma,NCT01588847,Anesthesia and Cancer Recurrence im Malignant Melanoma,https://clinicaltrials.gov/study/NCT01588847,NO,Malignant Melanoma,"PROCEDURE: Spinal anesthesia with Bupivacaine hyperbar 0.5 %|PROCEDURE: General anesthesia with Sufentanil, Propofol and Rocuronium and Sevoflurane",ALL,"ADULT, OLDER_ADULT",,"Fachklinik Hornheide, Department of Anesthesiology, Intensive Care and Pain Therapy, MÃ¼nster, D-48157, Germany","Study Chair : Hugo K Van Aken, MD PhD , University Hospital Muenster, Department of Anesthesia, Intensive Care and Pain Therapy"
Melanoma,NCT00142454,NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting),https://clinicaltrials.gov/study/NCT00142454,YES,Malignant Melanoma,DRUG: Imiquimod|BIOLOGICAL: NY-ESO-1 protein,ALL,"ADULT, OLDER_ADULT",PHASE1,"NYU Cancer Institute, New York, New York, 10016, United States","Principal Investigator : Nina Bhardwaj, MD, PhD , NYU Langone Health Study Director : Sylvia Adams, MD , NYU Langone Health"
Melanoma,NCT03278665,4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy,https://clinicaltrials.gov/study/NCT03278665,NO,Malignant Melanoma,DRUG: 4SC-202 in combination with Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"UniversitÃ¤tsklinikum Essen, Essen, Germany|Medizinische Hochschule Hannover, Hannover, Germany|UniversitÃ¤tsklinikum Heidelberg, Heidelberg, Germany|Klinikum der UniversitÃ¤t MÃ¼nchen, MÃ¼nchen, Germany|UniversitÃ¤tsklinikum TÃ¼bingen, TÃ¼bingen, Germany|UniversitÃ¤tsklinikum WÃ¼rzburg, WÃ¼rzburg, Germany|Istituto Nazionale Tumori Fondazione ""G. Pascale"", Napoli, Italy","Principal Investigator : Dirk Schadendorf, MD , UniversitÃ¤tsklinikum Essen"
Melanoma,NCT02272855,A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma,https://clinicaltrials.gov/study/NCT02272855,NO,Malignant Melanoma,BIOLOGICAL: HF10 plus Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"Clinical Site, San Francisco, California, 94115, United States|Clinical Site, Atlanta, Georgia, 30322, United States|Clinical Site, Portland, Oregon, 97239, United States|Clinical Site, Bethlehem, Pennsylvania, 18015, United States|Clinical Site, Hershey, Pennsylvania, 17033, United States|Clinical Site, Dallas, Texas, 75230, United States|Clinical Site, Houston, Texas, 77030, United States|Clinical Site, Salt Lake City, Utah, 84112, United States","Principal Investigator : Robert Andtbacka , University of Utah"
Melanoma,NCT02535078,Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT02535078,NO,Malignant Melanoma,DRUG: Tebentafusp (IMCgp100)|DRUG: durvalumab|DRUG: tremelimumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States",AstraZeneca
Melanoma,NCT06294379,Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy,https://clinicaltrials.gov/study/NCT06294379,NO,Malignant Melanoma,,ALL,"ADULT, OLDER_ADULT",,"Odense University Hospital, Odense C, 5000, Denmark",University of Copenhagen Aarhus University Hospital Aalborg University Hospital
Melanoma,NCT02968680,Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT02968680,NO,Cutaneous Melanoma|Melanoma,PROCEDURE: Sentinel Lymph Node Biopsy|DEVICE: Ultrasonography|DRUG: Sonazoid,ALL,"ADULT, OLDER_ADULT",PHASE1,"USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States","Principal Investigator : Kevin King, MD , University of Southern California"
Melanoma,NCT04547946,Observational Study for Melanoma Adjuvant Treatment With TafinlarÂ® + MekinistÂ® (Dabrafenib + Trametinib),https://clinicaltrials.gov/study/NCT04547946,NO,Malignant Melanoma,DRUG: dabrafenib + trametinib,ALL,"ADULT, OLDER_ADULT",,"Novartis Investigative Site, Coimbra, Center, 3000-075, Portugal|Novartis Investigative Site, Oporto, North, 4200-319, Portugal","Study Director : Novartis Pharmaceuticals , Novartis Pharmaceuticals"
Melanoma,NCT01942603,Minimal SN Tumor Burden,https://clinicaltrials.gov/study/NCT01942603,NO,Cutaneous Melanoma,,ALL,"ADULT, OLDER_ADULT",,"U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium|CHRU de Lille, Lille, France|CHU de Nice - Hopital De L'Archet, Nice, France|Institut Gustave Roussy, Paris, France|Charite - Universitaetsmedizin Berlin - Campus Mitte, Berlin, Germany|Universitaetsklinikum - Essen, Essen, Germany|UniversitaetsMedizin Mannheim, Mannheim, Germany|Istituto Europeo di Oncologia, Milan, Italy|Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Napoli, Italy|Istituto Oncologico Veneto IRCCS - Ospedale Busonera, Padova, Italy|The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Netherlands|Erasmus MC Cancer Institute - location Daniel den Hoed, Rotterdam, Netherlands|Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland|The Institute Of Oncology, Ljubljana, Slovenia|Hospital Clinic Universitari, Barcelona, Spain|Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Royal Bournemouth Hospital, Bournemouth, United Kingdom|Cambridge University Hospital NHS - Addenbrookes Hospital, Cambridge, United Kingdom|Guy's and St Thomas' NHS - St Thomas Hospital, London, United Kingdom|St George's Hospital NHS Trust, London, United Kingdom|Norfolk And Norwich Hospital, Norwich, United Kingdom|St Helens & Knowsley NHS Trust - Whiston Hospital, Prescott, United Kingdom",European Organisation for Research and Treatment of Cancer - EORTC
Melanoma,NCT01278940,Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT01278940,NO,Malignant Melanoma,BIOLOGICAL: Dendritic Cells (DC) malignant melanoma|PROCEDURE: IL-2,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,,"Principal Investigator : Steinar Aamdal, M.D PhD Prof , Oslo University Hospital - Norwegian Radium Hospital"
Melanoma,NCT03843593,A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery,https://clinicaltrials.gov/study/NCT03843593,NO,Cutaneous Melanoma,BEHAVIORAL: Demographics Questionnaire|BEHAVIORAL: Adjuvant Treatment Beliefs Scale10|BEHAVIORAL: Functional Assessment of Cancer Therapy - Melanoma (FACT-M)11|BEHAVIORAL: Functional Assessment of Chronic Illness Therapy - Treatment Satisfaction - General (FACIT-TS-G)13|BEHAVIORAL: Decisional Regret14|BEHAVIORAL: Clinician Preference for Treatment,ALL,"ADULT, OLDER_ADULT",,"Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States","Principal Investigator : Paul Chapman, MD , Memorial Sloan Kettering Cancer Center"
Melanoma,NCT00145158,Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT00145158,YES,Malignant Melanoma,BIOLOGICAL: 8 HLA-A2-restricted peptides and Montanide ISA51|BIOLOGICAL: 8 HLA-A2-restricted peptides and CpG 7909,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Clinique Universitaires St-Luc, Brussels, B-1200, Belgium|Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium","Study Chair : Nicolas VanBaren, MD , Ludwig Institute for Cancer Research Study Director : Thierry BOON, PhD , Ludwig Institute for Cancer Research"
Melanoma,NCT00235482,Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02),https://clinicaltrials.gov/study/NCT00235482,NO,Malignant Melanoma,DRUG: Coxsackievirus A21,ALL,"ADULT, OLDER_ADULT",PHASE1,"Melanoma Unit, Mater Misericordiae Hospital, Newcastle, New South Wales, 2298, Australia",Viralytics
Melanoma,NCT03628417,Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases,https://clinicaltrials.gov/study/NCT03628417,YES,Cutaneous Melanoma,PROCEDURE: Calcium Electroporation|PROCEDURE: Bleomycin based electrochemotherapy,ALL,"ADULT, OLDER_ADULT",,,Szeged University
Melanoma,NCT00358319,Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma,https://clinicaltrials.gov/study/NCT00358319,NO,Malignant Melanoma,DRUG: Karenitecin|DRUG: Valproic Acid,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States","Principal Investigator : Adil Daud, M.D. , UCSF (formerly at H. Lee Moffitt Cancer Center & Research Institute)"
Melanoma,NCT02650492,Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma,https://clinicaltrials.gov/study/NCT02650492,NO,Melanoma|Malignant Melanoma,DEVICE: Immunostimulating Interstitial Laser Thermotherapy,ALL,"ADULT, OLDER_ADULT",,"Karolinska University Hospital Solna, Stockholm, 17176, Sweden","Principal Investigator : Johan Hansson, MD PhD , Karolinska Institutet"
Melanoma,NCT00087776,Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma,https://clinicaltrials.gov/study/NCT00087776,NO,Malignant Melanoma,DRUG: Chemotherapy,ALL,"ADULT, OLDER_ADULT",,"Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, 19403, United States","American Regent, Inc."
Melanoma,NCT00729950,Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma,https://clinicaltrials.gov/study/NCT00729950,NO,Malignant Melanoma,BIOLOGICAL: MDX-010,ALL,"ADULT, OLDER_ADULT",PHASE1,"Arizona Cancer Center, Tucson, Arizona, 85724-5024, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Piedmont Oncology Specialists, Charlotte, North Carolina, 28207, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States","Study Director : Bristol-Myers Squibb , Bristol-Myers Squibb"
Melanoma,NCT01137006,"An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma",https://clinicaltrials.gov/study/NCT01137006,YES,Malignant Melanoma,BIOLOGICAL: IMC-20D7S (Cohort 1A)|BIOLOGICAL: IMC-20D7S (Cohort 2A)|BIOLOGICAL: IMC-20D7S (Cohort 3A)|BIOLOGICAL: IMC-20D7S (Cohort 4A)|BIOLOGICAL: IMC-20D7S (Cohort 1B)|BIOLOGICAL: IMC-20D7S (Cohort 2B)|BIOLOGICAL: IMC-20D7S (Cohort 3B),ALL,"ADULT, OLDER_ADULT",PHASE1,"ImClone Investigational Site, Boston, Massachusetts, 02114, United States|ImClone Investigational Site, New York, New York, 10021, United States","Study Director : E-mail: ClinicalTrials@ ImClone.com , Eli Lilly and Company"
Melanoma,NCT04217382,Pre Transplantation Melanoma,https://clinicaltrials.gov/study/NCT04217382,NO,Malignant Melanoma,OTHER: patient with melanoma pre transplantation,ALL,"ADULT, OLDER_ADULT",,"service de dermatologie - hopital Edouard Herriot, Lyon, Rhone, 69003, France","Principal Investigator : Emilie DUCROUX, MD , Service de Dermatologie, HÃ´pital Edouard Herriot, Lyon"
Melanoma,NCT00327600,Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00327600,NO,Malignant Melanoma,DRUG: imexon|DRUG: DTIC,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,"Investigational Site 009, Los Angeles, California, 90033, United States|Investigational Site 002, Santa Monica, California, 90404, United States|University of CO Anschutz Cancer Pavilion, Aurora, Colorado, 80010, United States|US Oncology Orlando, Cancer Centers of FL, Ocoee, Florida, 34761, United States|US Oncology Albany, New York Oncology, Albany, New York, 12208, United States|US Oncology Kettering, Kettering, Ohio, 45409, United States|US Oncology Greenville, Cancer Centers of the Carolinas, Greenville, South Carolina, 29615, United States|US Oncology, Tyler Cancer Center, Tyler, Texas, 75702, United States|Investigational Site 012, Salt Lake City, Utah, 84112, United States|US Oncology, Virginia Oncology Assoc, Norfolk, Virginia, 23502, United States|US Oncology Spokane, Cancer Care Northwest, Spokane, Washington, 99218, United States","Study Director : Evan Hersh, MD , AmpliMed Corporation"
Melanoma,NCT01636960,A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370),https://clinicaltrials.gov/study/NCT01636960,YES,Malignant Melanoma,BIOLOGICAL: PegIFN alfa-2b,ALL,"ADULT, OLDER_ADULT",PHASE1,,"Study Director : Medical Director , Merck Sharp & Dohme LLC"
Melanoma,NCT03538314,UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma,https://clinicaltrials.gov/study/NCT03538314,NO,Malignant Melanoma,DRUG: UV1|DRUG: GM-CSF,ALL,"ADULT, OLDER_ADULT",PHASE1,"John Wayne Cancer Center, Santa Monica, California, 90404, United States|University of Iowa Carver College of Medicine, Iowa City, Iowa, 52242, United States|St. Luke's University Health Network, Easton, Pennsylvania, 18045, United States|University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States",
Melanoma,NCT01138410,Study of a DNA Immunotherapy to Treat Melanoma,https://clinicaltrials.gov/study/NCT01138410,NO,Malignant Melanoma,BIOLOGICAL: SCIB1,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Department of Medical Oncology, The Royal Surrey County Hospital, Guildford, Surrey, GU2 7XX, United Kingdom|St James' Institute of Oncology, Leeds, LS9 7TF, United Kingdom|Christie Hospital, Manchester, M20 4BX, United Kingdom|Department of Clinical Oncology, City Hospital, Nottingham, NG5 1PB, United Kingdom|Department of Medical Oncology, Southampton General Hospital, Southampton, SO16 6YD, United Kingdom","Study Director : Poulam M Patel, MD , Department of Clinical Oncology, City Hospital, Nottingham, UK Principal Investigator : Paul Lorigan, MD , Department of Medical Oncology, Christie Hospital, Manchester, UK Principal Investigator : Maria Marples, MD , St James' Institute of Oncology, Leeds, UK Principal Investigator : Christian Ottensmeier, MD , Department of Medical Oncology, Southampton General Hospital, UK Principal Investigator : Hardev Pandha, MD , Department of Medical Oncology, Royal Surrey County Hospital, Guildford, UK"
Melanoma,NCT01124734,High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma,https://clinicaltrials.gov/study/NCT01124734,YES,Malignant Melanoma,DRUG: Interleukin-2|DRUG: Temozolomide,ALL,"ADULT, OLDER_ADULT",PHASE2,"Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States",
Melanoma,NCT01455259,Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors,https://clinicaltrials.gov/study/NCT01455259,NO,Malignant Melanoma,BIOLOGICAL: AdCD40L,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Uppsala University Hospital, Uppsala, 75185, Sweden","Study Chair : Thomas H TÃ¶tterman, MD, PhD , Uppsala University Principal Investigator : Gustav Ullenhag, MD, PhD , Uppsala University Hospital Study Director : Angelica SI Loskog, PhD , Uppsala University"
Melanoma,NCT00963664,Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma,https://clinicaltrials.gov/study/NCT00963664,NO,Melanoma|Malignant Melanoma,DRUG: lovastatin|DRUG: interferon alfa-2b,ALL,"ADULT, OLDER_ADULT",PHASE2,"NeoPlas Innovation, Nashville, Tennessee, 37027, United States","Principal Investigator : Stephen B. Cantrell, MD , NeoPlas Innovation"
Melanoma,NCT01696045,"Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma",https://clinicaltrials.gov/study/NCT01696045,YES,Malignant Melanoma,BIOLOGICAL: Ipilimumab,ALL,CHILD,PHASE2,"Phoenix Children'S Hospital, Phoenix, Arizona, 85016, United States|Childrens Hospital Of La, Los Angeles, California, 90027, United States|Children'S Hospital Of Orange County, Orange, California, 92868, United States|Children'S Hospital Colorado, Aurora, Colorado, 80045, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|James Whitcomb Riley Hospital For Children, Indianapolis, Indiana, 46202, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University Of Pittsburgh Medical Center Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|St. Jude Children'S Research Hospital, Memphis, Tennessee, 38105, United States|The University Of Texas Md Anderson Cancer Center, Houston, Texas, 77030, United States|Primary Children'S Medical Center, Salt Lake City, Utah, 84113, United States|University Of Utah, Salt Lake City, Utah, 84113, United States|Local Institution, Gent, 9000, Belgium|Local Institution, Copenhagen, 2100, Denmark|Local Institution, Lyon, 69008, France|Local Institution, Marseille Cedex 5, 13385, France|Local Institution, Nantes Cedex 1, 44093, France|Local Institution, Villejuif Cedex, 94805, France|Local Institution, Dortmund, 44137, Germany|Local Institution, Erlangen, 91054, Germany|Local Institution, Hamburg, 20246, Germany|Local Institution, M?nster, 48149, Germany|Local Institution, Munster, 48149, Germany|Local Institution, Mexico, D.F, 02990, Mexico|Local Institution, Df, Distrito Federal, 06720, Mexico|Local Institution, Leon, Guanajato, Guanajuato, 37000, Mexico|Local Institution, Esplugues de Llobregat- Barcelona, 08950, Spain|Local Institution, Bristol, Avon, BS2 8BJ, United Kingdom|Local Institution, Newcastle, Northumberland, NE1 4LP, United Kingdom|Local Institution, Sutton, Surrey, SM2 5PT, United Kingdom","Study Director : Bristol-Myers Squibb , Bristol-Myers Squibb"
Melanoma,NCT01264081,Lapatinib in Stage IV Melanoma With ERBB4 Mutations,https://clinicaltrials.gov/study/NCT01264081,YES,Malignant Melanoma,DRUG: Lapatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States","Principal Investigator : Udo Rudloff, M.D. , National Cancer Institute (NCI)"
Melanoma,NCT00145041,Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction,https://clinicaltrials.gov/study/NCT00145041,YES,Malignant Melanoma,DRUG: Vincristine Sulfate Liposomes Injection,ALL,"ADULT, OLDER_ADULT",PHASE1,"University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : Agop Bedikian, MD , MD Anderson Cancer Center, Dept of Melanoma"
Melanoma,NCT03034395,Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma,https://clinicaltrials.gov/study/NCT03034395,NO,Malignant Melanoma,PROCEDURE: Wide Local Excision,ALL,"ADULT, OLDER_ADULT",,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States","Principal Investigator : Joshua Mammen, MD , University of Kansas Medical Center"
Melanoma,NCT02537600,Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis,https://clinicaltrials.gov/study/NCT02537600,NO,Malignant Melanoma,DRUG: Cobimetinib + Vemurafenib combination treatment,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Bordeaux, Bordeaux, 33000, France|CHU Ambroise ParÃ©, Boulogne, 92104, France|CHU Brest - HÃ´pital Morvan, Brest, France|CHU Caen - HÃ´pital ClÃ©menceau, Caen, 14033, France|HÃ´pital Henri Mondor, Creteil, 94010, France|CHU de Dijon, Dijon, France|CHU Albert Michallon, Grenoble, 38014, France|Centre Hospitalier du Mans, Le Mans, 72037, France|CHRU Lille, Lille, 59037, France|Centre Hospitalier Lyon Sud, Lyon, 69495, France|CHU de Nantes, Nantes, 44093, France|Groupe Hospitalier l'Archet, Nice, 06202, France|HÃ´Ã®tal St louis, Paris, 75010, France|HÃ´pital Cochin, Paris, 75014, France|HÃ´pital Bichat, Paris, 75018, France|Centre EugÃ¨ne Marquis, Rennes, 35042, France|CHU Tours, Tours, 37044, France","Principal Investigator : Thierry Lesimple, MD , Centre EugÃ¨ne Marquis"
Melanoma,NCT01024231,Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma,https://clinicaltrials.gov/study/NCT01024231,YES,Malignant Melanoma,DRUG: BMS-936558 (MDX1106-04)|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE1,"Yale University School Of Medicine, New Haven, Connecticut, 06520, United States|Medstar Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, 20007, United States|Memorial Sloan Kettering Nassau, New York, New York, 11065, United States|Hillman Cancer Research Pavilion, Pittsburgh, Pennsylvania, 15232, United States","Study Director : Bristol-Myers Squibb , Bristol-Myers Squibb"
Melanoma,NCT02223884,A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy,https://clinicaltrials.gov/study/NCT02223884,NO,Malignant Melanoma,DRUG: docetaxel 35mg/m2|DRUG: Carboplatin AUC3,ALL,"ADULT, OLDER_ADULT",PHASE2,"Severance Hospital, Seoul, 120-752, Korea, Republic of",
Melanoma,NCT00733798,A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT00733798,NO,Melanoma|Malignant Melanoma|Metastatic Melanoma,DRUG: 131I-TM601,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Lacks Cancer Center, Grand Rapids, Michigan, 49503, United States|New York University School of Medicine, New York, New York, 10016, United States|Mary Crowley Cancer Center, Dallas, Texas, 75246, United States","Principal Investigator : Thomas Gribbin, MD , Lacks Cancer Center Principal Investigator : Neil Senzer, MD , Mary Crowley Cancer Center Principal Investigator : Anna Pavlick, DO , New York University Cancer Center"
Melanoma,NCT02673970,Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT02673970,NO,Malignant Melanoma,,ALL,"ADULT, OLDER_ADULT",,"UZ Brussel, Jette, Brabant, 1090, Belgium|UZ Brussel, Jette, Brussels, 1090, Belgium","Principal Investigator : Bart NEyns, MD; PhD , Universitair Ziekenhuis Brussel"
Melanoma,NCT05089370,Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma,https://clinicaltrials.gov/study/NCT05089370,NO,Malignant Melanoma,COMBINATION_PRODUCT: Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"University of Colorado Hospital, Aurora, Colorado, 80045, United States","Principal Investigator : Martin McCarter , Colorado Research Center"
Melanoma,NCT01543464,Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients,https://clinicaltrials.gov/study/NCT01543464,NO,Malignant Melanoma,DRUG: Chemotherapy: Temozolomide,ALL,"ADULT, OLDER_ADULT",PHASE2,"Trine Zeeberg Iversen, BrÃ¸nshÃ¸j, Copenhagen, 2700, Denmark","Principal Investigator : Trine Zeeberg Iversen, MD , Center for Cancer ImmuneTherapy Study Director : Inge Marie Svane, MD, PhD, Prof. , Center for Cancer ImmunoTherapy"
Melanoma,NCT05675709,Enhancing Skin Cancer Early Detection and Treatment in Primary Care,https://clinicaltrials.gov/study/NCT05675709,NO,Cutaneous Melanoma,BEHAVIORAL: Training and Education,ALL,"ADULT, OLDER_ADULT",,"OHSU Knight Cancer Institute, Portland, Oregon, 97239, United States","Principal Investigator : Susan A Flocke, Ph.D. , OHSU Knight Cancer Institute"
Melanoma,NCT00539591,Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma,https://clinicaltrials.gov/study/NCT00539591,YES,Malignant Melanoma,DRUG: Peginterferon alfa-2b|DRUG: Temozolomide|DRUG: Recombinant interferon alfa-2b,ALL,"CHILD, ADULT",PHASE2,"Rady Children's Hospital, San Diego, California, 92123, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|The Children's Cancer Hospital at UT M.D. Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : Alberto Pappo, MD , St. Jude Children's Research Hospital"
Melanoma,NCT02889861,IMCgp100-401 Rollover Study,https://clinicaltrials.gov/study/NCT02889861,YES,Malignant Melanoma,DRUG: IMCgp100,ALL,"ADULT, OLDER_ADULT",PHASE2,"Memorial Slone Kettering Cancer Center, New York, New York, 10065, United States|Dept of Oncology & Haematology, Churchill Hospital, Oxford, Oxfordshire, OX3 7LJ, United Kingdom|Dept of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, G12 OYN, United Kingdom",Immunocore Ltd
Melanoma,NCT01898039,Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients,https://clinicaltrials.gov/study/NCT01898039,NO,Malignant Melanoma,BIOLOGICAL: A2/4-1BBL melanoma vaccine|PROCEDURE: DNP sensititzation|DRUG: Cyclophosphamide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,"Sharett Institute of Oncology, Hadassah Medical Organization, Jerusalem, 91120, Israel",Hadassah Medical Organization
Melanoma,NCT03448666,ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases,https://clinicaltrials.gov/study/NCT03448666,NO,Malignant Melanoma,COMBINATION_PRODUCT: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"IEO Istituto Europeo di Oncologia, Milan, 20141, Italy","Principal Investigator : Pier Fr Ferrucci, MD , European Institute of Oncology"
Melanoma,NCT02071940,PLX3397 KIT in Acral aNd mucOsal Melanoma,https://clinicaltrials.gov/study/NCT02071940,NO,Malignant Melanoma,DRUG: PLX3397,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Christie NHS Foundation Trust, Manchester, Greater Manchester, M20 4BX, United Kingdom|The Beatson West of Scotland Cancer Centre, Glasgow, Scotland, G12 OXH, United Kingdom|Abertawe Bro Morgannwg University Health Board, Singleton Hospital, Swansea, Wales, SA2 8QA, United Kingdom|St James' University Hospital, Leeds, Yorkshire, LS9 7TF, United Kingdom|Cancer Clinical Trials Centre- Weston Park Hospital, Sheffield, Yorkshire, S10 2SJ, United Kingdom|Cambridge University Hospitals NHS FT - Addenbrookes Hospital, Cambridge, CB2 0QQ, United Kingdom|The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom|Oxford University Hospitals NHS Trust- Churchill Hospital, Oxford, OX3 7LE, United Kingdom",
Melanoma,NCT03563729,Melanoma Metastasized to the Brain and Steroids,https://clinicaltrials.gov/study/NCT03563729,NO,Malignant Melanoma,DRUG: Pembrolizumab Injection [Keytruda]|DRUG: Ipilimumab Injection [Yervoy]|DRUG: Nivolumab Injection [Opdivo]|DRUG: Encorafenib|DRUG: Binimetinib|DRUG: Dabrafenib|DRUG: Trametinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Herlev Universityhospital, Herlev, Hovedstaden, 2730, Denmark|Aarhus Universityhospital, Aarhus, Midt, 8000, Denmark|Odense Universityhospital, Odense, Syd, 5000, Denmark","Principal Investigator : Troels H Borch, PhD , Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology"
Melanoma,NCT00911443,"Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma",https://clinicaltrials.gov/study/NCT00911443,YES,Malignant Melanoma,BIOLOGICAL: Dacarbazine + Interferon alpha + Thymosin-alpha-1 1.6 mg|BIOLOGICAL: Dacarbazine + Interferon alpha + Thymosin-alpha-1 3.2 mg|BIOLOGICAL: Dacarbazine + Interferon alpha + Thymosin-alpha-1 6.4 mg|BIOLOGICAL: Dacarbazine + Thymosin-alpha-1 3.2 mg|DRUG: Dacarbazine + Interferon alpha,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Grenoble Hopital Albert Michallon Service de Dermatologie, La Tronche, 38043, France|CHU de Limoges Hopital Dupuytren Service de Dermatologie, Limoges, 87042, France|Hopital Saint-Eloi Service de Dermatologie, Montpellier, 34295, France|Centre Eugene Marquis Departement d'Oncologie Medicale, Rennes, 35042, France|Hopital Purpan Service de Dermatologie, Toulouse, 31059, France|Klinik fur Dermatologie und Allergologie der RWTH Aachen, Aachen, 52074, Germany|Klinik fur Dermatologie, Venerologie und Allergologie des Campus CharitÃ¨ Mitte, Berlin, 10117, Germany|Elbeklinikec Buxtehude Dermatologische Zentrum Abteilung fur Dermato-Onkologie, Buxtehude, 21614, Germany|Zentrum fur Dermatologie und Veneralogie Klinik der Johann-Wolfgang-Goethe-Universitat, Frankfurt, 60590, Germany|Klinikum Hannover, Hautklinik Linden, Hannover, D-30449, Germany|Universitatsklinikum Schlewig-Holstein Klinik fur Dermatologie, Veneralogie und Allergologie Universitats-Hautklinik Kiel, Kiel, 24105, Germany|Universitatsklinik fur Dermatologie und Venerologie Otto-von-Guericke-Universitat Magdeburg, Magdeburg, 39120, Germany|Dermatologische Klinik der Universitat Tubingen, Tubingen, 72076, Germany|Orszagos Bor-es Nemikortani Intezet, Budapest, H-1085, Hungary|Orszagos Onkologiai Intezet Borgyogyaszat, Budapest, H-1122, Hungary|Petz Aladar Megyei Korhaz, Borgyogyaszat, Gyor, H-9024, Hungary|Miskolc Megyei Korhaz Borgyogyaszat, Miskolc, H-3501, Hungary|Pecsi Egyetem Borgyogyaszati Klinika, Pecs, H-7600, Hungary|Szegedi Egyetem Borgyogyaszati Klinika, Szeged, H-6701, Hungary|Ospedale SS TrinitÃ Oncologia, Sora, Frosinone, 03039, Italy|Ospedale San Vincenzo U.O. Oncologia Medica, Taormina, Messina, 98039, Italy|UO Complessa Aziendale Nettuno/Albano/Frascati Day-Hospital di Oncologia Ospedale S. Giuseppe, Albano Laziale, Roma, 00041, Italy|Ospedale PF Calvi Dipartimento di Oncologia, Noale, Venezia, 30033, Italy|ASL 1 Servizio di Oncologia, Agrigento, Italy|Azienda Ospedaliera S. Elia, UO di Oncologia, Caltanissetta, 93100, Italy|Azienda Ospedaliera Garibaldi, UO Oncologia Medica, Catania, 95126, Italy|UniversitÃ ""G. D'Annunzio"" FacoltÃ di Medicina e Chirurgia, Clinica Dermatologica, Chieti, 66100, Italy|Azienda Ospedaliera Umberto IÂ° UO Servizio di Oncologia e Chemioterapia, Enna, 94100, Italy|UniversitÃ di Firenze Dipartimento di Scienze Dermatologiche, Firenze, 50121, Italy|Ospedale Pierantoni, Divisione Oncologia Medica, Forli, 47100, Italy|Istituto NazionaleRicerca sul Cancro, Dipartimento di Oncologia Medica 1, Genova, 16132, Italy|Istituto Europeo di Oncologia, Divisione di Chirurgia Generale, Milano, 20141, Italy|Casa di Cura San Pio X, UO Oncologia Medica, Milano, 20159, Italy|Ospedale Civile, UO di Oncologia, Ragusa, 97100, Italy|Azienda Ospedaliera Bianchi-Melacrino-Morelli, Oncologia Medica, Reggio Calabria, 89100, Italy|UniversitÃ di Roma ""Tor Vergata"" Oncologia Complementare, Dipartimento di Chirurgia, Roma, 00133, Italy|IFO Polo Oncologico Ist. Regina Elena, Divisione di Oncologia Medica A, Roma, 00144, Italy|Ospedale Sandro Pertini, Oncologia Medica, Roma, 00157, Italy|UniversitÃ ""La Sapienza"" Dipartimento di Malattie Cutanee-Veneree e Chirurgia Plastica Ricostruttiva, Roma, 00161, Italy|Istituto Dermopatico dell'Immacolata, Dipartimento di Immunodermatologia, Roma, 00167, Italy|Policlinico ""Le Scotte"" Dipartimento di Medicina Clinica, Scienze Immunologiche Applicate, Divisione di Dermatologia, Siena, 53100, Italy|U.O. Complessa, Immunoterapia Oncologica, Policlinico ""Le Scotte"", Siena, 53100, Italy|Ospedale Umberto IÂ°, Divisione di Oncologia Medica, Siracusa, 96100, Italy|Ospedale Bel Colle UO di Oncologia, Viterbo, 01100, Italy|Katedra i Klinika Onkologii i Radioterapii Akademia Medyczna, Gdansk, 80-211, Poland|Instytut Onkologii im. Marii Sklodowskiej-Curie, Oddzial w Krakowie, Klinika Chemioterapii, Krakow, 31-115, Poland|Wojewodzki Szpital Specjalistyczny im. M. Kopernika, Klinika Chemioterapii Oncologicznej, Lodz, 93-509, Poland|Samodzielny Publiczny Szpital Kliniczny nr 1, Klinika Chirurgii Onkologicznej, Lublin, 20-081, Poland|Wielkopolskie Centrum Onkologii, Zaklad Immunologii Nowotworow Katedry Onkologii AM, Poznan, 61-868, Poland|Oddzial Chemioterapii, Szczecin, 71-730, Poland|Klinika Onkologii Centralnego Szpitala WAM, Warszawa, Poland|Dolnoslakie Centrum Transplantacji Komorkowych z Krajowym Bankiem Dawcow Szpiku, Wroclaw, 53-439, Poland|Instituto Portugues de Oncologia de Francisco Gentil, Centro Regional de Oncologia de Lisboa S.A., Servicio de Medicina Oncologica 1, Pavilhao C, Lisboa, 1099-023, Portugal|Instituto Portugues de Oncologia de Francisco Gentil, Centro Regional de Oncologia do Porto S.A., Servicio de Medicina Oncologica, Piso 3, Porto, 4200, Portugal|Instituto Catalan Oncologico, Servicio de Oncologia, L'hospitalet de Llobregat, Barcelona, 08907, Spain|Hosp. Univ. de Canarias Servicio de Oncologia Medica, La Laguna, Santa Cruz de Tenerife, 38320, Spain|Hosp. Clinic i Provincial Servicio de Oncologia, Barcelona, 08036, Spain|Hosp. Universitario de Jaen Servicio de Oncologia, Jaen, 23007, Spain|Hosp. Clinico San Carlos Servicio de Oncologia, Pabellon B, Ala Sur-Sotano, Madrid, 28040, Spain|Hosp. Virgen de la Victoria de Malaga Servicio de Oncologia 1a planta Campus Universitario de Teatinos, Malaga, 29010, Spain|Hosp. Virgen del Rocio Servicio de Oncologia, Planta Baja - Centro de Diagnostico, Sevilla, 41013, Spain|Instituto Valenciano Oncologico, Valencia, 46009, Spain|Hospital General Universitario de Valencia Unidad de Oncologia Medica, Valencia, 46014, Spain|Zentrum fur Onkologie Hematologie und Transfusionsmedizin am Kantonsspital Aarau, Aarau, CH-5001, Switzerland","Principal Investigator : Virginia Ferraresi, MD , IFO Polo Oncologico Ist. Regina Elena, Divisione Oncologia Medica A - ROMA Study Director : Roberto Camerini, MD , Sigma-Tau SpA"
Melanoma,NCT04904185,ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT04904185,NO,Malignant Melanoma,DRUG: Cyclophosphamide|DRUG: Fludarabine Phosphate|BIOLOGICAL: Multiple Antigen Specific Endogenously derived T cells|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,"National Center for Cancer Immune Therapy (CCIT-DK), Herlev, 2730, Denmark","Study Director : Inge M Svane, Prof., M.D. , Study Director, National Center for Cancer Immune Therapy, Depth of Oncology, Herlev Hospital Principal Investigator : Tine J Monberg, M.D. , Ph.d. student, National Center for Cancer Immune Therapy, Depth of Oncology, Herlev Hospital"
Melanoma,NCT04382664,UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma,https://clinicaltrials.gov/study/NCT04382664,NO,Malignant Melanoma,BIOLOGICAL: UV1|BIOLOGICAL: Sargramostim|BIOLOGICAL: Ipilimumab|BIOLOGICAL: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"Mayo Clinic Hospital, Phoenix, Arizona, 85016-4880, United States|Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States|University of California Irvine Health, Orange, California, 92868, United States|California Cancer Associates for Research & Excellence (CCARE, San Marcos, California, 92083, United States|Ridley-Tree Cancer Center, Santa Barbara, California, 93105, United States|Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica, California, 90404, United States|University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|Holy Cross Medical Group, Fort Lauderdale, Florida, 33308, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136-1002, United States|Ocala Oncology Center, Ocala, Florida, 34474, United States|Rush University Medical Center - Rush University Cancer Center, Chicago, Illinois, 60612-3841, United States|NorthShore University Research Institute, Evanston, Illinois, 60201-1718, United States|Oncology Specialists, S.C., Park Ridge, Illinois, 60068, United States|Norton Cancer Institute, Louisville, Kentucky, 40241, United States|Nebraska Cancer Specialists- Midwest Cancer Center, Papillion, Nebraska, 68046-5706, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|State University of New York (SUNY) Upstate Medical University, New York, New York, 13210, United States|University of Rochester, Rochester, New York, 14642-0001, United States|NorthShore University HealthSystem, Greenville, South Carolina, 29607, United States|Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246-2092, United States|Antwerp University Hospital, Antwerp, 2650, Belgium|Cliniques Universitaires Saint-Luc, Brussel, 1200, Belgium|Leuven University Hospital, Leuven, 3000, Belgium|GZA Hospital Sint-Augustinus, Wilrijk, 2610, Belgium|Sykehuset Ã˜stfold HF, Gralum, 1714, Norway|SÃ¸rlandet Sykehus HF(SSHF), Kristiansand, 4615, Norway|Oslo University Hospital - The Norwegian Radium Hospital, Oslo, 4953, Norway|Stavanger University Hospital, Stavanger, 4068, Norway|Universitetssykehuset Nord-Norge HF, TromsÃ¸, 9019, Norway|St. Olavs Hospital HF, Trondheim, 7030, Norway|Ã…lesund Hospital- Helse Sunnmore HF, Ã…lesund, 6026, Norway|University Hospitals Bristol NHS Foundation Trust - Bristol Haematology and Oncology Centre, Bristol, BS2 8ED, United Kingdom|Velindre NHS Trust, Cardiff, CF15 7QZ, United Kingdom|The Royal Free London NHS Foundation Trust - The Royal Free Hospital, London, NW3 2QG, United Kingdom|Royal Marsden Hospital - Institute of Cancer Research - Chelsea, London, SM2 7LN, United Kingdom|Cancer Research UK Manchester Institute, Manchester, M20 4BX, United Kingdom|Oxford University Hospitals NHS Trust - Churchill Hospital, Oxford, OX3 7LE, United Kingdom","Principal Investigator : Karl Lewis , University of Colorado Hospital - Anschutz Cancer Pavilion"
Melanoma,NCT03383237,Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma,https://clinicaltrials.gov/study/NCT03383237,NO,Malignant Melanoma,DRUG: Apatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Henan Cancer Hospital, Zhengzhou, Henan, 450008, China","Principal Investigator : Zibing Wang , Henan Cancer Hospital"
Melanoma,NCT02303951,Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC,https://clinicaltrials.gov/study/NCT02303951,NO,Malignant Melanoma,DRUG: Vemurafenib|DRUG: Cobimetinib|DRUG: Atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"Department of Dermatology & Skin Cancer University Hospital La Timone, Aix-Marseille University, Marseille, 13385, France|Department of Dermatology, University Hospital of Nantes, Nantes, 44093, France|Hopital Saint-Louis Hopitaux Universitaires Saint-Louis Laboisiere Fernand-Widal, Paris, 75010, France|Department of Dermatology, Elbe Hospital, Buxtehude, 21614, Germany|UniversitÃ¤tsklinikum Carl Gustav Carus, Dresden, 01307, Germany|Department of Dermatology, University Hospital, Kiel, 24105, Germany|University hospital TÃ¼bingen, TÃ¼bingen, 72076, Germany","Principal Investigator : Claus Garbe, Prof. , University Hospital TÃ¼bingen"
Melanoma,NCT03903458,Tinostamustine and Nivolumab in Advanced Melanoma,https://clinicaltrials.gov/study/NCT03903458,NO,Malignant Melanoma,DRUG: Tinostamustine,ALL,"ADULT, OLDER_ADULT",PHASE1,"Kantonsspital GraubÃ¼nden, Chur, 7000, Switzerland|Cantonal Hospital St.Gallen, St.Gallen, 9007, Switzerland","Study Chair : Markus Joerger, Prof. , Cantonal Hospital St. Gallen, Switzerland"
Melanoma,NCT00111696,Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma,https://clinicaltrials.gov/study/NCT00111696,NO,Malignant Melanoma,BIOLOGICAL: MEDI-522,ALL,"ADULT, OLDER_ADULT",PHASE1,"University Of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15213, United States","Principal Investigator : Stergios Moschos, MD , University of Pittsburgh"
Melanoma,NCT01705392,Bevacizumab vs Dacarbazine in Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01705392,NO,Metastatic Malignant Melanoma|Unresectable Malignant Melanoma,DRUG: Bevacizumab|DRUG: Propranolol|DRUG: Enalapril|DRUG: Dacarbazine,ALL,"ADULT, OLDER_ADULT",PHASE2,"Haukeland University Hospital, Bergen, 5021, Norway","Principal Investigator : Oddbjorn Straume, MD PhD , Department of Oncology, Haukeland University Hospital, Bergen, Norway Study Director : Olav Mella, MD PhD , Department of Oncology, Haukeland University Hospital, Bergen, Norway"
Melanoma,NCT05756556,T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT05756556,NO,Melanoma|Malignant Melanoma,COMBINATION_PRODUCT: T3011 + Cobimetinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Gabrail Cancer and Research Center, Canton, Ohio, 44718, United States",ImmVira Pharma Co. Ltd
Melanoma,NCT04223648,Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma,https://clinicaltrials.gov/study/NCT04223648,NO,Malignant Melanoma,"DRUG: tremelimumab/durvalumab, ipilimumab/nivolumab and nivolumab monotherapy",ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,,"Principal Investigator : Michael Hurwitz, MD, PhD , Yale University"
Melanoma,NCT04126876,A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma,https://clinicaltrials.gov/study/NCT04126876,NO,Malignant Melanoma,DRUG: Tilsotolimod|DRUG: Saline (0.9% sodium chloride),ALL,"ADULT, OLDER_ADULT",PHASE2,"VU Medical Centere, Amsterdam, 1081 HV, Netherlands","Principal Investigator : Tanja de Gruijl , Amsterdam UMC, location VUmc Principal Investigator : Alfons JM van den Eertwegh , Amsterdam UMC, location VUmc"
Melanoma,NCT00104884,FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma,https://clinicaltrials.gov/study/NCT00104884,YES,Malignant Melanoma|Melanoma,DRUG: Depsipeptide,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Study Chair : David H. Lawson, MD , Emory University"
Melanoma,NCT02434354,A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma,https://clinicaltrials.gov/study/NCT02434354,YES,Malignant Melanoma,DRUG: pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States","Principal Investigator : Tara Mitchell, MD , Abramson Cancer Center at Penn Medicine"
Melanoma,NCT02902042,Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma,https://clinicaltrials.gov/study/NCT02902042,NO,Malignant Melanoma,DRUG: Encorafenib|DRUG: Binimetinib|DRUG: Pembrolizumab|DRUG: Pembrolizumab alone,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"UniversitÃ¤tsklinikum Freiburg, Freiburg, Baden-WÃ¼rttemberg, 79106, Germany|Klinikum Augsburg SÃ¼d, Augsburg, Bavaria, 86179, Germany|Klinikum rechts der Isar, MÃ¼nchen, Bavaria, 81675, Germany|Klinikum NÃ¼rnberg Nord, NÃ¼rnberg, Bavaria, 90419, Germany|Vivantes Klinikum im Friedrichshain, Berlin Friedrichshain, Berlin, 10249, Germany|UniversitÃ¤tsklinikum GieÃŸen und Marburg GmbH, Klinik fÃ¼r Dermatologie und Allergologie, GieÃŸen, Hessen, 35392, Germany|UniversitÃ¤tsklinikum der RWTH Aachen, Aachen, Nordrhein-Westfalen, 52074, Germany|University Hospital Essen, Department of Dermatology, Skin Cancer Center, Essen, North Rhine-Westphalia, 45122, Germany|HELIOS Klinikum Krefeld, Krefeld, North Rhine-Westphalia, 47805, Germany|Gesellschaft fÃ¼r Klinische Forschung Ludwigshafen mbH, Ludwigshafen am Rhein, Rheinland-Pfalz, 67063, Germany|StÃ¤dtisches Klinikum Dessau, Dessau, Saxony-Anhalt, 06847, Germany",
Melanoma,NCT00350597,GM-CSF as Adjuvant Therapy of Melanoma,https://clinicaltrials.gov/study/NCT00350597,NO,Malignant Melanoma,DRUG: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF),ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Northern California Melanoma Center, San Francisco, California, 94109, United States","Principal Investigator : Lynn E. Spitler, MD , Northern California Melanoma Center"
Melanoma,NCT04889118,Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study,https://clinicaltrials.gov/study/NCT04889118,YES,Malignant Melanoma,BIOLOGICAL: Pembrolizumab|DRUG: Lenvatinib|DRUG: Placebo for lenvatinib,ALL,"ADULT, OLDER_ADULT",PHASE3,"Beijing Cancer Hospital (0601), Beijing, Beijing, 100036, China|Fujian Provincial Cancer Hospital ( Site 0612), Fuzhou, Fujian, 350014, China|Sun Yat-Sen University Cancer Center (0602), Guangzhou, Guangdong, 510000, China|Henan Cancer Hospital ( Site 0610), Zhengzhou, Henan, 450003, China|Nanjing Drum Tower Hospital (0609), Nanjing, Jiangsu, 210008, China|The First Hospital Of Jilin University (0603), Chang Chun, Jilin, 130021, China|Fudan University Shanghai Cancer Center ( Site 0607), Shanghai, Shanghai, 200032, China|Tianjin Medical University Cancer Institute & Hospital (0606), Tianjin, Tianjin, 300060, China|Yunnan Cancer Hospital (0604), Kunming, Yunnan, 430030, China|Sir Run Run Shaw Hospital (0605), Hangzhou, Zhejiang, 310018, China|Zhejiang Cancer Hospital ( Site 0608), Hangzhou, Zhejiang, 310022, China","Study Director : Medical Director , Merck Sharp & Dohme LLC"
Melanoma,NCT02828202,"Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary",https://clinicaltrials.gov/study/NCT02828202,NO,Malignant Melanoma,OTHER: Biological|OTHER: Tissular|OTHER: Quality of life,ALL,"ADULT, OLDER_ADULT",,"CHU d'Amiens, Amiens, France|CH Annecy Genevois, Annecy, France|CHU de BesanÃ§on, BesanÃ§on, France|Assistance Publique - HÃ´pitaux de Paris (AP-HP), HÃ´pital Avicennes, Bobigny, 93000, France|CHU de Bordeaux HÃ´pital Haut LevÃªque, Bordeaux, France|CHU de Bordeaux HÃ´pital Saint-AndrÃ©, Bordeaux, France|Assistance Publique - HÃ´pitaux de Paris (AP-HP), HÃ´pital Ambroise ParÃ©, Boulogne-Billancourt, France|CHU de Brest, Brest, France|CHU de Caen, Caen, France|Assistance Publique - HÃ´pitaux de Paris (AP-HP), HÃ´pital Henri Mondor, CrÃ©teil, 94000, France|CHU de Dijon, Dijon, France|CHU de Grenoble, Grenoble, France|CHRU de Lille, Lille, France|Centre LÃ©on BÃ©rard, Lyon, France|Hospices Civils de Lyon, Lyon, France|AP-HM Hopital de la Timone, Marseille, France|CHU de Montpellier, Montpellier, France|CHU de Nancy, Nancy, France|CHU de Nantes, Nantes, France|CHU de Nice, Nice, France|CHRU de NÃ®mes, NÃ®mes, France|Assistance Publique - HÃ´pitaux de Paris (AP-HP), Hopital Saint-Louis, centre d'oncodermatologie, Paris, France|Assistance Publique - HÃ´pitaux de Paris (AP-HP), HÃ´pital Bichat, Paris, France|Assistance Publique - HÃ´pitaux de Paris (AP-HP), HÃ´pital Cochin, Paris, France|CHU de Rennes, Rennes, France|CLCC EugÃ¨ne Marquis, Rennes, France|CHU de Toulouse, Toulouse, France","Study Director : Celeste Lebbe, MD, PhD , AP-HP, Hopital Saint-Louis, centre d'oncodermatologie, Paris Study Director : Brigitte Dreno, MD, PhD , Nantes University Hospital"
Melanoma,NCT02612168,Melanoma Image Analysis Algorithm (MIAA) Validation Study,https://clinicaltrials.gov/study/NCT02612168,NO,Malignant Melanoma,DEVICE: Melanoma Image Analysis Algorithm (MIAA),ALL,"ADULT, OLDER_ADULT",,"Royal Devon and Exeter, Exeter, Devon, EX2 5DW, United Kingdom|Whipps Corss Hospital, Leytonstone, London, E11 1NR, United Kingdom|Royal Stoke University Hospital, Stoke, Staffordshire, ST4 6QG, United Kingdom|Russells Hall Hospital, Dudley, West Midlands, DY1 2HQ, United Kingdom|Bristol Royal Infirmary, Bristol, BS2 8AE, United Kingdom|Royal Free London NHS Foundation Trust, London, NW3 2QG, United Kingdom|Churchill Hospital, Oxford, OX3 7LE, United Kingdom","Principal Investigator : Ioulios Palamaras, MD PhD , Royal Free London NHS Foundation Trust"
Melanoma,NCT00034554,Study of gp75 Vaccine in Patients With Stage III and IV Melanoma,https://clinicaltrials.gov/study/NCT00034554,NO,Malignant Melanoma,BIOLOGICAL: gp75 DNA vaccine,ALL,"ADULT, OLDER_ADULT",PHASE1,"ImClone Investigational Site, New York, New York, 10021, United States","Study Chair : E-mail: ClinicalTrials@ ImClone.com , Eli Lilly and Company"
Melanoma,NCT06221397,Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT06221397,NO,"Melanoma|Melanoma, Skin",,ALL,"ADULT, OLDER_ADULT",,"University Hospital of Cruces, Barakaldo, Biscay, 48903, Spain","Principal Investigator : JesÃºs Gardeazabal, PhD , Hospital Universitario Cruces Principal Investigator : Rosa MarÃ­a Ize, PhD , Hospital Universitario Basurto"
Melanoma,NCT01002560,The Identification of Novel Prognostic Markers in Melanoma,https://clinicaltrials.gov/study/NCT01002560,NO,Malignant Melanoma,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5PT, United Kingdom","Principal Investigator : Professor Martin Gore , Royal Marsden NHS Foundation Trust"
Melanoma,NCT03178851,Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma,https://clinicaltrials.gov/study/NCT03178851,YES,Malignant Melanoma,BIOLOGICAL: Atezolizumab|DRUG: Cobimetinib|BIOLOGICAL: Atezolizumab|BIOLOGICAL: Atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,"HonorHealth Research Institute - Bisgrove, Scottsdale, Arizona, 85258, United States|University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Baylor University Medical Center, Dallas, Texas, 75231, United States|Blacktown Hospital, Blacktown, New South Wales, 2148, Australia|Melanoma Institute Australia, North Sydney, New South Wales, 2060, Australia|Mid North Coast Cancer Institute, Port Macquarie, New South Wales, 2444, Australia|Greenslopes Private Hospital; Clinic Pharmacy, Greenslopes, Queensland, 4120, Australia|Flinders Medical Centre, Bedford Park, South Australia, 5042, Australia|Peter Maccallum Cancer Centre, Melbourne, Victoria, 3000, Australia|Alfred Hospital, Melbourne, Victoria, 3004, Australia|University Clinical Centre of the Republic of Srpska, Banja Luka, 78000, Bosnia and Herzegovina|University Clinic Ctr Sarajevo, Sarajevo, 71 000, Bosnia and Herzegovina|Instituto de Ensino e Pesquisa Clinica do Ceara, Fortaleza, CE, 60130-241, Brazil|Cenantron - Centro Avancado de Tratamento Oncologico, Belo Horizonte, MG, 30130-090, Brazil|Instituto Nacional de Cancer - INCa; Oncologia, Rio de Janeiro, RJ, 20560-120, Brazil|Hospital Sao Vicente de Paulo, Passo Fundo, RS, 99010-090, Brazil|Hospital das Clinicas - UFRGS, Porto Alegre, RS, 90035-903, Brazil|Hospital Sao Lucas - PUCRS, Porto Alegre, RS, 90610-000, Brazil|Hospital Amaral Carvalho, Jau, SP, 17210-120, Brazil|Cape Town Oncology Trials, Cape Town, 7570, South Africa|GVI Constantiaberg, Cape Town, 7800, South Africa|Johese Clinical Research, Centurion, 1692, South Africa|Cancercare, George, 6529, South Africa|Wits Clinical Research; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, 2193, South Africa|Cancercare, Port Elizabeth, 6045, South Africa|Steve Biko Academic Hospital; Oncology, Pretoria, 0002, South Africa|Hospital Clinico Universitario de Santiago, Santiago de Compostela, LA CoruÃ±a, 15706, Spain|ClÃ­nica Universidad de Navarra, Pamplona, Navarra, 31620, Spain|Hospital Universitario Virgen Macarena, Seville, Sevilla, 41071, Spain|Hospital Universitari Quiron Dexeus, Barcelona, 08028, Spain|Hospital Clinic I Provincial, Barcelona, 08036, Spain|MD Anderson Cancer Center, Madrid, 28033, Spain|Hospital Universitario RamÃ³n y Cajal; Pharmacy, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid, 28041, Spain|Hospital Universitario La Paz; Servicio de Oncologia, Madrid, 28046, Spain|Central Municipal Hospital - Uzhgorod State University, Uzhgorod, Chernihiv Governorate, 88017, Ukraine|Public Institution: City Multispecialty Clinical Hospital #4 under Dnipropetrovsk Regional Council, Dnipropetrovsk, 49102, Ukraine|National Cancer Institute MOH of Ukraine, Kiev, 36022, Ukraine|Lviv State Oncology Regional Treatment and Diagnostic Centre, Lviv, 79031, Ukraine|Sumy Regional Clinical Onc Ctr, Sumy, 40005, Ukraine","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT06388252,Electrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous Melanoma,https://clinicaltrials.gov/study/NCT06388252,NO,Cutaneous Malignant Melanoma,PROCEDURE: Electrochemotherapy with Intratumoral Cysplatin|PROCEDURE: Electrochemotherapy with Intravenous Bleomycin,ALL,"ADULT, OLDER_ADULT",,"Institute of Oncology Ljubljana, Ljubljana, 1000, Slovenia","Principal Investigator : Barbara PeriÄ‡ , Dep. of Surgical Oncology, Institute of Oncology Ljubljana"
Melanoma,NCT03197636,Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients,https://clinicaltrials.gov/study/NCT03197636,NO,Malignant Melanoma,DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",,"AUH, Aarhus, 8000, Denmark",
Melanoma,NCT00299689,Phase II Trial of Ontak With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00299689,YES,Malignant Melanoma,DRUG: Denileukin diftitox,ALL,"ADULT, OLDER_ADULT",PHASE2,"James Graham Brown Cancer Center, Univ. of Louisville, Louisville, Kentucky, 40202, United States","Principal Investigator : Jason Chesney, MD, PhD , University of Louisville"
Melanoma,NCT01077050,SciBase International Melanoma Pivotal Study,https://clinicaltrials.gov/study/NCT01077050,YES,Malignant Melanoma,DEVICE: SciBase III Electrical Impedance Spectrometer,ALL,"ADULT, OLDER_ADULT",,"University of Arizona, Tucson, Arizona, 85719, United States|Sahlgrenska University Hospital, Gothenburg, 41345, Sweden","Study Director : Ulrik H Birgersson, PhD , SciBase and Karolinska Institutet"
Melanoma,NCT01288963,"IL-2 ""SELECT"" Tissue Collection Protocol in Patients With Advanced Melanoma",https://clinicaltrials.gov/study/NCT01288963,NO,Malignant Melanoma,DRUG: IL-2,ALL,"ADULT, OLDER_ADULT",,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States","Principal Investigator : David McDermott, MD , Beth Israel Deaconess Medical Center"
Melanoma,NCT01480323,A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2,https://clinicaltrials.gov/study/NCT01480323,NO,Malignant Melanoma,DRUG: Interleukin-2|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"University Hospital TÃ¼bingen, TÃ¼bingen, 72076, Germany","Principal Investigator : Benjamin Weide, Dr. med. , University Hospital TÃ¼bingen"
Melanoma,NCT02410863,Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma,https://clinicaltrials.gov/study/NCT02410863,NO,Malignant Melanoma,DRUG: Dabrafenib|DRUG: Trametinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"National Centre for Tumour Diseases (NCT), Heidelberg, BW, 69120, Germany|University Hospital TÃ¼bingen, TÃ¼bingen, BW, 72076, Germany|Elbe Kliniken Stade - Buxtehude GmbH, Clinic for Dermatology, Buxtehude, Lower Saxony, 21614, Germany|University Hospital Essen, Essen, NRW, 45147, Germany|University Hospital Mainz, Clinic for Dermatology, Mainz, Rhineland-Palatinate, 55131, Germany|UniversitÃ¤tsklinik Carl Gustav Carus der Technischen UniversitÃ¤t Dresden, Dresden, Saxony, 01307, Germany","Principal Investigator : Dirk Schadendorf, Prof. Dr. , University Hospital, Essen"
Melanoma,NCT00651703,Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients,https://clinicaltrials.gov/study/NCT00651703,NO,Malignant Melanoma,BIOLOGICAL: CYT004-MelQbG10 + Montanide|BIOLOGICAL: CYT004-MelQbG10 + Montanide + Imiquimod|BIOLOGICAL: CYT004-MelQbG10 + Imiquimod|BIOLOGICAL: CYT004-MelQbG10 intra nodal injection,ALL,"ADULT, OLDER_ADULT",PHASE2,"Ludwig Institute for Cancer Research; CHUV, Lausanne, VD, CH-1005, Switzerland|Dermatologische Klinik, UniversitÃ¤tsSpital ZÃ¼rich, Zurich, CH-8091, Switzerland",Cytos Biotechnology AG
Melanoma,NCT05050006,ITIL-168 in Advanced Melanoma,https://clinicaltrials.gov/study/NCT05050006,NO,Advanced Cutaneous Melanoma,BIOLOGICAL: ITIL-168,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of California San Diego, Moores Cancer Center, La Jolla, California, 92093, United States|The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|USC - Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|UCLA Health - Westwood Cancer Care, Los Angeles, California, 90095, United States|Stanford Cancer Institute, Stanford, California, 94305, United States|University of Colorado - Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|The University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Orlando Health Cancer Institute, Orlando, Florida, 32806, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Rush University Cancer Center, Chicago, Illinois, 60612, United States|Loyola University Chicago, Maywood, Illinois, 60153, United States|University of Louisville, James Graham Brown Cancer Center, Louisville, Kentucky, 40202, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Atlantic Health System - Morristown Medical Center, Morristown, New Jersey, 07962, United States|Cleveland Clinic - Taussig Cancer Center, Cleveland, Ohio, 44195, United States|St. Luke's University Health Network, Bethlehem, Pennsylvania, 18015, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|Cambridge University Hospital NHS Foundation Trust - Addenbrooke's Hospital, Cambridge, England, CB2 0QQ, United Kingdom","Study Director : Instil Study Director , Instil Bio, Inc."
Melanoma,NCT01689519,A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01689519,YES,Malignant Melanoma,DRUG: Placebo|DRUG: Vemurafenib|DRUG: Cobimetinib,ALL,"ADULT, OLDER_ADULT",PHASE3,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|The Angeles Clinic and Research Institute - W LA Office, Los Angeles, California, 90025, United States|University of California Davis Health System, Sacramento, California, 95817, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, 95403, United States|University Of Colorado, Aurora, Colorado, 80045, United States|Florida Cancer Specialists - Broadway, Fort Myers, Florida, 33901, United States|Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|Orlando Health Inc., Orlando, Florida, 32806, United States|Northwestern Center For Clinical Research, Chicago, Illinois, 60611, United States|Uni of Kansas Medical Center; Dept of Neurology, Kansas City, Kansas, 66160-7314, United States|U of L - Physicians Pulmonology; Dept of Neuroradiology and Dept of Diagnostic Radiology, Louisville, Kentucky, 40202, United States|Washington University School of Medicine; Dept of Medicine/Div of Medical Oncology, Saint Louis, Missouri, 63108, United States|Dartmouth-Hitchcock Medical Center; Department of Medicine, Lebanon, New Hampshire, 03756, United States|Novant Health Oncology Specialists, Winston-Salem, North Carolina, 27103, United States|University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States|St. Luke's University Health network, Bethlehem, Pennsylvania, 18015, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15261, United States|Rhode Island Hospital; Investigational Services, Providence, Rhode Island, 2903, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|Lake Macquarie Private Hospital, Gateshead, New South Wales, 2290, Australia|Lismore Base Hospital; Cancer Care & Haematology Unit, Lismore, New South Wales, 2480, Australia|Melanoma Institute Australia, North Sydney, New South Wales, 2060, Australia|Princess Alexandra Hospital, Woolloongabba, New South Wales, 2050, Australia|Royal Darwin Hospital, Casuarina, Northern Territory, 0811, Australia|Greenslopes Private Hospital, Greenslopes, Queensland, 4120, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, 4029, Australia|Royal Adelaide Hospital; Hepatology, Adelaide, South Australia, 5000, Australia|Ashford Cancer Centre, Ashford SA, South Australia, 5035, Australia|Royal Hobart Hospital, Hobart, Tasmania, 7000, Australia|Launceston General Hospital; Gastroenterology Research, Launceston, Tasmania, 7250, Australia|Peninsula and South Eastern Haematology and Oncology Group, Frankston, Victoria, 3199, Australia|Austin Hospital, Heidelberg, Victoria, 3084, Australia|Peter MacCallum Cancer Centre-East Melbourne, Melbourne, Victoria, 3000, Australia|The Alfred Hospital, Prahan, Victoria, 3181, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, 6150, Australia|Ordensklinikum Linz Elisabethinen, Linz, 4020, Austria|Landesklinikum St. PÃ¶lten, St. PÃ¶lten, 3100, Austria|Medizinische UniversitÃ¤t Wien, Wien, 1090, Austria|Institut Jules Bordet; Department of Medical Oncology, Bruxelles, 1000, Belgium|Cliniques Universitaires St-Luc, Bruxelles, 1200, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|Jessa Zkh (Campus Virga Jesse), Hasselt, 3500, Belgium|CHU Sart-Tilman, LiÃ¨ge, 4000, Belgium|AZ Delta (Campus Rumbeke), Roeselare, 8800, Belgium|BC Cancer Agency Vancouver Island Cancer Centre, Victoria, British Columbia, V8R 6V5, Canada|Juravinski Cancer Clinic; Department of Oncology, Hamilton, Ontario, L8V 5C2, Canada|The Ottawa Hospital Cancer Center; General Campus, Ottawa, Ontario, K1H 1C4, Canada|Toronto Sunnybrook Hospital, Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Hospital; Department of Med Oncology, Toronto, Ontario, M5G 2M9, Canada|London Health Sciences Centre Â· Victoria Hospital;Department of Pediatrics, London, Quebec, N6A 4G5, Canada|McGill University Health Centre/Glen Site / Royal Victoria Hospital, MontrÃ©al, Quebec, H2W 1S6, Canada|Masarykuv onkologicky ustav, Brno, 656 53, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Kralove, 500 05, Czechia|FakultnÃ­ nemocnice Olomouc, Olomouc, 775 20, Czechia|Fakultni nemocnice Ostrava, Ostrava - Poruba, 708 52, Czechia|Multiscan s.r.o., Pardubice, 532 03, Czechia|Nemocnice Na Bulovce, Prague, 180 01, Czechia|Vseobecna fakultni nemocnice v Praze, Praha 2, 128 08, Czechia|Fakultni nemocnice Kralovske Vinohrady, Praha, 100 34, Czechia|Fakultni nemocnice Motol; Neurologicka klinika, Praha, 150 06, Czechia|Groupe Hospitalier Saint AndrÃ© - HÃ´pital Saint AndrÃ©, Bordeaux, 33075, France|HÃ´pital Ambroise ParÃ© - Boulogne-Billancourt; Respiratory, Boulogne Billancourt, 92104, France|CHU Clermont Ferrand - HÃ´pital d'Estaing, Clermont Ferrand cedex 1, 63003, France|CHU de Dijon - Hopital le Bocage, Dijon, 21000, France|Centre Hospitalier Universitaire de Grenoble - Albert Michallon, La Tronche, 38700, France|Hopital Claude Huriez - CHU Lille, Lille, 59037, France|Hopital de la Timone, Marseille, 13005, France|Hopital Saint Eloi, Montpellier, 34295, France|CHU NANTES - HÃ´tel Dieu; Pharmacy, Nantes, 44093, France|CHU Nice - Hopital de l'Archet 2, Nice, 06202, France|Centre Hospitalier Lyon Sud, Pierre Benite, 69495, France|Hopital Robert Debre; DERMATOLOGIE, Reims, 51092, France|Centre Eugene Marquis; Service d'oncologie, Rennes, 35042, France|St. Josef-Hospital; Studienambulanz, Bochum, 44791, Germany|Elbekliniken Buxtehude GmbH, Buxtehude, 21614, Germany|UniversitÃ¤tsklinikum ""Carl Gustav Carus"" der Technischen UniversitÃ¤t Dresden, Dresden, 01307, Germany|Helios Klinikum Erfurt, Erfurt, 99089, Germany|UniversitÃ¤tsklinikum Essen, Essen, 45147, Germany|Universitaetsklinikum Freiburg, Freiburg, 79106, Germany|SRH Wald-Klinikum Gera; Klinik fÃ¼r Hautkrankheiten und Allergologie, Gera, 07548, Germany|UniversitÃ¤tsmedizin GÃ¶ttingen, GÃ¶ttingen, 37075, Germany|UniversitÃ¤tsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|UniversitÃ¤tsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Kiel; Klinik fuer Allgemeine Innere Medizin, Kiel, 24105, Germany|Universitaetsklinikum Koeln; Hematology/Oncology, Koeln, 50937, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, 55101, Germany|Klinikum Mannheim GmbH UniversitÃ¤tsklinikum, Mannheim, 68167, Germany|Fachklinik Hornheide, Muenster, 48157, Germany|Klinikum der Ludwigs-Maximilians-Universitaet Muenchen, MÃ¼nchen, 80337, Germany|Universitaetsklinikum Regensburg, Regensburg, 93053, Germany|UniversitÃ¤tsklinikum TÃ¼bingen, Tuebingen, 72076, Germany|UniversitÃ¤tsklinikum Wurzburg, WÃ¼rzburg, 97080, Germany|Orszagos Onkologiai Intezet, Budapest, 1122, Hungary|Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula, 5700, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz, Pecs, 7624, Hungary|Szegedi Tud.Egyetem Szent-Gyorgyi Albert Klin.Kozp., Szeged, 6720, Hungary|Soroka Medical Center; Oncology Dept, Beer Sheva, 8410100, Israel|Rambam Health Care Campus, Haifa, 3109600, Israel|HADASSAH UNIVERSITY HOSPITAL, EIN KAREM; Oncology, Jerusalem, 9112000, Israel|Rabin Medical Center-Beilinson Campus;Hematology-Oncology, Petach Tikva, 4941492, Israel|Chaim Sheba Medical Center, Ramat Gan, 5265601, Israel|Tel Aviv Sourasky MC, Dana children's hospital;Oncology Division, Tel Aviv, 6423906, Israel|Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Campania, 80131, Italy|Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola, Emilia-Romagna, 47014, Italy|A.O.U. Policlinico di Modena, Modena, Emilia-Romagna, 40124, Italy|Istituto Nazionale Tumori Regina Elena IRCCS, Roma, Lazio, 00144, Italy|Istituto Nazionale per la Ricerca sul Cancro di Genova, Genova, Liguria, 16132, Italy|Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni XXIII), Bergamo, Lombardia, 24127, Italy|Asst Degli Spedali Civili Di Brescia, Brescia, Lombardia, 25100, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, 20133, Italy|Istituto Tumori Giovanni Paolo II IRCSS; Ospedale Oncologico Bari, Bari, Puglia, 70126, Italy|A.O.U. Senese Policlinico Santa Maria Alle Scotte, Siena, Toscana, 53100, Italy|IOV - Istituto Oncologico Veneto IRCCS, Padova, Veneto, 35128, Italy|Amsterdam UMC Location VUMC, Amsterdam, 1081 HV, Netherlands|Leids Universitair Medisch Centrum; Cardiology, Leiden, 2333 ZA, Netherlands|Maastricht University Medical Center, Maastricht, 6229 HX, Netherlands|Auckland City Hospital, Auckland, 1023, New Zealand|Waikato Hospital, Hamilton, 3248, New Zealand|Radiumhospitalet, Oslo, 0379, Norway|TSBHI Altai Territorial oncological dispensary, Barnaul, 656045, Russian Federation|FSBSI ""N. N. Blokhin Russian Cancer Research Center"", Moscow, 115478, Russian Federation|Moscow city oncology hospital #62 of Moscow Healthcare Department, Moscow, 143423, Russian Federation|BHI of Omsk region Clinical Oncology Dispensary, Omsk, 644013, Russian Federation|Pyatigorsky Oncologic Dispensary, Pyatigorsk, 357524, Russian Federation|Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, LA CoruÃ±a, 15706, Spain|Clinica Universitaria de Navarra, Pamplona, Navarra, 31008, Spain|Hospital Universitario Virgen Macarena, Seville, Sevilla, 41071, Spain|Hospital ClÃ­nic i Provincial de Barcelona, Barcelona, 08036, Spain|MD Anderson Cancer Center, Madrid, 28033, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital General Universitario de Valencia, Valencia, 46014, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|LÃ¤nssjukhuset Ryhov, JÃ¶nkÃ¶ping, 551 85, Sweden|SkÃ¥nes Universitetssjukhus, Lund, 221 85, Sweden|Sahlgrenska Sjukhuset, MÃ¶lnlycke, 435 33, Sweden|Akademiska Sjukhuset, Uppsala, 751 85, Sweden|Inselspital-Universitaetsspital Bern, Bern, 3010, Switzerland|Kantonsspital Graubuenden, Chur, 7000, Switzerland|Bristol Haematology and Oncology Centre, Bristol, BS2 8ED, United Kingdom|Addenbrooke's Hospital, Cambridge, CB2 0QQ, United Kingdom|Velindre Cancer Centre, Cardiff, CF14 2TL, United Kingdom|Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, L7 8YA, United Kingdom|Barts and the London NHS Trust., London, EC1A 7BE, United Kingdom|St George's Hospital; Courtyard Clinic, London, SW17 0QT, United Kingdom|Royal Marsden Hospital - Fulham, London, SW3 6JJ, United Kingdom|Royal Marsden Hospital - London, London, SW3 6JJ, United Kingdom|Freeman Hospital, Newcastle upon Tyne, NE7 7DN, United Kingdom|Nottingham University Hospitals; QMC Campus, Nottingham, NG7 2UH, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|Royal Cornwall Hospital, Truro, TR1 3LQ, United Kingdom|New Cross Hospital, Wolverhampton, WV10 0QP, United Kingdom","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT02902029,Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma,https://clinicaltrials.gov/study/NCT02902029,NO,Malignant Melanoma,DRUG: Vemurafenib|DRUG: Cobimetinib|DRUG: Atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,"HÃ´pital Ambroise-ParÃ©, Boulogne-Billancourt, 92104, France|Hospital Claude Huriez, Lille, 59000, France|HÃ´pital de la Timone, Marseille, 13885, France|CHU de Nantes, Nantes, 44093, France|Centre Hospitalier Lyon Sud, Pierre-BÃ©nite, 69310, France|SLK-Kliniken Heilbronn GmbH, Heilbronn, Baden-Wuerttemberg, 74078, Germany|University Hospital Mannheim, Clinic for Dermatology, Mannheim, Baden-Wuerttemberg, 68167, Germany|National Centre for Tumour Diseases (NCT), Heidelberg, BW, 69120, Germany|University Hospital Essen, Department of Dermatology, Skin Cancer Center, Essen, North Rhine-Westphalia, 45122, Germany|HELIOS Klinikum Erfurt, Erfurt, Thuringia, 99089, Germany|CharitÃ©-UniversitÃ¤tsmedizin Berlin, Berlin, 10117, Germany|Elbe Kliniken Stade - Buxtehude, Buxtehude, 21614, Germany|UniversitÃ¤tsklinik Dresden, Dresden, 01307, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|UniversitÃ¤tsklinikum des Saarlandes, Homburg/Saar, 66421, Germany|UniversitÃ¤ts-Hautklinik Kiel, Kiel, 24105, Germany|UniversitÃ¤tsklinikum KÃ¶ln, KÃ¶ln, 50937, Germany|UniversitÃ¤tsklinikum Leipzig, Leipzig, 04103, Germany|Gesellschaft fÃ¼r Klinische Forschung Ludwigshafen mbH, Ludwigshafen, 67063, Germany|UniversitÃ¤tsklinikum Schleswig-Holstein, LÃ¼beck, 23538, Germany|UniversitÃ¤tsklinikum Mainz, Mainz, 55131, Germany|Johannes Wesling Klinikum Minden, Minden, 32429, Germany|Klinikum der UniversitÃ¤t MÃ¼nchen, MÃ¼nchen, 80337, Germany|UniversitÃ¤tsklinikum TÃ¼bingen, TÃ¼bingen, 72076, Germany|Uniklinikum WÃ¼rzburg, WÃ¼rzburg, 97080, Germany|""LAIKO"" General Hospital of Athens, Athens, 11527, Greece|Military Medical Academy, Belgrad, 11000, Serbia","Principal Investigator : Dirk Schadendorf, Prof. Dr. , University Hospital, Essen"
Melanoma,NCT03820986,Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003),https://clinicaltrials.gov/study/NCT03820986,YES,Malignant Melanoma,BIOLOGICAL: Pembrolizumab|DRUG: Lenvatinib|DRUG: Placebo for lenvatinib,ALL,"ADULT, OLDER_ADULT",PHASE3,"The Angeles Clinic and Research Institute ( Site 0707), Los Angeles, California, 90025, United States|UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0704), San Francisco, California, 30322, United States|California Pacific Medical Center Research Institute ( Site 0705), San Francisco, California, 94115, United States|John Wayne Cancer Institute ( Site 0706), Santa Monica, California, 90404, United States|University of Colorado Cancer Center ( Site 0708), Aurora, Colorado, 80045, United States|Yale Cancer Center ( Site 0709), New Haven, Connecticut, 06510, United States|Baptist MD Anderson Cancer Center ( Site 0767), Jacksonville, Florida, 32207, United States|Mid-Florida Cancer Centers ( Site 0764), Orange City, Florida, 32763, United States|AMG Oncology ( Site 0714), Park Ridge, Illinois, 60068, United States|Illinois Cancer Care, PC ( Site 0765), Peoria, Illinois, 61615, United States|Minnesota Oncology Specialist, PA ( Site 0766), Fridley, Minnesota, 55432, United States|St. Vincent Frontier Cancer Center ( Site 0724), Billings, Montana, 59102, United States|Atlantic Health System ( Site 0768), Morristown, New Jersey, 07960, United States|Valley Hospital ( Site 0749), Paramus, New Jersey, 07652, United States|University of North Carolina - Cancer Hospital ( Site 0751), Chapel Hill, North Carolina, 27514, United States|OHSU Center for Health & Healing ( Site 0731), Portland, Oregon, 97239, United States|Inova Schar Cancer Institute ( Site 0739), Fairfax, Virginia, 22031-4867, United States|Lismore Base Hospital ( Site 0453), Lismore, Australian Capital Territory, 2480, Australia|Melanoma Institute Australia ( Site 0452), North Sydney, New South Wales, 2060, Australia|Westmead Hospital ( Site 0451), Westmead, New South Wales, 2145, Australia|Princess Alexandra Hospital ( Site 0454), Wooloongabba, Queensland, 4102, Australia|Eastern Health ( Site 0457), Box Hill, Victoria, 3128, Australia|Fiona Stanley Hospital ( Site 0456), Murdoch, Western Australia, 6150, Australia|LKH Universitatsklinikum Graz ( Site 0776), Graz, Steiermark, 8036, Austria|Medizinische Universitat Wien ( Site 0778), Wien, 1090, Austria|PERSONAL - Oncologia de Precisao e Personalizada ( Site 0399), Belo Horizonte, Minas Gerais, 30130-090, Brazil|Hospital de Caridade de Ijui ( Site 0391), Ijui, Rio Grande Do Sul, 98700-000, Brazil|Hospital Sao Vicente de Paulo ( Site 0396), Passo Fundo, Rio Grande Do Sul, 99010-080, Brazil|Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 0397), Porto Alegre, Rio Grande Do Sul, 90610-000, Brazil|Instituto Nacional de Cancer Hospital do Cancer II ( Site 0394), Rio de Janeiro, 20220-410, Brazil|BC Cancer-Kelowna - Sindi Ahluwalia Hawkins Centre ( Site 0661), Kelowna, British Columbia, V1Y 5L3, Canada|Lions Gate Hospital ( Site 0662), North Vancouver, British Columbia, V7L 2L7, Canada|Sunnybrook Research Institute ( Site 0654), Toronto, Ontario, M4N 3M5, Canada|Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0652), Montreal, Quebec, H2W 3E4, Canada|McGill University Health Centre ( Site 0651), Montreal, Quebec, H4A 3J1, Canada|Centro InvestigaciÃ³n del CÃ¡ncer James Lind ( Site 0425), Temuco, Araucania, 4780000, Chile|Fundacion Arturo Lopez Perez FALP ( Site 0421), Santiago, Region M. De Santiago, 7500921, Chile|Pontificia Universidad Catolica de Chile ( Site 0422), Santiago, Region M. De Santiago, 8330024, Chile|Sociedad Medica Aren y Bachero Limitada ( Site 0426), Santiago, Region M. De Santiago, 8420383, Chile|Oncocentro ( Site 0424), Vina del Mar, Valparaiso, 2520598, Chile|Beijing Cancer Hospital ( Site 0601), Beijing, Beijing, 100036, China|Fujian Provincial Cancer Hospital ( Site 0612), Fuzhou, Fujian, 350014, China|Sun Yat-Sen University Cancer Center ( Site 0602), Guangzhou, Guangdong, 510000, China|Henan Cancer Hospital ( Site 0610), Zhengzhou, Henan, 450003, China|Nanjing Drum Tower Hospital ( Site 0609), Nanjing, Jiangsu, 210008, China|The First Hospital Of Jilin University ( Site 0603), Chang Chun, Jilin, 130021, China|Fudan University Shanghai Cancer Center ( Site 0607), Shanghai, Shanghai, 200032, China|Tianjin Medical University Cancer Institute & Hospital ( Site 0606), Tianjin, Tianjin, 300060, China|Yunnan Cancer Hospital ( Site 0604), Kunming, Yunnan, 430030, China|Sir Run Run Shaw Hospital ( Site 0605), Hangzhou, Zhejiang, 310018, China|Zhejiang Cancer Hospital ( Site 0608), Hangzhou, Zhejiang, 310022, China|Hopital ARCHET 2 ( Site 0009), Nice, Alpes-Maritimes, 06200, France|Hopital La Timone ( Site 0002), Marseille, Bouches-du-Rhone, 13385, France|CHU Dijon Bourgogne ( Site 0010), Dijon, Cote-d Or, 21079, France|Institut Claudius Regaud IUCT Oncopole ( Site 0003), Toulouse, Haute-Garonne, 31059, France|Hopital Ambroise Pare Boulogne ( Site 0007), Boulogne-Billancourt, Hauts-de-Seine, 92100, France|CHRU Lille - Hopital Claude Huriez ( Site 0004), Lille, Nord, 59037, France|CHU de Rouen ( Site 0013), Rouen, Seine-Maritime, 76000, France|Centre Hospitalier Victor Dupouy ( Site 0012), Argenteuil, Val-d Oise, 95100, France|Institut Gustave Roussy ( Site 0001), Villejuif, Val-de-Marne, 94805, France|CHU de la Miletrie Poitiers ( Site 0011), Poitiers, Vienne, 86021, France|Klinik fur Dermatologie Allergologie und Venerologie ( Site 0035), Hannover, Baden-Wurttemberg, 30625, Germany|Universitaetsklinikum Erlangen ( Site 0044), Erlangen, Bayern, 91054, Germany|Universitaetsklinikum Wuerzburg-Department of Dermatology ( Site 0036), Wuerzburg, Bayern, 97080, Germany|Hautkrebszentrum Buxtehude ( Site 0037), Buxtehude, Niedersachsen, 21614, Germany|Universitaetsklinikum Carl Gustav Carus ( Site 0041), Dresden, Sachsen, 01307, Germany|Universitaetsklinikum Leipzig ( Site 0040), Leipzig, Sachsen, 04103, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel ( Site 0033), Kiel, Schleswig-Holstein, 24105, Germany|SRH Wald-Klinikum Gera GmbH ( Site 0042), Gera, Thuringen, 07548, Germany|HaEmek Medical Center ( Site 0306), Afula, 1834111, Israel|Soroka Medical Center ( Site 0303), Beer Sheva, 8457108, Israel|Rambam Medical Center ( Site 0301), Haifa, 3109601, Israel|Hadassah Ein Karem Hebrew University Medical Center ( Site 0305), Jerusalem, 9112001, Israel|Rabin Medical Center ( Site 0302), Petah Tikva, 4941492, Israel|Chaim Sheba Medical Center ( Site 0304), Ramat Gan, 5262000, Israel|Sourasky Medical Center ( Site 0307), Tel Aviv, 6423906, Israel|Shamir Medical Center-Assaf Harofeh ( Site 0308), Zerifin, 70300, Israel|ASST Papa Giovanni XXIII ( Site 0062), Bergamo, Abruzzo, 24127, Italy|Azienda Ospedaliera Universitaria Senese ( Site 0065), Siena, Toscana, 53100, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0064), Milano, 20133, Italy|Istituto Europeo di Oncologia ( Site 0067), Milano, 20141, Italy|Istituto Nazionale Tumori Fondazione Pascale ( Site 0061), Napoli, 80131, Italy|Istituto Oncologico Veneto ( Site 0063), Padova, 35128, Italy|Kyungpook National University Chilgok Hospital ( Site 0553), Daegu, Taegu-Kwangyokshi, 41404, Korea, Republic of|Seoul National University Hospital ( Site 0554), Seoul, 03080, Korea, Republic of|Severance Hospital Yonsei University Health System ( Site 0552), Seoul, 03722, Korea, Republic of|Samsung Medical Center ( Site 0551), Seoul, 06351, Korea, Republic of|Centrum Onkologii im.prof. F. Lukaszczyka w Bydgoszczy ( Site 0273), Bydgoszcz, Kujawsko-pomorskie, 85-796, Poland|Pratia MCM Krakow ( Site 0280), Krakow, Malopolskie, 30-510, Poland|Uniwersyteckie Centrum Kliniczne ( Site 0281), Gdansk, Pomorskie, 80-214, Poland|Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 0278), Gliwice, Slaskie, 44-102, Poland|Szpital Kliniczny im. Heliodora Swiecickiego Uniwers Medyczn ( Site 0272), Poznan, Wielkopolskie, 60-780, Poland|Cancer Care Langenhoven Drive Oncology Centre ( Site 0805), Port Elizabeth, Eastern Cape, 6045, South Africa|Sandton Oncology Medical Group PTY LTD ( Site 0802), Johannesburg, Gauteng, 2196, South Africa|Cape Town Oncology Trials Pty Ltd ( Site 0803), Kraaifontein, Western Cape, 7570, South Africa|Hospital Duran i Reinals ICO de Hospitalet ( Site 0187), Hospitalet del Llobregat, Barcelona, 08908, Spain|Hospital Universitario Marques de Valdecilla ( Site 0181), Santander, Cantabria, 39008, Spain|Complejo Hospitalario Universitario A Coruna. CHUAC ( Site 0182), A Coruna, La Coruna, 15006, Spain|Hospital Universitario Insular de Gran Canaria ( Site 0189), Las Palmas de Gran Canaria, Las Palmas, 35001, Spain|Hospital Clinic i Provincial Barcelona ( Site 0190), Barcelona, 08036, Spain|Hospital General Universitario Gregorio Maranon ( Site 0191), Madrid, 28009, Spain|Hospital Universitario Ramon y Cajal ( Site 0183), Madrid, 28034, Spain|Hospital Universitario La Paz ( Site 0184), Madrid, 28046, Spain|Hospital Universitario Carlos Haya ( Site 0186), Malaga, 29010, Spain|Laenssjukhuset Ryhov ( Site 0215), Jonkoping, Jonkopings Lan, 551 85, Sweden|Centrallasarettet Vaxjo ( Site 0214), Vaxjo, Kronobergs Lan, 351 85, Sweden|Skanes Universitetssjukhus ( Site 0213), Lund, Skane Lan, 221 85, Sweden|Karolinska Universitetssjukhuset ( Site 0211), Solna, Stockholms Lan, 171 64, Sweden|Akademiska Sjukhuset ( Site 0218), Uppsala, Uppsala Lan, 751 85, Sweden|Norrlands Universitetssjukhus ( Site 0216), Umea, Vasterbottens Lan, 901 85, Sweden|Sahlgrenska Universitetssjukhuset ( Site 0212), Goteborg, Vastra Gotalands Lan, 413 45, Sweden|Universitaetsspital Basel ( Site 0094), Basel, Basel-Stadt, 4031, Switzerland|Kantonsspital Graubuenden ( Site 0091), Chur, Grisons, 7000, Switzerland|Kantonsspital Winterthur ( Site 0095), Winterthur, Zurich, 8401, Switzerland|Universitaetsspital Zuerich ( Site 0092), Zuerich-Flughafen, Zurich, 8058, Switzerland|Western General Hospital ( Site 0121), Edinburgh, Edinburgh, City Of, EH4 2XU, United Kingdom|Guys and St Thomas NHS Foundation Trust ( Site 0126), London, London, City Of, SE1 9RT, United Kingdom|Derriford Hospital ( Site 0129), Plymouth, PL6 8DH, United Kingdom|Singleton Hospital ( Site 0131), Swansea, SA2 8QA, United Kingdom","Study Director : Medical Director , Merck Sharp & Dohme LLC"
Melanoma,NCT00060710,CP-461 in the Treatment of Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT00060710,NO,Malignant Melanoma,DRUG: CP-461,ALL,"ADULT, OLDER_ADULT",PHASE2,"Columbia Presbyterian Medical Center, New York, New York, 10032, United States",Cell Pathways OSI Pharmaceuticals
Melanoma,NCT03551626,Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes,https://clinicaltrials.gov/study/NCT03551626,YES,Malignant Melanoma,DRUG: Dabrafenib|DRUG: Trametinib,ALL,"ADULT, OLDER_ADULT",PHASE3,"Novartis Investigative Site, Rosario, Sante Fe, S200KZE, Argentina|Novartis Investigative Site, Buenos Aires, C1125ABE, Argentina|Novartis Investigative Site, Cordoba, X5004BAL, Argentina|Novartis Investigative Site, Woolloongabba, Queensland, 4102, Australia|Novartis Investigative Site, Cairns, QLD 4870, Australia|Novartis Investigative Site, Rio de Janeiro, RJ, 20220410, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90035-003, Brazil|Novartis Investigative Site, Sao Paulo, SP, 01246 000, Brazil|Novartis Investigative Site, Calgary, Alberta, T2N 4N2, Canada|Novartis Investigative Site, Edmonton, Alberta, T6G 1Z2, Canada|Novartis Investigative Site, Hamilton, Ontario, L8V 5C2, Canada|Novartis Investigative Site, London, Ontario, N6A 4L6, Canada|Novartis Investigative Site, Ottawa, Ontario, K1H 8L6, Canada|Novartis Investigative Site, Toronto, Ontario, M4N 3M5, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 1Z6, Canada|Novartis Investigative Site, Montreal, Quebec, H3T 1E2, Canada|Novartis Investigative Site, Quebec, G1R 2J6, Canada|Novartis Investigative Site, Brno, Czech Republic, 656 53, Czechia|Novartis Investigative Site, Prague 8, Czech Republic, 180 00, Czechia|Novartis Investigative Site, Zlin, Czech Republic, 762 75, Czechia|Novartis Investigative Site, Hradec Kralove, CZE, 500 05, Czechia|Novartis Investigative Site, Ostrava, Poruba, 708 52, Czechia|Novartis Investigative Site, Prague, Prague 1, 11000, Czechia|Novartis Investigative Site, Olomouc, 779 00, Czechia|Novartis Investigative Site, Praha, 12808, Czechia|Novartis Investigative Site, Helsinki, 9, Finland|Novartis Investigative Site, Tampere, FIN-33521, Finland|Novartis Investigative Site, Turku, 20520, Finland|Novartis Investigative Site, Pierre Benite, Cedex 02, 69495, France|Novartis Investigative Site, Limoges, Haute Vienne, 87000, France|Novartis Investigative Site, Rennes Cedex, Ille Et Vilaine, 35062, France|Novartis Investigative Site, Besancon Cedex, 25030, France|Novartis Investigative Site, Bobigny Cedex, 93009, France|Novartis Investigative Site, Bordeaux Cedex, 33075, France|Novartis Investigative Site, Boulogne Billancourt, 92104, France|Novartis Investigative Site, Clermont Ferrand, 63003, France|Novartis Investigative Site, Dijon, 21034, France|Novartis Investigative Site, Grenoble Cedex 9, 38043, France|Novartis Investigative Site, Lille Cedex, 59037, France|Novartis Investigative Site, Lorient, 56322, France|Novartis Investigative Site, Marseille Cedex 05, 13885, France|Novartis Investigative Site, Montpellier, 34295, France|Novartis Investigative Site, Nice, 06202, France|Novartis Investigative Site, Paris 10, 75475, France|Novartis Investigative Site, Poitiers, 86021, France|Novartis Investigative Site, Reims, 51092, France|Novartis Investigative Site, Toulouse, 31059, France|Novartis Investigative Site, Villejuif, 94800, France|Novartis Investigative Site, Athens, 115 27, Greece|Novartis Investigative Site, Athens, 18547, Greece|Novartis Investigative Site, Athens, GR 115 22, Greece|Novartis Investigative Site, Thessaloniki, 54622, Greece|Novartis Investigative Site, Budapest, H 1122, Hungary|Novartis Investigative Site, Pecs, 7623, Hungary|Novartis Investigative Site, Szeged, H 6725, Hungary|Novartis Investigative Site, Jerusalem, 9112001, Israel|Novartis Investigative Site, Ramat Gan, 52621, Israel|Novartis Investigative Site, Bergamo, BG, 24127, Italy|Novartis Investigative Site, Meldola, FC, 47014, Italy|Novartis Investigative Site, Antella - Bagno A Ripoli, FI, 50011, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Modena, MO, 41124, Italy|Novartis Investigative Site, Palermo, PA, 90127, Italy|Novartis Investigative Site, Padova, PD, 35100, Italy|Novartis Investigative Site, Roma, RM, 00128, Italy|Novartis Investigative Site, Roma, RM, 00167, Italy|Novartis Investigative Site, Torino, TO, 10126, Italy|Novartis Investigative Site, Udine, UD, 33100, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Sapporo, Hokkaido, 060-8543, Japan|Novartis Investigative Site, Chuo ku, Tokyo, 104 0045, Japan|Novartis Investigative Site, Riga, LV 1079, Latvia|Novartis Investigative Site, Vilnius, LT-08660, Lithuania|Novartis Investigative Site, Alesund, NO-6026, Norway|Novartis Investigative Site, Oslo, 0379, Norway|Novartis Investigative Site, Gdansk, 80 952, Poland|Novartis Investigative Site, Warszawa, 02 781, Poland|Novartis Investigative Site, Wroclaw, 53 413, Poland|Novartis Investigative Site, Porto, 4200-072, Portugal|Novartis Investigative Site, Moscow Region Istra Village, 143423, Russian Federation|Novartis Investigative Site, Moscow, 115478, Russian Federation|Novartis Investigative Site, Omsk, 644013, Russian Federation|Novartis Investigative Site, St Petersburg, 197758, Russian Federation|Novartis Investigative Site, Bratislava, 812 50, Slovakia|Novartis Investigative Site, Kosice, 04191, Slovakia|Novartis Investigative Site, Ljubljana, 1000, Slovenia|Novartis Investigative Site, Goteborg, SE-413 45, Sweden|Novartis Investigative Site, Orebro, 701 85, Sweden|Novartis Investigative Site, Stockholm, SE 171 76, Sweden|Novartis Investigative Site, Umea, SE 901 85, Sweden|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Bristol, Avon, BS2 8ED, United Kingdom|Novartis Investigative Site, Northwood, Middlesex, HA6 2RN, United Kingdom|Novartis Investigative Site, Sheffield, South Yorkshire, S10 2JF, United Kingdom|Novartis Investigative Site, Cambridge, CB2 2QQ, United Kingdom|Novartis Investigative Site, Leeds, LS9 7TF, United Kingdom|Novartis Investigative Site, Manchester, M20 4BX, United Kingdom|Novartis Investigative Site, Southampton, SO16 6YD, United Kingdom","Study Director : Novartis Pharmaceuticals , Novartis Pharmaceuticals"
Melanoma,NCT03084640,Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma,https://clinicaltrials.gov/study/NCT03084640,NO,Malignant Melanoma,DRUG: CMP-001|DRUG: Pembrolizumab|DRUG: CMP-001,ALL,"ADULT, OLDER_ADULT",PHASE1,"University of California, Los Angeles, Los Angeles, California, 90095, United States|University of Colorado, Aurora, Colorado, 80045, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Pittsburgh Medical Center - Cancer Center, Pittsburgh, Pennsylvania, 15232, United States",Regeneron Pharmaceuticals
Melanoma,NCT00306566,Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients,https://clinicaltrials.gov/study/NCT00306566,NO,Malignant Melanoma,BIOLOGICAL: CYT004-MelQbG10,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Centre Pluridisciplinaire d'Oncologie & LICR, CHUV, Lausanne, Vaude, 1011, Switzerland","Principal Investigator : Danielle Lienard, MD , Centre Pluridisciplinaire d'Oncologie & LICR, CHUV"
Melanoma,NCT00135408,A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide,https://clinicaltrials.gov/study/NCT00135408,NO,Malignant Melanoma,DRUG: Ipilimumab+ Placebo|DRUG: Ipilimumab+ Budesonide,ALL,"ADULT, OLDER_ADULT",PHASE2,"Los Angeles, California, United States|San Francisco, California, United States|Charlotte, North Carolina, United States|Seattle, Washington, United States|Local Institution, Kitchener, Canada|Local Institution, Moncton, Canada|Local Institution, Tel Aviv, Israel|Local Institution, Forli, Italy|Local Institution, Lima, Peru|Local Institution, Hull, United Kingdom",Medarex
Melanoma,NCT02938728,Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma,https://clinicaltrials.gov/study/NCT02938728,NO,Malignant Melanoma,OTHER: Biopsies,ALL,"ADULT, OLDER_ADULT",,,Assistance Publique - HÃ´pitaux de Paris
Melanoma,NCT02050321,A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT02050321,YES,Malignant Melanoma,DRUG: Acitretin|DRUG: Vemurafenib,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Arizona Cancer Center, Tucson, Arizona, 85724, United States","Principal Investigator : Lee Cranmer, MD, PhD , University of Arizona"
Melanoma,NCT00715793,Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00715793,YES,Malignant Melanoma,DRUG: Decitabine|DRUG: Temozolomide|PROCEDURE: biopsy,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"UPMC Cancer Centers, Pittsburgh, Pennsylvania, 15232, United States","Principal Investigator : Hussein Tawbi, MD , University of Pittsburgh"
Melanoma,NCT00204594,Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28,https://clinicaltrials.gov/study/NCT00204594,NO,Malignant Melanoma,DRUG: rM28|DRUG: autologous PBMCs,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"University of Tuebingen, Department of dermatology, Tuebingen, 72076, Germany",
Melanoma,NCT00086489,"CP-675,206 In Patients With Advanced Melanoma",https://clinicaltrials.gov/study/NCT00086489,NO,Malignant Melanoma,"DRUG: CP-675,206|DRUG: CP-675,206",ALL,"ADULT, OLDER_ADULT",PHASE2,"Research Site, Los Angeles, California, 90095, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Chicago, Illinois, 60637-1460, United States|Research Site, Ann Arbor, Michigan, 48109-0008, United States|Research Site, Ann Arbor, Michigan, 48109-0843, United States|Research Site, Pittsburgh, Pennsylvania, 15232-1305, United States|Research Site, Pittsburgh, Pennsylvania, 15232, United States|Research Site, Nashville, Tennessee, 37232, United States|Research Site, Houston, Texas, 77030, United States",AstraZeneca
Melanoma,NCT02935790,Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab,https://clinicaltrials.gov/study/NCT02935790,NO,Malignant Melanoma,DRUG: ACY-241|DRUG: nivolumab|DRUG: ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE1,"NYU Langone Medical Center, New York, New York, 10016, United States","Principal Investigator : Jeffrey S Weber , Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center Principal Investigator : Elizabeth Buchbinder , Dana-Farber Cancer Institute"
Melanoma,NCT01748448,Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome,https://clinicaltrials.gov/study/NCT01748448,NO,Cutaneous Malignant Melanoma,DRUG: Vitamin D|DRUG: arachides oleum raffinatum,ALL,"ADULT, OLDER_ADULT",PHASE3,"Universitair Ziekenhuis Antwerpen, Dermatology, Edegem, 2650, Belgium|UZLeuven Gasthuisberg, Leuven, 3000, Belgium|Chef de Service du Service Universitaire de Dermatologie, LiÃ¨ge, 4000, Belgium|Dep. of Dermatology, Medical and Health Science Center University of Debrecen, Debrecen, 4032, Hungary","Principal Investigator : Marjan Garmyn, MD, PhD , Universitaire Ziekenhuizen KU Leuven"
Melanoma,NCT01307397,A Study of Vemurafenib in Participants With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01307397,YES,Malignant Melanoma,DRUG: Vemurafenib,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"University ""Mother Theresa"" Hospital Center; Oncology Department, Tirana, 1000, Albania|Hospital Britanico; Oncologia, Buenos Aires, C1280AEB, Argentina|FundaciÃ³n CIDEA, Buenos Aires, C1425DTG, Argentina|Inst. Alexander Fleming; Oncologia, Buenos Aires, C1426ANZ, Argentina|Melanoma Institute Australia, North Sydney, New South Wales, 2060, Australia|Newcastle Mater Misericordiae Hospital; Oncology, Waratah, New South Wales, 2298, Australia|Westmead Hospital, Westmead, New South Wales, 2145, Australia|Border Medical Oncology, Wodonga, New South Wales, 3690, Australia|Greenslopes Private Hospital; Gallipoli Research Centre, Greenslopes, Queensland, 4120, Australia|The Townsville Hospital; Townsville Cancer Centre, Townsville, Queensland, 4812, Australia|Princess Alexandra Hospital Woolloongabba; Clinical Hematology and Medical Oncology, Woolloongabba, Queensland, 4102, Australia|Royal Adelaide Hospital; Oncology, Adelaide, South Australia, 5000, Australia|Geelong Hospital; Geelong Cardiology Practice, Geelong, Victoria, 3220, Australia|Peter MacCallum Cancer Centre; Medical Oncology, Melbourne, Victoria, 3000, Australia|Alfred Hospital, Melbourne, Victoria, 3004, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, 6009, Australia|Landeskrankenhaus Feldkirch; Abteilung fÃ¼r Innere Medizin, Feldkirch, 6807, Austria|LKH Graz; Abteilung fÃ¼r allgemeine Dermatologie, Graz, 8036, Austria|LKH Innsbruck; UniversitÃ¤tsklinik fÃ¼r Dermatologie, Innsbruck, 6020, Austria|Krankenhaus der Elisabethinen Linz; Abteilung fÃ¼r Dermatologie, Linz, 4020, Austria|Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt., Salzburg, 5020, Austria|LKH Salzburg; UniversitÃ¤tsklinik fÃ¼r Dermatologie, Salzburg, 5020, Austria|Landesklinikum St. PÃ¶lten, St. PÃ¶lten, 3100, Austria|Medizinische UniversitÃ¤t Wien; Univ.Klinik fÃ¼r Dermatologie, Wien, 1090, Austria|UZ Brussel, Brussel, 1090, Belgium|Cliniques Universitaires St-Luc, Bruxelles, 1200, Belgium|Sint Augustinus Wilrijk, Wilrijk, 2610, Belgium|University Clinical Center of the Republic of Srpska, Banja Luka, 78000, Bosnia and Herzegovina|Clinic of Oncology, University Clinical Center Sarajevo, Sarajevo, 71000, Bosnia and Herzegovina|Instituto Nacional de Cancer - INCa; Pesquisa Clinica, Rio de Janeiro, RJ, 20230-130, Brazil|Hospital das Clinicas - UFRGS, Porto Alegre, RS, 90035-003, Brazil|Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, SP, 01246-000, Brazil|Hospital A. C. Camargo; Oncologia, Sao Paulo, SP, 01509-010, Brazil|Hospital Sao Jose, SÃ£o Paulo, SP, CEP 01321-001, Brazil|District Oncology Dispensary; Department for Oncology and Dermatology, Plovdiv, 4000, Bulgaria|National Specialized Hospital for Active Oncology Treatment; Dermatology Clinic, Sofia, 1756, Bulgaria|Cross Cancer Institute ; Dept of Medical Oncology, Edmonton, Alberta, T6G 1Z2, Canada|Lion'S Gate Hospital, North Vancouver, British Columbia, V7L 2L7, Canada|British Columbia Cancer Agency (Bcca) - Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada|St. Boniface General Hospital; Medicine, Winnipeg, Manitoba, R2H 2A6, Canada|QEII HSC; Oncology, Halifax, Nova Scotia, B3H 2Y9, Canada|Hamilton Health Sciences - Juravinski Cancer Centre, Hamilton, Ontario, L8V 5C2, Canada|London Regional Cancer Centre, London, Ontario, N6A 4L6, Canada|The Ottawa Hospital; Division of Infectious Diseases, Ottawa, Ontario, K1H 8L6, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|University Health Network; Princess Margaret Hospital; Medical Oncology Dept, Toronto, Ontario, M5G 2M9, Canada|McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal, Quebec, H3T 1E2, Canada|Chuq - Hopital Hotel Dieu de Quebec; Oncology, Quebec City, Quebec, G1R 2J6, Canada|Centro Javeriano de OncologÃ­a, Bogota, Colombia|Fundacion Santa Fe de BogotÃ¡, Bogota, Colombia|ClÃ­nica Imbanaco; Oncology, Cali, Colombia|Hospital Pablo Tobon Uribe, Medellin-Antioquia, Colombia|Clinical Hospital Sisters of Mercy, Zagreb, 10000, Croatia|MasarykÅ¯v onkologickÃ½ Ãºstav; Klinika komplexnÃ­ onkologickÃ© pÃ©Äe, Brno, 656 53, Czechia|University Hospital; Oncology and Radiotherapy, Hradec Kralove, 500 05, Czechia|Fakultni nemocnice Olomouc; Onkologicka klinika, Olomouc, 779 00, Czechia|Faculty Hospital; Dialysis Unit, Ostrava, 708 52, Czechia|1 Lekarska Fakulta Uni Karlovy; 3 Interni Klinika, Labor. Pro Endokrinologii A Metabolismus, Praha, 128 00, Czechia|Faculty Hospital Kralovske Vinohrady; Oncology, Praha, Czechia|Aarhus Universitetshospital; KrÃ¦ftafdelingen, Aarhus C, 8000, Denmark|Herlev Hospital; Onkologisk afdeling, Herlev, 2730, Denmark|Odense Universitetshospital, Onkologisk Afdeling R, Odense, 5000, Denmark|Hospital Regional Vicente Corral Moscoso, Servicio de OncologÃ­a, Cuenca, Ecuador|Hospital Abel Gilbert Ponton; Oncology, Guayaquil, EC090104, Ecuador|Hospital Solca Portoviejo; Oncologia, Portoviejo, EC130104, Ecuador|East Tallinn Central Hospital; Clinic of Internal Medicine, Tallinn, 11312, Estonia|North Estonia Medical Centre Foundation; Oncology Center, Tallinn, 13419, Estonia|Tartu University Hospital; Clinic of Hematology and Oncology, Tartu, 50406, Estonia|Helsinki University Central Hospital; Dept of Oncology, Helsinki, 00029, Finland|Tampere University Hospital; Dept of Oncology, Tampere, 33520, Finland|Turku Uni Central Hospital; Oncology Clinics, Turku, 20520, Finland|Uniklinik RWTH Aachen; Klinik fÃ¼r Dermatologie und Allergologie - Hautklinik, Aachen, 52074, Germany|Klinikum Augsburg SÃ¼d; Klinik fÃ¼r Dermatologie und Allergologie, Augsburg, 86179, Germany|CAMPUS BENJAMIN FRANKLIN CharitÃ©Centrum 14 Med.Klinik f.HÃ¤matologie u.Onkologie, Berlin, 12200, Germany|St. Josef-Hospital Klinik f. Dermatologie u. Allergologie, Bochum, 44791, Germany|Elbekliniken Buxtehude; Klinik fÃ¼r Dermatologie, Buxtehude, 21614, Germany|DRK-Krankenhaus; Hautklinik, Chemnitz, 09117, Germany|UniversitÃ¤tsklinikum ""Carl Gustav Carus""; Medizinische Klinik und Poliklinik I, Dresden, 01307, Germany|UniversitÃ¤tsklinikum DÃ¼sseldorf; Hautklinik, DÃ¼sseldorf, 40225, Germany|HELIOS Klinikum Erfurt, Klinik fÃ¼r Hautkrankheiten und Allergologie, Erfurt, 99089, Germany|UniversitÃ¤tsklinikum Erlangen; Hautklinik, Erlangen, 91054, Germany|UniversitÃ¤tsklinikum Essen, Essen, 45122, Germany|Klinik Johann Wolfgang von Goethe Uni; Klinik fuer Allgemein- und Viszeralchirurgie, Frankfurt, 60596, Germany|Uniklinikum Freiburg Dermatol, Freiburg, 79104, Germany|SRH Wald-Klinikum Gera; Klinik fÃ¼r Hautkrankheiten und Allergologie, Gera, 07548, Germany|UniversitÃ¤tsmedizin GÃ¶ttingen Georg-August-UniversitÃ¤t Zentrum Dermatologie, GÃ¶ttingen, 37075, Germany|UniversitÃ¤tsklinikum Hamburg-Eppendorf Zentrum f.Innere Medizin Klinik f.Dermatologie, Hamburg, 20246, Germany|Medizinische Hochschule; Hautklinik Linden, Hannover, 30449, Germany|Uni-Hautklinik, Heidelberg, 69115, Germany|Klinikum am Gesundbrunnen; Tumorzentrum, Heilbronn, 74078, Germany|UniversitÃ¤tsklinikum Jena; Klinik fÃ¼r Hautkrankheiten, Jena, 07743, Germany|Klinikum Kassel; Hautklinik, Kassel, 34125, Germany|UNI-Klinikum Campus Kiel Klinik f.Dermatologie Tagesklinik f.Dermatologie, Kiel, 24105, Germany|Klinik der Uni zu KÃ¶ln; Klinik & Poliklinik fuer Dermatologie & Venerologie, KÃ¶ln, 50937, Germany|UniversitÃ¤tsklinikum Leipzig Klinik f.Dermatologie Venerologie u.Allergologie, Leipzig, 04103, Germany|Klinikum d.Stadt Ludwigshafen Hautklinik, Ludwigshafen, 67063, Germany|UniversitÃ¤tsklinikum Schleswig-Holstein; Campus LÃ¼beck, LÃ¼beck, 23538, Germany|UniversitÃ¤tsklinikum Magdeburg; Hautklinik; Klinik fÃ¼r Dermatologie und Venerologie, Magdeburg, 39120, Germany|Johannes Gutenberg Unis-Klinik; Dept For Dermatology, Mainz, 55131, Germany|Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie, Mannheim, 68167, Germany|UniversitÃ¤tsklinikum Marburg Klinik f. Dermatologie, Marburg, 35043, Germany|Johannes-Wesling-Klinikum Minden; Onkologische Ambulanz / Tagesklinik, Minden, 32429, Germany|Klinikum der LMU MÃ¼nchen; Klinik und Poliklinik fÃ¼r Dermatologie und Allergologie, MÃ¼nchen, 80337, Germany|Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie, MÃ¼nchen, 80804, Germany|UniversitÃ¤tsklinikum MÃ¼nster, MÃ¼nster, 48149, Germany|Fachklinik Hornheide; Internistische Onkologie, MÃ¼nster, 48157, Germany|Klinikum NÃ¼rnberg Nord; Hautklinik; Klinik fÃ¼r Dermatologie, NÃ¼rnberg, 90419, Germany|Klinikum Dorothea Ch.Erxleben; Klinik fÃ¼r Dermatologie und Allergologie, Quedlinburg, 06484, Germany|KLINIKUM VEST GmbH Knappschaftskrankenhaus Abt.Haut- Allergie- Venen- und Umwelterkrankungen, Recklinghausen, 45657, Germany|UniversitÃ¤tsklinikum Regensburg; Klinik und Poliklinik fÃ¼r Dermatologie, Regensburg, 93053, Germany|Universitaets-Hautklinik Tuebingen, TÃ¼bingen, 72076, Germany|Wilhelm Fresenius Klinik; Klinik f. Dermatologie u. Allergologie, Wiesbaden, 65191, Germany|HELIOS Klinikum Barmen Zentrum Dermatologie Allergologie und Umweltmedizin, Wuppertal, 42283, Germany|UniversitÃ¤tsklinikum WÃ¼rzburg; Klinik und Poliklinik fÃ¼r Dermatologie Venerologie u. Allergologie, WÃ¼rzburg, 97080, Germany|Laiko General Hospital; 1St Pathological Clinic, Athens, 115 27, Greece|Hospital Hygeia; 1St Oncology Dept., Athens, 15123, Greece|Univ General Hosp Heraklion; Medical Oncology, Heraklion, 711 10, Greece|Metropolitan Hospital; Dept. of Oncology, Piraeus, 185 47, Greece|Semmelweis Egyetem; Bor-, Nemikortani es Boronkologiai Klinika, Budapest, 1085, Hungary|Orszagos Onkologiai Intezet; B Belgyogyaszati Osztaly, Budapest, 1122, Hungary|Debreceni Egyetem OEC; Borgyogyaszati Klinika, Debrecen, 4012, Hungary|Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika, Pecs, 7632, Hungary|Szegedi Tud.Egyetem Szent-Gyorgyi Albert Klin.Kozp., Szeged, 6720, Hungary|Rajiv Gandhi Cancer Inst.&Research Center; Medical Oncology, New Delhi, Delhi, 110085, India|Tata Memorial Hospital; Dept of Medical Oncology, Mumbai, Maharashtra, 400012, India|Curie Manavata Cancer Centre, Nashik, Maharashtra, 422004, India|Basavatarakam Indo-American Cancer Hospital & Research Institute, Hyderabad, 500034, India|Chhatrapati Shahuji Maharaj Medical University; Department of Oncology, Lucknow, 226003, India|Regional Cancer Centre; Dept of Oncology, Trivandrum, 695 011, India|Christian Med Clg & Hspt, Vellore, 632004, India|Cork Uni Hospital; Oncology Dept, Cork, Ireland|St Vincent'S Uni Hospital; Medical Oncology, Dublin, 4, Ireland|Mater Misericordiae Uni Hospital; Oncology, Dublin, 7, Ireland|Mater Private Hospital, Dublin, 7, Ireland|St James' Hospital; Cancer Clinical Trials Office, Dublin, Ireland|Galway Uni Hospital; Oncology Dept, Galway, Ireland|University Hospital Limerick - Oncology, Limerick, Ireland|Waterford Regional Hospital; Department Of Medical Oncology, Waterford, Ireland|Soroka Medical Center; Oncology Dept, Beer Sheva, 8410101, Israel|Ranbam Health Care Campus; Oncology - Hafia, Hafia, 3109601, Israel|Hadassah Ein Karem Hospital; Oncology Dept, Jerusalem, 91120-01, Israel|Chaim Sheba Medical Center; Oncology Dept, Ramat Gan, 5262100, Israel|Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Campania, 80131, Italy|IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola; Oncologia Medica, Meldola, Emilia-Romagna, 47014, Italy|A.O. Universitaria Policlinico Di Modena; Oncologia, Modena, Emilia-Romagna, 41100, Italy|AO Santa Maria Nuova; U.O. Day Hospital di Oncologi, Reggio Emilia, Emilia-Romagna, 42100, Italy|A.O. Universitaria S. Maria Della Misericordia Di Udine; Oncologia, Udine, Friuli-Venezia Giulia, 33100, Italy|Istituto Dermopatico dell'Immacolata (IDI)-IRCCS; IV Divisione Oncologica e Dermatologia Oncologica, Roma, Lazio, 00167, Italy|IFO - Istituto Regina Elena; Oncologia Medica, Roma, Lazio, 00168, Italy|IRCCS Istituto Nazionale Per La Ricerca Sul Cancro (IST); Oncologia Medica A, Genova, Liguria, 16132, Italy|Asst Papa Giovanni XXIII; Oncologia Medica, Bergamo, Lombardia, 24128, Italy|Az. Osp. Spedali Civili; Divisione Di Oncologia - Iii Medicina, Brescia, Lombardia, 25123, Italy|Irccs Ospedale San Raffaele;Oncologia Medica, Milano, Lombardia, 20132, Italy|Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milano, Lombardia, 20133, Italy|Irccs Istituto Europeo Di Oncologia (IEO); Oncologia Medica, Milano, Lombardia, 20141, Italy|Policlinico Le Molinette; Clinica Dermatologica, Torino, Piemonte, 10126, Italy|Istituto Tumori Giovanni Paolo II IRCSS; Ospedale Oncologico Bari, Bari, Puglia, 70126, Italy|Policlinico P. Giaccone; Istituto Di Oncologia, Clinica Medica 1, Palermo, Sicilia, 90127, Italy|Azienda Ospedaliero-Universitaria Careggi;S.C. Oncologia Medica 1, Firenze, Toscana, 50139, Italy|Azienda Ospedaliera S. Chiara; Dip di Onc,Trapianti e delle Nuove Tecnologie in Medicina, Pisa, Toscana, 50126, Italy|A.O.U. Senese Policlinico Santa Maria Alle Scotte, Siena, Toscana, 53100, Italy|Azienda Ospedaliera S. Maria - Terni; Oncologia, Terni, Umbria, 05100, Italy|IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Seconda, Padova, Veneto, 35128, Italy|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Seoul St Mary's Hospital, Seoul, 06591, Korea, Republic of|Seoul National University Hosp; Dept Internal Med Hem Onc, Seoul, 110-744, Korea, Republic of|Yonsei University Severance Hospital; Medical Oncology, Seoul, 120-752, Korea, Republic of|Asan Medical Center., Seoul, 138-736, Korea, Republic of|Daugavpils Regional Hospital, Daugavpils, 5417, Latvia|Rigas Austrumu Kliniska Universitates slimnica, Latvijas Onkologijas centrs, Riga, LV 1079, Latvia|Klaipeda University Hospital, Klaipeda, 92288, Lithuania|Vilnius University Hospital Santariskiu Clinic, Hematology, Oncology and Tranfusion Medicine Center, Vilnius, 08661, Lithuania|University Clinic for Radiotherapy and Oncology Skopje; Department of skin malignancies, Skopje, 1000, Macedonia, The Former Yugoslav Republic of|FundaciÃ³n Rodolfo Padilla Padilla, A.C.; Oncology, Leon, 37000, Mexico|Inst. Nacional de Cancerologia; Investigacion Clinica, Mexico City, 14000, Mexico|Hospital General de MÃ©xico; Unidad de Oncologia, Mexico DF, 06726, Mexico|Antoni Van Leeuwenhoek Ziekenhuis; Inwendige Geneeskunde, Amsterdam, 1066 CX, Netherlands|VU MEDISCH CENTRUM; Dept. of Medical Oncology, Amsterdam, 1081 HV, Netherlands|Tergooiziekenhuizen, Blaricum, 1261 AN, Netherlands|Amphia Ziekenhuis, Breda, 4818 CK, Netherlands|Academ Ziekenhuis Groningen; Medical Oncology, Groningen, 9713 GZ, Netherlands|Academisch Ziekenhuis Leiden; Clinical Oncology, Leiden, 2333 ZA, Netherlands|Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde, Maastricht, 6229 HX, Netherlands|UMC St Radboud; Interne Oncologie; Medical Oncology Department, Nijmegen, 6500 HB, Netherlands|Erasmus MC, Rotterdam, 3000 CA, Netherlands|Universitair Medisch Centrum Utrecht; Inwendige Geneeskunde Afd., Utrecht, 3584 CX, Netherlands|Haukeland Universitetshospital; Onkologisk Avd., Bergen, 5021, Norway|The Norvegian Radium Hospital Montebello; Dept of Oncology, Oslo, 0379, Norway|Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology, Arequipa, 04001, Peru|Instituto Nacional de Enfermedades Neoplasicas, Lima, 34, Peru|Szpital Uniwersytecki w Krakowie, OddziaÅ‚ Kliniczny Kliniki Onkologii, Krakow, 31-531, Poland|ZOZ MSWiA z Warminsko-Mazurskim Centrum Onkologii;Wojska Polskiego 37, Olsztyn, 10-228, Poland|NZOZ Med.-Polonia sp. z o.o., PoznaÅ„, 60-693, Poland|Centrum Onkologii- Instytut; im. M.SkÅ‚odowskiej-Curie, Warszawa, 02-781, Poland|IPO de Lisboa; Servico de Oncologia Medica, Lisboa, 1099-023, Portugal|IPO do Porto; Servico de Oncologia Medica, Porto, 4200-072, Portugal|Institut of Oncology Al. Trestioreanu Bucharest; Oncology, Bucuresti, 022328, Romania|Medisprof SRL, Cluj-Napoca, 400058, Romania|S.C. Life Search S.R.L; Medical Oncology Clinic, Timisoara, 300167, Romania|FSBI ""Scientific Research Institute of Oncology named after N.N.Petrov"" Ministry of Health of RF, St Petersburg, Leningrad, 197758, Russian Federation|Regional Clinical Oncology Dispensary, Krasnodar, 350040, Russian Federation|Russian Cancer Research Center, Moscow, 115478, Russian Federation|Moscow city oncology hospital #62 of Moscow Healthcare Department, Moscow, 143423, Russian Federation|St. Petersburg Oncology & Gynecology; City Clinical Oncology Dispensary, Saint-Petersburg, 197022, Russian Federation|Stavropol Clinical Oncology Dispansary, Stavropol, ND, Russian Federation|Bashkirian Republican Clinical Oncology Dispensary, UFA, 450054, Russian Federation|Institute for Oncology and Radiology of Serbia; Medical Oncology, Belgrade, 11000, Serbia|Clinical Center Bezanijska Kosa; Oncology, Belgrade, 11080, Serbia|Onkologicky ustav sv. Alzbety; Oddelenie ambulantnej chemoterapie, Bratislava, 812 50, Slovakia|Narodny Onkologicky Ustav; Oddelenie klinickej onkologie E, Bratislava, 833 10, Slovakia|POKO Poprad; Department of Oncology, Poprad, 058 01, Slovakia|Institute of Oncology Ljubljana, Ljubljana, 1000, Slovenia|Universitas Annex, University of the Free State; Clinical Oncology, Bloemfontein, 9300, South Africa|Cape Town Oncology Trials, Cape Town, 7570, South Africa|Cancercare, Cape Town, 7700, South Africa|Medical Oncology Centre of Rosebank; Oncology, Johannesburg, 2196, South Africa|Steve Biko Academic Hospital; Oncology, Pretoria, 0002, South Africa|Sandton Oncology Centre, Sandton, 2196, South Africa|Hospital Univ. Central de Asturias; Servicio de Oncologia, Oviedo, Asturias, 33011, Spain|Hospital Universitario Marques de Valdecilla; Servicio de Oncologia, Santander, Cantabria, 39008, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Islas Baleares, 07014, Spain|Hospital Universitario Materno Infantil de Gran Canaria; Servicio de Oncologia, Las Palmas de Gran Canaria, Las Palmas, 35016, Spain|Hospital Universitario de Santa LucÃ­a; Servicio de OncologÃ­a MÃ©dica, Cartagena (Murcia), Murcia, 30202, Spain|Clinica Universitaria de Navarra; Servicio de Oncologia, Pamplona, Navarra, 31008, Spain|Hospital Xeral CÃ­es; Servicio de Oncologia, Vigo, Pontevedra, 36312, Spain|Hospital Universitario de Canarias (HUC), La Laguna (Tenerife), Tenerife, 38320, Spain|Hospital de Cruces; Servicio de Oncologia, Barakaldo, Vizcaya, 48903, Spain|Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona, 08035, Spain|Hospital ClÃ­nic i Provincial; Servicio de HematologÃ­a y OncologÃ­a, Barcelona, 08036, Spain|Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia, Barcelona, 08916, Spain|Hospital Reina Sofia, Cordoba, 14004, Spain|Hospital Universitario Virgen de las Nieves; Servicio de Oncologia, Granada, 18014, Spain|Complejo Hospitalario Universitario A CoruÃ±a (CHUAC, Materno Infantil), OncologÃ­a, La CoruÃ±a, 15006, Spain|Complejo Asistencial Universitario de Leon; Servicio de Oncologia, Leon, 24071, Spain|Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, 28034, Spain|Hospital Universitario ClÃ­nico San Carlos; Servicio de Oncologia, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid, 28041, Spain|Hospital Universitario La Paz; Servicio de Oncologia, Madrid, 28046, Spain|Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia, Malaga, 29010, Spain|Hospital Regional Universitario Carlos Haya; Servicio de Oncologia, Malaga, 29010, Spain|Hospital Clinico Universitario de Salamanca; Servicio de Oncologia, Salamanca, 37007, Spain|Hospital Universitario Virgen Macarena; Servicio de Oncologia, Sevilla, 41009, Spain|Hospital General Universitario de Valencia; Servicio de oncologia, Valencia, 41014, Spain|Instituto Valenciano Oncologia; Oncologia Medica, Valencia, 46009, Spain|Hospital Universitario Miguel Servet; Servicio Oncologia, Zaragoza, 50009, Spain|Sahlgrenska Universitetssjukhuset; Onkology, Gothenburg, SE-41 343, Sweden|SkÃ¥nes Onkologiska Klinik, Universitetssjukhuset, Lund, 22185, Sweden|Karolinska Universitetssjukhuset, Solna, Stockholm, 171 76, Sweden|Norrlands universitetssjukhus; Onkologkliniken, UmeÃ¥, Sweden|Akademiska sjukhuset, Onkologkliniken, Uppsala, 75185, Sweden|Universitaetsspital Basel; Onkologie, Basel, 4031, Switzerland|Inselspital Bern; Medizinische Onkologie, Bern, 3010, Switzerland|Kantonsspital GraubÃ¼nden;Onkologie und HÃ¤matologie, Chur, 7000, Switzerland|CHUV; Departement d'Oncologie, Lausanne, 1011, Switzerland|Kantonsspital St. Gallen; Onkologie/HÃ¤matologie, St. Gallen, 9007, Switzerland|UniversitÃ¤tsspital ZÃ¼rich; Dermatologische Klinik, ZÃ¼rich, 8091, Switzerland|Adana Baskent University Hospital; Medical Oncology, Adana, 01120, Turkey|Cukurova Uni Faculty of Medicine; Medical Oncology, Adana, 01330, Turkey|Ankara Uni , Ibn-I Sina Hospital; Oncology Dept, Ankara, 06230, Turkey|Gazi Uni Medical Faculty Hospital; Oncology Dept, Ankara, 06500, Turkey|Akdeniz University School of Medicine; General Surgery, Antalya, 07000, Turkey|Ege University Medical Faculty; Medical Oncology Department, Bornova, Ä°ZMÄ°R, 35100, Turkey|Gaziantep University Medical Faculty, Medical Oncology Department, Gaziantep, 27310, Turkey|Kartal Training and Research Hospital;Medical Oncology Department, Istanbul, 34000, Turkey|Istanbul Uni Cerrahpasa Medical Faculty Hospital; Medical Oncology, Istanbul, 34300, Turkey|American Hospital, Medical Oncology Department, Istanbul, 34365, Turkey|Dokuz Eylul Uni ; Medical Oncology, Izmir, 35340, Turkey|Hacettepe Uni Medical Faculty Hospital; Oncology Dept, SÄ±hhiye, ANKARA, 06100, Turkey|Addenbrookes Nhs Trust; Oncology Clinical Trials Unit, Cambridge, CB2 0QQ, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|Royal Surrey County Hospital; St. Lukes Cancer Centre, Guildford, GU2 7XX, United Kingdom|St James University Hospital, Leeds, LS9 7TF, United Kingdom|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom|Christie Hospital; Breast Cancer Research Office, Manchester, M20 4QL, United Kingdom|Northern Centre for Cancer Care Freeman Hospital; Sir Bobby Robson Cancer Trials Research Centre, Newcastle upon Tyne, NE7 7DN, United Kingdom|Mount Vernon Hospital; Centre For Cancer Treatment, Northwood, HA6 2RN, United Kingdom|Nottingham University Hospitals City Campus, Nottingham, NG5 1PB, United Kingdom|Churchill Hospital; Oxford Cancer and Haematology Centre, Oxford, OX3 7LJ, United Kingdom|Southampton General Hospital; Medical Oncology, Southampton, SO16 6YD, United Kingdom|Singleton Hospital; Oncology, Swansea, SA2 8QA, United Kingdom","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT02523313,Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED,https://clinicaltrials.gov/study/NCT02523313,NO,Malignant Melanoma,DRUG: Nivolumab + Placebo|DRUG: Nivolumab + Ipilimumab|DRUG: Double Placebo Control,ALL,"ADULT, OLDER_ADULT",PHASE2,"CharitÃ© Berlin, Berlin, 10117, Germany|Elbe Klinikum Buxtehude, Buxtehude, 21614, Germany|UniversitÃ¤tsklinikum Dresden, Dresden, 01307, Germany|HELIOS Klinikum Erfurt, Erfurt, 99089, Germany|Studienzentrum Hautklinik UniversitÃ¤tsklinikum Essen (AÃ¶R) Klinik fÃ¼r Dermatologie, Essen, 45147, Germany|SRH Wald-Klinikum Gera GmbH, Gera, 07548, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|UniversitÃ¤trsklinikum Heidelberg Dermatologie / NCT, Heidelberg, 69120, Germany|SLK Kliniken Heilbronn GmbH, Heilbronn, 74078, Germany|UniversitÃ¤ts-Hautklinik Kiel Klinik f. Dermatologie, Venerologie u. Allergologie, Kiel, 24105, Germany|UniversitÃ¤tsklinikum Leipzig Klinik u. Poliklinik f. Dermatologie, Venerologie u. Allergologie, Leipzig, 04103, Germany|Klinikum der Stadt Ludwigshafen, Ludwigshafen, 67063, Germany|UKSH Campus LÃ¼beck, LÃ¼beck, 23538, Germany|UniversitÃ¤tsklinikum Mainz Hautklinik und Polklinik, Mainz, 55131, Germany|Klinik fÃ¼r Dermatologie, Venerologie und Allergologie UMM - UniversitÃ¤tsmedizin Mannheim, Mannheim, 68167, Germany|Johannes Wesling Klinikum Minden Hautklinik, Minden, 32429, Germany|UniversitÃ¤tsklinikum MÃ¼nchen (LMU), MÃ¼nchen, 80337, Germany|Fachklinik Hornheide, MÃ¼nster, 48157, Germany|UniversitÃ¤tsklinikum Regensburg, Regensburg, 93053, Germany|UniversitÃ¤tshautklinik TÃ¼bingen, TÃ¼bingen, 72076, Germany","Principal Investigator : Dirk Schadendorf, Prof. Dr. , Studienzentrum Hautklinik UniversitÃ¤tsklinikum Essen Klinik f. Dermatologie"
Melanoma,NCT00483301,"A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma",https://clinicaltrials.gov/study/NCT00483301,NO,Malignant Melanoma,DRUG: Sorafenib (BAY 43-9006)|DRUG: ABI-007(Abraxane),ALL,"ADULT, OLDER_ADULT",PHASE2,"Dr. Steven O'Day, Los Angeles, California, 90025, United States|Mt. Sinai Medical Center, Miami Beach, Florida, 33140, United States",
Melanoma,NCT01656642,A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01656642,NO,Malignant Melanoma,DRUG: Atezolizumab|DRUG: Cobimetinib|DRUG: Vemurafenib,ALL,"ADULT, OLDER_ADULT",PHASE1,"UCLA, Los Angeles, California, 90024, United States|The Angeles Clinic and Research Institute - W LA Office, Los Angeles, California, 90025, United States|University of Colorado Health Science Center; Biomedical Research Bldg. Room 511, Aurora, Colorado, 80045, United States|Florida Cancer Specialists - Sarasota, Sarasota, Florida, 34232, United States|Massachusetts General Hospital., Boston, Massachusetts, 02114, United States|Dana Farber Can Ins, Boston, Massachusetts, 02215, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States","Study Director : Clinical Trials , Genentech, Inc."
Melanoma,NCT01704287,Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002),https://clinicaltrials.gov/study/NCT01704287,YES,Malignant Melanoma,BIOLOGICAL: Pembrolizumab|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Dacarbazine|DRUG: Temozolomide,ALL,"ADULT, OLDER_ADULT",PHASE2,,"Study Director : Medical Director , Merck Sharp & Dohme LLC"
Melanoma,NCT01248936,A Study of RO5185426 in Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01248936,YES,Malignant Melanoma,DRUG: RO5185426,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Tucson, Arizona, 85724-5078, United States|Los Angeles, California, 90095, United States|San Francisco, California, 94115, United States|San Francisco, California, 94117, United States|Santa Monica, California, 90025, United States|Aurora, Colorado, 80045, United States|New Haven, Connecticut, 06520-8063, United States|Palm Harbor, Florida, 34684, United States|Tampa, Florida, 33612-9497, United States|Atlanta, Georgia, 30322, United States|Park Ridge, Illinois, 60068, United States|Boston, Massachusetts, 02114, United States|Boston, Massachusetts, 02215, United States|Detroit, Michigan, 48201, United States|St. Louis, Missouri, 63110, United States|New York, New York, 10016, United States|New York, New York, 10029, United States|New York, New York, 10032, United States|New York, New York, 10065, United States|Cincinnati, Ohio, 45242, United States|Oklahoma City, Oklahoma, 73104, United States|Portland, Oregon, 97225, United States|Philadelphia, Pennsylvania, 19104, United States|Columbia, South Carolina, 29210, United States|Nashville, Tennessee, 37203, United States|Dallas, Texas, 75246, United States|Richmond, Virginia, 23230, United States|Seattle, Washington, 98195, United States","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT02186249,Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma,https://clinicaltrials.gov/study/NCT02186249,NO,Malignant Melanoma,DRUG: Nivolumab|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",,"Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Mayo Clinic Arizona, Phoenix, Arizona, 85054, United States|6501 Truxtun Avenue, Bakersfield, California, 93309, United States|UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States|100 UCLA Medical Plaza, Los Angeles, California, 90095, United States|514 North Prospect Ave, Redondo Beach, California, 90277, United States|California Pacific Medical Center Research Institute, San Francisco, California, 94115, United States|University of California San Francisco, San Francisco, California, 94115, United States|Angeles Clinic and Research Institute, Santa Monica, California, 90404, United States|1325 East Church Street, Santa Monica, California, 93454, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|Rocky Mountain Cancer Centers, Littleton, Colorado, 80120, United States|Smilow Cancer Hospital at Yale University Cancer Center, New Haven, Connecticut, 06519, United States|Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, 20007, United States|Memorial Regional Hospital, Hollywood, Florida, 33021, United States|4500 San Pablo Road South, Jacksonville, Florida, 32224, United States|Cancer Specialists of North Florida, Jacksonville, Florida, 32256, United States|UF Health Cancer Center at Orlando Health, Longwood, Florida, 32750, United States|Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Winship Cancer Institute, Atlanta, Georgia, 30322, United States|600 Celebrate Life Parkway, Newnan, Georgia, 30265, United States|Evanston Premier Healthcare Research LLC, Evanston, Illinois, 60201, United States|Oncology Specialists, SC, Niles, Illinois, 60714, United States|Local Institution, Louisville, Kentucky, 40202, United States|Medstar Health Research Institute, Baltimore, Maryland, 21204, United States|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21231, United States|Center For Cancer and Blood Disorders, Bethesda, Maryland, 20817, United States|Massachusetts General Hospital, Boston, Massachusetts, 02214, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan, 49503, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|Atlantic Health System, Morristown, New Jersey, 07960-1089, United States|NYU Langone Medical Center, New York, New York, 10016, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10017, United States|Carolinas Healthcare System, Charlotte, North Carolina, 28204, United States|Tulsa Cancer Institute PLLC, Tulsa, Oklahoma, 74146, United States|Northwest Cancer Specialists PC, Portland, Oregon, 97213, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, 18103, United States|St Luke's Hospital, Bethlehem, Pennsylvania, 18015, United States|Greenville Health System, Easley, South Carolina, 29640, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States|Texas Oncology, Austin, Texas, 78731, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Texas Oncology, Midland, Texas, 79701, United States|Texas Oncology, Paris, Texas, 75460, United States|Virginia Cancer Institute, Richmond, Virginia, 23230, United States|Oncology and Hematology Associates of Southwest Virginia, Inc, Roanoke, Virginia, 24014, United States|Shenandoah Oncology Association, Winchester, Virginia, 22601, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada|Grand River Hospital, Kitchener, Ontario, N2G 1G3, Canada|London Health Sciences Centre, London, Ontario, N6A 4L6, Canada|Lakeridge Health Oshawa, Oshawa, Ontario, L1G 2B9, Canada|Sunnybrook Health Science Centre, Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada|Chuq Centre Hospitalier Universitaire de Quebec, Quebec, G1R 2J6, Canada","Study Director : Bristol-Myers Squibb , Bristol-Myers Squibb"
Melanoma,NCT00370136,Sentinel Node With Ultrasound Contrast in Melanoma,https://clinicaltrials.gov/study/NCT00370136,NO,Malignant Melanoma,DRUG: ultrasound contrast,ALL,"ADULT, OLDER_ADULT",,"Copenhagen univercity hospital, Department of Radiology, section of ultrasound, Copenhagen, 2100, Denmark","Principal Investigator : Michael B Nielsen, MDSc , Department of Radiology, section ultrasound"
Melanoma,NCT01522664,A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma,https://clinicaltrials.gov/study/NCT01522664,NO,Malignant Melanoma,DRUG: DEDN6526A,ALL,"ADULT, OLDER_ADULT",PHASE1,"Los Angeles, California, 90025, United States|Sarasota, Florida, 34232, United States|Detroit, Michigan, 48201, United States|Nashville, Tennessee, 37203, United States|Camperdown, New South Wales, 2050, Australia|East Melbourne, Victoria, 3002, Australia","Study Director : Clinical Trials , Genentech, Inc."
Melanoma,NCT01511913,"A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma",https://clinicaltrials.gov/study/NCT01511913,NO,Advanced Cutaneous Melanoma,,ALL,"ADULT, OLDER_ADULT",,"Local Institution, Gilbert, Arizona, 85234, United States|Local Institution, Hot Springs, Arkansas, 71913, United States|Local Institution, Encinitas, California, 92024, United States|Local Institution, La Jolla, California, 92093, United States|Local Institution, Long Beach, California, 90813, United States|Local Institution, Los Angeles, California, 90025, United States|Local Institution, Denver, Colorado, 80218, United States|Local Institution, Washington, District of Columbia, 20010, United States|Local Institution, Lakeland, Florida, 33085, United States|Local Institution, Miami Beach, Florida, 33140, United States|Local Institution, Orange Park, Florida, 32073, United States|Local Institution, Chicago, Illinois, 60612, United States|Local Institution, Niles, Illinois, 60714, United States|Local Institution, Detroit, Michigan, 48201, United States|Local Institution, Hattiesburg, Mississippi, 39401, United States|Local Institution, Lincoln, Nebraska, 18015, United States|Local Institution, Morristown, New Jersey, 07960, United States|Local Institution, Canton, Ohio, 44178, United States|Mid Ohio Onc/Hem, Inc, Columbus, Ohio, 43206, United States|Local Institution, Columbus, Ohio, 43219, United States|Local Institution, Middletown, Ohio, 45042, United States|Local Institution, Portland, Oregon, 97213, United States|Local Institution, Knoxville, Tennessee, 37920, United States|Local Institution, Everett, Washington, 98201, United States|Local Institution, Caba, 1426, Argentina|Local Institution, Caba, C1417DNT, Argentina|Local Institution, Caba, C1426ANZ, Argentina|Local Institution, Cordoba, X5006HBF, Argentina|Local Institution, Rosario- Santa Fe, S2000KZE, Argentina|Local Institution, Tucuman, T4000GTB, Argentina|Local Institution, Canberra, Australian Capital Territory, 02605, Australia|Local Institution, Corrimal, New South Wales, 02518, Australia|Local Institution, Lismore, New South Wales, 02480, Australia|Local Institution, Port Macquarie, New South Wales, 02444, Australia|Local Institution, Tamworth, New South Wales, 02340, Australia|Local Institution, Tweeds Head, New South Wales, 02485, Australia|Local Institution, Wagga Wagga, New South Wales, 2650, Australia|Local Institution, Waratah, New South Wales, 02298, Australia|Local Institution, Cairns, Queensland, 4870, Australia|Local Institution, Douglas, Queensland, 04810, Australia|Local Institution, Greenslopes, Queensland, 4120, Australia|Local Institution, Adelaide, South Australia, 05000, Australia|Local Institution, Bedford Park, South Australia, 05042, Australia|Local Institution, Kurralta Park, South Australia, 5037, Australia|Local Institution, Frankston, Victoria, 03199, Australia|Local Institution, Malvern, Victoria, 03144, Australia|Local Institution, Feldkirch, 6800, Austria|Local Institution, Graz, A-8036, Austria|Local Institution, Linz, A-4020, Austria|Local Institution, Salzburg, A-5020, Austria|Local Institution, St Poelten, A-3100, Austria|Local Institution, Vienna, A-1090, Austria|Local Institution, Brasschaat, 2930, Belgium|Local Institution, Brussels, 1200, Belgium|Local Institution, Edegem, 2650, Belgium|Local Institution, Haint Saint Paul, 7100, Belgium|Local Institution, Hasselt, 3500, Belgium|Local Institution, Kortrijk, 8500, Belgium|Local Institution, Leuven, 3000, Belgium|Local Institution, Moncton, New Brunswick, E1C 6Z8, Canada|Local Institution, London, Ontario, N6C 6B5, Canada|Local Institution, Mississauga, Ontario, L5M 2N1, Canada|Local Institution, Windsor, Ontario, N8W 2X3, Canada|Local Institution, Saskatoon, Saskatchewan, S7N 4H4, Canada|Local Institution, Quebec, G1V 4G2, Canada|Local Institution, QuÃ©bec, G1R 2J6, Canada|Local Institution, Bayonne, 64100, France|Local Institution, Besancon, 25000, France|Local Institution, Boulogne sur Mer, 62200, France|Local Institution, Boulogne, 92104, France|Local Institution, Brest Cedex, 29609, France|Local Institution, Clermont Ferrand CÃ©dex 1, 63003, France|Local Institution, Dijon, 21079, France|Local Institution, Grenoble CÃ©dex, 38043, France|Local Institution, Lille Cedex, 59037, France|Local Institution, Limoges Cedex, 87042, France|Local Institution, Montauban, 82000, France|Local Institution, Mougins, 06250, France|Local Institution, Nouvelle Caledonie, 98849, France|Local Institution, Paris Cedex 10, 75475, France|Local Institution, Pierre BÃ©nite, 69495, France|Local Institution, Quimper Cedex, 29107, France|Local Institution, Quimper, 29107, France|Local Institution, Soissons cedex, 02209, France|Local Institution, Strasbourg Cedex, 67065, France|Local Institution, Vandoeuvre Les Nancy, 54500, France|Local Institution, Augsburg, 86156, Germany|Local Institution, Bochum, 44791, Germany|Local Institution, Buxtehude, 21614, Germany|Local Institution, Chemnitz, 09117, Germany|Local Institution, Darmstadt, 64297, Germany|Local Institution, Dessau-Roblau, 06847, Germany|Local Institution, Dortmund, 44137, Germany|Local Institution, Dresden, 01307, Germany|Local Institution, DÃ¼sseldorf, 40225, Germany|Local Institution, Frankfurt, 60590, Germany|Local Institution, Gera, 07548, Germany|Local Institution, Halle/Saale, 06120, Germany|Local Institution, Hamburg, 20099, Germany|Local Institution, Hamburg, 20246, Germany|Local Institution, Hamburg, 20253, Germany|Local Institution, Hannover, 30625, Germany|Local Institution, Jena, 07743, Germany|Local Institution, Koblenz, 56068, Germany|Local Institution, LÃ¼denscheid, 58515, Germany|Local Institution, Magdeburg, 39120, Germany|Local Institution, Mainz, 55131, Germany|Local Institution, Mannheim, 68167, Germany|Local Institution, Marburg, 35043, Germany|Local Institution, MÃ¼nster, 48149, Germany|Local Institution, Plauen, 08529, Germany|Local Institution, Quedlinburg, 06484, Germany|Local Institution, Recklinghausen, 45657, Germany|Local Institution, Rostock, 18055, Germany|Local Institution, SchwÃ¤bisch Hall, 74523, Germany|Local Institution, Stuttgart, 70374, Germany|Local Institution, TÃ¼bingen, 72076, Germany|Local Institution, WÃ¼rzburg, 97080, Germany|Local Institution, Cholargos, Athens, 15562, Greece|Local institution, Goudi, Athens, 11527, Greece|Local Institution, Neo Faliro, Athens, 18547, Greece|Local Institution, Heraklion, Crete, 71100, Greece|Local Institution, Neas Efkarpia, Thessaloniki, 56429, Greece|Local Institutio, Alexandroupolis, 68100, Greece|Local Institution, Athens, 11528, Greece|Local Institution, Athens, 15233, Greece|Local Institution, Mezourlo, 41334, Greece|Local Institution, Neo Faliro, 18547, Greece|Local Institution, Wilton, Cork, T12 DC4A, Ireland|Local Institution, Cork, Ireland|Local Institution, Dublin, Ireland|Local Institution, Galway, Ireland|Local Institution, Tullamore, Ireland|Local Institution, Haifa, 31096, Israel|Local Institution, Tel Aviv, 64239, Israel|Local Institution, Tel Hashomer, 52621, Israel|Local Institution, Bydgoszcz, 85-796, Poland|Local Institution, Warszawa, 02-781, Poland|Local Institution, WrocÅ‚aw, 51-124, Poland|Local Institution, ÅÃ³dÅº, 93-510, Poland|Local Institution, Barcelona, 08036, Spain|Local Institution, Donostia, 20014, Spain|Local Institution, Las Palmas de Gran Canaria, 35016, Spain|Local Institution, Madrid, 28007, Spain|Local Institution, Madrid, 28033, Spain|Local Institution, Madrid, 28034, Spain|Local Institution, Madrid, 28041, Spain|Local Institution, Palma de Mallorca, 07198, Spain|Local Institution, Palma, 07198, Spain|Local Institution, Pamplona, 31008, Spain|Local Institution, Santa Cruz de Tenerife, 38010, Spain|Local Institution, Santander, 39008, Spain|Local Institution, Santiago De Compostela; A CoruÃ±a, 15706, Spain|Local Institution, Sevilla, 41013, Spain|Local Institution, Sta Cruz de Tenerife, 35320, Spain|Local Institution, Terrassa, 08027, Spain|Local Institution, Valladolid, 47012, Spain|Local Institution, Zaragoza, 50009, Spain|Local Institution, Baden, CH-5404, Switzerland|Local Institution, Lugano, CH-6900, Switzerland|Local Institution, Zurich, 8091, Switzerland|Local Institution, ZÃ¼rich, CH-8091, Switzerland|Local Institution, Rhyl, Denbigshire, LL18 5UJ, United Kingdom|Local Institution, London, England, NW3 2QG, United Kingdom|Local Institution, Chelmsford, Essex, Essex, CM1 7ET, United Kingdom|Local Institution, Southend, Essex, SS0 0RY, United Kingdom|Local Institution, Belfast, Ireland, BT9 7AB, United Kingdom|Local Institution, Cardiff, South Glamorgan, CF14 2TL, United Kingdom|Local Institution, Birmingham, B15 2TH, United Kingdom|Local Institution, Bristol, BS2 8ED, United Kingdom|Local Institution, Exeter, EX2 5DW, United Kingdom|Local Institution, Hull, HU16 5JQ, United Kingdom|Local Institution, Leeds, LS9 7TF, United Kingdom|Local Institution, Lincoln, LN2 5QY, United Kingdom|Local Institution, London, SE1 9RT, United Kingdom|Local Institution, London, SW3 6JJ, United Kingdom|Local Institution, London, United Kingdom|Local Institution, Oxfordshire, OX3 7LE, United Kingdom|Local Institution, Plymouth, PL6 8DH, United Kingdom|Local Institution, Poole, BH15 2JB, United Kingdom|Local Institution, Preston, PR2 9HT, United Kingdom|Local Institution, Staffordshire, ST46QG, United Kingdom|Local Institution, Taunton, Somerset, TA1 5DA, United Kingdom|Local Institution, Truro, Cornwall, TR1 3LJ, United Kingdom|Local Institution, Wirral, CH63 4JY, United Kingdom|Local Institution, Wolverhampton, WS13 6NH, United Kingdom|Local Institution, Yeovil, Somerset, BA21 4AT, United Kingdom","Study Director : Bristol-Myers Squibb , Bristol-Myers Squibb"
Melanoma,NCT01990248,An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS),https://clinicaltrials.gov/study/NCT01990248,NO,Malignant Melanoma,,ALL,"ADULT, OLDER_ADULT",,"LKH Feldkirch; Onkologie, Feldkirch, 6800, Austria|Ordensklinikum Linz Elisabethinen ; Dermatologie, Linz, 4020, Austria|Krankenhaus Hietzing Wien, Wien, 1130, Austria|ZNA Middelheim, Antwerpen, 2020, Belgium|CHIREC Edith Cavell, Bruxelles, 1180, Belgium|Cliniques Universitaires St-Luc, Bruxelles, 1200, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|FN Ostrava; Dermatology dep, Ostrava, 708 52, Czechia|University Hospital Prague, Praha, 150 06, Czechia|Komplexni onkologicke centrum Krajske nemocnice T. Bati, a.s. Zlin, Zlin, 760 01, Czechia|Klinikum Augsburg; Hauttumorzentrum, Augsburg, 86179, Germany|Charite- universitatsmedizin Berlin; Med. Klinik mit Schwerpunkt Hamatologie und Onkologie, Berlin, 12200, Germany|Ruhr-UniversitÃ¤t Bochum; Klinik fÃ¼r Dermatologie und Allergologie, Bochum, 44791, Germany|Universitatsklinikum Bonn; Klinisches Studienzentrum Klinik fur Dermatologie, Bonn, 53105, Germany|Medizinisches Zentrum, Bonn, 53111, Germany|Dermatologisches Zentrum am Elbe Klinikum Buxtehude, Buxtehude, 21614, Germany|DRK Krankenhaus Chemnitz-Rabenstein; Hautkrebszentrum Chemnitz, Chemnitz, 09117, Germany|UniversitÃ¤tsklinikum ""Carl Gustav Carus""; Klinik und Poliklinik fur Dermatologie, Dresden, 01307, Germany|UniversitÃ¤tsklinikum DÃ¼sseldorf; Hautklinik, DÃ¼sseldorf, 40225, Germany|Dermatologie und Allergologie HELIOS Hauttumorzentrum Erfurt, Erfurt, 99089, Germany|Universitatsklinikum Essen; Klinik fÃ¼r Dermatologie, Essen, 45147, Germany|SRH Wald-Klinikum Gera; Zentrum fur klinische Studien (ZKS), Gera, 07548, Germany|UniversitÃ¤tsmedizin Greifswald; Klinik und Poliklinik fÃ¼r Hautkrankheiten, Greifswald, 17487, Germany|Universitaetsmedizin Goettingen; Abteilung Dermato-Onkologie, GÃ¶ttingen, 37075, Germany|Univ.- Hautklinik Heidelberg, Heidelberg, 69115, Germany|Friedrich-Schiller-Universitaet Jena; Klinik fuer Dermatologie und dermatologische Allergologie, Jena, 07743, Germany|Klinikum Kassel GmbH; Hauttumorzentrum HTZ, Kassel, 34125, Germany|Studienzentrum UnterEms; Onkologische Schwerpunktpraxis Leer; Dr. med. Lothar MÃ¼ller, Leer, 26789, Germany|Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Hauttumorzentrum Rheinpfalz, Ludwigshafen, 67063, Germany|UKSH Universitatsklinikum Schleswig-Holstein; Studienzentrum Dermatologie 10d, LÃ¼beck, 23538, Germany|Klinik und Poliklinik fur Dermatologie; Universitatsklinikum Mainz, Mainz, 55131, Germany|Med. Fakultat Mannheim der Universitat Heidelberg; Klinik fur Dermatologie, Mannheim, 68167, Germany|Johannes Wesling Klinikum Minden;Haut Tumor Centrum Minden, Minden, 32429, Germany|UniversitÃ¤tsklinikum MÃ¼nster; Klinik fÃ¼r Hautkrankheiten; Allgemeine Dermatologie und Venerologie, Muenster, 48149, Germany|Fachklinik Hornheide; Abteilung fÃ¼r Dermatologie, Muenster, 48157, Germany|Klinikum NÃ¼rnberg Nord; Hautklinik; Klinik fÃ¼r Dermatologie, NÃ¼rnberg, 90419, Germany|Harzklinikum Dorothea Christiane Erxleben GmbH, Standort Quedlinburg; Hautkrebszentrum Harz, Quedlinburg, 06484, Germany|Klinikum Vest; Behandlungszentrum Kanppschaftskrankenhaus Recklinghausen, Recklinghausen, 45657, Germany|UniversitÃ¤tsmedizin Rostock; Klinik und Poliklinik fÃ¼r Dermatologie und Venerologie, Rostock, 18057, Germany|Eberhard-Karls-Universitat Tubingen; Sektion Dermatologische Onkologie, Tuebingen, 72076, Germany|UniversitÃ¤tsklinikum WÃ¼rzburg; Klinik und Poliklinik fÃ¼r Dermatologie Venerologie u. Allergologie, WÃ¼rzburg, 97080, Germany|Galway University Hospital; Clinical Trials Department, Galway, Ireland|Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Campania, 80131, Italy|Policlinico S. Orsola Malpighi;Dip. Ematologia, Oncologia e Medicina di Laboratorio, Bologna, Emilia-Romagna, 40138, Italy|Ausl Ravenna-Osp.Infermi; Day Hospital Oncologia Medica, Faenza, Emilia-Romagna, 48018, Italy|Universita di Modena e Reggio Emilia;Dipartimento di Oncologia ed Ematologia, Modena, Emilia-Romagna, 41100, Italy|Ospedale ""Guglielmo da Saliceto"";U.O. Medicina Oncologica, Piacenza, Emilia-Romagna, 29121, Italy|Azienda ASL di Rimini (Presidi di Rimini - Cattolica)) - Ospedale degli Infermi;U.O. Oncologia, Rimini, Emilia-Romagna, 47922, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, 20133, Italy|Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia, Milano, Lombardia, 20162, Italy|Fondazione IRCCS Policlinico San Matteo, Oncologia, Pavia, Lombardia, 27100, Italy|A.O.V.V. - P.O. di Sondrio; S.O.C. Oncologia Medica, Sondrio, Lombardia, 23100, Italy|A.U Careggi di Firenze;Oncologia, Firenze, Toscana, 50134, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana, 56100, Italy|Azienda Ospedaliera Universitaria Senese, U.O.C. Immunoterapia Oncologica, Siena, Toscana, 53100, Italy|Amphia Ziekenhuis, locatie Langendijk;Oncology, Breda, 4819 EV, Netherlands|Academ Ziekenhuis Groningen; Medical Oncology, Groningen, 9713 GZ, Netherlands|Atrium MC, Parkstad Heerlen; Poli Interne, Heerlen, 6419 PC, Netherlands|Maastricht University Medical Center,Division of Medical Oncology; Dept. Internal Medicine, Maastricht, 6229 HX, Netherlands|Centrum Onkologii w Bydgoszczy; Oddzial Kliniczny Onkologii, Bydgoszcz, 85-796, Poland|Szpital Uniwersytecki w Krakowie, OddziaÅ‚ Kliniczny Kliniki Onkologii, Krakow, 31-531, Poland|RegioNAlny Osrodek Onkologiczny PododdziaÅ‚ Diagnostyki i Terapii Onkologicznej, Lodz, 93-513, Poland|Regionalny Osrodek Onkologiczny; Oddzial Chorob Rozrostowych, Lodz, 93-513, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej; Opolskie Centrum Onkologii, Opole, 45-060, Poland|Centrum Onkologii - Instytut, Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, Warszawa, 02-781, Poland|Blekingesjukhuset; Kirurgkliniken, Karlskrona, 371 85, Sweden|Karolinska University Hospital;Department of Oncology-Pathology, Stockholm, 17176, Sweden|Royal Sussex County Hospital, Brighton, BN2 5BE, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, BS2 8ED, United Kingdom|Addenbrookes Hospital; Dept of Oncology, Cambridge, CB2 2QQ, United Kingdom|Velindre Cancer Centre, Cardiff, CF14 2TL, United Kingdom|Cheltenham General Hospital; Gloucestershire Oncology Centre, Cheltenham, GL53 7AN, United Kingdom|Dorset County Hospital NHS Foundation Trust;Research and Development/ Oncology, Dorchester, DT1 2JY, United Kingdom|St James University Hospital, Leeds, LS9 7TF, United Kingdom|Guys and St Thomas NHS Foundation Trust, Guys Hospital, London, SE1 9RT, United Kingdom|St George's Hospital; Oncology, London, SW17 0QT, United Kingdom|Imperial College Healthcare NHS Trust;Medical Oncology, London, W6 8RF, United Kingdom|St Helens & Knowsley Trust, St Helens, WA9 3DA, United Kingdom|The Clatterbridge Cancer Ctr For Oncolgy, Wirral, CH63 4JY, United Kingdom|New Cross Hospital; Deansley Centre, Wolverhampton, WV10 0QP, United Kingdom","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01898585,An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01898585,NO,Malignant Melanoma,DRUG: Zelboraf,ALL,"ADULT, OLDER_ADULT",PHASE4,"National Hospital; Oncotherapy Dept, Bloemfontein, 9301, South Africa|Groote Schuur Hospital ( Uni of Capetown ); Oncology Dept, Cape Town, 7506, South Africa|Cape Town Oncology Trials, Cape Town, 7570, South Africa|Cancercare, Cape Town, 7700, South Africa|Cancercare, George, 6529, South Africa|Mary Potter Oncology Centre, Groenkloof, 0181, South Africa|Medical Oncology Centre of Rosebank; Oncology, Johannesburg, 2196, South Africa|University of Pretoria; Department of Medical Oncology, Pretoria, 0002, South Africa|Sandton Oncology Medical Group, Sandton, 2196, South Africa","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01910181,A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01910181,YES,Malignant Melanoma,DRUG: Vemurafenib,ALL,"ADULT, OLDER_ADULT",PHASE1,"Beijing Cancer Hospital, Beijing, 100142, China|Sun Yet-sen University Cancer Center, Guangzhou, 510060, China","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01744860,Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples,https://clinicaltrials.gov/study/NCT01744860,YES,Malignant Melanoma,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Boulogne Billancourt, 92104, France|Colmar, 68024, France|Lille, 59037, France|Lyon, 69437, France|Marseille, 13015, France|Montpellier, 34295, France|Nantes, 44093, France|Paris, 75010, France|Pessac, 33604, France|Rouen, 76031, France|Vandoeuvre Les Nancy, 54511, France|Villejuif, 94505, France","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT00145145,Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00145145,YES,Malignant Melanoma,BIOLOGICAL: MAGE-3.A1 peptide and CpG 7909,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Cliniques Universitaires Saint-Luc (UCL), Brussels, B-1200, Belgium|Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium","Study Chair : Nicolas van Baren, MD , Ludwig Institute for Cancer Research Study Director : Thierry Boon, PhD , Ludwig Institute for Cancer Research"
Melanoma,NCT01164007,A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01164007,YES,Malignant Melanoma,DRUG: Bevacizumab|DRUG: Dacarbazine,ALL,"ADULT, OLDER_ADULT",PHASE2,"Istituto Europeo Di Oncologia, Milano, Lombardia, 20141, Italy","Study Chair : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT00949702,A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT00949702,YES,Malignant Melanoma,DRUG: vemurafenib,ALL,"ADULT, OLDER_ADULT",PHASE2,"UCLA - School of Medicine; Division of Hematology/Oncology, Los Angeles, California, 90095-6984, United States|University of Colorado, Denver, Colorado, 80262, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Massachusetts General Hospital;Hematology/ Oncology, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Inst. ; Dept. of Medical Oncology, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|New York University Medical Center, New York, New York, 10036, United States|Hospital of the Uni of Pennsylvania; Section of Hematology/Oncology, Philadelphia, Pennsylvania, 19104-4283, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|Vanderbilt-Ingram Cancer Ctr, Nashville, Tennessee, 37232, United States|Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas, 75246, United States|University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|Calvary Mater Newcastle; Melanoma Clinic, Newcastle, New South Wales, 2298, Australia|Westmead Hospital; Medical Oncology and Pallative Care, Westmead, New South Wales, 2145, Australia|Peter Maccallum Cancer Institute; Medical Oncology, Melbourne, Victoria, 3000, Australia","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT00052156,Vaccine Therapy for Patients With Stage IV Melanoma,https://clinicaltrials.gov/study/NCT00052156,NO,Malignant Melanoma,BIOLOGICAL: CancerVax vaccine (CANVAXIN),ALL,"ADULT, OLDER_ADULT",PHASE3,"Arizona Cancer Center, Tucson, Arizona, 85724, United States|Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, 72205, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|Kaiser Permanente Medical Group, Anaheim, California, United States|Cedars Sinai Comprehensive Cancer Center, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, 92658, United States|Comprehensive Cancer Center at DRMC, Palm Springs, California, 92262, United States|Kaiser Permanente Medical Group, Riverside, California, United States|Kaiser Permanente Medical Group, San Diego, California, 92120, United States|Sharp Hospital, San Diego, California, 92123, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, 94143-0128, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Lakeland Regional Cancer Center, Lakeland, Florida, 33805, United States|Mt. Sinai Comprehensive Cancer Center, Miami, Florida, United States|University of Miami, Miami, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612-9497, United States|The Cancer Institute at Good Samaritan Medical Center, West Palm Beach, Florida, 33401, United States|Loyola University Medical Center, Maywood, Illinois, United States|OSF Saint Francis Medica Center, Peoria, Illinois, 61637, United States|Wagner and Associates, Indianapolis, Indiana, 46256, United States|James Graham Brown Cancer Center, Louisville, Kentucky, 40202, United States|St. Agnes Healthcare, Baltimore, Maryland, 21229, United States|Franklin Square Hospital Center, Baltimore, Maryland, 21237, United States|Sidney Kimmel Comprehensive Cancer Center, Lutherville, Maryland, United States|Boston Medical Center, Boston, Massachusetts, 02118-2393, United States|Spectrum Health - Butterworth Campus, Grand Rapids, Michigan, 49546, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, 65203, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, 63110-0250, United States|The Cancer Cener at Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Medical Center of Princeton, Princeton, New Jersey, 08540, United States|Millard Fillmore Hospital, Buffalo, New York, 14209, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263-0001, United States|Columbia Presbyterian Medical Center, New York, New York, 10032, United States|Suny Health Science Center at Syracuse, Syracuse, New York, 13210, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, 27599-7295, United States|Wake Forest University, Winston Salem, North Carolina, United States|Christ Hospital, Cincinnati, Ohio, 45219, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, 43210-1240, United States|Dayton Clinical Oncology Group, Dayton, Ohio, 45409, United States|St. Lukes Hospital Cancer Center, Bethlehem, Pennsylvania, 18015, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, 19104-4283, United States|Lankenau Hospital, Wynnewood, Pennsylvania, 19096, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232-6838, United States|UT Southwest Medical Center- Dallas, Dallas, Texas, 75235-9154, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, 77030-4009, United States|Intermountain Health Care- Mckay-Dee Hospital, Ogden, Utah, 84403, United States|Intermountain Health Care-LDS Hospital, Salt Lake City, Utah, 84143, United States|University of Washington, Seattle, Washington, 98109, United States|Northwest Medical Specialties, Tacoma, Washington, 98405, United States|Royal Prince Alfred Hospital, Sydney, Sydney, New South Wales, 2050, Australia|NSW Breast Cancer Institute, Westmead, New South Wales, 2145, Australia|Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Peter MacCallum Cancer Center, Melbourne, Victoria, 3002, Australia|The Alfred Hospital, Melbourne, Victoria, 3181, Australia|INCA (National Cancer Institute), Rio de Janeiro, 20230, Brazil|Hospital Sirio Lebanes, Sao Paulo, 01308-050, Brazil|McGill University, Montreal, Quebec, Canada|CHU Pitie-Salpetriere, Paris, 75651, France|Klinikum Augsburg, Augsburg, Germany|Charite- University Medicine, Berlin, Germany|University of Jena, Jena, 07740, Germany|University Hospial of Mannheim, Mannheim, Germany|University of Tuebingen, Tuebingen, Germany|University of Ulm, Ulm, Germany|University Hospital Wuerzburg, Wuerzburg, Germany|Cork University, Cork, Ireland|Tel-Aviv Medical Center, Tel Aviv, 62995, Israel|Istituto Nazionale Tumori di Milano, Milan, 20133, Italy|Instituto Eurepeo di Oncologia, Milan, 20141, Italy|Istituto Nazionale dei Tumori, Naples, 80132, Italy|University Hospital of Groningen, Groningen, Netherlands|North Shore Hospital, Auckland, 92024, New Zealand|University of Zurich, Zurich, Switzerland|Harley Street Clinic, London, England, SW17 ORE, United Kingdom",CancerVax Corporation
Melanoma,NCT00052130,Vaccine Therapy for Patients With Stage III Melanoma,https://clinicaltrials.gov/study/NCT00052130,NO,Malignant Melanoma,BIOLOGICAL: CancerVax vaccine (CANVAXIN),ALL,"ADULT, OLDER_ADULT",PHASE3,"Arizona Cancer Center, Tucson, Arizona, 85724, United States|Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, 72205, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|Kaiser Permanente Medical Group, Anaheim, California, United States|Cedars Sinai Comprehensive Cancer Center, Los Angeles, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, 92658, United States|Comprehensive Cancer Center at DRMC, Palm Springs, California, 92262, United States|Kaiser Permanente Medical Group, Riverside, California, United States|Kaiser Permanente Medical Group, San Diego, California, 92120, United States|Sharp Hospital, San Diego, California, 92123, United States|UCSF Cancer Center and Cancer Research Institute, San Francisco, California, 94143-0128, United States|University of Colorado Cancer Center, Aurora, Colorado, United States|Lakeland Regional Cancer Center, Lakeland, Florida, 33805, United States|Mt. Sinai Comprehensive Cancer Center, Miami, Florida, United States|University of Miami, Miami, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612-9497, United States|The Cancer Institute at Good Samaritan Medical Center, West Palm Beach, Florida, 33401, United States|Winship Cancer Institute at Emory University, Atlanta, Georgia, 30322, United States|Loyola University Medical Center, Maywood, Illinois, United States|OSF Saint Francis Medica Center, Peoria, Illinois, 61637, United States|Cancer Care of Southern Indiana, Bloomington, Indiana, 47402, United States|Wagner and Associates, Indianapolis, Indiana, 46256, United States|James Graham Brown Cancer Center, Louisville, Kentucky, 40202, United States|St. Agnes Healthcare, Baltimore, Maryland, 21229, United States|Franklin Square Hospital Center, Baltimore, Maryland, 21237, United States|Sidney Kimmel Comprehensive Cancer Center, Lutherville, Maryland, United States|Boston Medical Center, Boston, Massachusetts, 02118-2393, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Spectrum Health - Butterworth Campus, Grand Rapids, Michigan, 49546, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, 65203, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, 63110-0250, United States|The Cancer Cener at Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Medical Center of Princeton, Princeton, New Jersey, 08540, United States|Millard Fillmore Hospital, Buffalo, New York, 14209, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263-0001, United States|Columbia Presbyterian Medical Center, New York, New York, 10032, United States|Suny Health Science Center at Syracuse, Syracuse, New York, 13210, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, 27599-7295, United States|Christ Hospital, Cincinnati, Ohio, 45219, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, 43210-1240, United States|Dayton Clinical Oncology Group, Dayton, Ohio, 45409, United States|St. Lukes Hospital Cancer Center, Bethlehem, Pennsylvania, 18015, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, 19104-4283, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Lankenau Hospital, Wynnewood, Pennsylvania, 19096, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232-6838, United States|UT Southwest Medical Center- Dallas, Dallas, Texas, 75235-9154, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, 77030-4009, United States|Intermountain Health Care- Mckay-Dee Hospital, Ogden, Utah, 84403, United States|Intermountain Health Care-LDS Hospital, Salt Lake City, Utah, 84143, United States|University of Washington, Seattle, Washington, 98195, United States|Northwest Medical Specialties, Tacoma, Washington, 98405, United States|Royal Prince Alfred Hospital, Sydney, Sydney, New South Wales, 2050, Australia|NSW Breast Cancer Institute, Westmead, New South Wales, 2145, Australia|Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Peter MacCallum Cancer Center, Melbourne, Victoria, 3002, Australia|The Alfred Hospital, Melbourne, Victoria, 3181, Australia|INCA (National Cancer Institute), Rio de Janeiro, 20230, Brazil|Hospital Sirio Lebanes, Sao Paulo, 01308-050, Brazil|McGill University, Montreal, Quebec, Canada|CHU Pitie-Salpetriere, Paris, 75651, France|Klinikum Augsburg, Augsburg, Germany|Charite- University Medicine, Berlin, Germany|University of Jena, Jena, Germany|University Hospial of Mannheim, Mannheim, Germany|University of Tuebingen, Tuebingen, Germany|University of Ulm, Ulm, Germany|University Hospital Wuerzburg, Wuerzburg, Germany|Cork University, Cork, Ireland|Tel-Aviv Medical Center, Tel Aviv, 62995, Israel|Istituto Nazionale Tumori di Milano, Milan, 20133, Italy|Instituto Eurepeo di Oncologia, Milan, 20141, Italy|Istituto Nazionale dei Tumori, Naples, 80132, Italy|University Hospital of Groningen, Groningen, Netherlands|North Shore Hospital, Auckland, 92024, New Zealand|University of Zurich, Zurich, Switzerland|St. Georges Hospital Medical School, London, England, SW17 ORE, United Kingdom",CancerVax Corporation
Melanoma,NCT00039000,Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma,https://clinicaltrials.gov/study/NCT00039000,NO,Malignant Melanoma,DRUG: HSPPC-96 or Oncophage,ALL,"ADULT, OLDER_ADULT",PHASE3,"Birmingham, Alabama, United States|Scottsdale, Arizona, United States|Berkeley, California, United States|Los Angeles, California, United States|Stanford, California, United States|Vista, California, United States|Denver, Colorado, United States|Farmington, Connecticut, United States|Jacksonville, Florida, United States|Lakeland, Florida, United States|Miami Beach, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Park Ridge, Illinois, United States|Kansas City, Kansas, United States|Louisville, Kentucky, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Robbinsdale, Minnesota, United States|Rochester, Minnesota, United States|Columbia, Missouri, United States|St. Louis, Missouri, United States|Lebanon, New Hampshire, United States|New Brunswick, New Jersey, United States|New York City, New York, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Tulsa, Oklahoma, United States|Portland, Oregon, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Knoxville, Tennessee, United States|Dallas, Texas, United States|Houston, Texas, United States|Madison, Wisconsin, United States|Adelaide, Australia|Camperdown, Australia|Melbourne, Australia|Newcastle, Australia|Wentworthville, Australia|Budapest, Hungary|Debrecen, Hungary|Pecs, Hungary|Szeged, Hungary|Aviano, Italy|Genova, Italy|Milan, Italy|Rimini, Italy|Bialystock, Poland|Bydgoszcz, Poland|Krakow, Poland|Arkhangelsk, Russian Federation|Chelyabinsk, Russian Federation|Kazan, Russian Federation|Krasnodar, Russian Federation|Moscow, Russian Federation|Novosibirsk, Russian Federation|Ryazan, Russian Federation|Samara, Russian Federation|St. Petersburg, Russian Federation|Stavropol, Russian Federation|Voronezh, Russian Federation|Gothenburg, Sweden|Lund, Sweden|Vaxjo, Sweden|Dnepropetrovsk, Ukraine|Donetsk, Ukraine|Ivano-Frankovsk, Ukraine|Kiev, Ukraine|Krivoy Rog, Ukraine|Lviv, Ukraine|Odessa, Ukraine|Uzhgorod, Ukraine|Vinnitsa, Ukraine|Leeds, United Kingdom|London, United Kingdom|Manchester, United Kingdom",Agenus Inc.
Melanoma,NCT01069627,A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01069627,YES,Malignant Melanoma,DRUG: bevacizumab [Avastin]|DRUG: fotemustine,ALL,"ADULT, OLDER_ADULT",PHASE2,"Firenze, 50100, Italy|Genova, 16132, Italy|Milano, 20133, Italy|Torino, 10126, Italy","Study Chair : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01164891,A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01164891,YES,Malignant Melanoma,DRUG: RO5185426,ALL,"ADULT, OLDER_ADULT",PHASE1,"ZÃ¼rich, 8091, Switzerland","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01253564,A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases,https://clinicaltrials.gov/study/NCT01253564,YES,Malignant Melanoma,DRUG: RO5185426,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHUV; Departement d'Oncologie, Lausanne, 1011, Switzerland|UniversitÃ¤tsspital ZÃ¼rich; Dermatologische Klinik, ZÃ¼rich, 8091, Switzerland","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01107418,A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01107418,YES,Malignant Melanoma,DRUG: RO5185426|DRUG: RO5185426|DRUG: RO5185426|DRUG: RO5185426|DRUG: RO5185426,ALL,"ADULT, OLDER_ADULT",PHASE1,"La Jolla, California, 92093, United States|San Francisco, California, 94115, United States|Stanford, California, 94305, United States|New Haven, Connecticut, 06510-3289, United States|Chicago, Illinois, 60637, United States|Park Ridge, Illinois, 60068, United States|Sioux City, Iowa, 51101, United States|Omaha, Nebraska, 68114, United States|Columbus, Ohio, 43219, United States|East Providence, Rhode Island, 02915, United States|Charlottesville, Virginia, 22908, United States|Adelaide, South Australia, 5000, Australia|Melbourne, Victoria, 3181, Australia","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01519323,BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations,https://clinicaltrials.gov/study/NCT01519323,YES,Malignant Melanoma,DRUG: vemurafenib,ALL,CHILD,PHASE1,"Los Angeles, California, 90027, United States|Aurora, Colorado, 80045, United States|St. Petersburgh, Florida, 33701, United States|Bethesda, Maryland, 20892, United States|Boston, Massachusetts, 02115, United States|New York, New York, 10065, United States|Memphis, Tennessee, 38105, United States|Houston, Texas, 77030, United States|Westmead, New South Wales, 2145, Australia|Brisbane, Queensland, 4029, Australia|Marseille, 13385, France|Pierre Benite, 69495, France|Kiel, 24116, Germany|Mainz, 55101, Germany|Tuebingen, 72076, Germany|Jerusalem, 9112001, Israel|Petach-Tikva, 49100, Israel|Roma, Lazio, 00165, Italy|Genova, Liguria, 16147, Italy|Milano, Lombardia, 20133, Italy|Wroclaw, 50-367, Poland|Bratislava, 83340, Slovakia|Esplugues De Llobregas, Barcelona, 08950, Spain|Sevilla, 41013, Spain|Newcastle upon Tyne, NE1 4LP, United Kingdom|Sutton, SM2 5PT, United Kingdom","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01378975,A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases,https://clinicaltrials.gov/study/NCT01378975,YES,Malignant Melanoma,DRUG: Vemurafenib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Los Angeles, California, 90025, United States|Aurora, Colorado, 80045, United States|Tampa, Florida, 33612-9497, United States|Boston, Massachusetts, 02114, United States|Boston, Massachusetts, 02215, United States|Detroit, Michigan, 48201, United States|Rochester, Minnesota, 55905, United States|Saint Louis, Missouri, 63110, United States|Charlotte, North Carolina, 28204-2839, United States|Dallas, Texas, 75246, United States|Seattle, Washington, 98195, United States|Wentworthville, New South Wales, 2145, Australia|Melbourne, Victoria, 3002, Australia|Toronto, Ontario, M4N 3M5, Canada|Bordeaux, 33075, France|Nice, 06202, France|Paris, 75006, France|Paris, 75475, France|Essen, 45122, Germany|Frankfurt, 60596, Germany|Kiel, 24105, Germany|Mannheim, 68167, Germany|MÃ¼nster, 48157, Germany|TÃ¼bingen, 72076, Germany|Tel-Hashomer, 52621, Israel|Milano, Lombardia, 20133, Italy|Siena, Toscana, 53100, Italy|Amsterdam, 1066 CX, Netherlands|Groningen, 9713 GZ, Netherlands|Pamplona, Navarra, 31008, Spain|Barcelona, 08036, Spain|Madrid, 28046, Spain|Northwood, HA6 2RN, United Kingdom","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT05620290,MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer,https://clinicaltrials.gov/study/NCT05620290,NO,Melanoma,DRUG: Definity|DEVICE: Sonalleve Focused Ultrasound Device,ALL,"ADULT, OLDER_ADULT",PHASE1,"Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada","Principal Investigator : Dr. Gregory Czarnota, MD, Ph.D. , Sunnybrook Health Sciences Centre"
Melanoma,NCT03493230,Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT ),https://clinicaltrials.gov/study/NCT03493230,NO,Malignant Melanoma Stage IV|Malignant Melanoma Stage III,BIOLOGICAL: quantification of BRAF and NRAS mutation,ALL,"ADULT, OLDER_ADULT",,,"Principal Investigator : Elodie LONG-MIRA, MD , Centre Hospitalier Universitaire de Nice"
Melanoma,NCT01586195,"Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E",https://clinicaltrials.gov/study/NCT01586195,YES,Malignant Melanoma,DRUG: Vemurafenib,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Arizona Cancer Center, Tucson, Arizona, 85724, United States|UCSD Moores Cancer Center, La Jolla, California, 92093, United States|UCLA School of Medicine; Hematology/Oncology, Los Angeles, California, 90095, United States|The Angeles Clinic and Research Institute, Santa Monica Office, Santa Monica, California, 90025, United States|University of Colorado; Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Emory University; Winship Cancer Institute, Atlanta, Georgia, 30308, United States|Oncology Specialists, S.C., Park Ridge, Illinois, 60068, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|Atlantic Health System, Morristown, New Jersey, 07960, United States|Columbia University Medical Center, New York, New York, 10032, United States|Mid Ohio Onc Hematology Inc, Columbus, Ohio, 43219, United States|UPCI Cancer Institute; Cancer Pavillion, Pittsburgh, Pennsylvania, 15232, United States|Vanderbilt Univ Medical Ctr, Nashville, Tennessee, 37232, United States|Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas, 75246, United States","Study Director : Clinical Trials , Genentech, Inc."
Melanoma,NCT05628883,"Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma",https://clinicaltrials.gov/study/NCT05628883,NO,Metastatic Melanoma|Unresectable Melanoma|Acral Melanoma|Mucosal Melanoma|Cutaneous Melanoma|Ocular Melanoma|Uveal Melanoma|Iris Melanoma|Conjunctival Melanoma|Non-Cutaneous Melanoma,BIOLOGICAL: TBio-4101|DRUG: Cyclophosphamide|DRUG: Fludarabine|DRUG: Interleukin-2,ALL,"ADULT, OLDER_ADULT",PHASE1,"Moffitt Cancer Center, Tampa, Florida, 33612, United States","Principal Investigator : Amod Sarnaik, MD , Moffitt Cancer Center"
Melanoma,NCT00826995,Comparison of Video-Based Versus Written Patient Education on Melanoma,https://clinicaltrials.gov/study/NCT00826995,NO,Melanoma|Malignant Melanoma,OTHER: Patient Educational Materials,ALL,"ADULT, OLDER_ADULT",,"University of California Davis Department of Dermatology, Sacramento, California, 95816, United States","Principal Investigator : April W Armstrong, MD , University of California, Davis"
Melanoma,NCT00616564,Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma,https://clinicaltrials.gov/study/NCT00616564,NO,Malignant Melanoma,DRUG: GM-CSF,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Jose Lutzky, MD, Miami Beach, Florida, 33140, United States|David Lawson, MD, Atlanta, Georgia, 30322, United States","Study Chair : Jose Lutzky, M.D. , Mount Sinai Medical Center Miami Beach"
Melanoma,NCT01001299,A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01001299,YES,Malignant Melanoma,DRUG: Drug cocktail|DRUG: RO5185426,ALL,"ADULT, OLDER_ADULT",PHASE1,"UCLA - School of Medicine, Los Angeles, California, 90095, United States|Massachusetts General Hospital;Hematology/ Oncology, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Vanderbilt-Ingram Cancer Ctr, Nashville, Tennessee, 37232, United States|Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas, 75246, United States","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01006980,A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3),https://clinicaltrials.gov/study/NCT01006980,YES,Malignant Melanoma,DRUG: Vemurafenib|DRUG: Dacarbazine,ALL,"ADULT, OLDER_ADULT",PHASE3,"Birmingham, Alabama, 35243, United States|Tucson, Arizona, 85724, United States|Los Angeles, California, 90095-1752, United States|San Francisco, California, 94117, United States|Santa Monica, California, 90404, United States|Aurora, Colorado, 80045, United States|Atlanta, Georgia, 30322, United States|Indianapolis, Indiana, 46202, United States|Boston, Massachusetts, 02114, United States|Boston, Massachusetts, 02115, United States|Boston, Massachusetts, 02215, United States|Detroit, Michigan, 48201, United States|St Louis, Missouri, 63110, United States|New York, New York, 10016, United States|New York, New York, 10065, United States|Chapel Hill, North Carolina, 27514, United States|Portland, Oregon, 97213, United States|Philadelphia, Pennsylvania, 19104, United States|Pittsburgh, Pennsylvania, 15213-2584, United States|Nashville, Tennessee, 37203, United States|Nashville, Tennessee, 37232, United States|Dallas, Texas, 75246, United States|Salt Lake City, Utah, 84112, United States|Seattle, Washington, 98109, United States|Brisbane, 4006, Australia|Frankston, 3199, Australia|Malvern, 3144, Australia|Melbourne, 3002, Australia|Melbourne, 3128, Australia|Nedlands, 6009, Australia|Newcastle, 2310, Australia|St Leonards, 2065, Australia|Sydney, 2060, Australia|Westmead, 2145, Australia|Woolloongabba, 4102, Australia|Edmonton, Alberta, T5J 3N4, Canada|Winnipeg, Manitoba, R2H 2A6, Canada|Hamilton, Ontario, L8V 5C2, Canada|Toronto, Ontario, M4N 3M5, Canada|Toronto, Ontario, M5G 2M9, Canada|Montreal, Quebec, H3A 1A1, Canada|Montreal, Quebec, H3T 1E2, Canada|Quebec City, Quebec, G1R 2J6, Canada|Bordeaux, 33075, France|Lille, 59037, France|Marseille, 13005, France|Montpellier, 34298, France|Nantes, 44093, France|Nice, 06202, France|Paris, 75010, France|Pierre Benite, 69495, France|Rouen, 76031, France|Villejuif, 94805, France|Buxtehude, 21614, Germany|Dresden, 01307, Germany|Erfurt, 99089, Germany|Essen, 45122, Germany|Frankfurt, 60596, Germany|Hannover, 30449, Germany|Heidelberg, 69120, Germany|Jena, 07743, Germany|Kiel, 24105, Germany|Koeln, 50924, Germany|Leipzig, 04103, Germany|Mainz, 55131, Germany|Minden, 32429, Germany|Muenchen, 81377, Germany|Regensburg, 93053, Germany|Tuebingen, 72076, Germany|Wuerzburg, 80337, Germany|Jerusalem, 91200, Israel|Ramat Gan, 52621, Israel|Tel Aviv, 64239, Israel|Bari, 70124, Italy|Genova, 16132, Italy|Milano, 20133, Italy|Milano, 20141, Italy|Milano, 20162, Italy|Napoli, 80131, Italy|Roma, 00158, Italy|Siena, 53100, Italy|Amsterdam, 1066 CX, Netherlands|Amsterdam, 1081 HV, Netherlands|Groningen, 9713 GZ, Netherlands|Auckland, New Zealand|Dunedin, 9001, New Zealand|Hamilton, 2001, New Zealand|Palmerston North, New Zealand|Wellington, 6021, New Zealand|Linkoeping, 58185, Sweden|Lund, 22185, Sweden|Stockholm, 17176, Sweden|UmeÃ¥, Sweden|Uppsala, 75185, Sweden|Lausanne, 1011, Switzerland|ZÃ¼rich, 8091, Switzerland|Cambridge, CB2 2QH, United Kingdom|Edinburgh, EH4 2XU, United Kingdom|Glasgow, G12 0YN, United Kingdom|London, E1 1BB, United Kingdom|London, NW3 2QG, United Kingdom|London, SE1 9RT, United Kingdom|London, SW3 3JJ, United Kingdom|Manchester, M20 4BX, United Kingdom|Newcastle Upon Tyne, NE7 7DN, United Kingdom|Northwood, HA6 2RN, United Kingdom|Nottingham, NG5 1PB, United Kingdom|Oxford, OX3 7LJ, United Kingdom|Southampton, SO16 6YD, United Kingdom|Sutton, SM2 5PT, United Kingdom|Swansea, SA2 8QA, United Kingdom","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT01271803,A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01271803,YES,Malignant Melanoma,DRUG: Cobimetinib|DRUG: vemurafenib,ALL,"ADULT, OLDER_ADULT",PHASE1,"UCLA Department of Medicine, Los Angeles, California, 90024, United States|University of California at San Francisco, San Francisco, California, 94115, United States|The Angeles Clinic and Research Institute, Santa Monica Office, Santa Monica, California, 90025, United States|University of Colorado; Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|University of Chicago, Chicago, Illinois, 60637, United States|Indiana University - Department of Medicine, Division of Gastroenterology/Hepatology, Indianapolis, Indiana, 46202, United States|Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building, Detroit, Michigan, 48201, United States|New York University Medical Center, New York, New York, 10036, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Peter Maccallum Cancer Institute; Medical Oncology, Melbourne, Victoria, 3000, Australia","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT02938299,Neoadjuvant L19IL2/L19TNF- Pivotal Study,https://clinicaltrials.gov/study/NCT02938299,NO,Malignant Melanoma,DRUG: L19IL2 + L19TNF|PROCEDURE: Surgery,ALL,"ADULT, OLDER_ADULT",PHASE3,"HÃ´pital de la Timone, Marseille, 13 005, France|HÃ´pital Universitaire de Nantes, Nantes, 44 093, France|Institut Gustave Roussy, Villejuif, 94 805, France|Klinik fÃ¼r Dermatologie und Allergologie, UniversitÃ¤tsklinikum Augsburg, Augsburg, 86156, Germany|CharitÃ© Campus Mitte (CCM), Berlin, D-10117, Germany|UniversitÃ¤tsklinikum Carl Gustav Carus an der Technischen UniversitÃ¤t Dresden, Dresden, D-01307, Germany|Klinik fÃ¼r Dermatologie, Medizinische FakultÃ¤t UniversitÃ¤tsklinikum Essen, Essen, 45122, Germany|Hauttumorzentrum Hannover (HTZH), Hannover, D-30625, Germany|Heidelberg University Hospital, Heidelberg, D-69120, Germany|Kiel University Hospital, Kiel, D-24105, Germany|Leipzig University Hospital, Leipzig, D-04103, Germany|Klinik und Polyklinik fÃ¼r Dermatologie, UniversitÃ¤tsklinikum Regensburg, Regensburg, 93042, Germany|TÃ¼bingen University Hospital, TÃ¼bingen, D-72076, Germany|IRCCS A.O.U. San Martino - IST, Genova, 16132, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Naples, 80131, Italy|Istituto Oncologico Veneto, IRCCS, Padova, 35128, Italy|AOU Senese, Siena, 53100, Italy|ASUGI Trieste, Trieste, 34128, Italy|AOU CittÃ della Salute e della Scienza, Turin, 10126, Italy|Medgart Centrum Medyczne, GdaÅ„sk, 80-980, Poland|Centrum Onkologii-Instytut im. Marii SkÅ‚odowskiej-Curie Warszawa, Warsaw, 02-781, Poland","Principal Investigator : Katharina C. KÃ¤hler, MD , University Hospital Schleswig-Holstein, Campus Kiel Principal Investigator : Mario Santinami, MD , Istituto Nazionale Tumori Milano Principal Investigator : Piotr Rutkowski, MD , Centrum Onkologii-Instytut im. Marii SkÅ‚odowskiej-Curie Warszawa Principal Investigator : Caroline Robert, MD , Gustave Roussy, Cancer Campus, Grand Paris"
Melanoma,NCT05900102,EVALUATING THE CURRENT STANDARD OF CARE FOR PATIENTS DIAGNOSED WITH MALIGNANT MELANOMA OF THE HEAD AND NECK - ACCESS TO STAGING AND SURGICAL TREATMENT,https://clinicaltrials.gov/study/NCT05900102,NO,Melanoma (Skin)|Melanoma,,ALL,"ADULT, OLDER_ADULT",,,
Melanoma,NCT04293289,Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma,https://clinicaltrials.gov/study/NCT04293289,NO,Malignant Melanoma|Angiosarcoma,"OTHER: CICS-1 (investigational device),SPM-011(investigational drug)",ALL,"ADULT, OLDER_ADULT",,"National Cancer Center Hospital, Chuo Ku, Tokyo, 104-0045, Japan",Stella Pharma Corporation
Melanoma,NCT00204607,Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients,https://clinicaltrials.gov/study/NCT00204607,NO,Malignant Melanoma,BIOLOGICAL: mRNA|DRUG: GM-CSF s.c.,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Department of Dermatology, University of TÃ¼bingen, TÃ¼bingen, 72076, Germany","Principal Investigator : Claus Garbe, Prof. Dr. , University of Tuebingen, Department of dermatology"
Melanoma,NCT02143999,An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma,https://clinicaltrials.gov/study/NCT02143999,NO,Malignant Melanoma,,ALL,"ADULT, OLDER_ADULT",,"Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica, Chieti, Abruzzo, 66100, Italy|IRCCS IST. Tumori Fondaz. Pascale; S.C. Oncologia Medica,Melanoma,Immunoterapia E Terapie Innovative, Napoli, Campania, 80131, Italy|Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; UnitÃ Operativa Oncologia Medica, Bologna, Emilia-Romagna, 40138, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST);U.O. di Immunoterapia, Meldola, Emilia-Romagna, 47014, Italy|Arcispedale Santa Maria Nuova; Oncologia, Reggio Emilia, Emilia-Romagna, 42100, Italy|Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica, Roma, Lazio, 00128, Italy|Policlinico Umberto i di Roma; dip. Scienze Radiologiche, Oncologiche, Anatomopatologiche, Roma, Lazio, 00161, Italy|IRCCS Istituto Nazionale Per La Ricerca Sul Cancro (IST); Oncologia Medica A, Genova, Liguria, 16132, Italy|Asst Papa Giovanni XXIII; Oncologia Medica, Bergamo, Lombardia, 24128, Italy|Az. Osp. Spedali Civili; Divisione Di Oncologia - Iii Medicina, Brescia, Lombardia, 25123, Italy|Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milano, Lombardia, 20133, Italy|Irccs Istituto Europeo Di Oncologia (Ieo); Unita' Di Ricerca Traslazionale Del Melanoma, Milano, Lombardia, 20141, Italy|Fondazione Del Piemonte Per L'oncologia IRCC Di Candiolo, Candiolo, Piemonte, 10060, Italy|Azienda Sanitaria Ospedaliera s. Croce e Carle; Oncologia Medica, Cuneo, Piemonte, 12100, Italy|Ospedale Maggiore Della Carita; Oncologia Medica, Novara, Piemonte, 28100, Italy|Azienda Ospedaliera CittÃ della Salute e della Scienza di Torino, Torino, Piemonte, 10126, Italy|Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari, Bari, Puglia, 70124, Italy|Policlinico P. Giaccone; Istituto Di Oncologia, Clinica Medica 1, Palermo, Sicilia, 90127, Italy|Ospedale S. Vincenzo; Oncologia Medica, Taormina, Sicilia, 98030, Italy|Azienda Sanitaria di Firenze Presidio Palagi - SC Dermatologia II e Fisioterapia Dermatologica, Firenze, Toscana, 50125, Italy|Azlenda Ospendaliero-Universitaria Pisana; C.O. Oncologia 2, Pisa, Toscana, 56100, Italy|Azienda Ospedaliera Universitaria Senese, U.O.C. Immunoterapia Oncologica, Siena, Toscana, 53100, Italy|Azienda Ospedaliero Universitaria di Ferrara - U.O. Di Oncologia, Cona (FE), Veneto, 44124, Italy|Azienda Ospedaliera di Verona-Policlinico G.B. Rossi; Oncologia Medica, Verona, Veneto, 37134, Italy","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT02296996,Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients,https://clinicaltrials.gov/study/NCT02296996,NO,Malignant Melanoma,DRUG: Dabrafenib + Trametinib,ALL,"ADULT, OLDER_ADULT",PHASE2,"UZ Brussel, Brussels, 1090, Belgium","Principal Investigator : Neyns Bart, MD, PhD , Universitair Ziekenhuis Brussel"
Melanoma,NCT00204516,Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens,https://clinicaltrials.gov/study/NCT00204516,NO,Malignant Melanoma,BIOLOGICAL: mRNA coding for melanoma associated antigens|DRUG: GM-CSF,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Department of Dermatology, University of Tuebingen, Tuebingen, 72076, Germany","Principal Investigator : Claus Garbe, Prof. Dr. , University of Tuebingen, Department of Dermatology"
Melanoma,NCT01264380,A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic Melanoma,https://clinicaltrials.gov/study/NCT01264380,YES,Malignant Melanoma,DRUG: RO5185426|DRUG: RO5185426|DRUG: RO5185426,ALL,"ADULT, OLDER_ADULT",PHASE1,"La Jolla, California, 92037, United States|Los Angeles, California, 90095-1752, United States|San Francisco, California, 94115-1705, United States|Aurora, Colorado, 80045, United States|Indianapolis, Indiana, 46202, United States|Iowa City, Iowa, 52242, United States|Lebanon, New Hampshire, 03756, United States|Charleston, South Carolina, 29425, United States|Nashville, Tennessee, 37232, United States|Dallas, Texas, 75246, United States","Study Director : Clinical Trials , Hoffmann-La Roche"
Melanoma,NCT00966173,International Melanoma Algorithm Training Study - IMATS,https://clinicaltrials.gov/study/NCT00966173,NO,Malignant Melanoma,DEVICE: SciBase III Electrical Impedance Spectrometer,ALL,"ADULT, OLDER_ADULT",,"Sahlgrenska University Hospital, Dpt. of Dermatology, Gothenburg, 41345, Sweden",SciBase AB
Melanoma,NCT04375527,Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma,https://clinicaltrials.gov/study/NCT04375527,NO,Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Locally Advanced Cutaneous Melanoma|Metastatic Cutaneous Melanoma|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Unresectable Cutaneous Melanoma,DRUG: Binimetinib|BIOLOGICAL: Nivolumab|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of California at Los Angeles, Los Angeles, California, 90095, United States","Principal Investigator : Roger Lo, MD , UCLA / Jonsson Comprehensive Cancer Center"
Melanoma,NCT06424626,A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma,https://clinicaltrials.gov/study/NCT06424626,NO,Melanoma|Mucosal Melanoma|Metastatic Melanoma,DRUG: AK104+Axitinib|DRUG: AK112+Axitinib,ALL,"ADULT, OLDER_ADULT",PHASE1,"Beijing Cancer Hospital, Beijing, 100142, China","Principal Investigator : Jun Guo, MD , Peking University Cancer Hospital & Institute"
Melanoma,NCT01444560,"miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi",https://clinicaltrials.gov/study/NCT01444560,NO,Cutaneous Melanoma|Nevi,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, NRW, 44791, Germany","Study Director : Falk G Bechara, PD Dr. , Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum"
Melanoma,NCT05645484,The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma,https://clinicaltrials.gov/study/NCT05645484,NO,Melanoma,DRUG: 18F-PFPN|DRUG: 18F-FDG,ALL,"ADULT, OLDER_ADULT",,"China, Hubei Province, Wuhan, Hubei, 430022, China","Study Director : Xiaoli Lan, PhD , Wuhan Union Hospital, China"
Melanoma,NCT04460053,Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion.,https://clinicaltrials.gov/study/NCT04460053,NO,Malignant Melanoma,PROCEDURE: Neurofilament light protein measurement in Isolated limb perfused patients,ALL,"ADULT, OLDER_ADULT",,"Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden","Principal Investigator : Roger Olofsson Bagge , Sahlgrenska University Hospital, Department of Sugery"
Melanoma,NCT00462423,"Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study",https://clinicaltrials.gov/study/NCT00462423,YES,Metastatic Malignant Melanoma,DRUG: Avastin|DRUG: Abraxane,ALL,"ADULT, OLDER_ADULT",PHASE2,"Northern California Melanoma Center, San Francisco, California, 94117, United States|The Angeles Clinic and Research Institute, Santa Monica, California, 90404, United States","Principal Investigator : Lynn E. Spitler, MD , Northern California Melanoma Center"
Melanoma,NCT01559818,A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001,https://clinicaltrials.gov/study/NCT01559818,YES,Malignant Melanoma,BIOLOGICAL: IMM-101,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"St Georges University of London, London, United Kingdom","Principal Investigator : Alberto Fusi, Dr , St George's, University of London"
Melanoma,NCT04364230,Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma),https://clinicaltrials.gov/study/NCT04364230,NO,Melanoma|Ocular Melanoma|Uveal Melanoma,DRUG: 6MHP|DRUG: NeoAg-mBRAF|DRUG: PolyICLC|DRUG: CDX-1140,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195, United States|University of Virginia, Charlottesville, Virginia, 22908, United States","Principal Investigator : Craig L. Slingluff, Jr., MD , University of Virginia"
Melanoma,NCT03325101,Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery,https://clinicaltrials.gov/study/NCT03325101,NO,Stage III Cutaneous Melanoma AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7,PROCEDURE: Cryosurgery|BIOLOGICAL: Pembrolizumab|PROCEDURE: Pheresis|BIOLOGICAL: Therapeutic Autologous Dendritic Cells,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Mayo Clinic, Rochester, Minnesota, 55905, United States","Principal Investigator : Matthew S. Block, M.D., Ph.D. , Mayo Clinic"
Melanoma,NCT02574533,Pilot Study of Vigilâ„¢ + Pembrolizumab for Advanced Melanoma,https://clinicaltrials.gov/study/NCT02574533,NO,Melanoma Recurrent|Malignant Melanoma|Melanoma,BIOLOGICAL: Vigil|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,"Texas Oncology P.A., Texas Cancer Center, Abilene, Texas, 79606, United States|Mary Crowley Medical Research Centers, Dallas, Texas, 75230, United States|Cancer Care Northwest, Spokane, Washington, 99202, United States","Study Director : Luisa Manning, MD , Gradalis, Inc."
Melanoma,NCT03409419,PET Imaging of the Immune System Using Analog Probes,https://clinicaltrials.gov/study/NCT03409419,NO,Malignant Melanoma,DRUG: [18F] CFA,ALL,"ADULT, OLDER_ADULT",,"University of California, Los Angeles, Los Angeles, California, 90095, United States","Principal Investigator : Antoni Ribas, M.D. , UCLA/Jonsson Comprehensive Cancer Center"
Melanoma,NCT04548817,Neurocutaneous Melanocytosis Registry,https://clinicaltrials.gov/study/NCT04548817,NO,Cutaneous Melanocytic Neoplasm|Large Cutaneous Melanocytic Nevi|Neurocutaneous Melanocytosis,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Boston Children's Hospital (Data Analysis Only), Boston, Massachusetts, 02115, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, 10065, United States","Principal Investigator : Yasmin Khakoo, MD , Memorial Sloan Kettering Cancer Center"
Melanoma,NCT01482260,Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma,https://clinicaltrials.gov/study/NCT01482260,NO,Cutaneous Malignant Melanoma,PROCEDURE: Biopsy,ALL,"CHILD, ADULT, OLDER_ADULT",,"Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, NRW, 44791, Germany","Study Director : Falk G Bechara, PD Dr. , Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum Study Chair : Peter Altmeyer, Prof. Dr. , Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum"
Melanoma,NCT03677739,Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families,https://clinicaltrials.gov/study/NCT03677739,NO,Clinical Stage 0 Cutaneous Melanoma AJCC v8|Clinical Stage I Cutaneous Melanoma AJCC v8|Clinical Stage IA Cutaneous Melanoma AJCC v8|Clinical Stage IB Cutaneous Melanoma AJCC v8|Clinical Stage II Cutaneous Melanoma AJCC v8|Clinical Stage IIA Cutaneous Melanoma AJCC v8|Clinical Stage IIB Cutaneous Melanoma AJCC v8|Clinical Stage IIC Cutaneous Melanoma AJCC v8|Clinical Stage III Cutaneous Melanoma AJCC v8|First Degree Relative|Pathologic Stage 0 Cutaneous Melanoma AJCC v8|Pathologic Stage I Cutaneous Melanoma AJCC v8|Pathologic Stage IA Cutaneous Melanoma AJCC v8|Pathologic Stage IB Cutaneous Melanoma AJCC v8|Pathologic Stage II Cutaneous Melanoma AJCC v8|Pathologic Stage IIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIC Cutaneous Melanoma AJCC v8|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,OTHER: Informational Intervention|OTHER: Informational Intervention|OTHER: Survey Administration,ALL,"ADULT, OLDER_ADULT",,"Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States","Principal Investigator : Sharon Manne , Rutgers Cancer Institute of New Jersey"
Melanoma,NCT02501551,"Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy",https://clinicaltrials.gov/study/NCT02501551,NO,Melanoma,DRUG: regorafenib,ALL,"ADULT, OLDER_ADULT",PHASE2,"Severance Hospital, Yonsei University Health System, Seoul, 120-752, Korea, Republic of",Yonsei University